<SEC-DOCUMENT>0000886163-21-000069.txt : 20210506
<SEC-HEADER>0000886163-21-000069.hdr.sgml : 20210506
<ACCEPTANCE-DATETIME>20210506160725
ACCESSION NUMBER:		0000886163-21-000069
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		59
CONFORMED PERIOD OF REPORT:	20210331
FILED AS OF DATE:		20210506
DATE AS OF CHANGE:		20210506

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIGAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000886163
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				770160744
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33093
		FILM NUMBER:		21897748

	BUSINESS ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-550-7500

	MAIL ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>lgnd-20210331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:f42e6ea9-4959-4941-8454-5f1ec5bc67fa,g:c4690a82-fe68-4d49-b4c9-c600693120e1,d:38905116b7634694b27917e6ac2a9ef4--><html xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:lgnd="http://www.ligand.com/20210331" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:srt="http://fasb.org/srt/2020-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lgnd-20210331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80L2ZyYWc6ZjRkYzI4ODc5ZGQ2NDAzOWIwMmRiYjBmZWIzYjRkMzQvdGFibGU6MzczMWM5ZmIxZDc1NGFkMThiZDJkZWE4NWNkZDQyMDcvdGFibGVyYW5nZTozNzMxYzlmYjFkNzU0YWQxOGJkMmRlYTg1Y2RkNDIwN18yLTEtMS0xLTA_f4f0e53a-adc5-46a5-926f-bb7b5a7dd085">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80L2ZyYWc6ZjRkYzI4ODc5ZGQ2NDAzOWIwMmRiYjBmZWIzYjRkMzQvdGFibGU6MzczMWM5ZmIxZDc1NGFkMThiZDJkZWE4NWNkZDQyMDcvdGFibGVyYW5nZTozNzMxYzlmYjFkNzU0YWQxOGJkMmRlYTg1Y2RkNDIwN18zLTEtMS0xLTA_e8dca035-79cd-47aa-a019-90908c3c676c">2021</ix:nonNumeric><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80L2ZyYWc6ZjRkYzI4ODc5ZGQ2NDAzOWIwMmRiYjBmZWIzYjRkMzQvdGFibGU6MzczMWM5ZmIxZDc1NGFkMThiZDJkZWE4NWNkZDQyMDcvdGFibGVyYW5nZTozNzMxYzlmYjFkNzU0YWQxOGJkMmRlYTg1Y2RkNDIwN180LTEtMS0xLTA_8e8b9d48-81b0-4b81-9e91-629a8e8ed6fd">Q1</ix:nonNumeric><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80L2ZyYWc6ZjRkYzI4ODc5ZGQ2NDAzOWIwMmRiYjBmZWIzYjRkMzQvdGFibGU6MzczMWM5ZmIxZDc1NGFkMThiZDJkZWE4NWNkZDQyMDcvdGFibGVyYW5nZTozNzMxYzlmYjFkNzU0YWQxOGJkMmRlYTg1Y2RkNDIwN181LTEtMS0xLTcy_cc91be27-dbaa-40fd-98c2-af6a2a40d0ed">0000886163</ix:nonNumeric><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80L2ZyYWc6ZjRkYzI4ODc5ZGQ2NDAzOWIwMmRiYjBmZWIzYjRkMzQvdGFibGU6MzczMWM5ZmIxZDc1NGFkMThiZDJkZWE4NWNkZDQyMDcvdGFibGVyYW5nZTozNzMxYzlmYjFkNzU0YWQxOGJkMmRlYTg1Y2RkNDIwN182LTEtMS0xLTYz_8e0506fe-f1d6-4cb8-b323-a2c224fc53ff">December 31</ix:nonNumeric><ix:nonNumeric contextRef="i51134d944b5f4636b4d6adfef00022a2_D20190101-20191231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfOS0wLTEtMS04OTI_e57440bd-fe3a-45d5-9ac9-1c064d8b653f">us-gaap:AccountingStandardsUpdate201613Member</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i73bb70b7323d4144a6e75d3e406c405c_D20180501-20180531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80Ni9mcmFnOjVjY2RiNTQ4NjcyODQyYzVhNzM0OWQ1YzYxNjkyYzA3L3RhYmxlOjEwNmE5MTU0M2Q3ZTQxNjc4NDdkNWZhMWYyZGJkNGEwL3RhYmxlcmFuZ2U6MTA2YTkxNTQzZDdlNDE2Nzg0N2Q1ZmExZjJkYmQ0YTBfMi0xLTEtMS0w_bd89a13a-0d6a-44a3-92ae-69f3488ca53f">0.0040244</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lgnd-20210331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i05707ba532fc425c921e61b0e8954f64_I20210503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-05-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i20dcdca84df1452281e6d47bd0f24185_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i495e15f4221043e8829bac34d84a0a92_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ie30239110ac54ae2af1d194e9c6384f4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e4b63fffd544d8c9290215bd3714192_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f9ffb7664b0411f8db3b6b38d6632e4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6be2d05e46c04f22a00605da2833d1da_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14b88249e38e42929cf58c0afff44f7c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib77e9a47601246a2acde91f6d3baa812_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15757d268ab84dc7a0e63e4c840a5172_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d37dcb59e8c407fbccb9bb97f5e380e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib506a1ffb8e046009e08fd19fcfe4209_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb9abae5afa744f0abd29ca447cf6dd6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21e3b58e4ca240c286f59fb2568bf37e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c6105b1f6594c02becde6c91bfe9eb1_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice9d2fa48f71444f8320d849c38a5579_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03da71fe5d974403b52f069f014e7fd2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ce6ddc6311c4def9385fa6d58b64327_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3eb7fefbebf14db2b9bee4226ca7c5e7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida90f84c04b649199b1a0d40a08f4c81_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3baac2718ea47419924d27ce1598c17_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie09c209670384c35b1d40e0d01cdef82_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i684becfb80a0442d9f4781a55aa08632_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i659c16b4cc3546ea8362ee2a92ecabe7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc903f14f4ef431ebf2bb9b5b6d868be_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51e4f49b1fdf4839b077e613a7899628_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieadcdc474507437085760e44dd5d5c01_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13ac40a9f8fa48ad99e9e26c593ecb34_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iece8fdee289d4aa8b8d7e5137317a46e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51134d944b5f4636b4d6adfef00022a2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if91e400ca45d4fb580a3202300f06470_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib27ffe698d824d4bb4ded2bed63e9c41_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09692c0a1c274da79fdc91e6f7c6284e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc4a3c6bfc704ae6bcbce2daf092ade2_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdec2dda7ca64a33ad8d5df2a891c250_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i544dd77eaedb4f5a956d59e518b4e511_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbbd2509899b45a8a4cb864e24eb6fca_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdf27ddbb0974314af1bf955199c9ad2_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70e6045ea57e4960b5e7b991ff6afe59_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i141de7606bb14beea82d45802f93d383_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4196bfc37550432080d7f0d6eec3b8d5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43bf79f5a943475489db1bfa57aa7668_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i242bcf58c1cd4fcfa0c2d36e1fe47f5c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd88764b91554104994dd396befa8270_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib71204e5781b46798722ee98c6925ade_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c38be1b284c4082985f73fc8fd4cb08_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic015ad72c3c0416383db07b48a5a7c6a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8df2708d62174fbdac6fecdf1774ab15_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd0f3e11676d4c139d4f33ff5e608d98_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i098bf91f61f44dc08cae022ea07af921_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i707023875ea742a58c7c82670518aa3a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbb090f086294a258eff6658c99e6ab0_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47e88f0429c44134b883d6f3aa820b25_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a07ebdd562e411fae6b15bb21f8c1aa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24b1ae2706284cdca4eb23d9915a4450_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c916d897e674db5919221cdca2f97bb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7ca3f45fb8d4984b3709f858a5d4195_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9eb656aa6e5479a85a382cc47a8eca1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a8c5e7437834c46ae9735a7aaa4148c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cd22ab765384cccacfc57e8e1996cc2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27ccac3b42614165a6aa9e91ee7ff005_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if16401e5b6d848aea59ba13c03311074_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87abf73938904ca5aa12b57c61dab1a0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bf3ec58e21145b6b4ceb58e80ec79b8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d3c8187465b443d8f77beeb3adb7d56_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i680ece1eaa8f4e9e96ce0f42882bf0ce_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib28fef4680854a929dbf60cedeb06434_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18f2c42543b54aeaab387d94848006f1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9b9c500f9c64c18aa188576147e659c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0c8207a04074c06b323ed60e1b6a82d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i992a781875754f6cafea588cdb51c0ca_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24b65a2994c74dc1966ff120cfabeae7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0997448e200d4b4ca09ddc4917d0b9fb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="position"><xbrli:measure>lgnd:position</xbrli:measure></xbrli:unit><xbrli:context id="i7852648236234a7383fffb89802800ca_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ead48471b4147b89d513734d4b371ce_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7203c2e57ce64b9499cf15be8da138c9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5b27dc5beda4d28a2d31e5f523528e7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd0a1696112f4034b165e99d7e54c9c0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c9320f5f705481e843a64fa98520fce_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3be05d22f1714924ba3f177f26a1f2ad_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6708118507a499aba0e32aaf3cbf208_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5726bdc386542a4a8883e9ff2d6dbac_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7981ffd8dd3442db85faa0971ba2b0f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i990fc430839b439297429383d8dc1565_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd41f0958aea453c93d67393583f4114_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib164760a00e846d5b34f96b078179fad_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if664c4e0370e4eecb98b57e6559c8596_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i286a8bb93953439fafa3f00769457019_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d642c075bb94ad9924379a085bcce17_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09abab2b25044ad981b26743b386f8ed_I20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb80e938ceac4acba68f8190bbb48240_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20687aac1929409b8e8ba72ed696b358_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dbd1ffbbe68420b892aebb33efbf91e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01775962d3284134ba883acf9233e929_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if96bbf53f57741718a23af11bbf99850_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72938e42d49d4e7eb47d38ac3ea3ef3c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70472c97b924411e836f34d9300a0722_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01ac0fd2b84c4fc5b18e59e48f25cc79_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4dc6712b5fe940d29478311fd3e7cffd_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadf9c6df9fa44ab3b0c1c35c985251b4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21a101cfd24747168bf94b313b3708e4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7f4f7589d8c492484b84f28687479b4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i676b57f3d66941bbb97cc26113e1e806_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i860855786f834ea394e0c7e66f585b07_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9054c6008288417ea8d10ca0540acb93_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e0fd90b4eb14c3eb7f87756026effcf_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94a7f3facc544380b14212b1d50f599d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc3c971711634a419850f39be2cfa217_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5f5f82fc4c44419894bfd3fe856e02b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14699c2d32754f1197a391489d15ff48_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e8d1f401b4d4013ac32b2787dcfde55_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0daa67408a4451890054460225dfe05_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53101502568a44758ee1969b8fdf9b5f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if91f9465b6884e95a7b42fca92d3ff5d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6913dd8993464fe78ba52964658dba31_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f881c4d7c174319a38f46630210dcbd_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6087cecae97d4d2abd6e060d610ce948_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77031116cff2427bb586198ff9e95cb4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f9b50f07b984d18a9dbe45a0861f8a5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7364700da439492b9c9c4b04d2cd984f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idee4babfe9e4448e9679afd11c8e1932_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06d16d86c2ee446498927c381c54d77a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19ca28155cef4fd5b5524f954cccaab7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40b8100a5b2440b48556561a4ba1e0d1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i109de96646db44268497efcc2f95bdc9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13a03a90dd824a3e802cc74fbc6ef67a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc817baab77c490b9eb5d576b2ff57d9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if692e5a3f16a4775a9bf2a0e13049d43_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c91fdccad734cd3acfb28a7aaee6b08_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39cdc2145c9b43dbb9e35f9deff11202_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5621884f55514f528b5732d922eb7ddd_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14f70b29c1fe4ff7aba75d3e69a1823a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b9807f967ff4cf582d5e8a8fece80fb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79f0b8beb45a4a4bbba8ce8211ecd94e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0a9f236332f4dba8a23b8e155f3a30f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71d6fc626ce745feb5e33003ac131708_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1d6ac0f98304bd8a2522d46969847b6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i833b7fb3b5b14e4e8b4ebb0909d05a2c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fddbe170634491dbd21d99d8b590f70_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4160bae3ab043dbb32c58acc74cd048_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6079969ef2d54e55ad4b585ec4ec53b9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f6a3b9c3c7b42919ab58c0e2df5585a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id388d63d20d04cfabec6273b9266aa22_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id897ba84812c48c2a65b9776129298aa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i357b9497652046d0aba3cbdc8518d7b4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife81c045c5a444e09b2d8bc249fece59_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i931f4e016c724c36974f1c1989897bd3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a4a9dc8a3eb408d89b937d07499587e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2078f46e4a554de986254804e81be7c6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8ff9c1d2a4e40b3a67f944c849a2bd2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie33ba4dc377840ee882fdaddd0d69bb0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia63b7b49beba4f378566a8be00c1898d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib65896a541534edc814e839cea969d72_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i820ccc6258144fb897101140c8a14d81_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c972363fdac4ab6a767c041ae940266_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3c2d8108f0346fea380bd0c9a9a1e5a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i261414f831ba4e1aac8a6551f971d92e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43ca9b3cd64f442287f5c9dbd74d520d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bc8c1e565e1493fa5a29d2c0d691486_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0660fc90350f4c508461c189c1838ea0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id89615ba04ac4f9f94097b92892cdf6f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia210fcf0a4934eb995df10b0db2c9c88_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f9eb705d8b94a9283d4c25e1ece7d11_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if977d0d8bf974b6fa76de0a2e644188d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5b8469bd6b24519a53e1cba447d8c57_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf6b5d5d9635440999d3e164431442cc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief120523936f41ed9556d9c5fbe600ad_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6205bd153ad465cbe32e8557a90f2df_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9214e2b7471f4a8588e5b99aada1a660_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ba8a0cf524d4e13b76c6e92d9cf97bf_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4294ac1f67eb491c96a6a8cce49fcabe_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92495438f1b146f898c4e64490283810_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8eb4e94ac6604758b1ea1704401c3d58_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbad4460fcf648928ffdb191dbdb6530_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03dd9ae0aed74d5a904172437cf8186f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58a521fe18574d6e968798b4c1586455_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ab71e0fd4724a4db71bf93a6413a975_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee481251a6b54158be7b4a7effbb8c67_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic79acce6117446459676d52e173a1126_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i943f22467f954f6993644f529795f102_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3b0aff995404ab8acd400501adf43bd_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a5a184f056f42c4b443fbae9b3fba2b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5cd59ec89e943c8bddbe705cb6e15f6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i657fb3d5faae4a9990079266a0c01a60_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62031fdd8c3645a7b3c2189805b7a8cb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="contingent_value_right"><xbrli:measure>lgnd:contingent_value_right</xbrli:measure></xbrli:unit><xbrli:context id="i972be18486384106a14259204b8f719b_D20100101-20100131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-01-01</xbrli:startDate><xbrli:endDate>2010-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="contingent_value_right_series"><xbrli:measure>lgnd:contingent_value_right_series</xbrli:measure></xbrli:unit><xbrli:context id="idce9b211fa9d42818fdc3f8ff61affb4_D20100101-20100131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2010-01-01</xbrli:startDate><xbrli:endDate>2010-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic427fd87f48e4f049d21351088ee3bc2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i372f6d3fb38e43cd82744ef34999bd0a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:Phase3ClinicalTrialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id28435ac625f4e8f8e07977537c41fef_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3739dfe7d8c541718c9f50a133133136_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife201f82dfa94172abde90879f18f167_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4464b8371b004313b6607d086dec25b2_D20201001-20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia37942031dbb40cf81304422e5ff426c_I20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="pure"><xbrli:measure>lgnd:pure</xbrli:measure></xbrli:unit><xbrli:context id="i4243023110cb4a6ca65bf4c4c5d8878f_I20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc64562484fc4d23b336ec8ed3fd3947_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cc2592d38964cbb996dc31f81ff2c9a_I20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1708e500e932475f92536d18e3d099b5_I20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6037a4915521428790837dff8096a89d_D20201001-20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ca2eca402bd48499cd198b19a231468_D20201001-20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie98b3c08f75e4b61b0c8b64a85133b0c_D20201001-20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbe299c7430a4957bb40d8a3d730a73e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07f491d71a074d669d852a83c5014e96_D20200909-20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-09</xbrli:startDate><xbrli:endDate>2020-09-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ec4f52c7742457e9f9a93bcedf7c43a_I20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:ContingentValueRightForInternalResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a4df23c7dc04ee1b5aa7abe12902388_I20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:ContingentValueRightOnProductRevenuesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb5b853ff6c948499b25bc488e171d3a_D20200909-20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:ContingentValueRightOnProductRevenuesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-09</xbrli:startDate><xbrli:endDate>2020-09-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie01bfe015cdf4254866d1eb4e646cb8b_I20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f8e586c985a4f67aa1ae11d2c8cc48d_I20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if95207dfe47f4c9e9c0f43e8b93447ea_D20200909-20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-09</xbrli:startDate><xbrli:endDate>2020-09-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1211f6f3075428083696490bd9e932a_D20200908-20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-08</xbrli:startDate><xbrli:endDate>2020-09-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddbb15ce39fa4680a70e166c8f3a4d15_I20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia183c7bcb9ba4693bb9d0a6d905ad0d1_I20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:MilestonePaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d532605276c48f3a3a254c0df053fa9_D20200908-20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:MilestonePaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-08</xbrli:startDate><xbrli:endDate>2020-09-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8d7bcd2b95d4fdda48d8864d7b7c451_I20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib568c9bfd11849cba166b146a4953fc6_I20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4acaa60d54747379cca9601b1b5b67e_D20200908-20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-08</xbrli:startDate><xbrli:endDate>2020-09-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e4887e0977c47cd936f0690fcc58a01_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icabfd60e6d5c4e879961167fb0781d8a_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1c6304e54ea4ff6822ec9ee1766e372_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1de02aee229949b29da1adff62f79608_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafdcef1bca214ba4be93eb50ada39288_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61296742d97b4da79a28c03d8f00b06c_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bd0a96ccb9e42b08636c5d927887d6f_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fa2bce4be0846e99213fe7062260432_I20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73bb70b7323d4144a6e75d3e406c405c_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="d"><xbrli:measure>utr:D</xbrli:measure></xbrli:unit><xbrli:context id="i48864de303954560905e76c4450e4c12_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f9fc4db17d04bf89dd453f8e14127a3_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fce823aabcc4d3d949530fe19c30792_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3951fe225b2c46a7b3923a0684c74ce9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="option"><xbrli:measure>lgnd:option</xbrli:measure></xbrli:unit><xbrli:context id="i25e12db65ee14bebb0cc5ab9db2dea3a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if492415c8fb84dc28c02e844ba8b7ba7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05243f1221bc4fd7befab87ff60f8de9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0057dd0957054317972b57951cde9e14_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i877eaef323064694bf3b6b4356d4f3fd_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaf759347d8c465a8cb4d42f49d35918_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e9d28d4cd3a4c1682fedb85842a9f81_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae8337fd239a4e7e99cf32e1f3b34254_I20190911"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0da24b8c33848ccb099afc62ba164b1_D20190911-20190911"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-11</xbrli:startDate><xbrli:endDate>2019-09-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="patent"><xbrli:measure>lgnd:patent</xbrli:measure></xbrli:unit><xbrli:context id="i4829221eea044e2c99470e6c93d2698c_D20191029-20191029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:LupinPatentInfringementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-29</xbrli:startDate><xbrli:endDate>2019-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="civil_complaint"><xbrli:measure>lgnd:civil_complaint</xbrli:measure></xbrli:unit><xbrli:context id="i9d01e2b13cbc4db1979d2caa61ff4664_D20191031-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:USDistrictCourtForTheNorthernDistrictOfOhioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-31</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="petition"><xbrli:measure>lgnd:petition</xbrli:measure></xbrli:unit><xbrli:context id="ied61350f910e4604aaf85a72e7548d42_D20190501-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:InterPartesReviewOfPatentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i903410136b034df7806df0765a803943_D20200501-20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lgnd:GlaxoSmithKlineBiologicalsSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:InterPartesReviewOfPatentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i38905116b7634694b27917e6ac2a9ef4_1"></div><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C.  20549</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________________</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGV4dHJlZ2lvbjpkMTI2NWJjYzg1YWQ0NTViOWQ2MDE5YmYwNzRkNDJlYV8xNzM_2ce849a2-3b52-4e9a-9f4d-7198bcd1de89">10-Q</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">________________________________________________________________________________________</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6OGU5ODFhZTJmMDVmNGE5ZWFjMjAxMTQ2NzUwNGYyZTgvdGFibGVyYW5nZTo4ZTk4MWFlMmYwNWY0YTllYWMyMDExNDY3NTA0ZjJlOF8wLTAtMS0xLTA_f692a876-c4c5-477a-a5d4-a01b3bf73a3b">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGV4dHJlZ2lvbjpkMTI2NWJjYzg1YWQ0NTViOWQ2MDE5YmYwNzRkNDJlYV8yOTg_e2ca8da7-3022-4d95-88ba-cc270f5eda49">March&#160;31, 2021</ix:nonNumeric>  </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">or</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.094%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6MWQ5ZjMxOWI4NWE2NDNjNjhiN2U0OWFiNzRmYjJiMGUvdGFibGVyYW5nZToxZDlmMzE5Yjg1YTY0M2M2OGI3ZTQ5YWI3NGZiMmIwZV8wLTAtMS0xLTA_d8519e30-a2ac-4a48-9bf0-e937a40fcecd">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the Transition Period From ______ to ______ .     </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGV4dHJlZ2lvbjpkMTI2NWJjYzg1YWQ0NTViOWQ2MDE5YmYwNzRkNDJlYV8yMTkx_47734af8-c246-4bdc-a45b-1f473e683a80">001-33093</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><img src="lgnd-20210331_g1.jpg" alt="lgnd-20210331_g1.jpg" style="height:86px;margin-bottom:5pt;vertical-align:text-bottom;width:250px"/></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGV4dHJlZ2lvbjpkMTI2NWJjYzg1YWQ0NTViOWQ2MDE5YmYwNzRkNDJlYV8zOTk_24e9de23-8d5e-4196-82ff-ab738b42e3b3">LIGAND PHARMACEUTICALS INCORPORATED</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.467%"><tr><td style="width:1.0%"></td><td style="width:39.481%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6N2MzMDJhNTgwMmVkNGI3OWFlMDZhMzg3Mzk3OGFiMjQvdGFibGVyYW5nZTo3YzMwMmE1ODAyZWQ0Yjc5YWUwNmEzODczOTc4YWIyNF8wLTAtMS0xLTA_515f0f13-2337-44ff-9205-60dde283cc0f">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6N2MzMDJhNTgwMmVkNGI3OWFlMDZhMzg3Mzk3OGFiMjQvdGFibGVyYW5nZTo3YzMwMmE1ODAyZWQ0Yjc5YWUwNmEzODczOTc4YWIyNF8wLTEtMS0xLTA_df058df0-adb4-4406-9478-e1f48128ebbf">77-0160744</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">incorporation or organization)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Identification No.)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6N2MzMDJhNTgwMmVkNGI3OWFlMDZhMzg3Mzk3OGFiMjQvdGFibGVyYW5nZTo3YzMwMmE1ODAyZWQ0Yjc5YWUwNmEzODczOTc4YWIyNF8zLTAtMS0xLTA_c41d15fb-37a4-4c26-a726-5c5956420fb3">3911 Sorrento Valley Boulevard,  Suite 110</ix:nonNumeric> </span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6N2MzMDJhNTgwMmVkNGI3OWFlMDZhMzg3Mzk3OGFiMjQvdGFibGVyYW5nZTo3YzMwMmE1ODAyZWQ0Yjc5YWUwNmEzODczOTc4YWIyNF80LTAtMS0xLTA_41f19261-aade-47cf-99fa-28321b74ac0d">San Diego</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6N2MzMDJhNTgwMmVkNGI3OWFlMDZhMzg3Mzk3OGFiMjQvdGFibGVyYW5nZTo3YzMwMmE1ODAyZWQ0Yjc5YWUwNmEzODczOTc4YWIyNF81LTAtMS0xLTA_fd681c7d-c227-43f3-94cb-49312f81da61">CA</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6N2MzMDJhNTgwMmVkNGI3OWFlMDZhMzg3Mzk3OGFiMjQvdGFibGVyYW5nZTo3YzMwMmE1ODAyZWQ0Yjc5YWUwNmEzODczOTc4YWIyNF81LTEtMS0xLTA_124ac633-e585-4aee-840e-5c52fb020a46">92121</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGV4dHJlZ2lvbjpkMTI2NWJjYzg1YWQ0NTViOWQ2MDE5YmYwNzRkNDJlYV8yMTky_5caafe00-a918-418f-bbcf-8481a32235fa">858</ix:nonNumeric>) <ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGV4dHJlZ2lvbjpkMTI2NWJjYzg1YWQ0NTViOWQ2MDE5YmYwNzRkNDJlYV8yMTkz_7a2e1acc-063a-4441-adfe-312fefd161f6">550-7500</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant's Telephone Number, Including Area Code) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.515%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading symbol:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered:</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:94%"><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6NmRkZjY0OGMxNDk5NDgxNTliMmNiNzAxZjNmOWI0ODAvdGFibGVyYW5nZTo2ZGRmNjQ4YzE0OTk0ODE1OWIyY2I3MDFmM2Y5YjQ4MF8xLTAtMS0xLTA_de63813c-d82a-425c-9183-f4abcfb654f0">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:94%"><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6NmRkZjY0OGMxNDk5NDgxNTliMmNiNzAxZjNmOWI0ODAvdGFibGVyYW5nZTo2ZGRmNjQ4YzE0OTk0ODE1OWIyY2I3MDFmM2Y5YjQ4MF8xLTEtMS0xLTA_c7e71502-563c-4079-9764-b55cbb52adaf">LGND</ix:nonNumeric></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:94%"><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6NmRkZjY0OGMxNDk5NDgxNTliMmNiNzAxZjNmOWI0ODAvdGFibGVyYW5nZTo2ZGRmNjQ4YzE0OTk0ODE1OWIyY2I3MDFmM2Y5YjQ4MF8xLTItMS0xLTA_2aa957ef-90d6-4d18-ad8d-22a150c647d5">The Nasdaq Global Market</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">________________________________________________________________________________________</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    <ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGV4dHJlZ2lvbjpkMTI2NWJjYzg1YWQ0NTViOWQ2MDE5YmYwNzRkNDJlYV8yMTk0_6286e97e-3d6d-4414-88f5-cd9b8b09bb88">Yes</ix:nonNumeric>  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    No  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    <ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGV4dHJlZ2lvbjpkMTI2NWJjYzg1YWQ0NTViOWQ2MDE5YmYwNzRkNDJlYV8yMTk1_d7fe37cd-e986-4ab4-a5db-6b2c0e207541">Yes</ix:nonNumeric>  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    No  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See definitions of  &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;  &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.  (Check one)</span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:84.649%"><tr><td style="width:1.0%"></td><td style="width:29.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.529%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6NzZiNDc2MTI2YjY5NDM4Yjk0NTg4MjA1ZDVhMjk2N2YvdGFibGVyYW5nZTo3NmI0NzYxMjZiNjk0MzhiOTQ1ODgyMDVkNWEyOTY3Zl8wLTAtMS0xLTA_36b779e5-c520-4df4-932e-bd34df6eba12">Large Accelerated Filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accelerated Filer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Accelerated Filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller Reporting Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6NzZiNDc2MTI2YjY5NDM4Yjk0NTg4MjA1ZDVhMjk2N2YvdGFibGVyYW5nZTo3NmI0NzYxMjZiNjk0MzhiOTQ1ODgyMDVkNWEyOTY3Zl8xLTQtMS0xLTA_c8afd1d5-6364-44ec-88fc-382e659aaadc">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging Growth Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6NzZiNDc2MTI2YjY5NDM4Yjk0NTg4MjA1ZDVhMjk2N2YvdGFibGVyYW5nZTo3NmI0NzYxMjZiNjk0MzhiOTQ1ODgyMDVkNWEyOTY3Zl8yLTEtMS0xLTA_95d817e7-88d3-4d9e-8b6c-64c7c9904199">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGV4dHJlZ2lvbjpkMTI2NWJjYzg1YWQ0NTViOWQ2MDE5YmYwNzRkNDJlYV8yMTkw_c952d3b5-015e-4ea8-8ed8-8f176460d2f7">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    No  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of May&#160;3, 2021, the registrant had <ix:nonFraction unitRef="shares" contextRef="i05707ba532fc425c921e61b0e8954f64_I20210503" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGV4dHJlZ2lvbjpkMTI2NWJjYzg1YWQ0NTViOWQ2MDE5YmYwNzRkNDJlYV8yMTUz_b7910b1e-1252-435f-91fa-7ddc2798c6cf">16,652,080</ix:nonFraction> shares of common stock outstanding.</span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i38905116b7634694b27917e6ac2a9ef4_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.902%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I.  FINANCIAL INFORMATION</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_13">ITEM 1.  Condensed Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_13">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_16">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_19">Condensed Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_19">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_22">Condensed Consolidated Statements of Comprehensive Income (Loss)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_22">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_25">Condensed Consolidated Statements of Stockholders' Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_25">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_28">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_28">8</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_31">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_67">ITEM 2.  Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_67">24</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_79">ITEM 3.  Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_79">29</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_82">ITEM 4.  Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_82">29</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II.  OTHER INFORMATION</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_88">ITEM 1.  Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_88">29</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_91">ITEM 1A.  Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_91">30</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_94">ITEM 2.  Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_94">31</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_97">ITEM 3.  Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_97">31</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_100">ITEM 4.  Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_100">31</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_103">ITEM 5.  Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_103">31</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_106">ITEM 6.  Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_109">32</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_109">SIGNATURE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38905116b7634694b27917e6ac2a9ef4_109">32</a></span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.170%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GLOSSARY OF TERMS AND ABBREVIATIONS</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Abbreviation</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definition</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020 Annual Report</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February 24, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$750.0 million aggregate principal amount of convertible senior unsecured notes due 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ab Initio</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ab Initio Biotherapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amgen</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amgen, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ANDA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Abbreviated New Drug Application</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting Standards Codification</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASU</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting Standards Update</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo Med, LLC</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CE</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Captisol-enabled</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals Incorporated, including subsidiaries</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CorMatrix Cardiovascular, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CVR</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent value right</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal Bioscience, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CStone Pharmaceuticals</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CStone Pharmaceuticals (Suzhou) Co., Ltd.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex Pharmaceuticals, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dianomi Therapeutics</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dianomi Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee Stock Purchase Plan, as amended and restated</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FASB</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financial Accounting Standards Board</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FDA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Food and Drug Administration</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GAAP</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Generally accepted accounting principles in the United States</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gilead</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gilead Sciences, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GRA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Glucagon receptor antagonist</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IND</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investigational New Drug</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals Incorporated, including subsidiaries</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NDA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New Drug Application</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfenex</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfenex Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfizer</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfizer Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Q1 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Company's fiscal quarter ended March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Q1 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Company's fiscal quarter ended March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SBC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SEC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities and Exchange Commission</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis, SA</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">sNDA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Supplemental New Drug Application</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Taurus</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Taurus Biosciences, LLC</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Teva</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd. and Actavis, LLC, collectively</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Travere</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Travere Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Viking</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Viking Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">xCella</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">xCella Biosciences, Inc.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">YTD</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year-to-date</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i38905116b7634694b27917e6ac2a9ef4_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div id="i38905116b7634694b27917e6ac2a9ef4_13"></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">     Item 1. Condensed Consolidated Financial Statements</span></div><div id="i38905116b7634694b27917e6ac2a9ef4_16"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in thousands, except par value)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.738%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMy0xLTEtMS0w_6db2f594-7d23-421b-9406-ab806be94839">31,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMy0zLTEtMS0w_ce343362-ad9e-458b-a7b8-0c52dad8079b">47,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNC0xLTEtMS0w_14d30b82-a365-4daf-a137-e8596c4bc404">307,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNC0zLTEtMS0w_b12fe4df-60a0-4de0-868c-19f8ac1ccea3">363,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNS0xLTEtMS0w_70bead7a-cefb-4ce9-89d4-c3cabff0b263">54,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNS0zLTEtMS0w_c46fc5d2-1fa9-4918-9073-2d429ed528b8">56,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNi0xLTEtMS0w_cc49fb79-afb7-4d27-92fd-b137f08d276d">36,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNi0zLTEtMS0w_8e5298ff-7819-4347-905f-7c89cacd1d59">26,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Income taxes receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNy0xLTEtMS0w_b5047910-0fb7-4019-85f8-909e86234cad">1,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNy0zLTEtMS0w_7ca7e396-a756-4979-b9ec-fa9e06599caf">2,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfOC0xLTEtMS0w_9e404f2f-99a8-485a-a753-47f3257e9926">5,708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfOC0zLTEtMS0w_d6b53f93-df77-4725-89fb-0b4650cf7103">3,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTAtMS0xLTEtMA_383e843e-f871-4e1b-a6b3-0ba87a425385">437,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTAtMy0xLTEtMA_37f1090e-a7da-4845-8eaf-04325d9c82d7">500,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTEtMS0xLTEtMA_fe022720-6673-4001-afd7-800a54bb9e76">27,432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTEtMy0xLTEtMA_b0dd1bf5-82f4-496b-b1f3-ce579964fd85">24,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTItMS0xLTEtMA_08fd18f4-4cb6-4eb2-be10-591d34f2d7aa">583,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTItMy0xLTEtMA_5b7fe72c-e8b2-4053-9658-392b726e9a69">595,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTMtMS0xLTEtMA_bbcca37f-0626-4934-960b-e2cec7c9f962">190,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTMtMy0xLTEtMA_fcde8ae7-f85d-4fb0-a852-96d9f76afe17">189,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial license and other economic rights, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="lgnd:CommercialLicenseRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTQtMS0xLTEtMA_6a16f438-a3e1-4184-a4d8-bb3921b53fd1">10,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:CommercialLicenseRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTQtMy0xLTEtMA_087f5e20-e27b-486c-beb8-991c45ff8975">10,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTUtMS0xLTEtMA_392be178-af4b-4a30-975d-485531de71c7">16,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTUtMy0xLTEtMA_444dce5a-fc92-4ffa-a8c3-7710cb834871">14,434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTYtMS0xLTEtMA_c6648df2-6b77-47d0-bdbb-318d1cd545d0">7,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTYtMy0xLTEtMA_b37a2f48-506b-40ef-bab4-86e4bc3a5706">6,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTctMS0xLTEtODcw_82f78cd9-a486-4f78-80de-627e8a090051">17,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTctMy0xLTEtMTMx_e46ca602-a884-475e-b4b5-a7af2ebe5916">15,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTctMS0xLTEtMA_f7109a61-65d4-4543-be41-b35a1a33d9c7">3,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTctMy0xLTEtMA_7bbbced2-ab8c-4ba8-bd94-66eff0c82419">4,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTgtMS0xLTEtMA_19b994cf-7c47-45be-824f-43e7952eec60">1,295,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTgtMy0xLTEtMA_dfdfa4ed-779c-445d-9c1c-0b0d4d3dfe9b">1,362,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accounts payable </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjEtMS0xLTEtMA_7c345b11-aacc-484b-a8ac-c097176b8f7d">9,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjEtMy0xLTEtMA_6eed9063-183d-4e6d-a33a-053dc0a7f0ac">3,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjItMS0xLTEtMA_d458b2be-de6d-4642-8ce9-7e6dcdfa7b01">12,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjItMy0xLTEtMA_830bb031-496c-4da5-9f5a-63c07bc7e6c3">18,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="lgnd:CurrentPortionOfLiabilityForContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjQtMS0xLTEtMA_fa5b1f35-5ae9-4777-881f-3748587633d4">41,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:CurrentPortionOfLiabilityForContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjQtMy0xLTEtMA_2e7becaf-29b6-43bc-a803-2fa2d8389e0a">39,884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjUtMS0xLTEtMA_bd761804-f3e1-44ba-b219-5f58d3c43f2d">25,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjUtMy0xLTEtMA_1a2a3e9f-81c5-4ca3-9fa5-d14287cd15bf">29,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjctMS0xLTEtODc1_ecf9ffec-fb5c-488f-8ceb-fa8842a30290">2,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjctMy0xLTEtMTQ5_c5ff085e-0ee7-46db-bd7d-5b4198f2f9de">1,885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current financing lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjgtMS0xLTEtODc1_09890b59-dda6-4056-a488-893651a8e91e">5,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjgtMy0xLTEtMTQ5_29e2c75c-a7db-479c-a10b-c5371fe76ced">6,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjctMS0xLTEtMA_bc85fd2a-866e-4b8c-8888-6a8c162f4228">95,805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjctMy0xLTEtMA_8e23db1f-acb2-4c6d-be47-4f3e3a8902bc">100,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023 convertible senior notes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjgtMS0xLTEtMA_61f0db40-656b-4537-9363-bdeee97ec82e">352,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjgtMy0xLTEtMA_b3e8c41f-4f7b-42e5-b8d5-f7cc6076d18c">442,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="lgnd:LiabilityForContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjktMS0xLTEtMA_26f39520-ca95-40db-883e-97056899d1bc">9,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:LiabilityForContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjktMy0xLTEtMA_227324ee-e343-4c78-8c34-8f1741a6be37">9,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzAtMS0xLTEtMA_85b7251c-2523-4f90-8101-ca19b9ae88b5">56,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzAtMy0xLTEtMA_2e1aeca7-048d-47aa-9935-ef30eaded6f1">64,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzEtMS0xLTEtMA_aafab3c2-aa95-4c3f-b9db-5cfa44a5bb12">6,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzEtMy0xLTEtMA_1c6d7d1c-5427-49eb-8ae8-084bd415f2f7">5,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzItMS0xLTEtMA_f9ac89ab-f053-4bed-a119-31284ebfde89">28,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzItMy0xLTEtMA_56fc3488-1dfb-4f44-8453-ef3dcf72ceaa">30,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzMtMS0xLTEtMA_fb49a806-2350-4e6f-b705-0436d842c482">549,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzMtMy0xLTEtMA_eeddb3de-e183-4195-8405-815ea4afc606">652,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzQtMS0xLTEtMA_ab72743f-f46c-41a8-a668-21fd47d25325"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzQtMy0xLTEtMA_585b914c-8356-45a0-88df-9ec647bf88e7"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders' equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOmU5ODQ0NzYwN2JlNjQ5ZGE4ZDYxMzY0ZjRmNWMwMDU2XzI0_17e763d8-f0bc-49af-84ea-c5db619c188f"><ix:nonFraction unitRef="usdPerShare" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOmU5ODQ0NzYwN2JlNjQ5ZGE4ZDYxMzY0ZjRmNWMwMDU2XzI0_745e8eff-5c21-4d3d-be4f-033dc68f3a47">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOmU5ODQ0NzYwN2JlNjQ5ZGE4ZDYxMzY0ZjRmNWMwMDU2XzM4_49d9985a-7ad6-4081-bdfe-2a29762f4ff5"><ix:nonFraction unitRef="shares" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOmU5ODQ0NzYwN2JlNjQ5ZGE4ZDYxMzY0ZjRmNWMwMDU2XzM4_a49e10f8-d89b-4528-ab23-bb331e8d067b">5,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOmU5ODQ0NzYwN2JlNjQ5ZGE4ZDYxMzY0ZjRmNWMwMDU2XzYw_2020db82-719f-47f1-b03b-e3b680da4af8"><ix:nonFraction unitRef="shares" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOmU5ODQ0NzYwN2JlNjQ5ZGE4ZDYxMzY0ZjRmNWMwMDU2XzYw_362bde13-9e15-4c40-b269-0c7c474187ac"><ix:nonFraction unitRef="shares" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOmU5ODQ0NzYwN2JlNjQ5ZGE4ZDYxMzY0ZjRmNWMwMDU2XzYw_6eff9aef-7dc5-4a24-b9e7-1739ec99188c"><ix:nonFraction unitRef="shares" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOmU5ODQ0NzYwN2JlNjQ5ZGE4ZDYxMzY0ZjRmNWMwMDU2XzYw_b07048f8-958b-4830-88f3-4925073dc21d">zero</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding at March&#160;31, 2021 and December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzYtMS0xLTEtMA_201fbcb5-e53c-498e-a05c-a2969b0728a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzYtMy0xLTEtMA_3de5aead-e15c-40bc-a886-1f93e9ef6c2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmQ4MGMwZDlhYzZjZDRiZTFiMjczNzNhNjU4ZWFkM2E1XzIx_1ff31cd6-6c91-4e38-af3b-d1f49812bd7d"><ix:nonFraction unitRef="usdPerShare" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmQ4MGMwZDlhYzZjZDRiZTFiMjczNzNhNjU4ZWFkM2E1XzIx_c2f56634-ee58-4ab9-a61d-631d19ff00d5">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmQ4MGMwZDlhYzZjZDRiZTFiMjczNzNhNjU4ZWFkM2E1XzM1_27710d93-2da2-495f-9743-bd70032c9401"><ix:nonFraction unitRef="shares" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmQ4MGMwZDlhYzZjZDRiZTFiMjczNzNhNjU4ZWFkM2E1XzM1_b3c853b6-f751-48a1-acfa-36b54a0450b4">60,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmQ4MGMwZDlhYzZjZDRiZTFiMjczNzNhNjU4ZWFkM2E1XzU3_69a4fd0f-9400-4ea2-998c-6ff2883c5843"><ix:nonFraction unitRef="shares" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmQ4MGMwZDlhYzZjZDRiZTFiMjczNzNhNjU4ZWFkM2E1XzU3_7514d5a8-33e7-4ff5-b1fa-df453db6b1d0">16,652</ix:nonFraction></ix:nonFraction> and  <ix:nonFraction unitRef="shares" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmQ4MGMwZDlhYzZjZDRiZTFiMjczNzNhNjU4ZWFkM2E1XzEwOTk1MTE2Mjc5MTI_515892c7-c0a0-4ab4-9019-10378f0057d1"><ix:nonFraction unitRef="shares" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmQ4MGMwZDlhYzZjZDRiZTFiMjczNzNhNjU4ZWFkM2E1XzEwOTk1MTE2Mjc5MTI_d3d1a599-277b-42f4-b764-aff87e1968cc">16,080</ix:nonFraction></ix:nonFraction>  shares issued and outstanding at March&#160;31, 2021 and December&#160;31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzctMS0xLTEtMA_f6dc6fd3-a4f8-4de7-af87-de864725a7e1">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzctMy0xLTEtMA_584971a2-5458-41b4-b4d4-051f4907c809">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzgtMS0xLTEtMA_4f4e821f-57ae-4b4c-a568-299df9105ad1">336,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzgtMy0xLTEtMA_0e9651b6-8314-466c-ae0c-b166c37d4891">318,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzktMS0xLTEtMA_eec4998a-1175-4fdf-bc01-b5727da9325c">856</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzktMy0xLTEtMA_f2c3909a-eff4-4a92-93b8-a5c1489a5d54">801</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Retained earnings </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNDAtMS0xLTEtMA_bdba6634-236b-4ec9-b6de-4a5436644585">410,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNDAtMy0xLTEtMA_4f544fa4-cf35-4600-9ed7-cd1bdb818c53">391,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total stockholders' equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNDEtMS0xLTEtMA_3d78f41e-3bf4-46d1-8e5a-d2ab1a858294">745,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNDEtMy0xLTEtMA_75ab1241-f6aa-4d16-a527-49ac95235d33">709,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities and stockholders' equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNDItMS0xLTEtMA_c6c856b3-35dc-4c68-8349-4136f25a462e">1,295,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNDItMy0xLTEtMA_6d85c583-b536-41f8-b469-c9c0a28972c0">1,362,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div id="i38905116b7634694b27917e6ac2a9ef4_19"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share amounts)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Royalties</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie30239110ac54ae2af1d194e9c6384f4_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfNC0xLTEtMS0w_b4f25a55-36ce-44a9-9150-485de4c253dc">7,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e4b63fffd544d8c9290215bd3714192_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfNC0zLTEtMS0w_b039c217-fe57-4e39-a360-68006b1f3281">6,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Captisol</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9ffb7664b0411f8db3b6b38d6632e4_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfNS0xLTEtMS0w_06d23c1d-e9ee-4cf7-95dc-a134fc0ea4c8">31,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6be2d05e46c04f22a00605da2833d1da_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfNS0zLTEtMS0w_a6010573-ba05-4368-be8d-0313e350f292">21,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Contract revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14b88249e38e42929cf58c0afff44f7c_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfNi0xLTEtMS0w_c218e595-a9a8-4125-b0f5-3d55d9a2cc06">16,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77e9a47601246a2acde91f6d3baa812_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfNi0zLTEtMS0w_784612a4-6a4e-474c-9d84-688caab0600a">5,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfNy0xLTEtMS0w_da5dac7b-4c8c-4898-bcdd-8198ca62fc9c">55,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfNy0zLTEtMS0w_1f68facc-1496-49a6-8782-861201bbd4ee">33,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cost of Captisol</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostDirectMaterial" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfOS0xLTEtMS0w_f3b3c17f-8cf9-4e17-9f3c-a605c19d4c3b">8,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostDirectMaterial" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfOS0zLTEtMS0w_b910fe70-6635-4a86-b9d9-c8a923b09ed6">4,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTAtMS0xLTEtMA_654d3521-29b9-4d3f-a0ff-15609155380e">11,786</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTAtMy0xLTEtMA_1b97bc6f-b508-4589-981f-c01219067337">3,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTEtMS0xLTEtMA_8fa33c65-7d70-4cd5-acbe-12027d2eb5a6">17,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTEtMy0xLTEtMA_158023eb-a443-4742-a50e-034665a2496b">11,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTItMS0xLTEtMA_903ad361-cbdb-4885-b3d8-3015fa6d98ad">12,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTItMy0xLTEtMA_aab9724c-d571-4b97-96e4-369858878524">9,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTMtMS0xLTEtMA_4f3b4eb1-02f1-4e01-9a62-f304dc802c8b">50,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTMtMy0xLTEtMA_b6028bf2-9532-483f-aa9c-ad7bfadb9607">29,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTUtMS0xLTEtMA_5824434f-7289-4c22-a74d-41ac18281573">4,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTUtMy0xLTEtMA_243fba4d-9aea-4640-a68a-20903493afb3">3,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Gain (loss) from short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTctMS0xLTEtMA_3bc0042c-7fd1-4be7-b1af-a1eb8a5ffe31">13,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTctMy0xLTEtMA_c669b555-5720-4696-8f19-68b01ecfd79e">30,741</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTgtMS0xLTEtMA_70586708-dd30-4481-8bd2-7a5d9b59c344">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTgtMy0xLTEtMA_22329c1a-aa9d-4b5d-b7d4-11c7f45b26d9">4,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTktMS0xLTEtMA_1c7f0d6b-dc37-41a4-8215-d1ba4c2496a1">5,831</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTktMy0xLTEtMA_8afd664f-5c25-4fdb-b694-adfea45fc6e4">8,548</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjAtMS0xLTEtMA_129ac7f1-6e00-482d-9b70-6daa4858ed4b">6,477</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjAtMy0xLTEtMA_55728fc4-46bd-4d07-80ed-ed0c19fede93">356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other income (loss), net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjEtMS0xLTEtMA_14e099bf-0ca4-426d-b6ea-aa4a1770feb9">1,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjEtMy0xLTEtMA_299472e5-0342-44cb-a613-3f8ab2218aa4">34,203</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss)  before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjItMS0xLTEtMA_7e1fa10c-5a76-4325-a804-11055e53061a">5,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjItMy0xLTEtMA_8b51a251-bd81-47dd-b708-015daa6c5077">30,415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjMtMS0xLTEtMA_62cef505-1ea2-4d51-986c-285f7fbaf37d">12,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjMtMy0xLTEtMA_b077a951-0131-46c4-8538-6887b5fb5b5a">6,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjQtMS0xLTEtMA_79a70e40-170c-4f27-91ff-ca2aa6971b31">18,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjQtMy0xLTEtMA_ac84ed72-4fb5-4111-8ac8-7963e56aaa7a">24,131</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Basic net income (loss) per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjYtMS0xLTEtMA_6dc3ebf8-9619-4b9f-aa66-bc8a6ca7d7da">1.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjYtMy0xLTEtMA_36703756-439e-4653-bbe6-5034c439365e">1.46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Shares used in basic per share calculations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjctMS0xLTEtMA_80e8748b-0766-4d97-8370-87d6762d5fda">16,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjctMy0xLTEtMA_04adf4d4-6515-4545-9d96-2409ae40fa3a">16,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Diluted net income (loss) per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjktMS0xLTEtMA_c2485cc1-ce5d-48ac-98e9-cd8ac242c1fd">1.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjktMy0xLTEtMA_99b5d8fc-b513-400c-8bde-da0ec6b7d702">1.46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Shares used in diluted per share calculations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMzAtMS0xLTEtMA_2f055dcf-6147-40fc-90a4-f7f4063c987f">17,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMzAtMy0xLTEtMA_275c83c1-2d5b-4bc7-9506-f51bce90303b">16,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i38905116b7634694b27917e6ac2a9ef4_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss):</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yMi9mcmFnOmMxMDZjZmMzYTllZDQ1YTE4MjIxZmUzYzJkNGNhZTg2L3RhYmxlOjkyN2FhMDUxZjZmMjRlZDc4MDM1NGY3MzY3YTFhMzdjL3RhYmxlcmFuZ2U6OTI3YWEwNTFmNmYyNGVkNzgwMzU0ZjczNjdhMWEzN2NfMy0xLTEtMS0w_d4f33f4b-28c6-436c-8226-b39965a6e079">18,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yMi9mcmFnOmMxMDZjZmMzYTllZDQ1YTE4MjIxZmUzYzJkNGNhZTg2L3RhYmxlOjkyN2FhMDUxZjZmMjRlZDc4MDM1NGY3MzY3YTFhMzdjL3RhYmxlcmFuZ2U6OTI3YWEwNTFmNmYyNGVkNzgwMzU0ZjczNjdhMWEzN2NfMy0zLTEtMS0w_c488d917-cf49-447b-9a43-375be582fbd4">24,131</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yMi9mcmFnOmMxMDZjZmMzYTllZDQ1YTE4MjIxZmUzYzJkNGNhZTg2L3RhYmxlOjkyN2FhMDUxZjZmMjRlZDc4MDM1NGY3MzY3YTFhMzdjL3RhYmxlcmFuZ2U6OTI3YWEwNTFmNmYyNGVkNzgwMzU0ZjczNjdhMWEzN2NfNC0xLTEtMS0w_7b2b75ff-b597-4399-a3d4-7e64d3034400">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yMi9mcmFnOmMxMDZjZmMzYTllZDQ1YTE4MjIxZmUzYzJkNGNhZTg2L3RhYmxlOjkyN2FhMDUxZjZmMjRlZDc4MDM1NGY3MzY3YTFhMzdjL3RhYmxlcmFuZ2U6OTI3YWEwNTFmNmYyNGVkNzgwMzU0ZjczNjdhMWEzN2NfNC0zLTEtMS0w_5bfc2a11-56da-498a-95ab-dc5e4595eb4f">2,772</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yMi9mcmFnOmMxMDZjZmMzYTllZDQ1YTE4MjIxZmUzYzJkNGNhZTg2L3RhYmxlOjkyN2FhMDUxZjZmMjRlZDc4MDM1NGY3MzY3YTFhMzdjL3RhYmxlcmFuZ2U6OTI3YWEwNTFmNmYyNGVkNzgwMzU0ZjczNjdhMWEzN2NfNS0xLTEtMS0w_dd575524-ceae-4460-b522-3a942db61bf3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yMi9mcmFnOmMxMDZjZmMzYTllZDQ1YTE4MjIxZmUzYzJkNGNhZTg2L3RhYmxlOjkyN2FhMDUxZjZmMjRlZDc4MDM1NGY3MzY3YTFhMzdjL3RhYmxlcmFuZ2U6OTI3YWEwNTFmNmYyNGVkNzgwMzU0ZjczNjdhMWEzN2NfNS0zLTEtMS0w_865a8195-a109-46ee-9fde-f3d3cc6c3295">1,879</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yMi9mcmFnOmMxMDZjZmMzYTllZDQ1YTE4MjIxZmUzYzJkNGNhZTg2L3RhYmxlOjkyN2FhMDUxZjZmMjRlZDc4MDM1NGY3MzY3YTFhMzdjL3RhYmxlcmFuZ2U6OTI3YWEwNTFmNmYyNGVkNzgwMzU0ZjczNjdhMWEzN2NfNy0xLTEtMS0w_a3043095-51c0-499c-9fbc-245a03b05d77">18,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yMi9mcmFnOmMxMDZjZmMzYTllZDQ1YTE4MjIxZmUzYzJkNGNhZTg2L3RhYmxlOjkyN2FhMDUxZjZmMjRlZDc4MDM1NGY3MzY3YTFhMzdjL3RhYmxlcmFuZ2U6OTI3YWEwNTFmNmYyNGVkNzgwMzU0ZjczNjdhMWEzN2NfNy0zLTEtMS0w_8e6f4ec7-9cf8-458d-a1dd-d0f9d028f1a9">28,782</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i38905116b7634694b27917e6ac2a9ef4_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid in capital</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i15757d268ab84dc7a0e63e4c840a5172_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMi0xLTEtMS0w_2d7004ce-9434-4ec7-a388-0f34d6d92ee5">16,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15757d268ab84dc7a0e63e4c840a5172_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMi0yLTEtMS0w_bdc320c1-22ec-4276-99be-68996164127d">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d37dcb59e8c407fbccb9bb97f5e380e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMi0zLTEtMS0w_5598442a-3419-4b49-8571-4ae4da38d641">318,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib506a1ffb8e046009e08fd19fcfe4209_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMi00LTEtMS0w_a4cce00b-6021-4f17-8849-8d4340ab2c64">801</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb9abae5afa744f0abd29ca447cf6dd6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMi01LTEtMS0w_d35c2027-4ad7-40d1-ac45-e96397bda8e0">391,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMi02LTEtMS0w_ba7b2492-9fb2-4bd0-b123-6794eb04daf2">709,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i21e3b58e4ca240c286f59fb2568bf37e_D20210101-20210331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMy0xLTEtMS0w_18a6d47e-5b2c-4c8c-acf9-9ca00b20ff74">572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21e3b58e4ca240c286f59fb2568bf37e_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMy0yLTEtMS0w_9bafded3-6081-4616-8e19-96cd7ed00aa3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c6105b1f6594c02becde6c91bfe9eb1_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMy0zLTEtMS0w_4aba8213-217e-4a5c-9b7d-054472fb2b41">20,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMy02LTEtMS0w_22b1ddde-20fe-4e86-b769-07fb0d0dafc6">20,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c6105b1f6594c02becde6c91bfe9eb1_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfNC0zLTEtMS0w_17276d3f-de00-48c2-9751-6f4ce23cef8c">8,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfNC02LTEtMS0w_5d21efc1-c50c-4cfc-b66a-82f179c47016">8,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice9d2fa48f71444f8320d849c38a5579_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfNi00LTEtMS0w_2371dca7-33be-4f93-9867-76b9116b1d16">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfNi02LTEtMS0w_906243bc-b0a3-4efd-ae49-21442cd1de8c">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reacquisition of equity due to 2023 debt extinguishment, net of tax</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c6105b1f6594c02becde6c91bfe9eb1_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfOC0zLTEtMS0w_a257b5f6-73d8-4823-acd7-bfba1f81b31f">9,086</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfOC02LTEtMS0w_42e1fb74-da02-4a85-a26c-cc06c72ab5ec">9,086</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Warrant and bond hedge unwind transactions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c6105b1f6594c02becde6c91bfe9eb1_D20210101-20210331" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfOS0zLTEtMS0zMjA4_e9f5b7db-0eed-41d4-9abd-a4e0ef87b96a">396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfNy02LTEtMS0zNDU1_bbf79f65-6238-4fe7-a9fa-f648be16dec0">396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect for 2023 Notes transactions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c6105b1f6594c02becde6c91bfe9eb1_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfOS0zLTEtMS0zMTgy_bc156544-a0a2-485b-be04-71373e3d8c48">2,032</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfOC02LTEtMS0zNDU1_e5059f51-5473-4177-9d0c-04b2764db878">2,032</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03da71fe5d974403b52f069f014e7fd2_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMTAtNS0xLTEtMA_1b039048-9946-4afa-8e87-874f6a9f65d9">18,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMTAtNi0xLTEtMA_a7755f52-4f9c-4275-84dd-7bf2ce76ece5">18,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ce6ddc6311c4def9385fa6d58b64327_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMTEtMS0xLTEtMA_713c3865-fcf3-4651-903c-29cd3aadc23b">16,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ce6ddc6311c4def9385fa6d58b64327_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMTEtMi0xLTEtMA_6c2e874c-f4b2-4cc0-98c1-dc880cf06616">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eb7fefbebf14db2b9bee4226ca7c5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMTEtMy0xLTEtMA_89f9f339-0d15-4676-8bb1-3d1cf4617ffb">336,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida90f84c04b649199b1a0d40a08f4c81_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMTEtNC0xLTEtMA_82fd54d3-7d14-412d-875c-4ec6e03a2b96">856</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3baac2718ea47419924d27ce1598c17_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMTEtNS0xLTEtMA_a09e32e4-2512-465a-b40b-20eebb020965">410,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMTEtNi0xLTEtMA_13852042-b9fd-4bcf-8c8a-9b290c0c80fe">745,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid in capital</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings (Accumulated deficit)</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie09c209670384c35b1d40e0d01cdef82_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMi0xLTEtMS0w_bd22649a-3310-489d-97ac-65019f24eb7e">16,823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie09c209670384c35b1d40e0d01cdef82_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMi0yLTEtMS0w_acf74738-c716-4bed-965b-613fe86380ff">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i684becfb80a0442d9f4781a55aa08632_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMi0zLTEtMS0w_57c3204c-cb0c-4e2c-9d19-4bd7230e2a60">367,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i659c16b4cc3546ea8362ee2a92ecabe7_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMi00LTEtMS0w_bba65de4-76d7-49f5-b823-01c4dfdf0367">216</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc903f14f4ef431ebf2bb9b5b6d868be_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMi01LTEtMS0w_508960ed-438f-4ac5-ac8a-1eabe4f5c03c">400,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51e4f49b1fdf4839b077e613a7899628_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMi02LTEtMS0w_4bdcfa31-cce9-455c-8416-57c2ae2e290f">767,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieadcdc474507437085760e44dd5d5c01_D20200101-20200331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMy0xLTEtMS0w_5f1f77eb-1120-4326-b64e-a2b6507bab41">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13ac40a9f8fa48ad99e9e26c593ecb34_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMy0zLTEtMS0w_463aecd8-afc4-4ec6-aa04-64312b6a58f7">1,008</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMy02LTEtMS0w_7151ea5e-8475-4b65-ae16-e9fc96104586">1,008</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13ac40a9f8fa48ad99e9e26c593ecb34_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfNC0zLTEtMS0w_866404ac-0cf0-4504-904c-af1f66bc5b3a">5,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfNC02LTEtMS0w_f258ec95-ac19-4cd8-9615-cd2e7fea5635">5,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ieadcdc474507437085760e44dd5d5c01_D20200101-20200331" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfNS0xLTEtMS0w_35d09884-097b-4c24-b46e-39a41680a4a0">878</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieadcdc474507437085760e44dd5d5c01_D20200101-20200331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfNS0yLTEtMS0w_8b1db134-2ebf-40c1-b55c-ec5461050402">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13ac40a9f8fa48ad99e9e26c593ecb34_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfNS0zLTEtMS0w_88cd7197-c8a7-4f37-9fac-49ae24ce29cf">73,286</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfNS02LTEtMS0w_de8e24d1-c2d0-4871-95a5-515343ec0d2c">73,287</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net gain on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iece8fdee289d4aa8b8d7e5137317a46e_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfNi00LTEtMS0w_dc6d2392-4924-497f-ac8c-e06a00bc7f4b">2,772</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfNi02LTEtMS0w_dd53b993-731a-478d-82f0-3bc4c89911bf">2,772</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iece8fdee289d4aa8b8d7e5137317a46e_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfNy00LTEtMS0w_66da4a2b-748b-44ec-b1de-9f7782b93a9e">1,879</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfNy02LTEtMS0w_aa025ab1-d52d-4aaf-8852-2349d3daf302">1,879</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reacquisition of equity due to 2023 debt extinguishment, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13ac40a9f8fa48ad99e9e26c593ecb34_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfOC0zLTEtMS0w_6bd49622-2745-4083-a9c5-3e01239a8e9f">2,745</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfOC02LTEtMS0w_c803d279-1693-48b4-8535-1d8a07e9b18d">2,745</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfOS0wLTEtMS04OTI_e57440bd-fe3a-45d5-9ac9-1c064d8b653f">Cumulative-effect adjustment from adoption of ASU 2016-13, net of tax</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if91e400ca45d4fb580a3202300f06470_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfOS01LTEtMS0xNzc_a536c2b9-936c-4b3e-9fb9-d6803e7f71ac">5,167</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib27ffe698d824d4bb4ded2bed63e9c41_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfOS02LTEtMS04OTQ_85556d2d-c0b9-4e75-a4c2-ec9a3f05178c">5,167</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09692c0a1c274da79fdc91e6f7c6284e_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfOS01LTEtMS0w_29ec1f93-ea32-432e-8b1d-655aa2f14fea">24,131</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfOS02LTEtMS0w_f49d4525-7f47-406e-8224-406b2293f40e">24,131</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifc4a3c6bfc704ae6bcbce2daf092ade2_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMTAtMS0xLTEtMA_99b3b512-7de9-4eed-8f0f-3e3e48d03db2">16,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc4a3c6bfc704ae6bcbce2daf092ade2_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMTAtMi0xLTEtMA_3c94cdc1-92f8-45f3-b3ab-3221a64f7d89">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdec2dda7ca64a33ad8d5df2a891c250_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMTAtMy0xLTEtMA_595f5947-9849-4c90-a4c6-5f9c0a9db4de">295,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i544dd77eaedb4f5a956d59e518b4e511_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMTAtNC0xLTEtMA_f2038f8d-fd53-43e3-bba6-562782f708f3">4,867</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbbd2509899b45a8a4cb864e24eb6fca_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMTAtNS0xLTEtMA_4eeee4f5-5e28-417a-bd32-50c02ecaa927">370,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdf27ddbb0974314af1bf955199c9ad2_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMTAtNi0xLTEtMA_18697e16-214f-4214-8c8d-20726caa2823">661,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i38905116b7634694b27917e6ac2a9ef4_28"></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNC0xLTEtMS0w_f1a83248-eb59-491c-b95a-eb9f6c621c4e">18,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNC0zLTEtMS0w_12f61ed1-1f97-48ff-8baf-a39996bd8ff5">24,131</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in estimated fair value of contingent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNy0xLTEtMS0w_79c8aa86-e381-422b-8704-6899d0b88aed">1,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" name="lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNy0zLTEtMS0w_cb90a6d3-d67a-4cd2-9d27-c9e8e1f3110e">372</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfOC0xLTEtMS0w_e63a336e-3bd7-41e5-8c05-dccaa5d8e849">12,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfOC0zLTEtMS0w_2b00e9a3-80a0-43a1-8510-acf9ec6f10d9">3,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of premium (discount) on investments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfOS0xLTEtMS0w_8d3ab268-921d-4381-a05c-698d593353b2">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfOS0zLTEtMS0w_a73c20fb-a5b0-4916-8a4e-c46744a562da">830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of debt discount and issuance fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTAtMS0xLTEtMA_0385051b-3e32-4d02-84bf-164fe7222db6">4,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTAtMy0xLTEtMA_543d76cc-cfab-4c65-bfb6-1c8e809118e6">7,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of commercial license and other economic rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" name="lgnd:AmortizationOfOtherEconomicRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTEtMS0xLTEtMA_a2ebd002-95f2-4c32-b287-8681eefbdc78">528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="lgnd:AmortizationOfOtherEconomicRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTEtMy0xLTEtMA_4bd9a689-ad5d-4184-a2db-401771df6cce">2,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss (gain) on debt extinguishment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTItMS0xLTEtMA_f3dcd443-2bd7-43a9-9b27-cea03e8c5e14">4,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTItMy0xLTEtMA_27313b2f-5bc4-4073-871e-88d486061468">659</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTMtMS0xLTEtMA_62930c42-609c-4bd3-a028-a39dda0d0c21">8,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTMtMy0xLTEtMA_89d42c09-1401-4a9a-b34c-4531e39bfee2">5,653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTQtMS0xLTEtMA_c168ad0d-b23c-4b25-8690-b89dfd919e6d">12,408</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTQtMy0xLTEtMA_50d9dfd1-b141-4703-bee8-2c27f1b4b4ce">10,419</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss (gain) from short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="lgnd:GainLossOnShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTUtMS0xLTEtMA_e3b50e8a-1836-41fb-b230-ccbabc42b57c">13,090</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="lgnd:GainLossOnShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTUtMy0xLTEtMA_3612e0e5-2002-4e5e-81f7-44aaeab498ca">25,456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTYtMS0xLTEtMA_2f23f075-b6e1-4c81-b3bd-8e2d1b6faa23">238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTYtMy0xLTEtMA_9aef7464-45d8-42b0-a422-7ff92c524958">5,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTgtMS0xLTEtMA_1d955a49-09e5-4bd9-a72f-43b1360ded73">2,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTgtMy0xLTEtMA_f3468eca-c910-48c8-8a1c-c14b2e169bd3">8,398</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTktMS0xLTEtMA_639d7d04-1351-4590-b098-842830818e87">9,670</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTktMy0xLTEtMA_016ba290-bb03-4309-acfa-f4e9d2afa661">1,251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts payable and accrued liabilities </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjAtMS0xLTEtMA_7e472e07-c9db-4e12-b280-d508a0823c38">470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjAtMy0xLTEtMA_b269f54d-2e3b-4bd3-9df7-e9efdf1aa3cd">2,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Income tax receivable and payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjEtMS0xLTEtMA_e66a8195-7a5f-436f-b020-b162ad114c82">1,072</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjEtMy0xLTEtMA_97152b6b-c801-45d9-ab35-869eda74e7e9">4,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjItMS0xLTEtMA_c374f50d-2674-4c9c-9d00-8f3b6bb724d8">5,695</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjItMy0xLTEtMA_3dc9d297-a997-411e-9f6b-c4ad4f748fa5">2,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjMtMS0xLTEtMA_d2ef979b-6438-46e2-a246-863a3aebc890">3,768</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjMtMy0xLTEtMA_357b8278-4701-4cc4-abf8-cd45e55ca531">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjQtMS0xLTEtMA_daea6327-5d0d-4845-9485-c2d6bd7ed1ba">10,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjQtMy0xLTEtMA_60675a79-0a91-49ae-bc1e-ea850382d8fc">16,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjgtMS0xLTEtMA_35f5cf28-32f0-43c9-886b-ff8a6bd500b4">72,148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjgtMy0xLTEtMA_a2f826f5-f378-4b78-827f-33cd41b59875">167,374</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjktMS0xLTEtMA_af327af5-6d64-4ba8-b497-0dffb6083572">109,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjktMy0xLTEtMA_8440123b-908c-48d9-af54-1abd9ac9004f">179,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from maturity of short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMzAtMS0xLTEtMA_527079f2-10b3-4561-9f31-fa261ad2aa91">31,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMzAtMy0xLTEtMA_dd8633c3-13d2-4ec6-aecc-47c07b4b74a1">297,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMzMtMS0xLTEtMA_cd12f647-0d14-40db-ab70-1f65d38f19fe">3,644</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMzMtMy0xLTEtMA_8c71319a-ec3d-4b2d-90ec-84f5c5724345">526</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMzQtMS0xLTEtMA_8089dfb9-b92e-4f55-b117-33234b07abfb">65,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMzQtMy0xLTEtMA_cbba94ca-dbbd-4027-af58-65e8d25b7d7e">308,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of 2023 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMzctMS0xLTEtMA_70f478b2-2991-4f07-98cf-617f9050a718">108,822</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMzctMy0xLTEtMA_993dc9c9-e9ae-4e9f-adc7-8f7fc4175fe8">203,210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments under financing lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMzUtMS0xLTEtMzEyNw_753ddc0f-0abc-4dac-b24a-8149a1d64986">3,801</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMzUtMy0xLTEtMzEzMQ_48218183-b169-4f9c-98c4-1e7d44b52ef4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from convertible bond hedge settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromHedgeFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMzktMS0xLTEtMA_5957c7b0-e659-464e-925c-a0ba307495ef">16,855</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromHedgeFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMzktMy0xLTEtMA_03028824-fe5b-4db0-bc88-072126a634f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to convertible bond holders for warrant purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForHedgeFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDAtMS0xLTEtMA_31d9bb32-ca17-4580-9507-354be94655ea">16,459</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsForHedgeFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDAtMy0xLTEtMA_b9f59316-e31f-4f03-b441-4c169b25222b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net proceeds from stock option exercises and ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDEtMS0xLTEtMA_06759512-18bb-40c6-9423-92d02f1e8a42">26,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDEtMy0xLTEtMA_2a690d1b-cebb-4909-95f7-1a228b400ddf">421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Taxes paid related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDItMS0xLTEtMA_386e9c80-10d7-46c7-b66d-8c3a0bc7fac9">5,901</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDItMy0xLTEtMA_97eb4843-2fe2-483b-aa46-6ecaabf23642">1,429</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share repurchase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDMtMS0xLTEtMA_f01ec9fd-33ad-4ffc-8ebb-13c610ce2614">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDMtMy0xLTEtMA_1bda2e60-6795-401d-8201-8c7225a95e25">73,287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to CVR Holders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="lgnd:PaymentsToContingentValueRightHoldersFinancingActivity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDQtMS0xLTEtMA_9ca38eeb-6a43-42f6-8299-8ad185929582">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="lgnd:PaymentsToContingentValueRightHoldersFinancingActivity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDQtMy0xLTEtMA_25d542b0-6d9e-45f6-af0a-665252cf24ab">1,800</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDYtMS0xLTEtMA_606c12ee-8020-4cdd-a5ca-223edeefcf60">91,635</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDYtMy0xLTEtMA_bc57f384-d21f-402b-9cbb-40f3c87b24f9">279,305</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDctMS0xLTEtMA_20d4ca84-3faf-4e60-9c46-fb3885c0f12d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDctMy0xLTEtMA_e6605cce-2b95-457a-93c9-a42b7e3cceb4">169</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDgtMS0xLTEtMA_26a9a1e6-3e42-4e10-9c61-c16787052e71">15,766</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDgtMy0xLTEtMA_989902d5-15ce-42e7-b2a5-61759787857d">45,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDktMS0xLTEtMA_13d3905f-2bf9-49a5-bc01-705cd8aec34d">47,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51e4f49b1fdf4839b077e613a7899628_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDktMy0xLTEtMA_ab249b4d-42ea-44c2-b824-b02feefe16ad">72,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNTAtMS0xLTEtMA_0d67f025-b6f7-4f2d-bd4f-ec5f0514f363">32,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdf27ddbb0974314af1bf955199c9ad2_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNTAtMy0xLTEtMA_0b3a4aa4-f091-4627-9ab4-0d337aa3f98a">118,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOmJmMTc2MGIyZDU0YjQzZGY5MzE0ZTYzNmM1YjFkYjkxL3RhYmxlcmFuZ2U6YmYxNzYwYjJkNTRiNDNkZjkzMTRlNjM2YzViMWRiOTFfMS0xLTEtMS0w_9e847a48-cef9-49dc-b157-04c6b72343e5">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOmJmMTc2MGIyZDU0YjQzZGY5MzE0ZTYzNmM1YjFkYjkxL3RhYmxlcmFuZ2U6YmYxNzYwYjJkNTRiNDNkZjkzMTRlNjM2YzViMWRiOTFfMS0zLTEtMS0w_cd6e19d6-55c5-41c9-9037-41e58958da87">597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash in other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" name="us-gaap:RestrictedCashCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOmJmMTc2MGIyZDU0YjQzZGY5MzE0ZTYzNmM1YjFkYjkxL3RhYmxlcmFuZ2U6YmYxNzYwYjJkNTRiNDNkZjkzMTRlNjM2YzViMWRiOTFfMy0xLTEtMS0w_f1b37ebd-31e5-4367-bfaf-c029f63a74c2">344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdf27ddbb0974314af1bf955199c9ad2_I20200331" decimals="-3" name="us-gaap:RestrictedCashCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOmJmMTc2MGIyZDU0YjQzZGY5MzE0ZTYzNmM1YjFkYjkxL3RhYmxlcmFuZ2U6YmYxNzYwYjJkNTRiNDNkZjkzMTRlNjM2YzViMWRiOTFfMy0zLTEtMS0w_5d3ea29a-a51f-48b4-8c91-f92ee965e5cc">730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental schedule of non-cash activity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued fixed asset purchases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOmJmMTc2MGIyZDU0YjQzZGY5MzE0ZTYzNmM1YjFkYjkxL3RhYmxlcmFuZ2U6YmYxNzYwYjJkNTRiNDNkZjkzMTRlNjM2YzViMWRiOTFfOS0xLTEtMS0w_f1de8f5b-9308-4d01-926f-e8a72106728a">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOmJmMTc2MGIyZDU0YjQzZGY5MzE0ZTYzNmM1YjFkYjkxL3RhYmxlcmFuZ2U6YmYxNzYwYjJkNTRiNDNkZjkzMTRlNjM2YzViMWRiOTFfOS0zLTEtMS0w_7f19032a-b197-4a86-b560-1d4e68100588">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued inventory purchases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" name="lgnd:AccruedInventoryPurchases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOmJmMTc2MGIyZDU0YjQzZGY5MzE0ZTYzNmM1YjFkYjkxL3RhYmxlcmFuZ2U6YmYxNzYwYjJkNTRiNDNkZjkzMTRlNjM2YzViMWRiOTFfMTEtMS0xLTEtMA_4c37a9f3-0bf8-4750-92c6-cab978671174">775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="lgnd:AccruedInventoryPurchases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOmJmMTc2MGIyZDU0YjQzZGY5MzE0ZTYzNmM1YjFkYjkxL3RhYmxlcmFuZ2U6YmYxNzYwYjJkNTRiNDNkZjkzMTRlNjM2YzViMWRiOTFfMTEtMy0xLTEtMA_d9b584c7-78a1-433e-9ef2-d0e84cb1d43d">1,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized loss on AFS investments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOmJmMTc2MGIyZDU0YjQzZGY5MzE0ZTYzNmM1YjFkYjkxL3RhYmxlcmFuZ2U6YmYxNzYwYjJkNTRiNDNkZjkzMTRlNjM2YzViMWRiOTFfMTMtMS0xLTEtMA_72063137-e0a5-48fd-a5a2-ae46f9bf3c43">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOmJmMTc2MGIyZDU0YjQzZGY5MzE0ZTYzNmM1YjFkYjkxL3RhYmxlcmFuZ2U6YmYxNzYwYjJkNTRiNDNkZjkzMTRlNjM2YzViMWRiOTFfMTMtMy0xLTEtMA_c1bcd696-17e3-437d-a89b-a8c5804d5ba9">3,541</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:90%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i38905116b7634694b27917e6ac2a9ef4_31"></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div id="i38905116b7634694b27917e6ac2a9ef4_34"></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unless the context requires otherwise, references in this report to &#8220;Ligand,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; the &#8220;Company,&#8221; and &#8220;our&#8221; refer to Ligand Pharmaceuticals Incorporated and its consolidated subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">1.  <ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg2MDI_3573a210-cef0-4e43-9262-b4aa6f45b732" continuedAt="i6e76dd3072a74c49af1a5a25bbcba44b" escape="true">Basis of Presentation and Summary of Significant Accounting Policies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i6e76dd3072a74c49af1a5a25bbcba44b" continuedAt="idd27aab19ebe4aa0977df5de0bf6f4b5"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg2MDQ_f048c74b-6e26-4198-a8df-af5c96d27473" continuedAt="i75d70d7997e743c4aa9ef7a75076b9fe" escape="true">Basis of Presentation</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i75d70d7997e743c4aa9ef7a75076b9fe">Our condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2020 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.</ix:continuation>  </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjE5OTAyMzMxMzYwNA_5ece32c4-f6c1-4093-a1ba-8ee52b4aacc0" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, &#8220;contract revenue&#8221; and &#8220;service revenue&#8221; presented in the condensed consolidated statement of operations for the three months ended March 31, 2020 have been combined into &#8220;contract revenue&#8221; in the condensed consolidated statement of operations to conform with the current period presentation. &#160;In addition, &#8220;gain (loss) from Viking&#8221; and a portion of &#160;&#8220;other expense, net&#8221; that related to other short-term investments presented in the condensed consolidated statement of operations for the three months ended March 31, 2020 have been combined into &#8220;gain (loss) from short-term investments&#8221; in the condensed consolidated statement of operations to conform with the current period presentation.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have described our significant accounting policies in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements in our 2020 Annual Report. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1Nzc_d5487625-ce10-42d8-989e-195261a5be58" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of COVID-19 Pandemic</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current COVID-19 worldwide pandemic has presented substantial public health and economic challenges and is affecting our employees and partners, patients, communities and business operations, as well as the U.S. and global economy and financial markets. International and U.S. governmental authorities in impacted regions have taken actions in an effort to slow the spread of COVID-19, including issuing varying forms of &#8220;stay-at-home&#8221; orders, and restricting business functions outside of one&#8217;s home. In response, we have restricted in-person access to our executive offices, our administrative employees are mostly working remotely, and we have limited the number of staff in our research and development laboratories and other facilities. The continued spread of the COVID-19 pandemic and the measures taken by the governments of countries have affected, and could continue to affect, our business and the business of our partners, including future disruptions to our supply chain and the manufacture or shipment of drug substance and finished drug product for Captisol, delays by us or our partners in the initiation or enrollment of patients in clinical trials, discontinuations by patients enrolled in clinical trials, difficulties launching or commercializing products and other related activities, which could delay ongoing clinical trials, increase development costs, reduce royalty revenues and have a material adverse effect on our business, financial condition and results of operations. Several of our partners have reported that their operations have been impacted including delays in research and development programs and deprioritizing clinical trials in favor of treating patients who have contracted the virus or to prevent the spread of the virus. This may lead to clinical trial protocol deviations or to discontinuation of treatment for patients who are currently enrolled in the clinical trials being conducted by us or our partners. In addition, certain of our partners have reported negative impacts on product sales which will impact our royalty revenues.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="idd27aab19ebe4aa0977df5de0bf6f4b5" continuedAt="ia725c3cbad994163baf34e321dfce9bf"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our partners are working to develop drugs to treat COVID-19. For example, we are supplying Captisol to partners, including Gilead for Veklury (remdesivir), the first FDA-approved treatment for COVID-19 for the treatment of patients with COVID-19 requiring hospitalization. In addition, certain of our OmniAb partners have initiated antibody discovery programs for the potential treatment of COVID-19.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The full extent to which the COVID-19 pandemic will directly or indirectly impact our business, the businesses of our partners, our results of operations and our financial condition will depend on future developments that are highly uncertain and cannot be accurately predicted, including new information that may emerge concerning COVID-19, the actions taken to contain it or treat its impact, including the timing and extent of governments reopening or further restricting activities, and the economic impact on local, regional, national and international markets.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1NDY_37ddf27d-63b7-44b4-bf01-3f3d87a3425d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The new guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP. This standard removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. This standard is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020 and adoption must be as of the beginning of the Company&#8217;s annual fiscal year. We are currently evaluating the impact of this standard on our consolidated financial statements and related disclosures. We intend to adopt this standard on January 1, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on our condensed consolidated financial statements or disclosures.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1ODM_12c499dd-105e-4f3c-bc1a-b9ace2e34fe1" continuedAt="i9f4b75f7e236413a8f5d90427b970359" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Royalties </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we own. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a sales-based royalty to be recorded when the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues are adjusted for in the period in which they become known, typically the following quarter. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Contract Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contract revenue includes service revenue, license fees and future contingent milestone based payments. We recognize service revenue for contracted R&amp;D services performed for our customers over time. We measure our progress using an input method based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time we estimate it will take us to complete the activities, or costs we incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make estimates and use judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We include contingent milestone based payments in the estimated transaction price when there is a basis to reasonably estimate the amount of the payment.  These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the&#160;transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon or after the development milestone or regulatory approval.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ia725c3cbad994163baf34e321dfce9bf" continuedAt="ic09edfbc87f3412b9c7377f3d2b2d1c1"><ix:continuation id="i9f4b75f7e236413a8f5d90427b970359" continuedAt="i8f29ee07cac647f5bb45864c300a1920"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Captisol Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue when control of Captisol material is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. We have elected to recognize the cost for freight and shipping when or after control over Captisol material has transferred to the customer as an expense in cost of Captisol. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. We use an observable price to determine the stand-alone selling price for separate performance obligations or a cost plus margin approach when one is not available. </span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8f29ee07cac647f5bb45864c300a1920">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry a contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue. During the three months ended March&#160;31, 2021, the amount recognized as revenue that was deferred at December 31, 2020 was $<ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMTc1OTM_27479fdf-cdcd-4ffb-9849-be213499a08a">7.3</ix:nonFraction> million. During the three months ended March&#160;31, 2020, the amount recognized as revenue that was deferred at December 31, 2019 was $<ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMTc3MDI_600a81fd-e9d8-4333-9ad0-8c5a23bcf2a7">1.0</ix:nonFraction> million.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation&#160;of&#160;Revenue </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1NDc_587a8e77-f932-45a2-aad0-22b5464193fe" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:61.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70e6045ea57e4960b5e7b991ff6afe59_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfNC0yLTEtMS0w_fca4f8c0-48f5-4a78-b30a-744ce76d04e4">4,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141de7606bb14beea82d45802f93d383_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfNC00LTEtMS0w_299a5a72-efd2-4194-ab7e-22de8b2a261c">4,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4196bfc37550432080d7f0d6eec3b8d5_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfNS0yLTEtMS0w_78ec19ce-91fc-4331-a975-de004c361b4a">2,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43bf79f5a943475489db1bfa57aa7668_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfNS00LTEtMS0w_3bf0b4ec-c01e-47a9-8180-600b5c933383">1,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i242bcf58c1cd4fcfa0c2d36e1fe47f5c_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfNi0yLTEtMS0w_be85cc70-a558-4221-b763-e4db0b9c9d0b">492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd88764b91554104994dd396befa8270_D20200101-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfNi00LTEtMS0w_2db2d39b-f671-48e9-b60e-1023b0d77755">584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie30239110ac54ae2af1d194e9c6384f4_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfOC0yLTEtMS0w_cea9560c-a212-4c08-9c32-ed196992dab4">7,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e4b63fffd544d8c9290215bd3714192_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfOC00LTEtMS0w_65abb636-2f94-4c89-98ba-ab2e45d35c0d">6,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9ffb7664b0411f8db3b6b38d6632e4_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTAtMi0xLTEtMA_06d23c1d-e9ee-4cf7-95dc-a134fc0ea4c8">31,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6be2d05e46c04f22a00605da2833d1da_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTAtNC0xLTEtMA_19bed2d9-7720-40dc-be8f-f49e37266356">21,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service Revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71204e5781b46798722ee98c6925ade_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTMtMi0xLTEtMA_fe34d971-b2e3-4a58-83fc-861b9bc3d794">5,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c38be1b284c4082985f73fc8fd4cb08_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTMtNC0xLTEtMA_39bd8e09-33f5-42fb-828a-6715a0dd4a74">3,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic015ad72c3c0416383db07b48a5a7c6a_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTQtMi0xLTEtMA_f8699719-8b25-4965-8da1-51b2c308c9f9">1,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8df2708d62174fbdac6fecdf1774ab15_D20200101-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTQtNC0xLTEtMA_f0c9b1ef-63c0-4e81-b59a-1b3c70d99982">975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Milestone</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd0f3e11676d4c139d4f33ff5e608d98_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTUtMi0xLTEtMA_edd65393-e99b-48b8-bcad-89221c280bc5">8,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098bf91f61f44dc08cae022ea07af921_D20200101-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTUtNC0xLTEtMA_0f48bd44-2052-4ac6-88a0-f52dd579ffb2">334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i707023875ea742a58c7c82670518aa3a_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTYtMi0xLTEtMA_36eb7e06-0329-4f49-9f8f-573b857c4802">1,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbb090f086294a258eff6658c99e6ab0_D20200101-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTYtNC0xLTEtMA_baf05372-1026-423e-b15a-093233b64629">821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14b88249e38e42929cf58c0afff44f7c_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTctMi0xLTEtMA_3bf6bca0-d65e-4da8-96d3-fbbf08f81c1e">16,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77e9a47601246a2acde91f6d3baa812_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTctNC0xLTEtMA_ac1f341a-8e23-4768-8373-15c3acbfbf85">5,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTktMi0xLTEtMA_70bad146-a137-4e25-bdd2-707c22d98751">55,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTktNC0xLTEtMA_6652d68d-6c4d-4797-9368-a6a53e4dd5b1">33,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ic09edfbc87f3412b9c7377f3d2b2d1c1" continuedAt="i064c0320a5de4d58bd0bb03f9c44bb8b"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Investments </span></div><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="lgnd:ScheduleOfShortTermInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1NDg_32fe1028-378a-4723-b612-3036d2d22f41" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term investments consist of the following at March&#160;31, 2021 and December 31, 2020 (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:21.722%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.410%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.359%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.909%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.359%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.659%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47e88f0429c44134b883d6f3aa820b25_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNC0xLTEtMS0w_ff64a326-af8e-497d-a406-8ee61209e12f">51,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47e88f0429c44134b883d6f3aa820b25_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNC0zLTEtMS0w_32bb501d-d48e-4a31-b141-230ac2fb88b3">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47e88f0429c44134b883d6f3aa820b25_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNC01LTEtMS0w_6fb96dd5-2269-47fa-8765-30566f1e41c5">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47e88f0429c44134b883d6f3aa820b25_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNC03LTEtMS0w_911ddca6-dc30-4478-b16f-5652c11166f5">51,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a07ebdd562e411fae6b15bb21f8c1aa_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNC05LTEtMS0w_9aff40fb-b6aa-4d93-9518-34a5a0c92744">84,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a07ebdd562e411fae6b15bb21f8c1aa_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNC0xMS0xLTEtMA_68fe819d-879d-48e7-9877-c933d7f4a7c6">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a07ebdd562e411fae6b15bb21f8c1aa_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNC0xMy0xLTEtMA_ee7b48e3-0c43-41cd-821f-c24abef3b59e">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a07ebdd562e411fae6b15bb21f8c1aa_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNC0xNS0xLTEtMA_880f9818-972e-49b1-a45c-c5a2b1e10b17">84,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24b1ae2706284cdca4eb23d9915a4450_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNS0xLTEtMS0w_0a3f54f5-13c0-409b-ba55-a1ba411e6d64">25,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24b1ae2706284cdca4eb23d9915a4450_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNS0zLTEtMS0w_3e707ca2-2480-41df-9537-cf4df2315ac9">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24b1ae2706284cdca4eb23d9915a4450_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNS01LTEtMS0w_049977b4-1b0a-45ce-bd53-71fcd16c8ed8">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24b1ae2706284cdca4eb23d9915a4450_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNS03LTEtMS0w_9b9014ed-b33f-4c27-a4b2-7ab343af75ec">25,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c916d897e674db5919221cdca2f97bb_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNS05LTEtMS0w_3bd3b1f3-6056-458b-a37f-5a7717222ba8">30,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c916d897e674db5919221cdca2f97bb_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNS0xMS0xLTEtMA_501a4698-eab2-437c-af12-56e5b536e133">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c916d897e674db5919221cdca2f97bb_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNS0xMy0xLTEtMA_ee923c5f-8cb8-4d9b-974d-85d6b3a65152">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c916d897e674db5919221cdca2f97bb_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNS0xNS0xLTEtMA_5b2cb5db-413a-4600-b9bb-a5fd6ee7b275">30,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7ca3f45fb8d4984b3709f858a5d4195_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi0xLTEtMS05MDE_dfb4e702-05a7-4883-b4d4-93f40a44f3b7">4,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7ca3f45fb8d4984b3709f858a5d4195_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi0zLTEtMS05MDE_ddebdedf-7885-4651-99b3-035c157b9dad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7ca3f45fb8d4984b3709f858a5d4195_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi01LTEtMS05MDE_624b0541-046c-4e86-a124-ce215acd1add">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7ca3f45fb8d4984b3709f858a5d4195_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi03LTEtMS05MDE_20d49f35-6eac-429c-ae5d-1c06b278bdfb">4,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9eb656aa6e5479a85a382cc47a8eca1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi05LTEtMS0yNzg_773af0fc-d45a-46e9-9110-824962dd453e">4,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9eb656aa6e5479a85a382cc47a8eca1_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi0xMS0xLTEtMjg5_b2e26bf1-384c-4e0f-8e30-5d81adcd01a6">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9eb656aa6e5479a85a382cc47a8eca1_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi0xMy0xLTEtMjk0_98e0f1ea-8bde-44c4-9154-39557cebc0d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9eb656aa6e5479a85a382cc47a8eca1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi0xNS0xLTEtOTAx_d899b523-1465-4877-8fa0-9532166cd847">4,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8c5e7437834c46ae9735a7aaa4148c_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi0xLTEtMS0w_2c4fecf9-5ccd-4638-b2fb-776e879768ee">19,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8c5e7437834c46ae9735a7aaa4148c_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi0zLTEtMS0w_cbfc9475-2958-43a1-858d-e311053cb73b">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8c5e7437834c46ae9735a7aaa4148c_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi01LTEtMS0w_db7296de-b9da-4864-81b1-4d28257ec153">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8c5e7437834c46ae9735a7aaa4148c_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi03LTEtMS0w_134d969b-4ecc-414f-921f-456eb56cfb64">19,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd22ab765384cccacfc57e8e1996cc2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi05LTEtMS0w_8cf310ec-670f-4452-8915-efef0310aa0e">45,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd22ab765384cccacfc57e8e1996cc2_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi0xMS0xLTEtMA_c54f1728-8e55-4917-a2a7-24fac80a5141">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9cd22ab765384cccacfc57e8e1996cc2_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi0xMy0xLTEtMA_de5ca339-99fe-4820-8b46-87a6841b95db">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd22ab765384cccacfc57e8e1996cc2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi0xNS0xLTEtMA_0a36f8a4-cf08-49ed-b4b5-2b3cc6af61bd">45,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27ccac3b42614165a6aa9e91ee7ff005_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNy0xLTEtMS0w_880c8388-a1f4-409c-93ab-bbee257cf64e">4,456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27ccac3b42614165a6aa9e91ee7ff005_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNy0zLTEtMS0w_31ac4cb6-2d6d-4976-b1f7-db28514f90aa">3,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27ccac3b42614165a6aa9e91ee7ff005_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNy01LTEtMS0w_40bebbee-fe66-4835-afa9-5a9df335fa30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27ccac3b42614165a6aa9e91ee7ff005_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNy03LTEtMS0w_c6b01b53-099f-41fa-a135-a7c980b10053">8,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if16401e5b6d848aea59ba13c03311074_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNy05LTEtMS0w_4608332a-888b-4d78-8031-0c5cc46a482d">4,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if16401e5b6d848aea59ba13c03311074_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNy0xMS0xLTEtMA_339eaa94-86c9-4b55-9e91-5cd473325741">360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if16401e5b6d848aea59ba13c03311074_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNy0xMy0xLTEtMA_2bb7444c-6b4a-4712-ba48-435ca6a7b9f4">1,388</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if16401e5b6d848aea59ba13c03311074_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNy0xNS0xLTEtMA_54350007-e59a-4b95-b6bd-f11747ccfd75">3,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87abf73938904ca5aa12b57c61dab1a0_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOC0xLTEtMS0w_93d7c807-c4d8-471c-a13e-90e0e59e198f">151,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87abf73938904ca5aa12b57c61dab1a0_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOC0zLTEtMS0w_e71ca65e-9872-4c91-9871-d3e61b09a063">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87abf73938904ca5aa12b57c61dab1a0_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOC01LTEtMS0w_a0cb7c68-9151-4510-a2e3-c1d3c5e91f15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87abf73938904ca5aa12b57c61dab1a0_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOC03LTEtMS0w_9c89d6cc-c551-442d-b17b-91918b757158">151,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bf3ec58e21145b6b4ceb58e80ec79b8_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOC05LTEtMS0w_bea27d50-ed93-4989-8aa6-8a3cfa8195b5">151,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bf3ec58e21145b6b4ceb58e80ec79b8_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOC0xMS0xLTEtMA_2d1d5e33-4604-4042-b796-80771c26c4ec">386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bf3ec58e21145b6b4ceb58e80ec79b8_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOC0xMy0xLTEtMA_479260bd-4967-46bd-9214-0a3f6f520932">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bf3ec58e21145b6b4ceb58e80ec79b8_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOC0xNS0xLTEtMA_825c66f2-6a1f-4328-bc68-ea0a158a4055">151,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Treasury bill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d3c8187465b443d8f77beeb3adb7d56_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtMS0xLTEtOTAz_f9258625-7406-4918-84b1-d7651c8c8f6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d3c8187465b443d8f77beeb3adb7d56_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtMy0xLTEtOTAz_58c28287-111a-4679-a6b9-214b9674d3f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d3c8187465b443d8f77beeb3adb7d56_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtNS0xLTEtOTAz_8d78a58e-c241-4ff2-93a4-d4c7594a982d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d3c8187465b443d8f77beeb3adb7d56_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtNy0xLTEtOTAz_5150b9f0-fabf-42f7-9d48-09d31ce83e5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i680ece1eaa8f4e9e96ce0f42882bf0ce_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtOS0xLTEtMjgy_e88ed081-a125-4ae4-be2f-c835cd0eff33">3,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i680ece1eaa8f4e9e96ce0f42882bf0ce_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtMTEtMS0xLTI5OA_2f70ac18-cd1a-4864-a00a-2379948b4ba3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i680ece1eaa8f4e9e96ce0f42882bf0ce_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtMTMtMS0xLTI5OA_bdbfb54e-af03-462f-a965-729d750493f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i680ece1eaa8f4e9e96ce0f42882bf0ce_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtMTUtMS0xLTkwMw_dca188f0-080d-4e6a-be0e-a3d3ad65ace8">3,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib28fef4680854a929dbf60cedeb06434_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOS0xLTEtMS0w_1fffb920-da1b-4e47-b10e-25e5352ef42d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib28fef4680854a929dbf60cedeb06434_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOS0zLTEtMS0w_898443ff-e6d3-4132-8c7d-6bf1b8b18621">1,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib28fef4680854a929dbf60cedeb06434_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOS01LTEtMS0w_de0d8985-12fd-462b-a9f5-f3824e82296d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib28fef4680854a929dbf60cedeb06434_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOS03LTEtMS0w_e5f1d30c-7f29-4066-be80-1de1c8776e91">1,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18f2c42543b54aeaab387d94848006f1_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOS05LTEtMS0w_d8b91fb4-8769-4cf4-9884-14552358b9f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18f2c42543b54aeaab387d94848006f1_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOS0xMS0xLTEtMA_7b4e1a10-354a-4fb9-804a-41533343a720">393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18f2c42543b54aeaab387d94848006f1_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOS0xMy0xLTEtMA_d6a7f834-50de-41cc-a980-f01c4208dbbc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18f2c42543b54aeaab387d94848006f1_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOS0xNS0xLTEtMA_51856142-840a-4057-8a1f-04b66dbbfa37">393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtMS0xLTEtMA_ef0952b2-2ed1-4381-99c1-331a5423b184">257,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtMy0xLTEtMA_3e74c023-22bc-4ca4-9b01-e09773918e85">5,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtNS0xLTEtMA_fb7a42e2-4cf5-4704-80e0-40dfaacf8be3">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtNy0xLTEtMA_87e7787e-8a7a-4364-aeec-b6456d37e5ad">262,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtOS0xLTEtMA_60d01704-0b37-4f10-b1f1-4d56c3659413">324,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtMTEtMS0xLTA_e86ca717-3ca0-429a-a6c7-6a41217af141">1,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtMTMtMS0xLTA_39ae02f1-a206-40ad-8c59-1482f8762e33">1,391</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtMTUtMS0xLTA_ed6e2f55-0891-49fd-8b02-e958c3f70a87">324,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9b9c500f9c64c18aa188576147e659c_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTItNy0xLTEtNDAwMw_1efd3764-093f-4fe1-82a6-fb340297d0ab">44,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c8207a04074c06b323ed60e1b6a82d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTItMTUtMS0xLTQwMTM_4315d57c-88ee-45d8-89d8-bed2734a5d06">32,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib28fef4680854a929dbf60cedeb06434_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTMtNy0xLTEtNDAwMw_b7a9ba94-4b85-461b-a752-4aa874c7d182">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18f2c42543b54aeaab387d94848006f1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTMtMTUtMS0xLTQwMTM_cd504654-1c95-4087-aad8-6eaaf2cdffa1">6,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTQtNy0xLTEtNDEwMA_ac88e89d-6809-4db2-9435-b3cc8120363c">307,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTQtMTUtMS0xLTQxMDM_ccfa7eb9-3604-4f25-bb89-66899559e9a2">363,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:22.5pt"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2021, we sold <ix:nonFraction unitRef="shares" contextRef="i992a781875754f6cafea588cdb51c0ca_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="lgnd:EquityMethodInvestmentSharesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjE5OTAyMzMwNTI1Mw_33a10d62-b7ae-4875-b262-e98fca99ef1d">0.3</ix:nonFraction>&#160;million shares of Viking and recognized a realized gain of $<ix:nonFraction unitRef="usd" contextRef="i992a781875754f6cafea588cdb51c0ca_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjE5OTAyMzMwNTIzOQ_9c34fa85-d0ba-49bd-a03e-1c127964b346">2.2</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2021, we exercised all outstanding Viking warrants to purchase <ix:nonFraction unitRef="shares" contextRef="i24b65a2994c74dc1966ff120cfabeae7_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMTgzMjc_4f2bffca-ed1d-4875-848c-4f3d26856c2d">1.5</ix:nonFraction> million shares of Viking's common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i0997448e200d4b4ca09ddc4917d0b9fb_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMTgzODY_e7f508d6-665f-4327-b71a-1cbc6a036412">1.50</ix:nonFraction> per share. As of March&#160;31, 2021, we have <ix:nonFraction unitRef="shares" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjE5OTAyMzMwMzk1OQ_9b56b4f3-f4c8-4988-a2c1-fe6166a1a073">zero</ix:nonFraction> Viking warrants outstanding.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (loss) from short-term investments in our condensed consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allowances are recorded for available-for-sale debt securities with unrealized losses. This limits of the amount of credit losses that can be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The provisions of the credit losses standard did not have a material impact on our available-for-sale debt securities during the three months ended March&#160;31, 2021.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1Nzk_1216198d-40b7-4ff5-816a-44154941c7b8" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmJjYzNiNjVkZmQ5ODQ3OTU4ZjRlNWQyMjRmYmViYjQ0L3RhYmxlcmFuZ2U6YmNjM2I2NWRmZDk4NDc5NThmNGU1ZDIyNGZiZWJiNDRfMi0xLTEtMS0w_7dbeec47-9c7c-4492-9ce8-f2a1a215195b">77,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmJjYzNiNjVkZmQ5ODQ3OTU4ZjRlNWQyMjRmYmViYjQ0L3RhYmxlcmFuZ2U6YmNjM2I2NWRmZDk4NDc5NThmNGU1ZDIyNGZiZWJiNDRfMi0zLTEtMS0w_e857dbc8-37fc-427a-8b02-e0f73dbf850a">77,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmJjYzNiNjVkZmQ5ODQ3OTU4ZjRlNWQyMjRmYmViYjQ0L3RhYmxlcmFuZ2U6YmNjM2I2NWRmZDk4NDc5NThmNGU1ZDIyNGZiZWJiNDRfMy0xLTEtMS0w_36591736-37e5-4a1b-a303-e3e69828d00b">23,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmJjYzNiNjVkZmQ5ODQ3OTU4ZjRlNWQyMjRmYmViYjQ0L3RhYmxlcmFuZ2U6YmNjM2I2NWRmZDk4NDc5NThmNGU1ZDIyNGZiZWJiNDRfMy0zLTEtMS0w_3159167e-f567-4aaf-a518-01d73c2eabca">23,509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmJjYzNiNjVkZmQ5ODQ3OTU4ZjRlNWQyMjRmYmViYjQ0L3RhYmxlcmFuZ2U6YmNjM2I2NWRmZDk4NDc5NThmNGU1ZDIyNGZiZWJiNDRfNS0xLTEtMS0w_d7a609d5-028a-4579-ac0d-00b51ecf7b6e">101,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmJjYzNiNjVkZmQ5ODQ3OTU4ZjRlNWQyMjRmYmViYjQ0L3RhYmxlcmFuZ2U6YmNjM2I2NWRmZDk4NDc5NThmNGU1ZDIyNGZiZWJiNDRfNS0zLTEtMS0w_3be77b85-1c24-4413-b5d3-424ef3201240">101,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment policy is capital preservation and we only invested in U.S.-dollar denominated investments. We held a total of <ix:nonFraction unitRef="position" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMTk3MjM_ca64cce5-04d5-4e1f-a399-1c41f2e15140">11</ix:nonFraction> positions which were in an unrealized loss position as of March&#160;31, 2021. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, <ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjAzMjY_5246d1a5-4ef7-4f39-90c9-ccacf799c126">no</ix:nonFraction> credit losses were recognized for the three months ended March&#160;31, 2021.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i064c0320a5de4d58bd0bb03f9c44bb8b" continuedAt="i2d33b64f31c04c859d2997a9a1100bee"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Credit Losses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers. During the three months ended March&#160;31, 2021, we considered the current and expected future economic and market conditions including, but not limited to, the anticipated unfavorable impacts of the surrounding novel coronavirus (COVID-19) pandemic on our business and recorded an adjustment of $<ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-4" format="ixt:numdotdecimal" name="lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMTA0NDUzNjA1MTM3OTk_39e3452f-b0d8-4ef9-95ae-9a58cd3056ac">0.02</ix:nonFraction>&#160;million of allowance for credit losses as of March&#160;31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Other Identifiable Intangible Assets</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1ODk_58415d71-1465-49e7-b682-e0f172fecac2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other identifiable intangible assets consist of the following (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfMi0xLTEtMS0w_bbcca37f-0626-4934-960b-e2cec7c9f962">190,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfMi0zLTEtMS0w_68ef91db-4286-4cec-8358-e6017c7c1870">189,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7852648236234a7383fffb89802800ca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfNC0xLTEtMS0w_9f4dc064-1d23-4e43-96c3-88d7a2308d16">277,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ead48471b4147b89d513734d4b371ce_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfNC0zLTEtMS0w_ba108f5e-adf1-4701-83ab-4f1bdee196c0">277,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7852648236234a7383fffb89802800ca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfNS0xLTEtMS0w_2a537586-6ad0-42b7-9eeb-86e0f1f62188">67,441</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ead48471b4147b89d513734d4b371ce_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfNS0zLTEtMS0w_534a184c-39cb-4cfa-aaa9-49fcf8d9b3bb">63,600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7203c2e57ce64b9499cf15be8da138c9_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfNi0xLTEtMS0w_5174cf93-94ea-4739-97da-78901deb7e01">2,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5b27dc5beda4d28a2d31e5f523528e7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfNi0zLTEtMS0w_4bf4092d-1ee1-4b1a-915a-ac320c1cc4ec">2,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7203c2e57ce64b9499cf15be8da138c9_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfNy0xLTEtMS0w_42a75402-aaa1-4692-8d0f-4bdaca282595">1,345</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5b27dc5beda4d28a2d31e5f523528e7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfNy0zLTEtMS0w_6b993f50-e645-4a43-b29a-563d1eb5a718">1,312</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd0a1696112f4034b165e99d7e54c9c0_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfOC0xLTEtMS0w_fd63b254-3aaf-4f09-b742-23cbac3acc4f">40,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c9320f5f705481e843a64fa98520fce_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfOC0zLTEtMS0w_c25929c6-ec62-4ba3-b978-57977fec324d">40,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd0a1696112f4034b165e99d7e54c9c0_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfOS0xLTEtMS0w_2aabfadc-968e-4052-aeac-f3c94d088095">16,264</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c9320f5f705481e843a64fa98520fce_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfOS0zLTEtMS0w_8769e6a5-3361-4b40-b4af-28c928d82826">15,597</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contractual relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3be05d22f1714924ba3f177f26a1f2ad_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfMTEtMS0xLTEtMzkw_81207791-a371-41df-a762-b5ddd6f33aea">362,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6708118507a499aba0e32aaf3cbf208_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfMTEtMy0xLTEtMzgy_22532c77-89f5-48f3-b3f2-ccdd6b055d8d">362,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3be05d22f1714924ba3f177f26a1f2ad_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfMTItMS0xLTEtMzkw_09244dff-174d-45d9-a2a6-6a98a00e31b0">14,487</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6708118507a499aba0e32aaf3cbf208_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfMTItMy0xLTEtMzgy_b8e4f13f-964b-409c-8ead-7d46b033f30d">7,243</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfMTAtMS0xLTEtMA_fa57e20c-a5d8-4e79-bca5-49d110825399">774,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfMTAtMy0xLTEtMA_ea1c3677-783c-4f6e-891d-c3c09c0b15a3">784,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial License and Other Economic Rights</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1ODU_175d0ff6-0a73-4728-95d1-3c86f22fd147" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license and other economic rights consist of the following (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.777%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5726bdc386542a4a8883e9ff2d6dbac_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfMi0yLTEtMS0w_17e4e8c0-9a8b-4cce-96da-c96619c8dcdb">17,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5726bdc386542a4a8883e9ff2d6dbac_I20210331" decimals="-3" format="ixt:numdotdecimal" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfMi00LTEtMS0w_d329d3ae-0c57-4a08-a79f-8d811ebc9154">9,530</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5726bdc386542a4a8883e9ff2d6dbac_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfMi02LTEtMS0w_1b3ff950-d114-436e-9bad-26ba240df0d0">8,166</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7981ffd8dd3442db85faa0971ba2b0f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfMi04LTEtMS0w_7671e83d-0c6c-4291-a0f8-71d77e9c047e">17,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7981ffd8dd3442db85faa0971ba2b0f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfMi0xMC0xLTEtMA_82951c34-f962-4fbb-8ba8-aac7960ac4f0">9,588</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7981ffd8dd3442db85faa0971ba2b0f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfMi0xMi0xLTEtMA_933e30fb-f1b9-4580-bdfe-746f60c61071">8,108</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i990fc430839b439297429383d8dc1565_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfNC0yLTEtMS0w_e6c42cab-f2f3-42f0-a902-41de800a8f76">10,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i990fc430839b439297429383d8dc1565_I20210331" decimals="-3" format="ixt:numdotdecimal" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfNC00LTEtMS0w_c598a3cf-292d-4b4a-8593-f44688e556a3">8,317</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i990fc430839b439297429383d8dc1565_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfNC02LTEtMS0w_c711d8a3-12ca-4a3c-b7d7-7a65e5ad7501">2,285</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd41f0958aea453c93d67393583f4114_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfNC04LTEtMS0w_00516d8c-1b1c-466f-a391-a333237533bf">10,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd41f0958aea453c93d67393583f4114_I20201231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfNC0xMC0xLTEtMA_2d008aa9-d904-4751-9aa5-88174b6af5f5">7,731</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd41f0958aea453c93d67393583f4114_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfNC0xMi0xLTEtMA_d8a61ae9-0146-40d8-91b8-c25ac57cd29b">2,871</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib164760a00e846d5b34f96b078179fad_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfNS0yLTEtMS0w_30ba5e26-e918-4296-bbe1-0d3ece82f58d">28,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib164760a00e846d5b34f96b078179fad_I20210331" decimals="-3" format="ixt:numdotdecimal" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfNS00LTEtMS0w_68bd4c6d-e64a-4162-9f88-18baf55f208f">17,847</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib164760a00e846d5b34f96b078179fad_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfNS02LTEtMS0w_9c1d27e4-f60e-4465-abeb-f23c4a61ee4d">10,451</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if664c4e0370e4eecb98b57e6559c8596_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfNS04LTEtMS0w_01eaaace-f7a8-4e76-bcc9-92f63204ec0c">28,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if664c4e0370e4eecb98b57e6559c8596_I20201231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfNS0xMC0xLTEtMA_ad412614-f21f-4f9b-8078-337f0b37f2d5">17,319</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if664c4e0370e4eecb98b57e6559c8596_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfNS0xMi0xLTEtMA_1b37194c-1fb0-4301-92f7-cd8bea9e3538">10,979</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $<ix:nonFraction unitRef="usd" contextRef="ib164760a00e846d5b34f96b078179fad_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjIwNDc_8be5615f-9540-4591-a3b9-56e5fc9bab41">11.9</ix:nonFraction> million and credit loss adjustments of $<ix:nonFraction unitRef="usd" contextRef="ib164760a00e846d5b34f96b078179fad_I20210331" decimals="-5" format="ixt:numdotdecimal" name="lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjIwODQ_a64575c8-f946-47e1-85cb-fb22cb18f0a9">6.0</ix:nonFraction> million as of March&#160;31, 2021.</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $<ix:nonFraction unitRef="usd" contextRef="if664c4e0370e4eecb98b57e6559c8596_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMTA5OTUxMTY3MjIyMg_9f614490-44bf-4c9d-8dba-1242cc4e45db">11.3</ix:nonFraction> million and credit loss adjustments of $<ix:nonFraction unitRef="usd" contextRef="if664c4e0370e4eecb98b57e6559c8596_I20201231" decimals="-5" format="ixt:numdotdecimal" name="lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMTA5OTUxMTY3MjI3Ng_1118d834-1af1-4f1b-8678-2f9cfd6c12ee">6.0</ix:nonFraction> million as of December&#160;31, 2020.</span></div></ix:nonNumeric><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commercial license and other economics rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis in April 2013 and April 2015, CorMatrix in May 2016, and Dianomi in January 2019. Commercial license rights acquired are accounted for as financial assets and other economic rights are accounted for as funded research and developments as further discussed below and in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 1,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Notes to Consolidated Financial Statements in our 2020 Annual Report. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In May 2017, we entered into a Royalty Agreement with Aziyo pursuant to which we will receive royalties from certain marketed products that Aziyo acquired from CorMatrix. We account for the Aziyo commercial license right as a financial asset, and in accordance with ASC 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Receivables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, we amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the Royalty Agreement with Aziyo as of March&#160;31, 2021 is <ix:nonFraction unitRef="number" contextRef="i286a8bb93953439fafa3f00769457019_D20210101-20210331" decimals="2" name="lgnd:ForecastedCashFlowsEffectiveInterestRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjMyNDE_716cd584-f78b-45c0-ae5b-e43fc0269cd9">23</ix:nonFraction>%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i2d33b64f31c04c859d2997a9a1100bee" continuedAt="idb350fc976eb448982122938c83277d8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The payments received during the three months ended March&#160;31, 2021 were accordingly allocated between revenue and the amortization of the commercial license rights.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to 2020, we accounted for commercial license rights related to developmental pipeline products such as Selexis and Dianomi on a non-accrual basis. Starting in 2020, given the expected cash flow from the Selexis program, we started to account for the Selexis commercial license right as a financial asset in accordance with ASC 310, and amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the royalty agreement with Selexis as of March&#160;31, 2021 is <ix:nonFraction unitRef="number" contextRef="i0d642c075bb94ad9924379a085bcce17_D20210101-20210331" decimals="2" name="lgnd:ForecastedCashFlowsEffectiveInterestRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjE5OTAyMzMwMzk2OQ_7e25eebf-6595-4908-9374-4dbb4cc062a4">21</ix:nonFraction>%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. The payments received during the three months ended March&#160;31, 2021 were accordingly allocated between revenue and the amortization of the commercial license rights. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We recorded a $<ix:nonFraction unitRef="usd" contextRef="i09abab2b25044ad981b26743b386f8ed_I20200101" decimals="-5" format="ixt:numdotdecimal" name="lgnd:CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjQ4Njk_216c8112-52d8-47d5-9882-9347d97e2773">5.5</ix:nonFraction> million pre-tax reserve for credit losses upon adoption of the credit losses standard (ASU 2016-13) on January 1, 2020. We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the three months ended March&#160;31, 2021, we further considered the current and expected future economic and market conditions surrounding novel coronavirus (COVID-19) pandemic and concluded no further adjustment was needed on the allowance for credit losses as of March 31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accrued Liabilities</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1Njg_769fb355-5573-40f7-a382-be2778d78b7d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfMi0yLTEtMS0w_487baeb9-4c82-4379-bb22-43828a435022">3,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfMi00LTEtMS0w_1ef1ae80-8a04-4114-a1eb-96fe796af37b">8,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfMy0yLTEtMS0w_e72decbb-7f64-4717-8aef-3381c1ab160a">958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfMy00LTEtMS0w_7347ca5d-e556-4c0b-b8e6-8b67a4926740">977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" name="lgnd:LicenseeAccrualCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfNC0yLTEtMS0w_fa1f68e3-d522-4257-8987-20154bc1b0ff">468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" name="lgnd:LicenseeAccrualCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfNC00LTEtMS0w_22dd51f7-20cf-44a0-be8c-35c836e15df0">421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties owed to third parties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" name="us-gaap:AccruedRoyaltiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfNS0yLTEtMS0w_5a0eb9d7-729b-4f9e-859f-40635a58666d">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" name="us-gaap:AccruedRoyaltiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfNS00LTEtMS0w_b78679c7-3ad7-41b5-bad1-cbc9f5d8bc48">693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Return reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" name="lgnd:ReturnsAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfNi0yLTEtMS0w_ccbccd53-1d90-40f0-a9bd-654fc6ee51cb">682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" name="lgnd:ReturnsAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfNi00LTEtMS0w_45e9ec3a-0b4b-448c-9b1c-b22de13c0af7">687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="lgnd:AccruedAssetAcquisitionsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfNy0yLTEtMS05MTk_80cc359e-3068-4853-84d5-dba32a780f1b">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:AccruedAssetAcquisitionsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfNy00LTEtMS00MjI_e2df8efb-2b05-4136-92a7-b4e4330cf4ee">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subcontractor</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="lgnd:AccruedSubcontractorExpensesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfOS0yLTEtMS05MjI_c9857c18-a592-4608-8626-a26aedfa1e78">1,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" name="lgnd:AccruedSubcontractorExpensesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfOS00LTEtMS00MzA_a85a691a-d232-4bbb-9fdc-4a94af0dc985">733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" name="lgnd:AccruedSupplierExpensesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfMTAtMi0xLTEtOTIy_8c87f15d-c0b6-40c2-9026-41a8a18cde76">788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" name="lgnd:AccruedSupplierExpensesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfMTAtNC0xLTEtNDMw_43ad3487-d502-4fb6-bca8-c60902f348c9">604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfOC0yLTEtMS0w_08584a4e-e400-46f8-bfcf-2efe66572be6">1,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" name="us-gaap:InterestPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfOC00LTEtMS0w_d1c8e048-eaad-4821-bf2f-aa17ac366d53">464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfOS0yLTEtMS0w_b194bd0b-2c9a-4a6d-84a9-5e7157ca1049">2,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfOS00LTEtMS0w_7dcbaabe-272e-4a2b-b016-48198c432749">3,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfMTAtMi0xLTEtMA_2ccd2956-bd47-4948-bc0d-90fa56dabc4d">12,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfMTAtNC0xLTEtMA_95ad2195-6e02-4552-8c9a-4e7525c26e19">18,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1OTU_2ab47c3c-c182-40ed-ba2a-3f0874c55f64" continuedAt="iccc13dc1f5c14b56828cf6f210be1e27" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period until the last tranche vests. <ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="lgnd:ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1OTA_3f9ec636-b1c5-4cb7-b7ed-9d2824b35be4" continuedAt="icd710baa66294ba992f10cf0f0b2b96d" escape="true">The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><ix:continuation id="icd710baa66294ba992f10cf0f0b2b96d"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb80e938ceac4acba68f8190bbb48240_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmZlYjYxMTg1ODVhYzRmMDZhOTI2ZDRlNGE0NzJkYWNmL3RhYmxlcmFuZ2U6ZmViNjExODU4NWFjNGYwNmE5MjZkNGU0YTQ3MmRhY2ZfMy0xLTEtMS0w_da4f74ed-c8fe-4ce8-98fe-b498630b99fe">3,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20687aac1929409b8e8ba72ed696b358_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmZlYjYxMTg1ODVhYzRmMDZhOTI2ZDRlNGE0NzJkYWNmL3RhYmxlcmFuZ2U6ZmViNjExODU4NWFjNGYwNmE5MjZkNGU0YTQ3MmRhY2ZfMy0zLTEtMS0w_c3d98aac-2425-48ac-be3b-b7c4e8f9b494">2,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dbd1ffbbe68420b892aebb33efbf91e_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmZlYjYxMTg1ODVhYzRmMDZhOTI2ZDRlNGE0NzJkYWNmL3RhYmxlcmFuZ2U6ZmViNjExODU4NWFjNGYwNmE5MjZkNGU0YTQ3MmRhY2ZfNC0xLTEtMS0w_6d3c6e88-53c4-433e-88b7-ae0771643f97">4,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01775962d3284134ba883acf9233e929_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmZlYjYxMTg1ODVhYzRmMDZhOTI2ZDRlNGE0NzJkYWNmL3RhYmxlcmFuZ2U6ZmViNjExODU4NWFjNGYwNmE5MjZkNGU0YTQ3MmRhY2ZfNC0zLTEtMS0w_3d5dfccc-3c27-45e4-9c53-852259b961f2">3,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmZlYjYxMTg1ODVhYzRmMDZhOTI2ZDRlNGE0NzJkYWNmL3RhYmxlcmFuZ2U6ZmViNjExODU4NWFjNGYwNmE5MjZkNGU0YTQ3MmRhY2ZfNS0xLTEtMS0w_11b6f08d-4b79-4d58-a44a-01de1829faeb">8,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmZlYjYxMTg1ODVhYzRmMDZhOTI2ZDRlNGE0NzJkYWNmL3RhYmxlcmFuZ2U6ZmViNjExODU4NWFjNGYwNmE5MjZkNGU0YTQ3MmRhY2ZfNS0zLTEtMS0w_74eca78e-573c-42f2-9725-b8131091ade7">5,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="idb350fc976eb448982122938c83277d8"><ix:continuation id="iccc13dc1f5c14b56828cf6f210be1e27"><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1OTE_48824c79-b911-46ee-b47d-368dab1695c4" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjI3OWEwN2YwNDQ5MDQxZGRiMmI2M2I1YzMyNmRkNWI2L3RhYmxlcmFuZ2U6Mjc5YTA3ZjA0NDkwNDFkZGIyYjYzYjVjMzI2ZGQ1YjZfMy0xLTEtMS0w_a2f0aae2-b2e7-48f4-bccd-02054e994d2f">0.5</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjI3OWEwN2YwNDQ5MDQxZGRiMmI2M2I1YzMyNmRkNWI2L3RhYmxlcmFuZ2U6Mjc5YTA3ZjA0NDkwNDFkZGIyYjYzYjVjMzI2ZGQ1YjZfMy0zLTEtMS0w_c3de20db-7325-411b-9444-64ff45565018">1.4</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjI3OWEwN2YwNDQ5MDQxZGRiMmI2M2I1YzMyNmRkNWI2L3RhYmxlcmFuZ2U6Mjc5YTA3ZjA0NDkwNDFkZGIyYjYzYjVjMzI2ZGQ1YjZfNC0xLTEtMS0w_c7781c8f-54f8-4ab8-a81e-46bca929c62a">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjI3OWEwN2YwNDQ5MDQxZGRiMmI2M2I1YzMyNmRkNWI2L3RhYmxlcmFuZ2U6Mjc5YTA3ZjA0NDkwNDFkZGIyYjYzYjVjMzI2ZGQ1YjZfNC0zLTEtMS0w_bb3d5a75-ed72-4886-8a83-711c240d4f14">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjI3OWEwN2YwNDQ5MDQxZGRiMmI2M2I1YzMyNmRkNWI2L3RhYmxlcmFuZ2U6Mjc5YTA3ZjA0NDkwNDFkZGIyYjYzYjVjMzI2ZGQ1YjZfNS0xLTEtMS0w_c0fda8ac-a975-4c96-8078-98861224b0b3">63</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjI3OWEwN2YwNDQ5MDQxZGRiMmI2M2I1YzMyNmRkNWI2L3RhYmxlcmFuZ2U6Mjc5YTA3ZjA0NDkwNDFkZGIyYjYzYjVjMzI2ZGQ1YjZfNS0zLTEtMS0w_491fbf57-d352-494c-9256-d4d7cee6a4b7">47</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjI3OWEwN2YwNDQ5MDQxZGRiMmI2M2I1YzMyNmRkNWI2L3RhYmxlcmFuZ2U6Mjc5YTA3ZjA0NDkwNDFkZGIyYjYzYjVjMzI2ZGQ1YjZfNi0xLTEtMS0w_78759ee2-0956-4657-8281-b776e11edc63">5.0</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjI3OWEwN2YwNDQ5MDQxZGRiMmI2M2I1YzMyNmRkNWI2L3RhYmxlcmFuZ2U6Mjc5YTA3ZjA0NDkwNDFkZGIyYjYzYjVjMzI2ZGQ1YjZfNi0zLTEtMS0w_30df53c4-a73b-4c38-b8da-95c20d14bf92">4.7</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a <ix:nonNumeric contextRef="if96bbf53f57741718a23af11bbf99850_D20210101-20210331" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjE5OTAyMzMwMzk5OA_307284e0-73ce-4b91-8b04-89b809ab1754">three-year</ix:nonNumeric> performance period, with a range of <ix:nonFraction unitRef="number" contextRef="i72938e42d49d4e7eb47d38ac3ea3ef3c_D20210101-20210331" decimals="INF" name="lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjE5OTAyMzMwMzk3NA_872a7852-c871-4767-b2d3-1f1d301bf8b0">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i70472c97b924411e836f34d9300a0722_D20210101-20210331" decimals="INF" name="lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjE5OTAyMzMwMzk3OQ_e1be2c3f-1795-414b-bf3a-707b591dbc1c">200</ix:nonFraction>% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1Njk_0557d067-5c3b-42b3-988a-ac22985188fa" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the applicable conversion price of the respective notes. It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 4, Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 6, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1NTU_77c86535-bc2a-44a8-b4d5-a41b96dce142" escape="true"><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1NTY_7db17bca-27a9-4807-89c1-20ca4ca4fbe9" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:72.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.832%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.984%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjY5YjIyN2RjMWVjMzRjMGQ5ODgzZWZhNzkzZmM1ZjMxL3RhYmxlcmFuZ2U6NjliMjI3ZGMxZWMzNGMwZDk4ODNlZmE3OTNmYzVmMzFfMy0xLTEtMS0w_70bb3aa8-b0fb-428e-98b3-24a8826c6180">16,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjY5YjIyN2RjMWVjMzRjMGQ5ODgzZWZhNzkzZmM1ZjMxL3RhYmxlcmFuZ2U6NjliMjI3ZGMxZWMzNGMwZDk4ODNlZmE3OTNmYzVmMzFfMy0zLTEtMS0w_a491cb6d-84f3-4d4c-8c7a-eadf7bb32690">16,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjY5YjIyN2RjMWVjMzRjMGQ5ODgzZWZhNzkzZmM1ZjMxL3RhYmxlcmFuZ2U6NjliMjI3ZGMxZWMzNGMwZDk4ODNlZmE3OTNmYzVmMzFfNS0xLTEtMS0w_c1d9b01f-3bc5-4c7c-b391-41e73f20b6ad">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjY5YjIyN2RjMWVjMzRjMGQ5ODgzZWZhNzkzZmM1ZjMxL3RhYmxlcmFuZ2U6NjliMjI3ZGMxZWMzNGMwZDk4ODNlZmE3OTNmYzVmMzFfNS0zLTEtMS0w_8c068dab-69f0-4bb4-bfa2-18f13c9156be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjY5YjIyN2RjMWVjMzRjMGQ5ODgzZWZhNzkzZmM1ZjMxL3RhYmxlcmFuZ2U6NjliMjI3ZGMxZWMzNGMwZDk4ODNlZmE3OTNmYzVmMzFfNi0xLTEtMS0w_27306ef3-4690-4d5d-b352-9461cd9a9974">701</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjY5YjIyN2RjMWVjMzRjMGQ5ODgzZWZhNzkzZmM1ZjMxL3RhYmxlcmFuZ2U6NjliMjI3ZGMxZWMzNGMwZDk4ODNlZmE3OTNmYzVmMzFfNi0zLTEtMS0w_ead1feab-c72b-4638-b0f1-5d7706c4a442">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjY5YjIyN2RjMWVjMzRjMGQ5ODgzZWZhNzkzZmM1ZjMxL3RhYmxlcmFuZ2U6NjliMjI3ZGMxZWMzNGMwZDk4ODNlZmE3OTNmYzVmMzFfNy0xLTEtMS0w_da8b2824-12e8-42dc-8d58-08cbfd2222eb">17,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjY5YjIyN2RjMWVjMzRjMGQ5ODgzZWZhNzkzZmM1ZjMxL3RhYmxlcmFuZ2U6NjliMjI3ZGMxZWMzNGMwZDk4ODNlZmE3OTNmYzVmMzFfNy0zLTEtMS0w_20f2fc68-4bfc-4d63-a704-f379dbd0ab46">16,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjY5YjIyN2RjMWVjMzRjMGQ5ODgzZWZhNzkzZmM1ZjMxL3RhYmxlcmFuZ2U6NjliMjI3ZGMxZWMzNGMwZDk4ODNlZmE3OTNmYzVmMzFfOC0xLTEtMS0w_7406d575-535c-45d6-8d7e-71744ebb4bef">4,277</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjY5YjIyN2RjMWVjMzRjMGQ5ODgzZWZhNzkzZmM1ZjMxL3RhYmxlcmFuZ2U6NjliMjI3ZGMxZWMzNGMwZDk4ODNlZmE3OTNmYzVmMzFfOC0zLTEtMS0w_81c16c3c-0eb3-4a72-aca1-fb3c66c45583">10,144</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="i38905116b7634694b27917e6ac2a9ef4_37"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.  <ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RleHRyZWdpb246Zjc0ZDNjMmEyNzk0NDNkNmFiNGFiNGRiNDcxZmU1MzZfNTI2OA_b64bab1c-af21-4021-b423-732c22c9a289" continuedAt="ifb15ec7e304d4d838e851b1831e5145a" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ifb15ec7e304d4d838e851b1831e5145a" continuedAt="i0babea0a9ca64771b2d90115729dc2d6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured on a Recurring Basis</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RleHRyZWdpb246Zjc0ZDNjMmEyNzk0NDNkNmFiNGFiNGRiNDcxZmU1MzZfNTI3Mg_dfc3c939-657b-433a-bab6-a4903e7056a3" continuedAt="i024d1e8a5197409fb2bea4dc9f626bc2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.830%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, excluding Viking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01ac0fd2b84c4fc5b18e59e48f25cc79_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMy0yLTEtMS0w_4edd886a-1d82-43a4-b112-ed1504767d96">8,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dc6712b5fe940d29478311fd3e7cffd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMy00LTEtMS0w_ab3b49f3-f830-46a1-bcff-0c1a20f9f30c">253,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf9c6df9fa44ab3b0c1c35c985251b4_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMy02LTEtMS0w_0dd2544c-ba14-44fb-a20d-0f2fff14a437">1,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21a101cfd24747168bf94b313b3708e4_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMy04LTEtMS0w_54b4e5a6-4959-4ba2-8669-71a7edd09638">262,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7f4f7589d8c492484b84f28687479b4_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMy0xMC0xLTEtMA_62e79d7f-eb80-4663-94f6-87faf0bc2167">3,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i676b57f3d66941bbb97cc26113e1e806_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMy0xMi0xLTEtMA_1636e155-3287-4920-a87d-51d1853197b6">320,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i860855786f834ea394e0c7e66f585b07_I20201231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMy0xNC0xLTEtMA_612b3902-0c12-4cf3-9a4a-bd6a83c1e6f7">393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9054c6008288417ea8d10ca0540acb93_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMy0xNi0xLTEtMA_d7e2dc9c-f951-4a34-b7bb-cf620eb535bd">324,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e0fd90b4eb14c3eb7f87756026effcf_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNC0yLTEtMS0w_c5bef006-7a55-40e9-83ec-164d66cff929">44,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94a7f3facc544380b14212b1d50f599d_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNC00LTEtMS0w_5dc21d19-e5f4-4afd-9c35-020d45ddca66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc3c971711634a419850f39be2cfa217_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNC02LTEtMS0w_7a73b89a-2668-46d8-a84b-9bc83605324b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f5f82fc4c44419894bfd3fe856e02b_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNC04LTEtMS0w_d3ec8e6e-b55a-4262-b3da-b8e29e9dc21a">44,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14699c2d32754f1197a391489d15ff48_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNC0xMC0xLTEtMA_87fdd99b-d9cd-4a8c-97f5-3b24181b6678">32,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e8d1f401b4d4013ac32b2787dcfde55_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNC0xMi0xLTEtMA_c5904ab7-22b4-4358-b04f-0d039a54ab07">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0daa67408a4451890054460225dfe05_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNC0xNC0xLTEtMA_808d9d17-3d46-45ad-b421-9f307a53d659">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53101502568a44758ee1969b8fdf9b5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNC0xNi0xLTEtMA_febc46ab-081d-48f9-b352-3d21b648f30e">32,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if91f9465b6884e95a7b42fca92d3ff5d_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNS0yLTEtMS0w_9262dfe7-df65-4bef-b928-eda65f220da3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6913dd8993464fe78ba52964658dba31_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNS00LTEtMS0w_f29b7976-4bfe-4b7e-8b88-9f5c955abf47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f881c4d7c174319a38f46630210dcbd_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNS02LTEtMS0w_0d35ac37-cccc-4dc6-b623-a59d57a906ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6087cecae97d4d2abd6e060d610ce948_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNS04LTEtMS0w_c03fe2e9-38a4-4521-a924-d15215be513f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77031116cff2427bb586198ff9e95cb4_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNS0xMC0xLTEtMA_de224c6f-f615-4799-87a0-70d173a8baed">6,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f9b50f07b984d18a9dbe45a0861f8a5_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNS0xMi0xLTEtMA_1f41fb16-1a33-4bbe-9cad-e913f8f97047">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7364700da439492b9c9c4b04d2cd984f_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNS0xNC0xLTEtMA_d32848fa-6e1c-4eba-876f-f601c8f810ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee4babfe9e4448e9679afd11c8e1932_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNS0xNi0xLTEtMA_5ee5d5f7-7508-4821-a579-d1cce9a28332">6,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06d16d86c2ee446498927c381c54d77a_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNi0yLTEtMS0w_ea5830b4-473c-4fb2-a33d-7603feeac765">52,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19ca28155cef4fd5b5524f954cccaab7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNi00LTEtMS0w_9bf61aeb-b9ab-43d0-b7c2-d073a1a45b25">253,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b8100a5b2440b48556561a4ba1e0d1_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNi02LTEtMS0w_31864b55-d473-48b3-bc4e-e38f75a16034">1,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i109de96646db44268497efcc2f95bdc9_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNi04LTEtMS0w_66254efe-ba1a-4619-bb4b-a5dd163cead6">307,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13a03a90dd824a3e802cc74fbc6ef67a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNi0xMC0xLTEtMA_3dc5ef7b-d614-442b-8431-f22d1b6d7d51">42,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc817baab77c490b9eb5d576b2ff57d9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNi0xMi0xLTEtMA_b2e25218-9d94-446a-857f-b27ac94ec7f9">320,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if692e5a3f16a4775a9bf2a0e13049d43_I20201231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNi0xNC0xLTEtMA_3e194307-c25b-431e-b2ed-4e296d7992a3">393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c91fdccad734cd3acfb28a7aaee6b08_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNi0xNi0xLTEtMA_49d3b275-c1ee-427d-af5f-de259c29c93e">363,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39cdc2145c9b43dbb9e35f9deff11202_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOC0yLTEtMS0w_14270bb8-7916-462e-bff4-67aaeeab3b13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5621884f55514f528b5732d922eb7ddd_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOC00LTEtMS0w_bc78889f-1198-4a05-a52a-44dea0c29a37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14f70b29c1fe4ff7aba75d3e69a1823a_I20210331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOC02LTEtMS0w_aff9532a-be0f-4220-bfa9-4c95369afa7e">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b9807f967ff4cf582d5e8a8fece80fb_I20210331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOC04LTEtMS0w_3acb23b9-d0d2-4181-87a1-066fd1f24316">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79f0b8beb45a4a4bbba8ce8211ecd94e_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOC0xMC0xLTEtMA_f526a7c7-d58e-4d78-83ee-0bfe70567e76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0a9f236332f4dba8a23b8e155f3a30f_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOC0xMi0xLTEtMA_5a72a302-a548-4685-8402-d334ffb6239c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71d6fc626ce745feb5e33003ac131708_I20201231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOC0xNC0xLTEtMA_f05602ad-e7f4-4b90-957e-f4dfec242903">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1d6ac0f98304bd8a2522d46969847b6_I20201231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOC0xNi0xLTEtMA_1c4a66c4-c367-480d-b3f5-d0b9da156285">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i833b7fb3b5b14e4e8b4ebb0909d05a2c_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOS0yLTEtMS0w_11fe13f4-37bb-440a-a306-0cbc6dbcff73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fddbe170634491dbd21d99d8b590f70_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOS00LTEtMS0w_fd56316c-4c98-4fa2-814d-f2fbca91ba07">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4160bae3ab043dbb32c58acc74cd048_I20210331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOS02LTEtMS0w_ebe85218-ce47-40ad-8c3c-0b13d5e4cf17">496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6079969ef2d54e55ad4b585ec4ec53b9_I20210331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOS04LTEtMS0w_f86585a4-9b1a-4a98-b95d-62a7db24ce88">496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f6a3b9c3c7b42919ab58c0e2df5585a_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOS0xMC0xLTEtMA_b6178cd8-a0bf-4eba-9556-4b74513f4b5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id388d63d20d04cfabec6273b9266aa22_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOS0xMi0xLTEtMA_cb03cd50-42ce-46d6-b44b-63442cae1a95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id897ba84812c48c2a65b9776129298aa_I20201231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOS0xNC0xLTEtMA_c140a329-72e8-40bb-b439-024a45db02fe">508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i357b9497652046d0aba3cbdc8518d7b4_I20201231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOS0xNi0xLTEtMA_6f55fa4c-2493-4e30-9af3-d1430216370d">508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife81c045c5a444e09b2d8bc249fece59_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTAtMi0xLTEtMA_0df33768-93d4-459f-aa8d-335d170dfcf7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931f4e016c724c36974f1c1989897bd3_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTAtNC0xLTEtMA_11756169-b0d9-4564-b387-3eef879e13b2">4,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a4a9dc8a3eb408d89b937d07499587e_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTAtNi0xLTEtMA_452f630a-f120-4e70-9d32-cff254dad5e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2078f46e4a554de986254804e81be7c6_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTAtOC0xLTEtMA_80714dd5-2d35-4ae1-b487-e6dcedb7deb3">4,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8ff9c1d2a4e40b3a67f944c849a2bd2_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTAtMTAtMS0xLTA_086d42fb-288b-41ac-b2ea-65e5c3b34912">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie33ba4dc377840ee882fdaddd0d69bb0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTAtMTItMS0xLTA_6efc5efb-8780-4115-89c1-9374e8dd5930">3,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia63b7b49beba4f378566a8be00c1898d_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTAtMTQtMS0xLTA_8dcde095-9f75-464d-96e7-34f3d1c1d7f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib65896a541534edc814e839cea969d72_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTAtMTYtMS0xLTA_8b0a7c2e-feee-4dfb-aa8d-7d38e54c4339">3,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820ccc6258144fb897101140c8a14d81_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTEtMi0xLTEtMA_6f883b06-e9f5-42ed-8afa-e286d8a2b13b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c972363fdac4ab6a767c041ae940266_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTEtNC0xLTEtMA_2c67b17f-a274-4218-8622-616514d1443d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3c2d8108f0346fea380bd0c9a9a1e5a_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTEtNi0xLTEtMA_570a0cc1-e7ce-4de9-84f1-3a664099b115">7,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i261414f831ba4e1aac8a6551f971d92e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTEtOC0xLTEtMA_b3f20e77-2be7-4207-a8c8-f3a43f7ccf77">7,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43ca9b3cd64f442287f5c9dbd74d520d_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTEtMTAtMS0xLTA_faf98fab-42e6-4bd6-ad46-4f2e56d0b810">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc8c1e565e1493fa5a29d2c0d691486_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTEtMTItMS0xLTA_ba45309f-191c-4d2c-b0bd-dbf557ac5490">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0660fc90350f4c508461c189c1838ea0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTEtMTQtMS0xLTA_1b5ae8e3-e081-455b-ae37-00b7515ff0f1">6,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id89615ba04ac4f9f94097b92892cdf6f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTEtMTYtMS0xLTA_3045f398-4aa4-4139-809d-db8bf1f87185">6,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pfenex contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia210fcf0a4934eb995df10b0db2c9c88_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItMi0xLTEtOTMw_99de4ab6-bd06-4535-a534-e9059231cb94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f9eb705d8b94a9283d4c25e1ece7d11_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItNC0xLTEtOTMw_9164c120-3fe9-4b03-8b5a-978e7e6b52e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if977d0d8bf974b6fa76de0a2e644188d_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItNi0xLTEtOTMw_1bd45190-6a3b-4d58-be27-e72a85a335fa">37,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5b8469bd6b24519a53e1cba447d8c57_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItOC0xLTEtOTMw_b0eab3f7-1daf-400a-a2c6-8d5dc5f70766">37,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf6b5d5d9635440999d3e164431442cc_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItMTAtMS0xLTUxMQ_f2391ddd-3a35-4a48-8014-827acb25a100">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief120523936f41ed9556d9c5fbe600ad_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItMTItMS0xLTUxMQ_366a0875-51f8-4196-b3e2-4d69d8c51061">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6205bd153ad465cbe32e8557a90f2df_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItMTQtMS0xLTUxMQ_c3a31fdf-bd26-4b2c-b88b-dde7a4131193">37,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9214e2b7471f4a8588e5b99aada1a660_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItMTYtMS0xLTkzMA_9652b152-8c06-4a67-b8a5-2979ae5f1238">37,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">xCella contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ba8a0cf524d4e13b76c6e92d9cf97bf_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtMi0xLTEtMjM1Nw_b88f11a8-6eaa-4663-9269-87033f91a745">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4294ac1f67eb491c96a6a8cce49fcabe_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtNC0xLTEtMjM1Nw_9c5dea85-9558-49d4-95ef-862cc5afa66a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92495438f1b146f898c4e64490283810_I20210331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtNi0xLTEtMjM1Nw_ac84c6d0-8467-4bf4-a9cf-c39591c7d8c8">240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8eb4e94ac6604758b1ea1704401c3d58_I20210331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtOC0xLTEtMjY5OQ_11e93a02-392b-409b-a6c1-c8bcb5838ca3">240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbad4460fcf648928ffdb191dbdb6530_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtMTAtMS0xLTIzOTg_8a59670a-ffc1-4069-8fed-b58446125317">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03dd9ae0aed74d5a904172437cf8186f_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtMTItMS0xLTIzOTg_74184841-c1e4-445f-be82-942f24bf08d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58a521fe18574d6e968798b4c1586455_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtMTQtMS0xLTIzOTg_660bf2b3-f0c7-4060-a9be-936ec1844437">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ab71e0fd4724a4db71bf93a6413a975_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtMTYtMS0xLTI2OTk_88a9e49c-7c21-4496-9455-20033bfbc686">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensor</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee481251a6b54158be7b4a7effbb8c67_I20210331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItMi0xLTEtMA_1faa6d84-bd74-448c-9c89-9670c0d2165e">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic79acce6117446459676d52e173a1126_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItNC0xLTEtMA_2a4fc1b4-2707-4908-9d79-70fcf2bb47f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i943f22467f954f6993644f529795f102_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItNi0xLTEtMA_93d570a0-baa5-4bda-89dd-83ecf1568b23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3b0aff995404ab8acd400501adf43bd_I20210331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItOC0xLTEtMA_ffcee557-6d51-487d-8cb4-1c67551d1f4c">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a5a184f056f42c4b443fbae9b3fba2b_I20201231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItMTAtMS0xLTA_b93d4d9b-8e10-41a2-adfb-f539f9a03371">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cd59ec89e943c8bddbe705cb6e15f6_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItMTItMS0xLTA_c3e4b648-bba0-4a7a-bdc8-f37ebb1db40a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i657fb3d5faae4a9990079266a0c01a60_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItMTQtMS0xLTA_32fbf6a2-fa38-4166-91a8-914f89668885">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62031fdd8c3645a7b3c2189805b7a8cb_I20201231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItMTYtMS0xLTA_b299cb2a-5a29-4bdc-884d-01f4202dc551">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06d16d86c2ee446498927c381c54d77a_I20210331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtMi0xLTEtMA_58ce260b-c6fb-43f6-a6a1-a7211727671e">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19ca28155cef4fd5b5524f954cccaab7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtNC0xLTEtMA_9b148b4f-b087-4d4d-9b84-0cea63d363f6">4,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b8100a5b2440b48556561a4ba1e0d1_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtNi0xLTEtMA_fdabf6ef-adef-4176-a469-db866d7cbec2">46,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i109de96646db44268497efcc2f95bdc9_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtOC0xLTEtMA_4feb15a3-3c50-442b-9bd8-b6ce75482d72">51,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13a03a90dd824a3e802cc74fbc6ef67a_I20201231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtMTAtMS0xLTA_df346cde-45d1-48b5-94fb-f23dc72781a4">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc817baab77c490b9eb5d576b2ff57d9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtMTItMS0xLTA_ebe2f9ad-963d-4032-995f-ecddfd31f9a6">3,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if692e5a3f16a4775a9bf2a0e13049d43_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtMTQtMS0xLTA_116c21a4-e075-4e35-8a95-c9b1294017c0">45,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c91fdccad734cd3acfb28a7aaee6b08_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtMTYtMS0xLTA_85e3b35b-4e8f-44c3-9296-f8a9ded202ea">49,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.&#160;Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Investment in Viking warrants, which we received as a result of Viking&#8217;s partial repayment of the Viking note receivable and our purchase of Viking common stock and warrants in April 2016, are classified as level 1 as the fair value is determined using quoted market prices in active markets for the same securities. The change of the fair value is recorded in "Gain (loss) from short-term investments" in our condensed consolidated statement of operations. During the three months ended March&#160;31, 2021, we exercised all of the outstanding Viking warrants. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Crystal contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on development or regulatory milestones as defined in the merger agreement with Crystal. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders <ix:nonFraction unitRef="contingent_value_right" contextRef="i972be18486384106a14259204b8f719b_D20100101-20100131" decimals="INF" format="ixt-sec:numwordsen" name="lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RleHRyZWdpb246Zjc0ZDNjMmEyNzk0NDNkNmFiNGFiNGRiNDcxZmU1MzZfMjU0Ng_3ddd3085-0e08-4441-930b-ea87868d1503">four</ix:nonFraction> tradable CVRs, <ix:nonFraction unitRef="contingent_value_right" contextRef="i972be18486384106a14259204b8f719b_D20100101-20100131" decimals="INF" format="ixt-sec:numwordsen" name="lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RleHRyZWdpb246Zjc0ZDNjMmEyNzk0NDNkNmFiNGFiNGRiNDcxZmU1MzZfMjU2NA_bd4d205e-e1de-4fb2-afe4-7f6d2e5b7871">one</ix:nonFraction> CVR from each of <ix:nonFraction unitRef="contingent_value_right_series" contextRef="idce9b211fa9d42818fdc3f8ff61affb4_D20100101-20100131" decimals="INF" format="ixt-sec:numwordsen" name="lgnd:NumberOfContingentValueRightsSeries" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RleHRyZWdpb246Zjc0ZDNjMmEyNzk0NDNkNmFiNGFiNGRiNDcxZmU1MzZfMjU4NA_ef1fd8d6-9d4c-4583-995c-4d2e04ea0df8">four</ix:nonFraction> respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every <ix:nonNumeric contextRef="i972be18486384106a14259204b8f719b_D20100101-20100131" format="ixt-sec:durwordsen" name="lgnd:BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RleHRyZWdpb246Zjc0ZDNjMmEyNzk0NDNkNmFiNGFiNGRiNDcxZmU1MzZfMjcxOQ_68845909-5dcb-4d89-b110-1963e097632e">six months</ix:nonNumeric> as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $<ix:nonFraction unitRef="usd" contextRef="ic427fd87f48e4f049d21351088ee3bc2_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RleHRyZWdpb246Zjc0ZDNjMmEyNzk0NDNkNmFiNGFiNGRiNDcxZmU1MzZfMzUyMQ_39bac294-696f-4c16-8b7e-a85d41e8d557">375</ix:nonFraction> million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $<ix:nonFraction unitRef="usd" contextRef="i372f6d3fb38e43cd82744ef34999bd0a_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RleHRyZWdpb246Zjc0ZDNjMmEyNzk0NDNkNmFiNGFiNGRiNDcxZmU1MzZfMzYzNg_8db042f6-1f14-482b-8be1-d788af461842">10</ix:nonFraction> million payment upon initiation of a Phase 3 clinical trial. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Pfenex contingent liabilities was determined using a probability-adjusted income approach. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of the Company.</span></div></ix:nonNumeric><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i024d1e8a5197409fb2bea4dc9f626bc2" continuedAt="i90a6acd77a7d4c208d37a914db46c3c5">7.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"><ix:continuation id="i90a6acd77a7d4c208d37a914db46c3c5">The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. Management concluded that no earnout liability would be recognized at the acquisition date in September 2020.  In the three months ended March&#160;31, 2021, management recorded an earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RleHRyZWdpb246Zjc0ZDNjMmEyNzk0NDNkNmFiNGFiNGRiNDcxZmU1MzZfMjE5OTAyMzI2NDM1NQ_d68cec29-eaa3-4109-8310-8a02de3b490d" continuedAt="ib7d4094f9a204c90a8ba7db1b6ebd1c2" escape="true">A reconciliation of the level 3 financial instruments as of March&#160;31, 2021 is as follows (in thousands):</ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i0babea0a9ca64771b2d90115729dc2d6" continuedAt="i4f883c89f28e423b9ba9c75f5a612f13"><div style="margin-bottom:6pt"><ix:continuation id="ib7d4094f9a204c90a8ba7db1b6ebd1c2"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28435ac625f4e8f8e07977537c41fef_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOmJlMTEzMjI2MjE2YTQxOGY5MGEyNTM2ZjQ3ZWM2OWI3L3RhYmxlcmFuZ2U6YmUxMTMyMjYyMTZhNDE4ZjkwYTI1MzZmNDdlYzY5YjdfMS0xLTEtMS0yNDE5_6a3f5810-f213-4a0c-945e-005613abd0b9">45,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3739dfe7d8c541718c9f50a133133136_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOmJlMTEzMjI2MjE2YTQxOGY5MGEyNTM2ZjQ3ZWM2OWI3L3RhYmxlcmFuZ2U6YmUxMTMyMjYyMTZhNDE4ZjkwYTI1MzZmNDdlYzY5YjdfMS0xLTEtMS0yNDQ0_5379f076-a589-46dd-9e04-9fbc7afbb3db">1,323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent liabilities from xCella asset acquisition</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3739dfe7d8c541718c9f50a133133136_D20210101-20210331" decimals="-3" name="lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOmJlMTEzMjI2MjE2YTQxOGY5MGEyNTM2ZjQ3ZWM2OWI3L3RhYmxlcmFuZ2U6YmUxMTMyMjYyMTZhNDE4ZjkwYTI1MzZmNDdlYzY5YjdfMi0xLTEtMS0zMzg0_4d7f2f3a-a1b9-43aa-99ba-6727a36a3c9f">240</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of March 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife201f82dfa94172abde90879f18f167_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOmJlMTEzMjI2MjE2YTQxOGY5MGEyNTM2ZjQ3ZWM2OWI3L3RhYmxlcmFuZ2U6YmUxMTMyMjYyMTZhNDE4ZjkwYTI1MzZmNDdlYzY5YjdfMi0xLTEtMS0yNzA2_08158137-5928-4fe2-8327-a3d2fa46c32f">46,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Measured on a Non-Recurring Basis</span></div><div style="text-indent:22pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets and long-lived assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4f883c89f28e423b9ba9c75f5a612f13">There were no triggering events identified and no indication of impairment of our goodwill, indefinite-lived intangible assets, or long-lived assets during the three months ended March&#160;31, 2021.</ix:continuation> </span></div><div><span><br/></span></div><div id="i38905116b7634694b27917e6ac2a9ef4_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.  <ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfODE1Mw_d62087b2-1f00-463a-ab65-cd7bffb1a8db" continuedAt="i53225490c5fc43058eb3fae5185b04e2" escape="true">Acquisitions</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i53225490c5fc43058eb3fae5185b04e2" continuedAt="i4e409aeb08594d8290144ba17c9ff283"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Pfenex Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On October 1, 2020, we acquired Pfenex, which develops next-generation and novel protein therapeutics to improve existing therapies and create new therapies for biological targets linked to critical, unmet diseases using a protein expression technology platform.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preliminary purchase price of $<ix:nonFraction unitRef="usd" contextRef="i4464b8371b004313b6607d086dec25b2_D20201001-20201001" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDM5ODA0NjUzMDk5MA_1f6b417c-a32d-45ec-aa9b-ed54e4089e56">465.1</ix:nonFraction>&#160;million included $<ix:nonFraction unitRef="usd" contextRef="i4464b8371b004313b6607d086dec25b2_D20201001-20201001" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDM5ODA0NjUzMTAxMg_c5773dd4-7a88-4d11-9a3f-e65d5e2f74db">429.6</ix:nonFraction>&#160;million cash consideration paid upon acquisition, and a contingent CVR payment of up to $<ix:nonFraction unitRef="usd" contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDM5ODA0NjUzMTAzMg_b8dc8fc7-8639-4e53-bf65-d13ffb9f6a69">77.8</ix:nonFraction>&#160;million in cash based on a certain specified milestone with an estimated initial fair value of $<ix:nonFraction unitRef="usd" contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001" decimals="-5" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDM5ODA0NjUzMTA1NA_dfda6592-cc20-4058-860f-02e6abb59e55">37.0</ix:nonFraction>&#160;million. The CVR will only be paid in full if the milestone is achieved by December&#160;31, 2021. The amount of the CVR included in the purchase price was reduced by $<ix:nonFraction unitRef="usd" contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDM5ODA0NjUzMTA4MQ_ebb726b5-351a-446e-96b4-4ca3a6ad96af">1.5</ix:nonFraction>&#160;million that was determined to be post-combination expense. The fair value of the CVR liability was determined using a probability-adjusted income approach. These cash flows were then discounted to present value using a discount rate based on market participants' cost of debt reflective of the Company, which was <ix:nonFraction unitRef="pure" contextRef="i4243023110cb4a6ca65bf4c4c5d8878f_I20201001" decimals="3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDM5ODA0NjUzMTEwNw_12cc0fd9-ad4f-44a2-9ea1-1b8866a1d696">7.1</ix:nonFraction>%. The liability is periodically assessed based on events and circumstances related to the underlying milestone, and any change in fair value is recorded in our consolidated statements of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the acquisition, a portion of Pfenex's equity awards that were outstanding and unvested prior to the acquisition became fully vested per the terms of the merger agreement. The acceleration of vesting required us to allocate the fair value of the equity attributable to pre-combination service to the purchase price and the remaining amount was considered our post-combination expense. We paid $<ix:nonFraction unitRef="usd" contextRef="i4464b8371b004313b6607d086dec25b2_D20201001-20201001" decimals="-5" format="ixt:numdotdecimal" name="lgnd:PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDM5ODA0NjUzMTEyMw_b9333a41-ba24-44e0-9252-8f1bbd9dcba5">17.3</ix:nonFraction>&#160;million in cash for equity compensation, which is attributable to pre-combination services and is reflected as a component of the total purchase price paid of $<ix:nonFraction unitRef="usd" contextRef="i4464b8371b004313b6607d086dec25b2_D20201001-20201001" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDM5ODA0NjUzMTE0NA_c5773dd4-7a88-4d11-9a3f-e65d5e2f74db">429.6</ix:nonFraction>&#160;million. In addition, the fair value of equity compensation attributable to the post-combination service period was $<ix:nonFraction unitRef="usd" contextRef="idc64562484fc4d23b336ec8ed3fd3947_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDM5ODA0NjUzMTE2MA_a02bcc00-adae-4026-ae26-0396c65ec4c6">8.7</ix:nonFraction>&#160;million. These amounts were associated with the accelerated vesting of stock options previously granted to Pfenex employees and were fully paid in cash, which was recognized as general and administrative expenses during the fourth quarter of 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjE5OTAyMzI4MzI5Mw_f8c6449e-7058-49bb-ac0f-8acd5d3834b1" continuedAt="i2e7e0201d2b149c383136bd5c4dde046" escape="true">The following table sets forth an allocation of the preliminary purchase price to the identifiable tangible and intangible assets acquired and liabilities assumed, with the excess recorded to goodwill (in thousands):</ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i4e409aeb08594d8290144ba17c9ff283" continuedAt="iab9557f209bd40e0a918842e19f3cee3"><div style="margin-bottom:6pt"><ix:continuation id="i2e7e0201d2b149c383136bd5c4dde046" continuedAt="i20f4219142f44811a09aeea886b6de57"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfMC0xLTEtMS0yNDc4_9f4158e5-a980-4673-843b-ff55bd3edc7f">51,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001" decimals="-3" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfMS0xLTEtMS0yNDc4_9e0f0e7b-054d-45e8-9c07-bc5fba3b2dbb">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts and unbilled receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfMi0xLTEtMS0yNDc4_6189e688-2289-408f-bf0e-5edbfb495a13">1,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfMy0xLTEtMS0yNDc4_63e8748a-163b-4709-a8c3-22c0515a38cb">7,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Right-of-use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001" decimals="-3" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfNC0xLTEtMS0yNDc4_98583c21-5bfe-4bf0-9930-01346a608f64">3,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfNS0xLTEtMS0yNDc4_9ef499e2-50ec-457a-8c6c-b045c7cd4536">1,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangibles acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001" decimals="-3" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfNi0xLTEtMS0yNDc4_95abe231-a4b5-4779-a2c0-a85ec44e7541">385,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfNy0xLTEtMS0yNDc4_ee075a3e-5812-40f1-8128-8d6f0eec1aef">91,837</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfOC0xLTEtMS0yNDc4_87e4da09-75e2-4e15-b8d3-8b7b2528f67e">6,814</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001" decimals="-3" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfOS0xLTEtMS0yNDc4_a71e5875-721f-480e-9400-711f3f0d965c">8,455</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfMTAtMS0xLTEtMjQ3OA_ae3aba59-d2cd-4bad-98e5-1c662001f99a">3,908</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001" decimals="-3" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfMTEtMS0xLTEtMjQ3OA_860c5915-31eb-45f6-b4e7-5767ede81961">3,070</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfMTItMS0xLTEtMjQ3OA_e44c1f6b-12cf-4d99-8ef1-7ebcc4acbd3c">1,382</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfMTMtMS0xLTEtMjQ3OA_5ba7016d-bc6f-4b6f-a4c9-475bfa4a5513">53,296</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfMTQtMS0xLTEtMjcxNw_95fb068f-5e4e-4de7-9db5-070857c34b45">465,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"><ix:continuation id="i20f4219142f44811a09aeea886b6de57">(1) Goodwill represents the excess of the purchase price over the preliminary fair value of the underlying assets acquired and liabilities assumed. Goodwill is attributable to the assembled workforce of experienced personnel at Pfenex and expected synergies. <ix:nonFraction unitRef="usd" contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjE5OTAyMzI4Nzc1Mg_ef2e8f51-bc8b-4d64-ba50-f33788b1a752">None</ix:nonFraction> of the goodwill is expected to be deductible for tax purposes.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Acquired intangibles include $<ix:nonFraction unitRef="usd" contextRef="i7cc2592d38964cbb996dc31f81ff2c9a_I20201001" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjE5OTAyMzI4MjA1Mg_e025ca0c-95f0-4faa-9dc7-540785ccf45f">362</ix:nonFraction>&#160;million of contractual relationships and $<ix:nonFraction unitRef="usd" contextRef="i1708e500e932475f92536d18e3d099b5_I20201001" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjE5OTAyMzI4MjA2Ng_78afb461-cdd3-438b-a9fd-d15587014e02">23</ix:nonFraction>&#160;million of core technology. The fair values of the contractual relationships were based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, collaboration and product revenue streams derived from the licensing of the related technologies over the estimated contractual relationship period. The fair value of the contractual relationships is being amortized on a straight-line basis over the weighted average estimated useful life of <ix:nonNumeric contextRef="i6037a4915521428790837dff8096a89d_D20201001-20201001" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMzg0ODI5MDcyOTMxNQ_6f4fa363-d7cc-4e0c-a58f-9dd1e0a12704">12.9</ix:nonNumeric> years. The fair values of the acquired technologies were based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, collaboration and product revenue streams derived from the licensing of the related technologies over the estimated useful lives. These projected cash flows were discounted to present value using discount rate, which varies from <ix:nonFraction unitRef="number" contextRef="i3ca2eca402bd48499cd198b19a231468_D20201001-20201001" decimals="INF" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjE5OTAyMzI4MjA5MA_d1046dab-38ee-4fba-9e74-4121dfcf8418">12</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ie98b3c08f75e4b61b0c8b64a85133b0c_D20201001-20201001" decimals="INF" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjE5OTAyMzI4MjA5NQ_205ee95d-207c-4e8f-a81b-844e4b32edc2">15</ix:nonFraction>%. The total acquired intangibles are being amortized on a straight-line basis over the weighted average estimated useful life of <ix:nonNumeric contextRef="i4464b8371b004313b6607d086dec25b2_D20201001-20201001" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMzg0ODI5MDcyOTE2Ng_18b279ef-3cfb-40fc-a9d7-e1901525dbe7">13.0</ix:nonNumeric> years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The estimated fair values of assets acquired and liabilities assumed, including deferred tax assets and liabilities, and purchased intangibles are provisional. The accounting for these amounts falls within the measurement period and therefore we may adjust these provisional amounts to reflect new information obtained about facts and circumstances that existed as of the acquisition date.  </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjE5OTAyMzI4Nzc2MQ_f847d344-827e-4a04-bba6-ec12d6933df2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following summary presents our unaudited pro forma consolidated results of operations for the quarter ended March 31, 2020 as if the Pfenex acquisition had occurred on January 1, 2020, which gives effect to certain transaction accounting adjustments, including amortization of acquired intangibles and share based compensation expense for retained Pfenex employees. The pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as of the date indicated, nor is it necessarily indicative of future operating results (in thousands, except per share amounts):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbe299c7430a4957bb40d8a3d730a73e_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjNlZGVhZThlMjUwMzRmYjJhMjAwMDY1MTU3Zjg4ZDljL3RhYmxlcmFuZ2U6M2VkZWFlOGUyNTAzNGZiMmEyMDAwNjUxNTdmODhkOWNfMS0xLTEtMS0yNzcx_d4678245-1d68-4d8a-b0d0-d5f8ed949ff5">33,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbe299c7430a4957bb40d8a3d730a73e_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjNlZGVhZThlMjUwMzRmYjJhMjAwMDY1MTU3Zjg4ZDljL3RhYmxlcmFuZ2U6M2VkZWFlOGUyNTAzNGZiMmEyMDAwNjUxNTdmODhkOWNfMi0xLTEtMS0yNzcx_11ff1c51-1edb-443c-ad04-a49edc7b33c4">37,939</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net loss per common share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic and diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="icbe299c7430a4957bb40d8a3d730a73e_D20200101-20200331" decimals="2" sign="-" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjNlZGVhZThlMjUwMzRmYjJhMjAwMDY1MTU3Zjg4ZDljL3RhYmxlcmFuZ2U6M2VkZWFlOGUyNTAzNGZiMmEyMDAwNjUxNTdmODhkOWNfNC0xLTEtMS0yNzc4_94af7278-b863-485f-8d06-ff05cc286d0e"><ix:nonFraction unitRef="usdPerShare" contextRef="icbe299c7430a4957bb40d8a3d730a73e_D20200101-20200331" decimals="2" sign="-" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjNlZGVhZThlMjUwMzRmYjJhMjAwMDY1MTU3Zjg4ZDljL3RhYmxlcmFuZ2U6M2VkZWFlOGUyNTAzNGZiMmEyMDAwNjUxNTdmODhkOWNfNC0xLTEtMS0yNzc4_9a44cdf5-47d5-4a15-b6bc-f5ea94f816d2">2.30</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Taurus Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 9, 2020, we acquired Taurus, which discovers and develops novel antibodies from immunized cows and cow-derived libraries. The purchase price of $<ix:nonFraction unitRef="usd" contextRef="i07f491d71a074d669d852a83c5014e96_D20200909-20200909" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjAw_a1da8ff8-f62a-4ff2-98e0-ccbccefba574">5.1</ix:nonFraction> million included $<ix:nonFraction unitRef="usd" contextRef="i07f491d71a074d669d852a83c5014e96_D20200909-20200909" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjEy_359795ed-3a72-4395-a42e-125df18524ca">4.6</ix:nonFraction> million in cash, and a $<ix:nonFraction unitRef="usd" contextRef="i07f491d71a074d669d852a83c5014e96_D20200909-20200909" decimals="-5" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationConsiderationTransferredHoldback" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjMw_2c537eb4-4c29-4575-bff6-92afea56b613">0.5</ix:nonFraction> million holdback to satisfy indemnification obligations which will be settled by September 2021.  We also issued nontransferable CVRs for up to $<ix:nonFraction unitRef="usd" contextRef="i5ec4f52c7742457e9f9a93bcedf7c43a_I20200909" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMzY5_47507541-9ed5-441f-bb26-250df2aadb11">4.5</ix:nonFraction> million tied to partnered and internal research and development and for up to $<ix:nonFraction unitRef="usd" contextRef="i4a4df23c7dc04ee1b5aa7abe12902388_I20200909" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDQy_55995eaa-d584-4c95-b92b-3dfd30713385">25.0</ix:nonFraction> million as a <ix:nonFraction unitRef="number" contextRef="ieb5b853ff6c948499b25bc488e171d3a_D20200909-20200909" decimals="INF" name="lgnd:BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDUw_34313018-c9d5-491b-9c8e-abb625eba2dd">25</ix:nonFraction>% share of post-clinical Taurus product revenues (including milestone payments) received by us. We evaluated this acquisition in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, to discern whether the assets and operations of Taurus met the definition of a business. We concluded that substantially all of the fair value of the gross assets acquired is concentrated in the acquired core technology. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="iab9557f209bd40e0a918842e19f3cee3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accordingly, we accounted for this transaction as an asset acquisition. Of the $<ix:nonFraction unitRef="usd" contextRef="i07f491d71a074d669d852a83c5014e96_D20200909-20200909" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfOTI4_e60e4605-0a90-46df-9fa9-a81e8253fee5">5.1</ix:nonFraction> million consideration transferred, we recognized (1) $<ix:nonFraction unitRef="usd" contextRef="ie01bfe015cdf4254866d1eb4e646cb8b_I20200909" decimals="-4" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfOTc2_48169b91-2709-4f68-9d20-cde7eac55a2c">0.05</ix:nonFraction> million of tangible assets acquired, and (2) $<ix:nonFraction unitRef="usd" contextRef="i2f8e586c985a4f67aa1ae11d2c8cc48d_I20200909" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMTAxNg_6f34704e-c603-4ae7-a996-289fef154433">5.0</ix:nonFraction> million of core completed technology intangibles acquired. The core technology is being amortized on a straight-line basis over the estimated useful life of <ix:nonNumeric contextRef="if95207dfe47f4c9e9c0f43e8b93447ea_D20200909-20200909" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMTE2OA_373f86fc-75cb-4854-a789-725d337fc24f">10</ix:nonNumeric> years. We account for the CVRs in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, when the contingency is resolved and the liability becomes payable. <ix:nonFraction unitRef="usd" contextRef="ie01bfe015cdf4254866d1eb4e646cb8b_I20200909" decimals="-5" format="ixt-sec:numwordsen" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMTMwNw_24e4e9e7-1eab-430d-ae99-170267049ddc">None</ix:nonFraction> of the CVRs are recognized as of March&#160;31, 2021.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">xCella Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 8, 2020, we acquired xCella, an antibody discovery company. We paid $<ix:nonFraction unitRef="usd" contextRef="ib1211f6f3075428083696490bd9e932a_D20200908-20200908" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMTQ2OQ_456ef140-b518-435d-8ea4-536b81b6aecd">7.1</ix:nonFraction> million in cash (including a $<ix:nonFraction unitRef="usd" contextRef="ib1211f6f3075428083696490bd9e932a_D20200908-20200908" decimals="-5" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationConsiderationTransferredHoldback" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMTQ5Mw_d9efc198-5144-41c4-a5a6-893a3d1b93b7">0.5</ix:nonFraction> million holdback to satisfy indemnification obligations which will be settled by September 2021), and issued earnout rights for up to $<ix:nonFraction unitRef="usd" contextRef="iddbb15ce39fa4680a70e166c8f3a4d15_I20200908" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMTYyMg_36dd3c66-9d6e-40b0-8d61-d73da8407b2a">5.0</ix:nonFraction> million tied to our use of the xCella technology for partnered research and development and for up to $<ix:nonFraction unitRef="usd" contextRef="ia183c7bcb9ba4693bb9d0a6d905ad0d1_I20200908" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMTcxOQ_ca9e5c9d-7146-4adb-8d0d-24e852e610cd">25.75</ix:nonFraction> million as a <ix:nonFraction unitRef="number" contextRef="i8d532605276c48f3a3a254c0df053fa9_D20200908-20200908" decimals="INF" name="lgnd:BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMTcyNw_17447634-f045-4ad1-ab88-fcda6a6b8c73">25</ix:nonFraction>% share of any future milestone payments we received under a certain existing xCella partner arrangement. We evaluated this acquisition in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, to discern whether the assets and operations of xCella met the definition of a business. We concluded that substantially all of the fair value of the gross assets acquired is concentrated in the acquired core technology. Accordingly, we accounted for this transaction as an asset acquisition. Of the $<ix:nonFraction unitRef="usd" contextRef="ib1211f6f3075428083696490bd9e932a_D20200908-20200908" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjIxNQ_bed4f4ad-7a09-4932-8e5e-bd1d668681d8">7.1</ix:nonFraction> million consideration transferred, we recognized (1) $<ix:nonFraction unitRef="usd" contextRef="ia8d7bcd2b95d4fdda48d8864d7b7c451_I20200908" decimals="-5" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjI2Mw_c1246843-7d2b-4063-a815-4c2bded96fb7">0.2</ix:nonFraction> million of tangible assets acquired, (2) $(<ix:nonFraction unitRef="usd" contextRef="ia8d7bcd2b95d4fdda48d8864d7b7c451_I20200908" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjI5OQ_81e3d0c6-08de-419f-af18-156fb6ab6694">0.1</ix:nonFraction>) million of liabilities assumed, (3) $<ix:nonFraction unitRef="usd" contextRef="ib568c9bfd11849cba166b146a4953fc6_I20200908" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjMzMA_72a0ff5e-2089-4965-bbb1-0afa11347035">7.8</ix:nonFraction> million of core completed technology acquired, and (4) $(<ix:nonFraction unitRef="usd" contextRef="ia8d7bcd2b95d4fdda48d8864d7b7c451_I20200908" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjM4MA_39a1198a-eafe-4b62-8c4c-1825a995bce5">0.8</ix:nonFraction>) million of deferred tax liability. The core technology is being amortized on a straight-line basis over the estimated useful life of <ix:nonNumeric contextRef="ia4acaa60d54747379cca9601b1b5b67e_D20200908-20200908" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjUwOA_3d0a2ae4-8907-4606-87f5-b5e1fe5495bd">15</ix:nonNumeric> years. We account for the earnout rights in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, when the contingency is resolved and the liability becomes payable. <ix:nonFraction unitRef="usd" contextRef="ia8d7bcd2b95d4fdda48d8864d7b7c451_I20200908" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjY1Nw_4ccdf85d-5c1e-47a7-ae86-40144c51bd5c">None</ix:nonFraction> of the earnout rights are recognized as of the acquisition date. During the three months ended March&#160;31, 2021, we recognized $<ix:nonFraction unitRef="usd" contextRef="i2e4887e0977c47cd936f0690fcc58a01_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMTA0NDUzNjA0OTY1NDQ_58f11d52-4735-4113-8b23-63357d282b1e">0.2</ix:nonFraction> million in earnout rights when certain contingencies were resolved during the period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Icagen Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 1, 2020, we acquired the core assets, including its partnered programs and ion channel technology, from Icagen and certain of its affiliates. The acquisition was accounted for as a business combination and we applied the acquisition method of accounting. Accordingly, we recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the applicable date of acquisition. We did <ix:nonFraction unitRef="usd" contextRef="icabfd60e6d5c4e879961167fb0781d8a_D20200401-20200401" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMzE4Mw_48ab111b-b8e8-443f-9a65-3a8d92ceb997">no</ix:nonFraction>t incur any material acquisition-related costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The purchase price of $<ix:nonFraction unitRef="usd" contextRef="icabfd60e6d5c4e879961167fb0781d8a_D20200401-20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMzI1Ng_649101eb-8e76-485c-9376-833cf3a863d3">19.9</ix:nonFraction> million included $<ix:nonFraction unitRef="usd" contextRef="icabfd60e6d5c4e879961167fb0781d8a_D20200401-20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMzI2OA_d4102397-df06-4b14-9c81-bf48c5fad2f1">15.1</ix:nonFraction> million cash consideration paid upon acquisition, and a contingent earn-out payment of up to $<ix:nonFraction unitRef="usd" contextRef="ic1c6304e54ea4ff6822ec9ee1766e372_I20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMzM1Ng_ba25c87b-44c6-47da-a5c1-38143cba3dd8">25.0</ix:nonFraction>&#160;million of cash payments based on certain revenue milestones with an estimated fair value of $<ix:nonFraction unitRef="usd" contextRef="ic1c6304e54ea4ff6822ec9ee1766e372_I20200401" decimals="-5" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMzQ0NA_92a9d68b-8ec4-4a79-8e47-c9bd52dd4a79">4.8</ix:nonFraction> million. The fair value of the earn-out liability was determined using a probability weighted income approach incorporating the estimated future cash flows from expected future milestones. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of Icagen. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 2, Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, for further discussion. The liability will be periodically assessed based on events and circumstances related to the underlying milestones, and any change in fair value will be recorded in our consolidated statements of operations. The carrying amount of the liability may fluctuate significantly and actual amount paid may be materially different than the carrying amount of the liability. There was no change in the fair value of the contingent liabilities during the second quarter of 2020. As the acquisition is not considered significant, pro forma information has not been provided. The results of Icagen have been included in our results of operations since the date of acquisition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The allocation of the purchase price consisted of (1) $<ix:nonFraction unitRef="usd" contextRef="ic1c6304e54ea4ff6822ec9ee1766e372_I20200401" decimals="-5" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDU3Mg_0d41d869-483f-4f84-a889-8ee26db272fa">1.8</ix:nonFraction> million of fair value of tangible assets acquired, (2) $(<ix:nonFraction unitRef="usd" contextRef="ic1c6304e54ea4ff6822ec9ee1766e372_I20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDYyMg_931110bf-b010-4621-9d56-1e0323c90b20">0.8</ix:nonFraction>) million of liabilities assumed, (3) $<ix:nonFraction unitRef="usd" contextRef="ic1c6304e54ea4ff6822ec9ee1766e372_I20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDY1Mw_24429f3a-1c02-42f8-8227-e4cd3e56bae5">12.8</ix:nonFraction> million of acquired intangibles, (4) $(<ix:nonFraction unitRef="usd" contextRef="ic1c6304e54ea4ff6822ec9ee1766e372_I20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDY4NQ_a7868e3c-705a-4f6e-b6c2-25db8a880c8f">3.7</ix:nonFraction>) million of deferred revenue in connection with assumed performance obligations under a collaboration agreement, (5) $<ix:nonFraction unitRef="usd" contextRef="ic1c6304e54ea4ff6822ec9ee1766e372_I20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDc5Ng_d3599fb1-17ed-4699-b006-8bbdc6ef6e52">0.8</ix:nonFraction> million of deferred tax asset associated with the deferred revenue, and (6) $<ix:nonFraction unitRef="usd" contextRef="icabfd60e6d5c4e879961167fb0781d8a_D20200401-20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDg2Nw_df380749-d9b2-4a9c-9eb3-20f63ba35cce">9.0</ix:nonFraction> million of goodwill, the majority of which is deductible for tax purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Acquired intangibles include $<ix:nonFraction unitRef="usd" contextRef="i1de02aee229949b29da1adff62f79608_I20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDk2OA_a0b9d2c6-8511-4cc0-b5d2-a350861f4758">11.1</ix:nonFraction> million of customer relationships and $<ix:nonFraction unitRef="usd" contextRef="iafdcef1bca214ba4be93eb50ada39288_I20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNTAwMQ_ef579f5d-abec-46d9-bc73-3efb491c35b4">1.7</ix:nonFraction> million of core technology. The fair values of the customer relationships were based on a discounted cash flow analysis incorporating the estimated future cash flows from these relationships during the contractual term. These cash flows were then discounted to present value using a discount rate of <ix:nonFraction unitRef="number" contextRef="i61296742d97b4da79a28c03d8f00b06c_D20200401-20200401" decimals="INF" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNTI5Ng_b3945656-d2cd-4568-bb4e-c3bc89fe7a7a">17</ix:nonFraction>%. The fair value of the customer relationships is being amortized on a straight-line basis over the weighted average estimated useful life of <ix:nonNumeric contextRef="i61296742d97b4da79a28c03d8f00b06c_D20200401-20200401" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNTQ0MA_bd39e3ed-1558-4248-bb5b-df6da5b34fad">9.6</ix:nonNumeric> years. The fair value of the core technology was based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, and collaboration revenue streams derived from the licensing of the related technologies. These projected cash flows were discounted to present value using a discount rate of <ix:nonFraction unitRef="number" contextRef="i9bd0a96ccb9e42b08636c5d927887d6f_D20200401-20200401" decimals="INF" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNTc4MA_a870888c-b7d7-479c-a802-e8e6650ac436">17</ix:nonFraction>%. The fair value of the core technology is being amortized on a straight-line basis over the estimated useful life of <ix:nonNumeric contextRef="i9bd0a96ccb9e42b08636c5d927887d6f_D20200401-20200401" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNTkwMA_857f4161-da16-4ac0-b4b5-aba313050e38">10</ix:nonNumeric> years. The total acquired intangibles are being amortized on a straight-line basis over the estimated useful life of <ix:nonNumeric contextRef="icabfd60e6d5c4e879961167fb0781d8a_D20200401-20200401" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNjAyMA_bcc76dd3-fee9-4442-a857-8fbeb59b07b2">9.7</ix:nonNumeric> years.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="i38905116b7634694b27917e6ac2a9ef4_43"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.  <ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfNTk3Mg_59754d95-6b06-4c9f-97e8-17e107dda6f3" continuedAt="i3086a757dc9d478a804217f7979bc2e9" escape="true">Convertible Senior Notes</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i3086a757dc9d478a804217f7979bc2e9" continuedAt="iaff8f9428302402f8b2806f65dae0e97"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">0.75%&#160;Convertible&#160;Senior&#160;Notes&#160;due 2023</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued&#160;$<ix:nonFraction unitRef="usd" contextRef="i5fa2bce4be0846e99213fe7062260432_I20180531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfOTk_04197e56-382a-43a3-983a-4ed2bf68a483">750.0</ix:nonFraction>&#160;million&#160;aggregate principal amount of&#160;<ix:nonFraction unitRef="number" contextRef="i5fa2bce4be0846e99213fe7062260432_I20180531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMTMy_c2edd0d7-792e-4675-9080-d5bd676081c9">0.75</ix:nonFraction>%&#160;convertible&#160;senior&#160;notes. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $<ix:nonFraction unitRef="usd" contextRef="i73bb70b7323d4144a6e75d3e406c405c_D20180501-20180531" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMjg4_a423d2d2-3366-4ff3-8cf4-c031164e5c24">733.1</ix:nonFraction> million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our election, based on an initial conversion rate, subject to adjustment, of&#160;4.0244&#160;shares per $1,000 principal amount of the 2023 Notes which represents an initial conversion price of approximately&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="i5fa2bce4be0846e99213fe7062260432_I20180531" decimals="2" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfNjA5_20f0a442-20cd-49ff-b430-80e0c9ed3652">248.48</ix:nonFraction> per share.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes may convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances: </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least <ix:nonFraction unitRef="d" contextRef="i48864de303954560905e76c4450e4c12_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfOTQy_90645d61-6e59-4a81-ac00-b7a024de9a5b">20</ix:nonFraction> trading days (whether or not consecutive) during the <ix:nonFraction unitRef="d" contextRef="i48864de303954560905e76c4450e4c12_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfOTk4_05d9410a-dbd3-4830-927d-364d9f739a32">30</ix:nonFraction> consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day is greater than <ix:nonFraction unitRef="number" contextRef="i48864de303954560905e76c4450e4c12_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMTE5Mw_a50f4ffb-54ea-4fb1-80b2-6648de42341d">130</ix:nonFraction>% of the conversion price on such trading day; </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) during the <ix:nonFraction unitRef="d" contextRef="i6f9fc4db17d04bf89dd453f8e14127a3_D20180501-20180531" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMTI1OA_01c39852-2623-491e-b7f9-60a96dbb35fc">five</ix:nonFraction> business day period immediately following any <ix:nonFraction unitRef="d" contextRef="i6f9fc4db17d04bf89dd453f8e14127a3_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMTMwNw_54787fb8-c07c-46c9-8583-a1625a426cb6">10</ix:nonFraction> consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than <ix:nonFraction unitRef="number" contextRef="i6f9fc4db17d04bf89dd453f8e14127a3_D20180501-20180531" decimals="INF" name="lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMTQxNg_2ca3bfad-f0f5-4208-a22f-077d6be67897">98</ix:nonFraction>% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i5fa2bce4be0846e99213fe7062260432_I20180531" decimals="2" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMTg0MA_4e474865-7212-4d03-bcea-c63322b3974b">248.48</ix:nonFraction>. As of March&#160;31, 2021, the &#8220;if-converted value&#8221; did not exceed the principal amount of the 2023 Notes. In connection with the issuance of the 2023 Notes, we incurred $<ix:nonFraction unitRef="usd" contextRef="i9fce823aabcc4d3d949530fe19c30792_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMTk5Nw_fb5b2e84-23d2-4c7e-a8ff-489d2960d433">16.9</ix:nonFraction> million of issuance costs, which primarily consisted of underwriting, legal and other professional fees. The portion of these costs allocated to the liability component totaling $<ix:nonFraction unitRef="usd" contextRef="i9fce823aabcc4d3d949530fe19c30792_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMjE3MA_d28624a7-185d-4625-be87-2eb49975f993">13.7</ix:nonFraction> million is amortized to interest expense using the effective interest method over the five year expected life of the 2023 Notes. It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, we repurchased $<ix:nonFraction unitRef="usd" contextRef="i9fce823aabcc4d3d949530fe19c30792_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentRepurchaseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMjU4Nw_346fc57a-0623-4f11-a600-da2a50b784f0">104.5</ix:nonFraction>&#160;million in principal of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="i3951fe225b2c46a7b3923a0684c74ce9_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMjYyNQ_73f56650-dd05-4d83-a0c2-dd101702dd86">109.1</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="i3951fe225b2c46a7b3923a0684c74ce9_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentIncreaseAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMjY2Nw_7de4cdec-2903-4f5c-8aac-34dd73536bb1">0.2</ix:nonFraction>&#160;million. We accounted for the repurchase as a debt extinguishment, which resulted in (1) a loss of $<ix:nonFraction unitRef="usd" contextRef="i3951fe225b2c46a7b3923a0684c74ce9_D20210101-20210331" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMjc1OA_6d2ba0c1-3bb3-4eb3-bc32-7a43b48143c1">4.8</ix:nonFraction>&#160;million reflected in other income (expense), net, in our condensed consolidated statement of operations for the three months ended March&#160;31, 2021; (2) a $<ix:nonFraction unitRef="usd" contextRef="i3951fe225b2c46a7b3923a0684c74ce9_D20210101-20210331" decimals="-5" sign="-" format="ixt:numdotdecimal" name="lgnd:IncreaseDecreaseInDebtDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMjg3OA_602cc7a2-5115-4371-a74f-167196245249">9.6</ix:nonFraction> million reduction in debt discount, and (3) a $<ix:nonFraction unitRef="usd" contextRef="i3951fe225b2c46a7b3923a0684c74ce9_D20210101-20210331" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMjkxOQ_ff05da67-da3d-4041-9ed4-2e24c87424ff">9.1</ix:nonFraction>&#160;million reduction to additional paid in capital, net of tax, related to the reacquisition of the equity component in our condensed consolidated balance sheet as of March&#160;31, 2021. After the repurchases, approximately $<ix:nonFraction unitRef="usd" contextRef="i9fce823aabcc4d3d949530fe19c30792_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMzExOQ_bfbca9fe-d316-4378-a84f-cac2e69e6d45">390.8</ix:nonFraction>&#160;million in principal amount of the 2023 Notes remain outstanding. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Bond Hedge and Warrant Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering <ix:nonFraction unitRef="shares" contextRef="i5fa2bce4be0846e99213fe7062260432_I20180531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMzM0Nw_1ccadb76-e933-40dc-ad51-1739884c0617">3,018,327</ix:nonFraction> shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i5fa2bce4be0846e99213fe7062260432_I20180531" decimals="2" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMzYyMQ_ab453394-63b0-4da1-8fc3-e7e49f53fd22">248.48</ix:nonFraction> per share and are exercisable when and if the 2023 Notes are converted. We paid $<ix:nonFraction unitRef="usd" contextRef="i73bb70b7323d4144a6e75d3e406c405c_D20180501-20180531" decimals="-5" format="ixt:numdotdecimal" name="lgnd:PaymentsForConvertibleBondHedges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMzcwNA_9f0ac84c-4b1e-4080-9fd8-e09a3d999872">140.3</ix:nonFraction> million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering approximately <ix:nonFraction unitRef="shares" contextRef="i5fa2bce4be0846e99213fe7062260432_I20180531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfNDYwNA_c8eb0d6a-640a-4641-afc1-7365400f17ea">3,018,327</ix:nonFraction> shares of common stock with an exercise price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i5fa2bce4be0846e99213fe7062260432_I20180531" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfNDY3MA_ec288234-875b-4bf4-a3ea-4819e1569c2e">315.38</ix:nonFraction> per share, subject to certain adjustments. We received $<ix:nonFraction unitRef="usd" contextRef="i73bb70b7323d4144a6e75d3e406c405c_D20180501-20180531" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfNDcyOA_61c1b6b5-009f-4462-b01f-1c5830c8c363">90.0</ix:nonFraction> million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="iaff8f9428302402f8b2806f65dae0e97"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, in connection with the repurchases of $<ix:nonFraction unitRef="usd" contextRef="i9fce823aabcc4d3d949530fe19c30792_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentRepurchaseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMzg0ODI5MDcwNjg3Mw_346fc57a-0623-4f11-a600-da2a50b784f0">104.5</ix:nonFraction>&#160;million in principal of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="i3951fe225b2c46a7b3923a0684c74ce9_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMzg0ODI5MDcwNjg5MA_73f56650-dd05-4d83-a0c2-dd101702dd86">109.1</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="i3951fe225b2c46a7b3923a0684c74ce9_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentIncreaseAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMzg0ODI5MDcwNjkwNQ_7de4cdec-2903-4f5c-8aac-34dd73536bb1">0.2</ix:nonFraction>&#160;million, during the quarter ended March 31, 2021, we entered into Warrant Early Unwind Agreements and Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We paid $<ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="lgnd:PaymentsToUnwindWarrants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMzg0ODI5MDcxMTE2Mg_b89149ba-60c3-4792-8854-177c78050070">16.5</ix:nonFraction>&#160;million as part of the Warrant Early Unwind Agreements reducing the number of shares covered by the warrants from <ix:nonFraction unitRef="shares" contextRef="i5fa2bce4be0846e99213fe7062260432_I20180531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMzg0ODI5MDcwNjU3OA_1ccadb76-e933-40dc-ad51-1739884c0617">3,018,327</ix:nonFraction> to <ix:nonFraction unitRef="shares" contextRef="i9fce823aabcc4d3d949530fe19c30792_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMzg0ODI5MDcwNjcxMQ_2b50a698-256b-4ef7-8d4b-4d231bb3afaa">2,597,750</ix:nonFraction>. We received $<ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="lgnd:ProceedsFromUnwindingConvertibleBondHedges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMzg0ODI5MDcwNzAwNw_6f4dc338-8f9d-450a-aa4e-3504c3b05092">16.9</ix:nonFraction>&#160;million as part of the Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to <ix:nonFraction unitRef="option" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="INF" format="ixt:numdotdecimal" name="lgnd:NumberOfOptionsUnderConvertibleBondHedges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMjE5OTAyMzI3MDIxNA_92211a43-16ac-45d2-b6ca-df6176df5b6f">645,500</ix:nonFraction>. These unwind transactions resulted in a $<ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMjE5OTAyMzI2OTI1NQ_9cfa8b20-384d-4ffe-b5b2-17e5ecf0760b">0.4</ix:nonFraction>&#160;million net increase in additional paid-in-capital in our condensed consolidated balance sheet as of March 31, 2021.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfNTk3NA_d426a417-f40e-4f04-a98d-a4af38eacb08" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the 2023 Notes (in thousands): </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:68.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.655%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Principal amount of the 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fce823aabcc4d3d949530fe19c30792_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RhYmxlOjg1ZTdiNmE5OTUxMTQzN2NiZTI3Yzg5MGIxMDBkM2IwL3RhYmxlcmFuZ2U6ODVlN2I2YTk5NTExNDM3Y2JlMjdjODkwYjEwMGQzYjBfMS0xLTEtMS0w_1bcdff0b-2b43-4b95-a837-0e02258f99a4">390,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25e12db65ee14bebb0cc5ab9db2dea3a_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RhYmxlOjg1ZTdiNmE5OTUxMTQzN2NiZTI3Yzg5MGIxMDBkM2IwL3RhYmxlcmFuZ2U6ODVlN2I2YTk5NTExNDM3Y2JlMjdjODkwYjEwMGQzYjBfMS0zLTEtMS0w_042f6e67-35ab-4507-bd09-1da8acb8b22e">495,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fce823aabcc4d3d949530fe19c30792_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RhYmxlOjg1ZTdiNmE5OTUxMTQzN2NiZTI3Yzg5MGIxMDBkM2IwL3RhYmxlcmFuZ2U6ODVlN2I2YTk5NTExNDM3Y2JlMjdjODkwYjEwMGQzYjBfMi0xLTEtMS0w_25da41f8-d158-4146-85a4-acc7cf3c5101">38,467</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25e12db65ee14bebb0cc5ab9db2dea3a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RhYmxlOjg1ZTdiNmE5OTUxMTQzN2NiZTI3Yzg5MGIxMDBkM2IwL3RhYmxlcmFuZ2U6ODVlN2I2YTk5NTExNDM3Y2JlMjdjODkwYjEwMGQzYjBfMi0zLTEtMS0w_2028844d-0542-44e4-877c-4120f05dec8f">52,987</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total long-term portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fce823aabcc4d3d949530fe19c30792_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RhYmxlOjg1ZTdiNmE5OTUxMTQzN2NiZTI3Yzg5MGIxMDBkM2IwL3RhYmxlcmFuZ2U6ODVlN2I2YTk5NTExNDM3Y2JlMjdjODkwYjEwMGQzYjBfMy0xLTEtMS0w_078b4f94-8675-4ab2-b425-93184a50e877">352,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25e12db65ee14bebb0cc5ab9db2dea3a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RhYmxlOjg1ZTdiNmE5OTUxMTQzN2NiZTI3Yzg5MGIxMDBkM2IwL3RhYmxlcmFuZ2U6ODVlN2I2YTk5NTExNDM3Y2JlMjdjODkwYjEwMGQzYjBfMy0zLTEtMS0w_dce876fb-c02a-4598-99e2-583548dabe1d">442,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying value of equity component of the 2023 Notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fce823aabcc4d3d949530fe19c30792_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RhYmxlOjg1ZTdiNmE5OTUxMTQzN2NiZTI3Yzg5MGIxMDBkM2IwL3RhYmxlcmFuZ2U6ODVlN2I2YTk5NTExNDM3Y2JlMjdjODkwYjEwMGQzYjBfNS0xLTEtMS0w_8037721b-34d7-4170-b118-b7b04b323d0d">35,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25e12db65ee14bebb0cc5ab9db2dea3a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RhYmxlOjg1ZTdiNmE5OTUxMTQzN2NiZTI3Yzg5MGIxMDBkM2IwL3RhYmxlcmFuZ2U6ODVlN2I2YTk5NTExNDM3Y2JlMjdjODkwYjEwMGQzYjBfNS0zLTEtMS0w_09563713-e4ae-4429-9568-eb066e6513e2">48,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of the 2023 Notes outstanding (Level 2)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fce823aabcc4d3d949530fe19c30792_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RhYmxlOjg1ZTdiNmE5OTUxMTQzN2NiZTI3Yzg5MGIxMDBkM2IwL3RhYmxlcmFuZ2U6ODVlN2I2YTk5NTExNDM3Y2JlMjdjODkwYjEwMGQzYjBfNi0xLTEtMS0w_ee7a4405-dc28-478b-805f-0f9cabfcaa33">404,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25e12db65ee14bebb0cc5ab9db2dea3a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RhYmxlOjg1ZTdiNmE5OTUxMTQzN2NiZTI3Yzg5MGIxMDBkM2IwL3RhYmxlcmFuZ2U6ODVlN2I2YTk5NTExNDM3Y2JlMjdjODkwYjEwMGQzYjBfNi0zLTEtMS0w_de73142b-adba-4c81-b214-a05c60e2d245">466,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="i38905116b7634694b27917e6ac2a9ef4_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.  <ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80OS9mcmFnOjI1NTEzMWQ3YWRlYzQyYWNhMWUyM2M2MDE4MWU2NjQxL3RleHRyZWdpb246MjU1MTMxZDdhZGVjNDJhY2ExZTIzYzYwMTgxZTY2NDFfMTAzOQ_e0c0a46b-b3a5-4620-8b31-da18362e071a" continuedAt="i4bf5297b0be24762984b456d9f2a8c9e" escape="true">Income Tax</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i4bf5297b0be24762984b456d9f2a8c9e">Our effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in various state jurisdictions with different statutory rates, benefits related to tax credits, and the tax impact of non-deductible expenses, stock award activities and other permanent differences between income before income taxes and taxable income. The effective tax rate for the three months ended March&#160;31, 2021 and 2020 was (<ix:nonFraction unitRef="number" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="3" sign="-" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80OS9mcmFnOjI1NTEzMWQ3YWRlYzQyYWNhMWUyM2M2MDE4MWU2NjQxL3RleHRyZWdpb246MjU1MTMxZDdhZGVjNDJhY2ExZTIzYzYwMTgxZTY2NDFfNDI5_ac781156-e365-4057-8345-69f0c5bbfee1">214.1</ix:nonFraction>)% and <ix:nonFraction unitRef="number" contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80OS9mcmFnOjI1NTEzMWQ3YWRlYzQyYWNhMWUyM2M2MDE4MWU2NjQxL3RleHRyZWdpb246MjU1MTMxZDdhZGVjNDJhY2ExZTIzYzYwMTgxZTY2NDFfNDM5ODA0NjUxMjE1NQ_a91109ba-b4a2-4ec3-a4e8-0184acca9177">20.7</ix:nonFraction>%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three months ended March&#160;31, 2021 was significantly impacted by discrete tax benefits related to net excess tax windfalls from share-based compensation resulting from increased stock option exercise activity, stock award vesting and appreciation of our stock price during the period.</ix:continuation> </span></div><div><span><br/></span></div><div id="i38905116b7634694b27917e6ac2a9ef4_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.  <ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RleHRyZWdpb246NDU1MzQzZDRhNTc0NGIxMzg0MDU1NzhmN2RmMzRjOGFfMTcxMw_4b8ac1d8-965e-41b9-a8ea-527ba14af223" continuedAt="i1edf04ea19424a07b4761ee00f0c2e58" escape="true">Stockholders&#8217; Equity</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i1edf04ea19424a07b4761ee00f0c2e58" continuedAt="i77cffceca995468ba35e4e1547e241e2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grant options and awards to employees and non-employee directors pursuant to a stockholder approved stock incentive plan, which is described in further detail in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of the Notes to Consolidated Financial Statements in our 2020 Annual Report.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RleHRyZWdpb246NDU1MzQzZDRhNTc0NGIxMzg0MDU1NzhmN2RmMzRjOGFfMTcwOQ_ca9c6d16-242c-4774-9e13-a616020c5d1c" escape="true"><ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RleHRyZWdpb246NDU1MzQzZDRhNTc0NGIxMzg0MDU1NzhmN2RmMzRjOGFfMTcxNA_429e3359-7257-4b14-ae18-b1d8182480f8" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if492415c8fb84dc28c02e844ba8b7ba7_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfMi0xLTEtMS0w_174aac1a-d5b9-4631-93a2-8c7cd68e11b5">2,561,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if492415c8fb84dc28c02e844ba8b7ba7_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfMi0zLTEtMS0w_5eabd05e-9cf5-41aa-81a9-f2ac5bea7aba">85.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i05243f1221bc4fd7befab87ff60f8de9_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfMi01LTEtMS0w_33509ba5-bbd4-41ff-b8f1-10e9f5c4c3c0">206,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i05243f1221bc4fd7befab87ff60f8de9_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfMi03LTEtMS0w_7407a42d-aceb-4d60-904b-4cf0246cbb47">106.88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0057dd0957054317972b57951cde9e14_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfMy0xLTEtMS0w_20ebcb38-4bf2-46a1-98b2-29ccc45449a8">265,529</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0057dd0957054317972b57951cde9e14_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfMy0zLTEtMS0w_7266d2b0-b42e-4431-8fdb-37307f237ead">172.39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if96bbf53f57741718a23af11bbf99850_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfMy01LTEtMS0w_6b33cfce-85d0-46e4-b704-e23196b29e77">153,166</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if96bbf53f57741718a23af11bbf99850_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfMy03LTEtMS0w_300c1553-b1b0-4c01-8e27-3e2275744898">173.32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0057dd0957054317972b57951cde9e14_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfNC0xLTEtMS0w_9260689e-962b-4e17-8ece-fddad8d1c26c">522,172</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0057dd0957054317972b57951cde9e14_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfNC0zLTEtMS0w_4f168751-ac0f-4452-8ed3-c0501e544463">51.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if96bbf53f57741718a23af11bbf99850_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfNC01LTEtMS0w_9e88842b-484e-44be-a2c5-7b7df6c8e57b">88,959</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if96bbf53f57741718a23af11bbf99850_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfNC03LTEtMS0w_05c1b016-72ac-4680-9bc5-928dfec56fd1">127.16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0057dd0957054317972b57951cde9e14_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfNS0xLTEtMS0w_a0be69a4-2df9-49d8-98bd-8f001a4d1b61">58,862</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0057dd0957054317972b57951cde9e14_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfNS0zLTEtMS0w_66b11e95-f359-42a3-96fb-a803ebaffee1">101.77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if96bbf53f57741718a23af11bbf99850_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfNS01LTEtMS0w_ce2c5607-f27a-455e-be5e-45e625b3804a">5,024</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if96bbf53f57741718a23af11bbf99850_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfNS03LTEtMS0w_b525383c-ad89-4918-a240-2ee5d88d1ba4">110.91</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i877eaef323064694bf3b6b4356d4f3fd_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfNi0xLTEtMS0w_5089f16f-0046-4e32-a725-ff4e2c6e757f">2,246,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i877eaef323064694bf3b6b4356d4f3fd_I20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfNi0zLTEtMS0w_e896c49d-876d-423e-b36d-2c097c6b998c">103.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idaf759347d8c465a8cb4d42f49d35918_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfNi01LTEtMS0w_4259bffe-1454-4c5a-a5cb-3664756d48e5">265,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idaf759347d8c465a8cb4d42f49d35918_I20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfNi03LTEtMS0w_28bdaf5f-4266-4e86-b5ef-a54e5682c76b">138.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, outstanding options to purchase <ix:nonFraction unitRef="shares" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RleHRyZWdpb246NDU1MzQzZDRhNTc0NGIxMzg0MDU1NzhmN2RmMzRjOGFfNDQ3_81164564-f986-40dd-ab45-2442147a03ff">1.2</ix:nonFraction> million shares were exercisable with a weighted average exercise price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RleHRyZWdpb246NDU1MzQzZDRhNTc0NGIxMzg0MDU1NzhmN2RmMzRjOGFfNTI2_4867978b-4f57-4b0e-b3e3-070d944dfdb5">89.20</ix:nonFraction>.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="i77cffceca995468ba35e4e1547e241e2" continuedAt="i5ca4629c965649da8e6f5baed675a5d7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price at which common stock is purchased under the Amended Employee Stock Purchase Plan, or ESPP, is equal to <ix:nonFraction unitRef="number" contextRef="i4e9d28d4cd3a4c1682fedb85842a9f81_D20210101-20210331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RleHRyZWdpb246NDU1MzQzZDRhNTc0NGIxMzg0MDU1NzhmN2RmMzRjOGFfNjc1_68652898-8374-4e1e-be6e-5ccde9208986">85</ix:nonFraction>% of the fair market value of the common stock on the first or last day of the offering period, whichever is lower. As of March&#160;31, 2021, <ix:nonFraction unitRef="shares" contextRef="i4e9d28d4cd3a4c1682fedb85842a9f81_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RleHRyZWdpb246NDU1MzQzZDRhNTc0NGIxMzg0MDU1NzhmN2RmMzRjOGFfODAy_bf625f62-af38-4720-ac77-f5b8a9d4536f">52,808</ix:nonFraction> shares were available for future purchases under the ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did <ix:nonFraction unitRef="usd" contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RleHRyZWdpb246NDU1MzQzZDRhNTc0NGIxMzg0MDU1NzhmN2RmMzRjOGFfMTAxOQ_08da452d-f33b-4227-b7fe-11fc2b2277c7">no</ix:nonFraction>t have any share repurchases during the first quarter of 2021.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5ca4629c965649da8e6f5baed675a5d7">On September 11, 2019, our Board of Directors approved a stock repurchase program authorizing, but not obligating, the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="iae8337fd239a4e7e99cf32e1f3b34254_I20190911" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RleHRyZWdpb246NDU1MzQzZDRhNTc0NGIxMzg0MDU1NzhmN2RmMzRjOGFfMTIzNQ_3273d5f7-62b7-475b-9671-916d14d6c764">500.0</ix:nonFraction> million of our common stock from time to time over the next <ix:nonNumeric contextRef="ic0da24b8c33848ccb099afc62ba164b1_D20190911-20190911" format="ixt-sec:durwordsen" name="us-gaap:StockRepurchaseProgramPeriodInForce1" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RleHRyZWdpb246NDU1MzQzZDRhNTc0NGIxMzg0MDU1NzhmN2RmMzRjOGFfMTI5MA_92c7b6dd-828b-46b5-ada8-92c0bc793b99">three years</ix:nonNumeric>. We expect to acquire shares primarily through open-market transactions and may enter into Rule 10b5-1 trading plans, to facilitate open-market repurchases. The timing and amount of repurchase transactions will be determined by management based on our evaluation of market conditions, share price, legal requirements and other factors. Authorization to repurchase $<ix:nonFraction unitRef="usd" contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RleHRyZWdpb246NDU1MzQzZDRhNTc0NGIxMzg0MDU1NzhmN2RmMzRjOGFfMTY1Nw_fe7ddb60-d35b-4f69-96d5-ef028733cddd">248.8</ix:nonFraction> million of our common stock remained available as of March&#160;31, 2021.</ix:continuation> </span></div><div><span><br/></span></div><div id="i38905116b7634694b27917e6ac2a9ef4_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.  <ix:nonNumeric contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81NS9mcmFnOmQ0MDU4NDhhOTg2OTQzYTFiNWJkYTM2MjQyODdmMmNiL3RleHRyZWdpb246ZDQwNTg0OGE5ODY5NDNhMWI1YmRhMzYyNDI4N2YyY2JfMzY5OA_54de1286-612a-4f1a-ad32-8628ed1c494d" continuedAt="icb1892ea530c48f59971c2441137e5be" escape="true">Commitment and Contingencies: Legal Proceedings</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="icb1892ea530c48f59971c2441137e5be" continuedAt="i2153b55d860e474789de354548f83065"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 450,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Contingencies</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As additional information becomes available, we assess the potential liability related to our pending litigation and revises our estimates. Revisions in our estimates of potential liability could materially impact our results of operations.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 9, 2019, CyDex, our wholly-owned subsidiary, received a Paragraph IV certification Notice Letter from Alembic Global Holdings SA (&#8220;Alembic&#8221;) stating that Alembic had submitted an ANDA to the FDA, seeking approval to manufacture, offer to sell, and sell a generic version of EVOMELA</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> prior to the expiration of any of the &#8217;077 patent; the &#8217;088 patent, the &#8217;582 patent, or U.S. Patent No. 10,040,872 (&#8220;the &#8217;872 patent&#8221;), and alleging that these patents, each of which relates to Captisol</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, are invalid, unenforceable, and/or would not be infringed by Alembic&#8217;s ANDA product. On May 23, 2019, CyDex filed a complaint against Alembic, Alembic Pharmaceuticals, Ltd., and Alembic Pharmaceuticals, Inc. in the U.S. District Court for the District of Delaware, asserting that the filing of Alembic&#8217;s ANDA constitutes infringement of each of the &#8217;088 patent and the &#8217;582 patent. On July 29, 2019, Alembic filed an answer and counterclaims seeking declarations of non-infringement and invalidity as to each of the asserted patents and, on August 19, 2019, CyDex filed an answer to Alembic&#8217;s counterclaims. On April 7, 2020, the Court ordered that the Scheduling Order be amended such that, inter alia, the fact discovery cut off occurred on November 2, 2020, the close of expert discovery was set for March 22, 2021, and that May 17, 2021 would remain the first day of a five-to-six-day bench trial.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 2, 2020, the District Court issued an order construing the disputed issues of claim construction, adopting the claim construction positions urged by CyDex. On January 13, 2021, the District Court entered an order noting that the parties were engaged in ongoing settlement efforts, and ordering that (i) all deadlines in the litigation be stayed, and (ii) the parties submit a joint status report within 30 days. In early February, and again in early March, the parties submitted status reports stating that they have made substantial progress toward finalizing an agreement. All deadlines are presently stayed.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 16, 2019, CyDex received a Paragraph IV certification Notice Letter from Lupin Ltd. (&#8220;Lupin&#8221;) stating that Lupin had submitted an ANDA to the FDA, seeking approval to manufacture, offer to sell, and sell a generic version of EVOMELA</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> prior to the expiration of any of the &#8217;077 patent; the &#8217;088 patent, the &#8217;582 patent, or the &#8217;872 patent, and alleging that these patents, each of which relates to Captisol</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, are invalid, unenforceable, and/or would not be infringed by Lupin&#8217;s ANDA product. CyDex filed a complaint on October 29, 2019, alleging patent infringement against Lupin. Lupin filed an answer on December 11, 2019 and counterclaimed for declaratory judgments of invalidity and non-infringement as to all <ix:nonFraction unitRef="patent" contextRef="i4829221eea044e2c99470e6c93d2698c_D20191029-20191029" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GainContingencyPatentsAllegedlyInfringedUponNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81NS9mcmFnOmQ0MDU4NDhhOTg2OTQzYTFiNWJkYTM2MjQyODdmMmNiL3RleHRyZWdpb246ZDQwNTg0OGE5ODY5NDNhMWI1YmRhMzYyNDI4N2YyY2JfMjE5OTAyMzI3NDMyMQ_b2ff389c-3b2d-4818-8013-4230dd09d89d">four</ix:nonFraction> patents and CyDex filed its answer to Lupin&#8217;s counterclaims on January 2, 2020. The parties entered into a settlement agreement on April 26, 2021 and the lawsuit has been dismissed.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2019, we received <ix:nonFraction unitRef="civil_complaint" contextRef="i9d01e2b13cbc4db1979d2caa61ff4664_D20191031-20191031" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81NS9mcmFnOmQ0MDU4NDhhOTg2OTQzYTFiNWJkYTM2MjQyODdmMmNiL3RleHRyZWdpb246ZDQwNTg0OGE5ODY5NDNhMWI1YmRhMzYyNDI4N2YyY2JfMjE5OTAyMzI3NDMwMw_f625c23e-2279-42ba-b726-d97a633091d3">three</ix:nonFraction> civil complaints filed in the US District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation (&#8220;JPML&#8221;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#8220;MDL&#8221;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i2153b55d860e474789de354548f83065"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">defendants other than the company and no individualized factual allegations have been advanced against us in any of the <ix:nonFraction unitRef="civil_complaint" contextRef="i9d01e2b13cbc4db1979d2caa61ff4664_D20191031-20191031" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81NS9mcmFnOmQ0MDU4NDhhOTg2OTQzYTFiNWJkYTM2MjQyODdmMmNiL3RleHRyZWdpb246ZDQwNTg0OGE5ODY5NDNhMWI1YmRhMzYyNDI4N2YyY2JfMjE5OTAyMzI3NDMwOQ_495af632-8b78-492c-b3d1-0c2ac4ea886c">three</ix:nonFraction> complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May and August of 2019, Pfenex Inc., which was acquired by us in October 2020, filed <ix:nonFraction unitRef="petition" contextRef="ied61350f910e4604aaf85a72e7548d42_D20190501-20190831" decimals="INF" format="ixt-sec:numwordsen" name="lgnd:NumberOfPetitionsFiled" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81NS9mcmFnOmQ0MDU4NDhhOTg2OTQzYTFiNWJkYTM2MjQyODdmMmNiL3RleHRyZWdpb246ZDQwNTg0OGE5ODY5NDNhMWI1YmRhMzYyNDI4N2YyY2JfMjE5OTAyMzI3NDI4MA_402d3f3c-efcf-46d1-b108-da9618f45d54">three</ix:nonFraction> petitions (IPR2019- 01027, IPR2019-01028 and IPR2019-01478) for inter partes review of U.S. Patent No. 9,422,345 (&#8220;the &#8216;345 patent,&#8221; entitled &#8220;Expression System&#8221;), which is owned by GlaxoSmithKline Biologicals S.A. (&#8220;GSK&#8221;) , with the Patent Trial and Appeal Board (&#8220;PTAB&#8221;) of the U.S. Patent and Trademark Office. In November 2019 and February 2020, the Board instituted trial on invalidity grounds in IPR2019-01028, but exercised its discretion not to institute trial on IPR2019-01027 or IPR2019-01478. In May 2020, GSK filed <ix:nonFraction unitRef="petition" contextRef="i903410136b034df7806df0765a803943_D20200501-20200531" decimals="INF" format="ixt-sec:numwordsen" name="lgnd:NumberOfPetitionsFiled" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81NS9mcmFnOmQ0MDU4NDhhOTg2OTQzYTFiNWJkYTM2MjQyODdmMmNiL3RleHRyZWdpb246ZDQwNTg0OGE5ODY5NDNhMWI1YmRhMzYyNDI4N2YyY2JfMjE5OTAyMzI3NDI5MA_1af9dbf7-56c7-4e8b-a2a3-b7bd837fe4d3">two</ix:nonFraction> petitions (IPR2020-00890 and IPR2020-00962) for inter partes review of U.S. Patent No. 8,530,171 (&#8220;the &#8216;171 patent,&#8221; entitled &#8220;High Level Expression of Recombinant Toxin Proteins&#8221;), which is owned by Pfenex, with the PTAB of the U.S. Patent and Trademark Office. On June 29, 2020, GSK filed a motion to withdraw IPR2020-00890, which was granted on August 28, 2020. In October 2020, Pfenex and GSK executed a confidential settlement agreement agreeing to terminate the proceedings before the PTAB resolving these issues. Pfenex and GSK filed a joint motion to terminate IPR2019-01028 and IPR2020-00962 on October 30, 2020, and an amended joint motion to terminate on November 4, 2020. A decision granting the parties&#8217; joint motion to terminate in IPR2019-01028 was issued on November 12, 2020. The PTAB subsequently granted the parties&#8217; joint motion to terminate in IPR2020-00962 on December 30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 12, 2021, Abvivo submitted a JAMS arbitration demand naming the Company as respondent. Abvivo claims that the Company is in violation of the assignment provision of that certain Commercial Platform License and Services Agreement (&#8220;CPLSA&#8221;), dated October 9, 2019, by and among OMT and Crystal, on the one hand, and Abvivo, on the other hand because the Company allegedly withheld its consent to a proposed assignment required for Abvivo to negotiate a discovery and development alliance with certain third parties. On January 26, 2021, we submitted a response to the demand, denying all claims and alleging counterclaims against Abvivo and Brian Lundstrom, a Company employee and the sole owner of Abvivo. We allege that Mr. Lundstrom breached his fiduciary duty of loyalty to the Company and that Abvivo and Mr. Lundstrom fraudulently induced the Company, OMT and Crystal into certain business transactions and contracts. Abvivo and Mr. Lundstrom&#8217;s response to these counterclaims was due on February 9, 2021, but they did not submit a response. Under JAMS rules, the counterclaims are deemed denied. On February 22, 2021, Abvivo submitted documents to JAMS which indicated that it seeks to dismiss its claim without prejudice, which we oppose. On February 25, 2021, we submitted additional counterclaims against Abvivo and Mr. Lundstrom.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These counterclaims allege that Abvivo and Mr. Lundstrom made false promises regarding the CPLSA, Abvivo&#8217;s breach of and failure to perform under the CPLSA, and Abvivo&#8217;s infringement of certain Ligand trademarks.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11, 2021, Abvivo and Mr. Lundstrom submitted an answer to our amended counterclaims denying all of the claims and asserting various affirmative defenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The arbitration will be conducted by a three arbitrator panel, the members of which were appointed on March 30, 2021. We intend to vigorously defend ourselves against this action.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="i38905116b7634694b27917e6ac2a9ef4_67"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. &#160;&#160;&#160;&#160;Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline">Caution:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">  This discussion and analysis may contain predictions, estimates and other forward-looking statements that involve a number of risks and uncertainties, including those discussed in Part II, Item 1A. Risk Factors. This outlook represents our current judgment on the future direction of our business. These statements include those related to our Captisol-related revenues and manufacturing capacity, our Kyprolis, and other product royalty revenues, the impact of COVID-19, product returns, and product development. Actual events or results may differ materially from our expectations. For example, there can be no assurance that our revenues or expenses will meet any expectations or follow any trend(s), that we will be able to retain our key employees or that we will be able to enter into any strategic partnerships or other transactions. We cannot assure you that we will receive expected Kyprolis, Captisol and other product revenues to support our ongoing business or that our internal or partnered pipeline products will progress in their development, gain marketing approval or achieve success in the market. In addition, ongoing or future arbitration, or litigation or disputes with third parties may have a material adverse effect on us. Such risks and uncertainties, and others, could cause actual results to differ materially from any future performance suggested. We undertake no obligation to make any revisions to these forward-looking statements to reflect events or circumstances arising after the date of this quarterly report. This caution is made under the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our trademarks, trade names and service marks referenced herein include Ligand. Each other trademark, trade name or service mark appearing in this quarterly report belongs to its owner.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">References to &#8220;Ligand Pharmaceuticals Incorporated,&#8221; &#8220;Ligand,&#8221; the &#8220;Company,&#8221; &#8220;we&#8221; or &#8220;our&#8221; include Ligand Pharmaceuticals Incorporated and our wholly owned subsidiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:54pt"><span><br/></span></div><div id="i38905116b7634694b27917e6ac2a9ef4_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. We employ research technologies such as antibody discovery technologies, ion channel discovery technology, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pseudomonas fluorescens </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">protein expression technology, formulation science and liver targeted pro-drug technologies to assist companies in their work toward securing prescription drug and biologic approvals. We currently have partnerships and license agreements with over 130 pharmaceutical and biotechnology companies. Over 300 programs are in various stages of commercialization, development or research and are fully funded by our collaboration partners and licensees. We have contributed novel research and technologies for approved medicines that treat cancer, osteoporosis, fungal infections and postpartum depression, among others. Our collaboration partners and licensees have programs currently in clinical development targeting cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others. We have over 1,400 issued patents worldwide.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have assembled our large portfolio of fully-funded programs either by licensing our own proprietary drug development programs, licensing our platform technologies such as Captisol or OmniAb to partners for use with their proprietary programs, or acquiring existing partnered programs from other companies. Fully-funded programs, which we refer to as "shots on goal," are those for which our partners pay all of the development and commercialization costs. For our internal programs, we generally plan to advance drug candidates through early-stage drug development or clinical proof-of-concept and then seek partners to continue development and potential commercialization.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Our goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified and lower-risk business than a typical biotech company. Our business model is based on doing what we do best: drug discovery, early-stage drug development, product reformulation and partnering. We partner with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management and commercialization) to ultimately generate our revenue. We believe that focusing on discovery and early-stage drug development while benefiting from our partners&#8217; development and commercialization expertise will reduce our internal expenses and allow us to have a larger number of drug candidates progress to later stages of drug development.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue consists of three primary elements: royalties from commercialized products, sale of Captisol material, and contract revenue from license, milestone and other service payments. In addition to discovering and developing our own proprietary drugs, we selectively pursue acquisitions to bring in new assets, pipelines, and technologies to aid in generating additional potential new revenue streams.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of COVID-19 Pandemic</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> described in Item 1. Condensed Consolidated Financial Statements - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. For additional information on the various risks posed by the COVID-19 pandemic, please read Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Risk Factors"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in this report.</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Portfolio Program Updates </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:95%">OmniAb</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:95%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:95%"> Platform Updates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OmniAb is our industry-leading, AI- and BI- (Biological Intelligence&#8482;) powered multi-species antibody platform for the discovery of mono- and bispecific therapeutic human antibodies. 2020 was a year of major investment with the acquisition and development of multiple technologies that enhance the offering for OmniAb partners, including the addition of antigen-generation services as well as deep-sequence analysis of functional antibody repertoires. As of March 31, 2021, 17 different OmniAb-derived antibodies have been studied in approximately 73 active or completed clinical trials. Progress by multiple OmniAb partners during the first quarter of 2021 resulted in more than $4 million in milestone payments being earned by us.  We expect the first regulatory approvals for OmniAb-derived antibodies in 2021.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 11, 2021, Aptevo Therapeutics provided an update on their ongoing Phase 1/1b trial of APVO436 in AML/HR-MDS, noting that patient dosing in cohorts 1 through 9 has completed and enrollment in cohort 10 is ongoing. APVO436 is an OmniAb-derived bispecific antibody targeting CD123 and CD3 for the potential treatment of hematological malignancies.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 8, 2021, CStone Pharmaceuticals announced that the OmniAb-derived anti-PD-L1 antibody sugemalimab was granted Breakthrough Therapy Designation (BTD) in China for the treatment of patients with relapsed or refractory extranodal natural killer/T-cell lymphoma (R/R ENKTL). In October 2020, sugemalimab was granted Orphan Drug Designation in the U.S. for the treatment of T-cell lymphoma and BTD for the treatment of R/R ENKTL. An NDA for sugemalimab is under review in China for Stage IV squamous/non-squamous non-small cell lung cancer, and CStone expects a determination in the second half of 2021. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 27, 2021, Harbour BioMed announced that Batoclimab (HBM9161), a novel investigational anti-FcRn antibody, was granted BTD in China for treatment of adult patients with myasthenia gravis. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pelican Platform Updates</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pelican Expression Technology&#8482; is our proprietary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pseudomonas fluorescens</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> protein expression technology that has major collaborations with Jazz Pharmaceuticals, Merck, Serum Institute of India, Alvogen and Arcellx, each of which has potential to contribute meaningfully to our royalty revenue.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 12, 2021, Merck announced that the U.S. FDA accepted for priority review a Biologics License Application (BLA) for V114, Merck&#8217;s investigational 15-valent pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in adults 18 years of age and older. The FDA set a Prescription Drug User Fee Act (PDUFA), or target action date, of July 18, 2021. The European Medicines Agency is also reviewing an application for licensure of V114 in adults.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 18, 2021, Alvogen&#8217;s partner Thermarex announced the launch of Livogiva</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the EU. Livogiva is a biosimilar of the reference medicine Forsteo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (teriparatide) and therapeutic equivalence has been demonstrated in a Phase 3 clinical study in patients with severe osteoporosis who were treated for 6 months.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2021, Arcellx announced FDA clearance of their Investigational New Drug application for ACLX-001, an engineered cell therapy for the treatment of multiple myeloma. Arcellx presented preclinical data supporting Arcellx&#8217;s ARC-SparX platform cell therapy ACLX-001, a novel BCMA-targeted CAR-T, at the AACR annual meeting in April of 2021.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:99%">Captisol</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:99%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:99%"> Business Updates </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Captisol is utilized in the formulation of Gilead Sciences&#8217; Veklury</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (remdesivir). The product has been approved or authorized for temporary use as a treatment for COVID-19 in approximately 50 countries worldwide and is included in more than 40 ongoing interventional or observational clinical studies. In addition to supplying Gilead,  we are also supplying Captisol </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to Gilead&#8217;s voluntary licensing generic partners who are manufacturing remdesivir for 127 other countries. Gilead announced the decision to stop its Phase 3 study with intravenous Veklury in high-risk non-hospitalized patients with COVID-19 due to the evolution of the COVID-19 landscape. Gilead stated they continue to develop an investigational inhaled dosage form of remdesivir and expect results from the ongoing proof-of-concept study later this year.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2021, the FDA approved the addition of the anti-CD38 monoclonal antibody (mAb) Sarclisa (isatuximab) to the combination of Kyprolis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (carfilzomib) and dexamethasone to treat adult patients with relapsed or refractory multiple myeloma who have received one to three prior lines of therapy. Kyprolis is also approved in combination with the anti-CD38 mAb Darzalex (daratumumab) plus dexamethasone for the treatment of patients with relapsed or refractory multiple myeloma who have received a maximum of three prior lines of therapy.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 27, 2021, Aldeyra announced positive topline results from the Phase 3 INVIGORATE trial of 0.25% reproxalap ophthalmic solution (reproxalap), an investigational, novel small-molecule covalent inhibitor of RASP (reactive aldehyde species), in patients with allergic conjunctivitis. The clinical trial achieved statistical significance (p&lt;0.0001) for the primary endpoint of change from baseline in subject-reported ocular itching score, and all secondary endpoints including investigator-assessed ocular redness, patient-reported ocular tearing score and total ocular severity score. Aldeyra plans to meet with the FDA in the second half of 2021 to discuss the INVIGORATE results and the potential submission of an NDA.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:99%">Other Business Updates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2021, Sermonix Pharmaceuticals announced a preclinical collaboration with Jay Gertz, Ph.D., a researcher at the Huntsman Cancer Institute and associate professor of oncological sciences at the University of Utah, to examine the potential effects of lasofoxifene on unique models of endometrial cancer that carry ESR1 mutations. Lasofoxifene has shown novel activity in ESR1 mutations, and Sermonix is currently enrolling patients in two Phase 2 Evaluation of Lasofoxifene in ESR1 Mutations (ELAINE) studies in metastatic breast cancer.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 3, 2021, we announced that we no longer plan to initiate the next CE-iohexol clinical trial at this time, as we assess the potential partnering or potential future partner involvement in any downstream clinical work. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span><br/></span></div><div id="i38905116b7634694b27917e6ac2a9ef4_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="text-indent:14pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:59.609%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.501%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.501%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.501%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.174%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Royalties</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,112</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,565&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">31,272</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16,766</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">55,150</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,161&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,989&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Royalty revenue is a function of our partners&#8217; product sales and the applicable royalty rate. Kyprolis royalty rates are under a tiered royalty rate structure with the highest tier being 3.0%. Evomela has a fixed royalty rate of 20%. Contract revenue includes service revenue, license fees and development, regulatory and sales based milestone payments.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Royalty revenue increased slightly in Q1 2021 compared to Q1 2020. Captisol sales increased in Q1 2021 compared to Q1 2020, primarily reflecting higher sales of Captisol for use in the manufacturing of remdesivir. Contract revenue increased in Q1 2021 compared to Q1 2020, with the increase primarily attributable to 1) the timing of partner milestone events and 2) the additional contract revenue of $4.2 million and $3.3 million from the acquisitions of Icagen in April 2020 and Pfenex in October 2020, respectively. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents royalty revenue by program:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:23.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.105%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2021 Estimated Partner Product Sales</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2021 Royalty Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2020 Partner Product Sales</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2020 Royalty Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">266.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">286.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">20.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">27.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">304.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">339.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Costs and Expenses</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.653%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of Captisol</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,153</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11,786</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">17,879</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12,617</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">50,435</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,373&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating costs and expenses increased by $21.1 million, or 72%, primarily due to the acquisition of Pfenex on October 1, 2020 and Icagen on April 1, 2020, as well as increase in Captisol sales revenue for the current period. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of Captisol increased primarily due to higher Captisol sales during Q1 2021 as mentioned above. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangibles increased in 2021 compared to the same period in 2020 primarily due to the amortization of contractual relationships and technologies acquired from Icagen in April 2020 and Pfenex in October 2020. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any one time, we are working on multiple programs. As such, we generally do not track our R&amp;D expenses on a specific program basis. Our R&amp;D expenses increased year over year in 2021 due to the costs associated with our acquisitions of Icagen in April 2020 and Pfenex in October 2020, which primarily consisted of salaries, lab costs and intangible amortizations associated with Icagen ($3.9 million) and Pfenex ($11.4 million). The increase was partially offset by a $2.5 million year over year decrease in amortization of other economic rights related to economic rights acquired from Palvella in December 2018. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses increased primarily due to additional expenses from the Icagen and Pfenex acquisitions as well as additional share-based compensation expense during Q1 2021.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) from short-term investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">13,061</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(30,741)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43,802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">296</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,730&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,434)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(5,831)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,548)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(6,477)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,833)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other income (expense), net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,049</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(34,203)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,252&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fluctuation in the gain (loss) from short-term investments is primarily driven by the changes in the fair value of our ownership in Viking common stock and warrants (an unrealized gain of $9.1 million in Q1 2021 as compared to an unrealized loss of $29.7 million in Q1 2020). </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consists primarily of interest earned on our short-term investments. The decreases over the prior period were due to the decrease in our short-term investment balance.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense includes the 0.75% coupon cash interest expense in addition to the non-cash accretion of discount (including the amortization of debt issuance cost) on our 2023 Notes for the three months ended March&#160;31, 2021. The decrease over the prior period was primarily due to lower average debt outstanding balance during Q1 2021 as compared to Q1 2020. In Q1 2021, we repurchased $104.5&#160;million in principal of the 2023 Notes for $109.1&#160;million in cash, including accrued interest of $0.2&#160;million. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4, Convertible Senior Notes.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net, in Q1 2021 included a $4.8&#160;million loss on debt extinguishment in connection with the 2023 Notes repurchase during the three months ended March&#160;31, 2021. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Benefit</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,764</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(30,415)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,179&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12,342</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,284&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,058&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">18,106</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24,131)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(214.1)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We compute our income tax provision by applying the estimated annual effective tax rate to income from operations and adding the effects of any discrete income tax items specific to the period. The effective tax rate for the three months ended March&#160;31, 2021 and March&#160;31, 2020 was (214.1)% and 20.7%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three months ended March&#160;31, 2021 was significantly impacted by discrete tax benefits from share-based compensation resulting from increased stock option exercise activity, stock award vesting and appreciation of our stock price during the period.</span></div><div><span><br/></span></div><div id="i38905116b7634694b27917e6ac2a9ef4_76"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Liquidity and Capital Resources </span></div><div style="text-indent:45pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, our cash, cash equivalents, and short-term investments totaled $339.2 million, which decreased by $72.0&#160;million from the end of last year due to factors described in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Summary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below. Our primary source of liquidity, other than our holdings of cash, cash equivalents, and short-term investments, has been cash flows from operations. Our ability to generate cash from operations provides us with the financial flexibility we need to meet operating, investing, and financing needs.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have liquidated our short-term investments and/or issued debt and equity securities to finance our business needs as a supplement to cash provided by operating activities. Our short-term investments include U.S. government debt securities, investment-grade corporate debt securities, mutual funds and certificates of deposit. We have established guidelines relative to diversification and maturities of our investments in order to provide both safety and liquidity. These guidelines are periodically reviewed and modified to take advantage of trends in yields and interest rates. Additionally, we own certain securities which are classified as short-term investments that we received as a result of a milestone and an upfront license payment as well as 7,000,000 shares of common stock in Viking.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued an aggregate principal amount of $750.0 million of the 2023 Notes. In conjunction of the 2023 Notes offering, we used a portion of the proceeds from such issuance totaling $49.7 million to repurchase 260,000 shares of our common stock. During the first quarter of 2021, we repurchased $104.5&#160;million in principal of the 2023 Notes for $109.1&#160;million in cash, including accrued interest of $0.2&#160;million. After the repurchases, $390.8&#160;million in principal amount of the 2023 Notes remain outstanding. We may continue to use cash on hand to repurchase additional 2023 Notes through open-market transactions, including through Rule 10b5-1 trading plan to facilitate open-market repurchases, or otherwise, from time to time. The timing and amount of repurchase transactions will be determined by management based on the evaluation of market conditions, trading price of the 2023 Notes, legal requirements and other factors. The 2023 Notes were not convertible as of March&#160;31, 2021. It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4, Convertible Senior Notes.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing funds, cash generated from operations and existing sources of and access to financing are adequate to fund our need for working capital, capital expenditures, debt service requirements, continued advancement of research and development efforts, potential stock repurchases and other business initiatives we plan to strategically pursue, including acquisitions and strategic investments.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, we had $51.1 million in fair value of contingent consideration liabilities associated with prior acquisitions to be settled in future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases and Off-Balance Sheet Arrangements</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease our office facilities under operating lease arrangements with varying terms through September 2026. The agreements provide for increases in annual rents based on changes in the Consumer Price Index or fixed percentage increases of 3.0%. We had no off-balance sheet arrangements at March&#160;31, 2021 and December&#160;31, 2020.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flow Summary</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.475%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Investing activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65,115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">308,536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Financing activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(91,635)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(279,305)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2021, we repurchased $104.5&#160;million in principal of the 2023 Notes for $109.1&#160;million in cash, including accrued interest of $0.2&#160;million. During the three months ended March&#160;31, 2020, we repurchased $234.4 million in principal of the 2023 Notes for $203.8 million in cash, including accrued interest of $0.6 million; and used $73.3 million to repurchase our common stock.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%">Contractual Obligations</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes outside the ordinary course of business to the Contractual Obligations table set forth in our 2020 Annual Report.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our policies require the application of management judgment in making estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Those estimates and assumptions are based on historical experience and various other factors deemed applicable and reasonable under the circumstances. The use of judgment in determining such estimates and assumptions is by nature, subject to a degree of uncertainty. Accordingly, actual results could differ materially from the estimates made. There have been no material changes in our critical accounting policies and estimates as compared to the critical accounting policies and estimates described in our 2020 Annual Report, other than the adoption of the Accounting Standards Updates described in Item 1. Condensed consolidated Financial Statements - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> related to allowance for credit losses.</span></div><div style="text-indent:14pt"><span><br/></span></div><div id="i38905116b7634694b27917e6ac2a9ef4_79"></div><div><span><br/></span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="text-indent:45pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no substantial changes to our market risks in the three months ended March&#160;31, 2021, when compared to the disclosures in Item 7A of our 2020 Annual Report.</span></div><div><span><br/></span></div><div id="i38905116b7634694b27917e6ac2a9ef4_82"></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Controls and Procedures</span></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures as of March&#160;31, 2021 were effective to ensure that information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting that occurred during the quarter ended March&#160;31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div id="i38905116b7634694b27917e6ac2a9ef4_85"></div><div style="padding-left:54pt;text-indent:-54pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II.&#160;&#160;&#160;&#160;OTHER INFORMATION</span></div><div><span><br/></span></div><div id="i38905116b7634694b27917e6ac2a9ef4_88"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information that updates the disclosures set forth under Part I. Item 3. Legal Proceedings in our 2020 Annual Report, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 7, Commitment and Contingencies: Legal Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Condensed Consolidated Financial Statements contained in Part I. Item 1. of this report.</span></div><div><span><br/></span></div><div id="i38905116b7634694b27917e6ac2a9ef4_91"></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.  Risk Factors</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the risk factors included in Part I. Item 1A. Risk Factors in our 2020 Annual Report, other than as set forth below:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future revenue from sales of Captisol material to our license partners may be lower than expected.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from sales of Captisol material to our collaborative partners, including Amgen and Gilead, represent a significant portion of our current revenues. Any setback that may occur with respect to Captisol could significantly impair our operating results and/or reduce the market price of our stock. Setbacks for Captisol could include problems with shipping, distribution, manufacturing, product safety, marketing, government regulation or reimbursement, licenses and approvals, intellectual property rights, competition with existing or new products and physician or patient acceptance of the products using Captisol. In addition, revenue from Captisol sales related to remdesivir may not continue or materially increase due to a number of factors, including: if Gilead successfully develops or manufactures an alternative formulation of remdesivir that does not incorporate Captisol or uses less Captisol in such formulation; if remdesivir is later shown to not be effective or safe for the treatment of COVID-19; the FDA revises or revokes its approval of remdesivir; if alternative therapies or vaccines are approved; or the risk of COVID-19 infection significantly diminishes, in which case the commercial opportunity could be materially and adversely affected. For example, Gilead has announced plans to develop an inhaled dosage form of remdesivir that uses less Captisol than the current formulation and expects result from an ongoing proof-of-concept study later this year.  </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If products or product candidates incorporating Captisol material were to cause any unexpected adverse events, the perception of Captisol safety could be seriously harmed. If this were to occur, we may not be able to sell Captisol unless and until we are able to demonstrate that the adverse event was unrelated to Captisol, which we may not be able to do. Further, the FDA could require us to submit additional information for regulatory review or approval, including data from extensive safety testing or clinical testing of products using Captisol. This would be expensive and it may delay the marketing of Captisol-enabled products and receipt of revenue related to those products, which could significantly impair our operating results and/or reduce the market price of our stock.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain Captisol from Hovione, our third party manufacturer, primarily at their facilities in Portugal and Ireland. If Hovione were to cease to be able, for any reason, to supply Captisol to us in the amounts we require, or decline to supply Captisol to us, we would be required to seek an alternative source, which could potentially take a considerable length of time and impact our revenue and customer relationships. In the event of a Captisol supply interruption, we are permitted to designate and, with Hovione&#8217;s assistance, qualify one or more alternate suppliers, although there is no assurance that we could do so timely or at an acceptable cost, if at all. In addition to manufacturing at Hovione&#8217;s facilities in Ireland and Portugal, we have now added final step processing capacity for Captisol in both the United States and England.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain inventory of Captisol, which has a five year shelf life, at three geographically dispersed storage locations in the United States and Europe. If we were to encounter problems maintaining our inventory, such as natural disasters, at one or more of these locations, it could lead to supply interruptions. In addition, we will rely on Hovione to expand manufacturing capacity of Captisol and any failure by Hovione to timely implement such increased capacity could adversely affect our ability to supply Captisol to our partners. While we believe we maintain adequate inventory of Captisol to meet our current partner needs, and our planned expansion of Captisol capacity will be sufficient to meet future partner needs, our estimates and projections for Captisol demand may not be correct and any supply interruptions could materially adversely impact our operating results. In addition, our plan to invest additional capital for the expansion of Captisol manufacturing capacity may not yield a return on investment if future Captisol sales fall below our expectations.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently depend on our arrangements with our partners and licensees to sell products using our Captisol technology. These agreements generally provide that our partners may terminate the agreements at will. If our partners discontinue sales of products using Captisol, fail to obtain regulatory approval for products using Captisol, fail to satisfy their obligations under their agreements with us, or choose to utilize a competing product, or if we are unable to establish new licensing and marketing relationships, our financial results and growth prospects would be materially affected. Furthermore, we maintain significant accounts receivable balances with certain customers purchasing Captisol materials, which may result in the concentration of credit risk. We generally do not require any collateral from our customers to secure payment of these accounts receivable. If </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any of our major customers were to default in the payment of their obligations to us, our business, operating results and cash flows could be adversely affected.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, under most of our Captisol outlicenses, the amount of royalties we receive will be reduced or will cease when the relevant patent expires. Our low-chloride patents and foreign equivalents are not expected to expire until 2033, our high purity patents and foreign equivalents are not expected to expire until 2029 and our morphology patents and foreign equivalents are not expected to expire until 2026 in United States, but the initially filed patents relating to Captisol expired starting in 2010 in the United States and in 2016 in most countries outside the United States. If our other intellectual property rights are not sufficient to prevent a generic form of Captisol from coming to market and if in such case our partners choose to terminate their agreements with us, our Captisol revenue may decrease significantly.</span></div><div><span><br/></span></div><div id="i38905116b7634694b27917e6ac2a9ef4_94"></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">None.</span></div><div id="i38905116b7634694b27917e6ac2a9ef4_97"></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Defaults Upon Senior Securities</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i38905116b7634694b27917e6ac2a9ef4_100"></div><div><span><br/></span></div><div style="text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">   Item 4.  Mine Safety Disclosures</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div id="i38905116b7634694b27917e6ac2a9ef4_103"></div><div><span><br/></span></div><div style="text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.&#160;&#160;&#160;&#160;Other Information</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i38905116b7634694b27917e6ac2a9ef4_106"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.  Exhibits</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:13.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.108%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616321000050/exhibit1067_bondhedgexbarc.htm">10.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Call Option Amendment Agreed, dated January 28, 2021, between the Registrant and Barclays Bank PLC (incorporated by reference to Exhibit 10.67 to the Registrant&#8217;s Annual Report on Form 10-K filed February 24, 2021).</span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616321000050/exhibit1068.htm">10.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Call Option Amendment Agreed, dated January 28, 2021, between the Registrant and Deutsche Bank AG, London Branch (incorporated by reference to Exhibit 10.68 to the Registrant&#8217;s Annual Report on Form 10-K filed February 24, 2021).</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616321000050/ligand-ex1069xbondhedgeame.htm">10.3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Call Option Amendment Agreed, dated January 28, 2021, between the Registrant and Goldman Sachs &amp; Co. LLC (incorporated by reference to Exhibit 10.69 to the Registrant&#8217;s Annual Report on Form 10-K filed February 24, 2021.</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lgnd_33121exhibit311.htm">31.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification by Principal Executive Officer, Pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lgnd_33121exhibit312.htm">31.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification by Principal Financial Officer, Pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lgnd_33121exhibit321.htm">32.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certifications by Principal Executive Officer and Principal Financial Officer, Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following financial information from our Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2021, formatted in iXBRL (inline eXtensible Business Reporting Language): (i) Consolidated Condensed Balance Sheets, (ii) Consolidated Condensed Statements of Operations, (iii) Consolidated Condensed Statement of Comprehensive Income, (iv) Consolidated Condensed Statements of Stockholders' Equity, (v) Consolidated Condensed Statements of Cash Flows, and (vi) the Notes to Consolidated Condensed Financial Statements.*</span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2021, formatted in Inline XBRL and contained in Exhibit 101.</span></div></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span><br/></span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-45pt"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-45pt"><span><br/></span></div><div id="i38905116b7634694b27917e6ac2a9ef4_109"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.711%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Matthew Korenberg</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew Korenberg</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Finance and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Duly Authorized Officer and Principal Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">32</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>lgnd_33121exhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i537bf2f464ef4eefa8f5ae31a8c9bd57_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO EXCHANGE ACT RULE 13a-14(a)&#47;15d-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">I, John L. Higgins, certify that&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.064%"><tr><td style="width:1.0%"></td><td style="width:11.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.089%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Quarterly Report on Form 10-Q of Ligand Pharmaceuticals Incorporated&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Date&#58;&#160;&#160;&#160;May&#160;6, 2021 </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.166%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2pt;padding-right:-2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John L. Higgins</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John L. Higgins</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2pt;padding-right:-2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>lgnd_33121exhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i4b6082d334c846d9888f1367828e67b8_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO EXCHANGE ACT RULE 13a-14(a)&#47;15d-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">I, Matthew Korenberg, certify that&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Quarterly Report on Form 10-Q of Ligand Pharmaceuticals Incorporated&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Date&#58;&#160;&#160;&#160;&#160;May&#160;6, 2021 </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.416%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Matthew Korenberg</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew Korenberg</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Finance and Chief Financial Officer</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>lgnd_33121exhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ic57df4a2cbed4687baac71253e052e00_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Exhibit 32.1</font></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">In connection with the Quarterly Report of Ligand Pharmaceuticals Incorporated (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended March&#160;31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, John L. Higgins, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:10.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.877%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.866%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.944%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John L. Higgins</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John L. Higgins<br>Chief Executive Officer <br>(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">In connection with the Quarterly Report of Ligand Pharmaceuticals Incorporated (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended March&#160;31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Matthew Korenberg, Executive Vice President, Finance and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:10.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.146%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Matthew Korenberg</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Matthew Korenberg<br>Executive Vice President, Finance and Chief Financial Officer<br>(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. A signed original of this written statement required </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>lgnd-20210331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:f42e6ea9-4959-4941-8454-5f1ec5bc67fa,g:c4690a82-fe68-4d49-b4c9-c600693120e1-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lgnd="http://www.ligand.com/20210331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.ligand.com/20210331">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20210331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20210331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20210331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20210331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.ligand.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnaudited" roleURI="http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnauditedParenthetical" roleURI="http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsUnaudited" roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited" roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquityUnaudited" roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsUnaudited" roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPolicies" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables">
        <link:definition>2303301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2404401 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails">
        <link:definition>2405402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails">
        <link:definition>2406403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails">
        <link:definition>2407404 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails">
        <link:definition>2408405 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails">
        <link:definition>2409406 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License and Other Economic Rights (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails">
        <link:definition>2410407 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails">
        <link:definition>2411408 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails">
        <link:definition>2412409 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails">
        <link:definition>2413410 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.ligand.com/role/FairValueMeasurements">
        <link:definition>2114102 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.ligand.com/role/FairValueMeasurementsTables">
        <link:definition>2315302 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails">
        <link:definition>2416411 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" roleURI="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails">
        <link:definition>2417412 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Acquisitions" roleURI="http://www.ligand.com/role/Acquisitions">
        <link:definition>2118103 - Disclosure - Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsTables" roleURI="http://www.ligand.com/role/AcquisitionsTables">
        <link:definition>2319303 - Disclosure - Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsNarrativeDetails" roleURI="http://www.ligand.com/role/AcquisitionsNarrativeDetails">
        <link:definition>2420413 - Disclosure - Acquisitions - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" roleURI="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails">
        <link:definition>2421414 - Disclosure - Acquisitions - Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsProFormaFinancialInformationDetails" roleURI="http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails">
        <link:definition>2422415 - Disclosure - Acquisitions - Pro Forma Financial Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotes" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotes">
        <link:definition>2123104 - Disclosure - Convertible Senior Notes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesTables" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesTables">
        <link:definition>2324304 - Disclosure - Convertible Senior Notes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesNarrativeDetails" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails">
        <link:definition>2425416 - Disclosure - Convertible Senior Notes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesNotesPayableDetails" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails">
        <link:definition>2426417 - Disclosure - Convertible Senior Notes - Notes Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTax" roleURI="http://www.ligand.com/role/IncomeTax">
        <link:definition>2127105 - Disclosure - Income Tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxNarrativeDetails" roleURI="http://www.ligand.com/role/IncomeTaxNarrativeDetails">
        <link:definition>2428418 - Disclosure - Income Tax - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.ligand.com/role/StockholdersEquity">
        <link:definition>2129106 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.ligand.com/role/StockholdersEquityTables">
        <link:definition>2330305 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails">
        <link:definition>2431419 - Disclosure - Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails">
        <link:definition>2432420 - Disclosure - Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesLegalProceedings" roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings">
        <link:definition>2133107 - Disclosure - Commitment and Contingencies: Legal Proceedings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesLegalProceedingsNarrativeDetails" roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails">
        <link:definition>2434421 - Disclosure - Commitment and Contingencies: Legal Proceedings - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" abstract="false" name="PaymentsToContingentValueRightHoldersFinancingActivity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_EquityMethodInvestmentSharesSold" abstract="false" name="EquityMethodInvestmentSharesSold" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" abstract="false" name="ForecastedCashFlowsEffectiveInterestRatePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" abstract="true" name="LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyCrystalMember" abstract="true" name="LiabilityForContingentValueRightsCompanyCrystalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ContingentValueRightOnProductRevenuesMember" abstract="true" name="ContingentValueRightOnProductRevenuesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" abstract="false" name="CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRights" abstract="false" name="LiabilityForContingentValueRights" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" abstract="false" name="ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AziyoMember" abstract="true" name="AziyoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_ReturnsAccrual" abstract="false" name="ReturnsAccrual" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ConvertibleSeniorNotesDue2023Member" abstract="true" name="ConvertibleSeniorNotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_LupinPatentInfringementMember" abstract="true" name="LupinPatentInfringementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_BasisOfPresentationLineItems" abstract="true" name="BasisOfPresentationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_AccruedAssetAcquisitionsCurrent" abstract="false" name="AccruedAssetAcquisitionsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationConsiderationTransferredHoldback" abstract="false" name="BusinessCombinationConsiderationTransferredHoldback" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_PaymentsForConvertibleBondHedges" abstract="false" name="PaymentsForConvertibleBondHedges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_MetabasisMember" abstract="true" name="MetabasisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_MilestonePaymentsMember" abstract="true" name="MilestonePaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_SelexisMember" abstract="true" name="SelexisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_MaterialSalesCaptisolMember" abstract="true" name="MaterialSalesCaptisolMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" abstract="true" name="LiabilityForContingentValueRightsCompanyXCellaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_AccruedInventoryPurchases" abstract="false" name="AccruedInventoryPurchases" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyPfenexMember" abstract="true" name="LiabilityForContingentValueRightsCompanyPfenexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_PfenexMember" abstract="true" name="PfenexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_TaurusBiosciencesLLCMember" abstract="true" name="TaurusBiosciencesLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyCydexMember" abstract="true" name="LiabilityForContingentValueRightsCompanyCydexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" abstract="true" name="DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_LicenseFeesMember" abstract="true" name="LicenseFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_NumberOfOptionsUnderConvertibleBondHedges" abstract="false" name="NumberOfOptionsUnderConvertibleBondHedges" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" abstract="true" name="LicenseFeesMilestonesAndProductOtherProductOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_KyprolisMember" abstract="true" name="KyprolisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_AccruedSubcontractorExpensesCurrent" abstract="false" name="AccruedSubcontractorExpensesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BasisOfPresentationTable" abstract="true" name="BasisOfPresentationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" abstract="false" name="ScheduleOfCommercialLicenseRightsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" abstract="false" name="BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AmortizationOfOtherEconomicRights" abstract="false" name="AmortizationOfOtherEconomicRights" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_EvomelaMember" abstract="true" name="EvomelaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_IcagenMember" abstract="true" name="IcagenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" abstract="true" name="LiabilityForContingentValueRightsCompanyMetabasisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" abstract="true" name="EarnoutRightsForPartnerResearchAndDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="lgnd_NumberOfPetitionsFiled" abstract="false" name="NumberOfPetitionsFiled" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_NumberOfContingentValueRightsSeries" abstract="false" name="NumberOfContingentValueRightsSeries" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_ContractRevenueServiceMember" abstract="true" name="ContractRevenueServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_GainLossOnShortTermInvestments" abstract="false" name="GainLossOnShortTermInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_EmployeeStockPurchasePlanAbstract" abstract="true" name="EmployeeStockPurchasePlanAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" abstract="false" name="COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_CurrentPortionOfLiabilityForContingentValueRights" abstract="false" name="CurrentPortionOfLiabilityForContingentValueRights" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_GlaxoSmithKlineBiologicalsSAMember" abstract="true" name="GlaxoSmithKlineBiologicalsSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" abstract="false" name="DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" abstract="false" name="ScheduleOfShortTermInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" abstract="false" name="BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" abstract="false" name="NonCashChangeInEstimatedFairValueOfContingentValueRights" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" abstract="false" name="FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" abstract="false" name="BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" abstract="true" name="LiabilityForContingentValueRightsCompanyIcagenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" abstract="false" name="ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" abstract="false" name="BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_CommercialLicenseRights" abstract="false" name="CommercialLicenseRights" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_InterPartesReviewOfPatentMember" abstract="true" name="InterPartesReviewOfPatentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_ContractRevenueMember" abstract="true" name="ContractRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" abstract="false" name="DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="lgnd_AccruedSupplierExpensesCurrent" abstract="false" name="AccruedSupplierExpensesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" abstract="false" name="PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_SelexisAndDianomiMember" abstract="true" name="SelexisAndDianomiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_RoyaltyOtherMember" abstract="true" name="RoyaltyOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_PaymentsToUnwindWarrants" abstract="false" name="PaymentsToUnwindWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_IncreaseDecreaseInDebtDiscount" abstract="false" name="IncreaseDecreaseInDebtDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" abstract="true" name="USDistrictCourtForTheNorthernDistrictOfOhioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_Phase3ClinicalTrialMember" abstract="true" name="Phase3ClinicalTrialMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_ProceedsFromUnwindingConvertibleBondHedges" abstract="false" name="ProceedsFromUnwindingConvertibleBondHedges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" abstract="true" name="ContingentValueRightForInternalResearchAndDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_MilestoneMember" abstract="true" name="MilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" abstract="true" name="CommercialLicenseAndOtherEconomicRightsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_LicenseeAccrualCurrent" abstract="false" name="LicenseeAccrualCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AziyoAndCorMatrixMember" abstract="true" name="AziyoAndCorMatrixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" abstract="false" name="FiniteLivedIntangibleAssetsCreditLossAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_XCellaBiosciencesIncMember" abstract="true" name="XCellaBiosciencesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>lgnd-20210331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:f42e6ea9-4959-4941-8454-5f1ec5bc67fa,g:c4690a82-fe68-4d49-b4c9-c600693120e1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ligand.com/role/CoverPage" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a0d09c27-76f6-4d74-88c5-1c2279edf788" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_cf6c7790-1fa3-4188-9ceb-3aa8c5d91213" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a0d09c27-76f6-4d74-88c5-1c2279edf788" xlink:to="loc_us-gaap_AccountsPayableCurrent_cf6c7790-1fa3-4188-9ceb-3aa8c5d91213" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_04e71ff3-9a8f-4f56-82fc-e5db4e425600" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a0d09c27-76f6-4d74-88c5-1c2279edf788" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_04e71ff3-9a8f-4f56-82fc-e5db4e425600" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_cf92c30c-d1af-454c-a547-6ac47e4492d9" xlink:href="lgnd-20210331.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a0d09c27-76f6-4d74-88c5-1c2279edf788" xlink:to="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_cf92c30c-d1af-454c-a547-6ac47e4492d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_1d4231d9-6704-47a9-b051-c91cacfc08c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a0d09c27-76f6-4d74-88c5-1c2279edf788" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_1d4231d9-6704-47a9-b051-c91cacfc08c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_ce5f6927-5b69-40db-8413-9a5699fa1d94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a0d09c27-76f6-4d74-88c5-1c2279edf788" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_ce5f6927-5b69-40db-8413-9a5699fa1d94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_b5bd1b1a-d20d-44ee-8c4e-c6436d640eb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a0d09c27-76f6-4d74-88c5-1c2279edf788" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_b5bd1b1a-d20d-44ee-8c4e-c6436d640eb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ec769519-ff85-4d6a-ba13-a0615990dacf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e1860e0f-3e6d-4a69-8d76-8ee4a5499963" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ec769519-ff85-4d6a-ba13-a0615990dacf" xlink:to="loc_us-gaap_Goodwill_e1860e0f-3e6d-4a69-8d76-8ee4a5499963" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c5da1a46-fe32-4041-8eb4-7d2c2caae190" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ec769519-ff85-4d6a-ba13-a0615990dacf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c5da1a46-fe32-4041-8eb4-7d2c2caae190" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9f44d3bd-daf0-49b5-9299-4df2ec7bb69a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ec769519-ff85-4d6a-ba13-a0615990dacf" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_9f44d3bd-daf0-49b5-9299-4df2ec7bb69a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c5dc1f23-50b2-4642-886f-4d59293e79ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ec769519-ff85-4d6a-ba13-a0615990dacf" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c5dc1f23-50b2-4642-886f-4d59293e79ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_4ad4c407-0095-4140-97e4-c69ef263e979" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ec769519-ff85-4d6a-ba13-a0615990dacf" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_4ad4c407-0095-4140-97e4-c69ef263e979" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_4d0cb922-3e7d-4c8e-97df-d7a7b1f6840e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ec769519-ff85-4d6a-ba13-a0615990dacf" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_4d0cb922-3e7d-4c8e-97df-d7a7b1f6840e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a1a5c76b-5117-4938-abab-96e52e609d41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ec769519-ff85-4d6a-ba13-a0615990dacf" xlink:to="loc_us-gaap_AssetsCurrent_a1a5c76b-5117-4938-abab-96e52e609d41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights_b896309a-c2f4-4d79-9513-83492f8d85ff" xlink:href="lgnd-20210331.xsd#lgnd_CommercialLicenseRights"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ec769519-ff85-4d6a-ba13-a0615990dacf" xlink:to="loc_lgnd_CommercialLicenseRights_b896309a-c2f4-4d79-9513-83492f8d85ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9e5d0162-104e-4d0d-8b8a-3876c4117b26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ec769519-ff85-4d6a-ba13-a0615990dacf" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_9e5d0162-104e-4d0d-8b8a-3876c4117b26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_41b603c8-2a4d-40ca-b400-f5a73e0f8137" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_20ca0137-5499-4187-95ec-d38bd3d7be42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_41b603c8-2a4d-40ca-b400-f5a73e0f8137" xlink:to="loc_us-gaap_Liabilities_20ca0137-5499-4187-95ec-d38bd3d7be42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6470b3ce-27db-4592-96f3-1bc167d121cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_41b603c8-2a4d-40ca-b400-f5a73e0f8137" xlink:to="loc_us-gaap_StockholdersEquity_6470b3ce-27db-4592-96f3-1bc167d121cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_4a6bd539-2ea3-468f-a43e-35f885207b6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_41b603c8-2a4d-40ca-b400-f5a73e0f8137" xlink:to="loc_us-gaap_CommitmentsAndContingencies_4a6bd539-2ea3-468f-a43e-35f885207b6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e638bda4-ac9a-4b3a-932f-bb9d81e113db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8d956cad-000c-4536-bef6-14efdf0d69bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e638bda4-ac9a-4b3a-932f-bb9d81e113db" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8d956cad-000c-4536-bef6-14efdf0d69bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_390a68ba-a201-4218-b018-176a682773d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e638bda4-ac9a-4b3a-932f-bb9d81e113db" xlink:to="loc_us-gaap_CommonStockValue_390a68ba-a201-4218-b018-176a682773d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_cba1438d-b0e8-4eaf-9116-4a0e4c9b33e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e638bda4-ac9a-4b3a-932f-bb9d81e113db" xlink:to="loc_us-gaap_AdditionalPaidInCapital_cba1438d-b0e8-4eaf-9116-4a0e4c9b33e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_291543c1-38e2-4bcc-bb23-ab4a4e284793" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e638bda4-ac9a-4b3a-932f-bb9d81e113db" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_291543c1-38e2-4bcc-bb23-ab4a4e284793" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_6814ec1f-d887-48fb-abfd-3150f57014e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e638bda4-ac9a-4b3a-932f-bb9d81e113db" xlink:to="loc_us-gaap_PreferredStockValue_6814ec1f-d887-48fb-abfd-3150f57014e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_01cb7370-8c51-44c8-8e74-6c5fd0c746eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f1de4b0b-2ea7-474a-b2b6-e7ecf5069916" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_01cb7370-8c51-44c8-8e74-6c5fd0c746eb" xlink:to="loc_us-gaap_LiabilitiesCurrent_f1de4b0b-2ea7-474a-b2b6-e7ecf5069916" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_b5e5b155-30b2-43a8-a9c9-ca3a700c20ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_01cb7370-8c51-44c8-8e74-6c5fd0c746eb" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_b5e5b155-30b2-43a8-a9c9-ca3a700c20ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights_4ac2169f-790f-4337-8dcc-6fb077aac481" xlink:href="lgnd-20210331.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_01cb7370-8c51-44c8-8e74-6c5fd0c746eb" xlink:to="loc_lgnd_LiabilityForContingentValueRights_4ac2169f-790f-4337-8dcc-6fb077aac481" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_16e0e2e1-fc88-42ba-a03c-57d8abf2e2c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_01cb7370-8c51-44c8-8e74-6c5fd0c746eb" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_16e0e2e1-fc88-42ba-a03c-57d8abf2e2c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_04e33e7a-de73-4c7e-b714-ab6397cdb07e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_01cb7370-8c51-44c8-8e74-6c5fd0c746eb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_04e33e7a-de73-4c7e-b714-ab6397cdb07e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_0d079341-37e7-4ce5-8c24-c3352faecd14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_01cb7370-8c51-44c8-8e74-6c5fd0c746eb" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_0d079341-37e7-4ce5-8c24-c3352faecd14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c9118b41-8c5d-437d-b6b0-071819639968" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a7b0d458-50ff-4238-97f5-b854f64e3215" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c9118b41-8c5d-437d-b6b0-071819639968" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a7b0d458-50ff-4238-97f5-b854f64e3215" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_bb3fe9be-c0c8-499e-9189-16754a6b14c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c9118b41-8c5d-437d-b6b0-071819639968" xlink:to="loc_us-gaap_ShortTermInvestments_bb3fe9be-c0c8-499e-9189-16754a6b14c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_80a01703-a534-46fa-bedd-4a7280e8823f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c9118b41-8c5d-437d-b6b0-071819639968" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_80a01703-a534-46fa-bedd-4a7280e8823f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_3941795d-c62e-4cbd-b404-b865a1eec87d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c9118b41-8c5d-437d-b6b0-071819639968" xlink:to="loc_us-gaap_InventoryNet_3941795d-c62e-4cbd-b404-b865a1eec87d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_564b0268-b65a-4905-a77f-2437d966943f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c9118b41-8c5d-437d-b6b0-071819639968" xlink:to="loc_us-gaap_IncomeTaxesReceivable_564b0268-b65a-4905-a77f-2437d966943f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_cabb2866-e494-4877-90f8-8652895940a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c9118b41-8c5d-437d-b6b0-071819639968" xlink:to="loc_us-gaap_OtherAssetsCurrent_cabb2866-e494-4877-90f8-8652895940a6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_685369b8-2af7-4b0a-a744-85efe114c31c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d591ce05-8352-4b66-8c51-09d784bb706d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_685369b8-2af7-4b0a-a744-85efe114c31c" xlink:to="loc_us-gaap_OperatingIncomeLoss_d591ce05-8352-4b66-8c51-09d784bb706d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_807ab51e-335e-428a-91f3-f9f2eaa2a6b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_685369b8-2af7-4b0a-a744-85efe114c31c" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_807ab51e-335e-428a-91f3-f9f2eaa2a6b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_170ead1f-033c-4e1d-b277-626d3160df77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_13da3a22-70ac-4587-8461-d0c37eae5210" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_170ead1f-033c-4e1d-b277-626d3160df77" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_13da3a22-70ac-4587-8461-d0c37eae5210" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1f396030-2bd7-4f7c-af90-fc8fa4c045be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_170ead1f-033c-4e1d-b277-626d3160df77" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1f396030-2bd7-4f7c-af90-fc8fa4c045be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_b7bf50eb-b3a4-45d3-9d03-4d5c10c804a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_6598aea6-a9fd-4c46-827c-3524629eed4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b7bf50eb-b3a4-45d3-9d03-4d5c10c804a8" xlink:to="loc_us-gaap_GainLossOnInvestments_6598aea6-a9fd-4c46-827c-3524629eed4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_d9ad19e8-d982-4bc1-bc0d-d168f9f7e9c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b7bf50eb-b3a4-45d3-9d03-4d5c10c804a8" xlink:to="loc_us-gaap_InvestmentIncomeInterest_d9ad19e8-d982-4bc1-bc0d-d168f9f7e9c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_6fcbd2e3-fffa-4550-a1b9-fe2fc5bfd741" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b7bf50eb-b3a4-45d3-9d03-4d5c10c804a8" xlink:to="loc_us-gaap_InterestExpense_6fcbd2e3-fffa-4550-a1b9-fe2fc5bfd741" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_fa9a9982-0f42-41a4-a0b1-9a92c9d15e6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b7bf50eb-b3a4-45d3-9d03-4d5c10c804a8" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_fa9a9982-0f42-41a4-a0b1-9a92c9d15e6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_bd01fe92-d6e9-49b8-846d-54cbcaf5bd2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_5cd78b1d-c892-4237-ae64-71cd89e6d0a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostDirectMaterial"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_bd01fe92-d6e9-49b8-846d-54cbcaf5bd2f" xlink:to="loc_us-gaap_CostDirectMaterial_5cd78b1d-c892-4237-ae64-71cd89e6d0a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_ccb33251-bc4f-4ff4-85f5-443b3ba023c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_bd01fe92-d6e9-49b8-846d-54cbcaf5bd2f" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_ccb33251-bc4f-4ff4-85f5-443b3ba023c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_ac6dd153-2ab2-4e60-9a61-4eb33d3a8891" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_bd01fe92-d6e9-49b8-846d-54cbcaf5bd2f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_ac6dd153-2ab2-4e60-9a61-4eb33d3a8891" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_b6325c59-04b0-4deb-89c9-408278005c6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_bd01fe92-d6e9-49b8-846d-54cbcaf5bd2f" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_b6325c59-04b0-4deb-89c9-408278005c6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_55be0b95-f539-48f5-9d61-d59a9c54ffd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_d49d164d-173c-44ad-839f-f3e29f570c83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_55be0b95-f539-48f5-9d61-d59a9c54ffd7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_d49d164d-173c-44ad-839f-f3e29f570c83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_6a0ebc08-cea8-4586-ade9-c24301d258a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_55be0b95-f539-48f5-9d61-d59a9c54ffd7" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_6a0ebc08-cea8-4586-ade9-c24301d258a5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_068e51a1-a965-4588-81c8-4014fe00a9a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f91c2d53-fbda-4b71-84a6-c70f90e9bc42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_068e51a1-a965-4588-81c8-4014fe00a9a9" xlink:to="loc_us-gaap_NetIncomeLoss_f91c2d53-fbda-4b71-84a6-c70f90e9bc42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_aad4eed9-f425-429c-b5e9-72643d2cc257" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_068e51a1-a965-4588-81c8-4014fe00a9a9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_aad4eed9-f425-429c-b5e9-72643d2cc257" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f33e28f8-0437-4913-90e6-e08380772c26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_068e51a1-a965-4588-81c8-4014fe00a9a9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f33e28f8-0437-4913-90e6-e08380772c26" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CondensedConsolidatedStatementsofStockholdersEquityUnaudited"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6f974696-dd73-4407-a1cf-f9e5df1394fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_6e1c7d3a-23e3-4937-b333-8555bb740721" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6f974696-dd73-4407-a1cf-f9e5df1394fa" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_6e1c7d3a-23e3-4937-b333-8555bb740721" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_1a1e4084-cc3f-4471-82b4-670e42d661f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6f974696-dd73-4407-a1cf-f9e5df1394fa" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_1a1e4084-cc3f-4471-82b4-670e42d661f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_3f9c9e01-933b-4b21-b2e5-250b4ec66a18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6f974696-dd73-4407-a1cf-f9e5df1394fa" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_3f9c9e01-933b-4b21-b2e5-250b4ec66a18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3755a8a2-9df2-477d-b197-4ea9dadc0ddf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6f974696-dd73-4407-a1cf-f9e5df1394fa" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3755a8a2-9df2-477d-b197-4ea9dadc0ddf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d5ceb297-64f1-4ec1-addc-ecffe6a6aaa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cdf1356f-3479-4bd7-afb0-753dbfe1fdea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d5ceb297-64f1-4ec1-addc-ecffe6a6aaa2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cdf1356f-3479-4bd7-afb0-753dbfe1fdea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4b6265cf-a1e0-4897-94c1-a78ff27ec94d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d5ceb297-64f1-4ec1-addc-ecffe6a6aaa2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4b6265cf-a1e0-4897-94c1-a78ff27ec94d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b5024192-f2c3-4371-8ce9-5618eb8b7925" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d5ceb297-64f1-4ec1-addc-ecffe6a6aaa2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b5024192-f2c3-4371-8ce9-5618eb8b7925" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_487987d8-8dd9-4d01-add6-0ae5e1b93390" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d5ceb297-64f1-4ec1-addc-ecffe6a6aaa2" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_487987d8-8dd9-4d01-add6-0ae5e1b93390" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5aac7d8c-51a5-47c2-ab01-b6d8bed57991" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_01171831-8af3-407e-8dad-3ef22c84ff37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5aac7d8c-51a5-47c2-ab01-b6d8bed57991" xlink:to="loc_us-gaap_ProfitLoss_01171831-8af3-407e-8dad-3ef22c84ff37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_87e53e77-1208-4234-ba9f-0b76ce8013f8" xlink:href="lgnd-20210331.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5aac7d8c-51a5-47c2-ab01-b6d8bed57991" xlink:to="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_87e53e77-1208-4234-ba9f-0b76ce8013f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_465b31b4-c7db-4785-9d65-626e4bf79e69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5aac7d8c-51a5-47c2-ab01-b6d8bed57991" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_465b31b4-c7db-4785-9d65-626e4bf79e69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_eb101777-3211-4f90-bc8d-cbe8cc3b08c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5aac7d8c-51a5-47c2-ab01-b6d8bed57991" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_eb101777-3211-4f90-bc8d-cbe8cc3b08c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_eea05646-8809-4a08-95c0-dc0c3fd06e13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5aac7d8c-51a5-47c2-ab01-b6d8bed57991" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_eea05646-8809-4a08-95c0-dc0c3fd06e13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfOtherEconomicRights_3f2fb3c7-0706-4ee3-8452-35e65824c49d" xlink:href="lgnd-20210331.xsd#lgnd_AmortizationOfOtherEconomicRights"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5aac7d8c-51a5-47c2-ab01-b6d8bed57991" xlink:to="loc_lgnd_AmortizationOfOtherEconomicRights_3f2fb3c7-0706-4ee3-8452-35e65824c49d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_634e89e5-28ab-4243-8d3d-5da30939fbed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5aac7d8c-51a5-47c2-ab01-b6d8bed57991" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_634e89e5-28ab-4243-8d3d-5da30939fbed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_72e6e377-b3f1-4aa4-9b87-ecbcf5fe6263" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5aac7d8c-51a5-47c2-ab01-b6d8bed57991" xlink:to="loc_us-gaap_ShareBasedCompensation_72e6e377-b3f1-4aa4-9b87-ecbcf5fe6263" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_d484192d-1296-4186-a46e-5b625d89b105" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5aac7d8c-51a5-47c2-ab01-b6d8bed57991" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_d484192d-1296-4186-a46e-5b625d89b105" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments_e8de9d92-aa6b-442d-8974-5da4b8e6f9e7" xlink:href="lgnd-20210331.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5aac7d8c-51a5-47c2-ab01-b6d8bed57991" xlink:to="loc_lgnd_GainLossOnShortTermInvestments_e8de9d92-aa6b-442d-8974-5da4b8e6f9e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_a445d2cc-9468-47ae-9e6d-d71314666c98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5aac7d8c-51a5-47c2-ab01-b6d8bed57991" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_a445d2cc-9468-47ae-9e6d-d71314666c98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a77e89be-328d-4021-af12-e4b52d972b58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5aac7d8c-51a5-47c2-ab01-b6d8bed57991" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a77e89be-328d-4021-af12-e4b52d972b58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_87a8ee84-f163-4e2d-a7ff-cf4624c24cd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5aac7d8c-51a5-47c2-ab01-b6d8bed57991" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_87a8ee84-f163-4e2d-a7ff-cf4624c24cd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_59ac0959-d6ea-4036-9246-33fda3a13955" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5aac7d8c-51a5-47c2-ab01-b6d8bed57991" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_59ac0959-d6ea-4036-9246-33fda3a13955" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_e501f8d2-f449-4cb8-bbe6-3f8cf37452f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5aac7d8c-51a5-47c2-ab01-b6d8bed57991" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_e501f8d2-f449-4cb8-bbe6-3f8cf37452f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_e0c3c26e-78ed-4d4b-9c66-e4c70911102b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5aac7d8c-51a5-47c2-ab01-b6d8bed57991" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_e0c3c26e-78ed-4d4b-9c66-e4c70911102b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_311cc2ed-6876-469c-9823-8fac98e45a4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5aac7d8c-51a5-47c2-ab01-b6d8bed57991" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_311cc2ed-6876-469c-9823-8fac98e45a4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_41cac3ee-c5c3-4ad5-b641-8e544517848a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_e465a281-d8a8-488b-a411-6601dd5e3b2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_41cac3ee-c5c3-4ad5-b641-8e544517848a" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_e465a281-d8a8-488b-a411-6601dd5e3b2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_0c4d75e0-2b92-43c2-b85e-58672eab7681" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_41cac3ee-c5c3-4ad5-b641-8e544517848a" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_0c4d75e0-2b92-43c2-b85e-58672eab7681" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeFinancingActivities_ec744d78-2320-41a2-bdac-82b5fc70bbdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromHedgeFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_41cac3ee-c5c3-4ad5-b641-8e544517848a" xlink:to="loc_us-gaap_ProceedsFromHedgeFinancingActivities_ec744d78-2320-41a2-bdac-82b5fc70bbdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities_8087c3fd-0e7e-4e09-be00-68035adc2a26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_41cac3ee-c5c3-4ad5-b641-8e544517848a" xlink:to="loc_us-gaap_PaymentsForHedgeFinancingActivities_8087c3fd-0e7e-4e09-be00-68035adc2a26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_3b83b694-4673-4121-9cff-d5cfda536bd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_41cac3ee-c5c3-4ad5-b641-8e544517848a" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_3b83b694-4673-4121-9cff-d5cfda536bd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_7d8709af-2e93-42b8-8750-1dd0550a6bc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_41cac3ee-c5c3-4ad5-b641-8e544517848a" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_7d8709af-2e93-42b8-8750-1dd0550a6bc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_411f19cb-2baf-42da-907a-b4eb0ea7a45a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_41cac3ee-c5c3-4ad5-b641-8e544517848a" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_411f19cb-2baf-42da-907a-b4eb0ea7a45a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_317abe12-e93b-4c40-a126-75502fd180c6" xlink:href="lgnd-20210331.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_41cac3ee-c5c3-4ad5-b641-8e544517848a" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_317abe12-e93b-4c40-a126-75502fd180c6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_ccab1c9f-3394-417c-babf-5b0d062d9517" xlink:href="lgnd-20210331.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_24c3effb-9aa5-4318-9087-8ccabe16f150" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_ccab1c9f-3394-417c-babf-5b0d062d9517" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_24c3effb-9aa5-4318-9087-8ccabe16f150" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9deaf751-5ff6-465e-996b-b18f0bb57145" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_ccab1c9f-3394-417c-babf-5b0d062d9517" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9deaf751-5ff6-465e-996b-b18f0bb57145" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2d2d4244-bf10-4010-86d1-5b973a64f45f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b09927c3-7067-4266-82e8-c0e8fe05604a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2d2d4244-bf10-4010-86d1-5b973a64f45f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b09927c3-7067-4266-82e8-c0e8fe05604a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_251f6393-5652-4acf-93af-e07e51f44a3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2d2d4244-bf10-4010-86d1-5b973a64f45f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_251f6393-5652-4acf-93af-e07e51f44a3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_244bf7ee-f67e-401c-b109-b870373bf7e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2d2d4244-bf10-4010-86d1-5b973a64f45f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_244bf7ee-f67e-401c-b109-b870373bf7e7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_787d457c-1261-4b18-8fa8-133bb51fc66f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_88fbaa17-0b7d-4e8f-a5cf-9e72ef91fef8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_787d457c-1261-4b18-8fa8-133bb51fc66f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_88fbaa17-0b7d-4e8f-a5cf-9e72ef91fef8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_f3539ed2-02da-4393-bf25-d8c4939ccc63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_787d457c-1261-4b18-8fa8-133bb51fc66f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_f3539ed2-02da-4393-bf25-d8c4939ccc63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_fb65e6f3-647c-4382-8254-77edd27f971f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_fc7f8b1b-ff87-45ec-be14-2eb9e7c9f611" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_fb65e6f3-647c-4382-8254-77edd27f971f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_fc7f8b1b-ff87-45ec-be14-2eb9e7c9f611" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_b8380103-e750-427c-810b-4f8d483cf86b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_fb65e6f3-647c-4382-8254-77edd27f971f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_b8380103-e750-427c-810b-4f8d483cf86b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_d59b7886-0cc0-47cc-bae4-97976ab7746b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7be6645a-b99f-44b5-abbd-53ceb55e31b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_d59b7886-0cc0-47cc-bae4-97976ab7746b" xlink:to="loc_us-gaap_Goodwill_7be6645a-b99f-44b5-abbd-53ceb55e31b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a50de02a-feed-48e7-942f-51386b116a9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_d59b7886-0cc0-47cc-bae4-97976ab7746b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a50de02a-feed-48e7-942f-51386b116a9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_fc7c71d7-d488-465b-a3d3-a5b065070271" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_d59b7886-0cc0-47cc-bae4-97976ab7746b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_fc7c71d7-d488-465b-a3d3-a5b065070271" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7c2fdef3-c4bf-421b-a9ab-d404d4e4b7dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_6bc5ccc8-c963-4390-8ffc-bf70a03bbdf4" xlink:href="lgnd-20210331.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7c2fdef3-c4bf-421b-a9ab-d404d4e4b7dc" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_6bc5ccc8-c963-4390-8ffc-bf70a03bbdf4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_34595ea1-ecc6-4edf-8e01-e94a8164cbed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7c2fdef3-c4bf-421b-a9ab-d404d4e4b7dc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_34595ea1-ecc6-4edf-8e01-e94a8164cbed" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_ee4da4d8-af47-4723-97e4-270021ab601b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_023fbd2f-fa12-4a5b-b871-adfcd409f2fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ee4da4d8-af47-4723-97e4-270021ab601b" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_023fbd2f-fa12-4a5b-b871-adfcd409f2fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_180de445-47a1-4035-85d3-0f9dbb415360" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ee4da4d8-af47-4723-97e4-270021ab601b" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_180de445-47a1-4035-85d3-0f9dbb415360" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseeAccrualCurrent_5310057a-a896-42d0-a699-5ca56e3614e6" xlink:href="lgnd-20210331.xsd#lgnd_LicenseeAccrualCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ee4da4d8-af47-4723-97e4-270021ab601b" xlink:to="loc_lgnd_LicenseeAccrualCurrent_5310057a-a896-42d0-a699-5ca56e3614e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_fbbd5127-9187-4a1f-a304-af686096827c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ee4da4d8-af47-4723-97e4-270021ab601b" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_fbbd5127-9187-4a1f-a304-af686096827c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ReturnsAccrual_f1948a82-d5d2-43e3-a15d-4478bb4ff349" xlink:href="lgnd-20210331.xsd#lgnd_ReturnsAccrual"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ee4da4d8-af47-4723-97e4-270021ab601b" xlink:to="loc_lgnd_ReturnsAccrual_f1948a82-d5d2-43e3-a15d-4478bb4ff349" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedAssetAcquisitionsCurrent_a654fd05-ae02-4922-83d9-5cb7e4cd85d7" xlink:href="lgnd-20210331.xsd#lgnd_AccruedAssetAcquisitionsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ee4da4d8-af47-4723-97e4-270021ab601b" xlink:to="loc_lgnd_AccruedAssetAcquisitionsCurrent_a654fd05-ae02-4922-83d9-5cb7e4cd85d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSubcontractorExpensesCurrent_f1cfc05f-3a8b-4b6c-b0b3-3d0a9ddb033b" xlink:href="lgnd-20210331.xsd#lgnd_AccruedSubcontractorExpensesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ee4da4d8-af47-4723-97e4-270021ab601b" xlink:to="loc_lgnd_AccruedSubcontractorExpensesCurrent_f1cfc05f-3a8b-4b6c-b0b3-3d0a9ddb033b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSupplierExpensesCurrent_d8ea5397-ef91-4628-9fe7-f66fac0a18a1" xlink:href="lgnd-20210331.xsd#lgnd_AccruedSupplierExpensesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ee4da4d8-af47-4723-97e4-270021ab601b" xlink:to="loc_lgnd_AccruedSupplierExpensesCurrent_d8ea5397-ef91-4628-9fe7-f66fac0a18a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_e7f7ff39-80e3-42df-9be8-fa9e4dd726e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ee4da4d8-af47-4723-97e4-270021ab601b" xlink:to="loc_us-gaap_InterestPayableCurrent_e7f7ff39-80e3-42df-9be8-fa9e4dd726e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5e2c814a-4432-485f-9ad5-0f9f222f50e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ee4da4d8-af47-4723-97e4-270021ab601b" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5e2c814a-4432-485f-9ad5-0f9f222f50e1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_88018ae7-98d9-45ee-99eb-f4ec1c999d7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_f7b71467-9b06-4b21-bddc-36feb9850276" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_88018ae7-98d9-45ee-99eb-f4ec1c999d7c" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_f7b71467-9b06-4b21-bddc-36feb9850276" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_77d09cca-ed64-471c-bfef-d1b698b28b07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_88018ae7-98d9-45ee-99eb-f4ec1c999d7c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_77d09cca-ed64-471c-bfef-d1b698b28b07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_30ccc49c-10c5-464c-ae90-9da1003de862" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_88018ae7-98d9-45ee-99eb-f4ec1c999d7c" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_30ccc49c-10c5-464c-ae90-9da1003de862" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="lgnd-20210331.xsd#FairValueMeasurements"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/FairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="lgnd-20210331.xsd#FairValueMeasurementsTables"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/Acquisitions" xlink:type="simple" xlink:href="lgnd-20210331.xsd#Acquisitions"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/Acquisitions" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsTables" xlink:type="simple" xlink:href="lgnd-20210331.xsd#AcquisitionsTables"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/AcquisitionsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#AcquisitionsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/AcquisitionsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_f002196f-d7ae-480e-86ec-706b8213d586" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_e07e6bed-7581-48b0-95f7-7cd729426173" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_f002196f-d7ae-480e-86ec-706b8213d586" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_e07e6bed-7581-48b0-95f7-7cd729426173" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_9bace9c4-14bc-4a2a-96dc-8f1f48d48f84" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_f002196f-d7ae-480e-86ec-706b8213d586" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_9bace9c4-14bc-4a2a-96dc-8f1f48d48f84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_6cc8dc65-0a40-4290-8038-ac4ed1e3de0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_f002196f-d7ae-480e-86ec-706b8213d586" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_6cc8dc65-0a40-4290-8038-ac4ed1e3de0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_47b36ecb-05f6-4bb2-a0c7-8caa9841b990" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_f002196f-d7ae-480e-86ec-706b8213d586" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_47b36ecb-05f6-4bb2-a0c7-8caa9841b990" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_e5167c41-af01-4db9-8323-ab94d1d44c38" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_f002196f-d7ae-480e-86ec-706b8213d586" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_e5167c41-af01-4db9-8323-ab94d1d44c38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_7cb00da3-4295-4ad9-9b56-1f158469d173" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_f002196f-d7ae-480e-86ec-706b8213d586" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_7cb00da3-4295-4ad9-9b56-1f158469d173" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_db86fb61-a1ea-468e-891d-e74338c8ed22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_f002196f-d7ae-480e-86ec-706b8213d586" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_db86fb61-a1ea-468e-891d-e74338c8ed22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_9286355d-73dc-4cc2-9e1b-803df143472c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_f002196f-d7ae-480e-86ec-706b8213d586" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_9286355d-73dc-4cc2-9e1b-803df143472c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_8c368c46-63da-4154-9fa2-4b0b6cefcf13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_f002196f-d7ae-480e-86ec-706b8213d586" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_8c368c46-63da-4154-9fa2-4b0b6cefcf13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_7070c13e-d866-4ff8-b636-00f67e606180" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_f002196f-d7ae-480e-86ec-706b8213d586" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_7070c13e-d866-4ff8-b636-00f67e606180" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_f0613e9b-65e9-4a36-acde-47630899e2f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_f002196f-d7ae-480e-86ec-706b8213d586" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_f0613e9b-65e9-4a36-acde-47630899e2f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8cbc753c-5055-4906-8f81-9d40357a9945" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_f002196f-d7ae-480e-86ec-706b8213d586" xlink:to="loc_us-gaap_Goodwill_8cbc753c-5055-4906-8f81-9d40357a9945" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_fc1e6e70-3ae3-4887-85d8-415c5936cae7" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_f002196f-d7ae-480e-86ec-706b8213d586" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_fc1e6e70-3ae3-4887-85d8-415c5936cae7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_90738c05-f661-4be9-8571-32d9599749d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_f002196f-d7ae-480e-86ec-706b8213d586" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_90738c05-f661-4be9-8571-32d9599749d9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#AcquisitionsProFormaFinancialInformationDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="simple" xlink:href="lgnd-20210331.xsd#ConvertibleSeniorNotes"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="simple" xlink:href="lgnd-20210331.xsd#ConvertibleSeniorNotesTables"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#ConvertibleSeniorNotesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#ConvertibleSeniorNotesNotesPayableDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_62175678-0fc2-47e5-80ee-2c73c8ecbda8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_8413426c-8bcb-4f49-bbea-9c45afc4c811" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermNotesPayable_62175678-0fc2-47e5-80ee-2c73c8ecbda8" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_8413426c-8bcb-4f49-bbea-9c45afc4c811" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_67af8b3d-9a59-4b10-84a5-cc30bd22d23e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermNotesPayable_62175678-0fc2-47e5-80ee-2c73c8ecbda8" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_67af8b3d-9a59-4b10-84a5-cc30bd22d23e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTax" xlink:type="simple" xlink:href="lgnd-20210331.xsd#IncomeTax"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/IncomeTax" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#IncomeTaxNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/IncomeTaxNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquity" xlink:type="simple" xlink:href="lgnd-20210331.xsd#StockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/StockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="lgnd-20210331.xsd#StockholdersEquityTables"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#StockholdersEquityNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CommitmentandContingenciesLegalProceedings"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CommitmentandContingenciesLegalProceedingsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>lgnd-20210331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:f42e6ea9-4959-4941-8454-5f1ec5bc67fa,g:c4690a82-fe68-4d49-b4c9-c600693120e1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CoverPage" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CoverPage" xlink:type="extended" id="id963ba7e1ee64d66b2d264a419093c33_CoverPage"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended" id="ibd81e083b0034ffda1c37d5c62e76d08_CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended" id="i62daca2f1ac7463fabed6fa183430529_CondensedConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended" id="i3efc19df97fc450b840923e1d535ca0a_CondensedConsolidatedStatementsofOperationsUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e5d0bb7c-aa9d-462c-a629-d2c65fcf7372" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_85a7e92f-0efc-4fba-b38a-7e5348e594e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e5d0bb7c-aa9d-462c-a629-d2c65fcf7372" xlink:to="loc_us-gaap_RevenuesAbstract_85a7e92f-0efc-4fba-b38a-7e5348e594e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_b54e0520-7260-4bdc-8db4-fd8d2c7ecb65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_85a7e92f-0efc-4fba-b38a-7e5348e594e7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_b54e0520-7260-4bdc-8db4-fd8d2c7ecb65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_e4faa0e4-dc15-4bf0-8f10-cda530cecfe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e5d0bb7c-aa9d-462c-a629-d2c65fcf7372" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_e4faa0e4-dc15-4bf0-8f10-cda530cecfe9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_d0de397a-3085-4e3f-bb6b-0e5353dbb198" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostDirectMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_e4faa0e4-dc15-4bf0-8f10-cda530cecfe9" xlink:to="loc_us-gaap_CostDirectMaterial_d0de397a-3085-4e3f-bb6b-0e5353dbb198" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_2defa715-809c-4d0a-b652-3ecf75424abe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_e4faa0e4-dc15-4bf0-8f10-cda530cecfe9" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_2defa715-809c-4d0a-b652-3ecf75424abe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_295719fe-b0f9-4218-9f04-4b82296ef986" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_e4faa0e4-dc15-4bf0-8f10-cda530cecfe9" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_295719fe-b0f9-4218-9f04-4b82296ef986" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_081898b1-01b1-4619-8b7d-c359f9c40daf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_e4faa0e4-dc15-4bf0-8f10-cda530cecfe9" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_081898b1-01b1-4619-8b7d-c359f9c40daf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_a1277a27-d53f-47f5-bee2-d8e678fabe18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_e4faa0e4-dc15-4bf0-8f10-cda530cecfe9" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_a1277a27-d53f-47f5-bee2-d8e678fabe18" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_915f7255-9700-46f0-809c-b7e7e8fbe6b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e5d0bb7c-aa9d-462c-a629-d2c65fcf7372" xlink:to="loc_us-gaap_OperatingIncomeLoss_915f7255-9700-46f0-809c-b7e7e8fbe6b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6573fafe-d994-4920-bcbe-4cddccda5b7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e5d0bb7c-aa9d-462c-a629-d2c65fcf7372" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6573fafe-d994-4920-bcbe-4cddccda5b7c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_f2b387b9-eb0d-4eec-9c4a-afd6e6e4346a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6573fafe-d994-4920-bcbe-4cddccda5b7c" xlink:to="loc_us-gaap_GainLossOnInvestments_f2b387b9-eb0d-4eec-9c4a-afd6e6e4346a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_0779a7a2-3a3b-431c-8bbd-ece312e79dcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6573fafe-d994-4920-bcbe-4cddccda5b7c" xlink:to="loc_us-gaap_InvestmentIncomeInterest_0779a7a2-3a3b-431c-8bbd-ece312e79dcd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_2e96afb7-4faa-4d20-92ec-04b0a9bd872e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6573fafe-d994-4920-bcbe-4cddccda5b7c" xlink:to="loc_us-gaap_InterestExpense_2e96afb7-4faa-4d20-92ec-04b0a9bd872e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_28339df3-ea52-491d-9007-a8b6f072dc43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6573fafe-d994-4920-bcbe-4cddccda5b7c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_28339df3-ea52-491d-9007-a8b6f072dc43" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_5a42a1d3-4a2a-47ae-bec1-26ee4da3e99e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6573fafe-d994-4920-bcbe-4cddccda5b7c" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_5a42a1d3-4a2a-47ae-bec1-26ee4da3e99e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d05c1326-29bb-4b67-8504-e5df96379e30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e5d0bb7c-aa9d-462c-a629-d2c65fcf7372" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d05c1326-29bb-4b67-8504-e5df96379e30" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c1ad0160-4374-4b72-925c-9cb4864f1e99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e5d0bb7c-aa9d-462c-a629-d2c65fcf7372" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c1ad0160-4374-4b72-925c-9cb4864f1e99" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_80108290-f906-4831-9286-2d4e2162b938" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e5d0bb7c-aa9d-462c-a629-d2c65fcf7372" xlink:to="loc_us-gaap_NetIncomeLoss_80108290-f906-4831-9286-2d4e2162b938" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_15a1d192-e57a-4007-83d2-36a5a62173be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e5d0bb7c-aa9d-462c-a629-d2c65fcf7372" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_15a1d192-e57a-4007-83d2-36a5a62173be" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_3f9ab4c5-3107-407d-9115-c614c723dc27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_15a1d192-e57a-4007-83d2-36a5a62173be" xlink:to="loc_us-gaap_EarningsPerShareBasic_3f9ab4c5-3107-407d-9115-c614c723dc27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bfa9058b-84a1-4764-ad7f-e1711cb63817" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_15a1d192-e57a-4007-83d2-36a5a62173be" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bfa9058b-84a1-4764-ad7f-e1711cb63817" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a58593d2-80f7-40b4-95f0-fbc632e0b297" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_15a1d192-e57a-4007-83d2-36a5a62173be" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a58593d2-80f7-40b4-95f0-fbc632e0b297" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_049f621a-deb9-475c-b3ca-842ddda6baba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_15a1d192-e57a-4007-83d2-36a5a62173be" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_049f621a-deb9-475c-b3ca-842ddda6baba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8703230e-39d3-47dc-9e3d-392f3673375c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e5d0bb7c-aa9d-462c-a629-d2c65fcf7372" xlink:to="loc_us-gaap_StatementTable_8703230e-39d3-47dc-9e3d-392f3673375c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_cd517fe6-ac1d-4e3a-ac41-f5ba4e96693e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8703230e-39d3-47dc-9e3d-392f3673375c" xlink:to="loc_srt_ProductOrServiceAxis_cd517fe6-ac1d-4e3a-ac41-f5ba4e96693e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_cd517fe6-ac1d-4e3a-ac41-f5ba4e96693e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_cd517fe6-ac1d-4e3a-ac41-f5ba4e96693e" xlink:to="loc_srt_ProductsAndServicesDomain_cd517fe6-ac1d-4e3a-ac41-f5ba4e96693e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bcfe410e-ff87-4d58-9271-f58d657bd37f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_cd517fe6-ac1d-4e3a-ac41-f5ba4e96693e" xlink:to="loc_srt_ProductsAndServicesDomain_bcfe410e-ff87-4d58-9271-f58d657bd37f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_7dbaf350-a912-45d6-ac8b-004a011dc326" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_bcfe410e-ff87-4d58-9271-f58d657bd37f" xlink:to="loc_us-gaap_RoyaltyMember_7dbaf350-a912-45d6-ac8b-004a011dc326" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_070a5975-5c39-4552-a3a6-4823637161c2" xlink:href="lgnd-20210331.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_bcfe410e-ff87-4d58-9271-f58d657bd37f" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_070a5975-5c39-4552-a3a6-4823637161c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_e362f881-ca0e-4661-9465-f0d4abc89c18" xlink:href="lgnd-20210331.xsd#lgnd_ContractRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_bcfe410e-ff87-4d58-9271-f58d657bd37f" xlink:to="loc_lgnd_ContractRevenueMember_e362f881-ca0e-4661-9465-f0d4abc89c18" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited" xlink:type="extended" id="ia02477929da749f7b3292a000f53be2f_CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CondensedConsolidatedStatementsofStockholdersEquityUnaudited"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="extended" id="i54403b586a8048bd8bd7f9f76cd08527_CondensedConsolidatedStatementsofStockholdersEquityUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5f4e8f98-37ae-4eba-9747-57b3d7d971e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_8b529993-2156-451b-9cee-ddaea09597ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5f4e8f98-37ae-4eba-9747-57b3d7d971e1" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_8b529993-2156-451b-9cee-ddaea09597ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5f4e8f98-37ae-4eba-9747-57b3d7d971e1" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_6138d9f3-47c1-4717-bb28-84561db57d84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_us-gaap_SharesIssued_6138d9f3-47c1-4717-bb28-84561db57d84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ad9219c2-ffca-426b-8f65-c997093c647d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_us-gaap_StockholdersEquity_ad9219c2-ffca-426b-8f65-c997093c647d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0c3ebf5b-45aa-4e28-8263-7fc3dcab5884" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0c3ebf5b-45aa-4e28-8263-7fc3dcab5884" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2787dcbe-8134-4b1e-8a74-72e2ea3706ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2787dcbe-8134-4b1e-8a74-72e2ea3706ba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2aff1188-61a1-4c9e-bc2a-0a1746dd68ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2aff1188-61a1-4c9e-bc2a-0a1746dd68ac" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_96d6d439-e8bb-4be0-adde-e8ab20d29a8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_96d6d439-e8bb-4be0-adde-e8ab20d29a8f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_afc8bbe5-f566-4837-9228-3c71e5fad3d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_afc8bbe5-f566-4837-9228-3c71e5fad3d0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_2eabcacc-7c87-4727-b746-f690e827482c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_2eabcacc-7c87-4727-b746-f690e827482c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_68446c00-1da6-457a-87bf-deed3b9f6f33" xlink:href="lgnd-20210331.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_68446c00-1da6-457a-87bf-deed3b9f6f33" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_5ff8c8b4-9514-4599-a59e-deb8412093a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_5ff8c8b4-9514-4599-a59e-deb8412093a7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_2b356a82-b7f8-45be-a412-1185e372ed65" xlink:href="lgnd-20210331.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_2b356a82-b7f8-45be-a412-1185e372ed65" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_25364bb4-d82a-47da-a9da-c7a5f222c71f" xlink:href="lgnd-20210331.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_25364bb4-d82a-47da-a9da-c7a5f222c71f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_8504a1bb-437b-4834-8fc4-b39e2b171374" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_8504a1bb-437b-4834-8fc4-b39e2b171374" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fd812938-bd17-49aa-a89e-ee5b5d06a097" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_us-gaap_NetIncomeLoss_fd812938-bd17-49aa-a89e-ee5b5d06a097" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_5c8947c1-f1da-4b6d-a868-eae8697f2fd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_47518346-a1e7-4eed-b9eb-11fae12b7a0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ea4056ee-a479-48d1-b2ef-5c835cf7ee87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5f4e8f98-37ae-4eba-9747-57b3d7d971e1" xlink:to="loc_us-gaap_StatementTable_ea4056ee-a479-48d1-b2ef-5c835cf7ee87" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8c0a138f-8a68-43ba-89af-8d96381c569a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ea4056ee-a479-48d1-b2ef-5c835cf7ee87" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8c0a138f-8a68-43ba-89af-8d96381c569a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8c0a138f-8a68-43ba-89af-8d96381c569a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8c0a138f-8a68-43ba-89af-8d96381c569a" xlink:to="loc_us-gaap_EquityComponentDomain_8c0a138f-8a68-43ba-89af-8d96381c569a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3034bacc-8a7a-416c-acaa-a02a38610383" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8c0a138f-8a68-43ba-89af-8d96381c569a" xlink:to="loc_us-gaap_EquityComponentDomain_3034bacc-8a7a-416c-acaa-a02a38610383" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2354780c-40bd-41e5-9d6c-4153a72f48f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3034bacc-8a7a-416c-acaa-a02a38610383" xlink:to="loc_us-gaap_CommonStockMember_2354780c-40bd-41e5-9d6c-4153a72f48f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_556159a0-1cc1-4281-8e33-9943d4e1cf5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3034bacc-8a7a-416c-acaa-a02a38610383" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_556159a0-1cc1-4281-8e33-9943d4e1cf5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_665f65d4-170b-49c8-a29a-0c4fbe39f589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3034bacc-8a7a-416c-acaa-a02a38610383" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_665f65d4-170b-49c8-a29a-0c4fbe39f589" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_440ccf56-1a4c-419b-85d6-777a6e840845" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3034bacc-8a7a-416c-acaa-a02a38610383" xlink:to="loc_us-gaap_RetainedEarningsMember_440ccf56-1a4c-419b-85d6-777a6e840845" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f0d91692-2c0c-48a9-8fd9-1d77b4d89fc6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ea4056ee-a479-48d1-b2ef-5c835cf7ee87" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f0d91692-2c0c-48a9-8fd9-1d77b4d89fc6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f0d91692-2c0c-48a9-8fd9-1d77b4d89fc6_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f0d91692-2c0c-48a9-8fd9-1d77b4d89fc6" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f0d91692-2c0c-48a9-8fd9-1d77b4d89fc6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1276931f-93c6-4aa2-8af9-6b4ab2fee1be" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f0d91692-2c0c-48a9-8fd9-1d77b4d89fc6" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1276931f-93c6-4aa2-8af9-6b4ab2fee1be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_86cbcd48-30dc-4c2c-8dca-7b0bd9132afa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1276931f-93c6-4aa2-8af9-6b4ab2fee1be" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_86cbcd48-30dc-4c2c-8dca-7b0bd9132afa" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended" id="iee4c9378969a40cfb15764efdc4be6ca_CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended" id="i6ac2e16a848546e78ef01cb282ab0bf6_BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended" id="ica7be6b34f2a40deb5776bbec5a108cd_BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended" id="ia63f99db19c6451cb50e608e99f81e7c_BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i546ad009181f40d3bc3832d3fe9be22d_BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_035479a3-37c8-4885-b0b7-6ea234192d53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_035479a3-37c8-4885-b0b7-6ea234192d53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_4f605764-6b37-498d-8d1e-7b9708162fba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_4f605764-6b37-498d-8d1e-7b9708162fba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EquityMethodInvestmentSharesSold_28c83e9c-4a64-4bd1-9063-2079cbb53b31" xlink:href="lgnd-20210331.xsd#lgnd_EquityMethodInvestmentSharesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_lgnd_EquityMethodInvestmentSharesSold_28c83e9c-4a64-4bd1-9063-2079cbb53b31" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_09f7bf12-1691-43f2-a7d0-be7de413a676" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_09f7bf12-1691-43f2-a7d0-be7de413a676" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_05a8c5e9-8b3a-4ec4-8cfc-e0066e70672c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_05a8c5e9-8b3a-4ec4-8cfc-e0066e70672c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c9ef28b4-05ec-4731-ae56-27e9837f7af5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c9ef28b4-05ec-4731-ae56-27e9837f7af5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_926f2d36-ac85-467f-b07b-4f1850b045f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_926f2d36-ac85-467f-b07b-4f1850b045f1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_ec7887e0-e628-4bd8-9be5-6277ae02969c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_ec7887e0-e628-4bd8-9be5-6277ae02969c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_bce63b60-9fe1-4bdc-b990-97743b7b9673" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_bce63b60-9fe1-4bdc-b990-97743b7b9673" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_a61bc43f-2eec-4586-abee-89cffea38e52" xlink:href="lgnd-20210331.xsd#lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_a61bc43f-2eec-4586-abee-89cffea38e52" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_07e9086a-dc32-4feb-aef8-408471fefdbb" xlink:href="lgnd-20210331.xsd#lgnd_ForecastedCashFlowsEffectiveInterestRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_07e9086a-dc32-4feb-aef8-408471fefdbb" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_a3bb906a-741d-4221-9c80-dadda183be9a" xlink:href="lgnd-20210331.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_a3bb906a-741d-4221-9c80-dadda183be9a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_b9022eee-5e48-4d5d-9941-90d775bc6a36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_b9022eee-5e48-4d5d-9941-90d775bc6a36" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_1e032afa-6422-4e90-9040-4e8d5a845d29" xlink:href="lgnd-20210331.xsd#lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_1e032afa-6422-4e90-9040-4e8d5a845d29" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7cf4c6bf-70f9-4610-bcaa-0f8546cee317" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7cf4c6bf-70f9-4610-bcaa-0f8546cee317" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_10e3b19c-a74d-441a-aa38-4bfda5758f5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_10e3b19c-a74d-441a-aa38-4bfda5758f5f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5341b650-3122-48d5-98a2-a4ab7dabc24e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_10e3b19c-a74d-441a-aa38-4bfda5758f5f" xlink:to="loc_srt_RangeAxis_5341b650-3122-48d5-98a2-a4ab7dabc24e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5341b650-3122-48d5-98a2-a4ab7dabc24e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5341b650-3122-48d5-98a2-a4ab7dabc24e" xlink:to="loc_srt_RangeMember_5341b650-3122-48d5-98a2-a4ab7dabc24e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bb20d2ec-31a5-4603-a1f4-8ad83b945778" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5341b650-3122-48d5-98a2-a4ab7dabc24e" xlink:to="loc_srt_RangeMember_bb20d2ec-31a5-4603-a1f4-8ad83b945778" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_cb476ccf-dbfb-4770-91bc-8fc5e012d190" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bb20d2ec-31a5-4603-a1f4-8ad83b945778" xlink:to="loc_srt_MinimumMember_cb476ccf-dbfb-4770-91bc-8fc5e012d190" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_64c03bd3-a2f0-4fcd-9feb-73f192a40f82" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bb20d2ec-31a5-4603-a1f4-8ad83b945778" xlink:to="loc_srt_MaximumMember_64c03bd3-a2f0-4fcd-9feb-73f192a40f82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_74f4f2eb-b59f-4ace-9c65-25f596fcd080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_10e3b19c-a74d-441a-aa38-4bfda5758f5f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_74f4f2eb-b59f-4ace-9c65-25f596fcd080" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_74f4f2eb-b59f-4ace-9c65-25f596fcd080_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_74f4f2eb-b59f-4ace-9c65-25f596fcd080" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_74f4f2eb-b59f-4ace-9c65-25f596fcd080_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_96e184b0-e9fc-4194-8d41-0f56d4136852" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_74f4f2eb-b59f-4ace-9c65-25f596fcd080" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_96e184b0-e9fc-4194-8d41-0f56d4136852" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyAgreementsMember_874c0a73-46f5-4d66-9423-7562073b8534" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_96e184b0-e9fc-4194-8d41-0f56d4136852" xlink:to="loc_us-gaap_RoyaltyAgreementsMember_874c0a73-46f5-4d66-9423-7562073b8534" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_abe70a74-5f29-4189-90dd-ae7709f78381" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_96e184b0-e9fc-4194-8d41-0f56d4136852" xlink:to="loc_us-gaap_LicensingAgreementsMember_abe70a74-5f29-4189-90dd-ae7709f78381" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ff5ef38d-9fa6-4c73-9c84-a4b966d0be4e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_10e3b19c-a74d-441a-aa38-4bfda5758f5f" xlink:to="loc_srt_CounterpartyNameAxis_ff5ef38d-9fa6-4c73-9c84-a4b966d0be4e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ff5ef38d-9fa6-4c73-9c84-a4b966d0be4e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_ff5ef38d-9fa6-4c73-9c84-a4b966d0be4e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ff5ef38d-9fa6-4c73-9c84-a4b966d0be4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_689fbd61-3411-495e-90e2-a9b1f7959bac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_ff5ef38d-9fa6-4c73-9c84-a4b966d0be4e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_689fbd61-3411-495e-90e2-a9b1f7959bac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoMember_e4202add-1965-400b-8ee8-c58f133ffaa1" xlink:href="lgnd-20210331.xsd#lgnd_AziyoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_689fbd61-3411-495e-90e2-a9b1f7959bac" xlink:to="loc_lgnd_AziyoMember_e4202add-1965-400b-8ee8-c58f133ffaa1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember_a616df68-b421-4a0c-b668-302486625cb8" xlink:href="lgnd-20210331.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_689fbd61-3411-495e-90e2-a9b1f7959bac" xlink:to="loc_lgnd_SelexisAndDianomiMember_a616df68-b421-4a0c-b668-302486625cb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisMember_4fabaf64-42b4-4277-9f27-4046770642da" xlink:href="lgnd-20210331.xsd#lgnd_SelexisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_689fbd61-3411-495e-90e2-a9b1f7959bac" xlink:to="loc_lgnd_SelexisMember_4fabaf64-42b4-4277-9f27-4046770642da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dec5e986-783f-4ecb-9dfc-cf755c0e8fc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_10e3b19c-a74d-441a-aa38-4bfda5758f5f" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dec5e986-783f-4ecb-9dfc-cf755c0e8fc7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_dec5e986-783f-4ecb-9dfc-cf755c0e8fc7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dec5e986-783f-4ecb-9dfc-cf755c0e8fc7" xlink:to="loc_us-gaap_RelatedPartyDomain_dec5e986-783f-4ecb-9dfc-cf755c0e8fc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_53672d6a-42ce-4084-aee0-866afd13d8e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dec5e986-783f-4ecb-9dfc-cf755c0e8fc7" xlink:to="loc_us-gaap_RelatedPartyDomain_53672d6a-42ce-4084-aee0-866afd13d8e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_1609a85e-3529-4930-aa21-4973ae28a1fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_53672d6a-42ce-4084-aee0-866afd13d8e9" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_1609a85e-3529-4930-aa21-4973ae28a1fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c170ab55-d6f7-46e4-ae85-7e938a8dc394" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_10e3b19c-a74d-441a-aa38-4bfda5758f5f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c170ab55-d6f7-46e4-ae85-7e938a8dc394" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c170ab55-d6f7-46e4-ae85-7e938a8dc394_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c170ab55-d6f7-46e4-ae85-7e938a8dc394" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c170ab55-d6f7-46e4-ae85-7e938a8dc394_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_54f49adf-31ec-4c77-b244-43d0f4ae4beb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c170ab55-d6f7-46e4-ae85-7e938a8dc394" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_54f49adf-31ec-4c77-b244-43d0f4ae4beb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_54b92f2f-60d6-4b0f-affb-b146619c9a57" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_54f49adf-31ec-4c77-b244-43d0f4ae4beb" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_54b92f2f-60d6-4b0f-affb-b146619c9a57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_0763a51c-92c0-4879-9364-756440ca58fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_10e3b19c-a74d-441a-aa38-4bfda5758f5f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_0763a51c-92c0-4879-9364-756440ca58fa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0763a51c-92c0-4879-9364-756440ca58fa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0763a51c-92c0-4879-9364-756440ca58fa" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0763a51c-92c0-4879-9364-756440ca58fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b4e47644-4ff4-4e0c-ab79-87d9567e4f0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0763a51c-92c0-4879-9364-756440ca58fa" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b4e47644-4ff4-4e0c-ab79-87d9567e4f0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_f79c27f7-217b-49fa-b72c-242bdf1dc343" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b4e47644-4ff4-4e0c-ab79-87d9567e4f0f" xlink:to="loc_us-gaap_WarrantMember_f79c27f7-217b-49fa-b72c-242bdf1dc343" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_08b36198-fb71-4b9b-8a5d-d9df39dda640" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b4e47644-4ff4-4e0c-ab79-87d9567e4f0f" xlink:to="loc_us-gaap_CommonStockMember_08b36198-fb71-4b9b-8a5d-d9df39dda640" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_780cbc6d-4b74-4be5-8939-6b9d44bc012a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_10e3b19c-a74d-441a-aa38-4bfda5758f5f" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_780cbc6d-4b74-4be5-8939-6b9d44bc012a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_780cbc6d-4b74-4be5-8939-6b9d44bc012a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_780cbc6d-4b74-4be5-8939-6b9d44bc012a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_780cbc6d-4b74-4be5-8939-6b9d44bc012a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2aca2cf1-97c1-48d4-89e9-c3e5261a1aa6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_780cbc6d-4b74-4be5-8939-6b9d44bc012a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2aca2cf1-97c1-48d4-89e9-c3e5261a1aa6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_080fe873-088a-475f-ba6a-2a6918615afb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2aca2cf1-97c1-48d4-89e9-c3e5261a1aa6" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_080fe873-088a-475f-ba6a-2a6918615afb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1c238e0e-ee3b-4207-b21e-dd7fe5fd3eb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_10e3b19c-a74d-441a-aa38-4bfda5758f5f" xlink:to="loc_us-gaap_AwardTypeAxis_1c238e0e-ee3b-4207-b21e-dd7fe5fd3eb9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1c238e0e-ee3b-4207-b21e-dd7fe5fd3eb9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1c238e0e-ee3b-4207-b21e-dd7fe5fd3eb9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1c238e0e-ee3b-4207-b21e-dd7fe5fd3eb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ec9c3992-9d87-4a6a-9682-2a665babb950" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1c238e0e-ee3b-4207-b21e-dd7fe5fd3eb9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ec9c3992-9d87-4a6a-9682-2a665babb950" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_e2d9f4aa-9c6e-4cf3-baa5-66661aca4ab7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ec9c3992-9d87-4a6a-9682-2a665babb950" xlink:to="loc_us-gaap_RestrictedStockMember_e2d9f4aa-9c6e-4cf3-baa5-66661aca4ab7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="extended" id="i8fd16e1ec0e2490482e29fe2cabfa0ff_BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_0edb4829-caed-4fc8-a56a-b4841a5921fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7273f3ce-16a4-4970-9763-8b955046df6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0edb4829-caed-4fc8-a56a-b4841a5921fd" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7273f3ce-16a4-4970-9763-8b955046df6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_d8e23eb2-254a-40c9-b417-64875ba091e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0edb4829-caed-4fc8-a56a-b4841a5921fd" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_d8e23eb2-254a-40c9-b417-64875ba091e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_bd80e3f9-ec4b-4d53-ba40-c57f4293a6b4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d8e23eb2-254a-40c9-b417-64875ba091e7" xlink:to="loc_srt_ProductOrServiceAxis_bd80e3f9-ec4b-4d53-ba40-c57f4293a6b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bd80e3f9-ec4b-4d53-ba40-c57f4293a6b4_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_bd80e3f9-ec4b-4d53-ba40-c57f4293a6b4" xlink:to="loc_srt_ProductsAndServicesDomain_bd80e3f9-ec4b-4d53-ba40-c57f4293a6b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3be2be2d-2067-48dc-b07d-fafd242c4296" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_bd80e3f9-ec4b-4d53-ba40-c57f4293a6b4" xlink:to="loc_srt_ProductsAndServicesDomain_3be2be2d-2067-48dc-b07d-fafd242c4296" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_3d6cb500-bfff-4a32-bd3b-46cb4b0c7ba8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3be2be2d-2067-48dc-b07d-fafd242c4296" xlink:to="loc_us-gaap_RoyaltyMember_3d6cb500-bfff-4a32-bd3b-46cb4b0c7ba8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_KyprolisMember_2658ce8e-d912-4a54-9521-8255cd4f53c1" xlink:href="lgnd-20210331.xsd#lgnd_KyprolisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_3d6cb500-bfff-4a32-bd3b-46cb4b0c7ba8" xlink:to="loc_lgnd_KyprolisMember_2658ce8e-d912-4a54-9521-8255cd4f53c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EvomelaMember_10a80461-5336-463c-9295-6bbff312e900" xlink:href="lgnd-20210331.xsd#lgnd_EvomelaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_3d6cb500-bfff-4a32-bd3b-46cb4b0c7ba8" xlink:to="loc_lgnd_EvomelaMember_10a80461-5336-463c-9295-6bbff312e900" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember_474517e8-076a-4ad1-9b54-5e3733972ecd" xlink:href="lgnd-20210331.xsd#lgnd_RoyaltyOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_3d6cb500-bfff-4a32-bd3b-46cb4b0c7ba8" xlink:to="loc_lgnd_RoyaltyOtherMember_474517e8-076a-4ad1-9b54-5e3733972ecd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_c758e0ca-b9a8-4cc8-bbe0-abc23ed655b1" xlink:href="lgnd-20210331.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3be2be2d-2067-48dc-b07d-fafd242c4296" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_c758e0ca-b9a8-4cc8-bbe0-abc23ed655b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_81c9169f-4338-4cb3-9079-bffe947a8f73" xlink:href="lgnd-20210331.xsd#lgnd_ContractRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3be2be2d-2067-48dc-b07d-fafd242c4296" xlink:to="loc_lgnd_ContractRevenueMember_81c9169f-4338-4cb3-9079-bffe947a8f73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueServiceMember_bb7b409a-210b-4fcd-ae66-9ee6fdd2704b" xlink:href="lgnd-20210331.xsd#lgnd_ContractRevenueServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_81c9169f-4338-4cb3-9079-bffe947a8f73" xlink:to="loc_lgnd_ContractRevenueServiceMember_bb7b409a-210b-4fcd-ae66-9ee6fdd2704b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember_38bc6396-aff4-4734-8bac-36ac1a9503b8" xlink:href="lgnd-20210331.xsd#lgnd_LicenseFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_81c9169f-4338-4cb3-9079-bffe947a8f73" xlink:to="loc_lgnd_LicenseFeesMember_38bc6396-aff4-4734-8bac-36ac1a9503b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember_babe64a7-a57d-4ffc-b00c-ec468daf5134" xlink:href="lgnd-20210331.xsd#lgnd_MilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_81c9169f-4338-4cb3-9079-bffe947a8f73" xlink:to="loc_lgnd_MilestoneMember_babe64a7-a57d-4ffc-b00c-ec468daf5134" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_43799d2e-613f-4f33-8238-c1b7e1226c1c" xlink:href="lgnd-20210331.xsd#lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_81c9169f-4338-4cb3-9079-bffe947a8f73" xlink:to="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_43799d2e-613f-4f33-8238-c1b7e1226c1c" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="extended" id="ibbc001136e76422497cad1b427c99e0f_BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_557b8964-02cf-46fc-b416-ef7670d03caa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_fb4a2fff-0d9f-46d2-a921-ce14961eb619" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_557b8964-02cf-46fc-b416-ef7670d03caa" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_fb4a2fff-0d9f-46d2-a921-ce14961eb619" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_8bcb60ea-1f79-4d98-8124-3deb9b4561da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_557b8964-02cf-46fc-b416-ef7670d03caa" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_8bcb60ea-1f79-4d98-8124-3deb9b4561da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_33567409-ffc8-49e1-ac57-f548c171bcd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_557b8964-02cf-46fc-b416-ef7670d03caa" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_33567409-ffc8-49e1-ac57-f548c171bcd6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4c759ec7-4383-422d-aa6a-94cbaf696894" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_557b8964-02cf-46fc-b416-ef7670d03caa" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4c759ec7-4383-422d-aa6a-94cbaf696894" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_2f4edc16-03ba-470d-a735-6c6173dce81b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_557b8964-02cf-46fc-b416-ef7670d03caa" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_2f4edc16-03ba-470d-a735-6c6173dce81b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_3600189b-2b46-4b50-9f54-5cc1d03e552f" xlink:href="lgnd-20210331.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_557b8964-02cf-46fc-b416-ef7670d03caa" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_3600189b-2b46-4b50-9f54-5cc1d03e552f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_7f4238e7-a9f1-45d0-b84c-702393e9df97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_557b8964-02cf-46fc-b416-ef7670d03caa" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_7f4238e7-a9f1-45d0-b84c-702393e9df97" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_3cb2df67-5493-4c81-80d0-70557af4bbb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_7f4238e7-a9f1-45d0-b84c-702393e9df97" xlink:to="loc_us-gaap_FinancialInstrumentAxis_3cb2df67-5493-4c81-80d0-70557af4bbb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3cb2df67-5493-4c81-80d0-70557af4bbb5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3cb2df67-5493-4c81-80d0-70557af4bbb5" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3cb2df67-5493-4c81-80d0-70557af4bbb5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c8ed39e-94d1-4d3a-82b8-fe7cd7688591" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3cb2df67-5493-4c81-80d0-70557af4bbb5" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c8ed39e-94d1-4d3a-82b8-fe7cd7688591" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember_c63245a6-8767-4f85-8f0d-270c488f5bbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DemandDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c8ed39e-94d1-4d3a-82b8-fe7cd7688591" xlink:to="loc_us-gaap_DemandDepositsMember_c63245a6-8767-4f85-8f0d-270c488f5bbe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_d851101c-ce55-421a-98ea-553ebb87bd6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c8ed39e-94d1-4d3a-82b8-fe7cd7688591" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_d851101c-ce55-421a-98ea-553ebb87bd6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AgencySecuritiesMember_22ee3d2d-f252-4248-b7a9-4fa08a54e092" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AgencySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c8ed39e-94d1-4d3a-82b8-fe7cd7688591" xlink:to="loc_us-gaap_AgencySecuritiesMember_22ee3d2d-f252-4248-b7a9-4fa08a54e092" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_a3f29b8f-6774-44fc-b5eb-d910bd967982" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c8ed39e-94d1-4d3a-82b8-fe7cd7688591" xlink:to="loc_us-gaap_CommercialPaperMember_a3f29b8f-6774-44fc-b5eb-d910bd967982" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_cf41590b-e0d6-474a-a3db-567fa8aa8173" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c8ed39e-94d1-4d3a-82b8-fe7cd7688591" xlink:to="loc_us-gaap_EquitySecuritiesMember_cf41590b-e0d6-474a-a3db-567fa8aa8173" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_ecca2d82-4e40-4a55-8d46-8a06cc379831" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MutualFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c8ed39e-94d1-4d3a-82b8-fe7cd7688591" xlink:to="loc_us-gaap_MutualFundMember_ecca2d82-4e40-4a55-8d46-8a06cc379831" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_0de98bbd-40a4-4505-b365-9d0a232fe269" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c8ed39e-94d1-4d3a-82b8-fe7cd7688591" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_0de98bbd-40a4-4505-b365-9d0a232fe269" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2d9ad8ea-8fbf-4713-8168-fcb4a4ba4655" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c8ed39e-94d1-4d3a-82b8-fe7cd7688591" xlink:to="loc_us-gaap_CommonStockMember_2d9ad8ea-8fbf-4713-8168-fcb4a4ba4655" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_75fa32d4-5804-4ccb-b513-00bd74cfb94b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c8ed39e-94d1-4d3a-82b8-fe7cd7688591" xlink:to="loc_us-gaap_WarrantMember_75fa32d4-5804-4ccb-b513-00bd74cfb94b" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended" id="i7da879bbfcf14ca0ba6d89aa4e81fdf9_BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="extended" id="i338daefb5f2f4abc93c64a8e35506626_BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_81919fab-8a3e-4a22-a68a-7b4de706c60c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_8a3b971a-2df0-4772-b4c1-d8182141833c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_81919fab-8a3e-4a22-a68a-7b4de706c60c" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_8a3b971a-2df0-4772-b4c1-d8182141833c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3eaa448a-5566-459d-8b98-75f567efd770" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_8a3b971a-2df0-4772-b4c1-d8182141833c" xlink:to="loc_us-gaap_Goodwill_3eaa448a-5566-459d-8b98-75f567efd770" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a12be688-d895-48b0-8528-5f0ad58bb12b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_8a3b971a-2df0-4772-b4c1-d8182141833c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a12be688-d895-48b0-8528-5f0ad58bb12b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b2d2ac3a-fe42-46b0-82c0-8e2c1a654a42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_8a3b971a-2df0-4772-b4c1-d8182141833c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b2d2ac3a-fe42-46b0-82c0-8e2c1a654a42" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_7d6999c8-2c6b-4bdc-9bae-6863d39f3883" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_8a3b971a-2df0-4772-b4c1-d8182141833c" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_7d6999c8-2c6b-4bdc-9bae-6863d39f3883" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_42f7e721-2b04-4a7e-b0e5-0ea50cd2fe4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_81919fab-8a3e-4a22-a68a-7b4de706c60c" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_42f7e721-2b04-4a7e-b0e5-0ea50cd2fe4f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_331238fe-6076-48e0-a365-434ae0bbfa06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_42f7e721-2b04-4a7e-b0e5-0ea50cd2fe4f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_331238fe-6076-48e0-a365-434ae0bbfa06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_331238fe-6076-48e0-a365-434ae0bbfa06_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_331238fe-6076-48e0-a365-434ae0bbfa06" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_331238fe-6076-48e0-a365-434ae0bbfa06_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7554979f-858c-4c72-8a2a-dc5615b30d88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_331238fe-6076-48e0-a365-434ae0bbfa06" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7554979f-858c-4c72-8a2a-dc5615b30d88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember_8a0e38fa-2247-4cba-986d-1446ade244bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7554979f-858c-4c72-8a2a-dc5615b30d88" xlink:to="loc_us-gaap_PatentedTechnologyMember_8a0e38fa-2247-4cba-986d-1446ade244bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_423e9a7e-7435-4ad0-80b1-e2832a28c332" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7554979f-858c-4c72-8a2a-dc5615b30d88" xlink:to="loc_us-gaap_TradeNamesMember_423e9a7e-7435-4ad0-80b1-e2832a28c332" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_73f37fb9-c36f-499b-9eec-ba5830883bd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7554979f-858c-4c72-8a2a-dc5615b30d88" xlink:to="loc_us-gaap_CustomerRelationshipsMember_73f37fb9-c36f-499b-9eec-ba5830883bd8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_bfb5d43e-9a84-4513-ae8c-5b28597176f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7554979f-858c-4c72-8a2a-dc5615b30d88" xlink:to="loc_us-gaap_ContractualRightsMember_bfb5d43e-9a84-4513-ae8c-5b28597176f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_b86b8a25-3df7-4813-b2df-bedd1deec4e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7554979f-858c-4c72-8a2a-dc5615b30d88" xlink:to="loc_us-gaap_LicensingAgreementsMember_b86b8a25-3df7-4813-b2df-bedd1deec4e6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_db4bb5bf-1d9e-4a8b-ba7f-f79b5dfbfdcf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_42f7e721-2b04-4a7e-b0e5-0ea50cd2fe4f" xlink:to="loc_srt_CounterpartyNameAxis_db4bb5bf-1d9e-4a8b-ba7f-f79b5dfbfdcf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_db4bb5bf-1d9e-4a8b-ba7f-f79b5dfbfdcf_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_db4bb5bf-1d9e-4a8b-ba7f-f79b5dfbfdcf" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_db4bb5bf-1d9e-4a8b-ba7f-f79b5dfbfdcf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1c47352f-a067-46f8-a4c9-79ba8c6696b5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_db4bb5bf-1d9e-4a8b-ba7f-f79b5dfbfdcf" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1c47352f-a067-46f8-a4c9-79ba8c6696b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember_acfe6f03-22d4-44bd-8dc6-a0689ada5c26" xlink:href="lgnd-20210331.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1c47352f-a067-46f8-a4c9-79ba8c6696b5" xlink:to="loc_lgnd_SelexisAndDianomiMember_acfe6f03-22d4-44bd-8dc6-a0689ada5c26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoAndCorMatrixMember_7ee413c7-a654-4128-8f0d-6446794df671" xlink:href="lgnd-20210331.xsd#lgnd_AziyoAndCorMatrixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1c47352f-a067-46f8-a4c9-79ba8c6696b5" xlink:to="loc_lgnd_AziyoAndCorMatrixMember_7ee413c7-a654-4128-8f0d-6446794df671" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" xlink:type="extended" id="i0ff00fc44abe4ee1973d9c9b4d1f119b_BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c7bfb03-9bb8-4de4-a627-1d0e83b8ce09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_308b92be-5993-4d47-b556-ba3b6dd9d556" xlink:href="lgnd-20210331.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c7bfb03-9bb8-4de4-a627-1d0e83b8ce09" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_308b92be-5993-4d47-b556-ba3b6dd9d556" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e8e134cf-3531-4f1d-bc27-a71977c5b7a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_308b92be-5993-4d47-b556-ba3b6dd9d556" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e8e134cf-3531-4f1d-bc27-a71977c5b7a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_6011fcf5-5b04-4883-92eb-ca3bb8f4a779" xlink:href="lgnd-20210331.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_308b92be-5993-4d47-b556-ba3b6dd9d556" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_6011fcf5-5b04-4883-92eb-ca3bb8f4a779" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e7b2e085-a907-4fdc-92f1-2db63ee1d05a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_308b92be-5993-4d47-b556-ba3b6dd9d556" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e7b2e085-a907-4fdc-92f1-2db63ee1d05a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_49ab66f7-ee87-43fc-b3d7-6495e90960e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_308b92be-5993-4d47-b556-ba3b6dd9d556" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_49ab66f7-ee87-43fc-b3d7-6495e90960e0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_cda4f93e-33d3-4104-9035-b6029324f21f" xlink:href="lgnd-20210331.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_308b92be-5993-4d47-b556-ba3b6dd9d556" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_cda4f93e-33d3-4104-9035-b6029324f21f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ef899ae4-f5b9-4c46-8a9a-fe896e75c7f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c7bfb03-9bb8-4de4-a627-1d0e83b8ce09" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ef899ae4-f5b9-4c46-8a9a-fe896e75c7f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a0087291-166b-4a92-b500-a82aac0d982a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ef899ae4-f5b9-4c46-8a9a-fe896e75c7f6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a0087291-166b-4a92-b500-a82aac0d982a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a0087291-166b-4a92-b500-a82aac0d982a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a0087291-166b-4a92-b500-a82aac0d982a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a0087291-166b-4a92-b500-a82aac0d982a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ca61436c-d478-420b-9b90-a35c4ba86b56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a0087291-166b-4a92-b500-a82aac0d982a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ca61436c-d478-420b-9b90-a35c4ba86b56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_66da966e-b0a2-4b27-9b37-206806a6b675" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ca61436c-d478-420b-9b90-a35c4ba86b56" xlink:to="loc_us-gaap_LicensingAgreementsMember_66da966e-b0a2-4b27-9b37-206806a6b675" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_bf93a60a-5d4c-4af7-9cb5-c6910649ed18" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ef899ae4-f5b9-4c46-8a9a-fe896e75c7f6" xlink:to="loc_srt_CounterpartyNameAxis_bf93a60a-5d4c-4af7-9cb5-c6910649ed18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bf93a60a-5d4c-4af7-9cb5-c6910649ed18_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_bf93a60a-5d4c-4af7-9cb5-c6910649ed18" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bf93a60a-5d4c-4af7-9cb5-c6910649ed18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_63c630f3-b4e6-4a39-80af-be13d1d10fd5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_bf93a60a-5d4c-4af7-9cb5-c6910649ed18" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_63c630f3-b4e6-4a39-80af-be13d1d10fd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoAndCorMatrixMember_98badaec-30f0-46b0-8f4e-446b7fbd499a" xlink:href="lgnd-20210331.xsd#lgnd_AziyoAndCorMatrixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_63c630f3-b4e6-4a39-80af-be13d1d10fd5" xlink:to="loc_lgnd_AziyoAndCorMatrixMember_98badaec-30f0-46b0-8f4e-446b7fbd499a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember_e946ccd2-6f78-4add-b20e-ea32c8d0d562" xlink:href="lgnd-20210331.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_63c630f3-b4e6-4a39-80af-be13d1d10fd5" xlink:to="loc_lgnd_SelexisAndDianomiMember_e946ccd2-6f78-4add-b20e-ea32c8d0d562" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="extended" id="ie20abff1badc4137a1cf941d96a755b1_BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="extended" id="ifca0e83e12b849e1a534e1a1ff791a0f_BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems_13e38156-5cd0-467a-b24b-29f450804307" xlink:href="lgnd-20210331.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_e47596d8-3744-4a8b-83bb-eda5b657a8b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_13e38156-5cd0-467a-b24b-29f450804307" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_e47596d8-3744-4a8b-83bb-eda5b657a8b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable_691ad427-aa12-46d9-bdca-bcdf62f60c20" xlink:href="lgnd-20210331.xsd#lgnd_BasisOfPresentationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_lgnd_BasisOfPresentationLineItems_13e38156-5cd0-467a-b24b-29f450804307" xlink:to="loc_lgnd_BasisOfPresentationTable_691ad427-aa12-46d9-bdca-bcdf62f60c20" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c09b6233-569b-4cac-98ff-f15309304ae4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lgnd_BasisOfPresentationTable_691ad427-aa12-46d9-bdca-bcdf62f60c20" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c09b6233-569b-4cac-98ff-f15309304ae4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c09b6233-569b-4cac-98ff-f15309304ae4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c09b6233-569b-4cac-98ff-f15309304ae4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c09b6233-569b-4cac-98ff-f15309304ae4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f5aa70b2-a3c7-4e91-a220-8abaeb74ce8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c09b6233-569b-4cac-98ff-f15309304ae4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f5aa70b2-a3c7-4e91-a220-8abaeb74ce8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fbda7c4f-58ea-42c1-97c3-bc32e98e3f01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f5aa70b2-a3c7-4e91-a220-8abaeb74ce8f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fbda7c4f-58ea-42c1-97c3-bc32e98e3f01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1baec3b3-4fe8-4053-89d9-4838f9c8c1e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f5aa70b2-a3c7-4e91-a220-8abaeb74ce8f" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1baec3b3-4fe8-4053-89d9-4838f9c8c1e6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" xlink:type="extended" id="ia0dc2f17cb9a49e3bc1e8e7d7fd7c69f_BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="extended" id="i7733ab95b8f042b492bc9e7998606082_BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"/>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="lgnd-20210331.xsd#FairValueMeasurements"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/FairValueMeasurements" xlink:type="extended" id="i596b6d501df64871afa844444cba7947_FairValueMeasurements"/>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="lgnd-20210331.xsd#FairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsTables" xlink:type="extended" id="i93f3beff18004aa2b4ba0a37d8102880_FairValueMeasurementsTables"/>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended" id="i9fab591c7f914c31b4a7ea576eebdddc_FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_129df3d4-517d-478e-806e-a6909661866b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_e88c13af-f5ff-439c-98e1-ac3e0799789e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_129df3d4-517d-478e-806e-a6909661866b" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_e88c13af-f5ff-439c-98e1-ac3e0799789e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_b54b5640-fdf9-4b51-bc38-5a015196888d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_129df3d4-517d-478e-806e-a6909661866b" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_b54b5640-fdf9-4b51-bc38-5a015196888d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_26a89cde-aed3-49fc-89f8-da5cdf58a5b0" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_129df3d4-517d-478e-806e-a6909661866b" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_26a89cde-aed3-49fc-89f8-da5cdf58a5b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_2f17dbe3-385b-43af-b737-cd648c866dc8" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_129df3d4-517d-478e-806e-a6909661866b" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_2f17dbe3-385b-43af-b737-cd648c866dc8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsSeries_686960bc-e163-48c9-8d25-16497df5b90a" xlink:href="lgnd-20210331.xsd#lgnd_NumberOfContingentValueRightsSeries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_129df3d4-517d-478e-806e-a6909661866b" xlink:to="loc_lgnd_NumberOfContingentValueRightsSeries_686960bc-e163-48c9-8d25-16497df5b90a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_245eb736-d71e-40de-a19c-83a858e420a5" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_129df3d4-517d-478e-806e-a6909661866b" xlink:to="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_245eb736-d71e-40de-a19c-83a858e420a5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_3b1eabaa-d07f-43cf-9dec-d4fc4d27637f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_129df3d4-517d-478e-806e-a6909661866b" xlink:to="loc_us-gaap_Investments_3b1eabaa-d07f-43cf-9dec-d4fc4d27637f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_68fd6b81-07f6-40f8-875a-e7342ce6e384" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_129df3d4-517d-478e-806e-a6909661866b" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_68fd6b81-07f6-40f8-875a-e7342ce6e384" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f7198d4d-113f-4cca-8b55-6c265de1b3b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_129df3d4-517d-478e-806e-a6909661866b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f7198d4d-113f-4cca-8b55-6c265de1b3b8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_62f67e38-1b32-49b4-9a79-69f8c2c5db88" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f7198d4d-113f-4cca-8b55-6c265de1b3b8" xlink:to="loc_srt_RangeAxis_62f67e38-1b32-49b4-9a79-69f8c2c5db88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_62f67e38-1b32-49b4-9a79-69f8c2c5db88_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_62f67e38-1b32-49b4-9a79-69f8c2c5db88" xlink:to="loc_srt_RangeMember_62f67e38-1b32-49b4-9a79-69f8c2c5db88_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c198e5e6-f45f-45c3-8c7c-2db132334cfb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_62f67e38-1b32-49b4-9a79-69f8c2c5db88" xlink:to="loc_srt_RangeMember_c198e5e6-f45f-45c3-8c7c-2db132334cfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_68c6c77b-39d7-4c03-898f-d1654aa332b4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c198e5e6-f45f-45c3-8c7c-2db132334cfb" xlink:to="loc_srt_MaximumMember_68c6c77b-39d7-4c03-898f-d1654aa332b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_5850dca8-74db-4e35-a0e9-375e75916641" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f7198d4d-113f-4cca-8b55-6c265de1b3b8" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_5850dca8-74db-4e35-a0e9-375e75916641" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_5850dca8-74db-4e35-a0e9-375e75916641_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_5850dca8-74db-4e35-a0e9-375e75916641" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_5850dca8-74db-4e35-a0e9-375e75916641_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_3ff25a11-5733-4d1d-83ab-0d55de0be398" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_5850dca8-74db-4e35-a0e9-375e75916641" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_3ff25a11-5733-4d1d-83ab-0d55de0be398" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_dbbb46ff-b4db-4047-9dac-0c9da0c5db2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_3ff25a11-5733-4d1d-83ab-0d55de0be398" xlink:to="loc_us-gaap_TransferredOverTimeMember_dbbb46ff-b4db-4047-9dac-0c9da0c5db2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_30e323d3-931c-43df-bea3-315058884584" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f7198d4d-113f-4cca-8b55-6c265de1b3b8" xlink:to="loc_srt_ProductOrServiceAxis_30e323d3-931c-43df-bea3-315058884584" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_30e323d3-931c-43df-bea3-315058884584_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_30e323d3-931c-43df-bea3-315058884584" xlink:to="loc_srt_ProductsAndServicesDomain_30e323d3-931c-43df-bea3-315058884584_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2be600c1-3642-4c75-a342-59ba6a438e65" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_30e323d3-931c-43df-bea3-315058884584" xlink:to="loc_srt_ProductsAndServicesDomain_2be600c1-3642-4c75-a342-59ba6a438e65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_4810e833-b8ac-44e6-8c3d-c3da6740e2aa" xlink:href="lgnd-20210331.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2be600c1-3642-4c75-a342-59ba6a438e65" xlink:to="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_4810e833-b8ac-44e6-8c3d-c3da6740e2aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember_8ce488cc-2473-413b-88a8-57384adefa67" xlink:href="lgnd-20210331.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2be600c1-3642-4c75-a342-59ba6a438e65" xlink:to="loc_lgnd_Phase3ClinicalTrialMember_8ce488cc-2473-413b-88a8-57384adefa67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_91369927-1990-42ec-b352-0ac079f07437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f7198d4d-113f-4cca-8b55-6c265de1b3b8" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_91369927-1990-42ec-b352-0ac079f07437" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_91369927-1990-42ec-b352-0ac079f07437_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_91369927-1990-42ec-b352-0ac079f07437" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_91369927-1990-42ec-b352-0ac079f07437_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_6ab22124-a592-4467-99a1-944fc907954b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_91369927-1990-42ec-b352-0ac079f07437" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_6ab22124-a592-4467-99a1-944fc907954b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_a52af159-2abd-4741-a62c-88e885dd1c56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_6ab22124-a592-4467-99a1-944fc907954b" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_a52af159-2abd-4741-a62c-88e885dd1c56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_41dace89-1665-432f-bb37-2c1c4c09abb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f7198d4d-113f-4cca-8b55-6c265de1b3b8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_41dace89-1665-432f-bb37-2c1c4c09abb0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_41dace89-1665-432f-bb37-2c1c4c09abb0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_41dace89-1665-432f-bb37-2c1c4c09abb0" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_41dace89-1665-432f-bb37-2c1c4c09abb0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_889235ea-e09c-45c4-98a4-c890f8a4d238" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_41dace89-1665-432f-bb37-2c1c4c09abb0" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_889235ea-e09c-45c4-98a4-c890f8a4d238" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_22cdc08e-aefc-4111-9a10-9c33345f6a80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_889235ea-e09c-45c4-98a4-c890f8a4d238" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_22cdc08e-aefc-4111-9a10-9c33345f6a80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1174e9ea-279f-49eb-8709-9e596f34ce64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_889235ea-e09c-45c4-98a4-c890f8a4d238" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1174e9ea-279f-49eb-8709-9e596f34ce64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a9018c32-89a6-4827-b853-b034cc5bc7f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_889235ea-e09c-45c4-98a4-c890f8a4d238" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a9018c32-89a6-4827-b853-b034cc5bc7f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_3f3b6f54-ead1-4a96-9f3d-253e49d7d49a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f7198d4d-113f-4cca-8b55-6c265de1b3b8" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_3f3b6f54-ead1-4a96-9f3d-253e49d7d49a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_3f3b6f54-ead1-4a96-9f3d-253e49d7d49a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_3f3b6f54-ead1-4a96-9f3d-253e49d7d49a" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_3f3b6f54-ead1-4a96-9f3d-253e49d7d49a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_15c2439c-3363-40c6-be86-df5261d7f2c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_3f3b6f54-ead1-4a96-9f3d-253e49d7d49a" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_15c2439c-3363-40c6-be86-df5261d7f2c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_711bb368-9660-46e6-8894-a4c1cd903aa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_15c2439c-3363-40c6-be86-df5261d7f2c6" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_711bb368-9660-46e6-8894-a4c1cd903aa7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_bca359c8-b565-4a79-945f-ff7e5ad87aca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_15c2439c-3363-40c6-be86-df5261d7f2c6" xlink:to="loc_us-gaap_EquitySecuritiesMember_bca359c8-b565-4a79-945f-ff7e5ad87aca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_6cf21c3d-4648-4581-8390-8c0c90335988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_15c2439c-3363-40c6-be86-df5261d7f2c6" xlink:to="loc_us-gaap_WarrantMember_6cf21c3d-4648-4581-8390-8c0c90335988" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_079f5982-9f42-4bd6-a3d2-cceaed7e7cb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f7198d4d-113f-4cca-8b55-6c265de1b3b8" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_079f5982-9f42-4bd6-a3d2-cceaed7e7cb9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_079f5982-9f42-4bd6-a3d2-cceaed7e7cb9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_079f5982-9f42-4bd6-a3d2-cceaed7e7cb9" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_079f5982-9f42-4bd6-a3d2-cceaed7e7cb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d76c21a0-e9c8-4cc3-a23c-4429a0676efc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_079f5982-9f42-4bd6-a3d2-cceaed7e7cb9" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d76c21a0-e9c8-4cc3-a23c-4429a0676efc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember_4d0dd6d2-2ea7-4d6a-930d-0d83e30c43f4" xlink:href="lgnd-20210331.xsd#lgnd_LiabilityForContingentValueRightsCompanyCrystalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d76c21a0-e9c8-4cc3-a23c-4429a0676efc" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember_4d0dd6d2-2ea7-4d6a-930d-0d83e30c43f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_29bd9524-0b75-497f-9c91-aca00c3cdb06" xlink:href="lgnd-20210331.xsd#lgnd_LiabilityForContingentValueRightsCompanyCydexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d76c21a0-e9c8-4cc3-a23c-4429a0676efc" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_29bd9524-0b75-497f-9c91-aca00c3cdb06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_fddd031d-a653-4d07-8123-3be840ef9757" xlink:href="lgnd-20210331.xsd#lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d76c21a0-e9c8-4cc3-a23c-4429a0676efc" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_fddd031d-a653-4d07-8123-3be840ef9757" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_a5b148db-fd93-4512-b278-c96434459b40" xlink:href="lgnd-20210331.xsd#lgnd_LiabilityForContingentValueRightsCompanyIcagenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d76c21a0-e9c8-4cc3-a23c-4429a0676efc" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_a5b148db-fd93-4512-b278-c96434459b40" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_fd861f80-94ef-4640-89f2-45de2afff21e" xlink:href="lgnd-20210331.xsd#lgnd_LiabilityForContingentValueRightsCompanyPfenexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d76c21a0-e9c8-4cc3-a23c-4429a0676efc" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_fd861f80-94ef-4640-89f2-45de2afff21e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_3780571c-21be-4b58-be01-03854a021cae" xlink:href="lgnd-20210331.xsd#lgnd_LiabilityForContingentValueRightsCompanyXCellaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d76c21a0-e9c8-4cc3-a23c-4429a0676efc" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_3780571c-21be-4b58-be01-03854a021cae" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_04a8b7c4-888c-4456-a256-f5394dd623fd" xlink:href="lgnd-20210331.xsd#lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d76c21a0-e9c8-4cc3-a23c-4429a0676efc" xlink:to="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_04a8b7c4-888c-4456-a256-f5394dd623fd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6a5bffdb-38d4-48ae-867c-996def481482" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f7198d4d-113f-4cca-8b55-6c265de1b3b8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6a5bffdb-38d4-48ae-867c-996def481482" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6a5bffdb-38d4-48ae-867c-996def481482_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6a5bffdb-38d4-48ae-867c-996def481482" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6a5bffdb-38d4-48ae-867c-996def481482_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_102f04af-2b15-41d2-869c-49f209f16557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6a5bffdb-38d4-48ae-867c-996def481482" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_102f04af-2b15-41d2-869c-49f209f16557" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisMember_1790bfcf-a0c5-4351-bcc0-a538a5d078bc" xlink:href="lgnd-20210331.xsd#lgnd_MetabasisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_102f04af-2b15-41d2-869c-49f209f16557" xlink:to="loc_lgnd_MetabasisMember_1790bfcf-a0c5-4351-bcc0-a538a5d078bc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="extended" id="ice85b7ad4aa3407f9d0407cc5c4972b0_FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_bba7974e-901f-4dd8-ac9f-54a22b42d553" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0c8efa69-4d71-46fa-a7dd-48e3fa5d9199" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_bba7974e-901f-4dd8-ac9f-54a22b42d553" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0c8efa69-4d71-46fa-a7dd-48e3fa5d9199" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c18d5539-18d2-4e36-80bd-1c81b67f0b07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0c8efa69-4d71-46fa-a7dd-48e3fa5d9199" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c18d5539-18d2-4e36-80bd-1c81b67f0b07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_ba2ae5d2-027b-4dc5-8222-edd3888f545c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0c8efa69-4d71-46fa-a7dd-48e3fa5d9199" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_ba2ae5d2-027b-4dc5-8222-edd3888f545c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_3475e07a-0510-40da-a12a-889cebf2672b" xlink:href="lgnd-20210331.xsd#lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0c8efa69-4d71-46fa-a7dd-48e3fa5d9199" xlink:to="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_3475e07a-0510-40da-a12a-889cebf2672b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_fc6ed765-1481-451b-b584-3a0e93dfed29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cf623f3d-c1bb-41fa-8f8a-25495ef18b8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_bba7974e-901f-4dd8-ac9f-54a22b42d553" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cf623f3d-c1bb-41fa-8f8a-25495ef18b8e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_733eb5fc-a81d-470a-aa8b-fb29b06d982c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cf623f3d-c1bb-41fa-8f8a-25495ef18b8e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_733eb5fc-a81d-470a-aa8b-fb29b06d982c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_733eb5fc-a81d-470a-aa8b-fb29b06d982c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_733eb5fc-a81d-470a-aa8b-fb29b06d982c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_733eb5fc-a81d-470a-aa8b-fb29b06d982c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0abfc7da-93e0-4a10-bbba-6917fcedb8cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_733eb5fc-a81d-470a-aa8b-fb29b06d982c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0abfc7da-93e0-4a10-bbba-6917fcedb8cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b62bbd5c-1334-46bb-875d-138e028a88dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0abfc7da-93e0-4a10-bbba-6917fcedb8cc" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b62bbd5c-1334-46bb-875d-138e028a88dc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/Acquisitions" xlink:type="simple" xlink:href="lgnd-20210331.xsd#Acquisitions"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/Acquisitions" xlink:type="extended" id="i1df22aad379148e099602cc5cd4a5369_Acquisitions"/>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsTables" xlink:type="simple" xlink:href="lgnd-20210331.xsd#AcquisitionsTables"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/AcquisitionsTables" xlink:type="extended" id="ia466e0a8530d4046bf0605f56f18eab5_AcquisitionsTables"/>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#AcquisitionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/AcquisitionsNarrativeDetails" xlink:type="extended" id="i1588b37290d34d408091763a03e1aa26_AcquisitionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b6d82cd5-7594-45d3-83eb-bb39531414f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b6d82cd5-7594-45d3-83eb-bb39531414f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_0c8b8428-3e33-49f5-bf1d-4e1bfcb0b5a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_0c8b8428-3e33-49f5-bf1d-4e1bfcb0b5a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3723b883-34ff-42e7-ae71-fff75e63a903" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3723b883-34ff-42e7-ae71-fff75e63a903" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_ee02b1bb-ba9a-49bc-9490-8e3626fb53e8" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_ee02b1bb-ba9a-49bc-9490-8e3626fb53e8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_351a3374-db77-4fe3-b1dc-593457cb4c65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_351a3374-db77-4fe3-b1dc-593457cb4c65" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_c112a3f5-bd50-49ff-8748-c60eed915061" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_c112a3f5-bd50-49ff-8748-c60eed915061" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_4b432a96-e532-4307-b586-43fd19d39a77" xlink:href="lgnd-20210331.xsd#lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_4b432a96-e532-4307-b586-43fd19d39a77" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_ddd2322c-554a-44d2-b15c-733738273d2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_ddd2322c-554a-44d2-b15c-733738273d2b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_9f464200-91dd-4dcf-b542-2a22758fa3bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_9f464200-91dd-4dcf-b542-2a22758fa3bf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_47efddab-a69d-456c-8c26-21367f597218" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_47efddab-a69d-456c-8c26-21367f597218" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_22da7711-8851-4117-81aa-9b7433610d96" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_22da7711-8851-4117-81aa-9b7433610d96" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationConsiderationTransferredHoldback_5940ce9a-5070-459b-ae67-a01ba01a4b62" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationConsiderationTransferredHoldback"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_lgnd_BusinessCombinationConsiderationTransferredHoldback_5940ce9a-5070-459b-ae67-a01ba01a4b62" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_f7170523-2c78-4b5a-b072-6e865644a9ff" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_f7170523-2c78-4b5a-b072-6e865644a9ff" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_d577fba5-49e0-40fa-9cd8-c7d392fe6173" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_d577fba5-49e0-40fa-9cd8-c7d392fe6173" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_3d03d805-a3d7-4585-ba5f-7eb0bd20ecd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_3d03d805-a3d7-4585-ba5f-7eb0bd20ecd2" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_7a9cd4d0-9d8f-4982-8b2a-fbf6187945c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_7a9cd4d0-9d8f-4982-8b2a-fbf6187945c7" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_207c0c9b-71e3-48f2-af8b-3c291c302812" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_207c0c9b-71e3-48f2-af8b-3c291c302812" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_9dccd892-5669-4d3b-a3ef-d358b2dc00fc" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_9dccd892-5669-4d3b-a3ef-d358b2dc00fc" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_3fdca531-e7d5-4e44-b7e3-b5897a65871d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_3fdca531-e7d5-4e44-b7e3-b5897a65871d" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_b4321c2e-697e-449f-86a8-826de43f492c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_b4321c2e-697e-449f-86a8-826de43f492c" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_d421c10d-ad3e-4991-b037-f2c5a9c4630f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_d421c10d-ad3e-4991-b037-f2c5a9c4630f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd797b12-7007-4f1c-ad10-4873fd0e89a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd797b12-7007-4f1c-ad10-4873fd0e89a3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_389fa13f-933b-43a8-8afb-ee26ea42e764" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd797b12-7007-4f1c-ad10-4873fd0e89a3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_389fa13f-933b-43a8-8afb-ee26ea42e764" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_389fa13f-933b-43a8-8afb-ee26ea42e764_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_389fa13f-933b-43a8-8afb-ee26ea42e764" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_389fa13f-933b-43a8-8afb-ee26ea42e764_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cda00b2b-3f9e-4d37-a0e9-a8c200b77901" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_389fa13f-933b-43a8-8afb-ee26ea42e764" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cda00b2b-3f9e-4d37-a0e9-a8c200b77901" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_d4f83511-752e-441c-bc6e-e537c1fa578a" xlink:href="lgnd-20210331.xsd#lgnd_PfenexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cda00b2b-3f9e-4d37-a0e9-a8c200b77901" xlink:to="loc_lgnd_PfenexMember_d4f83511-752e-441c-bc6e-e537c1fa578a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TaurusBiosciencesLLCMember_f923e9b8-4e71-4305-9260-d2b965c3f48b" xlink:href="lgnd-20210331.xsd#lgnd_TaurusBiosciencesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cda00b2b-3f9e-4d37-a0e9-a8c200b77901" xlink:to="loc_lgnd_TaurusBiosciencesLLCMember_f923e9b8-4e71-4305-9260-d2b965c3f48b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_XCellaBiosciencesIncMember_2a7d108b-562e-4762-aa44-0c51b46077f9" xlink:href="lgnd-20210331.xsd#lgnd_XCellaBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cda00b2b-3f9e-4d37-a0e9-a8c200b77901" xlink:to="loc_lgnd_XCellaBiosciencesIncMember_2a7d108b-562e-4762-aa44-0c51b46077f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IcagenMember_32d5c3e8-d642-4377-aec6-0c826d6d5a52" xlink:href="lgnd-20210331.xsd#lgnd_IcagenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cda00b2b-3f9e-4d37-a0e9-a8c200b77901" xlink:to="loc_lgnd_IcagenMember_32d5c3e8-d642-4377-aec6-0c826d6d5a52" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fd44f0b0-30f4-4008-941a-5eac86f45c66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd797b12-7007-4f1c-ad10-4873fd0e89a3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fd44f0b0-30f4-4008-941a-5eac86f45c66" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fd44f0b0-30f4-4008-941a-5eac86f45c66_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fd44f0b0-30f4-4008-941a-5eac86f45c66" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fd44f0b0-30f4-4008-941a-5eac86f45c66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3f0d6db0-1e9d-4059-a12e-21e557d73df0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fd44f0b0-30f4-4008-941a-5eac86f45c66" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3f0d6db0-1e9d-4059-a12e-21e557d73df0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_1cc8c54b-779e-402f-bf5b-f39709d0142f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3f0d6db0-1e9d-4059-a12e-21e557d73df0" xlink:to="loc_us-gaap_ContractualRightsMember_1cc8c54b-779e-402f-bf5b-f39709d0142f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_08b616a2-b617-49b1-b220-a8936d38747c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3f0d6db0-1e9d-4059-a12e-21e557d73df0" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_08b616a2-b617-49b1-b220-a8936d38747c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_84048f3e-6c06-41f7-9108-37f688a28517" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3f0d6db0-1e9d-4059-a12e-21e557d73df0" xlink:to="loc_us-gaap_CustomerRelationshipsMember_84048f3e-6c06-41f7-9108-37f688a28517" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_5fe4bf65-66ee-471d-83af-39e603ed35db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd797b12-7007-4f1c-ad10-4873fd0e89a3" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_5fe4bf65-66ee-471d-83af-39e603ed35db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_5fe4bf65-66ee-471d-83af-39e603ed35db_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_5fe4bf65-66ee-471d-83af-39e603ed35db" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_5fe4bf65-66ee-471d-83af-39e603ed35db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_3461756f-9a59-4dba-800c-151f9399ae05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_5fe4bf65-66ee-471d-83af-39e603ed35db" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_3461756f-9a59-4dba-800c-151f9399ae05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_33a7039d-7345-455e-9fd4-443156d3607e" xlink:href="lgnd-20210331.xsd#lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_3461756f-9a59-4dba-800c-151f9399ae05" xlink:to="loc_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_33a7039d-7345-455e-9fd4-443156d3607e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentValueRightOnProductRevenuesMember_f191998d-f11e-4f1e-9609-17a4fabda345" xlink:href="lgnd-20210331.xsd#lgnd_ContingentValueRightOnProductRevenuesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_3461756f-9a59-4dba-800c-151f9399ae05" xlink:to="loc_lgnd_ContingentValueRightOnProductRevenuesMember_f191998d-f11e-4f1e-9609-17a4fabda345" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_4b252c83-b7cc-4fa2-8c4b-8fb650f0159d" xlink:href="lgnd-20210331.xsd#lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_3461756f-9a59-4dba-800c-151f9399ae05" xlink:to="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_4b252c83-b7cc-4fa2-8c4b-8fb650f0159d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestonePaymentsMember_68d6c4ed-c5b7-4a2c-b2fa-0003d51e74c7" xlink:href="lgnd-20210331.xsd#lgnd_MilestonePaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_3461756f-9a59-4dba-800c-151f9399ae05" xlink:to="loc_lgnd_MilestonePaymentsMember_68d6c4ed-c5b7-4a2c-b2fa-0003d51e74c7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_5219d5b3-3d1c-458e-9ece-4f35f826990b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd797b12-7007-4f1c-ad10-4873fd0e89a3" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_5219d5b3-3d1c-458e-9ece-4f35f826990b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_5219d5b3-3d1c-458e-9ece-4f35f826990b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_5219d5b3-3d1c-458e-9ece-4f35f826990b" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_5219d5b3-3d1c-458e-9ece-4f35f826990b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_b2e83dfe-ac1a-431d-b61f-df4060d14b3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_5219d5b3-3d1c-458e-9ece-4f35f826990b" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_b2e83dfe-ac1a-431d-b61f-df4060d14b3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_d0cd1b26-6163-46c2-88af-2db31083819c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_b2e83dfe-ac1a-431d-b61f-df4060d14b3e" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_d0cd1b26-6163-46c2-88af-2db31083819c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7fb73ae1-d048-43fd-955d-ed2366d78449" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd797b12-7007-4f1c-ad10-4873fd0e89a3" xlink:to="loc_srt_RangeAxis_7fb73ae1-d048-43fd-955d-ed2366d78449" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7fb73ae1-d048-43fd-955d-ed2366d78449_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7fb73ae1-d048-43fd-955d-ed2366d78449" xlink:to="loc_srt_RangeMember_7fb73ae1-d048-43fd-955d-ed2366d78449_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b11577d5-2de7-4220-b3b2-9e8970b08881" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7fb73ae1-d048-43fd-955d-ed2366d78449" xlink:to="loc_srt_RangeMember_b11577d5-2de7-4220-b3b2-9e8970b08881" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_46b09992-0587-4ed9-88f5-70bd494a1120" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b11577d5-2de7-4220-b3b2-9e8970b08881" xlink:to="loc_srt_MinimumMember_46b09992-0587-4ed9-88f5-70bd494a1120" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b9d6025a-74d2-4251-a62b-83f8e5305f9b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b11577d5-2de7-4220-b3b2-9e8970b08881" xlink:to="loc_srt_MaximumMember_b9d6025a-74d2-4251-a62b-83f8e5305f9b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended" id="i62534c67c1434674bb31147aa1497bf9_AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_0aa9cbd4-8174-4c46-b643-1f68926bb9cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_0aa9cbd4-8174-4c46-b643-1f68926bb9cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_da9c6a0d-0de9-40e8-86b5-8f178b1c7ba5" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_da9c6a0d-0de9-40e8-86b5-8f178b1c7ba5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_74d59948-e5ec-44f5-8f74-562bcb6adc8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_74d59948-e5ec-44f5-8f74-562bcb6adc8f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7dd81871-8bf8-46db-bf5d-35ae7cdee902" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7dd81871-8bf8-46db-bf5d-35ae7cdee902" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_0152a21f-60ab-4f85-b0c3-267e919affbc" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_0152a21f-60ab-4f85-b0c3-267e919affbc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_cccb0e8c-08cb-4d55-8c91-a839b16d1121" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_cccb0e8c-08cb-4d55-8c91-a839b16d1121" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_d3987558-a66a-4b3c-a9e3-9d2636f10b55" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_d3987558-a66a-4b3c-a9e3-9d2636f10b55" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8a881d03-93f8-4908-948b-898e4bacd602" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_us-gaap_Goodwill_8a881d03-93f8-4908-948b-898e4bacd602" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_928707de-973b-4a61-b7b5-3063fc2fcef1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_928707de-973b-4a61-b7b5-3063fc2fcef1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_79a1f38f-a670-481a-b221-88db03b7512d" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_79a1f38f-a670-481a-b221-88db03b7512d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_80753ef1-9498-4bae-980e-81c746a28774" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_80753ef1-9498-4bae-980e-81c746a28774" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_e6a77243-d925-4a9d-8abe-2cab7ce38a24" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_e6a77243-d925-4a9d-8abe-2cab7ce38a24" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_af875ead-0231-47fe-ab31-3d3c95620612" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_af875ead-0231-47fe-ab31-3d3c95620612" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_e1245627-d49b-4eb6-900f-3ee14b0c6870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_e1245627-d49b-4eb6-900f-3ee14b0c6870" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d186c079-99d8-4d63-9411-8afa7d5d1399" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d186c079-99d8-4d63-9411-8afa7d5d1399" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_b9e01121-c951-422c-b57f-b8963a9c05df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_b9e01121-c951-422c-b57f-b8963a9c05df" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e71bccfc-f57e-4719-81b9-b421381a36c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e71bccfc-f57e-4719-81b9-b421381a36c9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3515b5ad-b226-42bb-a903-293a6bfc9d00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e71bccfc-f57e-4719-81b9-b421381a36c9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3515b5ad-b226-42bb-a903-293a6bfc9d00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3515b5ad-b226-42bb-a903-293a6bfc9d00_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3515b5ad-b226-42bb-a903-293a6bfc9d00" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3515b5ad-b226-42bb-a903-293a6bfc9d00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8e0981e8-3c76-46cc-9862-1a5a7fb59cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3515b5ad-b226-42bb-a903-293a6bfc9d00" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8e0981e8-3c76-46cc-9862-1a5a7fb59cbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_3254e847-2054-4566-bdec-a0290a53cfaa" xlink:href="lgnd-20210331.xsd#lgnd_PfenexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8e0981e8-3c76-46cc-9862-1a5a7fb59cbe" xlink:to="loc_lgnd_PfenexMember_3254e847-2054-4566-bdec-a0290a53cfaa" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#AcquisitionsProFormaFinancialInformationDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails" xlink:type="extended" id="id5630eb71c384cb4ad2a0ba6ca3b567b_AcquisitionsProFormaFinancialInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_1dbea12e-26f2-44ac-b6a8-998bd606a21e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_e854d356-d74a-4755-9bd9-8c34ed4d0f2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1dbea12e-26f2-44ac-b6a8-998bd606a21e" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_e854d356-d74a-4755-9bd9-8c34ed4d0f2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_ab480f35-0d3a-4f10-b0c8-2d0980d70291" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1dbea12e-26f2-44ac-b6a8-998bd606a21e" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_ab480f35-0d3a-4f10-b0c8-2d0980d70291" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareProFormaAbstract_8c81f3b3-a54a-48ed-8b67-210eda471c06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareProFormaAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1dbea12e-26f2-44ac-b6a8-998bd606a21e" xlink:to="loc_us-gaap_EarningsPerShareProFormaAbstract_8c81f3b3-a54a-48ed-8b67-210eda471c06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_31eaab1d-b075-45c1-a577-b175a443b51b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareProFormaAbstract_8c81f3b3-a54a-48ed-8b67-210eda471c06" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_31eaab1d-b075-45c1-a577-b175a443b51b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_f9b56e2a-03df-4707-8c8b-78542cf70dc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareProFormaAbstract_8c81f3b3-a54a-48ed-8b67-210eda471c06" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_f9b56e2a-03df-4707-8c8b-78542cf70dc4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4d3d06f8-bdd3-4a34-afbf-71e5229732b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1dbea12e-26f2-44ac-b6a8-998bd606a21e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4d3d06f8-bdd3-4a34-afbf-71e5229732b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_abd133df-4c60-4938-93dd-7cd76f93ecf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4d3d06f8-bdd3-4a34-afbf-71e5229732b2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_abd133df-4c60-4938-93dd-7cd76f93ecf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_abd133df-4c60-4938-93dd-7cd76f93ecf1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_abd133df-4c60-4938-93dd-7cd76f93ecf1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_abd133df-4c60-4938-93dd-7cd76f93ecf1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a55fbda0-28d4-4f28-8591-8da7b347d095" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_abd133df-4c60-4938-93dd-7cd76f93ecf1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a55fbda0-28d4-4f28-8591-8da7b347d095" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_2f37f4d3-8af4-4e94-a057-ab6d17d51a80" xlink:href="lgnd-20210331.xsd#lgnd_PfenexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a55fbda0-28d4-4f28-8591-8da7b347d095" xlink:to="loc_lgnd_PfenexMember_2f37f4d3-8af4-4e94-a057-ab6d17d51a80" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="simple" xlink:href="lgnd-20210331.xsd#ConvertibleSeniorNotes"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="extended" id="i63e675222c244c90ba4789bb23cdd342_ConvertibleSeniorNotes"/>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="simple" xlink:href="lgnd-20210331.xsd#ConvertibleSeniorNotesTables"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="extended" id="iaee3a39df45f4f03be8ea5ffe684257e_ConvertibleSeniorNotesTables"/>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#ConvertibleSeniorNotesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="extended" id="i185d16e9e4a0439987c28b7ccbd6ee2e_ConvertibleSeniorNotesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_ccde61b1-fdc4-4b16-a1e6-df4288943cf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_ccde61b1-fdc4-4b16-a1e6-df4288943cf2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c71bf6fb-e3d6-453a-a162-bacd49f6f033" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c71bf6fb-e3d6-453a-a162-bacd49f6f033" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_82038fe9-dc8f-4fab-9c99-8369d4aa1ea7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_82038fe9-dc8f-4fab-9c99-8369d4aa1ea7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_93933815-da71-4b04-a808-cbaa611982b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_93933815-da71-4b04-a808-cbaa611982b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_a32d28bc-ff2c-453e-8ca6-38737dd8f3dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_a32d28bc-ff2c-453e-8ca6-38737dd8f3dc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_d329754f-f677-455a-b565-0cab70c2d5be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_d329754f-f677-455a-b565-0cab70c2d5be" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_2786cf27-0969-4788-aaef-3f6e1598d0b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_2786cf27-0969-4788-aaef-3f6e1598d0b6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_1b51338b-84aa-4379-b3cf-29ef904c2d83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_1b51338b-84aa-4379-b3cf-29ef904c2d83" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_a81241bb-eeb7-4981-b955-7fcffc9f4dcc" xlink:href="lgnd-20210331.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_a81241bb-eeb7-4981-b955-7fcffc9f4dcc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_b6d1e8ff-e43c-4eda-a806-e68d18c5b72a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_b6d1e8ff-e43c-4eda-a806-e68d18c5b72a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_bfd981ad-878d-497b-84eb-283f7dd4b810" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_bfd981ad-878d-497b-84eb-283f7dd4b810" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_2e7e10c3-9566-47c7-a566-0561b9aa6d3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_2e7e10c3-9566-47c7-a566-0561b9aa6d3a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_0df5aadd-bf2f-401b-938f-27f8b70c92ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_0df5aadd-bf2f-401b-938f-27f8b70c92ef" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_3c7113f2-abcc-4d2f-a573-2a5c5a5b2eb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_3c7113f2-abcc-4d2f-a573-2a5c5a5b2eb6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5d70f8f9-6d4b-4895-9519-5ac2868561f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5d70f8f9-6d4b-4895-9519-5ac2868561f3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount_e4bdd89e-6863-4edf-9ee1-a22ecd50c5d0" xlink:href="lgnd-20210331.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_lgnd_IncreaseDecreaseInDebtDiscount_e4bdd89e-6863-4edf-9ee1-a22ecd50c5d0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_bbd91731-7d39-472e-a04e-6eecf04bc9fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_bbd91731-7d39-472e-a04e-6eecf04bc9fa" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_bb545a10-516e-48ab-ae11-1c1ad13f8316" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_LongTermDebt_bb545a10-516e-48ab-ae11-1c1ad13f8316" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_02ec4311-f119-4242-8234-acf962da06df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_02ec4311-f119-4242-8234-acf962da06df" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForConvertibleBondHedges_fd9a22bd-2a89-448a-8f9c-27dec0085bbe" xlink:href="lgnd-20210331.xsd#lgnd_PaymentsForConvertibleBondHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_lgnd_PaymentsForConvertibleBondHedges_fd9a22bd-2a89-448a-8f9c-27dec0085bbe" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2b583c8f-f7e5-4230-b70a-718f126245f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2b583c8f-f7e5-4230-b70a-718f126245f6" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_dd58c650-91a7-44d4-9700-f36c3f9f76d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_dd58c650-91a7-44d4-9700-f36c3f9f76d4" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToUnwindWarrants_1c6bca9c-195d-4bd7-8526-ead5316a056e" xlink:href="lgnd-20210331.xsd#lgnd_PaymentsToUnwindWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_lgnd_PaymentsToUnwindWarrants_1c6bca9c-195d-4bd7-8526-ead5316a056e" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_130308c0-4821-4224-b9eb-d6fe182ff925" xlink:href="lgnd-20210331.xsd#lgnd_ProceedsFromUnwindingConvertibleBondHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_130308c0-4821-4224-b9eb-d6fe182ff925" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_4dc2f384-7374-458f-9b98-98f0658e59bc" xlink:href="lgnd-20210331.xsd#lgnd_NumberOfOptionsUnderConvertibleBondHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_4dc2f384-7374-458f-9b98-98f0658e59bc" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2b0e70f9-2380-444e-9227-3d810452b56e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_DebtInstrumentTable_2b0e70f9-2380-444e-9227-3d810452b56e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f0d4391f-c67e-46bb-a1f7-4e8d112421b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2b0e70f9-2380-444e-9227-3d810452b56e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f0d4391f-c67e-46bb-a1f7-4e8d112421b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f0d4391f-c67e-46bb-a1f7-4e8d112421b4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f0d4391f-c67e-46bb-a1f7-4e8d112421b4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f0d4391f-c67e-46bb-a1f7-4e8d112421b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d563bb98-e4bc-493f-9767-eeb8bda30472" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f0d4391f-c67e-46bb-a1f7-4e8d112421b4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d563bb98-e4bc-493f-9767-eeb8bda30472" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_be1838cf-103e-4a0b-9b29-2dc23c3c492e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d563bb98-e4bc-493f-9767-eeb8bda30472" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_be1838cf-103e-4a0b-9b29-2dc23c3c492e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d383d016-3dcf-4039-9ffd-7fb5a775540c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2b0e70f9-2380-444e-9227-3d810452b56e" xlink:to="loc_us-gaap_DebtInstrumentAxis_d383d016-3dcf-4039-9ffd-7fb5a775540c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d383d016-3dcf-4039-9ffd-7fb5a775540c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d383d016-3dcf-4039-9ffd-7fb5a775540c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d383d016-3dcf-4039-9ffd-7fb5a775540c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6807872a-c48a-40de-b573-db7a4e537a97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d383d016-3dcf-4039-9ffd-7fb5a775540c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6807872a-c48a-40de-b573-db7a4e537a97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_0ba4b65a-bcdf-40c5-98f5-c0b3c215c7bf" xlink:href="lgnd-20210331.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6807872a-c48a-40de-b573-db7a4e537a97" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_0ba4b65a-bcdf-40c5-98f5-c0b3c215c7bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6b2d9433-8ce6-4de5-bbc1-c957cea588b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2b0e70f9-2380-444e-9227-3d810452b56e" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6b2d9433-8ce6-4de5-bbc1-c957cea588b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_6b2d9433-8ce6-4de5-bbc1-c957cea588b3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6b2d9433-8ce6-4de5-bbc1-c957cea588b3" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_6b2d9433-8ce6-4de5-bbc1-c957cea588b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a30ecab8-f07b-4a22-b33d-a7a42c98ef3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6b2d9433-8ce6-4de5-bbc1-c957cea588b3" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a30ecab8-f07b-4a22-b33d-a7a42c98ef3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_1ad6a9bf-373f-4b71-998f-87286e2e223f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a30ecab8-f07b-4a22-b33d-a7a42c98ef3d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_1ad6a9bf-373f-4b71-998f-87286e2e223f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_4670616a-5e51-4d8e-a5e6-eb096149ca3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a30ecab8-f07b-4a22-b33d-a7a42c98ef3d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_4670616a-5e51-4d8e-a5e6-eb096149ca3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_00691dbc-1ca3-4954-a778-0591916a2750" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2b0e70f9-2380-444e-9227-3d810452b56e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_00691dbc-1ca3-4954-a778-0591916a2750" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_00691dbc-1ca3-4954-a778-0591916a2750_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_00691dbc-1ca3-4954-a778-0591916a2750" xlink:to="loc_us-gaap_EquityComponentDomain_00691dbc-1ca3-4954-a778-0591916a2750_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_28785225-5e7e-4ed9-9da6-09be40048af0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_00691dbc-1ca3-4954-a778-0591916a2750" xlink:to="loc_us-gaap_EquityComponentDomain_28785225-5e7e-4ed9-9da6-09be40048af0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9a646e12-86b3-4ad1-98c6-370e9a13513a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_28785225-5e7e-4ed9-9da6-09be40048af0" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9a646e12-86b3-4ad1-98c6-370e9a13513a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#ConvertibleSeniorNotesNotesPayableDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="extended" id="iaac67ef880f34a23adaf7ae60d12ebc3_ConvertibleSeniorNotesNotesPayableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4dbc3939-f58b-4769-b9dd-6b7c7f83de4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_daba2bb7-9dbe-4d12-b7ec-ec445a59803a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4dbc3939-f58b-4769-b9dd-6b7c7f83de4f" xlink:to="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_daba2bb7-9dbe-4d12-b7ec-ec445a59803a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_bd3f1a01-2d78-4358-9654-b1383fbb64c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_daba2bb7-9dbe-4d12-b7ec-ec445a59803a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_bd3f1a01-2d78-4358-9654-b1383fbb64c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_088c893e-be97-44cd-850a-e0b824f7f73a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_daba2bb7-9dbe-4d12-b7ec-ec445a59803a" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_088c893e-be97-44cd-850a-e0b824f7f73a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_6e080d4c-ed42-490f-bc70-00b56fe6b513" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_daba2bb7-9dbe-4d12-b7ec-ec445a59803a" xlink:to="loc_us-gaap_LongTermNotesPayable_6e080d4c-ed42-490f-bc70-00b56fe6b513" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_9333fd5e-f708-4029-a2d9-1a05e90f6d80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4dbc3939-f58b-4769-b9dd-6b7c7f83de4f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_9333fd5e-f708-4029-a2d9-1a05e90f6d80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_c0199a11-0ea5-490c-9563-101c640e5568" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4dbc3939-f58b-4769-b9dd-6b7c7f83de4f" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_c0199a11-0ea5-490c-9563-101c640e5568" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d8858261-134d-418e-98b4-c5de6a675a48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4dbc3939-f58b-4769-b9dd-6b7c7f83de4f" xlink:to="loc_us-gaap_DebtInstrumentTable_d8858261-134d-418e-98b4-c5de6a675a48" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_66c3a38c-84ce-446c-87d7-fdf093637382" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d8858261-134d-418e-98b4-c5de6a675a48" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_66c3a38c-84ce-446c-87d7-fdf093637382" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_66c3a38c-84ce-446c-87d7-fdf093637382_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_66c3a38c-84ce-446c-87d7-fdf093637382" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_66c3a38c-84ce-446c-87d7-fdf093637382_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_46d39b0c-8a57-440c-aa3e-3b361a119bbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_66c3a38c-84ce-446c-87d7-fdf093637382" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_46d39b0c-8a57-440c-aa3e-3b361a119bbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_eebd555e-f3e2-417a-bdb6-0ce293c14cca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_46d39b0c-8a57-440c-aa3e-3b361a119bbb" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_eebd555e-f3e2-417a-bdb6-0ce293c14cca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_298ae494-da0f-42be-a646-2fd95885d393" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d8858261-134d-418e-98b4-c5de6a675a48" xlink:to="loc_us-gaap_DebtInstrumentAxis_298ae494-da0f-42be-a646-2fd95885d393" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_298ae494-da0f-42be-a646-2fd95885d393_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_298ae494-da0f-42be-a646-2fd95885d393" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_298ae494-da0f-42be-a646-2fd95885d393_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2eeede3c-810d-4c12-8909-5481a1eea49d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_298ae494-da0f-42be-a646-2fd95885d393" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2eeede3c-810d-4c12-8909-5481a1eea49d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_be54772b-5e38-4700-840e-cc1c049fcd53" xlink:href="lgnd-20210331.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2eeede3c-810d-4c12-8909-5481a1eea49d" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_be54772b-5e38-4700-840e-cc1c049fcd53" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTax" xlink:type="simple" xlink:href="lgnd-20210331.xsd#IncomeTax"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/IncomeTax" xlink:type="extended" id="ia97dd01ea68a400b81153e164bc84114_IncomeTax"/>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#IncomeTaxNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/IncomeTaxNarrativeDetails" xlink:type="extended" id="i6a3cdea1c3ae40f18426215252daca0c_IncomeTaxNarrativeDetails"/>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquity" xlink:type="simple" xlink:href="lgnd-20210331.xsd#StockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/StockholdersEquity" xlink:type="extended" id="icd30c01fb2044677ad67602a89ad59d0_StockholdersEquity"/>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="lgnd-20210331.xsd#StockholdersEquityTables"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="extended" id="i65e99934a71342e1ac56dc3a4156479b_StockholdersEquityTables"/>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="extended" id="i43299c90d73240a2ab22c1fd35c88259_StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_d4aefdf2-8bbd-47b0-862c-4253d501b2d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f11152cf-dcc3-434f-9c56-e01ad50c977e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d4aefdf2-8bbd-47b0-862c-4253d501b2d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f11152cf-dcc3-434f-9c56-e01ad50c977e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_31812c99-b0db-4484-86ed-245dacb10991" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f11152cf-dcc3-434f-9c56-e01ad50c977e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_31812c99-b0db-4484-86ed-245dacb10991" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_84d9e58a-233f-4251-88e0-126081f4d978" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f11152cf-dcc3-434f-9c56-e01ad50c977e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_84d9e58a-233f-4251-88e0-126081f4d978" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bc1c985d-3710-4445-b275-a73dba5848da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f11152cf-dcc3-434f-9c56-e01ad50c977e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bc1c985d-3710-4445-b275-a73dba5848da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_568766e3-d96b-4556-88fa-518f2a000b43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f11152cf-dcc3-434f-9c56-e01ad50c977e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_568766e3-d96b-4556-88fa-518f2a000b43" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_813ad454-9842-470c-923a-097961e2d3d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9ea02117-fbfb-4b81-be47-0d05bdc5264b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d4aefdf2-8bbd-47b0-862c-4253d501b2d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9ea02117-fbfb-4b81-be47-0d05bdc5264b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1b776d90-35a2-4b81-be9d-7a181a90f01b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9ea02117-fbfb-4b81-be47-0d05bdc5264b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1b776d90-35a2-4b81-be9d-7a181a90f01b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c4caeadf-2909-4598-a181-142918800347" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9ea02117-fbfb-4b81-be47-0d05bdc5264b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c4caeadf-2909-4598-a181-142918800347" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_21f69eee-7d98-4f4b-8563-e530fa75ee24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9ea02117-fbfb-4b81-be47-0d05bdc5264b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_21f69eee-7d98-4f4b-8563-e530fa75ee24" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_fce0a9ee-b8a9-4c6b-9bc4-b9a0923b4bc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9ea02117-fbfb-4b81-be47-0d05bdc5264b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_fce0a9ee-b8a9-4c6b-9bc4-b9a0923b4bc7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0d78db8d-759d-4673-882d-44851f3c4f65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a0eb7db6-50d2-4f2a-82d7-354179629efe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d4aefdf2-8bbd-47b0-862c-4253d501b2d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a0eb7db6-50d2-4f2a-82d7-354179629efe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3f351a44-c749-481d-94e3-b2bb95b60ba0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a0eb7db6-50d2-4f2a-82d7-354179629efe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3f351a44-c749-481d-94e3-b2bb95b60ba0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_827d7c00-0f31-4853-8363-6c8b17662af1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a0eb7db6-50d2-4f2a-82d7-354179629efe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_827d7c00-0f31-4853-8363-6c8b17662af1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8a58e0ac-7a61-4451-b725-98ec338730d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a0eb7db6-50d2-4f2a-82d7-354179629efe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8a58e0ac-7a61-4451-b725-98ec338730d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2855e6bc-30a4-40a2-8b2c-6f7c3e5c909b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a0eb7db6-50d2-4f2a-82d7-354179629efe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2855e6bc-30a4-40a2-8b2c-6f7c3e5c909b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8460a3bd-72be-4084-bd88-2a003da1dacc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_894224a1-dfe3-4c3b-8c9d-c49d28ae0c1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d4aefdf2-8bbd-47b0-862c-4253d501b2d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_894224a1-dfe3-4c3b-8c9d-c49d28ae0c1b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_16ec38de-fb3a-4be5-9e5d-ef630b2be52a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_894224a1-dfe3-4c3b-8c9d-c49d28ae0c1b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_16ec38de-fb3a-4be5-9e5d-ef630b2be52a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_54dd3541-6afa-41e8-be51-00eaaf606fd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_894224a1-dfe3-4c3b-8c9d-c49d28ae0c1b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_54dd3541-6afa-41e8-be51-00eaaf606fd3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_bd793f6e-47a9-412f-ba75-04c896523c03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_894224a1-dfe3-4c3b-8c9d-c49d28ae0c1b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_bd793f6e-47a9-412f-ba75-04c896523c03" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8496890e-c63e-46ce-831c-49816658d269" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_894224a1-dfe3-4c3b-8c9d-c49d28ae0c1b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8496890e-c63e-46ce-831c-49816658d269" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_82100def-3153-49f9-93f7-1fef6578d6b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_3932a3dd-61da-4dec-8e4b-e855f535889f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_d4aefdf2-8bbd-47b0-862c-4253d501b2d8" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_3932a3dd-61da-4dec-8e4b-e855f535889f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f4e5fa4e-9dc0-4f30-af15-f097f12aae6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_3932a3dd-61da-4dec-8e4b-e855f535889f" xlink:to="loc_us-gaap_AwardTypeAxis_f4e5fa4e-9dc0-4f30-af15-f097f12aae6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f4e5fa4e-9dc0-4f30-af15-f097f12aae6e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f4e5fa4e-9dc0-4f30-af15-f097f12aae6e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f4e5fa4e-9dc0-4f30-af15-f097f12aae6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e59a86ba-4b04-4292-b43c-8294e40fa2fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f4e5fa4e-9dc0-4f30-af15-f097f12aae6e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e59a86ba-4b04-4292-b43c-8294e40fa2fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_95d74c98-55e5-4626-9502-76e2af7c56bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e59a86ba-4b04-4292-b43c-8294e40fa2fa" xlink:to="loc_us-gaap_EmployeeStockOptionMember_95d74c98-55e5-4626-9502-76e2af7c56bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_04975e86-6230-418c-8b4f-39d7f5b82498" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e59a86ba-4b04-4292-b43c-8294e40fa2fa" xlink:to="loc_us-gaap_RestrictedStockMember_04975e86-6230-418c-8b4f-39d7f5b82498" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#StockholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended" id="i50940240a28a430f940a1232a72dd784_StockholdersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97c158d8-4fb4-4c27-908d-3f7620d11643" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_5f3312ae-2b9d-4909-b6bd-a80fa42ebfdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97c158d8-4fb4-4c27-908d-3f7620d11643" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_5f3312ae-2b9d-4909-b6bd-a80fa42ebfdc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_27d6434c-b751-4b35-ab12-da5efc7f0663" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97c158d8-4fb4-4c27-908d-3f7620d11643" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_27d6434c-b751-4b35-ab12-da5efc7f0663" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract_454e1e82-e239-446c-ab93-66c4f6b0c0aa" xlink:href="lgnd-20210331.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97c158d8-4fb4-4c27-908d-3f7620d11643" xlink:to="loc_lgnd_EmployeeStockPurchasePlanAbstract_454e1e82-e239-446c-ab93-66c4f6b0c0aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_7f0e0a18-2ad2-4cea-97b3-2f22d400b8cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_454e1e82-e239-446c-ab93-66c4f6b0c0aa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_7f0e0a18-2ad2-4cea-97b3-2f22d400b8cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_d6e118fa-0a2f-4fca-80de-5d6e513d1ce9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_454e1e82-e239-446c-ab93-66c4f6b0c0aa" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_d6e118fa-0a2f-4fca-80de-5d6e513d1ce9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_cb6f7443-36be-408b-a0fc-5ba3da32d584" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97c158d8-4fb4-4c27-908d-3f7620d11643" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_cb6f7443-36be-408b-a0fc-5ba3da32d584" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_27c49e2f-cf6c-419b-bb30-09bc89223764" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97c158d8-4fb4-4c27-908d-3f7620d11643" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_27c49e2f-cf6c-419b-bb30-09bc89223764" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_0db6775c-182f-4e34-b219-e4a80ec8241f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97c158d8-4fb4-4c27-908d-3f7620d11643" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_0db6775c-182f-4e34-b219-e4a80ec8241f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_893da9e5-2e60-4afd-95a8-547c8cf73fa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97c158d8-4fb4-4c27-908d-3f7620d11643" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_893da9e5-2e60-4afd-95a8-547c8cf73fa8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a78d1c28-a14a-4fac-9de0-d94504bc2cd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97c158d8-4fb4-4c27-908d-3f7620d11643" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a78d1c28-a14a-4fac-9de0-d94504bc2cd4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_1f170a59-dd0f-4aca-85d5-0955f5348366" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a78d1c28-a14a-4fac-9de0-d94504bc2cd4" xlink:to="loc_us-gaap_PlanNameAxis_1f170a59-dd0f-4aca-85d5-0955f5348366" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1f170a59-dd0f-4aca-85d5-0955f5348366_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_1f170a59-dd0f-4aca-85d5-0955f5348366" xlink:to="loc_us-gaap_PlanNameDomain_1f170a59-dd0f-4aca-85d5-0955f5348366_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1209084c-0626-4aa0-aa93-ef580bff3cde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_1f170a59-dd0f-4aca-85d5-0955f5348366" xlink:to="loc_us-gaap_PlanNameDomain_1209084c-0626-4aa0-aa93-ef580bff3cde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanMember_e8e1a1e9-a01c-496d-8f8f-3b45f6a951d6" xlink:href="lgnd-20210331.xsd#lgnd_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_1209084c-0626-4aa0-aa93-ef580bff3cde" xlink:to="loc_lgnd_EmployeeStockPurchasePlanMember_e8e1a1e9-a01c-496d-8f8f-3b45f6a951d6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CommitmentandContingenciesLegalProceedings"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings" xlink:type="extended" id="ia3e20b28c5854ea1b08dab845728222c_CommitmentandContingenciesLegalProceedings"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CommitmentandContingenciesLegalProceedingsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails" xlink:type="extended" id="i806307fe38134426a95f14c9d45c01c7_CommitmentandContingenciesLegalProceedingsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesLineItems_8d93bac3-94a5-4987-8ebe-a679699009c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_1a682155-7841-4ca7-b36c-5eed17236620" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_8d93bac3-94a5-4987-8ebe-a679699009c8" xlink:to="loc_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_1a682155-7841-4ca7-b36c-5eed17236620" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_8078e184-5f08-4960-8920-3c103772432c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_8d93bac3-94a5-4987-8ebe-a679699009c8" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_8078e184-5f08-4960-8920-3c103772432c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfPetitionsFiled_823c79f7-c759-42fe-86b2-9cdc865287a2" xlink:href="lgnd-20210331.xsd#lgnd_NumberOfPetitionsFiled"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_8d93bac3-94a5-4987-8ebe-a679699009c8" xlink:to="loc_lgnd_NumberOfPetitionsFiled_823c79f7-c759-42fe-86b2-9cdc865287a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesTable_4d0e1a6f-7efe-4e10-befc-a9442e21c768" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GainContingenciesLineItems_8d93bac3-94a5-4987-8ebe-a679699009c8" xlink:to="loc_us-gaap_GainContingenciesTable_4d0e1a6f-7efe-4e10-befc-a9442e21c768" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_d453bb99-b2cc-419a-9124-0ccec7a1b49a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_GainContingenciesTable_4d0e1a6f-7efe-4e10-befc-a9442e21c768" xlink:to="loc_srt_LitigationCaseAxis_d453bb99-b2cc-419a-9124-0ccec7a1b49a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_d453bb99-b2cc-419a-9124-0ccec7a1b49a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_d453bb99-b2cc-419a-9124-0ccec7a1b49a" xlink:to="loc_srt_LitigationCaseTypeDomain_d453bb99-b2cc-419a-9124-0ccec7a1b49a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_728efd6c-2301-4de4-9193-4de4f9a5fb97" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_d453bb99-b2cc-419a-9124-0ccec7a1b49a" xlink:to="loc_srt_LitigationCaseTypeDomain_728efd6c-2301-4de4-9193-4de4f9a5fb97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LupinPatentInfringementMember_0ab83b0e-8370-4468-9c0d-62b61466d980" xlink:href="lgnd-20210331.xsd#lgnd_LupinPatentInfringementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_728efd6c-2301-4de4-9193-4de4f9a5fb97" xlink:to="loc_lgnd_LupinPatentInfringementMember_0ab83b0e-8370-4468-9c0d-62b61466d980" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_abe5254b-682d-4c6e-839c-deaf0b1ec501" xlink:href="lgnd-20210331.xsd#lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_728efd6c-2301-4de4-9193-4de4f9a5fb97" xlink:to="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_abe5254b-682d-4c6e-839c-deaf0b1ec501" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_InterPartesReviewOfPatentMember_8de7d56b-8cb1-4a1a-a60e-9c5ff5a25175" xlink:href="lgnd-20210331.xsd#lgnd_InterPartesReviewOfPatentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_728efd6c-2301-4de4-9193-4de4f9a5fb97" xlink:to="loc_lgnd_InterPartesReviewOfPatentMember_8de7d56b-8cb1-4a1a-a60e-9c5ff5a25175" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_9b972573-da34-4d3f-960a-f5d19ad3bd53" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_GainContingenciesTable_4d0e1a6f-7efe-4e10-befc-a9442e21c768" xlink:to="loc_dei_LegalEntityAxis_9b972573-da34-4d3f-960a-f5d19ad3bd53" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9b972573-da34-4d3f-960a-f5d19ad3bd53_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_9b972573-da34-4d3f-960a-f5d19ad3bd53" xlink:to="loc_dei_EntityDomain_9b972573-da34-4d3f-960a-f5d19ad3bd53_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e62b4689-51d4-4fc7-b1d6-7b7955723527" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_9b972573-da34-4d3f-960a-f5d19ad3bd53" xlink:to="loc_dei_EntityDomain_e62b4689-51d4-4fc7-b1d6-7b7955723527" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_ea9efcc4-787c-4e28-9d2f-129b306f125d" xlink:href="lgnd-20210331.xsd#lgnd_PfenexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_e62b4689-51d4-4fc7-b1d6-7b7955723527" xlink:to="loc_lgnd_PfenexMember_ea9efcc4-787c-4e28-9d2f-129b306f125d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GlaxoSmithKlineBiologicalsSAMember_7f32f239-2fe9-42b4-b5ef-208fd8647718" xlink:href="lgnd-20210331.xsd#lgnd_GlaxoSmithKlineBiologicalsSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_e62b4689-51d4-4fc7-b1d6-7b7955723527" xlink:to="loc_lgnd_GlaxoSmithKlineBiologicalsSAMember_7f32f239-2fe9-42b4-b5ef-208fd8647718" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>lgnd-20210331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:f42e6ea9-4959-4941-8454-5f1ec5bc67fa,g:c4690a82-fe68-4d49-b4c9-c600693120e1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4825aced-a77c-4acc-b957-ae315786459e_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PfenexMember_7d32951b-d6c6-4a13-8c8d-fa0e92c87eab_terseLabel_en-US" xlink:label="lab_lgnd_PfenexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfenex</link:label>
    <link:label id="lab_lgnd_PfenexMember_label_en-US" xlink:label="lab_lgnd_PfenexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfenex [Member]</link:label>
    <link:label id="lab_lgnd_PfenexMember_documentation_en-US" xlink:label="lab_lgnd_PfenexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfenex</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember" xlink:href="lgnd-20210331.xsd#lgnd_PfenexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PfenexMember" xlink:to="lab_lgnd_PfenexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_b2e6240f-fe14-4f5e-9133-3531f5d4ea92_terseLabel_en-US" xlink:label="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate for forecasted cash flows (as a percent)</link:label>
    <link:label id="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_label_en-US" xlink:label="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecasted Cash Flows, Effective Interest Rate, Percent</link:label>
    <link:label id="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_documentation_en-US" xlink:label="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecasted Cash Flows, Effective Interest Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:href="lgnd-20210331.xsd#lgnd_ForecastedCashFlowsEffectiveInterestRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:to="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_99ebc9a9-14d6-4dc3-9301-3005081ef9bd_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_57030264-0555-4582-b757-e9ab69086713_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_4f863fd4-58be-4017-b27a-e923f9098790_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment and Contingencies: Legal Proceedings</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9e32d347-bf7b-4c08-afe9-3f84034676d8_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4d32cb1d-12e1-42a1-b6c5-efca2fe7c6ac_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_6ac6377b-927b-47c2-bb59-6b992e02e7b5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_8e203c1f-a302-4fe1-8a83-3a0cf9d254de_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_be3becf8-3231-4522-ba4f-145ecc681733_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability acquired in connection with the acquired intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_1acef178-4d3c-4192-bc44-56f91fb1d5c5_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patents allegedly infringed upon</link:label>
    <link:label id="lab_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_label_en-US" xlink:label="lab_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingency, Patents Allegedly Infringed upon, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber" xlink:to="lab_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_119b8969-3995-4c14-ae3e-9ec025560f53_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs vested (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_0a2b4f94-4d3f-4f0f-b25c-48e49df1ee19_negatedLabel_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to CVR Holders</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_label_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders, Financing Activity</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_documentation_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders, Financing Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:href="lgnd-20210331.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:to="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_093378c2-28f6-4401-95f7-bec2de210b4f_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs (Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_e1289c06-0404-4452-b51c-33080bcc583b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_08ffc758-d58a-46d2-9250-3b4130685525_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross contract asset</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetGross" xlink:to="lab_us-gaap_ContractWithCustomerAssetGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_a53f9f6e-fe98-4d1f-a4fd-63dd1f00dd4d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_692d97a9-89fb-4353-9855-2cabb916b153_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_9b9332bf-c3f7-4c53-bdf4-b2e0faf12214_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial license rights</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_0b085a56-c227-4394-bed8-83f222975581_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_37550172-f723-4c54-b7a4-864fcd78727e_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e3678e30-9438-4e19-873e-6c95143bec63_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_cb2c812e-0ba6-49d5-a0f7-35c8621a54d0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_71949fe5-3007-41d4-a4b7-a019e47e6988_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reacquisition of equity due to 2023 debt extinguishment, net of tax</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_a5a88e73-02e2-482e-9c38-4f5e91ac96b9_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to additional paid in capital, equity component of convertible debt</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_edc5898d-3d57-4497-838e-720c351ba0a6_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_3e4771c7-3f86-4e62-83b6-5fe1d2cde633_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_abe7a777-a3bd-432a-a736-104803e180c4_verboseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_label_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights [Abstract]</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_documentation_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:href="lgnd-20210331.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:to="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_6c1dec5a-27f6-4780-b22b-c78a0f88d349_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share purchase price as percent of market price (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_ce76a119-2d0e-42aa-a3c0-df230b67fb16_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_3cadb5ac-7c9b-46ea-ace2-1575f03726ed_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_23cccd00-3e60-4e51-872c-cf443768ab32_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (USD per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_b9f98c7d-3c06-4f87-940e-ea0b2054bd6f_terseLabel_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time</link:label>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_label_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredOverTimeMember" xlink:to="lab_us-gaap_TransferredOverTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_167ba930-f11e-4188-beb7-924120fdcfea_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0c7cf737-ef18-4505-9ee3-1a0be505a0f7_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_b11c6f24-d63d-4713-9395-32b1a79415d4_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ff5e4e58-e4f1-4ec9-8084-53552fb12024_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_e19e0f8d-bc07-44fa-b162-45ab615ef252_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_174dd9ac-e9fe-4408-95b2-e54ccc093e47_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_2a60eb9e-6399-4769-92ad-8abaf7f8824c_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_34ff0557-077c-45d0-aef6-84e472d5d2d3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_49453116-0ee6-4720-b382-8d451dd79fa9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock compensation plans, net</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_9203efd0-a7d4-4e9b-bf75-3b960d34962d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_77d96fe1-33ad-4e3a-aa7f-b68002e4bdab_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs vested (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_1dbf2387-f797-4c74-a975-8c5ae3c04ec3_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_4338b259-8743-4a9a-b2bf-7e6017f57afb_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayableMember" xlink:to="lab_us-gaap_ConvertibleNotesPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_037f663d-1089-4b7b-a780-cbec5f88b790_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_5a03596a-7ece-442d-a639-c3b8ac7e518a_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_95b8fdbd-71e0-411f-91ae-25940ae57d99_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discount (including unamortized debt issuance cost)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_ce636667-7e72-4937-b38b-50257fdeb20b_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_06cd1ab2-bbf2-42a5-9118-ac889bef27d0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_92f7c41c-cc9b-4e9c-983b-3c9d6c75d0fa_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average estimated useful life of finite-lived intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_df4bbea9-f0c6-4ebf-b4fd-e96bcdb2ed37_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_031e24fe-a390-4b29-99a2-6663744fc98a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2a18c046-8652-4182-b233-be833686b0eb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsForConvertibleBondHedges_5be62a73-1cfd-44ea-b7d5-9b21ce5f9ec2_terseLabel_en-US" xlink:label="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for convertible bond hedges</link:label>
    <link:label id="lab_lgnd_PaymentsForConvertibleBondHedges_label_en-US" xlink:label="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Convertible Bond Hedges</link:label>
    <link:label id="lab_lgnd_PaymentsForConvertibleBondHedges_documentation_en-US" xlink:label="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Convertible Bond Hedges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForConvertibleBondHedges" xlink:href="lgnd-20210331.xsd#lgnd_PaymentsForConvertibleBondHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsForConvertibleBondHedges" xlink:to="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_f8c4fad9-e5b8-4275-ba6b-5abf495810f0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_35652d85-6daf-48d8-a869-a6b37f03723c_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible assets acquired</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_dd80103f-ba11-4e18-a9ca-d063e808dbcb_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at March&#160;31, 2021 and December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_91ba0d51-cc28-4ee1-a9a8-29839750dbce_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturity of short-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_da3ed268-d241-46c4-8484-999c79271619_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of contingent earn-out payment</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Fair Value Disclosure</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:to="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_fc5eeaa5-7c24-4dfc-9980-38d8b431caa1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding options that are exercisable (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_7b243712-50a6-4492-b8fe-d27de82dc7fc_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ReturnsAccrual_18dd71d6-428b-4b48-80cb-008f0e38bd05_terseLabel_en-US" xlink:label="lab_lgnd_ReturnsAccrual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return reserve</link:label>
    <link:label id="lab_lgnd_ReturnsAccrual_label_en-US" xlink:label="lab_lgnd_ReturnsAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Returns Accrual</link:label>
    <link:label id="lab_lgnd_ReturnsAccrual_documentation_en-US" xlink:label="lab_lgnd_ReturnsAccrual" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Returns Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ReturnsAccrual" xlink:href="lgnd-20210331.xsd#lgnd_ReturnsAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ReturnsAccrual" xlink:to="lab_lgnd_ReturnsAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_45d93880-4046-4737-b130-48c5d0d55017_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_5eee9534-745a-4578-ac7d-144f401abf5e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_0c7e1646-7851-4ff5-820a-d53362773b57_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_0ee87660-a19f-4ea7-a0d9-6540e7a7a01a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments under financing lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainContingenciesLineItems_8dc3e751-0628-4854-a4ab-48f72963c817_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_GainContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_GainContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingenciesLineItems" xlink:to="lab_us-gaap_GainContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_87fd126d-4dea-4596-a2ab-ba7c3cba8936_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_18a261fe-96f9-4cc8-a7d2-71b6ac56d67f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_be3e5003-9f74-4e49-b200-996798fb6f44_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period in force of stock repurchase program</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Period in Force</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:to="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_07c153e5-2db1-4653-b11f-d5165032651e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_7efe7154-70e4-4af9-ad6f-cb06a02562e2_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_a4c0d2c8-a1a4-49e9-9a0f-e78e3e51d9db_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_99c143c2-5671-4b8e-ab3b-bed7fe07de82_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_5660063e-542f-4a87-ac8b-6171b9e94a91_terseLabel_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Line Items]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_label_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Line Items]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_documentation_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of presentation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems" xlink:href="lgnd-20210331.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BasisOfPresentationLineItems" xlink:to="lab_lgnd_BasisOfPresentationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_bf6837d7-04bd-4fef-a21d-64ba5bf7d141_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion rate (shares per $1,000)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_d18da366-847e-4e5a-9afc-b6d6b03ad2ab_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_08f5f9af-e1b5-4044-ba85-f85bd75bb301_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_17754dd5-1e9a-4a7f-be9f-638285d82c8a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseeAccrualCurrent_a62a5378-e577-4d54-880d-e0ece3ae81d1_terseLabel_en-US" xlink:label="lab_lgnd_LicenseeAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts owed to former licensees</link:label>
    <link:label id="lab_lgnd_LicenseeAccrualCurrent_label_en-US" xlink:label="lab_lgnd_LicenseeAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensee Accrual, Current</link:label>
    <link:label id="lab_lgnd_LicenseeAccrualCurrent_documentation_en-US" xlink:label="lab_lgnd_LicenseeAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensee Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseeAccrualCurrent" xlink:href="lgnd-20210331.xsd#lgnd_LicenseeAccrualCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseeAccrualCurrent" xlink:to="lab_lgnd_LicenseeAccrualCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_f870cb09-99c6-4383-ae9a-16cf6f02c17f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_b8dacb5f-c4cf-4dd4-b83f-f4bb6cbbac1d_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_45ab9846-2ca0-4412-894a-140b405e79a7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of computation of basic and diluted net income (loss) per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_4c9e4653-7c24-4cda-a748-c9a437389261_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss on AFS investments</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_cb0c5dd6-33b9-4d74-87ac-963d3cbdde3c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_890469bd-522b-4ad5-96bc-b740869f6910_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_9185f63d-4e61-44c3-89f8-c5888ff5d4d7_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_8fbc740c-8f5a-4a22-bbd8-7bb2714bf7ce_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_424d3e9c-7576-447a-89c4-407fce60eb45_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_6647de59-0086-4fdf-bceb-1ace21791c95_terseLabel_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties</link:label>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_label_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties [Member]</link:label>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_documentation_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:href="lgnd-20210331.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:to="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_4f9bd257-5c60-4b56-aaba-1e532d7ff95d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issued (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_16736b79-dba9-437c-8ccf-393bb0ea42e4_terseLabel_en-US" xlink:label="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Right for Internal Research and Development</link:label>
    <link:label id="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_label_en-US" xlink:label="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Right for Internal Research and Development [Member]</link:label>
    <link:label id="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_documentation_en-US" xlink:label="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Right for Internal Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" xlink:href="lgnd-20210331.xsd#lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" xlink:to="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_e2896734-e1c0-4970-a042-0b85b86128e5_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 convertible senior notes, net</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:to="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2ba7f0aa-9a20-4099-8502-1b32ca6c4b34_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant exercise price (USD per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_2630251e-2635-4957-8604-03ff2030287b_negatedLabel_en-US" xlink:label="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in estimated fair value of contingent liabilities</link:label>
    <link:label id="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_label_en-US" xlink:label="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NonCashChangeInEstimatedFairValueOfContingentValueRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:href="lgnd-20210331.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:to="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_b9befac5-188c-4a08-a101-c696168ffa5f_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_749ed744-66b3-4be8-8a68-0b94c607d785_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_eb61a58d-9d3b-472f-b2c0-6c02d5a266c8_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_df32b211-1fc0-4bc6-a837-e4b916a67f8f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_7c09359f-c1c8-4ebf-b12d-7b474b9a8df8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_7c88bd15-3681-4315-bc1d-b38f77b15095_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_bd0c51ea-1241-4bf0-962e-b8a0ec63ca0e_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Computation of Basic and Diluted Earnings per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges_ae832977-0fa5-4693-9c3a-7bf0cbf439d1_terseLabel_en-US" xlink:label="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from unwinding convertible bond hedges</link:label>
    <link:label id="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges_label_en-US" xlink:label="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Unwinding Convertible Bond Hedges</link:label>
    <link:label id="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges_documentation_en-US" xlink:label="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Unwinding Convertible Bond Hedges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:href="lgnd-20210331.xsd#lgnd_ProceedsFromUnwindingConvertibleBondHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:to="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_853f0e25-3527-4398-bd81-183550559b1c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_144aedd9-5746-45af-958b-8584fa98c97e_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_960de5e8-94ef-4ddd-97db-69816adabdd6_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of level 3 financial instruments as of December 31, 2020</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_8673c60e-256e-4033-a595-ce0d9aa6bad6_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of level 3 financial instruments as of March 31, 2021</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_1044f220-ff41-411c-ac6a-47a931be4f6a_terseLabel_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive potential common shares:</link:label>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:to="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_b52293c2-0be5-47aa-8346-63721fd28009_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_631ce95f-5cc3-483a-bf46-55431a521d74_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_9e76918e-94cb-4c96-8cdf-2bb62fcd73bc_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of CVRs issued per acquiree share</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_label_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued per Acquiree Share</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued per Acquiree Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:to="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_fd8ace36-0390-4f47-92ce-61383bbb502e_terseLabel_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial</link:label>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_label_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial [Member]</link:label>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_documentation_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember" xlink:href="lgnd-20210331.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_Phase3ClinicalTrialMember" xlink:to="lab_lgnd_Phase3ClinicalTrialMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_36e4b515-3e0f-42b7-b4e8-95901c03228a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_d046956f-4a5e-453a-8839-4f24fbe5ed17_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_a799f650-cb87-43b3-ba6e-5f6b933c5942_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_SelexisMember_c28c261c-4de5-44bd-8dee-f00b44f44a56_terseLabel_en-US" xlink:label="lab_lgnd_SelexisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis</link:label>
    <link:label id="lab_lgnd_SelexisMember_label_en-US" xlink:label="lab_lgnd_SelexisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis [Member]</link:label>
    <link:label id="lab_lgnd_SelexisMember_documentation_en-US" xlink:label="lab_lgnd_SelexisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisMember" xlink:href="lgnd-20210331.xsd#lgnd_SelexisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_SelexisMember" xlink:to="lab_lgnd_SelexisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_186b0c8e-34cd-49bb-a6df-8ad9651b94dd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AziyoMember_4a0e951d-f66e-4242-be31-a63b95c3b6a1_terseLabel_en-US" xlink:label="lab_lgnd_AziyoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo</link:label>
    <link:label id="lab_lgnd_AziyoMember_label_en-US" xlink:label="lab_lgnd_AziyoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AziyoMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoMember" xlink:href="lgnd-20210331.xsd#lgnd_AziyoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AziyoMember" xlink:to="lab_lgnd_AziyoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1fc03792-0926-45c1-93f3-886488e684f9_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bd3dda58-9a16-4466-9044-442fd1161eb9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d3506b26-69f2-4da5-940b-1dd05a25cfaa_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued fixed asset purchases</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_f02921c6-768e-4e25-9147-6222460e2b6a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7768f53e-7ac5-4962-a51c-9d0536f01ade_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedAssetAcquisitionsCurrent_2ffd1c4e-a249-4c59-8e33-702be03ca755_terseLabel_en-US" xlink:label="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition related liabilities</link:label>
    <link:label id="lab_lgnd_AccruedAssetAcquisitionsCurrent_label_en-US" xlink:label="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Asset Acquisitions, Current</link:label>
    <link:label id="lab_lgnd_AccruedAssetAcquisitionsCurrent_documentation_en-US" xlink:label="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Asset Acquisitions, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedAssetAcquisitionsCurrent" xlink:href="lgnd-20210331.xsd#lgnd_AccruedAssetAcquisitionsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedAssetAcquisitionsCurrent" xlink:to="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e981dbff-0742-4cf1-a185-37d83b5e868a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_9352979f-bca2-490a-bc4e-63f6c99a9491_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_7b9bfc82-1222-498d-96dc-6fcc748ef1c5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_4a6e337a-02c1-4454-b1ea-6a31b43af2e8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_7c83c1b3-1d2c-42ef-b056-f53c87814121_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_078f28c5-2ce9-42f6-b92c-bc326e2c1db9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_345ab066-8579-42bc-baa8-f9f454e404e9_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember_62338d5f-664a-4b7c-8e68-44d23f627028_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - Crystal</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Crystal [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Crystal [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember" xlink:href="lgnd-20210331.xsd#lgnd_LiabilityForContingentValueRightsCompanyCrystalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRights_16aaaa78-ed2d-43b9-921c-49ac015b1213_verboseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term contingent liabilities</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRights_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LiabilityForContingentValueRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights" xlink:href="lgnd-20210331.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRights" xlink:to="lab_lgnd_LiabilityForContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BasisOfPresentationTable_076171de-b1b2-452e-962d-a23c0fb2fcb9_terseLabel_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Table]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationTable_label_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Table]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationTable_documentation_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable" xlink:href="lgnd-20210331.xsd#lgnd_BasisOfPresentationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BasisOfPresentationTable" xlink:to="lab_lgnd_BasisOfPresentationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_45c943b0-3c80-41b6-8368-99f63a5dc3d9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_8ae44dfa-7db6-46ea-9b48-510d4f574158_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_GlaxoSmithKlineBiologicalsSAMember_c9586a36-0ef6-4822-a8db-918516e17221_terseLabel_en-US" xlink:label="lab_lgnd_GlaxoSmithKlineBiologicalsSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GSK</link:label>
    <link:label id="lab_lgnd_GlaxoSmithKlineBiologicalsSAMember_label_en-US" xlink:label="lab_lgnd_GlaxoSmithKlineBiologicalsSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GlaxoSmithKline Biologicals S.A. [Member]</link:label>
    <link:label id="lab_lgnd_GlaxoSmithKlineBiologicalsSAMember_documentation_en-US" xlink:label="lab_lgnd_GlaxoSmithKlineBiologicalsSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GlaxoSmithKline Biologicals S.A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GlaxoSmithKlineBiologicalsSAMember" xlink:href="lgnd-20210331.xsd#lgnd_GlaxoSmithKlineBiologicalsSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_GlaxoSmithKlineBiologicalsSAMember" xlink:to="lab_lgnd_GlaxoSmithKlineBiologicalsSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_4d02b279-ea64-414c-8795-6000ffa6a461_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate used to value intangible assets acquired (as a percent)</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Discount Rate</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_f93dd9c2-79c1-4708-a258-f4f2dae2beda_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock price trigger to classify convertible debt as current (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_cd911b16-dc24-4c8d-a681-a1d786071b21_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_93c79d01-823f-492f-b31a-0a020a3c9241_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9abf9e47-e7a9-44e7-a5f3-0bcc8f3a30b4_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8a5a362b-8292-48ce-ac0e-9fcf5d07a8b7_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_4eafb92c-be13-476d-9433-ff44950d1fbc_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_9204f3f3-9bf6-4286-86d5-69409ab3ee95_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_410dc866-3a1a-4eb5-b633-385b2905f697_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_4b5f69f5-7b54-48fe-aa87-f37b4325bf46_negatedTerseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities, Current</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_7d84b3ea-2b5f-4989-8c98-23f5420b39af_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_47d23e25-f69e-402a-93e9-25eec194d1f5_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_2d665e6f-0bed-4340-8e99-bb8c0b320b61_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_64fa5b85-5798-4e3d-b55b-dc968e2e2bb7_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsMember" xlink:to="lab_us-gaap_ShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_55286c19-25d8-4456-81b4-89255b4dc17b_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_f66d9973-c3ee-48f6-bf88-27a1e5aa09aa_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_1d12587a-3043-469e-8794-c0e418704d29_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContractRevenueMember_1b62dcbf-1146-4bb3-9bf0-ed47093992a1_terseLabel_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract revenue</link:label>
    <link:label id="lab_lgnd_ContractRevenueMember_label_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue [Member]</link:label>
    <link:label id="lab_lgnd_ContractRevenueMember_documentation_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember" xlink:href="lgnd-20210331.xsd#lgnd_ContractRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContractRevenueMember" xlink:to="lab_lgnd_ContractRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_126b0309-0c5f-4b6c-8603-5f4048d1a6dc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_81f8fc9d-1479-4153-93e2-d3854a6bcbc2_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized from milestone method revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_33ac3c84-2619-4503-9414-b49cdb64f67e_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted Prices in Active Markets for Identical Assets (Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_a6210984-fe22-4be2-a074-7cc01337f87a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_f8ff133f-16c4-464a-9f97-5790a932e560_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d4abfe98-302c-4dd8-b179-11873c637950_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0c70cb6b-f38b-4c37-8f31-85ee67b14711_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_0dd8cdd2-42c3-4050-954e-55e63a2da542_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_fcc5acbe-b4c8-4632-b1c8-1a03fcbb5291_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_fd07c2c8-6eef-4c2b-adf8-68ec6194dac7_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_d247c04c-3cea-4590-9bf8-af0ef65bcc5c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_ed03381d-1b65-48a2-b587-cbd12e47251d_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_1911ee31-1bae-47bc-97ae-6c4a2a481ab7_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_5bd2febc-6d7f-47dc-a8b1-a894da6f9bd5_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_8e616d07-ef57-4521-b88d-cb642b62fd7b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedSubcontractorExpensesCurrent_05f2719a-b9a1-4fbc-b4e5-1570175f6808_terseLabel_en-US" xlink:label="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subcontractor</link:label>
    <link:label id="lab_lgnd_AccruedSubcontractorExpensesCurrent_label_en-US" xlink:label="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Subcontractor Expenses, Current</link:label>
    <link:label id="lab_lgnd_AccruedSubcontractorExpensesCurrent_documentation_en-US" xlink:label="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Subcontractor Expenses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSubcontractorExpensesCurrent" xlink:href="lgnd-20210331.xsd#lgnd_AccruedSubcontractorExpensesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedSubcontractorExpensesCurrent" xlink:to="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4733abfe-474c-4750-884b-36d7128d5009_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_ea25ec92-61fa-4330-b4c4-d7b16f60b9e7_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_1868a039-0ea3-4935-ace2-a7999dd29eca_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_93acaa6c-4d98-41f5-85b0-adbf477ef192_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges_a3774a3f-4b06-4832-89af-dbddbbb70df1_terseLabel_en-US" xlink:label="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options under convertible bond hedges</link:label>
    <link:label id="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges_label_en-US" xlink:label="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options under Convertible Bond Hedges</link:label>
    <link:label id="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges_documentation_en-US" xlink:label="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options under Convertible Bond Hedges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:href="lgnd-20210331.xsd#lgnd_NumberOfOptionsUnderConvertibleBondHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:to="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_050923f6-ebf2-4184-8a8d-716203c6d29a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_fc51cb6f-704e-46eb-82de-2abd0781dc6d_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of the 2023 Notes outstanding (Level 2)</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_c3df54d7-e1cc-41b1-aa2e-279ebe9e3ce6_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs and expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_0b4e9fa8-d330-48e0-8e6d-be037a588156_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a0837452-b196-4c9f-afb9-a9567e991b39_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8102fdd5-19e9-4581-87db-a95b4d99ddd0_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_525bcadd-f4e2-42fc-a036-f65e02f3203e_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyMember_acebee1e-d0e1-4874-8131-dc292d9abcbd_verboseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_0a2cbbd3-180c-4192-80b4-871461224f17_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_label_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyMember" xlink:to="lab_us-gaap_RoyaltyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_f5728063-28f2-4bbe-a34f-f4fdd59b1a63_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock authorized (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_15a66b39-a152-44a3-a31f-97ad4726809d_terseLabel_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_label_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees, Milestones, and Product, Other, Product, Other [Member]</link:label>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_documentation_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees, Milestones, and Product, Other, Product, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:href="lgnd-20210331.xsd#lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:to="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_de7a14ad-d195-4811-8641-3cb9bebc0e9f_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_2e3f2bd5-db64-4bba-8524-1bdadab92f42_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from stock option exercises and ESPP</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MilestonePaymentsMember_1f32ce31-9c1f-49c1-96ce-6b254ede1f28_terseLabel_en-US" xlink:label="lab_lgnd_MilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments</link:label>
    <link:label id="lab_lgnd_MilestonePaymentsMember_label_en-US" xlink:label="lab_lgnd_MilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments [Member]</link:label>
    <link:label id="lab_lgnd_MilestonePaymentsMember_documentation_en-US" xlink:label="lab_lgnd_MilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestonePaymentsMember" xlink:href="lgnd-20210331.xsd#lgnd_MilestonePaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MilestonePaymentsMember" xlink:to="lab_lgnd_MilestonePaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_099b5cea-f426-454c-b9f6-df50988a0c4c_terseLabel_en-US" xlink:label="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License and Other Economic Rights</link:label>
    <link:label id="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License Rights [Table Text Block]</link:label>
    <link:label id="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_documentation_en-US" xlink:label="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:href="lgnd-20210331.xsd#lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:to="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_b4dc2d3c-26bb-4b25-b3fe-26657835214a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseFeesMember_020babfa-fcae-4163-9bc4-2fd94bb364e4_terseLabel_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees</link:label>
    <link:label id="lab_lgnd_LicenseFeesMember_label_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees [Member]</link:label>
    <link:label id="lab_lgnd_LicenseFeesMember_documentation_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember" xlink:href="lgnd-20210331.xsd#lgnd_LicenseFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseFeesMember" xlink:to="lab_lgnd_LicenseFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_84d9255e-7151-4cd8-9873-7f33dc8b1040_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_0f68c832-4891-418d-aba9-43e975860e83_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance period for awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_87e44055-66a6-4a19-b1ea-de81317e90a1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_649a8b60-e6e3-4aaa-af61-8647e16c879e_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future purchases (shares)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Expected to be Repurchased, Next Fiscal Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_1dc755bc-f4f5-437d-989c-346d6c6a48fd_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of CVRs issued from each CVR series</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_label_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:to="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_3e2a19e1-1b37-4551-bcee-a2c46da4e940_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_13533790-2afd-4ba9-9630-4bc34d0dbc81_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties owed to third parties</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_77258756-d5fd-498a-af96-cc264b19e88c_negatedLabel_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in debt discount</link:label>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_label_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Debt Discount</link:label>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_documentation_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Debt Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount" xlink:href="lgnd-20210331.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_IncreaseDecreaseInDebtDiscount" xlink:to="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_9dd4fb1f-3900-48d0-877d-35cb90c13cbe_negatedTerseLabel_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect for 2023 Notes transactions</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_label_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Tax Effect of Convertible Senior Notes Transactions</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_documentation_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Tax Effect of Convertible Senior Notes Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" xlink:href="lgnd-20210331.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" xlink:to="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_c2b85b03-8fc7-4938-a36b-568aec6129dd_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_5f8a04fe-c8d3-42ea-9999-ad22e295ef4d_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_eb652adf-7906-43b4-a24b-1844e1abf1f0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired that is expected to be deductible for tax purposes</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_788c5dcc-9af6-464e-9265-cedb24faeffa_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_bedddc19-b5f7-4ef0-9baa-190d40b230ce_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportion of milestone payments (as a percent)</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_label_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Percentage of Acquiree Revenues</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Percentage of Acquiree Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" xlink:to="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_70f5d518-e43a-4eda-b0f5-ebb0d86ed2cf_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining authorized stock repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToUnwindWarrants_863fc35b-6542-4af3-96ae-4662bba18a9e_terseLabel_en-US" xlink:label="lab_lgnd_PaymentsToUnwindWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to unwind warrants</link:label>
    <link:label id="lab_lgnd_PaymentsToUnwindWarrants_label_en-US" xlink:label="lab_lgnd_PaymentsToUnwindWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Unwind Warrants</link:label>
    <link:label id="lab_lgnd_PaymentsToUnwindWarrants_documentation_en-US" xlink:label="lab_lgnd_PaymentsToUnwindWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Unwind Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToUnwindWarrants" xlink:href="lgnd-20210331.xsd#lgnd_PaymentsToUnwindWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToUnwindWarrants" xlink:to="lab_lgnd_PaymentsToUnwindWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_db57e184-1966-4489-94de-c4bcef6d852d_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights_99490458-8531-4741-ad8c-5085439a2ad8_verboseLabel_en-US" xlink:label="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current contingent liabilities</link:label>
    <link:label id="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights_label_en-US" xlink:label="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CurrentPortionOfLiabilityForContingentValueRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:href="lgnd-20210331.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:to="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_46924793-2745-48f8-a74a-859654bff6b4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_3c93ea8b-f16a-4c4e-99f6-7a05660bf914_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_01ade149-ff1f-43f0-b48a-f9221a65d829_terseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit loss</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_label_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights, Allowance for Credit Loss</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_documentation_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" xlink:href="lgnd-20210331.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" xlink:to="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_f7d0a5e4-1dba-458c-a2d7-c43c66217d9e_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_fdbe4749-9283-410a-b6be-704a40dcf788_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_34c3f7e9-d410-42f1-bdcf-3966c853d1f3_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_228d58f7-b480-4609-9103-fe617620a891_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_b734c3b5-cb75-435b-a87d-3ca15556bcda_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent earn-out payment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromHedgeFinancingActivities_c49a79af-d1e0-4aa4-aee3-d628e2a2825f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from convertible bond hedge settlement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromHedgeFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Hedge, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromHedgeFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_af92e7eb-f3cc-4252-9eec-75997d429c3d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit losses related to available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ba9b8076-c86f-4154-97ee-da6ca94a3d95_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized stock repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_6215488f-8699-4a8c-9dcc-224cbf35a278_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_KyprolisMember_be7faaef-42c1-4f52-a327-6145038ec238_terseLabel_en-US" xlink:label="lab_lgnd_KyprolisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis</link:label>
    <link:label id="lab_lgnd_KyprolisMember_label_en-US" xlink:label="lab_lgnd_KyprolisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis [Member]</link:label>
    <link:label id="lab_lgnd_KyprolisMember_documentation_en-US" xlink:label="lab_lgnd_KyprolisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_KyprolisMember" xlink:href="lgnd-20210331.xsd#lgnd_KyprolisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_KyprolisMember" xlink:to="lab_lgnd_KyprolisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_30b066ee-b53c-4d67-864b-6c9941231a77_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Source</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a21563b1-0a8a-4991-80a9-63d7be02c968_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_92212d71-2670-4a28-a669-ec0dd82c9cdf_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_507ef102-4ef0-47c3-8fb9-82c0ebcd63a5_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_2e8f9c4f-9690-4959-b598-57dce1669e17_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_f2ef3de6-d8f9-40e1-86b0-1bc9cbef1d45_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_88fb80b4-ab08-4437-9ab9-54530ad42d9c_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased during period</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_98bfe25b-a007-41ab-b277-b6255623d904_netLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_d6f33b74-ab3e-4915-89dd-c49156328a88_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_a8b98216-bbcb-41d8-9024-0da493058ddf_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyAgreementsMember_f4d809a8-cfbe-4fe2-949b-132f48f341e7_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Agreements</link:label>
    <link:label id="lab_us-gaap_RoyaltyAgreementsMember_label_en-US" xlink:label="lab_us-gaap_RoyaltyAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyAgreementsMember" xlink:to="lab_us-gaap_RoyaltyAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_7194bdb7-5c52-4674-a459-58c389b787de_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareProFormaAbstract_3568165c-cd5b-42ff-86b7-b14de08f2da2_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareProFormaAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per common share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareProFormaAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareProFormaAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Pro Forma [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareProFormaAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareProFormaAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareProFormaAbstract" xlink:to="lab_us-gaap_EarningsPerShareProFormaAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_f2036994-00ad-4413-af86-7fedff944222_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Goodwill and Other Identifiable Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NumberOfPetitionsFiled_ef8bfe14-fd74-44c7-90ee-ef0a34613a97_terseLabel_en-US" xlink:label="lab_lgnd_NumberOfPetitionsFiled" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of petitions filed</link:label>
    <link:label id="lab_lgnd_NumberOfPetitionsFiled_label_en-US" xlink:label="lab_lgnd_NumberOfPetitionsFiled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Petitions Filed</link:label>
    <link:label id="lab_lgnd_NumberOfPetitionsFiled_documentation_en-US" xlink:label="lab_lgnd_NumberOfPetitionsFiled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Petitions Filed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfPetitionsFiled" xlink:href="lgnd-20210331.xsd#lgnd_NumberOfPetitionsFiled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NumberOfPetitionsFiled" xlink:to="lab_lgnd_NumberOfPetitionsFiled" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_a7d5271c-880c-45cc-9b91-415235becdc7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_caad4e2b-b4ab-4c41-b40d-41e51bb3bc46_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_5a73e6b8-f262-49b8-b5f7-807aeecadccc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Debt Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_05c306dc-dc28-4ebd-8c7b-a5389ee065de_terseLabel_en-US" xlink:label="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payout range (as a percent)</link:label>
    <link:label id="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_label_en-US" xlink:label="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent</link:label>
    <link:label id="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_documentation_en-US" xlink:label="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:href="lgnd-20210331.xsd#lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:to="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_7ec24016-f9b9-437b-bd11-a6acedd98acc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_2605a7f3-2d5b-4443-8755-ad9d78545df8_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viking Therapeutics, Inc.</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvesteeMember" xlink:to="lab_us-gaap_EquityMethodInvesteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_099fecf4-85da-4495-a295-5e753575c93e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_e7c95c66-b2e5-4125-955f-a2aecca2ff9c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_ab9fb4bd-8887-4cbd-90c3-4a6d0d62912f_terseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_cdc2ee26-3902-4872-9c6d-7600b7f6108e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_96f7d43f-8ee5-4b45-b593-814d5fb7cf27_negatedLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of premium (discount) on investments, net</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_9a834a95-2e48-4d35-ad2b-9c3a7180f2f0_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_4398c277-7327-4ce1-892d-827a9c2f0559_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9ae75080-87ff-4c06-91bb-06cabac61eac_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_bec1183a-ad62-47a3-adba-72e4fb95f3c8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_0efc7f9c-3212-4814-b5f1-bae08e1a8168_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_52453d31-3b22-4a51-b0ac-f2fdb9209c8e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts and unbilled receivables</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_65f25005-e8ce-47ce-a17e-0e6ac07c516e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_7bab9b4e-e437-409c-96e3-dccdb03c4cf7_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_eef5b806-4ffa-4f31-b602-6f36628a651d_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_f0d7ee23-e5da-40a7-8c20-ba6ada4bc4ee_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - xCella</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, xCella [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, xCella</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:href="lgnd-20210331.xsd#lgnd_LiabilityForContingentValueRightsCompanyXCellaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_d1bbe402-ac37-409f-add8-ca247f088477_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_5b1d27bb-8002-421d-a30a-aa37fc60931a_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_a20e2ba8-7d7f-40ef-9a3e-c5dee7aa6a8e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_4afda58b-af5b-4324-a9c7-8b961a350456_verboseLabel_en-US" xlink:label="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounting for Share-Based Compensation</link:label>
    <link:label id="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:href="lgnd-20210331.xsd#lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:to="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseRights_402488f8-f2be-4cac-aa38-ceba20ba4320_terseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial license and other economic rights, net</link:label>
    <link:label id="lab_lgnd_CommercialLicenseRights_label_en-US" xlink:label="lab_lgnd_CommercialLicenseRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CommercialLicenseRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights" xlink:href="lgnd-20210331.xsd#lgnd_CommercialLicenseRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseRights" xlink:to="lab_lgnd_CommercialLicenseRights" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_XCellaBiosciencesIncMember_9dd9d4dc-29c1-4023-a8c7-8806b632352e_terseLabel_en-US" xlink:label="lab_lgnd_XCellaBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">xCella</link:label>
    <link:label id="lab_lgnd_XCellaBiosciencesIncMember_label_en-US" xlink:label="lab_lgnd_XCellaBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">xCella Biosciences, Inc. [Member]</link:label>
    <link:label id="lab_lgnd_XCellaBiosciencesIncMember_documentation_en-US" xlink:label="lab_lgnd_XCellaBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">xCella Biosciences, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_XCellaBiosciencesIncMember" xlink:href="lgnd-20210331.xsd#lgnd_XCellaBiosciencesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_XCellaBiosciencesIncMember" xlink:to="lab_lgnd_XCellaBiosciencesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EvomelaMember_9bd15471-33d0-435f-8674-abfd90c8641c_terseLabel_en-US" xlink:label="lab_lgnd_EvomelaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evomela</link:label>
    <link:label id="lab_lgnd_EvomelaMember_label_en-US" xlink:label="lab_lgnd_EvomelaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evomela [Member]</link:label>
    <link:label id="lab_lgnd_EvomelaMember_documentation_en-US" xlink:label="lab_lgnd_EvomelaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evomela</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EvomelaMember" xlink:href="lgnd-20210331.xsd#lgnd_EvomelaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EvomelaMember" xlink:to="lab_lgnd_EvomelaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualRightsMember_53b8c88d-9554-4075-83f6-ab0c888f16ed_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual relationships</link:label>
    <link:label id="lab_us-gaap_ContractualRightsMember_1e45dfdc-ecff-49e0-8909-25e518f144d6_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Relationships</link:label>
    <link:label id="lab_us-gaap_ContractualRightsMember_label_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualRightsMember" xlink:to="lab_us-gaap_ContractualRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_4b3e639e-255e-4eac-8e0e-964588c65963_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_58f7a067-581e-4974-a3b5-fc6d46ab4573_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2071b237-c906-4822-a636-f59cec5103dd_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_21682ed4-98e5-436b-9b20-07f77930963e_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_54a8b472-c103-4a90-a98f-645e5d9c8380_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e8dbbc70-be66-4712-9e7a-980cba8ea057_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b09abe8e-64b6-4d86-ae89-e6fa1101a4b6_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_2a277b6b-c942-4bd2-b440-083c7968b18e_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Plan Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LupinPatentInfringementMember_20e8e729-8487-4538-810b-7e0da7168425_terseLabel_en-US" xlink:label="lab_lgnd_LupinPatentInfringementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lupin Patent Infringement</link:label>
    <link:label id="lab_lgnd_LupinPatentInfringementMember_label_en-US" xlink:label="lab_lgnd_LupinPatentInfringementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lupin Patent Infringement [Member]</link:label>
    <link:label id="lab_lgnd_LupinPatentInfringementMember_documentation_en-US" xlink:label="lab_lgnd_LupinPatentInfringementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lupin Patent Infringement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LupinPatentInfringementMember" xlink:href="lgnd-20210331.xsd#lgnd_LupinPatentInfringementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LupinPatentInfringementMember" xlink:to="lab_lgnd_LupinPatentInfringementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_040e4ebb-6292-4e46-8ea9-ed44fdc9f696_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_f44d942a-6695-43ba-a4fb-4fd68a4d34a4_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_c80951d6-aefa-4afb-8fe4-2d6268592f8d_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_5348bf41-635b-4b27-8b05-03bbcfbe4f33_terseLabel_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_label_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Foreign Currency Translation Adjustment</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_documentation_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Foreign Currency Translation Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" xlink:href="lgnd-20210331.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" xlink:to="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_d8f5c49a-e6b3-4599-b02d-330b728eabdf_terseLabel_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued inventory purchases</link:label>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_label_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Inventory Purchases</link:label>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_documentation_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Inventory Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedInventoryPurchases" xlink:href="lgnd-20210331.xsd#lgnd_AccruedInventoryPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedInventoryPurchases" xlink:to="lab_lgnd_AccruedInventoryPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_bdf707ea-1513-4572-9de7-ef43df319465_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_6a58f775-ac8e-4849-a5c3-e043ea616edf_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_68202605-3284-42cb-a751-2c9d7b401fd8_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frequency of cash payments to CVR holders</link:label>
    <link:label id="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_label_en-US" xlink:label="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders</link:label>
    <link:label id="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:to="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_929fd282-be78-4ae4-9782-70de9e99f6ff_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_469566f2-4cfc-4299-a26e-12a725d22ca3_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_f55ddfa1-74ec-4496-8f70-62c97820efe8_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SBC - Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_300364d6-878c-41e5-a331-c539916a220e_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_95db4158-2d24-42d7-ae97-e8e29f9e68b6_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in Viking common stock</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_15b5c6f0-3ae8-467d-85c2-b5b721812696_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_bdd6ba7f-5bfc-4f04-a570-577ee897a2cd_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_ec3884f8-7e53-4bd0-a386-1fe4f357a674_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_3e22dbbd-7a60-4b8d-ac2b-472115792287_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reacquisition of equity due to 2023 debt extinguishment, net of tax</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_2f427e9a-8e22-49fa-b623-dd77ceea0834_verboseLabel_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Captisol</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_label_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol [Member]</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_documentation_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember" xlink:href="lgnd-20210331.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MaterialSalesCaptisolMember" xlink:to="lab_lgnd_MaterialSalesCaptisolMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_449df0d2-8283-4343-8527-1541e918e9da_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_InterPartesReviewOfPatentMember_e67cd053-bcd4-45fc-8e2c-74ec2bcf18d2_terseLabel_en-US" xlink:label="lab_lgnd_InterPartesReviewOfPatentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inter Partes Review of Patent</link:label>
    <link:label id="lab_lgnd_InterPartesReviewOfPatentMember_label_en-US" xlink:label="lab_lgnd_InterPartesReviewOfPatentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inter Partes Review of Patent [Member]</link:label>
    <link:label id="lab_lgnd_InterPartesReviewOfPatentMember_documentation_en-US" xlink:label="lab_lgnd_InterPartesReviewOfPatentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inter Partes Review of Patent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_InterPartesReviewOfPatentMember" xlink:href="lgnd-20210331.xsd#lgnd_InterPartesReviewOfPatentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_InterPartesReviewOfPatentMember" xlink:to="lab_lgnd_InterPartesReviewOfPatentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_03e31aeb-b6b6-4e4b-9310-7c6bafc585fd_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsSeries_93b4a313-afeb-4d0c-b7d3-23d15884eda1_terseLabel_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of CVR Series</link:label>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsSeries_label_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Contingent Value Rights Series</link:label>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsSeries_documentation_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Contingent Value Rights Series</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsSeries" xlink:href="lgnd-20210331.xsd#lgnd_NumberOfContingentValueRightsSeries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NumberOfContingentValueRightsSeries" xlink:to="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_bff79c38-70a5-4828-80e7-0a4e16938cf3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_24feb85d-5975-467f-94bb-d37e6c98c9c4_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_f4d58034-224f-4858-91e5-0e1b5e37ddd3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EquityMethodInvestmentSharesSold_e3791e02-1a46-4e16-b87e-f5cad97e6cbb_terseLabel_en-US" xlink:label="lab_lgnd_EquityMethodInvestmentSharesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock sold in equity method investment (shares)</link:label>
    <link:label id="lab_lgnd_EquityMethodInvestmentSharesSold_label_en-US" xlink:label="lab_lgnd_EquityMethodInvestmentSharesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Shares Sold</link:label>
    <link:label id="lab_lgnd_EquityMethodInvestmentSharesSold_documentation_en-US" xlink:label="lab_lgnd_EquityMethodInvestmentSharesSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Shares Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EquityMethodInvestmentSharesSold" xlink:href="lgnd-20210331.xsd#lgnd_EquityMethodInvestmentSharesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EquityMethodInvestmentSharesSold" xlink:to="lab_lgnd_EquityMethodInvestmentSharesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_6d893db3-aa65-47c7-96c8-fc7a3915f348_terseLabel_en-US" xlink:label="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional allowance for credit losses recorded related to COVID-19</link:label>
    <link:label id="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_label_en-US" xlink:label="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:label id="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_documentation_en-US" xlink:label="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:href="lgnd-20210331.xsd#lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:to="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_c1e86c26-703d-4971-8dc1-a5f4159dca63_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (USD per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_9737452a-d198-4493-b642-cad87d9bd57f_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_cacde5d1-e9df-45e9-9715-c3c2829f2b94_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_04672d2f-8502-4dca-82f7-dd8b1f0f9271_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_a04663e1-3928-4cce-825d-3e751d08ed3a_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_a3415c48-490d-4998-b11f-7a80d5cd1450_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_cdbca43c-e315-4c5f-be09-e7ff5612e034_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair-Value Options Awarded to Employees and Directors</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_54662dc5-55a9-43e9-82fa-36971f5b0304_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_633ab9b2-441a-4590-b732-33befc7a91a6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-combination expense</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_4a309b2e-0b23-4647-a675-2bef90f34d31_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_cac9db86-eb59-4116-abc7-f0704e303ec6_verboseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_7dce0b32-0aac-444b-ae91-1e3e61d70d65_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_ffb2a53b-001e-4d7c-8ed2-2cbba315fac4_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_324917a2-50d9-4135-83e7-78805b4f8adc_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable and payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_611f6d6d-b09e-47fa-bccb-925cf49339ee_terseLabel_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_label_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Abstract]</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_documentation_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract" xlink:href="lgnd-20210331.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract" xlink:to="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForHedgeFinancingActivities_9ab4f8f0-6581-4e66-b031-736fbfd164c9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to convertible bond holders for warrant purchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForHedgeFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Hedge, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForHedgeFinancingActivities" xlink:to="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_76b5ffd2-3210-4fdc-ac2a-df14c6be3762_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_566c7ef1-01f4-414a-80af-397c81163411_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount of the 2023 Notes outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_ea1d9574-338d-42a1-bb28-661728ef4092_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Other Observable Inputs (Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_2ba60a31-7c63-451b-bd95-d23630dbadd9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_d788fbae-d7e8-43d3-b82c-1729c76146cf_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles acquired</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_110aa2d7-feb9-4f89-bbd7-1f3d42da0fad_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_aea1ac5d-9f40-45ab-8642-56711879480e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liability, measurement input (as a percent)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_7f46570f-c124-4675-9819-fb2a002e4369_verboseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - CyDex</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Cydex [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Cydex</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:href="lgnd-20210331.xsd#lgnd_LiabilityForContingentValueRightsCompanyCydexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_RoyaltyOtherMember_a2767016-aad7-4bd9-abb6-07476e9b3f1f_terseLabel_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_lgnd_RoyaltyOtherMember_label_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Other [Member]</link:label>
    <link:label id="lab_lgnd_RoyaltyOtherMember_documentation_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember" xlink:href="lgnd-20210331.xsd#lgnd_RoyaltyOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_RoyaltyOtherMember" xlink:to="lab_lgnd_RoyaltyOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1fbc186e-2b5b-48d5-81c2-8cc7428bc63f_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_5380a862-7c76-40fa-9339-7ca25613b972_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_446457ac-d141-48b3-abae-962602d03b72_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_b4add827-f4b0-40f0-b4ad-a0cd7ca76e17_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SBC - General and administrative expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_536bc730-0f8c-4648-89b2-e15181af0ea9_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill and Other Identifiable Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_f27e2141-6794-4566-9c6b-0a815a8c66bd_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_9b697b25-25a8-412b-9816-753a631db54c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1c42e239-059e-47ba-8831-9d77e35e523c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_016e9440-6b3a-46e9-9295-8fec7183de17_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_f31a502b-bcdd-42b0-975c-7195ee162d7c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion price (USD per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_8e1b5b2d-2b0d-4853-ab63-34dc3a281545_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - Pfenex</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Pfenex [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Pfenex</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember" xlink:href="lgnd-20210331.xsd#lgnd_LiabilityForContingentValueRightsCompanyPfenexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_711e32aa-05f9-4409-bb08-3df3a60f5a4f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f452a675-f26d-47b0-a370-8de5588db4b2_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in diluted per share calculations (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_49418722-1333-40aa-ba71-229e76dddf1b_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used to compute diluted income per share (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MutualFundMember_c26e226d-ce97-4649-b163-a4281855fe20_terseLabel_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual fund</link:label>
    <link:label id="lab_us-gaap_MutualFundMember_label_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Fund [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MutualFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MutualFundMember" xlink:to="lab_us-gaap_MutualFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_8b3801f6-36dc-4b18-b6a0-fb6b3fad0394_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_33d2525f-0ae8-4ace-9081-8384ee532021_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_80a80968-cc3a-4390-b05c-783b804d0057_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income (loss) per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_d63617fa-470c-46d3-a8a5-96f4e4b5798f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_eccaf4ba-a74c-48bd-a0ce-cf0d869d7f63_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_98bf01f7-17b8-401e-8737-44217ed96b2c_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_90d46e53-3f28-460c-ab3f-1ff86578c979_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedSupplierExpensesCurrent_d9a93cff-ff47-4c77-ba21-79e9a4efc065_terseLabel_en-US" xlink:label="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier</link:label>
    <link:label id="lab_lgnd_AccruedSupplierExpensesCurrent_label_en-US" xlink:label="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Supplier Expenses, Current</link:label>
    <link:label id="lab_lgnd_AccruedSupplierExpensesCurrent_documentation_en-US" xlink:label="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Supplier Expenses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSupplierExpensesCurrent" xlink:href="lgnd-20210331.xsd#lgnd_AccruedSupplierExpensesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedSupplierExpensesCurrent" xlink:to="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_bd65de99-200d-41e2-a1b0-b3b944bd02f0_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount and issuance fees</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_5a25e4e9-734c-477a-897c-0db6f4865d5f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_fe5eb1dc-9f42-4a4f-839d-208bcbcb4c0b_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of 2023 Notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1b0b350c-039e-46dd-87de-cba7ba0a03ff_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to additional paid-in-capital from warrants</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_8cc20bdc-4861-4fd4-86d0-b062b60522e7_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7a5c8158-8f80-4eb5-a46b-a92690d54ea7_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_aaa09856-1ce6-4d95-859f-c8ba3e7a1c23_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_a4a4f0ef-e05a-4d1c-abcd-d0e0cec6e7ef_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_30e5dfa7-13dc-467f-9aba-dee0d4df735d_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value; 60,000 shares authorized; 16,652 and 16,080 shares issued and outstanding at March&#160;31, 2021 and December&#160;31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_040898c6-78b9-482b-9257-5abf0d9c8e4e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_c3dd32bd-4835-4f6c-85f7-7b97d136621a_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_20eb3ea9-aae3-4d10-b832-49b1da0256d7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_a23a49ae-be8e-4187-b52e-fe8319862bfd_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MetabasisMember_0545d430-91e1-405d-9874-d8d13bf88b2c_terseLabel_en-US" xlink:label="lab_lgnd_MetabasisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis</link:label>
    <link:label id="lab_lgnd_MetabasisMember_label_en-US" xlink:label="lab_lgnd_MetabasisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis [Member]</link:label>
    <link:label id="lab_lgnd_MetabasisMember_documentation_en-US" xlink:label="lab_lgnd_MetabasisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisMember" xlink:href="lgnd-20210331.xsd#lgnd_MetabasisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MetabasisMember" xlink:to="lab_lgnd_MetabasisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_bfca0858-fe1c-4a02-a122-c897ed48d8d1_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash in other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostDirectMaterial_62734180-6410-44a7-bdb0-d3149ad0cf05_terseLabel_en-US" xlink:label="lab_us-gaap_CostDirectMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Captisol</link:label>
    <link:label id="lab_us-gaap_CostDirectMaterial_label_en-US" xlink:label="lab_us-gaap_CostDirectMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Direct Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostDirectMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostDirectMaterial" xlink:to="lab_us-gaap_CostDirectMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_b2c0e0ae-9363-40cc-955d-94fb2424d90a_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_9e2c05e5-8416-44fb-808d-8f95b7202957_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustments to contingent liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_30816cd8-e9b6-473d-a759-7444e969b55b_terseLabel_en-US" xlink:label="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Rights for Partner Research and Development</link:label>
    <link:label id="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_label_en-US" xlink:label="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Rights for Partner Research and Development [Member]</link:label>
    <link:label id="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_documentation_en-US" xlink:label="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Rights for Partner Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:href="lgnd-20210331.xsd#lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:to="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_6e5918a3-fe37-40d0-8430-3f833ac30fc3_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total goodwill and other identifiable intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_e3d44bf3-085f-4a67-b05c-e6cf59219f24_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b545f080-b959-4151-9bd0-1ddee90310d4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock compensation plans, net (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_025d4a05-a6c5-4f30-a8d1-e16df08ac8bb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_7cb3ec4f-7397-4d80-bbf3-9f989541bee9_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_TaurusBiosciencesLLCMember_066ef56d-5f1d-4a06-94a1-4875c4a39f25_terseLabel_en-US" xlink:label="lab_lgnd_TaurusBiosciencesLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taurus</link:label>
    <link:label id="lab_lgnd_TaurusBiosciencesLLCMember_label_en-US" xlink:label="lab_lgnd_TaurusBiosciencesLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taurus Biosciences, LLC [Member]</link:label>
    <link:label id="lab_lgnd_TaurusBiosciencesLLCMember_documentation_en-US" xlink:label="lab_lgnd_TaurusBiosciencesLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taurus Biosciences, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TaurusBiosciencesLLCMember" xlink:href="lgnd-20210331.xsd#lgnd_TaurusBiosciencesLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_TaurusBiosciencesLLCMember" xlink:to="lab_lgnd_TaurusBiosciencesLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6c0a9143-1a06-4557-ae01-84653767ec35_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e298bf63-bfd7-4333-9717-200452eda862_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_20d6bc66-d7c8-4331-838d-ff9c66a78d8a_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_c34cf697-9f6a-4807-911f-256c2742d55c_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_f55b5e2f-1156-430b-838f-d68f019465b9_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_6ddeeaa2-36ad-474f-89fb-dd38991c1883_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_76d48d3f-162c-4d90-b002-60740d637667_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_28033b6a-78f6-46d8-9782-dc34439bdcb8_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_152114a4-0d58-4072-a350-2a9cdb07064e_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_32dace5a-4bba-4a31-b4ac-3f63fe5d2562_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_bad6955b-6578-4097-867d-d0d0b62f885a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred in acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_e81f7eac-a3a2-473e-a101-86719e835734_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - Metabasis</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Metabasis [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Metabasis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:href="lgnd-20210331.xsd#lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_f390a851-f6e3-47dd-9112-b650b01b7f7d_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bc71eb6b-2e9b-42ea-a74e-2290272ff5a8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_f4f4ef9e-8fc8-4875-9801-4792fc185976_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AgencySecuritiesMember_95643a18-04ca-4cd3-a949-fb5f6a9785d1_terseLabel_en-US" xlink:label="lab_us-gaap_AgencySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agency bonds</link:label>
    <link:label id="lab_us-gaap_AgencySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AgencySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agency Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AgencySecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AgencySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AgencySecuritiesMember" xlink:to="lab_us-gaap_AgencySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_760529fa-c0ea-45d1-8d97-fc86cbb5f414_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_9e5910e8-762e-47e3-8edc-1f382518fb25_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_3873007b-eb2f-417d-b620-1d1a1d4183ae_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_5db23df4-d2d1-4067-bb5e-340d18f450d1_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current and Noncurrent [Abstract]</link:label>
    <link:label id="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_label_en-US" xlink:label="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current and Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:to="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContingentValueRightOnProductRevenuesMember_1f2caeb6-42d7-496d-b3fd-4f8d4cef289c_terseLabel_en-US" xlink:label="lab_lgnd_ContingentValueRightOnProductRevenuesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Right on Product Revenues</link:label>
    <link:label id="lab_lgnd_ContingentValueRightOnProductRevenuesMember_label_en-US" xlink:label="lab_lgnd_ContingentValueRightOnProductRevenuesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Right on Product Revenues [Member]</link:label>
    <link:label id="lab_lgnd_ContingentValueRightOnProductRevenuesMember_documentation_en-US" xlink:label="lab_lgnd_ContingentValueRightOnProductRevenuesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Right on Product Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentValueRightOnProductRevenuesMember" xlink:href="lgnd-20210331.xsd#lgnd_ContingentValueRightOnProductRevenuesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContingentValueRightOnProductRevenuesMember" xlink:to="lab_lgnd_ContingentValueRightOnProductRevenuesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e3e4fc64-7749-47b2-978d-ba01f6f8210c_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_29a5e4e9-a71c-4836-84e3-11b46997cc16_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_272faebb-2614-4707-b5af-80df4fa49931_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_32618470-1db6-4c0c-85ae-fc4ef2d1aa90_terseLabel_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant and bond hedge unwind transactions</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_label_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_documentation_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:href="lgnd-20210331.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:to="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7676ecc1-6bed-4e4c-83e2-0ef2cc660a7d_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AmortizationOfOtherEconomicRights_c29e521a-998c-4144-9b22-8e02512ed99f_verboseLabel_en-US" xlink:label="lab_lgnd_AmortizationOfOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of commercial license and other economic rights</link:label>
    <link:label id="lab_lgnd_AmortizationOfOtherEconomicRights_label_en-US" xlink:label="lab_lgnd_AmortizationOfOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Other Economic Rights</link:label>
    <link:label id="lab_lgnd_AmortizationOfOtherEconomicRights_documentation_en-US" xlink:label="lab_lgnd_AmortizationOfOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Other Economic Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfOtherEconomicRights" xlink:href="lgnd-20210331.xsd#lgnd_AmortizationOfOtherEconomicRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AmortizationOfOtherEconomicRights" xlink:to="lab_lgnd_AmortizationOfOtherEconomicRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_3701678c-e8cf-4725-988e-f4a103dbe48f_totalLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_13498947-3bd5-4e53-ac10-397493158f48_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_60935186-f8a0-47df-98bd-46be4569dffc_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized net loss on available-for-sale securities, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_30f08526-10d3-48b9-b659-f6ff2a9bc4f5_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_7363b30e-5063-4c31-85cc-85e2cfc23bdd_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_5186ca74-83d6-40cb-a80c-d999f65aeafc_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_02948a1a-c11d-4f3d-87ca-bea15b60f90d_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout rights recognized</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_label_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:to="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_0f37b7fe-58f8-4188-8cad-f62d10fb17c8_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_beb9332c-2fb8-445c-b8e3-1d636233245d_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss):</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_005a80d5-2b33-4258-8c63-a730ed0e1167_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_791d38a1-921a-4855-aec7-435ab158cb7a_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_d607424f-6939-42fd-9ba6-7090ad426dee_terseLabel_en-US" xlink:label="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Investments</link:label>
    <link:label id="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term investments [Table Text Block]</link:label>
    <link:label id="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:href="lgnd-20210331.xsd#lgnd_ScheduleOfShortTermInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:to="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_3716e690-963e-45dc-9b13-e329216e3b33_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of equity component of the 2023 Notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Carrying Amount of Equity Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:to="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_a9bd0198-0074-4271-ab4f-659cc05a1276_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt premium</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_c71305a3-56e9-4684-99c8-7a7c353ebe13_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - Icagen</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Icagen [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Icagen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:href="lgnd-20210331.xsd#lgnd_LiabilityForContingentValueRightsCompanyIcagenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_02764020-09e9-4a9d-87e8-57fd6e60ff50_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade name</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_4ebbce6e-d760-4bfa-a0a7-af9e7cf1afa6_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_6c3eb7fd-730c-4277-b0a4-80520196e6f2_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DemandDepositsMember_26d76d47-ccf1-4dde-b096-0be9b83bfd50_terseLabel_en-US" xlink:label="lab_us-gaap_DemandDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank deposits</link:label>
    <link:label id="lab_us-gaap_DemandDepositsMember_label_en-US" xlink:label="lab_us-gaap_DemandDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Demand Deposits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DemandDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DemandDepositsMember" xlink:to="lab_us-gaap_DemandDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_e5466e03-c2da-4af0-9888-c60d725b8e5a_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_46f10455-cf6a-45eb-8812-6b2db5884e70_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_dacea375-f1d6-42b0-b816-c2608b027360_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for restricted investments owed to former licensees</link:label>
    <link:label id="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_label_en-US" xlink:label="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Restricted Investments Owed to Former Licensees [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Restricted Investments Owed to Former Licensees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:href="lgnd-20210331.xsd#lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:to="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_a3c1b0a4-d6a0-442e-9608-8da7eb22a9fd_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1bf49585-b5ca-440a-8172-8ce5b48c38ca_netLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding warrants to purchase shares of Viking's common stock (shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_7ee40efe-8ce8-4616-8889-4f087e659551_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants issued in public offering (shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_SelexisAndDianomiMember_e90add07-8f27-4fa1-9a76-822e67267fe7_terseLabel_en-US" xlink:label="lab_lgnd_SelexisAndDianomiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis and Dianomi</link:label>
    <link:label id="lab_lgnd_SelexisAndDianomiMember_label_en-US" xlink:label="lab_lgnd_SelexisAndDianomiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis and Dianomi [Member]</link:label>
    <link:label id="lab_lgnd_SelexisAndDianomiMember_documentation_en-US" xlink:label="lab_lgnd_SelexisAndDianomiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis and Dianomi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember" xlink:href="lgnd-20210331.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_SelexisAndDianomiMember" xlink:to="lab_lgnd_SelexisAndDianomiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c33d5197-24d1-4d93-986b-cd4e2f904498_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_cff0b363-74c9-4692-ad6b-016aee0e17a2_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of short-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_ade62644-2ea9-4df3-8fd1-a3d405c007ba_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_ed29154a-d3b2-4d1c-9828-6e0d203637b2_negatedLabel_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit loss adjustments of finite-lived intangible assets</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_label_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Credit Loss Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_documentation_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Credit Loss Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:href="lgnd-20210331.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:to="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_b8e7fbb4-b780-4779-a87c-6ccc5b43cde7_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_163e15c0-4ba9-4ffb-9ae5-b28f61f0a290_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_5ecb3f29-4a40-4683-8ecc-0e6e78ed482c_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_94b1f226-ade9-46ff-860d-e947fefc2803_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_34d940fe-88c0-40ad-82b4-6788129e2012_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_0457071a-a3ba-4cf0-b3f0-b635cdb83a21_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_ec2351ec-1866-4a66-a921-a1034b735862_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Core Technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MilestoneMember_83d17eff-1cc2-4164-bf69-9e04d63fba59_terseLabel_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone</link:label>
    <link:label id="lab_lgnd_MilestoneMember_label_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone [Member]</link:label>
    <link:label id="lab_lgnd_MilestoneMember_documentation_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember" xlink:href="lgnd-20210331.xsd#lgnd_MilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MilestoneMember" xlink:to="lab_lgnd_MilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_b588d8e4-b9a3-4e2d-83b7-20cbc72e7296_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury bill</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback_a6919a63-89d7-4532-b065-aebd1db714b2_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holdback from acquisition</link:label>
    <link:label id="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback_label_en-US" xlink:label="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Holdback</link:label>
    <link:label id="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Holdback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationConsiderationTransferredHoldback" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationConsiderationTransferredHoldback"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationConsiderationTransferredHoldback" xlink:to="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_da8113ed-7ce4-44cd-bdf0-0803a3a34652_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_af4ff322-ddf6-4034-9d63-ee550750d070_netLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_85627741-1240-4922-872c-9e6aed551515_terseLabel_en-US" xlink:label="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum threshold of debt trading price trigger (as a percent)</link:label>
    <link:label id="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_label_en-US" xlink:label="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:href="lgnd-20210331.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:to="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_4e583744-585b-4c28-aa5f-964ed0b3f5bb_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares, Restricted Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_58cb293f-e339-40b1-a12b-3d6e8e14991a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_03163b92-40ab-4fb3-9cd4-d31624e9c983_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental schedule of non-cash activity:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_50235bbf-8455-4002-ac6b-50769837c719_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_388bec36-e049-4a34-9f0e-5eda84bdb527_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_03b8dc73-1363-44e7-ba65-2bd5ae09ef41_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_0715fb13-f55f-4339-80ac-352404a44b45_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (loss), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_820fd54c-eff7-482c-95ab-b20da0918bec_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_4c26e2d3-f814-4171-bc69-e8a909162fe2_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_4434b353-2ab3-4699-91f1-9fd9d574803f_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainContingenciesTable_ffadf79d-72bc-407e-9d94-07eafd265b23_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_GainContingenciesTable_label_en-US" xlink:label="lab_us-gaap_GainContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingenciesTable" xlink:to="lab_us-gaap_GainContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_70446d02-15c5-45c3-b96b-e51172495263_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in basic per share calculations (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f697bbee-055b-4ea1-a16d-d5c162bd9961_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_8e92bf10-7606-47d0-9de0-3c1ecdb7a7c9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_3879ee34-8db3-444b-8e56-819ae22dfb35_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash to settle unvested stock options recognized as share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cash Used to Settle Award</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_37c941ed-aec2-4ed8-b290-a6f27699442f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of positions in an unrealized loss position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_04b2abf7-8d72-4f9a-9ad7-61f7fd02553c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_d8be59dc-e01b-4357-8cfd-a29365b8cebb_terseLabel_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Convertible Senior Notes</link:label>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_label_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes due 2023 [Member]</link:label>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_documentation_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes due 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:href="lgnd-20210331.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:to="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanMember_f2d214d9-f5c6-46ae-85fd-ad9278b3d0d3_terseLabel_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EmployeeStockPurchasePlanMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanMember" xlink:href="lgnd-20210331.xsd#lgnd_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EmployeeStockPurchasePlanMember" xlink:to="lab_lgnd_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_cb94a79b-e00f-465b-aed7-d86bf2cb00bc_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_7c03737b-42d3-428a-9b0c-43c4a3ffc70c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_581ac5c5-ea5f-49d7-aff9-23bc9ae599ba_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_30ec6c9d-44d2-43d1-b009-d33e6d1fbc83_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:to="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermNotesPayable_72960c78-155b-47f5-a8c2-e1cf2775c01c_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term portion of notes payable</link:label>
    <link:label id="lab_us-gaap_LongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermNotesPayable" xlink:to="lab_us-gaap_LongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_f290617d-1221-45eb-9432-814df34651be_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContractRevenueServiceMember_ad3c3e52-54f3-4407-b455-83cbfeff3bd1_terseLabel_en-US" xlink:label="lab_lgnd_ContractRevenueServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Revenue</link:label>
    <link:label id="lab_lgnd_ContractRevenueServiceMember_label_en-US" xlink:label="lab_lgnd_ContractRevenueServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue, Service [Member]</link:label>
    <link:label id="lab_lgnd_ContractRevenueServiceMember_documentation_en-US" xlink:label="lab_lgnd_ContractRevenueServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue, Service</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueServiceMember" xlink:href="lgnd-20210331.xsd#lgnd_ContractRevenueServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContractRevenueServiceMember" xlink:to="lab_lgnd_ContractRevenueServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_9635dc47-e60b-4e52-8b88-f36da7ab9d7f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_df338d11-3bce-454f-9e21-d5edba3ac100_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Stock Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3620d4ae-ddca-475a-8329-df53562f1dbd_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a374329e-40a1-44ad-bc89-4236ca8c990e_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_c119cf76-212f-4349-b749-96b5ba8aa270_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_5dc9480e-740a-440c-b081-4da7b510e397_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized gain on sale of stock in equity method investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Realized Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_2cd5d3fb-85be-44ab-a7b1-86c90aeedc87_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, fair value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_eaaea6be-ccbb-4bb3-890b-bf80a4d8cc15_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_110b25f2-6dab-4033-8a11-13c2324618fe_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_1e32d2e9-5f6c-48c3-b9aa-740071173694_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_a2ce49a4-d80d-4265-ba01-25ac3275de74_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income (loss) per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_906c151c-a0b2-439b-b535-071c169f3bcb_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_5d2fb4b8-b8f6-4300-8265-3448e81a2a91_negatedLabel_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) from short-term investments</link:label>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_label_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Short-term Investments</link:label>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_documentation_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments" xlink:href="lgnd-20210331.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_GainLossOnShortTermInvestments" xlink:to="lab_lgnd_GainLossOnShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_0fab809a-2e65-4af6-883f-e3941fab6a58_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_5ad8de46-2070-434e-9645-df474579965d_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments for acquisition</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_e0c549bc-965f-44b9-bc48-72eb341bcb0b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pro Forma Information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AziyoAndCorMatrixMember_84c2b77c-3f9f-4ff0-8a49-d9b68a02bf14_terseLabel_en-US" xlink:label="lab_lgnd_AziyoAndCorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo and CorMatrix</link:label>
    <link:label id="lab_lgnd_AziyoAndCorMatrixMember_label_en-US" xlink:label="lab_lgnd_AziyoAndCorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo and CorMatrix [Member]</link:label>
    <link:label id="lab_lgnd_AziyoAndCorMatrixMember_documentation_en-US" xlink:label="lab_lgnd_AziyoAndCorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo and CorMatrix</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoAndCorMatrixMember" xlink:href="lgnd-20210331.xsd#lgnd_AziyoAndCorMatrixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AziyoAndCorMatrixMember" xlink:to="lab_lgnd_AziyoAndCorMatrixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_eb4a42fc-7e31-4351-8c59-3ec4c145b8d5_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentedTechnologyMember_9014b641-b8e4-4c2a-b60b-e117461df507_verboseLabel_en-US" xlink:label="lab_us-gaap_PatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complete technology</link:label>
    <link:label id="lab_us-gaap_PatentedTechnologyMember_label_en-US" xlink:label="lab_us-gaap_PatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patented Technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentedTechnologyMember" xlink:to="lab_us-gaap_PatentedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_07e5c1cf-1ff4-40f1-b1a3-f3530d0e7803_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_227b2bd3-8e19-41b3-a0ea-2745eb84746d_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Coupon Rates on Financing Arrangements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_7b139411-9f4b-4447-bcac-41e67c5ea525_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Level 3 Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_c0b5dd87-2d9a-4fd2-8fed-93db24c39c79_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_95c6e224-151c-4e43-bce7-74f0f24bc1eb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_5e240c8d-dec3-4dd4-ba1b-0efdc6c2b91a_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_d2d346ba-6002-4077-8d82-5bef11fc0e89_terseLabel_en-US" xlink:label="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross payments to acquire business attributable to vested portion of stock options</link:label>
    <link:label id="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_label_en-US" xlink:label="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross, Attributable to Vested Portion of Stock Options</link:label>
    <link:label id="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_documentation_en-US" xlink:label="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross, Attributable to Vested Portion of Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" xlink:href="lgnd-20210331.xsd#lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" xlink:to="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_53e916a7-c28c-4f57-80d4-d63380f8289a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consecutive trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_1c78b437-580a-4a86-8df4-47797cc5fd30_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_997c7e45-db0e-4a5c-8ce0-6388cd11f4f8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_98da2609-bd7c-4edb-8da7-1f3cdc748dfe_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_IcagenMember_08f864bf-e6d7-46a6-8473-13167c9dc891_terseLabel_en-US" xlink:label="lab_lgnd_IcagenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Icagen</link:label>
    <link:label id="lab_lgnd_IcagenMember_label_en-US" xlink:label="lab_lgnd_IcagenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Icagen [Member]</link:label>
    <link:label id="lab_lgnd_IcagenMember_documentation_en-US" xlink:label="lab_lgnd_IcagenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Icagen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IcagenMember" xlink:href="lgnd-20210331.xsd#lgnd_IcagenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_IcagenMember" xlink:to="lab_lgnd_IcagenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_709f3276-2d3c-4bc9-b274-91a4e34393f9_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d9ffa0cf-49a5-4138-bc33-cbc3904126ef_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_dc53b83e-58b1-42f8-9937-269203251eef_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_aec93974-3b3d-465d-b1c5-5bff97c494e7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization on finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_bc91f4b2-00cf-4a17-a515-ce744bd1d6ae_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_896a0d9b-3c75-4a23-af8e-eae6a7cee63c_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs and expenses</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpenses" xlink:to="lab_us-gaap_OperatingCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_dea68dc5-23a5-4658-b452-938929b501d5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_c4e38837-dcc3-483e-9494-a4bbb2f641c1_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock authorized (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_b0e6446e-e32c-41c5-8cd2-b51b3729ce8b_verboseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) from short-term investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_3f21863a-860f-4550-a198-4ba483add2df_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of short-term investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_abd15d8d-250a-4530-b823-5487b416b61a_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings (Accumulated deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_c1f35133-1169-4815-b3b4-f09efb930e64_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_00f881bf-613d-416c-b663-f2a0e9618c0e_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of civil complaints filed against entity</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_054c30b9-decc-453f-bd6c-1a8525bfa71b_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8686aa4c-55e3-4895-93d6-145faecbfa09_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_ab11bc7e-4d5c-4ca0-8883-0fea59d3cae5_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_85c60d27-baf5-4a65-ab87-8d060f8ddeee_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f3e6d7af-f091-4c77-90d8-184966847d13_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_678bc431-94cd-4713-b634-b3acdbec4f66_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_f4b7b4db-7ae1-4840-a528-c5ae315500e8_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_4f5d6007-baaa-4e90-97d3-65f812767327_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_e1681740-36d1-453f-8bd4-117378b57c3e_terseLabel_en-US" xlink:label="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities from xCella asset acquisition</link:label>
    <link:label id="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_label_en-US" xlink:label="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition</link:label>
    <link:label id="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_documentation_en-US" xlink:label="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:href="lgnd-20210331.xsd#lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:to="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_be7a43d4-2f85-44fb-9603-48fb82d99dcc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding options that are exercisable, weighted average exercise price (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_66b4dc44-97a8-4637-9bcc-967ba0739dbe_terseLabel_en-US" xlink:label="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US District Court for the Northern District of Ohio</link:label>
    <link:label id="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_label_en-US" xlink:label="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US District Court for the Northern District of Ohio [Member]</link:label>
    <link:label id="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_documentation_en-US" xlink:label="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US District Court for the Northern District of Ohio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:href="lgnd-20210331.xsd#lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:to="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_8847fd65-ebff-4905-9080-c6f5f2d6c31b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchased amount of debt instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_991b398d-70ea-47f8-98d2-59f679422561_negatedTerseLabel_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_label_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_documentation_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:href="lgnd-20210331.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:to="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_3c4f477a-9b2f-41bd-86f2-a0cad79cc6bd_totalLabel_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_label_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available for Sale and Equity Securities, FV-NI</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_documentation_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available for Sale and Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:href="lgnd-20210331.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:to="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_4b6ec985-d44d-41fd-84d9-c2e914fb756a_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest_76523051-11a6-4ec6-bb2a-77fad48b4913_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Increase, Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_9a334fde-c0fc-4c6e-ae41-1b1687a71217_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_e7fe5da8-88e1-40cf-9a5e-6e72b7884a19_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_584ee666-f862-4f71-806a-438b67b7be0b_negatedTerseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Lease Liabilities</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_483b0fa7-b96f-4ab9-8d8f-c179124e256d_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Recently Adopted and Accounting Standards Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_f9cb7258-d971-4fbd-a658-89875928323b_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_7df40ec4-0181-4eda-b17f-b7579a8a8cb5_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>lgnd-20210331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:f42e6ea9-4959-4941-8454-5f1ec5bc67fa,g:c4690a82-fe68-4d49-b4c9-c600693120e1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ligand.com/role/CoverPage" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ba4222d2-5fe8-4965-8549-a5a2e2d0b4da" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_DocumentType_ba4222d2-5fe8-4965-8549-a5a2e2d0b4da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_cf5d9b0c-eaee-469e-9ac8-1ae6479d3579" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_DocumentQuarterlyReport_cf5d9b0c-eaee-469e-9ac8-1ae6479d3579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_55d250b4-3931-4d8f-9131-004cd1c8e154" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_DocumentPeriodEndDate_55d250b4-3931-4d8f-9131-004cd1c8e154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_447f543e-5bb2-4b5d-bec1-7856fae1cd18" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_DocumentTransitionReport_447f543e-5bb2-4b5d-bec1-7856fae1cd18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_cd18bd9d-29a5-44ab-bc45-77d58a1c7c24" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_EntityFileNumber_cd18bd9d-29a5-44ab-bc45-77d58a1c7c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e7433951-e278-41d4-ba1b-f21481f7ab31" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_EntityRegistrantName_e7433951-e278-41d4-ba1b-f21481f7ab31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_9880055c-d771-4967-bc1d-90b2b24ac422" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_EntityIncorporationStateCountryCode_9880055c-d771-4967-bc1d-90b2b24ac422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_52a0fd95-cf70-49ab-8203-686fd9c1786a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_EntityTaxIdentificationNumber_52a0fd95-cf70-49ab-8203-686fd9c1786a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_8b9ab989-39d0-4b76-97ef-a50c0daf2211" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_EntityAddressAddressLine1_8b9ab989-39d0-4b76-97ef-a50c0daf2211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_9f5ca9f6-7c94-4d4b-8af2-f49a43c6e29f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_EntityAddressCityOrTown_9f5ca9f6-7c94-4d4b-8af2-f49a43c6e29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_8ae2aaac-dc70-4f8e-8e50-6ddb06de2bc3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_EntityAddressStateOrProvince_8ae2aaac-dc70-4f8e-8e50-6ddb06de2bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_dc9e7961-3fa8-46ab-9ebf-2c723a3d13a0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_EntityAddressPostalZipCode_dc9e7961-3fa8-46ab-9ebf-2c723a3d13a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f9d8b9fd-d4c4-46fb-8150-26289c9d8d0d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_CityAreaCode_f9d8b9fd-d4c4-46fb-8150-26289c9d8d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_055c8fd6-20b9-458c-95d3-cb04f50fc3b5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_LocalPhoneNumber_055c8fd6-20b9-458c-95d3-cb04f50fc3b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_1848791d-c857-4594-ba68-af9099dcc021" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_Security12bTitle_1848791d-c857-4594-ba68-af9099dcc021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_2cb89fba-8703-4db6-b52a-c98ab2709d53" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_TradingSymbol_2cb89fba-8703-4db6-b52a-c98ab2709d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_79a699d0-197e-4e1e-af83-42a5f69186aa" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_SecurityExchangeName_79a699d0-197e-4e1e-af83-42a5f69186aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_b977c03d-7f28-427c-904a-6214ad10c26e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_EntityCurrentReportingStatus_b977c03d-7f28-427c-904a-6214ad10c26e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_3ec170a9-edcd-4654-a807-d2bad1e1ae33" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_EntityInteractiveDataCurrent_3ec170a9-edcd-4654-a807-d2bad1e1ae33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_586e5a8a-a5f4-4005-a6d1-fea38be6dca4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_EntityFilerCategory_586e5a8a-a5f4-4005-a6d1-fea38be6dca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_85a9c6df-9f0c-4029-9c87-77c69ff7423e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_EntitySmallBusiness_85a9c6df-9f0c-4029-9c87-77c69ff7423e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_74c6107b-0252-4185-a629-39f49dea0287" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_EntityEmergingGrowthCompany_74c6107b-0252-4185-a629-39f49dea0287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_c9e712c0-d6fd-40f3-af5b-d305bef830e4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_EntityShellCompany_c9e712c0-d6fd-40f3-af5b-d305bef830e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_27957226-f460-4299-bdd2-a0a955150771" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_27957226-f460-4299-bdd2-a0a955150771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_245fa4a7-1d84-4d90-ab2f-a244bf27b2aa" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_AmendmentFlag_245fa4a7-1d84-4d90-ab2f-a244bf27b2aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_1db99215-f7eb-43bf-9fd2-8589eadf0e7d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_DocumentFiscalYearFocus_1db99215-f7eb-43bf-9fd2-8589eadf0e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_7ac9cc6f-da4f-4445-9a7d-9200d081d688" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_DocumentFiscalPeriodFocus_7ac9cc6f-da4f-4445-9a7d-9200d081d688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_f144300b-019f-4e0e-96af-11799155d459" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_EntityCentralIndexKey_f144300b-019f-4e0e-96af-11799155d459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_44a35fc0-bd7d-4138-9af2-17c0f301c7eb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_813408e7-2b77-497a-ad17-fccf4203f0aa" xlink:to="loc_dei_CurrentFiscalYearEndDate_44a35fc0-bd7d-4138-9af2-17c0f301c7eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_b7878a66-e3ae-436f-8748-c3e4f8e7cb7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_cad5b055-bb2c-4975-a7ab-95a976569bd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b7878a66-e3ae-436f-8748-c3e4f8e7cb7b" xlink:to="loc_us-gaap_AssetsAbstract_cad5b055-bb2c-4975-a7ab-95a976569bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_d230ec3d-d4f6-4993-be19-33a2f2d7489a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cad5b055-bb2c-4975-a7ab-95a976569bd1" xlink:to="loc_us-gaap_AssetsCurrentAbstract_d230ec3d-d4f6-4993-be19-33a2f2d7489a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7a807f7b-0c3d-47c8-b73a-1fb9c9b2ee29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d230ec3d-d4f6-4993-be19-33a2f2d7489a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7a807f7b-0c3d-47c8-b73a-1fb9c9b2ee29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_eee53446-e525-45ff-b27d-ac13f5a895c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d230ec3d-d4f6-4993-be19-33a2f2d7489a" xlink:to="loc_us-gaap_ShortTermInvestments_eee53446-e525-45ff-b27d-ac13f5a895c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_147bc937-0638-422b-ada7-42e2dcf3c60f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d230ec3d-d4f6-4993-be19-33a2f2d7489a" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_147bc937-0638-422b-ada7-42e2dcf3c60f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_259238ad-758c-46e8-b8e4-2f0aaf02a379" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d230ec3d-d4f6-4993-be19-33a2f2d7489a" xlink:to="loc_us-gaap_InventoryNet_259238ad-758c-46e8-b8e4-2f0aaf02a379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_d95238ca-370d-465a-9e01-17f8b1107b0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d230ec3d-d4f6-4993-be19-33a2f2d7489a" xlink:to="loc_us-gaap_IncomeTaxesReceivable_d95238ca-370d-465a-9e01-17f8b1107b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_be6f1af2-5ded-40a0-827b-e6dd8faeefae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d230ec3d-d4f6-4993-be19-33a2f2d7489a" xlink:to="loc_us-gaap_OtherAssetsCurrent_be6f1af2-5ded-40a0-827b-e6dd8faeefae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0446344e-2130-4795-82c0-96756643dc46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d230ec3d-d4f6-4993-be19-33a2f2d7489a" xlink:to="loc_us-gaap_AssetsCurrent_0446344e-2130-4795-82c0-96756643dc46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_ddc2e25a-4620-4172-b7d8-52edb82e6a38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cad5b055-bb2c-4975-a7ab-95a976569bd1" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_ddc2e25a-4620-4172-b7d8-52edb82e6a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1e6b2f7f-5e3f-41dd-b630-6bd76f6ea305" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cad5b055-bb2c-4975-a7ab-95a976569bd1" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1e6b2f7f-5e3f-41dd-b630-6bd76f6ea305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a7c3fd90-31d3-4614-a24c-53828d552bed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cad5b055-bb2c-4975-a7ab-95a976569bd1" xlink:to="loc_us-gaap_Goodwill_a7c3fd90-31d3-4614-a24c-53828d552bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights_0c3ce82c-7f71-4318-b082-2c7ff6af28f1" xlink:href="lgnd-20210331.xsd#lgnd_CommercialLicenseRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cad5b055-bb2c-4975-a7ab-95a976569bd1" xlink:to="loc_lgnd_CommercialLicenseRights_0c3ce82c-7f71-4318-b082-2c7ff6af28f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8eec7c9a-37df-4b9c-bfb6-0ff61464a3ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cad5b055-bb2c-4975-a7ab-95a976569bd1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8eec7c9a-37df-4b9c-bfb6-0ff61464a3ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_740f581a-8fda-47b1-8e51-1a749d130330" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cad5b055-bb2c-4975-a7ab-95a976569bd1" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_740f581a-8fda-47b1-8e51-1a749d130330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_1fe2edc7-673e-4550-9dc2-04117b5be5a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cad5b055-bb2c-4975-a7ab-95a976569bd1" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_1fe2edc7-673e-4550-9dc2-04117b5be5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_bec8b198-c2c7-42fe-b674-0234ffcbaf2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cad5b055-bb2c-4975-a7ab-95a976569bd1" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_bec8b198-c2c7-42fe-b674-0234ffcbaf2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d4f94fd0-39d8-4e97-8c78-0140454ed5f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cad5b055-bb2c-4975-a7ab-95a976569bd1" xlink:to="loc_us-gaap_Assets_d4f94fd0-39d8-4e97-8c78-0140454ed5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2f149463-7852-4a5b-bab6-4c0c0fcb1394" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b7878a66-e3ae-436f-8748-c3e4f8e7cb7b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2f149463-7852-4a5b-bab6-4c0c0fcb1394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_44598421-2d32-4bf1-a36d-9985582664d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2f149463-7852-4a5b-bab6-4c0c0fcb1394" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_44598421-2d32-4bf1-a36d-9985582664d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_f635068d-931e-4eb6-b876-04fd54109924" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44598421-2d32-4bf1-a36d-9985582664d7" xlink:to="loc_us-gaap_AccountsPayableCurrent_f635068d-931e-4eb6-b876-04fd54109924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_c1d5e752-1844-460f-aaf3-60d10fcdd8d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44598421-2d32-4bf1-a36d-9985582664d7" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_c1d5e752-1844-460f-aaf3-60d10fcdd8d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_9bed2aa4-2997-4fb9-8ac3-eceb008d0832" xlink:href="lgnd-20210331.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44598421-2d32-4bf1-a36d-9985582664d7" xlink:to="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_9bed2aa4-2997-4fb9-8ac3-eceb008d0832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_421566da-b23d-4587-aec2-d44493604fa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44598421-2d32-4bf1-a36d-9985582664d7" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_421566da-b23d-4587-aec2-d44493604fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_1e842b7c-d087-49f9-a7eb-b668d31e2618" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44598421-2d32-4bf1-a36d-9985582664d7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_1e842b7c-d087-49f9-a7eb-b668d31e2618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_83b47f0d-4643-42f3-aa87-aca06a15cd4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44598421-2d32-4bf1-a36d-9985582664d7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_83b47f0d-4643-42f3-aa87-aca06a15cd4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d649a38b-3677-4e73-9ab8-1070742e6bae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44598421-2d32-4bf1-a36d-9985582664d7" xlink:to="loc_us-gaap_LiabilitiesCurrent_d649a38b-3677-4e73-9ab8-1070742e6bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_d6ad5c0d-8445-470c-aa85-483df29581dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2f149463-7852-4a5b-bab6-4c0c0fcb1394" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_d6ad5c0d-8445-470c-aa85-483df29581dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights_80c74603-2ef3-4c07-8868-2619414c6b75" xlink:href="lgnd-20210331.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2f149463-7852-4a5b-bab6-4c0c0fcb1394" xlink:to="loc_lgnd_LiabilityForContingentValueRights_80c74603-2ef3-4c07-8868-2619414c6b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4e465f1e-ca50-4c8d-9dfa-2d72ff45566d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2f149463-7852-4a5b-bab6-4c0c0fcb1394" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4e465f1e-ca50-4c8d-9dfa-2d72ff45566d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3ed7f17f-1933-4613-8d3e-ee0b9351c3ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2f149463-7852-4a5b-bab6-4c0c0fcb1394" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3ed7f17f-1933-4613-8d3e-ee0b9351c3ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_b4c9275b-9754-4af0-9dce-4e689dc8012d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2f149463-7852-4a5b-bab6-4c0c0fcb1394" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_b4c9275b-9754-4af0-9dce-4e689dc8012d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_03e09f9b-35c8-4513-a4e6-230a5dc52f21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2f149463-7852-4a5b-bab6-4c0c0fcb1394" xlink:to="loc_us-gaap_Liabilities_03e09f9b-35c8-4513-a4e6-230a5dc52f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_44862eb0-3f70-4e0a-aa23-8f0c098a7940" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2f149463-7852-4a5b-bab6-4c0c0fcb1394" xlink:to="loc_us-gaap_CommitmentsAndContingencies_44862eb0-3f70-4e0a-aa23-8f0c098a7940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_94438424-785e-4e5e-b435-60658af0370f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2f149463-7852-4a5b-bab6-4c0c0fcb1394" xlink:to="loc_us-gaap_StockholdersEquityAbstract_94438424-785e-4e5e-b435-60658af0370f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_7fae0dc2-ab88-49e3-b335-3d7db15bd290" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_94438424-785e-4e5e-b435-60658af0370f" xlink:to="loc_us-gaap_PreferredStockValue_7fae0dc2-ab88-49e3-b335-3d7db15bd290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_dd196895-f63c-43cd-bed6-c6444dc19df0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_94438424-785e-4e5e-b435-60658af0370f" xlink:to="loc_us-gaap_CommonStockValue_dd196895-f63c-43cd-bed6-c6444dc19df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_ea0ccadf-a379-402d-8a96-28b64a446c42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_94438424-785e-4e5e-b435-60658af0370f" xlink:to="loc_us-gaap_AdditionalPaidInCapital_ea0ccadf-a379-402d-8a96-28b64a446c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c76c1c62-1b7a-4fa5-96b8-78e51fc21b2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_94438424-785e-4e5e-b435-60658af0370f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c76c1c62-1b7a-4fa5-96b8-78e51fc21b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d6bbc9fb-4d9d-45fd-a9e7-97778c66b868" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_94438424-785e-4e5e-b435-60658af0370f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d6bbc9fb-4d9d-45fd-a9e7-97778c66b868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f20be84e-5600-46dd-9362-9202a9355bea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_94438424-785e-4e5e-b435-60658af0370f" xlink:to="loc_us-gaap_StockholdersEquity_f20be84e-5600-46dd-9362-9202a9355bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_be03d459-6886-47d2-a092-d3bcd1fdb7b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2f149463-7852-4a5b-bab6-4c0c0fcb1394" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_be03d459-6886-47d2-a092-d3bcd1fdb7b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_64007719-ac7f-401a-b8de-8505d84a209f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_88f05bf9-59fc-4a30-b43d-c00d561aa205" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64007719-ac7f-401a-b8de-8505d84a209f" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_88f05bf9-59fc-4a30-b43d-c00d561aa205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_026ab092-b7ee-40e3-ab19-d42599f87813" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64007719-ac7f-401a-b8de-8505d84a209f" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_026ab092-b7ee-40e3-ab19-d42599f87813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_030e61c2-30c2-477d-9eed-b0c1d60d4b3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64007719-ac7f-401a-b8de-8505d84a209f" xlink:to="loc_us-gaap_PreferredStockSharesIssued_030e61c2-30c2-477d-9eed-b0c1d60d4b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_6fc98e2a-2b2d-4248-9b6f-c525293f7965" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64007719-ac7f-401a-b8de-8505d84a209f" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_6fc98e2a-2b2d-4248-9b6f-c525293f7965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_aa1f81a5-57c3-4822-86b3-17e6a826e24a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64007719-ac7f-401a-b8de-8505d84a209f" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_aa1f81a5-57c3-4822-86b3-17e6a826e24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_acaf37f2-a284-4616-a852-d79521864dc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64007719-ac7f-401a-b8de-8505d84a209f" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_acaf37f2-a284-4616-a852-d79521864dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_44170624-9d7e-4ba9-8248-cbe407151c67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64007719-ac7f-401a-b8de-8505d84a209f" xlink:to="loc_us-gaap_CommonStockSharesIssued_44170624-9d7e-4ba9-8248-cbe407151c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_35f0e0ba-e78b-4962-b706-4ebae03d5652" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64007719-ac7f-401a-b8de-8505d84a209f" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_35f0e0ba-e78b-4962-b706-4ebae03d5652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_7bbbaa95-8f29-4c88-9975-6e616a3c624f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8703230e-39d3-47dc-9e3d-392f3673375c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7bbbaa95-8f29-4c88-9975-6e616a3c624f" xlink:to="loc_us-gaap_StatementTable_8703230e-39d3-47dc-9e3d-392f3673375c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_cd517fe6-ac1d-4e3a-ac41-f5ba4e96693e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8703230e-39d3-47dc-9e3d-392f3673375c" xlink:to="loc_srt_ProductOrServiceAxis_cd517fe6-ac1d-4e3a-ac41-f5ba4e96693e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bcfe410e-ff87-4d58-9271-f58d657bd37f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_cd517fe6-ac1d-4e3a-ac41-f5ba4e96693e" xlink:to="loc_srt_ProductsAndServicesDomain_bcfe410e-ff87-4d58-9271-f58d657bd37f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_7dbaf350-a912-45d6-ac8b-004a011dc326" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_bcfe410e-ff87-4d58-9271-f58d657bd37f" xlink:to="loc_us-gaap_RoyaltyMember_7dbaf350-a912-45d6-ac8b-004a011dc326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_070a5975-5c39-4552-a3a6-4823637161c2" xlink:href="lgnd-20210331.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_bcfe410e-ff87-4d58-9271-f58d657bd37f" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_070a5975-5c39-4552-a3a6-4823637161c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_e362f881-ca0e-4661-9465-f0d4abc89c18" xlink:href="lgnd-20210331.xsd#lgnd_ContractRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_bcfe410e-ff87-4d58-9271-f58d657bd37f" xlink:to="loc_lgnd_ContractRevenueMember_e362f881-ca0e-4661-9465-f0d4abc89c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e5d0bb7c-aa9d-462c-a629-d2c65fcf7372" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8703230e-39d3-47dc-9e3d-392f3673375c" xlink:to="loc_us-gaap_StatementLineItems_e5d0bb7c-aa9d-462c-a629-d2c65fcf7372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_85a7e92f-0efc-4fba-b38a-7e5348e594e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e5d0bb7c-aa9d-462c-a629-d2c65fcf7372" xlink:to="loc_us-gaap_RevenuesAbstract_85a7e92f-0efc-4fba-b38a-7e5348e594e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_b54e0520-7260-4bdc-8db4-fd8d2c7ecb65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_85a7e92f-0efc-4fba-b38a-7e5348e594e7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_b54e0520-7260-4bdc-8db4-fd8d2c7ecb65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_e4faa0e4-dc15-4bf0-8f10-cda530cecfe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e5d0bb7c-aa9d-462c-a629-d2c65fcf7372" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_e4faa0e4-dc15-4bf0-8f10-cda530cecfe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_d0de397a-3085-4e3f-bb6b-0e5353dbb198" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostDirectMaterial"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_e4faa0e4-dc15-4bf0-8f10-cda530cecfe9" xlink:to="loc_us-gaap_CostDirectMaterial_d0de397a-3085-4e3f-bb6b-0e5353dbb198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_2defa715-809c-4d0a-b652-3ecf75424abe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_e4faa0e4-dc15-4bf0-8f10-cda530cecfe9" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_2defa715-809c-4d0a-b652-3ecf75424abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_295719fe-b0f9-4218-9f04-4b82296ef986" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_e4faa0e4-dc15-4bf0-8f10-cda530cecfe9" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_295719fe-b0f9-4218-9f04-4b82296ef986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_081898b1-01b1-4619-8b7d-c359f9c40daf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_e4faa0e4-dc15-4bf0-8f10-cda530cecfe9" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_081898b1-01b1-4619-8b7d-c359f9c40daf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_a1277a27-d53f-47f5-bee2-d8e678fabe18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_e4faa0e4-dc15-4bf0-8f10-cda530cecfe9" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_a1277a27-d53f-47f5-bee2-d8e678fabe18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_915f7255-9700-46f0-809c-b7e7e8fbe6b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e5d0bb7c-aa9d-462c-a629-d2c65fcf7372" xlink:to="loc_us-gaap_OperatingIncomeLoss_915f7255-9700-46f0-809c-b7e7e8fbe6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6573fafe-d994-4920-bcbe-4cddccda5b7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e5d0bb7c-aa9d-462c-a629-d2c65fcf7372" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6573fafe-d994-4920-bcbe-4cddccda5b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_f2b387b9-eb0d-4eec-9c4a-afd6e6e4346a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6573fafe-d994-4920-bcbe-4cddccda5b7c" xlink:to="loc_us-gaap_GainLossOnInvestments_f2b387b9-eb0d-4eec-9c4a-afd6e6e4346a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_0779a7a2-3a3b-431c-8bbd-ece312e79dcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6573fafe-d994-4920-bcbe-4cddccda5b7c" xlink:to="loc_us-gaap_InvestmentIncomeInterest_0779a7a2-3a3b-431c-8bbd-ece312e79dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_2e96afb7-4faa-4d20-92ec-04b0a9bd872e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6573fafe-d994-4920-bcbe-4cddccda5b7c" xlink:to="loc_us-gaap_InterestExpense_2e96afb7-4faa-4d20-92ec-04b0a9bd872e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_28339df3-ea52-491d-9007-a8b6f072dc43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6573fafe-d994-4920-bcbe-4cddccda5b7c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_28339df3-ea52-491d-9007-a8b6f072dc43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_5a42a1d3-4a2a-47ae-bec1-26ee4da3e99e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6573fafe-d994-4920-bcbe-4cddccda5b7c" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_5a42a1d3-4a2a-47ae-bec1-26ee4da3e99e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d05c1326-29bb-4b67-8504-e5df96379e30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e5d0bb7c-aa9d-462c-a629-d2c65fcf7372" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d05c1326-29bb-4b67-8504-e5df96379e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c1ad0160-4374-4b72-925c-9cb4864f1e99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e5d0bb7c-aa9d-462c-a629-d2c65fcf7372" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c1ad0160-4374-4b72-925c-9cb4864f1e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_80108290-f906-4831-9286-2d4e2162b938" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e5d0bb7c-aa9d-462c-a629-d2c65fcf7372" xlink:to="loc_us-gaap_NetIncomeLoss_80108290-f906-4831-9286-2d4e2162b938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_15a1d192-e57a-4007-83d2-36a5a62173be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e5d0bb7c-aa9d-462c-a629-d2c65fcf7372" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_15a1d192-e57a-4007-83d2-36a5a62173be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_3f9ab4c5-3107-407d-9115-c614c723dc27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_15a1d192-e57a-4007-83d2-36a5a62173be" xlink:to="loc_us-gaap_EarningsPerShareBasic_3f9ab4c5-3107-407d-9115-c614c723dc27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bfa9058b-84a1-4764-ad7f-e1711cb63817" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_15a1d192-e57a-4007-83d2-36a5a62173be" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bfa9058b-84a1-4764-ad7f-e1711cb63817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a58593d2-80f7-40b4-95f0-fbc632e0b297" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_15a1d192-e57a-4007-83d2-36a5a62173be" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a58593d2-80f7-40b4-95f0-fbc632e0b297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_049f621a-deb9-475c-b3ca-842ddda6baba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_15a1d192-e57a-4007-83d2-36a5a62173be" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_049f621a-deb9-475c-b3ca-842ddda6baba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9a5abe31-e644-41d7-a371-07a06467cecd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a8fcfbd3-3ede-49c6-a2ab-83100e8b04ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9a5abe31-e644-41d7-a371-07a06467cecd" xlink:to="loc_us-gaap_NetIncomeLoss_a8fcfbd3-3ede-49c6-a2ab-83100e8b04ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2664317e-0757-4751-b214-22a4e4b971eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9a5abe31-e644-41d7-a371-07a06467cecd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2664317e-0757-4751-b214-22a4e4b971eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_42898e00-e686-4185-a378-dfec9ac7347b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9a5abe31-e644-41d7-a371-07a06467cecd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_42898e00-e686-4185-a378-dfec9ac7347b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_bd6c1217-0a0e-4ee2-8e66-602f0b322e61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9a5abe31-e644-41d7-a371-07a06467cecd" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_bd6c1217-0a0e-4ee2-8e66-602f0b322e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CondensedConsolidatedStatementsofStockholdersEquityUnaudited"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_0c9875cc-b20c-4feb-b330-6f6ae16e232e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ea4056ee-a479-48d1-b2ef-5c835cf7ee87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_0c9875cc-b20c-4feb-b330-6f6ae16e232e" xlink:to="loc_us-gaap_StatementTable_ea4056ee-a479-48d1-b2ef-5c835cf7ee87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8c0a138f-8a68-43ba-89af-8d96381c569a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ea4056ee-a479-48d1-b2ef-5c835cf7ee87" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8c0a138f-8a68-43ba-89af-8d96381c569a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3034bacc-8a7a-416c-acaa-a02a38610383" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8c0a138f-8a68-43ba-89af-8d96381c569a" xlink:to="loc_us-gaap_EquityComponentDomain_3034bacc-8a7a-416c-acaa-a02a38610383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2354780c-40bd-41e5-9d6c-4153a72f48f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3034bacc-8a7a-416c-acaa-a02a38610383" xlink:to="loc_us-gaap_CommonStockMember_2354780c-40bd-41e5-9d6c-4153a72f48f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_556159a0-1cc1-4281-8e33-9943d4e1cf5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3034bacc-8a7a-416c-acaa-a02a38610383" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_556159a0-1cc1-4281-8e33-9943d4e1cf5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_665f65d4-170b-49c8-a29a-0c4fbe39f589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3034bacc-8a7a-416c-acaa-a02a38610383" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_665f65d4-170b-49c8-a29a-0c4fbe39f589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_440ccf56-1a4c-419b-85d6-777a6e840845" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3034bacc-8a7a-416c-acaa-a02a38610383" xlink:to="loc_us-gaap_RetainedEarningsMember_440ccf56-1a4c-419b-85d6-777a6e840845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f0d91692-2c0c-48a9-8fd9-1d77b4d89fc6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ea4056ee-a479-48d1-b2ef-5c835cf7ee87" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f0d91692-2c0c-48a9-8fd9-1d77b4d89fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1276931f-93c6-4aa2-8af9-6b4ab2fee1be" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f0d91692-2c0c-48a9-8fd9-1d77b4d89fc6" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1276931f-93c6-4aa2-8af9-6b4ab2fee1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_86cbcd48-30dc-4c2c-8dca-7b0bd9132afa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1276931f-93c6-4aa2-8af9-6b4ab2fee1be" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_86cbcd48-30dc-4c2c-8dca-7b0bd9132afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5f4e8f98-37ae-4eba-9747-57b3d7d971e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ea4056ee-a479-48d1-b2ef-5c835cf7ee87" xlink:to="loc_us-gaap_StatementLineItems_5f4e8f98-37ae-4eba-9747-57b3d7d971e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_8b529993-2156-451b-9cee-ddaea09597ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5f4e8f98-37ae-4eba-9747-57b3d7d971e1" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_8b529993-2156-451b-9cee-ddaea09597ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5f4e8f98-37ae-4eba-9747-57b3d7d971e1" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_6138d9f3-47c1-4717-bb28-84561db57d84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_us-gaap_SharesIssued_6138d9f3-47c1-4717-bb28-84561db57d84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ad9219c2-ffca-426b-8f65-c997093c647d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_us-gaap_StockholdersEquity_ad9219c2-ffca-426b-8f65-c997093c647d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0c3ebf5b-45aa-4e28-8263-7fc3dcab5884" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0c3ebf5b-45aa-4e28-8263-7fc3dcab5884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2787dcbe-8134-4b1e-8a74-72e2ea3706ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2787dcbe-8134-4b1e-8a74-72e2ea3706ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2aff1188-61a1-4c9e-bc2a-0a1746dd68ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2aff1188-61a1-4c9e-bc2a-0a1746dd68ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_96d6d439-e8bb-4be0-adde-e8ab20d29a8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_96d6d439-e8bb-4be0-adde-e8ab20d29a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_afc8bbe5-f566-4837-9228-3c71e5fad3d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_afc8bbe5-f566-4837-9228-3c71e5fad3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_2eabcacc-7c87-4727-b746-f690e827482c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_2eabcacc-7c87-4727-b746-f690e827482c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_68446c00-1da6-457a-87bf-deed3b9f6f33" xlink:href="lgnd-20210331.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_68446c00-1da6-457a-87bf-deed3b9f6f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_5ff8c8b4-9514-4599-a59e-deb8412093a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_5ff8c8b4-9514-4599-a59e-deb8412093a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_2b356a82-b7f8-45be-a412-1185e372ed65" xlink:href="lgnd-20210331.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_2b356a82-b7f8-45be-a412-1185e372ed65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_25364bb4-d82a-47da-a9da-c7a5f222c71f" xlink:href="lgnd-20210331.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_25364bb4-d82a-47da-a9da-c7a5f222c71f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_8504a1bb-437b-4834-8fc4-b39e2b171374" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_8504a1bb-437b-4834-8fc4-b39e2b171374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fd812938-bd17-49aa-a89e-ee5b5d06a097" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_us-gaap_NetIncomeLoss_fd812938-bd17-49aa-a89e-ee5b5d06a097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_5c8947c1-f1da-4b6d-a868-eae8697f2fd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_us-gaap_SharesIssued_5c8947c1-f1da-4b6d-a868-eae8697f2fd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_47518346-a1e7-4eed-b9eb-11fae12b7a0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f28eb41-cec7-4601-bcb8-7d8d4fe20c1d" xlink:to="loc_us-gaap_StockholdersEquity_47518346-a1e7-4eed-b9eb-11fae12b7a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_f11ae575-8f57-4f4b-9313-25d229003d79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5eb29a3b-8d15-45c4-b0a9-c891abb53b5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f11ae575-8f57-4f4b-9313-25d229003d79" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5eb29a3b-8d15-45c4-b0a9-c891abb53b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2fca1561-d8b7-42b2-ae01-bf0d320639f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5eb29a3b-8d15-45c4-b0a9-c891abb53b5a" xlink:to="loc_us-gaap_ProfitLoss_2fca1561-d8b7-42b2-ae01-bf0d320639f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e5fef416-3836-4d21-b9c0-7e0f1984c579" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5eb29a3b-8d15-45c4-b0a9-c891abb53b5a" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e5fef416-3836-4d21-b9c0-7e0f1984c579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_00005c7d-3ced-49da-b291-e39430a1327a" xlink:href="lgnd-20210331.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e5fef416-3836-4d21-b9c0-7e0f1984c579" xlink:to="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_00005c7d-3ced-49da-b291-e39430a1327a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_38bfb566-5ad1-402b-8c32-adbb23fe6671" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e5fef416-3836-4d21-b9c0-7e0f1984c579" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_38bfb566-5ad1-402b-8c32-adbb23fe6671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_be8a839a-8a8c-4498-8065-32a4344ff9e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e5fef416-3836-4d21-b9c0-7e0f1984c579" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_be8a839a-8a8c-4498-8065-32a4344ff9e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_2eb4e2f2-e45f-4775-b41a-7c6f31c241f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e5fef416-3836-4d21-b9c0-7e0f1984c579" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_2eb4e2f2-e45f-4775-b41a-7c6f31c241f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfOtherEconomicRights_b5edb724-1e16-4867-91e1-2f3820ff08ef" xlink:href="lgnd-20210331.xsd#lgnd_AmortizationOfOtherEconomicRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e5fef416-3836-4d21-b9c0-7e0f1984c579" xlink:to="loc_lgnd_AmortizationOfOtherEconomicRights_b5edb724-1e16-4867-91e1-2f3820ff08ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f60b7eb0-08cc-4164-bc24-9d9cef19533d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e5fef416-3836-4d21-b9c0-7e0f1984c579" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f60b7eb0-08cc-4164-bc24-9d9cef19533d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a8eac544-7f55-436b-85f7-83e3aea1f955" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e5fef416-3836-4d21-b9c0-7e0f1984c579" xlink:to="loc_us-gaap_ShareBasedCompensation_a8eac544-7f55-436b-85f7-83e3aea1f955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_f11dde21-c76a-40b3-a53a-cb56fd22512f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e5fef416-3836-4d21-b9c0-7e0f1984c579" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_f11dde21-c76a-40b3-a53a-cb56fd22512f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments_65da66aa-eb77-428b-9102-ceadad40551e" xlink:href="lgnd-20210331.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e5fef416-3836-4d21-b9c0-7e0f1984c579" xlink:to="loc_lgnd_GainLossOnShortTermInvestments_65da66aa-eb77-428b-9102-ceadad40551e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_372ccd33-13a2-4591-a1ec-710c0990235f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e5fef416-3836-4d21-b9c0-7e0f1984c579" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_372ccd33-13a2-4591-a1ec-710c0990235f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d759e2cd-7e52-4e43-8d5a-a894d421e03c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5eb29a3b-8d15-45c4-b0a9-c891abb53b5a" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d759e2cd-7e52-4e43-8d5a-a894d421e03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_4ba94737-b667-40e9-8a02-d5486c81a9c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d759e2cd-7e52-4e43-8d5a-a894d421e03c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_4ba94737-b667-40e9-8a02-d5486c81a9c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_20292b37-d234-4352-b0bf-9358e958c8f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d759e2cd-7e52-4e43-8d5a-a894d421e03c" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_20292b37-d234-4352-b0bf-9358e958c8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_42cb33d9-2105-49da-b438-0b9994bb0ab7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d759e2cd-7e52-4e43-8d5a-a894d421e03c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_42cb33d9-2105-49da-b438-0b9994bb0ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_c36c54de-17b5-4264-a85e-dbf4d90109f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d759e2cd-7e52-4e43-8d5a-a894d421e03c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_c36c54de-17b5-4264-a85e-dbf4d90109f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_0a220138-b3a3-483e-998b-3b7493d38d32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d759e2cd-7e52-4e43-8d5a-a894d421e03c" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_0a220138-b3a3-483e-998b-3b7493d38d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_0e443e2d-b230-49b2-8c12-ed249c349ffe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d759e2cd-7e52-4e43-8d5a-a894d421e03c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_0e443e2d-b230-49b2-8c12-ed249c349ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c4a0b338-58f9-4c07-9503-2609bde86679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5eb29a3b-8d15-45c4-b0a9-c891abb53b5a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c4a0b338-58f9-4c07-9503-2609bde86679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1609616-0890-46a9-aff3-1133160ddca7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f11ae575-8f57-4f4b-9313-25d229003d79" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1609616-0890-46a9-aff3-1133160ddca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_e462ff06-e7f4-4b98-abf9-391235a5e556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1609616-0890-46a9-aff3-1133160ddca7" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_e462ff06-e7f4-4b98-abf9-391235a5e556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_f4913bdd-3ec9-4cba-9066-efbd05a701b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1609616-0890-46a9-aff3-1133160ddca7" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_f4913bdd-3ec9-4cba-9066-efbd05a701b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_9c3a936d-c171-4996-b9f2-15fdd97cfb1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1609616-0890-46a9-aff3-1133160ddca7" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_9c3a936d-c171-4996-b9f2-15fdd97cfb1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ca9f6cbe-0aaa-41a3-980f-d2e7855d9f68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1609616-0890-46a9-aff3-1133160ddca7" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ca9f6cbe-0aaa-41a3-980f-d2e7855d9f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9bbb64df-76bf-4b85-b0bc-bfd598cdf69c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1609616-0890-46a9-aff3-1133160ddca7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9bbb64df-76bf-4b85-b0bc-bfd598cdf69c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d72a7558-277e-4459-8a37-fd02e22431bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f11ae575-8f57-4f4b-9313-25d229003d79" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d72a7558-277e-4459-8a37-fd02e22431bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_cf830a26-1f73-4ef6-9ca4-a4f983ca0a82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d72a7558-277e-4459-8a37-fd02e22431bb" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_cf830a26-1f73-4ef6-9ca4-a4f983ca0a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_793bd80f-d08a-4381-8b00-f9d72dc693ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d72a7558-277e-4459-8a37-fd02e22431bb" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_793bd80f-d08a-4381-8b00-f9d72dc693ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeFinancingActivities_fa7c73c7-c6bc-4d88-b62d-6f5f74d54d32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromHedgeFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d72a7558-277e-4459-8a37-fd02e22431bb" xlink:to="loc_us-gaap_ProceedsFromHedgeFinancingActivities_fa7c73c7-c6bc-4d88-b62d-6f5f74d54d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities_f872c175-bed5-4afc-8749-3638031f394e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d72a7558-277e-4459-8a37-fd02e22431bb" xlink:to="loc_us-gaap_PaymentsForHedgeFinancingActivities_f872c175-bed5-4afc-8749-3638031f394e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_c6d7ebdd-f133-4fd0-a2de-ddb8d2a428b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d72a7558-277e-4459-8a37-fd02e22431bb" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_c6d7ebdd-f133-4fd0-a2de-ddb8d2a428b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a6143c54-14cb-48bb-95de-96fc45edf035" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d72a7558-277e-4459-8a37-fd02e22431bb" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a6143c54-14cb-48bb-95de-96fc45edf035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5097c766-3843-4486-95f4-415ed54058d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d72a7558-277e-4459-8a37-fd02e22431bb" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5097c766-3843-4486-95f4-415ed54058d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_eb1acfe7-9b6a-4a2f-bc8b-67bcc7528f18" xlink:href="lgnd-20210331.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d72a7558-277e-4459-8a37-fd02e22431bb" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_eb1acfe7-9b6a-4a2f-bc8b-67bcc7528f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9aece5f0-bc67-4096-b305-f510c8597bb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d72a7558-277e-4459-8a37-fd02e22431bb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9aece5f0-bc67-4096-b305-f510c8597bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_442067fc-e803-43c7-86a6-812493a385e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f11ae575-8f57-4f4b-9313-25d229003d79" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_442067fc-e803-43c7-86a6-812493a385e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_41423953-375a-4d83-bb45-8d5bea469dc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f11ae575-8f57-4f4b-9313-25d229003d79" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_41423953-375a-4d83-bb45-8d5bea469dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9e7abf23-a0c1-4382-a530-d7b2ad30bf27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f11ae575-8f57-4f4b-9313-25d229003d79" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9e7abf23-a0c1-4382-a530-d7b2ad30bf27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6e66e8f7-e34c-467f-991b-165bab35a3ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f11ae575-8f57-4f4b-9313-25d229003d79" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6e66e8f7-e34c-467f-991b-165bab35a3ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_f6d99d6d-3bdc-4aea-bbab-e45f81d940bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f11ae575-8f57-4f4b-9313-25d229003d79" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_f6d99d6d-3bdc-4aea-bbab-e45f81d940bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_f67ca511-042f-4718-ae6e-313588dc434d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_f6d99d6d-3bdc-4aea-bbab-e45f81d940bb" xlink:to="loc_us-gaap_InterestPaidNet_f67ca511-042f-4718-ae6e-313588dc434d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_a11a7718-cce7-4ab2-aab7-81b564a266ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_f6d99d6d-3bdc-4aea-bbab-e45f81d940bb" xlink:to="loc_us-gaap_RestrictedCashCurrent_a11a7718-cce7-4ab2-aab7-81b564a266ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_57b10b30-892f-47aa-ad93-c078e851eca1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f11ae575-8f57-4f4b-9313-25d229003d79" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_57b10b30-892f-47aa-ad93-c078e851eca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_5de8ef42-09b2-4c39-8f06-d0113e563485" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_57b10b30-892f-47aa-ad93-c078e851eca1" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_5de8ef42-09b2-4c39-8f06-d0113e563485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedInventoryPurchases_e3bb1e59-4579-479a-a5cf-01e010629e58" xlink:href="lgnd-20210331.xsd#lgnd_AccruedInventoryPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_57b10b30-892f-47aa-ad93-c078e851eca1" xlink:to="loc_lgnd_AccruedInventoryPurchases_e3bb1e59-4579-479a-a5cf-01e010629e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_d32378ec-227f-400e-a2bc-c2b467a27cd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_57b10b30-892f-47aa-ad93-c078e851eca1" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_d32378ec-227f-400e-a2bc-c2b467a27cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6466ece7-ada0-4adf-aeba-26c041886f13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_596e5b8c-5cf8-41e4-8c83-d5b3e1862dfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6466ece7-ada0-4adf-aeba-26c041886f13" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_596e5b8c-5cf8-41e4-8c83-d5b3e1862dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_36839950-1a2f-4953-ab4a-dbbd0d8e13be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_27434c8b-db17-4f69-8013-094e65145531" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_36839950-1a2f-4953-ab4a-dbbd0d8e13be" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_27434c8b-db17-4f69-8013-094e65145531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_8d6ad0b4-8e87-4989-b3c3-ddcac2e16e8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_36839950-1a2f-4953-ab4a-dbbd0d8e13be" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_8d6ad0b4-8e87-4989-b3c3-ddcac2e16e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_b678c892-d361-40a5-b001-9b0fff9b3242" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_36839950-1a2f-4953-ab4a-dbbd0d8e13be" xlink:to="loc_us-gaap_UseOfEstimates_b678c892-d361-40a5-b001-9b0fff9b3242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_be45fecb-a2e7-463c-a9b5-7d0541dbf0bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_36839950-1a2f-4953-ab4a-dbbd0d8e13be" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_be45fecb-a2e7-463c-a9b5-7d0541dbf0bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7a6a31ca-33a4-4fb0-9686-c1bb0ca2ef20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_36839950-1a2f-4953-ab4a-dbbd0d8e13be" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7a6a31ca-33a4-4fb0-9686-c1bb0ca2ef20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_5b9aa91b-fdf6-4741-819b-92144e707d57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_36839950-1a2f-4953-ab4a-dbbd0d8e13be" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_5b9aa91b-fdf6-4741-819b-92144e707d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_3b5b9deb-4884-4e1c-bd72-0fc70c146fce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_36839950-1a2f-4953-ab4a-dbbd0d8e13be" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_3b5b9deb-4884-4e1c-bd72-0fc70c146fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_db8f72fe-e1cc-4af6-b60e-4b9067466734" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_70a7d09f-e882-4dc5-acda-c1511971a693" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_db8f72fe-e1cc-4af6-b60e-4b9067466734" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_70a7d09f-e882-4dc5-acda-c1511971a693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_32986573-86d5-4680-83f1-8b2a688004e5" xlink:href="lgnd-20210331.xsd#lgnd_ScheduleOfShortTermInvestmentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_db8f72fe-e1cc-4af6-b60e-4b9067466734" xlink:to="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_32986573-86d5-4680-83f1-8b2a688004e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_276c8d23-42d6-438a-857f-ac357b9116ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_db8f72fe-e1cc-4af6-b60e-4b9067466734" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_276c8d23-42d6-438a-857f-ac357b9116ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_57dd4b88-c86a-4f46-8376-4bab7b0470d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_db8f72fe-e1cc-4af6-b60e-4b9067466734" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_57dd4b88-c86a-4f46-8376-4bab7b0470d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_b1f0c849-a648-47c6-9429-011f6511b79c" xlink:href="lgnd-20210331.xsd#lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_db8f72fe-e1cc-4af6-b60e-4b9067466734" xlink:to="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_b1f0c849-a648-47c6-9429-011f6511b79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_fd145fab-d88f-43be-af1b-ac73feacd83b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_db8f72fe-e1cc-4af6-b60e-4b9067466734" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_fd145fab-d88f-43be-af1b-ac73feacd83b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_e8efce35-0b7a-4b1b-870c-c276c581faec" xlink:href="lgnd-20210331.xsd#lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_db8f72fe-e1cc-4af6-b60e-4b9067466734" xlink:to="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_e8efce35-0b7a-4b1b-870c-c276c581faec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_0f29b400-03a2-4f1e-9dc1-0c6ea7386250" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_db8f72fe-e1cc-4af6-b60e-4b9067466734" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_0f29b400-03a2-4f1e-9dc1-0c6ea7386250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ff525c71-4373-450c-bc02-40ec115d6213" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_db8f72fe-e1cc-4af6-b60e-4b9067466734" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ff525c71-4373-450c-bc02-40ec115d6213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_21a2d794-d718-4dca-a275-c85ae338859c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_10e3b19c-a74d-441a-aa38-4bfda5758f5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_21a2d794-d718-4dca-a275-c85ae338859c" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_10e3b19c-a74d-441a-aa38-4bfda5758f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5341b650-3122-48d5-98a2-a4ab7dabc24e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_10e3b19c-a74d-441a-aa38-4bfda5758f5f" xlink:to="loc_srt_RangeAxis_5341b650-3122-48d5-98a2-a4ab7dabc24e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bb20d2ec-31a5-4603-a1f4-8ad83b945778" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5341b650-3122-48d5-98a2-a4ab7dabc24e" xlink:to="loc_srt_RangeMember_bb20d2ec-31a5-4603-a1f4-8ad83b945778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_cb476ccf-dbfb-4770-91bc-8fc5e012d190" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bb20d2ec-31a5-4603-a1f4-8ad83b945778" xlink:to="loc_srt_MinimumMember_cb476ccf-dbfb-4770-91bc-8fc5e012d190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_64c03bd3-a2f0-4fcd-9feb-73f192a40f82" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bb20d2ec-31a5-4603-a1f4-8ad83b945778" xlink:to="loc_srt_MaximumMember_64c03bd3-a2f0-4fcd-9feb-73f192a40f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_74f4f2eb-b59f-4ace-9c65-25f596fcd080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_10e3b19c-a74d-441a-aa38-4bfda5758f5f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_74f4f2eb-b59f-4ace-9c65-25f596fcd080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_96e184b0-e9fc-4194-8d41-0f56d4136852" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_74f4f2eb-b59f-4ace-9c65-25f596fcd080" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_96e184b0-e9fc-4194-8d41-0f56d4136852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyAgreementsMember_874c0a73-46f5-4d66-9423-7562073b8534" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_96e184b0-e9fc-4194-8d41-0f56d4136852" xlink:to="loc_us-gaap_RoyaltyAgreementsMember_874c0a73-46f5-4d66-9423-7562073b8534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_abe70a74-5f29-4189-90dd-ae7709f78381" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_96e184b0-e9fc-4194-8d41-0f56d4136852" xlink:to="loc_us-gaap_LicensingAgreementsMember_abe70a74-5f29-4189-90dd-ae7709f78381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ff5ef38d-9fa6-4c73-9c84-a4b966d0be4e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_10e3b19c-a74d-441a-aa38-4bfda5758f5f" xlink:to="loc_srt_CounterpartyNameAxis_ff5ef38d-9fa6-4c73-9c84-a4b966d0be4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_689fbd61-3411-495e-90e2-a9b1f7959bac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_ff5ef38d-9fa6-4c73-9c84-a4b966d0be4e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_689fbd61-3411-495e-90e2-a9b1f7959bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoMember_e4202add-1965-400b-8ee8-c58f133ffaa1" xlink:href="lgnd-20210331.xsd#lgnd_AziyoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_689fbd61-3411-495e-90e2-a9b1f7959bac" xlink:to="loc_lgnd_AziyoMember_e4202add-1965-400b-8ee8-c58f133ffaa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember_a616df68-b421-4a0c-b668-302486625cb8" xlink:href="lgnd-20210331.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_689fbd61-3411-495e-90e2-a9b1f7959bac" xlink:to="loc_lgnd_SelexisAndDianomiMember_a616df68-b421-4a0c-b668-302486625cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisMember_4fabaf64-42b4-4277-9f27-4046770642da" xlink:href="lgnd-20210331.xsd#lgnd_SelexisMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_689fbd61-3411-495e-90e2-a9b1f7959bac" xlink:to="loc_lgnd_SelexisMember_4fabaf64-42b4-4277-9f27-4046770642da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dec5e986-783f-4ecb-9dfc-cf755c0e8fc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_10e3b19c-a74d-441a-aa38-4bfda5758f5f" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dec5e986-783f-4ecb-9dfc-cf755c0e8fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_53672d6a-42ce-4084-aee0-866afd13d8e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dec5e986-783f-4ecb-9dfc-cf755c0e8fc7" xlink:to="loc_us-gaap_RelatedPartyDomain_53672d6a-42ce-4084-aee0-866afd13d8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_1609a85e-3529-4930-aa21-4973ae28a1fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_53672d6a-42ce-4084-aee0-866afd13d8e9" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_1609a85e-3529-4930-aa21-4973ae28a1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c170ab55-d6f7-46e4-ae85-7e938a8dc394" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_10e3b19c-a74d-441a-aa38-4bfda5758f5f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c170ab55-d6f7-46e4-ae85-7e938a8dc394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_54f49adf-31ec-4c77-b244-43d0f4ae4beb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c170ab55-d6f7-46e4-ae85-7e938a8dc394" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_54f49adf-31ec-4c77-b244-43d0f4ae4beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_54b92f2f-60d6-4b0f-affb-b146619c9a57" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_54f49adf-31ec-4c77-b244-43d0f4ae4beb" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_54b92f2f-60d6-4b0f-affb-b146619c9a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_0763a51c-92c0-4879-9364-756440ca58fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_10e3b19c-a74d-441a-aa38-4bfda5758f5f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_0763a51c-92c0-4879-9364-756440ca58fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b4e47644-4ff4-4e0c-ab79-87d9567e4f0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0763a51c-92c0-4879-9364-756440ca58fa" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b4e47644-4ff4-4e0c-ab79-87d9567e4f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_f79c27f7-217b-49fa-b72c-242bdf1dc343" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b4e47644-4ff4-4e0c-ab79-87d9567e4f0f" xlink:to="loc_us-gaap_WarrantMember_f79c27f7-217b-49fa-b72c-242bdf1dc343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_08b36198-fb71-4b9b-8a5d-d9df39dda640" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b4e47644-4ff4-4e0c-ab79-87d9567e4f0f" xlink:to="loc_us-gaap_CommonStockMember_08b36198-fb71-4b9b-8a5d-d9df39dda640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_780cbc6d-4b74-4be5-8939-6b9d44bc012a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_10e3b19c-a74d-441a-aa38-4bfda5758f5f" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_780cbc6d-4b74-4be5-8939-6b9d44bc012a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2aca2cf1-97c1-48d4-89e9-c3e5261a1aa6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_780cbc6d-4b74-4be5-8939-6b9d44bc012a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2aca2cf1-97c1-48d4-89e9-c3e5261a1aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_080fe873-088a-475f-ba6a-2a6918615afb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2aca2cf1-97c1-48d4-89e9-c3e5261a1aa6" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_080fe873-088a-475f-ba6a-2a6918615afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1c238e0e-ee3b-4207-b21e-dd7fe5fd3eb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_10e3b19c-a74d-441a-aa38-4bfda5758f5f" xlink:to="loc_us-gaap_AwardTypeAxis_1c238e0e-ee3b-4207-b21e-dd7fe5fd3eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ec9c3992-9d87-4a6a-9682-2a665babb950" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1c238e0e-ee3b-4207-b21e-dd7fe5fd3eb9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ec9c3992-9d87-4a6a-9682-2a665babb950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_e2d9f4aa-9c6e-4cf3-baa5-66661aca4ab7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ec9c3992-9d87-4a6a-9682-2a665babb950" xlink:to="loc_us-gaap_RestrictedStockMember_e2d9f4aa-9c6e-4cf3-baa5-66661aca4ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_10e3b19c-a74d-441a-aa38-4bfda5758f5f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_035479a3-37c8-4885-b0b7-6ea234192d53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_035479a3-37c8-4885-b0b7-6ea234192d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_4f605764-6b37-498d-8d1e-7b9708162fba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_4f605764-6b37-498d-8d1e-7b9708162fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EquityMethodInvestmentSharesSold_28c83e9c-4a64-4bd1-9063-2079cbb53b31" xlink:href="lgnd-20210331.xsd#lgnd_EquityMethodInvestmentSharesSold"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_lgnd_EquityMethodInvestmentSharesSold_28c83e9c-4a64-4bd1-9063-2079cbb53b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_09f7bf12-1691-43f2-a7d0-be7de413a676" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_09f7bf12-1691-43f2-a7d0-be7de413a676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_05a8c5e9-8b3a-4ec4-8cfc-e0066e70672c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_05a8c5e9-8b3a-4ec4-8cfc-e0066e70672c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c9ef28b4-05ec-4731-ae56-27e9837f7af5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c9ef28b4-05ec-4731-ae56-27e9837f7af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_926f2d36-ac85-467f-b07b-4f1850b045f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_926f2d36-ac85-467f-b07b-4f1850b045f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_ec7887e0-e628-4bd8-9be5-6277ae02969c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_ec7887e0-e628-4bd8-9be5-6277ae02969c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_bce63b60-9fe1-4bdc-b990-97743b7b9673" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_bce63b60-9fe1-4bdc-b990-97743b7b9673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_a61bc43f-2eec-4586-abee-89cffea38e52" xlink:href="lgnd-20210331.xsd#lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_a61bc43f-2eec-4586-abee-89cffea38e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_07e9086a-dc32-4feb-aef8-408471fefdbb" xlink:href="lgnd-20210331.xsd#lgnd_ForecastedCashFlowsEffectiveInterestRatePercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_07e9086a-dc32-4feb-aef8-408471fefdbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_a3bb906a-741d-4221-9c80-dadda183be9a" xlink:href="lgnd-20210331.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_a3bb906a-741d-4221-9c80-dadda183be9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_b9022eee-5e48-4d5d-9941-90d775bc6a36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_b9022eee-5e48-4d5d-9941-90d775bc6a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_1e032afa-6422-4e90-9040-4e8d5a845d29" xlink:href="lgnd-20210331.xsd#lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_1e032afa-6422-4e90-9040-4e8d5a845d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7cf4c6bf-70f9-4610-bcaa-0f8546cee317" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bc72e9c4-f0f4-4d9e-a597-bef294985bef" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7cf4c6bf-70f9-4610-bcaa-0f8546cee317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_11fe0143-d3f7-4cc1-8cdd-e11882d46d31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_d8e23eb2-254a-40c9-b417-64875ba091e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_11fe0143-d3f7-4cc1-8cdd-e11882d46d31" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_d8e23eb2-254a-40c9-b417-64875ba091e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_bd80e3f9-ec4b-4d53-ba40-c57f4293a6b4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d8e23eb2-254a-40c9-b417-64875ba091e7" xlink:to="loc_srt_ProductOrServiceAxis_bd80e3f9-ec4b-4d53-ba40-c57f4293a6b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3be2be2d-2067-48dc-b07d-fafd242c4296" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_bd80e3f9-ec4b-4d53-ba40-c57f4293a6b4" xlink:to="loc_srt_ProductsAndServicesDomain_3be2be2d-2067-48dc-b07d-fafd242c4296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_3d6cb500-bfff-4a32-bd3b-46cb4b0c7ba8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3be2be2d-2067-48dc-b07d-fafd242c4296" xlink:to="loc_us-gaap_RoyaltyMember_3d6cb500-bfff-4a32-bd3b-46cb4b0c7ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_KyprolisMember_2658ce8e-d912-4a54-9521-8255cd4f53c1" xlink:href="lgnd-20210331.xsd#lgnd_KyprolisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_3d6cb500-bfff-4a32-bd3b-46cb4b0c7ba8" xlink:to="loc_lgnd_KyprolisMember_2658ce8e-d912-4a54-9521-8255cd4f53c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EvomelaMember_10a80461-5336-463c-9295-6bbff312e900" xlink:href="lgnd-20210331.xsd#lgnd_EvomelaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_3d6cb500-bfff-4a32-bd3b-46cb4b0c7ba8" xlink:to="loc_lgnd_EvomelaMember_10a80461-5336-463c-9295-6bbff312e900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember_474517e8-076a-4ad1-9b54-5e3733972ecd" xlink:href="lgnd-20210331.xsd#lgnd_RoyaltyOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_3d6cb500-bfff-4a32-bd3b-46cb4b0c7ba8" xlink:to="loc_lgnd_RoyaltyOtherMember_474517e8-076a-4ad1-9b54-5e3733972ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_c758e0ca-b9a8-4cc8-bbe0-abc23ed655b1" xlink:href="lgnd-20210331.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3be2be2d-2067-48dc-b07d-fafd242c4296" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_c758e0ca-b9a8-4cc8-bbe0-abc23ed655b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_81c9169f-4338-4cb3-9079-bffe947a8f73" xlink:href="lgnd-20210331.xsd#lgnd_ContractRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3be2be2d-2067-48dc-b07d-fafd242c4296" xlink:to="loc_lgnd_ContractRevenueMember_81c9169f-4338-4cb3-9079-bffe947a8f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueServiceMember_bb7b409a-210b-4fcd-ae66-9ee6fdd2704b" xlink:href="lgnd-20210331.xsd#lgnd_ContractRevenueServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_81c9169f-4338-4cb3-9079-bffe947a8f73" xlink:to="loc_lgnd_ContractRevenueServiceMember_bb7b409a-210b-4fcd-ae66-9ee6fdd2704b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember_38bc6396-aff4-4734-8bac-36ac1a9503b8" xlink:href="lgnd-20210331.xsd#lgnd_LicenseFeesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_81c9169f-4338-4cb3-9079-bffe947a8f73" xlink:to="loc_lgnd_LicenseFeesMember_38bc6396-aff4-4734-8bac-36ac1a9503b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember_babe64a7-a57d-4ffc-b00c-ec468daf5134" xlink:href="lgnd-20210331.xsd#lgnd_MilestoneMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_81c9169f-4338-4cb3-9079-bffe947a8f73" xlink:to="loc_lgnd_MilestoneMember_babe64a7-a57d-4ffc-b00c-ec468daf5134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_43799d2e-613f-4f33-8238-c1b7e1226c1c" xlink:href="lgnd-20210331.xsd#lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_81c9169f-4338-4cb3-9079-bffe947a8f73" xlink:to="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_43799d2e-613f-4f33-8238-c1b7e1226c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_0edb4829-caed-4fc8-a56a-b4841a5921fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d8e23eb2-254a-40c9-b417-64875ba091e7" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_0edb4829-caed-4fc8-a56a-b4841a5921fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7273f3ce-16a4-4970-9763-8b955046df6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0edb4829-caed-4fc8-a56a-b4841a5921fd" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7273f3ce-16a4-4970-9763-8b955046df6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a74c809c-437e-4009-8070-b559274a8809" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_7f4238e7-a9f1-45d0-b84c-702393e9df97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a74c809c-437e-4009-8070-b559274a8809" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_7f4238e7-a9f1-45d0-b84c-702393e9df97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_3cb2df67-5493-4c81-80d0-70557af4bbb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_7f4238e7-a9f1-45d0-b84c-702393e9df97" xlink:to="loc_us-gaap_FinancialInstrumentAxis_3cb2df67-5493-4c81-80d0-70557af4bbb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c8ed39e-94d1-4d3a-82b8-fe7cd7688591" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3cb2df67-5493-4c81-80d0-70557af4bbb5" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c8ed39e-94d1-4d3a-82b8-fe7cd7688591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember_c63245a6-8767-4f85-8f0d-270c488f5bbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DemandDepositsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c8ed39e-94d1-4d3a-82b8-fe7cd7688591" xlink:to="loc_us-gaap_DemandDepositsMember_c63245a6-8767-4f85-8f0d-270c488f5bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_d851101c-ce55-421a-98ea-553ebb87bd6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c8ed39e-94d1-4d3a-82b8-fe7cd7688591" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_d851101c-ce55-421a-98ea-553ebb87bd6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AgencySecuritiesMember_22ee3d2d-f252-4248-b7a9-4fa08a54e092" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AgencySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c8ed39e-94d1-4d3a-82b8-fe7cd7688591" xlink:to="loc_us-gaap_AgencySecuritiesMember_22ee3d2d-f252-4248-b7a9-4fa08a54e092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_a3f29b8f-6774-44fc-b5eb-d910bd967982" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c8ed39e-94d1-4d3a-82b8-fe7cd7688591" xlink:to="loc_us-gaap_CommercialPaperMember_a3f29b8f-6774-44fc-b5eb-d910bd967982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_cf41590b-e0d6-474a-a3db-567fa8aa8173" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c8ed39e-94d1-4d3a-82b8-fe7cd7688591" xlink:to="loc_us-gaap_EquitySecuritiesMember_cf41590b-e0d6-474a-a3db-567fa8aa8173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_ecca2d82-4e40-4a55-8d46-8a06cc379831" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MutualFundMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c8ed39e-94d1-4d3a-82b8-fe7cd7688591" xlink:to="loc_us-gaap_MutualFundMember_ecca2d82-4e40-4a55-8d46-8a06cc379831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_0de98bbd-40a4-4505-b365-9d0a232fe269" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c8ed39e-94d1-4d3a-82b8-fe7cd7688591" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_0de98bbd-40a4-4505-b365-9d0a232fe269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2d9ad8ea-8fbf-4713-8168-fcb4a4ba4655" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c8ed39e-94d1-4d3a-82b8-fe7cd7688591" xlink:to="loc_us-gaap_CommonStockMember_2d9ad8ea-8fbf-4713-8168-fcb4a4ba4655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_75fa32d4-5804-4ccb-b513-00bd74cfb94b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c8ed39e-94d1-4d3a-82b8-fe7cd7688591" xlink:to="loc_us-gaap_WarrantMember_75fa32d4-5804-4ccb-b513-00bd74cfb94b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_557b8964-02cf-46fc-b416-ef7670d03caa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_7f4238e7-a9f1-45d0-b84c-702393e9df97" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_557b8964-02cf-46fc-b416-ef7670d03caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_fb4a2fff-0d9f-46d2-a921-ce14961eb619" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_557b8964-02cf-46fc-b416-ef7670d03caa" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_fb4a2fff-0d9f-46d2-a921-ce14961eb619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_8bcb60ea-1f79-4d98-8124-3deb9b4561da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_557b8964-02cf-46fc-b416-ef7670d03caa" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_8bcb60ea-1f79-4d98-8124-3deb9b4561da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_33567409-ffc8-49e1-ac57-f548c171bcd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_557b8964-02cf-46fc-b416-ef7670d03caa" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_33567409-ffc8-49e1-ac57-f548c171bcd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4c759ec7-4383-422d-aa6a-94cbaf696894" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_557b8964-02cf-46fc-b416-ef7670d03caa" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4c759ec7-4383-422d-aa6a-94cbaf696894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_2f4edc16-03ba-470d-a735-6c6173dce81b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_557b8964-02cf-46fc-b416-ef7670d03caa" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_2f4edc16-03ba-470d-a735-6c6173dce81b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_3600189b-2b46-4b50-9f54-5cc1d03e552f" xlink:href="lgnd-20210331.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_557b8964-02cf-46fc-b416-ef7670d03caa" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_3600189b-2b46-4b50-9f54-5cc1d03e552f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_84fef677-2311-4e0f-b9f8-a3c31c34bc09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_09ae7e12-22df-4e9e-9ecf-7cd65d40a61f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_84fef677-2311-4e0f-b9f8-a3c31c34bc09" xlink:to="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_09ae7e12-22df-4e9e-9ecf-7cd65d40a61f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_965dc54f-b0f9-4415-a603-8135e0349241" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_09ae7e12-22df-4e9e-9ecf-7cd65d40a61f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_965dc54f-b0f9-4415-a603-8135e0349241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_cb5b9420-f0c7-44c5-bdec-1f9e2bf02363" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_09ae7e12-22df-4e9e-9ecf-7cd65d40a61f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_cb5b9420-f0c7-44c5-bdec-1f9e2bf02363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_08395024-6c6b-4003-96e3-e24fa26b21cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_09ae7e12-22df-4e9e-9ecf-7cd65d40a61f" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_08395024-6c6b-4003-96e3-e24fa26b21cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_fe19c812-9286-4dc2-bb7d-b964dea15828" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_84fef677-2311-4e0f-b9f8-a3c31c34bc09" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_fe19c812-9286-4dc2-bb7d-b964dea15828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_11fadda0-2f87-454d-be56-768f807add0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_fe19c812-9286-4dc2-bb7d-b964dea15828" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_11fadda0-2f87-454d-be56-768f807add0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_e11e4a5a-1c6b-4344-b9a9-86c9bcb02057" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_fe19c812-9286-4dc2-bb7d-b964dea15828" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_e11e4a5a-1c6b-4344-b9a9-86c9bcb02057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_65a8ae5e-8ebf-456f-9359-9ba731b4b81c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_fe19c812-9286-4dc2-bb7d-b964dea15828" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_65a8ae5e-8ebf-456f-9359-9ba731b4b81c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6397989b-1250-42fe-b65d-55bf0699f7f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_42f7e721-2b04-4a7e-b0e5-0ea50cd2fe4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6397989b-1250-42fe-b65d-55bf0699f7f0" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_42f7e721-2b04-4a7e-b0e5-0ea50cd2fe4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_331238fe-6076-48e0-a365-434ae0bbfa06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_42f7e721-2b04-4a7e-b0e5-0ea50cd2fe4f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_331238fe-6076-48e0-a365-434ae0bbfa06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7554979f-858c-4c72-8a2a-dc5615b30d88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_331238fe-6076-48e0-a365-434ae0bbfa06" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7554979f-858c-4c72-8a2a-dc5615b30d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember_8a0e38fa-2247-4cba-986d-1446ade244bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7554979f-858c-4c72-8a2a-dc5615b30d88" xlink:to="loc_us-gaap_PatentedTechnologyMember_8a0e38fa-2247-4cba-986d-1446ade244bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_423e9a7e-7435-4ad0-80b1-e2832a28c332" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7554979f-858c-4c72-8a2a-dc5615b30d88" xlink:to="loc_us-gaap_TradeNamesMember_423e9a7e-7435-4ad0-80b1-e2832a28c332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_73f37fb9-c36f-499b-9eec-ba5830883bd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7554979f-858c-4c72-8a2a-dc5615b30d88" xlink:to="loc_us-gaap_CustomerRelationshipsMember_73f37fb9-c36f-499b-9eec-ba5830883bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_bfb5d43e-9a84-4513-ae8c-5b28597176f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7554979f-858c-4c72-8a2a-dc5615b30d88" xlink:to="loc_us-gaap_ContractualRightsMember_bfb5d43e-9a84-4513-ae8c-5b28597176f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_b86b8a25-3df7-4813-b2df-bedd1deec4e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7554979f-858c-4c72-8a2a-dc5615b30d88" xlink:to="loc_us-gaap_LicensingAgreementsMember_b86b8a25-3df7-4813-b2df-bedd1deec4e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_db4bb5bf-1d9e-4a8b-ba7f-f79b5dfbfdcf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_42f7e721-2b04-4a7e-b0e5-0ea50cd2fe4f" xlink:to="loc_srt_CounterpartyNameAxis_db4bb5bf-1d9e-4a8b-ba7f-f79b5dfbfdcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1c47352f-a067-46f8-a4c9-79ba8c6696b5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_db4bb5bf-1d9e-4a8b-ba7f-f79b5dfbfdcf" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1c47352f-a067-46f8-a4c9-79ba8c6696b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember_acfe6f03-22d4-44bd-8dc6-a0689ada5c26" xlink:href="lgnd-20210331.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1c47352f-a067-46f8-a4c9-79ba8c6696b5" xlink:to="loc_lgnd_SelexisAndDianomiMember_acfe6f03-22d4-44bd-8dc6-a0689ada5c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoAndCorMatrixMember_7ee413c7-a654-4128-8f0d-6446794df671" xlink:href="lgnd-20210331.xsd#lgnd_AziyoAndCorMatrixMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1c47352f-a067-46f8-a4c9-79ba8c6696b5" xlink:to="loc_lgnd_AziyoAndCorMatrixMember_7ee413c7-a654-4128-8f0d-6446794df671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_81919fab-8a3e-4a22-a68a-7b4de706c60c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_42f7e721-2b04-4a7e-b0e5-0ea50cd2fe4f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_81919fab-8a3e-4a22-a68a-7b4de706c60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_8a3b971a-2df0-4772-b4c1-d8182141833c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_81919fab-8a3e-4a22-a68a-7b4de706c60c" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_8a3b971a-2df0-4772-b4c1-d8182141833c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3eaa448a-5566-459d-8b98-75f567efd770" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_8a3b971a-2df0-4772-b4c1-d8182141833c" xlink:to="loc_us-gaap_Goodwill_3eaa448a-5566-459d-8b98-75f567efd770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a12be688-d895-48b0-8528-5f0ad58bb12b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_8a3b971a-2df0-4772-b4c1-d8182141833c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a12be688-d895-48b0-8528-5f0ad58bb12b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b2d2ac3a-fe42-46b0-82c0-8e2c1a654a42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_8a3b971a-2df0-4772-b4c1-d8182141833c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b2d2ac3a-fe42-46b0-82c0-8e2c1a654a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_7d6999c8-2c6b-4bdc-9bae-6863d39f3883" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_8a3b971a-2df0-4772-b4c1-d8182141833c" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_7d6999c8-2c6b-4bdc-9bae-6863d39f3883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_49a0adee-caf3-45c0-8d80-1be8e9a24901" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ef899ae4-f5b9-4c46-8a9a-fe896e75c7f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_49a0adee-caf3-45c0-8d80-1be8e9a24901" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ef899ae4-f5b9-4c46-8a9a-fe896e75c7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a0087291-166b-4a92-b500-a82aac0d982a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ef899ae4-f5b9-4c46-8a9a-fe896e75c7f6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a0087291-166b-4a92-b500-a82aac0d982a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ca61436c-d478-420b-9b90-a35c4ba86b56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a0087291-166b-4a92-b500-a82aac0d982a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ca61436c-d478-420b-9b90-a35c4ba86b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_66da966e-b0a2-4b27-9b37-206806a6b675" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ca61436c-d478-420b-9b90-a35c4ba86b56" xlink:to="loc_us-gaap_LicensingAgreementsMember_66da966e-b0a2-4b27-9b37-206806a6b675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_bf93a60a-5d4c-4af7-9cb5-c6910649ed18" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ef899ae4-f5b9-4c46-8a9a-fe896e75c7f6" xlink:to="loc_srt_CounterpartyNameAxis_bf93a60a-5d4c-4af7-9cb5-c6910649ed18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_63c630f3-b4e6-4a39-80af-be13d1d10fd5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_bf93a60a-5d4c-4af7-9cb5-c6910649ed18" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_63c630f3-b4e6-4a39-80af-be13d1d10fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoAndCorMatrixMember_98badaec-30f0-46b0-8f4e-446b7fbd499a" xlink:href="lgnd-20210331.xsd#lgnd_AziyoAndCorMatrixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_63c630f3-b4e6-4a39-80af-be13d1d10fd5" xlink:to="loc_lgnd_AziyoAndCorMatrixMember_98badaec-30f0-46b0-8f4e-446b7fbd499a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember_e946ccd2-6f78-4add-b20e-ea32c8d0d562" xlink:href="lgnd-20210331.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_63c630f3-b4e6-4a39-80af-be13d1d10fd5" xlink:to="loc_lgnd_SelexisAndDianomiMember_e946ccd2-6f78-4add-b20e-ea32c8d0d562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c7bfb03-9bb8-4de4-a627-1d0e83b8ce09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ef899ae4-f5b9-4c46-8a9a-fe896e75c7f6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c7bfb03-9bb8-4de4-a627-1d0e83b8ce09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_308b92be-5993-4d47-b556-ba3b6dd9d556" xlink:href="lgnd-20210331.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c7bfb03-9bb8-4de4-a627-1d0e83b8ce09" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_308b92be-5993-4d47-b556-ba3b6dd9d556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e8e134cf-3531-4f1d-bc27-a71977c5b7a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_308b92be-5993-4d47-b556-ba3b6dd9d556" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e8e134cf-3531-4f1d-bc27-a71977c5b7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_6011fcf5-5b04-4883-92eb-ca3bb8f4a779" xlink:href="lgnd-20210331.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_308b92be-5993-4d47-b556-ba3b6dd9d556" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_6011fcf5-5b04-4883-92eb-ca3bb8f4a779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e7b2e085-a907-4fdc-92f1-2db63ee1d05a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_308b92be-5993-4d47-b556-ba3b6dd9d556" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e7b2e085-a907-4fdc-92f1-2db63ee1d05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_49ab66f7-ee87-43fc-b3d7-6495e90960e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_308b92be-5993-4d47-b556-ba3b6dd9d556" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_49ab66f7-ee87-43fc-b3d7-6495e90960e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_cda4f93e-33d3-4104-9035-b6029324f21f" xlink:href="lgnd-20210331.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_308b92be-5993-4d47-b556-ba3b6dd9d556" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_cda4f93e-33d3-4104-9035-b6029324f21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b9447d28-78d8-4946-bc6b-9c582ef4c1da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_339d5d97-87a4-4e8b-b77a-ea1619153ead" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b9447d28-78d8-4946-bc6b-9c582ef4c1da" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_339d5d97-87a4-4e8b-b77a-ea1619153ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_647db3ba-aa63-4ed7-b8d6-382b03578979" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_339d5d97-87a4-4e8b-b77a-ea1619153ead" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_647db3ba-aa63-4ed7-b8d6-382b03578979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_29a71b63-7799-4d0e-818f-780e7337f8fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_339d5d97-87a4-4e8b-b77a-ea1619153ead" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_29a71b63-7799-4d0e-818f-780e7337f8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseeAccrualCurrent_0ae3ba43-9b19-45d0-8f2d-8f755d9482c9" xlink:href="lgnd-20210331.xsd#lgnd_LicenseeAccrualCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_339d5d97-87a4-4e8b-b77a-ea1619153ead" xlink:to="loc_lgnd_LicenseeAccrualCurrent_0ae3ba43-9b19-45d0-8f2d-8f755d9482c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_a79e77bf-42e8-48b7-82f2-06467db4c461" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_339d5d97-87a4-4e8b-b77a-ea1619153ead" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_a79e77bf-42e8-48b7-82f2-06467db4c461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ReturnsAccrual_1c9adb5f-c813-4404-9332-acecdd8ac9f8" xlink:href="lgnd-20210331.xsd#lgnd_ReturnsAccrual"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_339d5d97-87a4-4e8b-b77a-ea1619153ead" xlink:to="loc_lgnd_ReturnsAccrual_1c9adb5f-c813-4404-9332-acecdd8ac9f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedAssetAcquisitionsCurrent_4676f641-fc17-4f88-946f-3ce6f5584bc7" xlink:href="lgnd-20210331.xsd#lgnd_AccruedAssetAcquisitionsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_339d5d97-87a4-4e8b-b77a-ea1619153ead" xlink:to="loc_lgnd_AccruedAssetAcquisitionsCurrent_4676f641-fc17-4f88-946f-3ce6f5584bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSubcontractorExpensesCurrent_efdb5a73-2c6f-4b00-a511-3c3a2664bddc" xlink:href="lgnd-20210331.xsd#lgnd_AccruedSubcontractorExpensesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_339d5d97-87a4-4e8b-b77a-ea1619153ead" xlink:to="loc_lgnd_AccruedSubcontractorExpensesCurrent_efdb5a73-2c6f-4b00-a511-3c3a2664bddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSupplierExpensesCurrent_955ed975-f4dc-40c2-9367-f079ab810ce7" xlink:href="lgnd-20210331.xsd#lgnd_AccruedSupplierExpensesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_339d5d97-87a4-4e8b-b77a-ea1619153ead" xlink:to="loc_lgnd_AccruedSupplierExpensesCurrent_955ed975-f4dc-40c2-9367-f079ab810ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_63d48367-785a-42af-bb49-b3397e6aa802" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_339d5d97-87a4-4e8b-b77a-ea1619153ead" xlink:to="loc_us-gaap_InterestPayableCurrent_63d48367-785a-42af-bb49-b3397e6aa802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_3537e58a-c60e-4790-a59d-a0c85b13d62d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_339d5d97-87a4-4e8b-b77a-ea1619153ead" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_3537e58a-c60e-4790-a59d-a0c85b13d62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_55bcf58e-0d46-465e-a258-03cb969bac32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_339d5d97-87a4-4e8b-b77a-ea1619153ead" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_55bcf58e-0d46-465e-a258-03cb969bac32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc0b6638-e91c-47be-b36d-fb3cc8cc8bc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable_691ad427-aa12-46d9-bdca-bcdf62f60c20" xlink:href="lgnd-20210331.xsd#lgnd_BasisOfPresentationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc0b6638-e91c-47be-b36d-fb3cc8cc8bc8" xlink:to="loc_lgnd_BasisOfPresentationTable_691ad427-aa12-46d9-bdca-bcdf62f60c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c09b6233-569b-4cac-98ff-f15309304ae4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_691ad427-aa12-46d9-bdca-bcdf62f60c20" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c09b6233-569b-4cac-98ff-f15309304ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f5aa70b2-a3c7-4e91-a220-8abaeb74ce8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c09b6233-569b-4cac-98ff-f15309304ae4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f5aa70b2-a3c7-4e91-a220-8abaeb74ce8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fbda7c4f-58ea-42c1-97c3-bc32e98e3f01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f5aa70b2-a3c7-4e91-a220-8abaeb74ce8f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fbda7c4f-58ea-42c1-97c3-bc32e98e3f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1baec3b3-4fe8-4053-89d9-4838f9c8c1e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f5aa70b2-a3c7-4e91-a220-8abaeb74ce8f" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1baec3b3-4fe8-4053-89d9-4838f9c8c1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems_13e38156-5cd0-467a-b24b-29f450804307" xlink:href="lgnd-20210331.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_691ad427-aa12-46d9-bdca-bcdf62f60c20" xlink:to="loc_lgnd_BasisOfPresentationLineItems_13e38156-5cd0-467a-b24b-29f450804307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_e47596d8-3744-4a8b-83bb-eda5b657a8b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_13e38156-5cd0-467a-b24b-29f450804307" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_e47596d8-3744-4a8b-83bb-eda5b657a8b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_70986b2c-ebbb-49d4-a322-962903796424" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_79ba8036-8200-4590-98e0-d2888ef631bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_70986b2c-ebbb-49d4-a322-962903796424" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_79ba8036-8200-4590-98e0-d2888ef631bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ebc319db-d059-4f6b-bf92-ee83a839ffee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_70986b2c-ebbb-49d4-a322-962903796424" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ebc319db-d059-4f6b-bf92-ee83a839ffee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_a58a75eb-6059-44c8-837f-c7595518e99e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_70986b2c-ebbb-49d4-a322-962903796424" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_a58a75eb-6059-44c8-837f-c7595518e99e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_033f99d7-833d-461f-86c2-d8c3b216a27b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_70986b2c-ebbb-49d4-a322-962903796424" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_033f99d7-833d-461f-86c2-d8c3b216a27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cf74c494-ae95-40e4-8177-c22225abd3e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_68a05853-dcc1-4818-b7e1-3222caedbefb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cf74c494-ae95-40e4-8177-c22225abd3e0" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_68a05853-dcc1-4818-b7e1-3222caedbefb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_9ead3340-2056-4e0e-a263-09904921e60d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_68a05853-dcc1-4818-b7e1-3222caedbefb" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_9ead3340-2056-4e0e-a263-09904921e60d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract_a18843a1-6f68-44e5-9f7a-3f1ae44ba33e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_68a05853-dcc1-4818-b7e1-3222caedbefb" xlink:to="loc_us-gaap_DilutiveSecuritiesAbstract_a18843a1-6f68-44e5-9f7a-3f1ae44ba33e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_729a81a3-9d50-4e47-a25d-899534a4a91b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_a18843a1-6f68-44e5-9f7a-3f1ae44ba33e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_729a81a3-9d50-4e47-a25d-899534a4a91b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e6c3a770-b611-467b-a134-ae39a5c22687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_a18843a1-6f68-44e5-9f7a-3f1ae44ba33e" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e6c3a770-b611-467b-a134-ae39a5c22687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bca92d11-13c0-4348-8ff6-3b245c6c4a6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_a18843a1-6f68-44e5-9f7a-3f1ae44ba33e" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bca92d11-13c0-4348-8ff6-3b245c6c4a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c09d9cd1-6de1-4340-9ece-0de2b9396f6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_68a05853-dcc1-4818-b7e1-3222caedbefb" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c09d9cd1-6de1-4340-9ece-0de2b9396f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="lgnd-20210331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_58539b56-993b-4ad4-b14d-c2a511f7400c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_14c842e0-0591-4222-8b3f-b0b4d01e224a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_58539b56-993b-4ad4-b14d-c2a511f7400c" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_14c842e0-0591-4222-8b3f-b0b4d01e224a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="lgnd-20210331.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b6a2920d-a412-4cd2-b99b-ddbc582fe1aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_54f96462-edc6-49d1-9356-4fb2fc4ac4e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b6a2920d-a412-4cd2-b99b-ddbc582fe1aa" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_54f96462-edc6-49d1-9356-4fb2fc4ac4e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_b87c9b93-f8a5-4046-b04a-e2b0f0ca20ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b6a2920d-a412-4cd2-b99b-ddbc582fe1aa" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_b87c9b93-f8a5-4046-b04a-e2b0f0ca20ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a976e6cb-8489-4ef6-9a9b-8c278e82cf9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f7198d4d-113f-4cca-8b55-6c265de1b3b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a976e6cb-8489-4ef6-9a9b-8c278e82cf9a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f7198d4d-113f-4cca-8b55-6c265de1b3b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_62f67e38-1b32-49b4-9a79-69f8c2c5db88" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f7198d4d-113f-4cca-8b55-6c265de1b3b8" xlink:to="loc_srt_RangeAxis_62f67e38-1b32-49b4-9a79-69f8c2c5db88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c198e5e6-f45f-45c3-8c7c-2db132334cfb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_62f67e38-1b32-49b4-9a79-69f8c2c5db88" xlink:to="loc_srt_RangeMember_c198e5e6-f45f-45c3-8c7c-2db132334cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_68c6c77b-39d7-4c03-898f-d1654aa332b4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c198e5e6-f45f-45c3-8c7c-2db132334cfb" xlink:to="loc_srt_MaximumMember_68c6c77b-39d7-4c03-898f-d1654aa332b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_5850dca8-74db-4e35-a0e9-375e75916641" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f7198d4d-113f-4cca-8b55-6c265de1b3b8" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_5850dca8-74db-4e35-a0e9-375e75916641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_3ff25a11-5733-4d1d-83ab-0d55de0be398" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_5850dca8-74db-4e35-a0e9-375e75916641" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_3ff25a11-5733-4d1d-83ab-0d55de0be398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_dbbb46ff-b4db-4047-9dac-0c9da0c5db2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_3ff25a11-5733-4d1d-83ab-0d55de0be398" xlink:to="loc_us-gaap_TransferredOverTimeMember_dbbb46ff-b4db-4047-9dac-0c9da0c5db2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_30e323d3-931c-43df-bea3-315058884584" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f7198d4d-113f-4cca-8b55-6c265de1b3b8" xlink:to="loc_srt_ProductOrServiceAxis_30e323d3-931c-43df-bea3-315058884584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2be600c1-3642-4c75-a342-59ba6a438e65" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_30e323d3-931c-43df-bea3-315058884584" xlink:to="loc_srt_ProductsAndServicesDomain_2be600c1-3642-4c75-a342-59ba6a438e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_4810e833-b8ac-44e6-8c3d-c3da6740e2aa" xlink:href="lgnd-20210331.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2be600c1-3642-4c75-a342-59ba6a438e65" xlink:to="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_4810e833-b8ac-44e6-8c3d-c3da6740e2aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember_8ce488cc-2473-413b-88a8-57384adefa67" xlink:href="lgnd-20210331.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2be600c1-3642-4c75-a342-59ba6a438e65" xlink:to="loc_lgnd_Phase3ClinicalTrialMember_8ce488cc-2473-413b-88a8-57384adefa67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_91369927-1990-42ec-b352-0ac079f07437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f7198d4d-113f-4cca-8b55-6c265de1b3b8" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_91369927-1990-42ec-b352-0ac079f07437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_6ab22124-a592-4467-99a1-944fc907954b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_91369927-1990-42ec-b352-0ac079f07437" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_6ab22124-a592-4467-99a1-944fc907954b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_a52af159-2abd-4741-a62c-88e885dd1c56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_6ab22124-a592-4467-99a1-944fc907954b" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_a52af159-2abd-4741-a62c-88e885dd1c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_41dace89-1665-432f-bb37-2c1c4c09abb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f7198d4d-113f-4cca-8b55-6c265de1b3b8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_41dace89-1665-432f-bb37-2c1c4c09abb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_889235ea-e09c-45c4-98a4-c890f8a4d238" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_41dace89-1665-432f-bb37-2c1c4c09abb0" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_889235ea-e09c-45c4-98a4-c890f8a4d238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_22cdc08e-aefc-4111-9a10-9c33345f6a80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_889235ea-e09c-45c4-98a4-c890f8a4d238" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_22cdc08e-aefc-4111-9a10-9c33345f6a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1174e9ea-279f-49eb-8709-9e596f34ce64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_889235ea-e09c-45c4-98a4-c890f8a4d238" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1174e9ea-279f-49eb-8709-9e596f34ce64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a9018c32-89a6-4827-b853-b034cc5bc7f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_889235ea-e09c-45c4-98a4-c890f8a4d238" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a9018c32-89a6-4827-b853-b034cc5bc7f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_3f3b6f54-ead1-4a96-9f3d-253e49d7d49a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f7198d4d-113f-4cca-8b55-6c265de1b3b8" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_3f3b6f54-ead1-4a96-9f3d-253e49d7d49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_15c2439c-3363-40c6-be86-df5261d7f2c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_3f3b6f54-ead1-4a96-9f3d-253e49d7d49a" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_15c2439c-3363-40c6-be86-df5261d7f2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_711bb368-9660-46e6-8894-a4c1cd903aa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_15c2439c-3363-40c6-be86-df5261d7f2c6" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_711bb368-9660-46e6-8894-a4c1cd903aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_bca359c8-b565-4a79-945f-ff7e5ad87aca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_15c2439c-3363-40c6-be86-df5261d7f2c6" xlink:to="loc_us-gaap_EquitySecuritiesMember_bca359c8-b565-4a79-945f-ff7e5ad87aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_6cf21c3d-4648-4581-8390-8c0c90335988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_15c2439c-3363-40c6-be86-df5261d7f2c6" xlink:to="loc_us-gaap_WarrantMember_6cf21c3d-4648-4581-8390-8c0c90335988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_079f5982-9f42-4bd6-a3d2-cceaed7e7cb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f7198d4d-113f-4cca-8b55-6c265de1b3b8" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_079f5982-9f42-4bd6-a3d2-cceaed7e7cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d76c21a0-e9c8-4cc3-a23c-4429a0676efc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_079f5982-9f42-4bd6-a3d2-cceaed7e7cb9" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d76c21a0-e9c8-4cc3-a23c-4429a0676efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember_4d0dd6d2-2ea7-4d6a-930d-0d83e30c43f4" xlink:href="lgnd-20210331.xsd#lgnd_LiabilityForContingentValueRightsCompanyCrystalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d76c21a0-e9c8-4cc3-a23c-4429a0676efc" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember_4d0dd6d2-2ea7-4d6a-930d-0d83e30c43f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_29bd9524-0b75-497f-9c91-aca00c3cdb06" xlink:href="lgnd-20210331.xsd#lgnd_LiabilityForContingentValueRightsCompanyCydexMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d76c21a0-e9c8-4cc3-a23c-4429a0676efc" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_29bd9524-0b75-497f-9c91-aca00c3cdb06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_fddd031d-a653-4d07-8123-3be840ef9757" xlink:href="lgnd-20210331.xsd#lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d76c21a0-e9c8-4cc3-a23c-4429a0676efc" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_fddd031d-a653-4d07-8123-3be840ef9757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_a5b148db-fd93-4512-b278-c96434459b40" xlink:href="lgnd-20210331.xsd#lgnd_LiabilityForContingentValueRightsCompanyIcagenMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d76c21a0-e9c8-4cc3-a23c-4429a0676efc" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_a5b148db-fd93-4512-b278-c96434459b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_fd861f80-94ef-4640-89f2-45de2afff21e" xlink:href="lgnd-20210331.xsd#lgnd_LiabilityForContingentValueRightsCompanyPfenexMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d76c21a0-e9c8-4cc3-a23c-4429a0676efc" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_fd861f80-94ef-4640-89f2-45de2afff21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_3780571c-21be-4b58-be01-03854a021cae" xlink:href="lgnd-20210331.xsd#lgnd_LiabilityForContingentValueRightsCompanyXCellaMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d76c21a0-e9c8-4cc3-a23c-4429a0676efc" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_3780571c-21be-4b58-be01-03854a021cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_04a8b7c4-888c-4456-a256-f5394dd623fd" xlink:href="lgnd-20210331.xsd#lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d76c21a0-e9c8-4cc3-a23c-4429a0676efc" xlink:to="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_04a8b7c4-888c-4456-a256-f5394dd623fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6a5bffdb-38d4-48ae-867c-996def481482" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f7198d4d-113f-4cca-8b55-6c265de1b3b8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6a5bffdb-38d4-48ae-867c-996def481482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_102f04af-2b15-41d2-869c-49f209f16557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6a5bffdb-38d4-48ae-867c-996def481482" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_102f04af-2b15-41d2-869c-49f209f16557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisMember_1790bfcf-a0c5-4351-bcc0-a538a5d078bc" xlink:href="lgnd-20210331.xsd#lgnd_MetabasisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_102f04af-2b15-41d2-869c-49f209f16557" xlink:to="loc_lgnd_MetabasisMember_1790bfcf-a0c5-4351-bcc0-a538a5d078bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_129df3d4-517d-478e-806e-a6909661866b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f7198d4d-113f-4cca-8b55-6c265de1b3b8" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_129df3d4-517d-478e-806e-a6909661866b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_e88c13af-f5ff-439c-98e1-ac3e0799789e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_129df3d4-517d-478e-806e-a6909661866b" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_e88c13af-f5ff-439c-98e1-ac3e0799789e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_b54b5640-fdf9-4b51-bc38-5a015196888d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_129df3d4-517d-478e-806e-a6909661866b" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_b54b5640-fdf9-4b51-bc38-5a015196888d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_26a89cde-aed3-49fc-89f8-da5cdf58a5b0" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_129df3d4-517d-478e-806e-a6909661866b" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_26a89cde-aed3-49fc-89f8-da5cdf58a5b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_2f17dbe3-385b-43af-b737-cd648c866dc8" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_129df3d4-517d-478e-806e-a6909661866b" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_2f17dbe3-385b-43af-b737-cd648c866dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsSeries_686960bc-e163-48c9-8d25-16497df5b90a" xlink:href="lgnd-20210331.xsd#lgnd_NumberOfContingentValueRightsSeries"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_129df3d4-517d-478e-806e-a6909661866b" xlink:to="loc_lgnd_NumberOfContingentValueRightsSeries_686960bc-e163-48c9-8d25-16497df5b90a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_245eb736-d71e-40de-a19c-83a858e420a5" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_129df3d4-517d-478e-806e-a6909661866b" xlink:to="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_245eb736-d71e-40de-a19c-83a858e420a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_3b1eabaa-d07f-43cf-9dec-d4fc4d27637f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_129df3d4-517d-478e-806e-a6909661866b" xlink:to="loc_us-gaap_Investments_3b1eabaa-d07f-43cf-9dec-d4fc4d27637f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_68fd6b81-07f6-40f8-875a-e7342ce6e384" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_129df3d4-517d-478e-806e-a6909661866b" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_68fd6b81-07f6-40f8-875a-e7342ce6e384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d294ce9b-ac13-4c9e-977b-99fbdc3301b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cf623f3d-c1bb-41fa-8f8a-25495ef18b8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d294ce9b-ac13-4c9e-977b-99fbdc3301b7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cf623f3d-c1bb-41fa-8f8a-25495ef18b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_733eb5fc-a81d-470a-aa8b-fb29b06d982c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cf623f3d-c1bb-41fa-8f8a-25495ef18b8e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_733eb5fc-a81d-470a-aa8b-fb29b06d982c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0abfc7da-93e0-4a10-bbba-6917fcedb8cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_733eb5fc-a81d-470a-aa8b-fb29b06d982c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0abfc7da-93e0-4a10-bbba-6917fcedb8cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b62bbd5c-1334-46bb-875d-138e028a88dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0abfc7da-93e0-4a10-bbba-6917fcedb8cc" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b62bbd5c-1334-46bb-875d-138e028a88dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_bba7974e-901f-4dd8-ac9f-54a22b42d553" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cf623f3d-c1bb-41fa-8f8a-25495ef18b8e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_bba7974e-901f-4dd8-ac9f-54a22b42d553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0c8efa69-4d71-46fa-a7dd-48e3fa5d9199" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_bba7974e-901f-4dd8-ac9f-54a22b42d553" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0c8efa69-4d71-46fa-a7dd-48e3fa5d9199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c18d5539-18d2-4e36-80bd-1c81b67f0b07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0c8efa69-4d71-46fa-a7dd-48e3fa5d9199" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c18d5539-18d2-4e36-80bd-1c81b67f0b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_ba2ae5d2-027b-4dc5-8222-edd3888f545c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0c8efa69-4d71-46fa-a7dd-48e3fa5d9199" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_ba2ae5d2-027b-4dc5-8222-edd3888f545c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_3475e07a-0510-40da-a12a-889cebf2672b" xlink:href="lgnd-20210331.xsd#lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0c8efa69-4d71-46fa-a7dd-48e3fa5d9199" xlink:to="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_3475e07a-0510-40da-a12a-889cebf2672b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_fc6ed765-1481-451b-b584-3a0e93dfed29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0c8efa69-4d71-46fa-a7dd-48e3fa5d9199" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_fc6ed765-1481-451b-b584-3a0e93dfed29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/Acquisitions" xlink:type="simple" xlink:href="lgnd-20210331.xsd#Acquisitions"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/Acquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_ab9ecfee-b806-4f6d-948e-b1a3d534ef7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_03c32662-4110-4eb8-9993-0e30de35e128" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_ab9ecfee-b806-4f6d-948e-b1a3d534ef7c" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_03c32662-4110-4eb8-9993-0e30de35e128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsTables" xlink:type="simple" xlink:href="lgnd-20210331.xsd#AcquisitionsTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/AcquisitionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_de1d1bf9-a33a-4a56-b8ba-7a51ebfc5b75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_6b9835bf-b70d-4e81-876a-3abfad95dac3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_de1d1bf9-a33a-4a56-b8ba-7a51ebfc5b75" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_6b9835bf-b70d-4e81-876a-3abfad95dac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_b663c70b-dc65-419d-9dc2-03791a17f927" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_de1d1bf9-a33a-4a56-b8ba-7a51ebfc5b75" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_b663c70b-dc65-419d-9dc2-03791a17f927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#AcquisitionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_c7aead8a-a1f9-400f-b443-51b088e08cfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd797b12-7007-4f1c-ad10-4873fd0e89a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_c7aead8a-a1f9-400f-b443-51b088e08cfa" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd797b12-7007-4f1c-ad10-4873fd0e89a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_389fa13f-933b-43a8-8afb-ee26ea42e764" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd797b12-7007-4f1c-ad10-4873fd0e89a3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_389fa13f-933b-43a8-8afb-ee26ea42e764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cda00b2b-3f9e-4d37-a0e9-a8c200b77901" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_389fa13f-933b-43a8-8afb-ee26ea42e764" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cda00b2b-3f9e-4d37-a0e9-a8c200b77901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_d4f83511-752e-441c-bc6e-e537c1fa578a" xlink:href="lgnd-20210331.xsd#lgnd_PfenexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cda00b2b-3f9e-4d37-a0e9-a8c200b77901" xlink:to="loc_lgnd_PfenexMember_d4f83511-752e-441c-bc6e-e537c1fa578a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TaurusBiosciencesLLCMember_f923e9b8-4e71-4305-9260-d2b965c3f48b" xlink:href="lgnd-20210331.xsd#lgnd_TaurusBiosciencesLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cda00b2b-3f9e-4d37-a0e9-a8c200b77901" xlink:to="loc_lgnd_TaurusBiosciencesLLCMember_f923e9b8-4e71-4305-9260-d2b965c3f48b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_XCellaBiosciencesIncMember_2a7d108b-562e-4762-aa44-0c51b46077f9" xlink:href="lgnd-20210331.xsd#lgnd_XCellaBiosciencesIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cda00b2b-3f9e-4d37-a0e9-a8c200b77901" xlink:to="loc_lgnd_XCellaBiosciencesIncMember_2a7d108b-562e-4762-aa44-0c51b46077f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IcagenMember_32d5c3e8-d642-4377-aec6-0c826d6d5a52" xlink:href="lgnd-20210331.xsd#lgnd_IcagenMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cda00b2b-3f9e-4d37-a0e9-a8c200b77901" xlink:to="loc_lgnd_IcagenMember_32d5c3e8-d642-4377-aec6-0c826d6d5a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fd44f0b0-30f4-4008-941a-5eac86f45c66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd797b12-7007-4f1c-ad10-4873fd0e89a3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fd44f0b0-30f4-4008-941a-5eac86f45c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3f0d6db0-1e9d-4059-a12e-21e557d73df0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fd44f0b0-30f4-4008-941a-5eac86f45c66" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3f0d6db0-1e9d-4059-a12e-21e557d73df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_1cc8c54b-779e-402f-bf5b-f39709d0142f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3f0d6db0-1e9d-4059-a12e-21e557d73df0" xlink:to="loc_us-gaap_ContractualRightsMember_1cc8c54b-779e-402f-bf5b-f39709d0142f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_08b616a2-b617-49b1-b220-a8936d38747c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3f0d6db0-1e9d-4059-a12e-21e557d73df0" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_08b616a2-b617-49b1-b220-a8936d38747c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_84048f3e-6c06-41f7-9108-37f688a28517" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3f0d6db0-1e9d-4059-a12e-21e557d73df0" xlink:to="loc_us-gaap_CustomerRelationshipsMember_84048f3e-6c06-41f7-9108-37f688a28517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_5fe4bf65-66ee-471d-83af-39e603ed35db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd797b12-7007-4f1c-ad10-4873fd0e89a3" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_5fe4bf65-66ee-471d-83af-39e603ed35db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_3461756f-9a59-4dba-800c-151f9399ae05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_5fe4bf65-66ee-471d-83af-39e603ed35db" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_3461756f-9a59-4dba-800c-151f9399ae05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_33a7039d-7345-455e-9fd4-443156d3607e" xlink:href="lgnd-20210331.xsd#lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_3461756f-9a59-4dba-800c-151f9399ae05" xlink:to="loc_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_33a7039d-7345-455e-9fd4-443156d3607e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentValueRightOnProductRevenuesMember_f191998d-f11e-4f1e-9609-17a4fabda345" xlink:href="lgnd-20210331.xsd#lgnd_ContingentValueRightOnProductRevenuesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_3461756f-9a59-4dba-800c-151f9399ae05" xlink:to="loc_lgnd_ContingentValueRightOnProductRevenuesMember_f191998d-f11e-4f1e-9609-17a4fabda345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_4b252c83-b7cc-4fa2-8c4b-8fb650f0159d" xlink:href="lgnd-20210331.xsd#lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_3461756f-9a59-4dba-800c-151f9399ae05" xlink:to="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_4b252c83-b7cc-4fa2-8c4b-8fb650f0159d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestonePaymentsMember_68d6c4ed-c5b7-4a2c-b2fa-0003d51e74c7" xlink:href="lgnd-20210331.xsd#lgnd_MilestonePaymentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_3461756f-9a59-4dba-800c-151f9399ae05" xlink:to="loc_lgnd_MilestonePaymentsMember_68d6c4ed-c5b7-4a2c-b2fa-0003d51e74c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_5219d5b3-3d1c-458e-9ece-4f35f826990b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd797b12-7007-4f1c-ad10-4873fd0e89a3" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_5219d5b3-3d1c-458e-9ece-4f35f826990b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_b2e83dfe-ac1a-431d-b61f-df4060d14b3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_5219d5b3-3d1c-458e-9ece-4f35f826990b" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_b2e83dfe-ac1a-431d-b61f-df4060d14b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_d0cd1b26-6163-46c2-88af-2db31083819c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_b2e83dfe-ac1a-431d-b61f-df4060d14b3e" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_d0cd1b26-6163-46c2-88af-2db31083819c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7fb73ae1-d048-43fd-955d-ed2366d78449" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd797b12-7007-4f1c-ad10-4873fd0e89a3" xlink:to="loc_srt_RangeAxis_7fb73ae1-d048-43fd-955d-ed2366d78449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b11577d5-2de7-4220-b3b2-9e8970b08881" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7fb73ae1-d048-43fd-955d-ed2366d78449" xlink:to="loc_srt_RangeMember_b11577d5-2de7-4220-b3b2-9e8970b08881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_46b09992-0587-4ed9-88f5-70bd494a1120" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b11577d5-2de7-4220-b3b2-9e8970b08881" xlink:to="loc_srt_MinimumMember_46b09992-0587-4ed9-88f5-70bd494a1120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b9d6025a-74d2-4251-a62b-83f8e5305f9b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b11577d5-2de7-4220-b3b2-9e8970b08881" xlink:to="loc_srt_MaximumMember_b9d6025a-74d2-4251-a62b-83f8e5305f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd797b12-7007-4f1c-ad10-4873fd0e89a3" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b6d82cd5-7594-45d3-83eb-bb39531414f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b6d82cd5-7594-45d3-83eb-bb39531414f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_0c8b8428-3e33-49f5-bf1d-4e1bfcb0b5a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_0c8b8428-3e33-49f5-bf1d-4e1bfcb0b5a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3723b883-34ff-42e7-ae71-fff75e63a903" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3723b883-34ff-42e7-ae71-fff75e63a903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_ee02b1bb-ba9a-49bc-9490-8e3626fb53e8" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_ee02b1bb-ba9a-49bc-9490-8e3626fb53e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_351a3374-db77-4fe3-b1dc-593457cb4c65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_351a3374-db77-4fe3-b1dc-593457cb4c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_c112a3f5-bd50-49ff-8748-c60eed915061" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_c112a3f5-bd50-49ff-8748-c60eed915061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_4b432a96-e532-4307-b586-43fd19d39a77" xlink:href="lgnd-20210331.xsd#lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_4b432a96-e532-4307-b586-43fd19d39a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_ddd2322c-554a-44d2-b15c-733738273d2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_ddd2322c-554a-44d2-b15c-733738273d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_9f464200-91dd-4dcf-b542-2a22758fa3bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_9f464200-91dd-4dcf-b542-2a22758fa3bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_47efddab-a69d-456c-8c26-21367f597218" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_47efddab-a69d-456c-8c26-21367f597218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_22da7711-8851-4117-81aa-9b7433610d96" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_22da7711-8851-4117-81aa-9b7433610d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationConsiderationTransferredHoldback_5940ce9a-5070-459b-ae67-a01ba01a4b62" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationConsiderationTransferredHoldback"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_lgnd_BusinessCombinationConsiderationTransferredHoldback_5940ce9a-5070-459b-ae67-a01ba01a4b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_f7170523-2c78-4b5a-b072-6e865644a9ff" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_f7170523-2c78-4b5a-b072-6e865644a9ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_d577fba5-49e0-40fa-9cd8-c7d392fe6173" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_d577fba5-49e0-40fa-9cd8-c7d392fe6173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_3d03d805-a3d7-4585-ba5f-7eb0bd20ecd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_3d03d805-a3d7-4585-ba5f-7eb0bd20ecd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_7a9cd4d0-9d8f-4982-8b2a-fbf6187945c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_7a9cd4d0-9d8f-4982-8b2a-fbf6187945c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_207c0c9b-71e3-48f2-af8b-3c291c302812" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_207c0c9b-71e3-48f2-af8b-3c291c302812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_9dccd892-5669-4d3b-a3ef-d358b2dc00fc" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_9dccd892-5669-4d3b-a3ef-d358b2dc00fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_3fdca531-e7d5-4e44-b7e3-b5897a65871d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_3fdca531-e7d5-4e44-b7e3-b5897a65871d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_b4321c2e-697e-449f-86a8-826de43f492c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_b4321c2e-697e-449f-86a8-826de43f492c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_d421c10d-ad3e-4991-b037-f2c5a9c4630f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d732d487-75b5-4b4d-874f-f09312309d4e" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_d421c10d-ad3e-4991-b037-f2c5a9c4630f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_656f510a-9a55-49ca-9a26-90d335171b6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e71bccfc-f57e-4719-81b9-b421381a36c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_656f510a-9a55-49ca-9a26-90d335171b6f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e71bccfc-f57e-4719-81b9-b421381a36c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3515b5ad-b226-42bb-a903-293a6bfc9d00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e71bccfc-f57e-4719-81b9-b421381a36c9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3515b5ad-b226-42bb-a903-293a6bfc9d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8e0981e8-3c76-46cc-9862-1a5a7fb59cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3515b5ad-b226-42bb-a903-293a6bfc9d00" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8e0981e8-3c76-46cc-9862-1a5a7fb59cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_3254e847-2054-4566-bdec-a0290a53cfaa" xlink:href="lgnd-20210331.xsd#lgnd_PfenexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8e0981e8-3c76-46cc-9862-1a5a7fb59cbe" xlink:to="loc_lgnd_PfenexMember_3254e847-2054-4566-bdec-a0290a53cfaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e71bccfc-f57e-4719-81b9-b421381a36c9" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_0aa9cbd4-8174-4c46-b643-1f68926bb9cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_0aa9cbd4-8174-4c46-b643-1f68926bb9cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_da9c6a0d-0de9-40e8-86b5-8f178b1c7ba5" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_da9c6a0d-0de9-40e8-86b5-8f178b1c7ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_74d59948-e5ec-44f5-8f74-562bcb6adc8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_74d59948-e5ec-44f5-8f74-562bcb6adc8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7dd81871-8bf8-46db-bf5d-35ae7cdee902" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7dd81871-8bf8-46db-bf5d-35ae7cdee902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_0152a21f-60ab-4f85-b0c3-267e919affbc" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_0152a21f-60ab-4f85-b0c3-267e919affbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_cccb0e8c-08cb-4d55-8c91-a839b16d1121" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_cccb0e8c-08cb-4d55-8c91-a839b16d1121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_d3987558-a66a-4b3c-a9e3-9d2636f10b55" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_d3987558-a66a-4b3c-a9e3-9d2636f10b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8a881d03-93f8-4908-948b-898e4bacd602" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_us-gaap_Goodwill_8a881d03-93f8-4908-948b-898e4bacd602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_928707de-973b-4a61-b7b5-3063fc2fcef1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_928707de-973b-4a61-b7b5-3063fc2fcef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_79a1f38f-a670-481a-b221-88db03b7512d" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_79a1f38f-a670-481a-b221-88db03b7512d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_80753ef1-9498-4bae-980e-81c746a28774" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_80753ef1-9498-4bae-980e-81c746a28774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_e6a77243-d925-4a9d-8abe-2cab7ce38a24" xlink:href="lgnd-20210331.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_e6a77243-d925-4a9d-8abe-2cab7ce38a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_af875ead-0231-47fe-ab31-3d3c95620612" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_af875ead-0231-47fe-ab31-3d3c95620612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_e1245627-d49b-4eb6-900f-3ee14b0c6870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_e1245627-d49b-4eb6-900f-3ee14b0c6870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d186c079-99d8-4d63-9411-8afa7d5d1399" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d186c079-99d8-4d63-9411-8afa7d5d1399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_b9e01121-c951-422c-b57f-b8963a9c05df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cd7231ea-be36-4baf-836d-93bd3bc51cc1" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_b9e01121-c951-422c-b57f-b8963a9c05df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#AcquisitionsProFormaFinancialInformationDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_c988d682-5c9c-486f-a522-dbab9d49fae9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4d3d06f8-bdd3-4a34-afbf-71e5229732b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_c988d682-5c9c-486f-a522-dbab9d49fae9" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4d3d06f8-bdd3-4a34-afbf-71e5229732b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_abd133df-4c60-4938-93dd-7cd76f93ecf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4d3d06f8-bdd3-4a34-afbf-71e5229732b2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_abd133df-4c60-4938-93dd-7cd76f93ecf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a55fbda0-28d4-4f28-8591-8da7b347d095" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_abd133df-4c60-4938-93dd-7cd76f93ecf1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a55fbda0-28d4-4f28-8591-8da7b347d095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_2f37f4d3-8af4-4e94-a057-ab6d17d51a80" xlink:href="lgnd-20210331.xsd#lgnd_PfenexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a55fbda0-28d4-4f28-8591-8da7b347d095" xlink:to="loc_lgnd_PfenexMember_2f37f4d3-8af4-4e94-a057-ab6d17d51a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_1dbea12e-26f2-44ac-b6a8-998bd606a21e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4d3d06f8-bdd3-4a34-afbf-71e5229732b2" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_1dbea12e-26f2-44ac-b6a8-998bd606a21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_e854d356-d74a-4755-9bd9-8c34ed4d0f2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1dbea12e-26f2-44ac-b6a8-998bd606a21e" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_e854d356-d74a-4755-9bd9-8c34ed4d0f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_ab480f35-0d3a-4f10-b0c8-2d0980d70291" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1dbea12e-26f2-44ac-b6a8-998bd606a21e" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_ab480f35-0d3a-4f10-b0c8-2d0980d70291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareProFormaAbstract_8c81f3b3-a54a-48ed-8b67-210eda471c06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareProFormaAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1dbea12e-26f2-44ac-b6a8-998bd606a21e" xlink:to="loc_us-gaap_EarningsPerShareProFormaAbstract_8c81f3b3-a54a-48ed-8b67-210eda471c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_31eaab1d-b075-45c1-a577-b175a443b51b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareProFormaAbstract_8c81f3b3-a54a-48ed-8b67-210eda471c06" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_31eaab1d-b075-45c1-a577-b175a443b51b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_f9b56e2a-03df-4707-8c8b-78542cf70dc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareProFormaAbstract_8c81f3b3-a54a-48ed-8b67-210eda471c06" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_f9b56e2a-03df-4707-8c8b-78542cf70dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="simple" xlink:href="lgnd-20210331.xsd#ConvertibleSeniorNotes"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f5fab79a-ea27-4d0e-bc91-a93f1c00e776" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_3a5a5d87-0cb1-4c35-9894-22a0b067e48e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f5fab79a-ea27-4d0e-bc91-a93f1c00e776" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_3a5a5d87-0cb1-4c35-9894-22a0b067e48e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="simple" xlink:href="lgnd-20210331.xsd#ConvertibleSeniorNotesTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_dbf92c05-b9c2-42ab-b93b-cb0cb6fccfba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_c998598f-c626-4a0c-85d0-4696b7718eff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_dbf92c05-b9c2-42ab-b93b-cb0cb6fccfba" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_c998598f-c626-4a0c-85d0-4696b7718eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#ConvertibleSeniorNotesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4b48d7b8-b929-4110-adce-5932e99f780b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2b0e70f9-2380-444e-9227-3d810452b56e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4b48d7b8-b929-4110-adce-5932e99f780b" xlink:to="loc_us-gaap_DebtInstrumentTable_2b0e70f9-2380-444e-9227-3d810452b56e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f0d4391f-c67e-46bb-a1f7-4e8d112421b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2b0e70f9-2380-444e-9227-3d810452b56e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f0d4391f-c67e-46bb-a1f7-4e8d112421b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d563bb98-e4bc-493f-9767-eeb8bda30472" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f0d4391f-c67e-46bb-a1f7-4e8d112421b4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d563bb98-e4bc-493f-9767-eeb8bda30472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_be1838cf-103e-4a0b-9b29-2dc23c3c492e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d563bb98-e4bc-493f-9767-eeb8bda30472" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_be1838cf-103e-4a0b-9b29-2dc23c3c492e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d383d016-3dcf-4039-9ffd-7fb5a775540c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2b0e70f9-2380-444e-9227-3d810452b56e" xlink:to="loc_us-gaap_DebtInstrumentAxis_d383d016-3dcf-4039-9ffd-7fb5a775540c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6807872a-c48a-40de-b573-db7a4e537a97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d383d016-3dcf-4039-9ffd-7fb5a775540c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6807872a-c48a-40de-b573-db7a4e537a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_0ba4b65a-bcdf-40c5-98f5-c0b3c215c7bf" xlink:href="lgnd-20210331.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6807872a-c48a-40de-b573-db7a4e537a97" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_0ba4b65a-bcdf-40c5-98f5-c0b3c215c7bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6b2d9433-8ce6-4de5-bbc1-c957cea588b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2b0e70f9-2380-444e-9227-3d810452b56e" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6b2d9433-8ce6-4de5-bbc1-c957cea588b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a30ecab8-f07b-4a22-b33d-a7a42c98ef3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6b2d9433-8ce6-4de5-bbc1-c957cea588b3" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a30ecab8-f07b-4a22-b33d-a7a42c98ef3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_1ad6a9bf-373f-4b71-998f-87286e2e223f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a30ecab8-f07b-4a22-b33d-a7a42c98ef3d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_1ad6a9bf-373f-4b71-998f-87286e2e223f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_4670616a-5e51-4d8e-a5e6-eb096149ca3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a30ecab8-f07b-4a22-b33d-a7a42c98ef3d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_4670616a-5e51-4d8e-a5e6-eb096149ca3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_00691dbc-1ca3-4954-a778-0591916a2750" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2b0e70f9-2380-444e-9227-3d810452b56e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_00691dbc-1ca3-4954-a778-0591916a2750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_28785225-5e7e-4ed9-9da6-09be40048af0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_00691dbc-1ca3-4954-a778-0591916a2750" xlink:to="loc_us-gaap_EquityComponentDomain_28785225-5e7e-4ed9-9da6-09be40048af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9a646e12-86b3-4ad1-98c6-370e9a13513a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_28785225-5e7e-4ed9-9da6-09be40048af0" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9a646e12-86b3-4ad1-98c6-370e9a13513a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2b0e70f9-2380-444e-9227-3d810452b56e" xlink:to="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_ccde61b1-fdc4-4b16-a1e6-df4288943cf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_ccde61b1-fdc4-4b16-a1e6-df4288943cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c71bf6fb-e3d6-453a-a162-bacd49f6f033" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c71bf6fb-e3d6-453a-a162-bacd49f6f033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_82038fe9-dc8f-4fab-9c99-8369d4aa1ea7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_82038fe9-dc8f-4fab-9c99-8369d4aa1ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_93933815-da71-4b04-a808-cbaa611982b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_93933815-da71-4b04-a808-cbaa611982b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_a32d28bc-ff2c-453e-8ca6-38737dd8f3dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_a32d28bc-ff2c-453e-8ca6-38737dd8f3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_d329754f-f677-455a-b565-0cab70c2d5be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_d329754f-f677-455a-b565-0cab70c2d5be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_2786cf27-0969-4788-aaef-3f6e1598d0b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_2786cf27-0969-4788-aaef-3f6e1598d0b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_1b51338b-84aa-4379-b3cf-29ef904c2d83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_1b51338b-84aa-4379-b3cf-29ef904c2d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_a81241bb-eeb7-4981-b955-7fcffc9f4dcc" xlink:href="lgnd-20210331.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_a81241bb-eeb7-4981-b955-7fcffc9f4dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_b6d1e8ff-e43c-4eda-a806-e68d18c5b72a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_b6d1e8ff-e43c-4eda-a806-e68d18c5b72a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_bfd981ad-878d-497b-84eb-283f7dd4b810" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_bfd981ad-878d-497b-84eb-283f7dd4b810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_2e7e10c3-9566-47c7-a566-0561b9aa6d3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_2e7e10c3-9566-47c7-a566-0561b9aa6d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_0df5aadd-bf2f-401b-938f-27f8b70c92ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_0df5aadd-bf2f-401b-938f-27f8b70c92ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_3c7113f2-abcc-4d2f-a573-2a5c5a5b2eb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_3c7113f2-abcc-4d2f-a573-2a5c5a5b2eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5d70f8f9-6d4b-4895-9519-5ac2868561f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5d70f8f9-6d4b-4895-9519-5ac2868561f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount_e4bdd89e-6863-4edf-9ee1-a22ecd50c5d0" xlink:href="lgnd-20210331.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_lgnd_IncreaseDecreaseInDebtDiscount_e4bdd89e-6863-4edf-9ee1-a22ecd50c5d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_bbd91731-7d39-472e-a04e-6eecf04bc9fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_bbd91731-7d39-472e-a04e-6eecf04bc9fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_bb545a10-516e-48ab-ae11-1c1ad13f8316" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_LongTermDebt_bb545a10-516e-48ab-ae11-1c1ad13f8316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_02ec4311-f119-4242-8234-acf962da06df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_02ec4311-f119-4242-8234-acf962da06df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForConvertibleBondHedges_fd9a22bd-2a89-448a-8f9c-27dec0085bbe" xlink:href="lgnd-20210331.xsd#lgnd_PaymentsForConvertibleBondHedges"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_lgnd_PaymentsForConvertibleBondHedges_fd9a22bd-2a89-448a-8f9c-27dec0085bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2b583c8f-f7e5-4230-b70a-718f126245f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2b583c8f-f7e5-4230-b70a-718f126245f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_dd58c650-91a7-44d4-9700-f36c3f9f76d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_dd58c650-91a7-44d4-9700-f36c3f9f76d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToUnwindWarrants_1c6bca9c-195d-4bd7-8526-ead5316a056e" xlink:href="lgnd-20210331.xsd#lgnd_PaymentsToUnwindWarrants"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_lgnd_PaymentsToUnwindWarrants_1c6bca9c-195d-4bd7-8526-ead5316a056e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_130308c0-4821-4224-b9eb-d6fe182ff925" xlink:href="lgnd-20210331.xsd#lgnd_ProceedsFromUnwindingConvertibleBondHedges"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_130308c0-4821-4224-b9eb-d6fe182ff925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_4dc2f384-7374-458f-9b98-98f0658e59bc" xlink:href="lgnd-20210331.xsd#lgnd_NumberOfOptionsUnderConvertibleBondHedges"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b7d387f-491d-4ab0-a6ff-7ff1e616ee23" xlink:to="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_4dc2f384-7374-458f-9b98-98f0658e59bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#ConvertibleSeniorNotesNotesPayableDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3dc3378b-1b0c-42fb-8ad9-2e6ba4790845" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d8858261-134d-418e-98b4-c5de6a675a48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3dc3378b-1b0c-42fb-8ad9-2e6ba4790845" xlink:to="loc_us-gaap_DebtInstrumentTable_d8858261-134d-418e-98b4-c5de6a675a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_66c3a38c-84ce-446c-87d7-fdf093637382" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d8858261-134d-418e-98b4-c5de6a675a48" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_66c3a38c-84ce-446c-87d7-fdf093637382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_46d39b0c-8a57-440c-aa3e-3b361a119bbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_66c3a38c-84ce-446c-87d7-fdf093637382" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_46d39b0c-8a57-440c-aa3e-3b361a119bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_eebd555e-f3e2-417a-bdb6-0ce293c14cca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_46d39b0c-8a57-440c-aa3e-3b361a119bbb" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_eebd555e-f3e2-417a-bdb6-0ce293c14cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_298ae494-da0f-42be-a646-2fd95885d393" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d8858261-134d-418e-98b4-c5de6a675a48" xlink:to="loc_us-gaap_DebtInstrumentAxis_298ae494-da0f-42be-a646-2fd95885d393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2eeede3c-810d-4c12-8909-5481a1eea49d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_298ae494-da0f-42be-a646-2fd95885d393" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2eeede3c-810d-4c12-8909-5481a1eea49d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_be54772b-5e38-4700-840e-cc1c049fcd53" xlink:href="lgnd-20210331.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2eeede3c-810d-4c12-8909-5481a1eea49d" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_be54772b-5e38-4700-840e-cc1c049fcd53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4dbc3939-f58b-4769-b9dd-6b7c7f83de4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d8858261-134d-418e-98b4-c5de6a675a48" xlink:to="loc_us-gaap_DebtInstrumentLineItems_4dbc3939-f58b-4769-b9dd-6b7c7f83de4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_daba2bb7-9dbe-4d12-b7ec-ec445a59803a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4dbc3939-f58b-4769-b9dd-6b7c7f83de4f" xlink:to="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_daba2bb7-9dbe-4d12-b7ec-ec445a59803a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_bd3f1a01-2d78-4358-9654-b1383fbb64c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_daba2bb7-9dbe-4d12-b7ec-ec445a59803a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_bd3f1a01-2d78-4358-9654-b1383fbb64c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_088c893e-be97-44cd-850a-e0b824f7f73a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_daba2bb7-9dbe-4d12-b7ec-ec445a59803a" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_088c893e-be97-44cd-850a-e0b824f7f73a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_6e080d4c-ed42-490f-bc70-00b56fe6b513" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_daba2bb7-9dbe-4d12-b7ec-ec445a59803a" xlink:to="loc_us-gaap_LongTermNotesPayable_6e080d4c-ed42-490f-bc70-00b56fe6b513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_9333fd5e-f708-4029-a2d9-1a05e90f6d80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4dbc3939-f58b-4769-b9dd-6b7c7f83de4f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_9333fd5e-f708-4029-a2d9-1a05e90f6d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_c0199a11-0ea5-490c-9563-101c640e5568" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4dbc3939-f58b-4769-b9dd-6b7c7f83de4f" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_c0199a11-0ea5-490c-9563-101c640e5568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTax" xlink:type="simple" xlink:href="lgnd-20210331.xsd#IncomeTax"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/IncomeTax" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6f72c564-ec42-48e2-9682-eaa18150fb7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_c1e1a7f9-7fa2-43bd-925a-35f142d268fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6f72c564-ec42-48e2-9682-eaa18150fb7e" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_c1e1a7f9-7fa2-43bd-925a-35f142d268fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#IncomeTaxNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/IncomeTaxNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d0901b78-cfae-47e3-966a-d77114e06f71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c0c2d9b6-d08a-45e9-b861-cd417463c008" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d0901b78-cfae-47e3-966a-d77114e06f71" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c0c2d9b6-d08a-45e9-b861-cd417463c008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquity" xlink:type="simple" xlink:href="lgnd-20210331.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b932d6a6-9055-4542-8606-7bd85be4e918" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3cfddc00-e82e-4c77-b6a0-829310717199" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b932d6a6-9055-4542-8606-7bd85be4e918" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3cfddc00-e82e-4c77-b6a0-829310717199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="lgnd-20210331.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c8336f5a-85a5-491c-998c-09a2b10ce833" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_96404e06-d62a-40f1-bce1-9c0d149fcecc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c8336f5a-85a5-491c-998c-09a2b10ce833" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_96404e06-d62a-40f1-bce1-9c0d149fcecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_83bfbcbb-0ad1-4a33-a6da-b30c4cb8774d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c8336f5a-85a5-491c-998c-09a2b10ce833" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_83bfbcbb-0ad1-4a33-a6da-b30c4cb8774d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_74169171-b16d-44d9-bb27-d3b5ade798fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_3932a3dd-61da-4dec-8e4b-e855f535889f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_74169171-b16d-44d9-bb27-d3b5ade798fc" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_3932a3dd-61da-4dec-8e4b-e855f535889f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f4e5fa4e-9dc0-4f30-af15-f097f12aae6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_3932a3dd-61da-4dec-8e4b-e855f535889f" xlink:to="loc_us-gaap_AwardTypeAxis_f4e5fa4e-9dc0-4f30-af15-f097f12aae6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e59a86ba-4b04-4292-b43c-8294e40fa2fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f4e5fa4e-9dc0-4f30-af15-f097f12aae6e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e59a86ba-4b04-4292-b43c-8294e40fa2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_95d74c98-55e5-4626-9502-76e2af7c56bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e59a86ba-4b04-4292-b43c-8294e40fa2fa" xlink:to="loc_us-gaap_EmployeeStockOptionMember_95d74c98-55e5-4626-9502-76e2af7c56bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_04975e86-6230-418c-8b4f-39d7f5b82498" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e59a86ba-4b04-4292-b43c-8294e40fa2fa" xlink:to="loc_us-gaap_RestrictedStockMember_04975e86-6230-418c-8b4f-39d7f5b82498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_d4aefdf2-8bbd-47b0-862c-4253d501b2d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_3932a3dd-61da-4dec-8e4b-e855f535889f" xlink:to="loc_us-gaap_ClassOfStockLineItems_d4aefdf2-8bbd-47b0-862c-4253d501b2d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f11152cf-dcc3-434f-9c56-e01ad50c977e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d4aefdf2-8bbd-47b0-862c-4253d501b2d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f11152cf-dcc3-434f-9c56-e01ad50c977e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_31812c99-b0db-4484-86ed-245dacb10991" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f11152cf-dcc3-434f-9c56-e01ad50c977e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_31812c99-b0db-4484-86ed-245dacb10991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_84d9e58a-233f-4251-88e0-126081f4d978" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f11152cf-dcc3-434f-9c56-e01ad50c977e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_84d9e58a-233f-4251-88e0-126081f4d978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bc1c985d-3710-4445-b275-a73dba5848da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f11152cf-dcc3-434f-9c56-e01ad50c977e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bc1c985d-3710-4445-b275-a73dba5848da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_568766e3-d96b-4556-88fa-518f2a000b43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f11152cf-dcc3-434f-9c56-e01ad50c977e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_568766e3-d96b-4556-88fa-518f2a000b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_813ad454-9842-470c-923a-097961e2d3d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f11152cf-dcc3-434f-9c56-e01ad50c977e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_813ad454-9842-470c-923a-097961e2d3d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9ea02117-fbfb-4b81-be47-0d05bdc5264b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d4aefdf2-8bbd-47b0-862c-4253d501b2d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9ea02117-fbfb-4b81-be47-0d05bdc5264b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1b776d90-35a2-4b81-be9d-7a181a90f01b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9ea02117-fbfb-4b81-be47-0d05bdc5264b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1b776d90-35a2-4b81-be9d-7a181a90f01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c4caeadf-2909-4598-a181-142918800347" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9ea02117-fbfb-4b81-be47-0d05bdc5264b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c4caeadf-2909-4598-a181-142918800347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_21f69eee-7d98-4f4b-8563-e530fa75ee24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9ea02117-fbfb-4b81-be47-0d05bdc5264b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_21f69eee-7d98-4f4b-8563-e530fa75ee24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_fce0a9ee-b8a9-4c6b-9bc4-b9a0923b4bc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9ea02117-fbfb-4b81-be47-0d05bdc5264b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_fce0a9ee-b8a9-4c6b-9bc4-b9a0923b4bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0d78db8d-759d-4673-882d-44851f3c4f65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9ea02117-fbfb-4b81-be47-0d05bdc5264b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0d78db8d-759d-4673-882d-44851f3c4f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a0eb7db6-50d2-4f2a-82d7-354179629efe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d4aefdf2-8bbd-47b0-862c-4253d501b2d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a0eb7db6-50d2-4f2a-82d7-354179629efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3f351a44-c749-481d-94e3-b2bb95b60ba0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a0eb7db6-50d2-4f2a-82d7-354179629efe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3f351a44-c749-481d-94e3-b2bb95b60ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_827d7c00-0f31-4853-8363-6c8b17662af1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a0eb7db6-50d2-4f2a-82d7-354179629efe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_827d7c00-0f31-4853-8363-6c8b17662af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8a58e0ac-7a61-4451-b725-98ec338730d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a0eb7db6-50d2-4f2a-82d7-354179629efe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8a58e0ac-7a61-4451-b725-98ec338730d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2855e6bc-30a4-40a2-8b2c-6f7c3e5c909b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a0eb7db6-50d2-4f2a-82d7-354179629efe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2855e6bc-30a4-40a2-8b2c-6f7c3e5c909b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8460a3bd-72be-4084-bd88-2a003da1dacc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a0eb7db6-50d2-4f2a-82d7-354179629efe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8460a3bd-72be-4084-bd88-2a003da1dacc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_894224a1-dfe3-4c3b-8c9d-c49d28ae0c1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d4aefdf2-8bbd-47b0-862c-4253d501b2d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_894224a1-dfe3-4c3b-8c9d-c49d28ae0c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_16ec38de-fb3a-4be5-9e5d-ef630b2be52a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_894224a1-dfe3-4c3b-8c9d-c49d28ae0c1b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_16ec38de-fb3a-4be5-9e5d-ef630b2be52a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_54dd3541-6afa-41e8-be51-00eaaf606fd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_894224a1-dfe3-4c3b-8c9d-c49d28ae0c1b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_54dd3541-6afa-41e8-be51-00eaaf606fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_bd793f6e-47a9-412f-ba75-04c896523c03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_894224a1-dfe3-4c3b-8c9d-c49d28ae0c1b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_bd793f6e-47a9-412f-ba75-04c896523c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8496890e-c63e-46ce-831c-49816658d269" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_894224a1-dfe3-4c3b-8c9d-c49d28ae0c1b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8496890e-c63e-46ce-831c-49816658d269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_82100def-3153-49f9-93f7-1fef6578d6b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_894224a1-dfe3-4c3b-8c9d-c49d28ae0c1b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_82100def-3153-49f9-93f7-1fef6578d6b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#StockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_288540f1-8a71-46e8-a72f-28002b8e6726" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a78d1c28-a14a-4fac-9de0-d94504bc2cd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_288540f1-8a71-46e8-a72f-28002b8e6726" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a78d1c28-a14a-4fac-9de0-d94504bc2cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_1f170a59-dd0f-4aca-85d5-0955f5348366" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a78d1c28-a14a-4fac-9de0-d94504bc2cd4" xlink:to="loc_us-gaap_PlanNameAxis_1f170a59-dd0f-4aca-85d5-0955f5348366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1209084c-0626-4aa0-aa93-ef580bff3cde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_1f170a59-dd0f-4aca-85d5-0955f5348366" xlink:to="loc_us-gaap_PlanNameDomain_1209084c-0626-4aa0-aa93-ef580bff3cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanMember_e8e1a1e9-a01c-496d-8f8f-3b45f6a951d6" xlink:href="lgnd-20210331.xsd#lgnd_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_1209084c-0626-4aa0-aa93-ef580bff3cde" xlink:to="loc_lgnd_EmployeeStockPurchasePlanMember_e8e1a1e9-a01c-496d-8f8f-3b45f6a951d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97c158d8-4fb4-4c27-908d-3f7620d11643" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a78d1c28-a14a-4fac-9de0-d94504bc2cd4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97c158d8-4fb4-4c27-908d-3f7620d11643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_5f3312ae-2b9d-4909-b6bd-a80fa42ebfdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97c158d8-4fb4-4c27-908d-3f7620d11643" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_5f3312ae-2b9d-4909-b6bd-a80fa42ebfdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_27d6434c-b751-4b35-ab12-da5efc7f0663" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97c158d8-4fb4-4c27-908d-3f7620d11643" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_27d6434c-b751-4b35-ab12-da5efc7f0663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract_454e1e82-e239-446c-ab93-66c4f6b0c0aa" xlink:href="lgnd-20210331.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97c158d8-4fb4-4c27-908d-3f7620d11643" xlink:to="loc_lgnd_EmployeeStockPurchasePlanAbstract_454e1e82-e239-446c-ab93-66c4f6b0c0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_7f0e0a18-2ad2-4cea-97b3-2f22d400b8cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_454e1e82-e239-446c-ab93-66c4f6b0c0aa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_7f0e0a18-2ad2-4cea-97b3-2f22d400b8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_d6e118fa-0a2f-4fca-80de-5d6e513d1ce9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_454e1e82-e239-446c-ab93-66c4f6b0c0aa" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_d6e118fa-0a2f-4fca-80de-5d6e513d1ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_cb6f7443-36be-408b-a0fc-5ba3da32d584" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97c158d8-4fb4-4c27-908d-3f7620d11643" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_cb6f7443-36be-408b-a0fc-5ba3da32d584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_27c49e2f-cf6c-419b-bb30-09bc89223764" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97c158d8-4fb4-4c27-908d-3f7620d11643" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_27c49e2f-cf6c-419b-bb30-09bc89223764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_0db6775c-182f-4e34-b219-e4a80ec8241f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97c158d8-4fb4-4c27-908d-3f7620d11643" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_0db6775c-182f-4e34-b219-e4a80ec8241f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_893da9e5-2e60-4afd-95a8-547c8cf73fa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97c158d8-4fb4-4c27-908d-3f7620d11643" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_893da9e5-2e60-4afd-95a8-547c8cf73fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CommitmentandContingenciesLegalProceedings"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_38a369be-fec6-45be-9f6d-4551bf1dd527" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_6989c32c-eafd-4fee-934f-7183ae2f16b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_38a369be-fec6-45be-9f6d-4551bf1dd527" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_6989c32c-eafd-4fee-934f-7183ae2f16b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210331.xsd#CommitmentandContingenciesLegalProceedingsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_496f2752-9531-4f62-9fce-e4ee5a12b0d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesTable_4d0e1a6f-7efe-4e10-befc-a9442e21c768" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_496f2752-9531-4f62-9fce-e4ee5a12b0d9" xlink:to="loc_us-gaap_GainContingenciesTable_4d0e1a6f-7efe-4e10-befc-a9442e21c768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_d453bb99-b2cc-419a-9124-0ccec7a1b49a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesTable_4d0e1a6f-7efe-4e10-befc-a9442e21c768" xlink:to="loc_srt_LitigationCaseAxis_d453bb99-b2cc-419a-9124-0ccec7a1b49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_728efd6c-2301-4de4-9193-4de4f9a5fb97" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_d453bb99-b2cc-419a-9124-0ccec7a1b49a" xlink:to="loc_srt_LitigationCaseTypeDomain_728efd6c-2301-4de4-9193-4de4f9a5fb97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LupinPatentInfringementMember_0ab83b0e-8370-4468-9c0d-62b61466d980" xlink:href="lgnd-20210331.xsd#lgnd_LupinPatentInfringementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_728efd6c-2301-4de4-9193-4de4f9a5fb97" xlink:to="loc_lgnd_LupinPatentInfringementMember_0ab83b0e-8370-4468-9c0d-62b61466d980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_abe5254b-682d-4c6e-839c-deaf0b1ec501" xlink:href="lgnd-20210331.xsd#lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_728efd6c-2301-4de4-9193-4de4f9a5fb97" xlink:to="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_abe5254b-682d-4c6e-839c-deaf0b1ec501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_InterPartesReviewOfPatentMember_8de7d56b-8cb1-4a1a-a60e-9c5ff5a25175" xlink:href="lgnd-20210331.xsd#lgnd_InterPartesReviewOfPatentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_728efd6c-2301-4de4-9193-4de4f9a5fb97" xlink:to="loc_lgnd_InterPartesReviewOfPatentMember_8de7d56b-8cb1-4a1a-a60e-9c5ff5a25175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_9b972573-da34-4d3f-960a-f5d19ad3bd53" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesTable_4d0e1a6f-7efe-4e10-befc-a9442e21c768" xlink:to="loc_dei_LegalEntityAxis_9b972573-da34-4d3f-960a-f5d19ad3bd53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e62b4689-51d4-4fc7-b1d6-7b7955723527" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_9b972573-da34-4d3f-960a-f5d19ad3bd53" xlink:to="loc_dei_EntityDomain_e62b4689-51d4-4fc7-b1d6-7b7955723527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_ea9efcc4-787c-4e28-9d2f-129b306f125d" xlink:href="lgnd-20210331.xsd#lgnd_PfenexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_e62b4689-51d4-4fc7-b1d6-7b7955723527" xlink:to="loc_lgnd_PfenexMember_ea9efcc4-787c-4e28-9d2f-129b306f125d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GlaxoSmithKlineBiologicalsSAMember_7f32f239-2fe9-42b4-b5ef-208fd8647718" xlink:href="lgnd-20210331.xsd#lgnd_GlaxoSmithKlineBiologicalsSAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_e62b4689-51d4-4fc7-b1d6-7b7955723527" xlink:to="loc_lgnd_GlaxoSmithKlineBiologicalsSAMember_7f32f239-2fe9-42b4-b5ef-208fd8647718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesLineItems_8d93bac3-94a5-4987-8ebe-a679699009c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesTable_4d0e1a6f-7efe-4e10-befc-a9442e21c768" xlink:to="loc_us-gaap_GainContingenciesLineItems_8d93bac3-94a5-4987-8ebe-a679699009c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_1a682155-7841-4ca7-b36c-5eed17236620" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_8d93bac3-94a5-4987-8ebe-a679699009c8" xlink:to="loc_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_1a682155-7841-4ca7-b36c-5eed17236620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_8078e184-5f08-4960-8920-3c103772432c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_8d93bac3-94a5-4987-8ebe-a679699009c8" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_8078e184-5f08-4960-8920-3c103772432c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfPetitionsFiled_823c79f7-c759-42fe-86b2-9cdc865287a2" xlink:href="lgnd-20210331.xsd#lgnd_NumberOfPetitionsFiled"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_8d93bac3-94a5-4987-8ebe-a679699009c8" xlink:to="loc_lgnd_NumberOfPetitionsFiled_823c79f7-c759-42fe-86b2-9cdc865287a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>lgnd-20210331_g1.jpg
<TEXT>
begin 644 lgnd-20210331_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!817AI9@  34T *@    @ ! $Q  (
M   1    /E$0  $    ! 0   %$1  0    !   N(U$2  0    !   N(P
M  !!9&]B92!);6%G95)E861Y  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" (+!<8# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\IP<88*1\RY%?E!^TU\ /%G_  3Z_:3BM;74;J":PE74O#^M0#RS<Q;CM?N
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MIKEW/?W/A359-+M[B9R\CV_E1RQJS'DE2[*,]%"CM7UM7PQ_P09_Y-T\8_\
M8QG_ -)8:^YZA[@%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "OYQZ_HXK^<>JB 44450!1110 5^WG_!+S_DPOX=?]><__I7-
M7XAU^WG_  2\_P"3"_AU_P!><_\ Z5S4I >^4445 !1110 5@?%3P!:_%;X9
M^(?#%]@6GB'3KC3I6QDHLL;)N'N-V1[@5OT4 ?@M\(/&FK_L9_M7Z5JE_:NF
MI^!]::#4+9>&=%9H;B-2<?>C,@!Z?,#7[:>-/%NG>/?V>=9UO2+N*^TO5O#]
MQ=VEQ&<K-$]NS*P^H-?'7_!7#_@GA>?$UYOBCX'L&NM;MX0-=TV!,RW\:+A;
MB-1RTBJ &4<LJ@CE<-\X?\$_O^"E]_\ LJ6K>$/%5G/XA^']W(V;< -<:67)
M\PQ*W#QMDEHF(&<D$$L&IZ@4/^"._P#R?IX7_P"O._\ _222OTP_X*%_"0?&
MG]CCQWI"0&>\M].;4K-57+^=;$3J%_VF"%/HY'>C]G7XA? CXFS6VK_#H_#\
M:GM(065E;V>HP;A@@QE5F3()'3!YZU[!JVJ6FBZ?+<WUS;VEI$I:26>18XT'
M<ECP!]:38'XY_P#!'GXH+\.OVVM&M)IO)M?%5E<Z/(2?E+LHEB!]S)"BCW>O
MIC_@N7^TA;:)\/-&^&-A<*^HZW.FJ:HBG)AM8B?*1O=Y?F'_ %Q]QG6_:J_;
MO^ 7[.5M+%X%\*^ _%WC>V8/9OINE6QLM/F!RLKW*+@E2,A8F+9&"4ZCX8^#
MGP;^(7_!1G]HNZ=I[B_U'5+@76MZU.F8-/B) W-C &%&V.-<9V@# !(?F!]7
M_P#!!_X%S";QC\1+R K;R1+H&GLR\3?,LUP1GL"L !'?<.U%?>WP7^$.B_ 7
MX7:+X1\/P&#2M$MQ!%NY>5NKR.>[NQ9F/JQX XHI,#^>^BBBK **** "BBB@
M#]4?^"#/_)NGC'_L8S_Z2PU]SU\,?\$&?^3=/&/_ &,9_P#26&ON>H>X!111
M2 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K^<>OZ.
M*_G'JH@%%%%4 4444 %?MY_P2\_Y,+^'7_7G/_Z5S5^(=?MY_P $O/\ DPOX
M=?\ 7G/_ .E<U*0'OE%%%0 4444 %%%% !7R[^UI_P $HOAW^TUJ%SK-AYG@
MOQ3<9:2^T^%6M[IS_%-;Y"LV>2R%&)/)-?45% 'Y$?$+_@B3\8O"EVXT9_#7
MBBVY,;6U_P#9I2/]I9@B@^P9A[US=A_P2/\ V@]<N(XKOPG#:1Q*$22ZUVR=
M(UST 29R /0"OV;HI\P'YL? K_@@]?2WD5U\1_%UM#;J06T_05:1Y!GH9Y5
M7W C;KP1BOO[X/\ P4\+? /P7!X?\(Z+9Z)I<'/EP*2\S="\CG+2.?[S$G@<
M\5U-%%P"BBBD!_./1116@!1110 4444 ?JC_ ,$&?^3=/&/_ &,9_P#26&ON
M>OAC_@@S_P FZ>,?^QC/_I+#7W/4/< HHHI %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !6#XW^*/AKX:VPF\0Z_HVAQL-RF^O(X-X_V0Q!/X5\?_P#!0/\ X**Z
MCX*\37G@7P#="UO;%C#JVK( SPR=X(>H#+T9^H;(&"":^#]:UR]\2:I-?:C>
M75_>W#;Y;BYE:664^K,Q))^IK\CXH\5\+EV(E@\#3]K.+LVW:*?9;MVZ[+S9
M^Q<*>$6*S+#QQF/J>RA)722O)KHWLHWZ;OR1^KVN?\%'?@QH3LC^-(;B11D+
M;6%U,&^C+&5_6LK_ (>C?!K_ *&"_P#_  57/_Q%?E917P,_&7.F[QITDO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "OYQZ_HXK^<>JB 44450!1110 5^WG_!+S_DPOX=?]><
M_P#Z5S5^(=?MY_P2\_Y,+^'7_7G/_P"E<U*0'OE%%%0 4444 %%%% !1110
M4444 %%%% !1110!_./1116@!1110 4444 ?JC_P09_Y-T\8_P#8QG_TEAK[
MGKX8_P""#/\ R;IXQ_[&,_\ I+#7W/4/< HHHI %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7\X]?T<5_./51 ****H HHHH *_;S_@EY_P F%_#K
M_KSG_P#2N:OQ#K]O/^"7G_)A?PZ_Z\Y__2N:E(#WRBBBH **** "BBB@ HHH
MH **** "BBB@ HHHH _G'HHHK0 HHHH **** /U1_P""#/\ R;IXQ_[&,_\
MI+#7W/7PQ_P09_Y-T\8_]C&?_26&ON>H>X!1112 **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%<AXH_:"\!>!Y3'K7C?PAH[J<%;W6;>W(/T=Q0!U]%
M>/:A_P % _@IIJJ9/B9X2;?T\J]$OY[,X_&C3_\ @H'\%-25C'\3/"2[.OFW
MHB_+?C/X4 >PT5P.A?M6?"_Q.R+IWQ&\"WLCA2(X==M6?GH"H?(/L1FNVTS5
MK76K19[.YM[N!NDD,@D0]^HX[T 6**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BL_P 0>+=*\)VXFU74]/TR
M$\A[NX2%?S8@5PVL_MC_  E\/LRW?Q-\!Q2*0&C&NVSR+D9&55R1Q[4 >DT5
MXU>_\%#/@E83^7)\2_"S,!G,=SYJ_FH(JSIO[>WP7U98S%\3O!J>:VT>=J4<
M.#G'.\C ]S@4 >N45R_A7XW^"_';JNA^+_"^LL^-HL=5@N"V>F-C&NHH ***
M* "BBB@ HHHH *_G'K^CBOYQZJ(!1115 %%%% !7[>?\$O/^3"_AU_UYS_\
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MGFM;JV<2PS0N4DB<'(96'((/((K]9?\ @F)_P4I3]H[3X/ _C6XA@\<V,/\
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M $U^\?X=N-S?GW<W,E[<R332/+-*Q=W=BS.Q.223R23WIE%6D 4444 %%%%
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M $KFK\0Z_;S_ ()>?\F%_#K_ *\Y_P#TKFI2 ]\HHHJ "BBB@ HHHH ****
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M110 4444 ?SCT445H 4444 %%%% 'ZH_\$&?^3=/&/\ V,9_])8:^YZ^&/\
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M=^TG)\3/@3J'@74KCS-3\#2+]C+M\TEC,6*#GD^7('7T"M&*_)ZOH+_@E_\
M&Q_@C^V;X4N))A#IWB*4Z#?9.%9+@A8R3T 680L2>RFDP/VVHHHJ "BBB@ H
MHHH _,O_ (+ZZ/+!\0/AQJ!_U-UI][;IQ_%')$S?I*M?GW7[!?\ !8W]G:_^
M-O[,46L:/;27>J^"+LZD8HU+/):,A6<* .2N(W_W8V]J_'VK6P!16Y\/?AKX
M@^+/BB#1?#.C:CKFJW)^2VLX&E?&>6./NJ,\L< =R*_0C]DO_@B#!;16^L_%
MV^,\IPZ^']-GPB=]L]PO+'J"L1 &,B0]*&P/@WX+_L^^,_VA_$HTGP;X>U'7
M;L$>:T"8AM@>C2RMA(Q[LPK[]_9J_P""&&FZ6+?4OBEKK:G-@.=&TAVBMU.<
M[9+@@.XQP0@3!Z,:^\O W@#0_ACX:M]&\.Z1IVB:5:C$5K90+#$OJ<*!DGN3
MR>YK7J6P.6^%7P2\(_ _05TSPCX=TGP_9@ ,MI;A'FQWD?[TC>[$GWKJ:**0
M!1110 4444 %%%% !1110 5P/[1/[,_@_P#:C\"2Z!XNTN.]AP3;72 )=6#G
M_EI#)C*G@9'(;&"".*[ZB@#\+OVUOV*_$?[&'Q(&EZFQU'0]1WR:1JR1[8[V
M-<95AD[)5R-RY[@@D$&O&*_?;]J+]G+0_P!JCX,ZKX0UQ%5+M/,L[H+NDT^Y
M4'RYD]P3@C(W*64\$U^$WQ/^'&J_"'XAZSX8URW-MJVA7;V=S'U&Y3C<I[JP
MP0>X(/>K3 PJ***8!1110 5^J'_!"_XX-XM^"/B'P-=SE[GPE>B[LU8]+6YW
M$JOJ%F20G_KJ*_*^OJ7_ ((\?%(_#G]MG1K*24QVGBNSN-(ER?EW%?.CX]3)
M"BC_ '_<TGL!^R=%%%0 4444 %%%% '\_G[2?_)Q?C[_ +&/4?\ TJDKBJ[7
M]I/_ ).+\??]C'J/_I5)7%5H@"BBB@ HHHH **** "BBNK^"_P $_$W[07Q
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M544 ?@-^T3^S'XR_9:\;MH7C#2GLIGRUM=1YDM+] <;X9, ,.F1PPR,@'BN
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MS_Z2PU]SU#W ****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!_/Y^TG_R<7X^_[&/4?_2J2N*KM?VD_P#DXOQ]_P!C'J/_ *52
M5Q5:( HHHH **** /VJ_X))_\H^?A_\ ]Q'_ -.5U7T=7SC_ ,$D_P#E'S\/
M_P#N(_\ IRNJ^CJA@%%%%( HHHH X#]JKXHM\%OV;_&WBB.017.CZ/<2VK$X
M'V@H5A'XR,@_&OP&)+$DDDGJ:_7_ /X+7>-SX6_8JETY6&?$NM6=@R[L$JA>
MY)QW&;=?S%?D!51 ****H HHHH W?AC\/K_XK_$70_#.EKOU#7KZ&P@XR%:1
MPNX^PSD^@!K]^_A5\-M,^#OPVT/PMHT0ATS0;..S@&.6"+@LWJS'+$]R2:_*
M?_@BA\)U\=_M=OKMQ%OMO!VES7J,1E1<2X@C!]]KRL/0I7Z\5,F 4445(!11
M10 4444 %%%% !1110 5ROQO^$^G_'3X1>(O"&J*ILM?L9+1F(SY+D920?[2
M.%<>ZBNJHH _G8\7>%KSP/XLU31=1C\G4-'NY;&ZC_N2Q.4<?@RFLZOIG_@K
MI\,Q\./VX?$DL4?E6WB6"WUF$8ZF1-DA_&:*4_C7S-6@!1110 5+87\VEWT-
MU;R-#<6TBRQ2*<%&4Y!'N"*BHH _H4^#OQ B^*_PE\,>)X=HC\0Z5;:B%4\)
MYL2N5^H+$8[8KI*^<?\ @DWXQ;QA^P?X+\Q]\^E_:M/D]A'<R;!_W[,=?1U9
M@%%%% !1110 C*&4@@$'@@]Z^?O'?_!+;X&_$3Q;-K5]X)B@N[J3S9TL;ZXL
MX)F)R28XW55SWV!>OK7T%10!RWPI^"/A'X&:"=,\(>'=*\/V;D&1;. (TQ'1
MG?[SGW8DUU-%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^9O_!=;
M]GB+1?%7AOXF6%N$36A_8^K,HP&GC0M;N?5FB5U^D*5^F5>#?\%-/A<OQ7_8
MD\=6BQA[G2;+^V;<XR4:U83.1[F-9%_X$:: _$"BBBK **** "NG^"?CMOA=
M\8_"GB169#H.KVNH$CN(IE<CW! (([@US%% ']&ZL&4$$$'D$=Z6N+_9O\5'
MQS^SSX$UIFWOJOAZPNW.>=SV\;,#R>02<\GFNTK, HHHH **** /Y_/VD_\
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M110 4444 %%%% !1110 4444 ?S^?M)_\G%^/O\ L8]1_P#2J2N*KM?VD_\
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M HHHH **** -CX?^ -8^*?C73?#N@6$^IZQJ\XM[6VB&6D8_H !DDG@ $D@
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MU:8!1113 **** "OV\_X)>?\F%_#K_KSG_\ 2N:OQ#K]O/\ @EY_R87\.O\
MKSG_ /2N:E(#WRBBBH **** "BBB@ HHHH **** "BBB@ HHHH _G'HHHK0
MHHHH **** /U1_X(,_\ )NGC'_L8S_Z2PU]SU\,?\$&?^3=/&/\ V,9_])8:
M^YZA[@%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?_26&ON>H>X!1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG_TEAK[GJ'N 4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@L/%>BVNI:7>VFHZ=>QB:WNK:5989T/1E=20P/J#4- 7****0!1110 4444
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M(Y]V/)JO113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]F/\
M@CO_ ,F&>&/^OR__ /2J2OJ"OE__ (([_P#)AGAC_K\O_P#TJDKZ@J& 4444
M@"BBB@#^?S]I/_DXOQ]_V,>H_P#I5)7%5VO[2?\ R<7X^_[&/4?_ $JDKBJT
M0!1110 4444 ?M5_P23_ .4?/P__ .XC_P"G*ZKZ.KYQ_P""2?\ RCY^'_\
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M<=.5-? WQA^./BSX_>+7USQAKM_KNHL"J/</\D"YSLC086-,_P *@"N4HII
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MO_@YM/\ XNC_ (<[_'K_ *%?3?\ P<VG_P 71<#Y?HKZ@_X<[_'K_H5]-_\
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M% 'ZH_\ !!G_ )-T\8_]C&?_ $EAK[GKX8_X(,_\FZ>,?^QC/_I+#7W/4/<
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MA7>Y520BY R?09(&?<4R@ HHHH **** "BBB@ HHHH **** "BBB@ HH +$
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MX[U3XG^-M5\1:W=O>ZMK5T]W=3/U>1R2<#L!T '   ' K(JT@"BBBF 4444
M%%:/A'PCJGCWQ+9:-HMA=ZIJNHRB&VM;:,R2S.>P4?G[ $U^G_[$?_!&_0?A
MM:6?B+XIQ6OB/Q$<2QZ,")-.L/02]IW'?/[L'(P_#4FP/@W]G;]A;XG?M0/'
M+X7\-W']DNVUM6OO]%L%P<'$C??QW$89AZ5]M_!7_@@_X>TJ"&Y\?^+M1U>Z
MX9[+1D%K;J?[IE<,[CW"QFOONSLX=.LXK>WBC@MX$$<44:A4C4# 4 <  < "
MI*EL#Q_X9_L"?!OX2)'_ &/\/?#K31<K<7]O_:$ZGU#SEV4_0BO6[*Q@TVT2
M"VABMX(AM2.- B(/0 <"I:*0!1110 4444 %%%% !1110!^$'[=W_)YOQ/\
M^QDO?_1K5Y-7K/[=W_)YOQ/_ .QDO?\ T:U>35H@"BBB@ HHHH _9C_@CO\
M\F&>&/\ K\O_ /TJDKZ@KY?_ ."._P#R89X8_P"OR_\ _2J2OJ"H8!1112 *
M*** /Y_/VD_^3B_'W_8QZC_Z525Q5=K^TG_R<7X^_P"QCU'_ -*I*XJM$ 44
M44 %%%% '[5?\$D_^4?/P_\ ^XC_ .G*ZKZ.KYQ_X))_\H^?A_\ ]Q'_ -.5
MU7T=4, HHHI %%%% !1110 4444 %%%% !1110 4444 ?./_  5L_P"4?/Q
M_P"X=_Z<K6OQ5K]JO^"MG_*/GX@?]P[_ -.5K7XJU<0"BBBF 4444 =K^S9_
MR<7X!_[&/3O_ $JCK^@.OY_/V;/^3B_ /_8QZ=_Z51U_0'4R ****D HHHH
M_-7_ (+]Z:8O$OPPO-J!9[;4H0P^\2CVQP?8>8,?4U^>-?IK_P %]=!^T?#W
MX<ZGLR+/4;RUW;,X\V*)L9[9\GIWQ[5^956M@"BBBF 4444 =I^S?K1\-_M$
M> M1!(-AXCT^Y! R1LN8VZ'KTK^@2OYS+"]?3;Z&XB($MO(LB9&1D'(_E7]%
M.AZO%X@T6SOX#F"]@2XC.<Y5U##]#4R M4445(!1110 4444 %%%% !1110
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MHJ "BBB@ HHHH **** "BBB@ HHHH **** /YQZ***T **** "BBB@#]4?\
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M%7P?PUI\N-;OX),KJLZ'(@0CK"C#)/1W QPH+?"-6D 4444P"BBB@ K]O/\
M@EY_R87\.O\ KSG_ /2N:OQ#K]O/^"7G_)A?PZ_Z\Y__ $KFI2 ]\HHHJ "B
MBB@ HHHH **** "BBB@ HHHH **** /YQZ***T **** "BBB@#]4?^"#/_)N
MGC'_ +&,_P#I+#7W/7PQ_P $&?\ DW3QC_V,9_\ 26&ON>H>X!1112 ****
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MW!'_ '[_ -[[OY5W-S)>W,DTTCRS2L7=W8LSL3DDD\DD]ZI(!E%%%4 4444
M%%%% !7[>?\ !+S_ ),+^'7_ %YS_P#I7-7XAU^WG_!+S_DPOX=?]><__I7-
M2D![Y1114 %%%% !1110 4444 %%%% !1110 4444 ?SCT445H 4444 %%%%
M 'ZH_P#!!G_DW3QC_P!C&?\ TEAK[GKX8_X(,_\ )NGC'_L8S_Z2PU]SU#W
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M@_;:_IS0VVL6H6#6=,#Y?3[C![=3&^"4;N,C[RL!Z[68!1110 4444 %%%%
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M:K_@DG_RCY^'_P#W$?\ TY75?1U?./\ P23_ .4?/P__ .XC_P"G*ZKZ.J&
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MDDD)9F8Y+$]23W--HHJ@"BBB@ HHHH **** "OV\_P""7G_)A?PZ_P"O.?\
M]*YJ_$.OV\_X)>?\F%_#K_KSG_\ 2N:E(#WRBBBH **** "BBB@ HHHH ***
M* "BBB@ HHHH _G'HHHK0 HHHH **** /:?V9_V^?B%^R9X4O]%\'W.E0V.I
M7?VV875DL[&38J<$G@84<5Z3_P /I/CA_P __AO_ ,%*?XU\FT4K ?67_#Z3
MXX?\_P#X;_\ !2G^-'_#Z3XX?\__ (;_ /!2G^-?)M%%D!]9?\/I/CA_S_\
MAO\ \%*?XT?\/I/CA_S_ /AO_P %*?XU\FT460'UE_P^D^.'_/\ ^&__  4I
M_C1_P^D^.'_/_P"&_P#P4I_C7R;119 ?67_#Z3XX?\__ (;_ /!2G^-'_#Z3
MXX?\_P#X;_\ !2G^-?)M%%D!]9?\/I/CA_S_ /AO_P %*?XT?\/I/CA_S_\
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MA!)%+$X=)5(R&5AP01W%35^+'[#O_!23Q=^R%JT.FW4EQXB\#ROB?2)I<M:
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M?_*/GX?_ /<1_P#3E=5]'5\X_P#!)/\ Y1\_#_\ [B/_ *<KJOHZH8!1112
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M$UXE10!_0]\.?B'H_P 6? VE^)/#]]%J.C:S;K<VMQ'T=3V(/*L#D%3RI!!
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M\_Y,+^'7_7G/_P"E<U?B'7[>?\$O/^3"_AU_UYS_ /I7-2D![Y1114 %%%%
M!1110 4444 %%%% !1110 4444 ?AK_P4.^ =W^SU^UCXKTR6W>+3-5NY-7T
MN0KA);:=V<!3WV,6C/O&:\1K]XOVL_V//"'[8G@1-'\302PWED6DTW4[;"W6
MGR,!DJ2,,C8&Y#PV!T(5A^8WQY_X(_?%[X1:G.^BZ;%XYT9,F.[TIE$^.P>V
M8^8&]DWC_:JTP/E:BO2'_8W^+L;E3\+/B-E3CCPW>$?GY=)_PQU\7?\ HE?Q
M'_\ ":O?_C=,#SBBO1_^&.OB[_T2OXC_ /A-7O\ \;H_X8Z^+O\ T2OXC_\
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M?%FAZ=KVF2\^3=Q!]C8QN1OO(WHRD$>M-,#^>JBOTI_:,_X(56=^]QJ'PO\
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MG>$_"6E^!/#MII&BZ?9Z5I=A&(K>UM85BAA4=E5>!6C114@9OC+_ )%#5?\
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M HHJYH7AW4/%.I)9Z98WFHWDGW(+6%II&^BJ"30!U/[-G_)Q?@'_ +&/3O\
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M#P3_ .".U_\ B*U?#WPG\*^$9$?2?#7A_2WCY5K33H8"O.>-JC'(!^HKH**
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M+_X(<^#FU[]KK4=49#Y.A>'[B4/C@222Q1*/Q5I#_P !-)@?K;1114 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% 'YH_\%^?^1O^&?\ UYZA
M_P"AV]?GK7Z9_P#!?;PM)=^ _AOK8!\K3[^]L6.>,SQQ./\ TG-?F95K8 HH
MHI@%%%% 'W7_ ,$'/&\.D_'CQCH$KJDFM:*EU#D_?:WF *CWVS,?HI]*_4VO
MP&_9<^.=U^S;\??#'C2U5Y1HMX&N85ZSV[@QS1CMEHV<#/0X/:OWF\%>,M,^
M(?A'3==T:[BO]*U>V2[M;B,Y66-P"I]N#R#R#P:B0&G1112 **** "BBB@ H
MHHH **** "BBB@ HHHH **** &7-S'96TDTTB10Q*7=W8*J*!DDD\  =Z_"/
M]N'X^K^TO^U!XJ\5V\COI=Q<_9=,#9&+2$".(X/W=P7>1ZN:^^?^"PG[=,'P
MS\#77PM\-78;Q+XA@V:S-$W.FV3CF(D?\M)E.,=HRV1\RFORMJHH HHHJ@"B
MBB@ K]/_ /@@S\*VTCX6>-?&4T9#:YJ,6F6Y9>?+MT+LRGT9I\'WB]J_,.VM
MI+VYCAAC>6:5@B(BEF=B<  #DDGM7[U_L>_!!?V=/V:?"'A$HJ7>F6"O?%>=
MUU*3+.<]QYCL![ >E*0'I5%%%0 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\C'_ "RVX/OZ\]:.8#\)**_8GXP?\$O?@5I&@?;;7P'';W#SHA,>K7ZKC:>
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
$* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>lgnd-20210331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:lgnd="http://www.ligand.com/20210331"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="lgnd-20210331.xsd" xlink:type="simple"/>
    <context id="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i05707ba532fc425c921e61b0e8954f64_I20210503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2021-05-03</instant>
        </period>
    </context>
    <context id="i20dcdca84df1452281e6d47bd0f24185_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i495e15f4221043e8829bac34d84a0a92_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie30239110ac54ae2af1d194e9c6384f4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7e4b63fffd544d8c9290215bd3714192_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i5f9ffb7664b0411f8db3b6b38d6632e4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6be2d05e46c04f22a00605da2833d1da_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i14b88249e38e42929cf58c0afff44f7c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib77e9a47601246a2acde91f6d3baa812_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i119a000c978f4b048a77543cbb616f54_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i15757d268ab84dc7a0e63e4c840a5172_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4d37dcb59e8c407fbccb9bb97f5e380e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib506a1ffb8e046009e08fd19fcfe4209_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieb9abae5afa744f0abd29ca447cf6dd6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i21e3b58e4ca240c286f59fb2568bf37e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3c6105b1f6594c02becde6c91bfe9eb1_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ice9d2fa48f71444f8320d849c38a5579_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i03da71fe5d974403b52f069f014e7fd2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3ce6ddc6311c4def9385fa6d58b64327_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3eb7fefbebf14db2b9bee4226ca7c5e7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ida90f84c04b649199b1a0d40a08f4c81_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie3baac2718ea47419924d27ce1598c17_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie09c209670384c35b1d40e0d01cdef82_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i684becfb80a0442d9f4781a55aa08632_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i659c16b4cc3546ea8362ee2a92ecabe7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibc903f14f4ef431ebf2bb9b5b6d868be_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i51e4f49b1fdf4839b077e613a7899628_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieadcdc474507437085760e44dd5d5c01_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i13ac40a9f8fa48ad99e9e26c593ecb34_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iece8fdee289d4aa8b8d7e5137317a46e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i51134d944b5f4636b4d6adfef00022a2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if91e400ca45d4fb580a3202300f06470_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib27ffe698d824d4bb4ded2bed63e9c41_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i09692c0a1c274da79fdc91e6f7c6284e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ifc4a3c6bfc704ae6bcbce2daf092ade2_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="icdec2dda7ca64a33ad8d5df2a891c250_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i544dd77eaedb4f5a956d59e518b4e511_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ibbbd2509899b45a8a4cb864e24eb6fca_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ibdf27ddbb0974314af1bf955199c9ad2_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i70e6045ea57e4960b5e7b991ff6afe59_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i141de7606bb14beea82d45802f93d383_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i4196bfc37550432080d7f0d6eec3b8d5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i43bf79f5a943475489db1bfa57aa7668_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i242bcf58c1cd4fcfa0c2d36e1fe47f5c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibd88764b91554104994dd396befa8270_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib71204e5781b46798722ee98c6925ade_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3c38be1b284c4082985f73fc8fd4cb08_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic015ad72c3c0416383db07b48a5a7c6a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8df2708d62174fbdac6fecdf1774ab15_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="icd0f3e11676d4c139d4f33ff5e608d98_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i098bf91f61f44dc08cae022ea07af921_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i707023875ea742a58c7c82670518aa3a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="idbb090f086294a258eff6658c99e6ab0_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i47e88f0429c44134b883d6f3aa820b25_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9a07ebdd562e411fae6b15bb21f8c1aa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i24b1ae2706284cdca4eb23d9915a4450_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6c916d897e674db5919221cdca2f97bb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id7ca3f45fb8d4984b3709f858a5d4195_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if9eb656aa6e5479a85a382cc47a8eca1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4a8c5e7437834c46ae9735a7aaa4148c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9cd22ab765384cccacfc57e8e1996cc2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i27ccac3b42614165a6aa9e91ee7ff005_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if16401e5b6d848aea59ba13c03311074_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i87abf73938904ca5aa12b57c61dab1a0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5bf3ec58e21145b6b4ceb58e80ec79b8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1d3c8187465b443d8f77beeb3adb7d56_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i680ece1eaa8f4e9e96ce0f42882bf0ce_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib28fef4680854a929dbf60cedeb06434_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i18f2c42543b54aeaab387d94848006f1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie9b9c500f9c64c18aa188576147e659c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic0c8207a04074c06b323ed60e1b6a82d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i992a781875754f6cafea588cdb51c0ca_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i24b65a2994c74dc1966ff120cfabeae7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0997448e200d4b4ca09ddc4917d0b9fb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7852648236234a7383fffb89802800ca_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4ead48471b4147b89d513734d4b371ce_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7203c2e57ce64b9499cf15be8da138c9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie5b27dc5beda4d28a2d31e5f523528e7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idd0a1696112f4034b165e99d7e54c9c0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9c9320f5f705481e843a64fa98520fce_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3be05d22f1714924ba3f177f26a1f2ad_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie6708118507a499aba0e32aaf3cbf208_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if5726bdc386542a4a8883e9ff2d6dbac_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if7981ffd8dd3442db85faa0971ba2b0f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i990fc430839b439297429383d8dc1565_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibd41f0958aea453c93d67393583f4114_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib164760a00e846d5b34f96b078179fad_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if664c4e0370e4eecb98b57e6559c8596_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i286a8bb93953439fafa3f00769457019_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0d642c075bb94ad9924379a085bcce17_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i09abab2b25044ad981b26743b386f8ed_I20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <context id="ieb80e938ceac4acba68f8190bbb48240_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i20687aac1929409b8e8ba72ed696b358_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7dbd1ffbbe68420b892aebb33efbf91e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i01775962d3284134ba883acf9233e929_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if96bbf53f57741718a23af11bbf99850_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i72938e42d49d4e7eb47d38ac3ea3ef3c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i70472c97b924411e836f34d9300a0722_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i01ac0fd2b84c4fc5b18e59e48f25cc79_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4dc6712b5fe940d29478311fd3e7cffd_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iadf9c6df9fa44ab3b0c1c35c985251b4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i21a101cfd24747168bf94b313b3708e4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic7f4f7589d8c492484b84f28687479b4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i676b57f3d66941bbb97cc26113e1e806_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i860855786f834ea394e0c7e66f585b07_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9054c6008288417ea8d10ca0540acb93_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6e0fd90b4eb14c3eb7f87756026effcf_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i94a7f3facc544380b14212b1d50f599d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifc3c971711634a419850f39be2cfa217_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib5f5f82fc4c44419894bfd3fe856e02b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i14699c2d32754f1197a391489d15ff48_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8e8d1f401b4d4013ac32b2787dcfde55_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib0daa67408a4451890054460225dfe05_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i53101502568a44758ee1969b8fdf9b5f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if91f9465b6884e95a7b42fca92d3ff5d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6913dd8993464fe78ba52964658dba31_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8f881c4d7c174319a38f46630210dcbd_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6087cecae97d4d2abd6e060d610ce948_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i77031116cff2427bb586198ff9e95cb4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2f9b50f07b984d18a9dbe45a0861f8a5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7364700da439492b9c9c4b04d2cd984f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idee4babfe9e4448e9679afd11c8e1932_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i06d16d86c2ee446498927c381c54d77a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i19ca28155cef4fd5b5524f954cccaab7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i40b8100a5b2440b48556561a4ba1e0d1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i109de96646db44268497efcc2f95bdc9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i13a03a90dd824a3e802cc74fbc6ef67a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifc817baab77c490b9eb5d576b2ff57d9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if692e5a3f16a4775a9bf2a0e13049d43_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9c91fdccad734cd3acfb28a7aaee6b08_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i39cdc2145c9b43dbb9e35f9deff11202_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5621884f55514f528b5732d922eb7ddd_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i14f70b29c1fe4ff7aba75d3e69a1823a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6b9807f967ff4cf582d5e8a8fece80fb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i79f0b8beb45a4a4bbba8ce8211ecd94e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie0a9f236332f4dba8a23b8e155f3a30f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i71d6fc626ce745feb5e33003ac131708_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic1d6ac0f98304bd8a2522d46969847b6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i833b7fb3b5b14e4e8b4ebb0909d05a2c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4fddbe170634491dbd21d99d8b590f70_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id4160bae3ab043dbb32c58acc74cd048_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6079969ef2d54e55ad4b585ec4ec53b9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1f6a3b9c3c7b42919ab58c0e2df5585a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id388d63d20d04cfabec6273b9266aa22_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id897ba84812c48c2a65b9776129298aa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i357b9497652046d0aba3cbdc8518d7b4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ife81c045c5a444e09b2d8bc249fece59_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i931f4e016c724c36974f1c1989897bd3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2a4a9dc8a3eb408d89b937d07499587e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2078f46e4a554de986254804e81be7c6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if8ff9c1d2a4e40b3a67f944c849a2bd2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie33ba4dc377840ee882fdaddd0d69bb0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia63b7b49beba4f378566a8be00c1898d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib65896a541534edc814e839cea969d72_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i820ccc6258144fb897101140c8a14d81_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0c972363fdac4ab6a767c041ae940266_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie3c2d8108f0346fea380bd0c9a9a1e5a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i261414f831ba4e1aac8a6551f971d92e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i43ca9b3cd64f442287f5c9dbd74d520d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9bc8c1e565e1493fa5a29d2c0d691486_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0660fc90350f4c508461c189c1838ea0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id89615ba04ac4f9f94097b92892cdf6f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia210fcf0a4934eb995df10b0db2c9c88_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8f9eb705d8b94a9283d4c25e1ece7d11_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if977d0d8bf974b6fa76de0a2e644188d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if5b8469bd6b24519a53e1cba447d8c57_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="icf6b5d5d9635440999d3e164431442cc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ief120523936f41ed9556d9c5fbe600ad_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id6205bd153ad465cbe32e8557a90f2df_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9214e2b7471f4a8588e5b99aada1a660_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9ba8a0cf524d4e13b76c6e92d9cf97bf_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4294ac1f67eb491c96a6a8cce49fcabe_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i92495438f1b146f898c4e64490283810_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8eb4e94ac6604758b1ea1704401c3d58_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="icbad4460fcf648928ffdb191dbdb6530_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i03dd9ae0aed74d5a904172437cf8186f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i58a521fe18574d6e968798b4c1586455_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7ab71e0fd4724a4db71bf93a6413a975_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iee481251a6b54158be7b4a7effbb8c67_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic79acce6117446459676d52e173a1126_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i943f22467f954f6993644f529795f102_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if3b0aff995404ab8acd400501adf43bd_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2a5a184f056f42c4b443fbae9b3fba2b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia5cd59ec89e943c8bddbe705cb6e15f6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i657fb3d5faae4a9990079266a0c01a60_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i62031fdd8c3645a7b3c2189805b7a8cb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i972be18486384106a14259204b8f719b_D20100101-20100131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-01-01</startDate>
            <endDate>2010-01-31</endDate>
        </period>
    </context>
    <context id="idce9b211fa9d42818fdc3f8ff61affb4_D20100101-20100131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2010-01-01</startDate>
            <endDate>2010-01-31</endDate>
        </period>
    </context>
    <context id="ic427fd87f48e4f049d21351088ee3bc2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i372f6d3fb38e43cd82744ef34999bd0a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:Phase3ClinicalTrialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id28435ac625f4e8f8e07977537c41fef_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3739dfe7d8c541718c9f50a133133136_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ife201f82dfa94172abde90879f18f167_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4464b8371b004313b6607d086dec25b2_D20201001-20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-01</endDate>
        </period>
    </context>
    <context id="ia37942031dbb40cf81304422e5ff426c_I20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="i4243023110cb4a6ca65bf4c4c5d8878f_I20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="idc64562484fc4d23b336ec8ed3fd3947_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7cc2592d38964cbb996dc31f81ff2c9a_I20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="i1708e500e932475f92536d18e3d099b5_I20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="i6037a4915521428790837dff8096a89d_D20201001-20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-01</endDate>
        </period>
    </context>
    <context id="i3ca2eca402bd48499cd198b19a231468_D20201001-20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-01</endDate>
        </period>
    </context>
    <context id="ie98b3c08f75e4b61b0c8b64a85133b0c_D20201001-20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-01</endDate>
        </period>
    </context>
    <context id="icbe299c7430a4957bb40d8a3d730a73e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i07f491d71a074d669d852a83c5014e96_D20200909-20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-09</startDate>
            <endDate>2020-09-09</endDate>
        </period>
    </context>
    <context id="i5ec4f52c7742457e9f9a93bcedf7c43a_I20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:ContingentValueRightForInternalResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-09</instant>
        </period>
    </context>
    <context id="i4a4df23c7dc04ee1b5aa7abe12902388_I20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:ContingentValueRightOnProductRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-09</instant>
        </period>
    </context>
    <context id="ieb5b853ff6c948499b25bc488e171d3a_D20200909-20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:ContingentValueRightOnProductRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-09</startDate>
            <endDate>2020-09-09</endDate>
        </period>
    </context>
    <context id="ie01bfe015cdf4254866d1eb4e646cb8b_I20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-09</instant>
        </period>
    </context>
    <context id="i2f8e586c985a4f67aa1ae11d2c8cc48d_I20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-09</instant>
        </period>
    </context>
    <context id="if95207dfe47f4c9e9c0f43e8b93447ea_D20200909-20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-09</startDate>
            <endDate>2020-09-09</endDate>
        </period>
    </context>
    <context id="ib1211f6f3075428083696490bd9e932a_D20200908-20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-08</startDate>
            <endDate>2020-09-08</endDate>
        </period>
    </context>
    <context id="iddbb15ce39fa4680a70e166c8f3a4d15_I20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-08</instant>
        </period>
    </context>
    <context id="ia183c7bcb9ba4693bb9d0a6d905ad0d1_I20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:MilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-08</instant>
        </period>
    </context>
    <context id="i8d532605276c48f3a3a254c0df053fa9_D20200908-20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:MilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-08</startDate>
            <endDate>2020-09-08</endDate>
        </period>
    </context>
    <context id="ia8d7bcd2b95d4fdda48d8864d7b7c451_I20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-08</instant>
        </period>
    </context>
    <context id="ib568c9bfd11849cba166b146a4953fc6_I20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-08</instant>
        </period>
    </context>
    <context id="ia4acaa60d54747379cca9601b1b5b67e_D20200908-20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-08</startDate>
            <endDate>2020-09-08</endDate>
        </period>
    </context>
    <context id="i2e4887e0977c47cd936f0690fcc58a01_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icabfd60e6d5c4e879961167fb0781d8a_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="ic1c6304e54ea4ff6822ec9ee1766e372_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="i1de02aee229949b29da1adff62f79608_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="iafdcef1bca214ba4be93eb50ada39288_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="i61296742d97b4da79a28c03d8f00b06c_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i9bd0a96ccb9e42b08636c5d927887d6f_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i5fa2bce4be0846e99213fe7062260432_I20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-31</instant>
        </period>
    </context>
    <context id="i73bb70b7323d4144a6e75d3e406c405c_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="i48864de303954560905e76c4450e4c12_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="i6f9fc4db17d04bf89dd453f8e14127a3_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="i9fce823aabcc4d3d949530fe19c30792_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3951fe225b2c46a7b3923a0684c74ce9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i25e12db65ee14bebb0cc5ab9db2dea3a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if492415c8fb84dc28c02e844ba8b7ba7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i05243f1221bc4fd7befab87ff60f8de9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0057dd0957054317972b57951cde9e14_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i877eaef323064694bf3b6b4356d4f3fd_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="idaf759347d8c465a8cb4d42f49d35918_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4e9d28d4cd3a4c1682fedb85842a9f81_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iae8337fd239a4e7e99cf32e1f3b34254_I20190911">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2019-09-11</instant>
        </period>
    </context>
    <context id="ic0da24b8c33848ccb099afc62ba164b1_D20190911-20190911">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2019-09-11</startDate>
            <endDate>2019-09-11</endDate>
        </period>
    </context>
    <context id="i4829221eea044e2c99470e6c93d2698c_D20191029-20191029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:LupinPatentInfringementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-29</startDate>
            <endDate>2019-10-29</endDate>
        </period>
    </context>
    <context id="i9d01e2b13cbc4db1979d2caa61ff4664_D20191031-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:USDistrictCourtForTheNorthernDistrictOfOhioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-31</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="ied61350f910e4604aaf85a72e7548d42_D20190501-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:InterPartesReviewOfPatentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="i903410136b034df7806df0765a803943_D20200501-20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:InterPartesReviewOfPatentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lgnd:GlaxoSmithKlineBiologicalsSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="position">
        <measure>lgnd:position</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="contingent_value_right">
        <measure>lgnd:contingent_value_right</measure>
    </unit>
    <unit id="contingent_value_right_series">
        <measure>lgnd:contingent_value_right_series</measure>
    </unit>
    <unit id="pure">
        <measure>lgnd:pure</measure>
    </unit>
    <unit id="d">
        <measure>utr:D</measure>
    </unit>
    <unit id="option">
        <measure>lgnd:option</measure>
    </unit>
    <unit id="patent">
        <measure>lgnd:patent</measure>
    </unit>
    <unit id="civil_complaint">
        <measure>lgnd:civil_complaint</measure>
    </unit>
    <unit id="petition">
        <measure>lgnd:petition</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80L2ZyYWc6ZjRkYzI4ODc5ZGQ2NDAzOWIwMmRiYjBmZWIzYjRkMzQvdGFibGU6MzczMWM5ZmIxZDc1NGFkMThiZDJkZWE4NWNkZDQyMDcvdGFibGVyYW5nZTozNzMxYzlmYjFkNzU0YWQxOGJkMmRlYTg1Y2RkNDIwN18yLTEtMS0xLTA_f4f0e53a-adc5-46a5-926f-bb7b5a7dd085">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80L2ZyYWc6ZjRkYzI4ODc5ZGQ2NDAzOWIwMmRiYjBmZWIzYjRkMzQvdGFibGU6MzczMWM5ZmIxZDc1NGFkMThiZDJkZWE4NWNkZDQyMDcvdGFibGVyYW5nZTozNzMxYzlmYjFkNzU0YWQxOGJkMmRlYTg1Y2RkNDIwN18zLTEtMS0xLTA_e8dca035-79cd-47aa-a019-90908c3c676c">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80L2ZyYWc6ZjRkYzI4ODc5ZGQ2NDAzOWIwMmRiYjBmZWIzYjRkMzQvdGFibGU6MzczMWM5ZmIxZDc1NGFkMThiZDJkZWE4NWNkZDQyMDcvdGFibGVyYW5nZTozNzMxYzlmYjFkNzU0YWQxOGJkMmRlYTg1Y2RkNDIwN180LTEtMS0xLTA_8e8b9d48-81b0-4b81-9e91-629a8e8ed6fd">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80L2ZyYWc6ZjRkYzI4ODc5ZGQ2NDAzOWIwMmRiYjBmZWIzYjRkMzQvdGFibGU6MzczMWM5ZmIxZDc1NGFkMThiZDJkZWE4NWNkZDQyMDcvdGFibGVyYW5nZTozNzMxYzlmYjFkNzU0YWQxOGJkMmRlYTg1Y2RkNDIwN181LTEtMS0xLTcy_cc91be27-dbaa-40fd-98c2-af6a2a40d0ed">0000886163</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80L2ZyYWc6ZjRkYzI4ODc5ZGQ2NDAzOWIwMmRiYjBmZWIzYjRkMzQvdGFibGU6MzczMWM5ZmIxZDc1NGFkMThiZDJkZWE4NWNkZDQyMDcvdGFibGVyYW5nZTozNzMxYzlmYjFkNzU0YWQxOGJkMmRlYTg1Y2RkNDIwN182LTEtMS0xLTYz_8e0506fe-f1d6-4cb8-b323-a2c224fc53ff">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i51134d944b5f4636b4d6adfef00022a2_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfOS0wLTEtMS04OTI_e57440bd-fe3a-45d5-9ac9-1c064d8b653f">us-gaap:AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i73bb70b7323d4144a6e75d3e406c405c_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80Ni9mcmFnOjVjY2RiNTQ4NjcyODQyYzVhNzM0OWQ1YzYxNjkyYzA3L3RhYmxlOjEwNmE5MTU0M2Q3ZTQxNjc4NDdkNWZhMWYyZGJkNGEwL3RhYmxlcmFuZ2U6MTA2YTkxNTQzZDdlNDE2Nzg0N2Q1ZmExZjJkYmQ0YTBfMi0xLTEtMS0w_bd89a13a-0d6a-44a3-92ae-69f3488ca53f"
      unitRef="number">0.0040244</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <dei:DocumentType
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGV4dHJlZ2lvbjpkMTI2NWJjYzg1YWQ0NTViOWQ2MDE5YmYwNzRkNDJlYV8xNzM_2ce849a2-3b52-4e9a-9f4d-7198bcd1de89">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6OGU5ODFhZTJmMDVmNGE5ZWFjMjAxMTQ2NzUwNGYyZTgvdGFibGVyYW5nZTo4ZTk4MWFlMmYwNWY0YTllYWMyMDExNDY3NTA0ZjJlOF8wLTAtMS0xLTA_f692a876-c4c5-477a-a5d4-a01b3bf73a3b">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGV4dHJlZ2lvbjpkMTI2NWJjYzg1YWQ0NTViOWQ2MDE5YmYwNzRkNDJlYV8yOTg_e2ca8da7-3022-4d95-88ba-cc270f5eda49">2021-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6MWQ5ZjMxOWI4NWE2NDNjNjhiN2U0OWFiNzRmYjJiMGUvdGFibGVyYW5nZToxZDlmMzE5Yjg1YTY0M2M2OGI3ZTQ5YWI3NGZiMmIwZV8wLTAtMS0xLTA_d8519e30-a2ac-4a48-9bf0-e937a40fcecd">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGV4dHJlZ2lvbjpkMTI2NWJjYzg1YWQ0NTViOWQ2MDE5YmYwNzRkNDJlYV8yMTkx_47734af8-c246-4bdc-a45b-1f473e683a80">001-33093</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGV4dHJlZ2lvbjpkMTI2NWJjYzg1YWQ0NTViOWQ2MDE5YmYwNzRkNDJlYV8zOTk_24e9de23-8d5e-4196-82ff-ab738b42e3b3">LIGAND PHARMACEUTICALS INCORPORATED</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6N2MzMDJhNTgwMmVkNGI3OWFlMDZhMzg3Mzk3OGFiMjQvdGFibGVyYW5nZTo3YzMwMmE1ODAyZWQ0Yjc5YWUwNmEzODczOTc4YWIyNF8wLTAtMS0xLTA_515f0f13-2337-44ff-9205-60dde283cc0f">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6N2MzMDJhNTgwMmVkNGI3OWFlMDZhMzg3Mzk3OGFiMjQvdGFibGVyYW5nZTo3YzMwMmE1ODAyZWQ0Yjc5YWUwNmEzODczOTc4YWIyNF8wLTEtMS0xLTA_df058df0-adb4-4406-9478-e1f48128ebbf">77-0160744</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6N2MzMDJhNTgwMmVkNGI3OWFlMDZhMzg3Mzk3OGFiMjQvdGFibGVyYW5nZTo3YzMwMmE1ODAyZWQ0Yjc5YWUwNmEzODczOTc4YWIyNF8zLTAtMS0xLTA_c41d15fb-37a4-4c26-a726-5c5956420fb3">3911 Sorrento Valley Boulevard,  Suite 110</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6N2MzMDJhNTgwMmVkNGI3OWFlMDZhMzg3Mzk3OGFiMjQvdGFibGVyYW5nZTo3YzMwMmE1ODAyZWQ0Yjc5YWUwNmEzODczOTc4YWIyNF80LTAtMS0xLTA_41f19261-aade-47cf-99fa-28321b74ac0d">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6N2MzMDJhNTgwMmVkNGI3OWFlMDZhMzg3Mzk3OGFiMjQvdGFibGVyYW5nZTo3YzMwMmE1ODAyZWQ0Yjc5YWUwNmEzODczOTc4YWIyNF81LTAtMS0xLTA_fd681c7d-c227-43f3-94cb-49312f81da61">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6N2MzMDJhNTgwMmVkNGI3OWFlMDZhMzg3Mzk3OGFiMjQvdGFibGVyYW5nZTo3YzMwMmE1ODAyZWQ0Yjc5YWUwNmEzODczOTc4YWIyNF81LTEtMS0xLTA_124ac633-e585-4aee-840e-5c52fb020a46">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGV4dHJlZ2lvbjpkMTI2NWJjYzg1YWQ0NTViOWQ2MDE5YmYwNzRkNDJlYV8yMTky_5caafe00-a918-418f-bbcf-8481a32235fa">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGV4dHJlZ2lvbjpkMTI2NWJjYzg1YWQ0NTViOWQ2MDE5YmYwNzRkNDJlYV8yMTkz_7a2e1acc-063a-4441-adfe-312fefd161f6">550-7500</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6NmRkZjY0OGMxNDk5NDgxNTliMmNiNzAxZjNmOWI0ODAvdGFibGVyYW5nZTo2ZGRmNjQ4YzE0OTk0ODE1OWIyY2I3MDFmM2Y5YjQ4MF8xLTAtMS0xLTA_de63813c-d82a-425c-9183-f4abcfb654f0">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6NmRkZjY0OGMxNDk5NDgxNTliMmNiNzAxZjNmOWI0ODAvdGFibGVyYW5nZTo2ZGRmNjQ4YzE0OTk0ODE1OWIyY2I3MDFmM2Y5YjQ4MF8xLTEtMS0xLTA_c7e71502-563c-4079-9764-b55cbb52adaf">LGND</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6NmRkZjY0OGMxNDk5NDgxNTliMmNiNzAxZjNmOWI0ODAvdGFibGVyYW5nZTo2ZGRmNjQ4YzE0OTk0ODE1OWIyY2I3MDFmM2Y5YjQ4MF8xLTItMS0xLTA_2aa957ef-90d6-4d18-ad8d-22a150c647d5">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGV4dHJlZ2lvbjpkMTI2NWJjYzg1YWQ0NTViOWQ2MDE5YmYwNzRkNDJlYV8yMTk0_6286e97e-3d6d-4414-88f5-cd9b8b09bb88">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGV4dHJlZ2lvbjpkMTI2NWJjYzg1YWQ0NTViOWQ2MDE5YmYwNzRkNDJlYV8yMTk1_d7fe37cd-e986-4ab4-a5db-6b2c0e207541">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6NzZiNDc2MTI2YjY5NDM4Yjk0NTg4MjA1ZDVhMjk2N2YvdGFibGVyYW5nZTo3NmI0NzYxMjZiNjk0MzhiOTQ1ODgyMDVkNWEyOTY3Zl8wLTAtMS0xLTA_36b779e5-c520-4df4-932e-bd34df6eba12">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6NzZiNDc2MTI2YjY5NDM4Yjk0NTg4MjA1ZDVhMjk2N2YvdGFibGVyYW5nZTo3NmI0NzYxMjZiNjk0MzhiOTQ1ODgyMDVkNWEyOTY3Zl8xLTQtMS0xLTA_c8afd1d5-6364-44ec-88fc-382e659aaadc">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGFibGU6NzZiNDc2MTI2YjY5NDM4Yjk0NTg4MjA1ZDVhMjk2N2YvdGFibGVyYW5nZTo3NmI0NzYxMjZiNjk0MzhiOTQ1ODgyMDVkNWEyOTY3Zl8yLTEtMS0xLTA_95d817e7-88d3-4d9e-8b6c-64c7c9904199">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGV4dHJlZ2lvbjpkMTI2NWJjYzg1YWQ0NTViOWQ2MDE5YmYwNzRkNDJlYV8yMTkw_c952d3b5-015e-4ea8-8ed8-8f176460d2f7">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i05707ba532fc425c921e61b0e8954f64_I20210503"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xL2ZyYWc6ZDEyNjViY2M4NWFkNDU1YjlkNjAxOWJmMDc0ZDQyZWEvdGV4dHJlZ2lvbjpkMTI2NWJjYzg1YWQ0NTViOWQ2MDE5YmYwNzRkNDJlYV8yMTUz_b7910b1e-1252-435f-91fa-7ddc2798c6cf"
      unitRef="shares">16652080</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMy0xLTEtMS0w_6db2f594-7d23-421b-9406-ab806be94839"
      unitRef="usd">31853000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMy0zLTEtMS0w_ce343362-ad9e-458b-a7b8-0c52dad8079b"
      unitRef="usd">47619000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNC0xLTEtMS0w_14d30b82-a365-4daf-a137-e8596c4bc404"
      unitRef="usd">307354000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNC0zLTEtMS0w_b12fe4df-60a0-4de0-868c-19f8ac1ccea3"
      unitRef="usd">363567000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNS0xLTEtMS0w_70bead7a-cefb-4ce9-89d4-c3cabff0b263"
      unitRef="usd">54436000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNS0zLTEtMS0w_c46fc5d2-1fa9-4918-9073-2d429ed528b8"
      unitRef="usd">56847000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNi0xLTEtMS0w_cc49fb79-afb7-4d27-92fd-b137f08d276d"
      unitRef="usd">36932000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNi0zLTEtMS0w_8e5298ff-7819-4347-905f-7c89cacd1d59"
      unitRef="usd">26487000</us-gaap:InventoryNet>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNy0xLTEtMS0w_b5047910-0fb7-4019-85f8-909e86234cad"
      unitRef="usd">1145000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNy0zLTEtMS0w_7ca7e396-a756-4979-b9ec-fa9e06599caf"
      unitRef="usd">2217000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:OtherAssetsCurrent
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfOC0xLTEtMS0w_9e404f2f-99a8-485a-a753-47f3257e9926"
      unitRef="usd">5708000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfOC0zLTEtMS0w_d6b53f93-df77-4725-89fb-0b4650cf7103"
      unitRef="usd">3822000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTAtMS0xLTEtMA_383e843e-f871-4e1b-a6b3-0ba87a425385"
      unitRef="usd">437428000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTAtMy0xLTEtMA_37f1090e-a7da-4845-8eaf-04325d9c82d7"
      unitRef="usd">500559000</us-gaap:AssetsCurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTEtMS0xLTEtMA_fe022720-6673-4001-afd7-800a54bb9e76"
      unitRef="usd">27432000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTEtMy0xLTEtMA_b0dd1bf5-82f4-496b-b1f3-ce579964fd85"
      unitRef="usd">24320000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTItMS0xLTEtMA_08fd18f4-4cb6-4eb2-be10-591d34f2d7aa"
      unitRef="usd">583785000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTItMy0xLTEtMA_5b7fe72c-e8b2-4053-9658-392b726e9a69"
      unitRef="usd">595330000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTMtMS0xLTEtMA_bbcca37f-0626-4934-960b-e2cec7c9f962"
      unitRef="usd">190515000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTMtMy0xLTEtMA_fcde8ae7-f85d-4fb0-a852-96d9f76afe17"
      unitRef="usd">189662000</us-gaap:Goodwill>
    <lgnd:CommercialLicenseRights
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTQtMS0xLTEtMA_6a16f438-a3e1-4184-a4d8-bb3921b53fd1"
      unitRef="usd">10451000</lgnd:CommercialLicenseRights>
    <lgnd:CommercialLicenseRights
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTQtMy0xLTEtMA_087f5e20-e27b-486c-beb8-991c45ff8975"
      unitRef="usd">10979000</lgnd:CommercialLicenseRights>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTUtMS0xLTEtMA_392be178-af4b-4a30-975d-485531de71c7"
      unitRef="usd">16896000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTUtMy0xLTEtMA_444dce5a-fc92-4ffa-a8c3-7710cb834871"
      unitRef="usd">14434000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTYtMS0xLTEtMA_c6648df2-6b77-47d0-bdbb-318d1cd545d0"
      unitRef="usd">7611000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTYtMy0xLTEtMA_b37a2f48-506b-40ef-bab4-86e4bc3a5706"
      unitRef="usd">6892000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTctMS0xLTEtODcw_82f78cd9-a486-4f78-80de-627e8a090051"
      unitRef="usd">17950000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTctMy0xLTEtMTMx_e46ca602-a884-475e-b4b5-a7af2ebe5916"
      unitRef="usd">15842000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTctMS0xLTEtMA_f7109a61-65d4-4543-be41-b35a1a33d9c7"
      unitRef="usd">3053000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTctMy0xLTEtMA_7bbbced2-ab8c-4ba8-bd94-66eff0c82419"
      unitRef="usd">4267000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTgtMS0xLTEtMA_19b994cf-7c47-45be-824f-43e7952eec60"
      unitRef="usd">1295121000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMTgtMy0xLTEtMA_dfdfa4ed-779c-445d-9c1c-0b0d4d3dfe9b"
      unitRef="usd">1362285000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjEtMS0xLTEtMA_7c345b11-aacc-484b-a8ac-c097176b8f7d"
      unitRef="usd">9469000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjEtMy0xLTEtMA_6eed9063-183d-4e6d-a33a-053dc0a7f0ac"
      unitRef="usd">3784000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjItMS0xLTEtMA_d458b2be-de6d-4642-8ce9-7e6dcdfa7b01"
      unitRef="usd">12110000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjItMy0xLTEtMA_830bb031-496c-4da5-9f5a-63c07bc7e6c3"
      unitRef="usd">18530000</us-gaap:AccruedLiabilitiesCurrent>
    <lgnd:CurrentPortionOfLiabilityForContingentValueRights
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjQtMS0xLTEtMA_fa5b1f35-5ae9-4777-881f-3748587633d4"
      unitRef="usd">41509000</lgnd:CurrentPortionOfLiabilityForContingentValueRights>
    <lgnd:CurrentPortionOfLiabilityForContingentValueRights
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjQtMy0xLTEtMA_2e7becaf-29b6-43bc-a803-2fa2d8389e0a"
      unitRef="usd">39884000</lgnd:CurrentPortionOfLiabilityForContingentValueRights>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjUtMS0xLTEtMA_bd761804-f3e1-44ba-b219-5f58d3c43f2d"
      unitRef="usd">25107000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjUtMy0xLTEtMA_1a2a3e9f-81c5-4ca3-9fa5-d14287cd15bf"
      unitRef="usd">29435000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjctMS0xLTEtODc1_ecf9ffec-fb5c-488f-8ceb-fa8842a30290"
      unitRef="usd">2173000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjctMy0xLTEtMTQ5_c5ff085e-0ee7-46db-bd7d-5b4198f2f9de"
      unitRef="usd">1885000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjgtMS0xLTEtODc1_09890b59-dda6-4056-a488-893651a8e91e"
      unitRef="usd">5437000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjgtMy0xLTEtMTQ5_29e2c75c-a7db-479c-a10b-c5371fe76ced"
      unitRef="usd">6593000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjctMS0xLTEtMA_bc85fd2a-866e-4b8c-8888-6a8c162f4228"
      unitRef="usd">95805000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjctMy0xLTEtMA_8e23db1f-acb2-4c6d-be47-4f3e3a8902bc"
      unitRef="usd">100111000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjgtMS0xLTEtMA_61f0db40-656b-4537-9363-bdeee97ec82e"
      unitRef="usd">352313000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjgtMy0xLTEtMA_b3e8c41f-4f7b-42e5-b8d5-f7cc6076d18c"
      unitRef="usd">442293000</us-gaap:ConvertibleDebtNoncurrent>
    <lgnd:LiabilityForContingentValueRights
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjktMS0xLTEtMA_26f39520-ca95-40db-883e-97056899d1bc"
      unitRef="usd">9548000</lgnd:LiabilityForContingentValueRights>
    <lgnd:LiabilityForContingentValueRights
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMjktMy0xLTEtMA_227324ee-e343-4c78-8c34-8f1741a6be37"
      unitRef="usd">9249000</lgnd:LiabilityForContingentValueRights>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzAtMS0xLTEtMA_85b7251c-2523-4f90-8101-ca19b9ae88b5"
      unitRef="usd">56812000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzAtMy0xLTEtMA_2e1aeca7-048d-47aa-9935-ef30eaded6f1"
      unitRef="usd">64598000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzEtMS0xLTEtMA_aafab3c2-aa95-4c3f-b9db-5cfa44a5bb12"
      unitRef="usd">6081000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzEtMy0xLTEtMA_1c6d7d1c-5427-49eb-8ae8-084bd415f2f7"
      unitRef="usd">5643000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzItMS0xLTEtMA_f9ac89ab-f053-4bed-a119-31284ebfde89"
      unitRef="usd">28722000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzItMy0xLTEtMA_56fc3488-1dfb-4f44-8453-ef3dcf72ceaa"
      unitRef="usd">30866000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzMtMS0xLTEtMA_fb49a806-2350-4e6f-b705-0436d842c482"
      unitRef="usd">549281000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzMtMy0xLTEtMA_eeddb3de-e183-4195-8405-815ea4afc606"
      unitRef="usd">652760000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzQtMS0xLTEtMA_ab72743f-f46c-41a8-a668-21fd47d25325"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzQtMy0xLTEtMA_585b914c-8356-45a0-88df-9ec647bf88e7"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOmU5ODQ0NzYwN2JlNjQ5ZGE4ZDYxMzY0ZjRmNWMwMDU2XzI0_17e763d8-f0bc-49af-84ea-c5db619c188f"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOmU5ODQ0NzYwN2JlNjQ5ZGE4ZDYxMzY0ZjRmNWMwMDU2XzI0_745e8eff-5c21-4d3d-be4f-033dc68f3a47"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOmU5ODQ0NzYwN2JlNjQ5ZGE4ZDYxMzY0ZjRmNWMwMDU2XzM4_49d9985a-7ad6-4081-bdfe-2a29762f4ff5"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOmU5ODQ0NzYwN2JlNjQ5ZGE4ZDYxMzY0ZjRmNWMwMDU2XzM4_a49e10f8-d89b-4528-ab23-bb331e8d067b"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOmU5ODQ0NzYwN2JlNjQ5ZGE4ZDYxMzY0ZjRmNWMwMDU2XzYw_2020db82-719f-47f1-b03b-e3b680da4af8"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOmU5ODQ0NzYwN2JlNjQ5ZGE4ZDYxMzY0ZjRmNWMwMDU2XzYw_362bde13-9e15-4c40-b269-0c7c474187ac"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOmU5ODQ0NzYwN2JlNjQ5ZGE4ZDYxMzY0ZjRmNWMwMDU2XzYw_6eff9aef-7dc5-4a24-b9e7-1739ec99188c"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOmU5ODQ0NzYwN2JlNjQ5ZGE4ZDYxMzY0ZjRmNWMwMDU2XzYw_b07048f8-958b-4830-88f3-4925073dc21d"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzYtMS0xLTEtMA_201fbcb5-e53c-498e-a05c-a2969b0728a5"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzYtMy0xLTEtMA_3de5aead-e15c-40bc-a886-1f93e9ef6c2e"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmQ4MGMwZDlhYzZjZDRiZTFiMjczNzNhNjU4ZWFkM2E1XzIx_1ff31cd6-6c91-4e38-af3b-d1f49812bd7d"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmQ4MGMwZDlhYzZjZDRiZTFiMjczNzNhNjU4ZWFkM2E1XzIx_c2f56634-ee58-4ab9-a61d-631d19ff00d5"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmQ4MGMwZDlhYzZjZDRiZTFiMjczNzNhNjU4ZWFkM2E1XzM1_27710d93-2da2-495f-9743-bd70032c9401"
      unitRef="shares">60000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmQ4MGMwZDlhYzZjZDRiZTFiMjczNzNhNjU4ZWFkM2E1XzM1_b3c853b6-f751-48a1-acfa-36b54a0450b4"
      unitRef="shares">60000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmQ4MGMwZDlhYzZjZDRiZTFiMjczNzNhNjU4ZWFkM2E1XzU3_69a4fd0f-9400-4ea2-998c-6ff2883c5843"
      unitRef="shares">16652000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmQ4MGMwZDlhYzZjZDRiZTFiMjczNzNhNjU4ZWFkM2E1XzU3_7514d5a8-33e7-4ff5-b1fa-df453db6b1d0"
      unitRef="shares">16652000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmQ4MGMwZDlhYzZjZDRiZTFiMjczNzNhNjU4ZWFkM2E1XzEwOTk1MTE2Mjc5MTI_515892c7-c0a0-4ab4-9019-10378f0057d1"
      unitRef="shares">16080000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmQ4MGMwZDlhYzZjZDRiZTFiMjczNzNhNjU4ZWFkM2E1XzEwOTk1MTE2Mjc5MTI_d3d1a599-277b-42f4-b764-aff87e1968cc"
      unitRef="shares">16080000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzctMS0xLTEtMA_f6dc6fd3-a4f8-4de7-af87-de864725a7e1"
      unitRef="usd">17000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzctMy0xLTEtMA_584971a2-5458-41b4-b4d4-051f4907c809"
      unitRef="usd">16000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzgtMS0xLTEtMA_4f4e821f-57ae-4b4c-a568-299df9105ad1"
      unitRef="usd">336621000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzgtMy0xLTEtMA_0e9651b6-8314-466c-ae0c-b166c37d4891"
      unitRef="usd">318358000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzktMS0xLTEtMA_eec4998a-1175-4fdf-bc01-b5727da9325c"
      unitRef="usd">-856000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfMzktMy0xLTEtMA_f2c3909a-eff4-4a92-93b8-a5c1489a5d54"
      unitRef="usd">-801000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNDAtMS0xLTEtMA_bdba6634-236b-4ec9-b6de-4a5436644585"
      unitRef="usd">410058000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNDAtMy0xLTEtMA_4f544fa4-cf35-4600-9ed7-cd1bdb818c53"
      unitRef="usd">391952000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNDEtMS0xLTEtMA_3d78f41e-3bf4-46d1-8e5a-d2ab1a858294"
      unitRef="usd">745840000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNDEtMy0xLTEtMA_75ab1241-f6aa-4d16-a527-49ac95235d33"
      unitRef="usd">709525000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNDItMS0xLTEtMA_c6c856b3-35dc-4c68-8349-4136f25a462e"
      unitRef="usd">1295121000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xNi9mcmFnOmEwYzk1ZjUwZDBkYjQ3NTNiYWE5YWFiNjQ5ZDAzYWEwL3RhYmxlOjEyNTk0ZTI4NWE0YTQ4NDliMjUzMDJkNzNmMmUwNzU4L3RhYmxlcmFuZ2U6MTI1OTRlMjg1YTRhNDg0OWIyNTMwMmQ3M2YyZTA3NThfNDItMy0xLTEtMA_6d85c583-b536-41f8-b469-c9c0a28972c0"
      unitRef="usd">1362285000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie30239110ac54ae2af1d194e9c6384f4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfNC0xLTEtMS0w_b4f25a55-36ce-44a9-9150-485de4c253dc"
      unitRef="usd">7112000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i7e4b63fffd544d8c9290215bd3714192_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfNC0zLTEtMS0w_b039c217-fe57-4e39-a360-68006b1f3281"
      unitRef="usd">6565000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5f9ffb7664b0411f8db3b6b38d6632e4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfNS0xLTEtMS0w_06d23c1d-e9ee-4cf7-95dc-a134fc0ea4c8"
      unitRef="usd">31272000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6be2d05e46c04f22a00605da2833d1da_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfNS0zLTEtMS0w_a6010573-ba05-4368-be8d-0313e350f292"
      unitRef="usd">21109000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i14b88249e38e42929cf58c0afff44f7c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfNi0xLTEtMS0w_c218e595-a9a8-4125-b0f5-3d55d9a2cc06"
      unitRef="usd">16766000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib77e9a47601246a2acde91f6d3baa812_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfNi0zLTEtMS0w_784612a4-6a4e-474c-9d84-688caab0600a"
      unitRef="usd">5487000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfNy0xLTEtMS0w_da5dac7b-4c8c-4898-bcdd-8198ca62fc9c"
      unitRef="usd">55150000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfNy0zLTEtMS0w_1f68facc-1496-49a6-8782-861201bbd4ee"
      unitRef="usd">33161000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:CostDirectMaterial
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfOS0xLTEtMS0w_f3b3c17f-8cf9-4e17-9f3c-a605c19d4c3b"
      unitRef="usd">8153000</us-gaap:CostDirectMaterial>
    <us-gaap:CostDirectMaterial
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfOS0zLTEtMS0w_b910fe70-6635-4a86-b9d9-c8a923b09ed6"
      unitRef="usd">4683000</us-gaap:CostDirectMaterial>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTAtMS0xLTEtMA_654d3521-29b9-4d3f-a0ff-15609155380e"
      unitRef="usd">11786000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTAtMy0xLTEtMA_1b97bc6f-b508-4589-981f-c01219067337"
      unitRef="usd">3535000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTEtMS0xLTEtMA_8fa33c65-7d70-4cd5-acbe-12027d2eb5a6"
      unitRef="usd">17879000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTEtMy0xLTEtMA_158023eb-a443-4742-a50e-034665a2496b"
      unitRef="usd">11891000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTItMS0xLTEtMA_903ad361-cbdb-4885-b3d8-3015fa6d98ad"
      unitRef="usd">12617000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTItMy0xLTEtMA_aab9724c-d571-4b97-96e4-369858878524"
      unitRef="usd">9264000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTMtMS0xLTEtMA_4f3b4eb1-02f1-4e01-9a62-f304dc802c8b"
      unitRef="usd">50435000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTMtMy0xLTEtMA_b6028bf2-9532-483f-aa9c-ad7bfadb9607"
      unitRef="usd">29373000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTUtMS0xLTEtMA_5824434f-7289-4c22-a74d-41ac18281573"
      unitRef="usd">4715000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTUtMy0xLTEtMA_243fba4d-9aea-4640-a68a-20903493afb3"
      unitRef="usd">3788000</us-gaap:OperatingIncomeLoss>
    <us-gaap:GainLossOnInvestments
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTctMS0xLTEtMA_3bc0042c-7fd1-4be7-b1af-a1eb8a5ffe31"
      unitRef="usd">13061000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTctMy0xLTEtMA_c669b555-5720-4696-8f19-68b01ecfd79e"
      unitRef="usd">-30741000</us-gaap:GainLossOnInvestments>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTgtMS0xLTEtMA_70586708-dd30-4481-8bd2-7a5d9b59c344"
      unitRef="usd">296000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTgtMy0xLTEtMA_22329c1a-aa9d-4b5d-b7d4-11c7f45b26d9"
      unitRef="usd">4730000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTktMS0xLTEtMA_1c7f0d6b-dc37-41a4-8215-d1ba4c2496a1"
      unitRef="usd">5831000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMTktMy0xLTEtMA_8afd664f-5c25-4fdb-b694-adfea45fc6e4"
      unitRef="usd">8548000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjAtMS0xLTEtMA_129ac7f1-6e00-482d-9b70-6daa4858ed4b"
      unitRef="usd">-6477000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjAtMy0xLTEtMA_55728fc4-46bd-4d07-80ed-ed0c19fede93"
      unitRef="usd">356000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjEtMS0xLTEtMA_14e099bf-0ca4-426d-b6ea-aa4a1770feb9"
      unitRef="usd">1049000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjEtMy0xLTEtMA_299472e5-0342-44cb-a613-3f8ab2218aa4"
      unitRef="usd">-34203000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjItMS0xLTEtMA_7e1fa10c-5a76-4325-a804-11055e53061a"
      unitRef="usd">5764000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjItMy0xLTEtMA_8b51a251-bd81-47dd-b708-015daa6c5077"
      unitRef="usd">-30415000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjMtMS0xLTEtMA_62cef505-1ea2-4d51-986c-285f7fbaf37d"
      unitRef="usd">-12342000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjMtMy0xLTEtMA_b077a951-0131-46c4-8538-6887b5fb5b5a"
      unitRef="usd">-6284000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjQtMS0xLTEtMA_79a70e40-170c-4f27-91ff-ca2aa6971b31"
      unitRef="usd">18106000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjQtMy0xLTEtMA_ac84ed72-4fb5-4111-8ac8-7963e56aaa7a"
      unitRef="usd">-24131000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjYtMS0xLTEtMA_6dc3ebf8-9619-4b9f-aa66-bc8a6ca7d7da"
      unitRef="usdPerShare">1.10</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjYtMy0xLTEtMA_36703756-439e-4653-bbe6-5034c439365e"
      unitRef="usdPerShare">-1.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjctMS0xLTEtMA_80e8748b-0766-4d97-8370-87d6762d5fda"
      unitRef="shares">16435000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjctMy0xLTEtMA_04adf4d4-6515-4545-9d96-2409ae40fa3a"
      unitRef="shares">16529000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjktMS0xLTEtMA_c2485cc1-ce5d-48ac-98e9-cd8ac242c1fd"
      unitRef="usdPerShare">1.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMjktMy0xLTEtMA_99b5d8fc-b513-400c-8bde-da0ec6b7d702"
      unitRef="usdPerShare">-1.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMzAtMS0xLTEtMA_2f055dcf-6147-40fc-90a4-f7f4063c987f"
      unitRef="shares">17248000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8xOS9mcmFnOjFiMGFlNjIyZDM2NDRmYmFiZTkyYjhiNWY1ZDZiMTFiL3RhYmxlOmIyYWE4MDU0MjUyYzQxMDc4ZThhZjA5ZmU0NGI2MWZkL3RhYmxlcmFuZ2U6YjJhYTgwNTQyNTJjNDEwNzhlOGFmMDlmZTQ0YjYxZmRfMzAtMy0xLTEtMA_275c83c1-2d5b-4bc7-9506-f51bce90303b"
      unitRef="shares">16529000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yMi9mcmFnOmMxMDZjZmMzYTllZDQ1YTE4MjIxZmUzYzJkNGNhZTg2L3RhYmxlOjkyN2FhMDUxZjZmMjRlZDc4MDM1NGY3MzY3YTFhMzdjL3RhYmxlcmFuZ2U6OTI3YWEwNTFmNmYyNGVkNzgwMzU0ZjczNjdhMWEzN2NfMy0xLTEtMS0w_d4f33f4b-28c6-436c-8226-b39965a6e079"
      unitRef="usd">18106000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yMi9mcmFnOmMxMDZjZmMzYTllZDQ1YTE4MjIxZmUzYzJkNGNhZTg2L3RhYmxlOjkyN2FhMDUxZjZmMjRlZDc4MDM1NGY3MzY3YTFhMzdjL3RhYmxlcmFuZ2U6OTI3YWEwNTFmNmYyNGVkNzgwMzU0ZjczNjdhMWEzN2NfMy0zLTEtMS0w_c488d917-cf49-447b-9a43-375be582fbd4"
      unitRef="usd">-24131000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yMi9mcmFnOmMxMDZjZmMzYTllZDQ1YTE4MjIxZmUzYzJkNGNhZTg2L3RhYmxlOjkyN2FhMDUxZjZmMjRlZDc4MDM1NGY3MzY3YTFhMzdjL3RhYmxlcmFuZ2U6OTI3YWEwNTFmNmYyNGVkNzgwMzU0ZjczNjdhMWEzN2NfNC0xLTEtMS0w_7b2b75ff-b597-4399-a3d4-7e64d3034400"
      unitRef="usd">-55000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yMi9mcmFnOmMxMDZjZmMzYTllZDQ1YTE4MjIxZmUzYzJkNGNhZTg2L3RhYmxlOjkyN2FhMDUxZjZmMjRlZDc4MDM1NGY3MzY3YTFhMzdjL3RhYmxlcmFuZ2U6OTI3YWEwNTFmNmYyNGVkNzgwMzU0ZjczNjdhMWEzN2NfNC0zLTEtMS0w_5bfc2a11-56da-498a-95ab-dc5e4595eb4f"
      unitRef="usd">-2772000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yMi9mcmFnOmMxMDZjZmMzYTllZDQ1YTE4MjIxZmUzYzJkNGNhZTg2L3RhYmxlOjkyN2FhMDUxZjZmMjRlZDc4MDM1NGY3MzY3YTFhMzdjL3RhYmxlcmFuZ2U6OTI3YWEwNTFmNmYyNGVkNzgwMzU0ZjczNjdhMWEzN2NfNS0xLTEtMS0w_dd575524-ceae-4460-b522-3a942db61bf3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yMi9mcmFnOmMxMDZjZmMzYTllZDQ1YTE4MjIxZmUzYzJkNGNhZTg2L3RhYmxlOjkyN2FhMDUxZjZmMjRlZDc4MDM1NGY3MzY3YTFhMzdjL3RhYmxlcmFuZ2U6OTI3YWEwNTFmNmYyNGVkNzgwMzU0ZjczNjdhMWEzN2NfNS0zLTEtMS0w_865a8195-a109-46ee-9fde-f3d3cc6c3295"
      unitRef="usd">-1879000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yMi9mcmFnOmMxMDZjZmMzYTllZDQ1YTE4MjIxZmUzYzJkNGNhZTg2L3RhYmxlOjkyN2FhMDUxZjZmMjRlZDc4MDM1NGY3MzY3YTFhMzdjL3RhYmxlcmFuZ2U6OTI3YWEwNTFmNmYyNGVkNzgwMzU0ZjczNjdhMWEzN2NfNy0xLTEtMS0w_a3043095-51c0-499c-9fbc-245a03b05d77"
      unitRef="usd">18051000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yMi9mcmFnOmMxMDZjZmMzYTllZDQ1YTE4MjIxZmUzYzJkNGNhZTg2L3RhYmxlOjkyN2FhMDUxZjZmMjRlZDc4MDM1NGY3MzY3YTFhMzdjL3RhYmxlcmFuZ2U6OTI3YWEwNTFmNmYyNGVkNzgwMzU0ZjczNjdhMWEzN2NfNy0zLTEtMS0w_8e6f4ec7-9cf8-458d-a1dd-d0f9d028f1a9"
      unitRef="usd">-28782000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i15757d268ab84dc7a0e63e4c840a5172_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMi0xLTEtMS0w_2d7004ce-9434-4ec7-a388-0f34d6d92ee5"
      unitRef="shares">16080000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i15757d268ab84dc7a0e63e4c840a5172_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMi0yLTEtMS0w_bdc320c1-22ec-4276-99be-68996164127d"
      unitRef="usd">16000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4d37dcb59e8c407fbccb9bb97f5e380e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMi0zLTEtMS0w_5598442a-3419-4b49-8571-4ae4da38d641"
      unitRef="usd">318358000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib506a1ffb8e046009e08fd19fcfe4209_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMi00LTEtMS0w_a4cce00b-6021-4f17-8849-8d4340ab2c64"
      unitRef="usd">-801000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ieb9abae5afa744f0abd29ca447cf6dd6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMi01LTEtMS0w_d35c2027-4ad7-40d1-ac45-e96397bda8e0"
      unitRef="usd">391952000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMi02LTEtMS0w_ba7b2492-9fb2-4bd0-b123-6794eb04daf2"
      unitRef="usd">709525000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i21e3b58e4ca240c286f59fb2568bf37e_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMy0xLTEtMS0w_18a6d47e-5b2c-4c8c-acf9-9ca00b20ff74"
      unitRef="shares">572000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i21e3b58e4ca240c286f59fb2568bf37e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMy0yLTEtMS0w_9bafded3-6081-4616-8e19-96cd7ed00aa3"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i3c6105b1f6594c02becde6c91bfe9eb1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMy0zLTEtMS0w_4aba8213-217e-4a5c-9b7d-054472fb2b41"
      unitRef="usd">20580000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMy02LTEtMS0w_22b1ddde-20fe-4e86-b769-07fb0d0dafc6"
      unitRef="usd">20581000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3c6105b1f6594c02becde6c91bfe9eb1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfNC0zLTEtMS0w_17276d3f-de00-48c2-9751-6f4ce23cef8c"
      unitRef="usd">8405000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfNC02LTEtMS0w_5d21efc1-c50c-4cfc-b66a-82f179c47016"
      unitRef="usd">8405000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="ice9d2fa48f71444f8320d849c38a5579_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfNi00LTEtMS0w_2371dca7-33be-4f93-9867-76b9116b1d16"
      unitRef="usd">-55000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfNi02LTEtMS0w_906243bc-b0a3-4efd-ae49-21442cd1de8c"
      unitRef="usd">-55000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i3c6105b1f6594c02becde6c91bfe9eb1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfOC0zLTEtMS0w_a257b5f6-73d8-4823-acd7-bfba1f81b31f"
      unitRef="usd">-9086000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfOC02LTEtMS0w_42e1fb74-da02-4a85-a26c-cc06c72ab5ec"
      unitRef="usd">-9086000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions
      contextRef="i3c6105b1f6594c02becde6c91bfe9eb1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfOS0zLTEtMS0zMjA4_e9f5b7db-0eed-41d4-9abd-a4e0ef87b96a"
      unitRef="usd">396000</lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfNy02LTEtMS0zNDU1_bbf79f65-6238-4fe7-a9fa-f648be16dec0"
      unitRef="usd">396000</lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions
      contextRef="i3c6105b1f6594c02becde6c91bfe9eb1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfOS0zLTEtMS0zMTgy_bc156544-a0a2-485b-be04-71373e3d8c48"
      unitRef="usd">2032000</lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfOC02LTEtMS0zNDU1_e5059f51-5473-4177-9d0c-04b2764db878"
      unitRef="usd">2032000</lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions>
    <us-gaap:NetIncomeLoss
      contextRef="i03da71fe5d974403b52f069f014e7fd2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMTAtNS0xLTEtMA_1b039048-9946-4afa-8e87-874f6a9f65d9"
      unitRef="usd">18106000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMTAtNi0xLTEtMA_a7755f52-4f9c-4275-84dd-7bf2ce76ece5"
      unitRef="usd">18106000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="i3ce6ddc6311c4def9385fa6d58b64327_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMTEtMS0xLTEtMA_713c3865-fcf3-4651-903c-29cd3aadc23b"
      unitRef="shares">16652000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i3ce6ddc6311c4def9385fa6d58b64327_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMTEtMi0xLTEtMA_6c2e874c-f4b2-4cc0-98c1-dc880cf06616"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3eb7fefbebf14db2b9bee4226ca7c5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMTEtMy0xLTEtMA_89f9f339-0d15-4676-8bb1-3d1cf4617ffb"
      unitRef="usd">336621000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ida90f84c04b649199b1a0d40a08f4c81_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMTEtNC0xLTEtMA_82fd54d3-7d14-412d-875c-4ec6e03a2b96"
      unitRef="usd">-856000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie3baac2718ea47419924d27ce1598c17_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMTEtNS0xLTEtMA_a09e32e4-2512-465a-b40b-20eebb020965"
      unitRef="usd">410058000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmM5NTk4YTUxNGEwZTQzYzdhMjFiZGE5YWIzZTE3YmI0L3RhYmxlcmFuZ2U6Yzk1OThhNTE0YTBlNDNjN2EyMWJkYTlhYjNlMTdiYjRfMTEtNi0xLTEtMA_13852042-b9fd-4bcf-8c8a-9b290c0c80fe"
      unitRef="usd">745840000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="ie09c209670384c35b1d40e0d01cdef82_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMi0xLTEtMS0w_bd22649a-3310-489d-97ac-65019f24eb7e"
      unitRef="shares">16823000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ie09c209670384c35b1d40e0d01cdef82_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMi0yLTEtMS0w_acf74738-c716-4bed-965b-613fe86380ff"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i684becfb80a0442d9f4781a55aa08632_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMi0zLTEtMS0w_57c3204c-cb0c-4e2c-9d19-4bd7230e2a60"
      unitRef="usd">367326000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i659c16b4cc3546ea8362ee2a92ecabe7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMi00LTEtMS0w_bba65de4-76d7-49f5-b823-01c4dfdf0367"
      unitRef="usd">-216000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibc903f14f4ef431ebf2bb9b5b6d868be_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMi01LTEtMS0w_508960ed-438f-4ac5-ac8a-1eabe4f5c03c"
      unitRef="usd">400105000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i51e4f49b1fdf4839b077e613a7899628_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMi02LTEtMS0w_4bdcfa31-cce9-455c-8416-57c2ae2e290f"
      unitRef="usd">767232000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ieadcdc474507437085760e44dd5d5c01_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMy0xLTEtMS0w_5f1f77eb-1120-4326-b64e-a2b6507bab41"
      unitRef="shares">105000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i13ac40a9f8fa48ad99e9e26c593ecb34_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMy0zLTEtMS0w_463aecd8-afc4-4ec6-aa04-64312b6a58f7"
      unitRef="usd">-1008000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMy02LTEtMS0w_7151ea5e-8475-4b65-ae16-e9fc96104586"
      unitRef="usd">-1008000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i13ac40a9f8fa48ad99e9e26c593ecb34_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfNC0zLTEtMS0w_866404ac-0cf0-4504-904c-af1f66bc5b3a"
      unitRef="usd">5653000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfNC02LTEtMS0w_f258ec95-ac19-4cd8-9615-cd2e7fea5635"
      unitRef="usd">5653000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ieadcdc474507437085760e44dd5d5c01_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfNS0xLTEtMS0w_35d09884-097b-4c24-b46e-39a41680a4a0"
      unitRef="shares">878000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ieadcdc474507437085760e44dd5d5c01_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfNS0yLTEtMS0w_8b1db134-2ebf-40c1-b55c-ec5461050402"
      unitRef="usd">1000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i13ac40a9f8fa48ad99e9e26c593ecb34_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfNS0zLTEtMS0w_88cd7197-c8a7-4f37-9fac-49ae24ce29cf"
      unitRef="usd">73286000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfNS02LTEtMS0w_de8e24d1-c2d0-4871-95a5-515343ec0d2c"
      unitRef="usd">73287000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="iece8fdee289d4aa8b8d7e5137317a46e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfNi00LTEtMS0w_dc6d2392-4924-497f-ac8c-e06a00bc7f4b"
      unitRef="usd">-2772000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfNi02LTEtMS0w_dd53b993-731a-478d-82f0-3bc4c89911bf"
      unitRef="usd">-2772000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
      contextRef="iece8fdee289d4aa8b8d7e5137317a46e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfNy00LTEtMS0w_66da4a2b-748b-44ec-b1de-9f7782b93a9e"
      unitRef="usd">-1879000</lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfNy02LTEtMS0w_aa025ab1-d52d-4aaf-8852-2349d3daf302"
      unitRef="usd">-1879000</lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i13ac40a9f8fa48ad99e9e26c593ecb34_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfOC0zLTEtMS0w_6bd49622-2745-4083-a9c5-3e01239a8e9f"
      unitRef="usd">-2745000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfOC02LTEtMS0w_c803d279-1693-48b4-8535-1d8a07e9b18d"
      unitRef="usd">-2745000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:StockholdersEquity
      contextRef="if91e400ca45d4fb580a3202300f06470_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfOS01LTEtMS0xNzc_a536c2b9-936c-4b3e-9fb9-d6803e7f71ac"
      unitRef="usd">-5167000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib27ffe698d824d4bb4ded2bed63e9c41_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfOS02LTEtMS04OTQ_85556d2d-c0b9-4e75-a4c2-ec9a3f05178c"
      unitRef="usd">-5167000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i09692c0a1c274da79fdc91e6f7c6284e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfOS01LTEtMS0w_29ec1f93-ea32-432e-8b1d-655aa2f14fea"
      unitRef="usd">-24131000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfOS02LTEtMS0w_f49d4525-7f47-406e-8224-406b2293f40e"
      unitRef="usd">-24131000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="ifc4a3c6bfc704ae6bcbce2daf092ade2_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMTAtMS0xLTEtMA_99b3b512-7de9-4eed-8f0f-3e3e48d03db2"
      unitRef="shares">16050000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ifc4a3c6bfc704ae6bcbce2daf092ade2_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMTAtMi0xLTEtMA_3c94cdc1-92f8-45f3-b3ab-3221a64f7d89"
      unitRef="usd">16000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icdec2dda7ca64a33ad8d5df2a891c250_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMTAtMy0xLTEtMA_595f5947-9849-4c90-a4c6-5f9c0a9db4de"
      unitRef="usd">295940000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i544dd77eaedb4f5a956d59e518b4e511_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMTAtNC0xLTEtMA_f2038f8d-fd53-43e3-bba6-562782f708f3"
      unitRef="usd">-4867000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibbbd2509899b45a8a4cb864e24eb6fca_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMTAtNS0xLTEtMA_4eeee4f5-5e28-417a-bd32-50c02ecaa927"
      unitRef="usd">370807000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibdf27ddbb0974314af1bf955199c9ad2_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yNS9mcmFnOmFhNzk0MzdmYjhlNjRiMDJhNzZiNDBkMjY1MDU2ZDdmL3RhYmxlOmE4NmU0M2U5ZDBmMjQ1ZTlhM2QyM2E5ZWUzYjU5ZTU3L3RhYmxlcmFuZ2U6YTg2ZTQzZTlkMGYyNDVlOWEzZDIzYTllZTNiNTllNTdfMTAtNi0xLTEtMA_18697e16-214f-4214-8c8d-20726caa2823"
      unitRef="usd">661896000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNC0xLTEtMS0w_f1a83248-eb59-491c-b95a-eb9f6c621c4e"
      unitRef="usd">18106000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNC0zLTEtMS0w_12f61ed1-1f97-48ff-8baf-a39996bd8ff5"
      unitRef="usd">-24131000</us-gaap:ProfitLoss>
    <lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNy0xLTEtMS0w_79c8aa86-e381-422b-8704-6899d0b88aed"
      unitRef="usd">-1684000</lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights>
    <lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNy0zLTEtMS0w_cb90a6d3-d67a-4cd2-9d27-c9e8e1f3110e"
      unitRef="usd">372000</lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfOC0xLTEtMS0w_e63a336e-3bd7-41e5-8c05-dccaa5d8e849"
      unitRef="usd">12565000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfOC0zLTEtMS0w_2b00e9a3-80a0-43a1-8510-acf9ec6f10d9"
      unitRef="usd">3422000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfOS0xLTEtMS0w_8d3ab268-921d-4381-a05c-698d593353b2"
      unitRef="usd">-150000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfOS0zLTEtMS0w_a73c20fb-a5b0-4916-8a4e-c46744a562da"
      unitRef="usd">-830000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTAtMS0xLTEtMA_0385051b-3e32-4d02-84bf-164fe7222db6"
      unitRef="usd">4916000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTAtMy0xLTEtMA_543d76cc-cfab-4c65-bfb6-1c8e809118e6"
      unitRef="usd">7203000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <lgnd:AmortizationOfOtherEconomicRights
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTEtMS0xLTEtMA_a2ebd002-95f2-4c32-b287-8681eefbdc78"
      unitRef="usd">528000</lgnd:AmortizationOfOtherEconomicRights>
    <lgnd:AmortizationOfOtherEconomicRights
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTEtMy0xLTEtMA_4bd9a689-ad5d-4184-a2db-401771df6cce"
      unitRef="usd">2958000</lgnd:AmortizationOfOtherEconomicRights>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTItMS0xLTEtMA_f3dcd443-2bd7-43a9-9b27-cea03e8c5e14"
      unitRef="usd">-4840000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTItMy0xLTEtMA_27313b2f-5bc4-4073-871e-88d486061468"
      unitRef="usd">659000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ShareBasedCompensation
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTMtMS0xLTEtMA_62930c42-609c-4bd3-a028-a39dda0d0c21"
      unitRef="usd">8405000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTMtMy0xLTEtMA_89d42c09-1401-4a9a-b34c-4531e39bfee2"
      unitRef="usd">5653000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTQtMS0xLTEtMA_c168ad0d-b23c-4b25-8690-b89dfd919e6d"
      unitRef="usd">12408000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTQtMy0xLTEtMA_50d9dfd1-b141-4703-bee8-2c27f1b4b4ce"
      unitRef="usd">10419000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <lgnd:GainLossOnShortTermInvestments
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTUtMS0xLTEtMA_e3b50e8a-1836-41fb-b230-ccbabc42b57c"
      unitRef="usd">13090000</lgnd:GainLossOnShortTermInvestments>
    <lgnd:GainLossOnShortTermInvestments
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTUtMy0xLTEtMA_3612e0e5-2002-4e5e-81f7-44aaeab498ca"
      unitRef="usd">-25456000</lgnd:GainLossOnShortTermInvestments>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTYtMS0xLTEtMA_2f23f075-b6e1-4c81-b3bd-8e2d1b6faa23"
      unitRef="usd">238000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTYtMy0xLTEtMA_9aef7464-45d8-42b0-a422-7ff92c524958"
      unitRef="usd">5668000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTgtMS0xLTEtMA_1d955a49-09e5-4bd9-a72f-43b1360ded73"
      unitRef="usd">-2411000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTgtMy0xLTEtMA_f3468eca-c910-48c8-8a1c-c14b2e169bd3"
      unitRef="usd">8398000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTktMS0xLTEtMA_639d7d04-1351-4590-b098-842830818e87"
      unitRef="usd">9670000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMTktMy0xLTEtMA_016ba290-bb03-4309-acfa-f4e9d2afa661"
      unitRef="usd">-1251000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjAtMS0xLTEtMA_7e472e07-c9db-4e12-b280-d508a0823c38"
      unitRef="usd">470000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjAtMy0xLTEtMA_b269f54d-2e3b-4bd3-9df7-e9efdf1aa3cd"
      unitRef="usd">2114000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjEtMS0xLTEtMA_e66a8195-7a5f-436f-b020-b162ad114c82"
      unitRef="usd">1072000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjEtMy0xLTEtMA_97152b6b-c801-45d9-ab35-869eda74e7e9"
      unitRef="usd">4081000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjItMS0xLTEtMA_c374f50d-2674-4c9c-9d00-8f3b6bb724d8"
      unitRef="usd">-5695000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjItMy0xLTEtMA_3dc9d297-a997-411e-9f6b-c4ad4f748fa5"
      unitRef="usd">2215000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjMtMS0xLTEtMA_d2ef979b-6438-46e2-a246-863a3aebc890"
      unitRef="usd">-3768000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjMtMy0xLTEtMA_357b8278-4701-4cc4-abf8-cd45e55ca531"
      unitRef="usd">50000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjQtMS0xLTEtMA_daea6327-5d0d-4845-9485-c2d6bd7ed1ba"
      unitRef="usd">10754000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjQtMy0xLTEtMA_60675a79-0a91-49ae-bc1e-ea850382d8fc"
      unitRef="usd">16922000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjgtMS0xLTEtMA_35f5cf28-32f0-43c9-886b-ff8a6bd500b4"
      unitRef="usd">72148000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjgtMy0xLTEtMA_a2f826f5-f378-4b78-827f-33cd41b59875"
      unitRef="usd">167374000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjktMS0xLTEtMA_af327af5-6d64-4ba8-b497-0dffb6083572"
      unitRef="usd">109407000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMjktMy0xLTEtMA_8440123b-908c-48d9-af54-1abd9ac9004f"
      unitRef="usd">179431000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMzAtMS0xLTEtMA_527079f2-10b3-4561-9f31-fa261ad2aa91"
      unitRef="usd">31500000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMzAtMy0xLTEtMA_dd8633c3-13d2-4ec6-aecc-47c07b4b74a1"
      unitRef="usd">297005000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMzMtMS0xLTEtMA_cd12f647-0d14-40db-ab70-1f65d38f19fe"
      unitRef="usd">3644000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMzMtMy0xLTEtMA_8c71319a-ec3d-4b2d-90ec-84f5c5724345"
      unitRef="usd">526000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMzQtMS0xLTEtMA_8089dfb9-b92e-4f55-b117-33234b07abfb"
      unitRef="usd">65115000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMzQtMy0xLTEtMA_cbba94ca-dbbd-4027-af58-65e8d25b7d7e"
      unitRef="usd">308536000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMzctMS0xLTEtMA_70f478b2-2991-4f07-98cf-617f9050a718"
      unitRef="usd">108822000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMzctMy0xLTEtMA_993dc9c9-e9ae-4e9f-adc7-8f7fc4175fe8"
      unitRef="usd">203210000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMzUtMS0xLTEtMzEyNw_753ddc0f-0abc-4dac-b24a-8149a1d64986"
      unitRef="usd">3801000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMzUtMy0xLTEtMzEzMQ_48218183-b169-4f9c-98c4-1e7d44b52ef4"
      unitRef="usd">0</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:ProceedsFromHedgeFinancingActivities
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMzktMS0xLTEtMA_5957c7b0-e659-464e-925c-a0ba307495ef"
      unitRef="usd">16855000</us-gaap:ProceedsFromHedgeFinancingActivities>
    <us-gaap:ProceedsFromHedgeFinancingActivities
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfMzktMy0xLTEtMA_03028824-fe5b-4db0-bc88-072126a634f4"
      unitRef="usd">0</us-gaap:ProceedsFromHedgeFinancingActivities>
    <us-gaap:PaymentsForHedgeFinancingActivities
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDAtMS0xLTEtMA_31d9bb32-ca17-4580-9507-354be94655ea"
      unitRef="usd">16459000</us-gaap:PaymentsForHedgeFinancingActivities>
    <us-gaap:PaymentsForHedgeFinancingActivities
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDAtMy0xLTEtMA_b9f59316-e31f-4f03-b441-4c169b25222b"
      unitRef="usd">0</us-gaap:PaymentsForHedgeFinancingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDEtMS0xLTEtMA_06759512-18bb-40c6-9423-92d02f1e8a42"
      unitRef="usd">26493000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDEtMy0xLTEtMA_2a690d1b-cebb-4909-95f7-1a228b400ddf"
      unitRef="usd">421000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDItMS0xLTEtMA_386e9c80-10d7-46c7-b66d-8c3a0bc7fac9"
      unitRef="usd">5901000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDItMy0xLTEtMA_97eb4843-2fe2-483b-aa46-6ecaabf23642"
      unitRef="usd">1429000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDMtMS0xLTEtMA_f01ec9fd-33ad-4ffc-8ebb-13c610ce2614"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDMtMy0xLTEtMA_1bda2e60-6795-401d-8201-8c7225a95e25"
      unitRef="usd">73287000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <lgnd:PaymentsToContingentValueRightHoldersFinancingActivity
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDQtMS0xLTEtMA_9ca38eeb-6a43-42f6-8299-8ad185929582"
      unitRef="usd">0</lgnd:PaymentsToContingentValueRightHoldersFinancingActivity>
    <lgnd:PaymentsToContingentValueRightHoldersFinancingActivity
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDQtMy0xLTEtMA_25d542b0-6d9e-45f6-af0a-665252cf24ab"
      unitRef="usd">1800000</lgnd:PaymentsToContingentValueRightHoldersFinancingActivity>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDYtMS0xLTEtMA_606c12ee-8020-4cdd-a5ca-223edeefcf60"
      unitRef="usd">-91635000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDYtMy0xLTEtMA_bc57f384-d21f-402b-9cbb-40f3c87b24f9"
      unitRef="usd">-279305000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDctMS0xLTEtMA_20d4ca84-3faf-4e60-9c46-fb3885c0f12d"
      unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDctMy0xLTEtMA_e6605cce-2b95-457a-93c9-a42b7e3cceb4"
      unitRef="usd">-169000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDgtMS0xLTEtMA_26a9a1e6-3e42-4e10-9c61-c16787052e71"
      unitRef="usd">-15766000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDgtMy0xLTEtMA_989902d5-15ce-42e7-b2a5-61759787857d"
      unitRef="usd">45984000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDktMS0xLTEtMA_13d3905f-2bf9-49a5-bc01-705cd8aec34d"
      unitRef="usd">47963000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i51e4f49b1fdf4839b077e613a7899628_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNDktMy0xLTEtMA_ab249b4d-42ea-44c2-b824-b02feefe16ad"
      unitRef="usd">72273000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNTAtMS0xLTEtMA_0d67f025-b6f7-4f2d-bd4f-ec5f0514f363"
      unitRef="usd">32197000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ibdf27ddbb0974314af1bf955199c9ad2_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOjA5NmU5Y2UyMjQ2YTRiYTlhNDNjYjY2NTVmMmRhODhmL3RhYmxlcmFuZ2U6MDk2ZTljZTIyNDZhNGJhOWE0M2NiNjY1NWYyZGE4OGZfNTAtMy0xLTEtMA_0b3a4aa4-f091-4627-9ab4-0d337aa3f98a"
      unitRef="usd">118257000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOmJmMTc2MGIyZDU0YjQzZGY5MzE0ZTYzNmM1YjFkYjkxL3RhYmxlcmFuZ2U6YmYxNzYwYjJkNTRiNDNkZjkzMTRlNjM2YzViMWRiOTFfMS0xLTEtMS0w_9e847a48-cef9-49dc-b157-04c6b72343e5"
      unitRef="usd">241000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOmJmMTc2MGIyZDU0YjQzZGY5MzE0ZTYzNmM1YjFkYjkxL3RhYmxlcmFuZ2U6YmYxNzYwYjJkNTRiNDNkZjkzMTRlNjM2YzViMWRiOTFfMS0zLTEtMS0w_cd6e19d6-55c5-41c9-9037-41e58958da87"
      unitRef="usd">597000</us-gaap:InterestPaidNet>
    <us-gaap:RestrictedCashCurrent
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOmJmMTc2MGIyZDU0YjQzZGY5MzE0ZTYzNmM1YjFkYjkxL3RhYmxlcmFuZ2U6YmYxNzYwYjJkNTRiNDNkZjkzMTRlNjM2YzViMWRiOTFfMy0xLTEtMS0w_f1b37ebd-31e5-4367-bfaf-c029f63a74c2"
      unitRef="usd">344000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="ibdf27ddbb0974314af1bf955199c9ad2_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOmJmMTc2MGIyZDU0YjQzZGY5MzE0ZTYzNmM1YjFkYjkxL3RhYmxlcmFuZ2U6YmYxNzYwYjJkNTRiNDNkZjkzMTRlNjM2YzViMWRiOTFfMy0zLTEtMS0w_5d3ea29a-a51f-48b4-8c91-f92ee965e5cc"
      unitRef="usd">730000</us-gaap:RestrictedCashCurrent>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOmJmMTc2MGIyZDU0YjQzZGY5MzE0ZTYzNmM1YjFkYjkxL3RhYmxlcmFuZ2U6YmYxNzYwYjJkNTRiNDNkZjkzMTRlNjM2YzViMWRiOTFfOS0xLTEtMS0w_f1de8f5b-9308-4d01-926f-e8a72106728a"
      unitRef="usd">87000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOmJmMTc2MGIyZDU0YjQzZGY5MzE0ZTYzNmM1YjFkYjkxL3RhYmxlcmFuZ2U6YmYxNzYwYjJkNTRiNDNkZjkzMTRlNjM2YzViMWRiOTFfOS0zLTEtMS0w_7f19032a-b197-4a86-b560-1d4e68100588"
      unitRef="usd">63000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <lgnd:AccruedInventoryPurchases
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOmJmMTc2MGIyZDU0YjQzZGY5MzE0ZTYzNmM1YjFkYjkxL3RhYmxlcmFuZ2U6YmYxNzYwYjJkNTRiNDNkZjkzMTRlNjM2YzViMWRiOTFfMTEtMS0xLTEtMA_4c37a9f3-0bf8-4750-92c6-cab978671174"
      unitRef="usd">775000</lgnd:AccruedInventoryPurchases>
    <lgnd:AccruedInventoryPurchases
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOmJmMTc2MGIyZDU0YjQzZGY5MzE0ZTYzNmM1YjFkYjkxL3RhYmxlcmFuZ2U6YmYxNzYwYjJkNTRiNDNkZjkzMTRlNjM2YzViMWRiOTFfMTEtMy0xLTEtMA_d9b584c7-78a1-433e-9ef2-d0e84cb1d43d"
      unitRef="usd">1445000</lgnd:AccruedInventoryPurchases>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOmJmMTc2MGIyZDU0YjQzZGY5MzE0ZTYzNmM1YjFkYjkxL3RhYmxlcmFuZ2U6YmYxNzYwYjJkNTRiNDNkZjkzMTRlNjM2YzViMWRiOTFfMTMtMS0xLTEtMA_72063137-e0a5-48fd-a5a2-ae46f9bf3c43"
      unitRef="usd">-55000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8yOC9mcmFnOjI1MjVlYzRiMzM5MjRiOWY4ZWJiZjEyYmU3MGY0Y2E1L3RhYmxlOmJmMTc2MGIyZDU0YjQzZGY5MzE0ZTYzNmM1YjFkYjkxL3RhYmxlcmFuZ2U6YmYxNzYwYjJkNTRiNDNkZjkzMTRlNjM2YzViMWRiOTFfMTMtMy0xLTEtMA_c1bcd696-17e3-437d-a89b-a8c5804d5ba9"
      unitRef="usd">-3541000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg2MDI_3573a210-cef0-4e43-9262-b4aa6f45b732">Basis of Presentation and Summary of Significant Accounting Policies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2020 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, &#x201c;contract revenue&#x201d; and &#x201c;service revenue&#x201d; presented in the condensed consolidated statement of operations for the three months ended March 31, 2020 have been combined into &#x201c;contract revenue&#x201d; in the condensed consolidated statement of operations to conform with the current period presentation. &#160;In addition, &#x201c;gain (loss) from Viking&#x201d; and a portion of &#160;&#x201c;other expense, net&#x201d; that related to other short-term investments presented in the condensed consolidated statement of operations for the three months ended March 31, 2020 have been combined into &#x201c;gain (loss) from short-term investments&#x201d; in the condensed consolidated statement of operations to conform with the current period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have described our significant accounting policies in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 1, Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the Notes to Consolidated Financial Statements in our 2020 Annual Report. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impact of COVID-19 Pandemic&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The current COVID-19 worldwide pandemic has presented substantial public health and economic challenges and is affecting our employees and partners, patients, communities and business operations, as well as the U.S. and global economy and financial markets. International and U.S. governmental authorities in impacted regions have taken actions in an effort to slow the spread of COVID-19, including issuing varying forms of &#x201c;stay-at-home&#x201d; orders, and restricting business functions outside of one&#x2019;s home. In response, we have restricted in-person access to our executive offices, our administrative employees are mostly working remotely, and we have limited the number of staff in our research and development laboratories and other facilities. The continued spread of the COVID-19 pandemic and the measures taken by the governments of countries have affected, and could continue to affect, our business and the business of our partners, including future disruptions to our supply chain and the manufacture or shipment of drug substance and finished drug product for Captisol, delays by us or our partners in the initiation or enrollment of patients in clinical trials, discontinuations by patients enrolled in clinical trials, difficulties launching or commercializing products and other related activities, which could delay ongoing clinical trials, increase development costs, reduce royalty revenues and have a material adverse effect on our business, financial condition and results of operations. Several of our partners have reported that their operations have been impacted including delays in research and development programs and deprioritizing clinical trials in favor of treating patients who have contracted the virus or to prevent the spread of the virus. This may lead to clinical trial protocol deviations or to discontinuation of treatment for patients who are currently enrolled in the clinical trials being conducted by us or our partners. In addition, certain of our partners have reported negative impacts on product sales which will impact our royalty revenues.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of our partners are working to develop drugs to treat COVID-19. For example, we are supplying Captisol to partners, including Gilead for Veklury (remdesivir), the first FDA-approved treatment for COVID-19 for the treatment of patients with COVID-19 requiring hospitalization. In addition, certain of our OmniAb partners have initiated antibody discovery programs for the potential treatment of COVID-19.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The full extent to which the COVID-19 pandemic will directly or indirectly impact our business, the businesses of our partners, our results of operations and our financial condition will depend on future developments that are highly uncertain and cannot be accurately predicted, including new information that may emerge concerning COVID-19, the actions taken to contain it or treat its impact, including the timing and extent of governments reopening or further restricting activities, and the economic impact on local, regional, national and international markets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The new guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP. This standard removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. This standard is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020 and adoption must be as of the beginning of the Company&#x2019;s annual fiscal year. We are currently evaluating the impact of this standard on our consolidated financial statements and related disclosures. We intend to adopt this standard on January 1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on our condensed consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Royalties &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We receive royalty revenue on sales by our partners of products covered by patents that we own. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a sales-based royalty to be recorded when the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues are adjusted for in the period in which they become known, typically the following quarter. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Contract Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our contract revenue includes service revenue, license fees and future contingent milestone based payments. We recognize service revenue for contracted R&amp;amp;D services performed for our customers over time. We measure our progress using an input method based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time we estimate it will take us to complete the activities, or costs we incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make estimates and use judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We include contingent milestone based payments in the estimated transaction price when there is a basis to reasonably estimate the amount of the payment.  These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the&#160;transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon or after the development milestone or regulatory approval.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Captisol Sales&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue when control of Captisol material is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. We have elected to recognize the cost for freight and shipping when or after control over Captisol material has transferred to the customer as an expense in cost of Captisol. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. We use an observable price to determine the stand-alone selling price for separate performance obligations or a cost plus margin approach when one is not available. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry a contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue. During the three months ended March&#160;31, 2021, the amount recognized as revenue that was deferred at December 31, 2020 was $7.3 million. During the three months ended March&#160;31, 2020, the amount recognized as revenue that was deferred at December 31, 2019 was $1.0 million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation&#160;of&#160;Revenue &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Kyprolis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Evomela&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Captisol&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;License Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Milestone&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-term Investments &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our short-term investments consist of the following at March&#160;31, 2021 and December 31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.722%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Mutual fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Treasury bill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;262,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;324,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;324,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Viking warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;307,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;363,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March 31, 2021, we sold 0.3&#160;million shares of Viking and recognized a realized gain of $2.2&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March 31, 2021, we exercised all outstanding Viking warrants to purchase 1.5 million shares of Viking's common stock at an exercise price of $1.50 per share. As of March&#160;31, 2021, we have zero Viking warrants outstanding.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gain (loss) from short-term investments in our condensed consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Allowances are recorded for available-for-sale debt securities with unrealized losses. This limits of the amount of credit losses that can be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The provisions of the credit losses standard did not have a material impact on our available-for-sale debt securities during the three months ended March&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;After one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investment policy is capital preservation and we only invested in U.S.-dollar denominated investments. We held a total of 11 positions which were in an unrealized loss position as of March&#160;31, 2021. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, no credit losses were recognized for the three months ended March&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable and Allowance for Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers. During the three months ended March&#160;31, 2021, we considered the current and expected future economic and market conditions including, but not limited to, the anticipated unfavorable impacts of the surrounding novel coronavirus (COVID-19) pandemic on our business and recorded an adjustment of $0.02&#160;million of allowance for credit losses as of March&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Other Identifiable Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and other identifiable intangible assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;190,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Definite lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Complete technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;277,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;277,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(67,441)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(63,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Contractual relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total goodwill and other identifiable intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;774,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;784,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Commercial License and Other Economic Rights&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial license and other economic rights consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aziyo and CorMatrix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,166&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,588)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Selexis and Dianomi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,285&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,871&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17,847)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10,451&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10,979&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Amounts represent accumulated amortization to principal of $11.9 million and credit loss adjustments of $6.0 million as of March&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(2) Amounts represent accumulated amortization to principal of $11.3 million and credit loss adjustments of $6.0 million as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Commercial license and other economics rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis in April 2013 and April 2015, CorMatrix in May 2016, and Dianomi in January 2019. Commercial license rights acquired are accounted for as financial assets and other economic rights are accounted for as funded research and developments as further discussed below and in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 1,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; of the Notes to Consolidated Financial Statements in our 2020 Annual Report. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In May 2017, we entered into a Royalty Agreement with Aziyo pursuant to which we will receive royalties from certain marketed products that Aziyo acquired from CorMatrix. We account for the Aziyo commercial license right as a financial asset, and in accordance with ASC 310, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Receivables&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, we amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the Royalty Agreement with Aziyo as of March&#160;31, 2021 is 23%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The payments received during the three months ended March&#160;31, 2021 were accordingly allocated between revenue and the amortization of the commercial license rights.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prior to 2020, we accounted for commercial license rights related to developmental pipeline products such as Selexis and Dianomi on a non-accrual basis. Starting in 2020, given the expected cash flow from the Selexis program, we started to account for the Selexis commercial license right as a financial asset in accordance with ASC 310, and amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the royalty agreement with Selexis as of March&#160;31, 2021 is 21%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. The payments received during the three months ended March&#160;31, 2021 were accordingly allocated between revenue and the amortization of the commercial license rights. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We recorded a $5.5 million pre-tax reserve for credit losses upon adoption of the credit losses standard (ASU 2016-13) on January 1, 2020. We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the three months ended March&#160;31, 2021, we further considered the current and expected future economic and market conditions surrounding novel coronavirus (COVID-19) pandemic and concluded no further adjustment was needed on the allowance for credit losses as of March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties owed to third parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Return reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subcontractor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Supplier&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period until the last tranche vests. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three-year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Income (Loss) Per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the applicable conversion price of the respective notes. It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 4, Convertible Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 6, Stockholders&#x2019; Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.832%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.984%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive potential common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares used to compute diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Potentially dilutive shares excluded from calculation due to anti-dilutive effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg2MDQ_f048c74b-6e26-4198-a8df-af5c96d27473">Basis of PresentationOur condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2020 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjE5OTAyMzMxMzYwNA_5ece32c4-f6c1-4093-a1ba-8ee52b4aacc0">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, &#x201c;contract revenue&#x201d; and &#x201c;service revenue&#x201d; presented in the condensed consolidated statement of operations for the three months ended March 31, 2020 have been combined into &#x201c;contract revenue&#x201d; in the condensed consolidated statement of operations to conform with the current period presentation. &#160;In addition, &#x201c;gain (loss) from Viking&#x201d; and a portion of &#160;&#x201c;other expense, net&#x201d; that related to other short-term investments presented in the condensed consolidated statement of operations for the three months ended March 31, 2020 have been combined into &#x201c;gain (loss) from short-term investments&#x201d; in the condensed consolidated statement of operations to conform with the current period presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:UseOfEstimates
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1Nzc_d5487625-ce10-42d8-989e-195261a5be58">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1NDY_37ddf27d-63b7-44b4-bf01-3f3d87a3425d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The new guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP. This standard removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. This standard is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020 and adoption must be as of the beginning of the Company&#x2019;s annual fiscal year. We are currently evaluating the impact of this standard on our consolidated financial statements and related disclosures. We intend to adopt this standard on January 1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on our condensed consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1ODM_12c499dd-105e-4f3c-bc1a-b9ace2e34fe1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Royalties &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We receive royalty revenue on sales by our partners of products covered by patents that we own. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a sales-based royalty to be recorded when the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues are adjusted for in the period in which they become known, typically the following quarter. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Contract Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our contract revenue includes service revenue, license fees and future contingent milestone based payments. We recognize service revenue for contracted R&amp;amp;D services performed for our customers over time. We measure our progress using an input method based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time we estimate it will take us to complete the activities, or costs we incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make estimates and use judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We include contingent milestone based payments in the estimated transaction price when there is a basis to reasonably estimate the amount of the payment.  These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the&#160;transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon or after the development milestone or regulatory approval.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Captisol Sales&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue when control of Captisol material is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. We have elected to recognize the cost for freight and shipping when or after control over Captisol material has transferred to the customer as an expense in cost of Captisol. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. We use an observable price to determine the stand-alone selling price for separate performance obligations or a cost plus margin approach when one is not available. &lt;/span&gt;&lt;/div&gt;The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry a contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue. During the three months ended March&#160;31, 2021, the amount recognized as revenue that was deferred at December 31, 2020 was $7.3 million. During the three months ended March&#160;31, 2020, the amount recognized as revenue that was deferred at December 31, 2019 was $1.0 million.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMTc1OTM_27479fdf-cdcd-4ffb-9849-be213499a08a"
      unitRef="usd">7300000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMTc3MDI_600a81fd-e9d8-4333-9ad0-8c5a23bcf2a7"
      unitRef="usd">1000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1NDc_587a8e77-f932-45a2-aad0-22b5464193fe">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Kyprolis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Evomela&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Captisol&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;License Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Milestone&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i70e6045ea57e4960b5e7b991ff6afe59_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfNC0yLTEtMS0w_fca4f8c0-48f5-4a78-b30a-744ce76d04e4"
      unitRef="usd">4287000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i141de7606bb14beea82d45802f93d383_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfNC00LTEtMS0w_299a5a72-efd2-4194-ab7e-22de8b2a261c"
      unitRef="usd">4405000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4196bfc37550432080d7f0d6eec3b8d5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfNS0yLTEtMS0w_78ec19ce-91fc-4331-a975-de004c361b4a"
      unitRef="usd">2333000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i43bf79f5a943475489db1bfa57aa7668_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfNS00LTEtMS0w_3bf0b4ec-c01e-47a9-8180-600b5c933383"
      unitRef="usd">1576000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i242bcf58c1cd4fcfa0c2d36e1fe47f5c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfNi0yLTEtMS0w_be85cc70-a558-4221-b763-e4db0b9c9d0b"
      unitRef="usd">492000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibd88764b91554104994dd396befa8270_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfNi00LTEtMS0w_2db2d39b-f671-48e9-b60e-1023b0d77755"
      unitRef="usd">584000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie30239110ac54ae2af1d194e9c6384f4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfOC0yLTEtMS0w_cea9560c-a212-4c08-9c32-ed196992dab4"
      unitRef="usd">7112000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i7e4b63fffd544d8c9290215bd3714192_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfOC00LTEtMS0w_65abb636-2f94-4c89-98ba-ab2e45d35c0d"
      unitRef="usd">6565000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5f9ffb7664b0411f8db3b6b38d6632e4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTAtMi0xLTEtMA_06d23c1d-e9ee-4cf7-95dc-a134fc0ea4c8"
      unitRef="usd">31272000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6be2d05e46c04f22a00605da2833d1da_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTAtNC0xLTEtMA_19bed2d9-7720-40dc-be8f-f49e37266356"
      unitRef="usd">21109000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib71204e5781b46798722ee98c6925ade_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTMtMi0xLTEtMA_fe34d971-b2e3-4a58-83fc-861b9bc3d794"
      unitRef="usd">5462000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3c38be1b284c4082985f73fc8fd4cb08_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTMtNC0xLTEtMA_39bd8e09-33f5-42fb-828a-6715a0dd4a74"
      unitRef="usd">3357000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic015ad72c3c0416383db07b48a5a7c6a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTQtMi0xLTEtMA_f8699719-8b25-4965-8da1-51b2c308c9f9"
      unitRef="usd">1043000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8df2708d62174fbdac6fecdf1774ab15_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTQtNC0xLTEtMA_f0c9b1ef-63c0-4e81-b59a-1b3c70d99982"
      unitRef="usd">975000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="icd0f3e11676d4c139d4f33ff5e608d98_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTUtMi0xLTEtMA_edd65393-e99b-48b8-bcad-89221c280bc5"
      unitRef="usd">8417000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i098bf91f61f44dc08cae022ea07af921_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTUtNC0xLTEtMA_0f48bd44-2052-4ac6-88a0-f52dd579ffb2"
      unitRef="usd">334000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i707023875ea742a58c7c82670518aa3a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTYtMi0xLTEtMA_36eb7e06-0329-4f49-9f8f-573b857c4802"
      unitRef="usd">1844000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idbb090f086294a258eff6658c99e6ab0_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTYtNC0xLTEtMA_baf05372-1026-423e-b15a-093233b64629"
      unitRef="usd">821000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i14b88249e38e42929cf58c0afff44f7c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTctMi0xLTEtMA_3bf6bca0-d65e-4da8-96d3-fbbf08f81c1e"
      unitRef="usd">16766000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib77e9a47601246a2acde91f6d3baa812_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTctNC0xLTEtMA_ac1f341a-8e23-4768-8373-15c3acbfbf85"
      unitRef="usd">5487000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTktMi0xLTEtMA_70bad146-a137-4e25-bdd2-707c22d98751"
      unitRef="usd">55150000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjUyZWI4NDkxZjZkODRmZmZiNTk3YzU3MmZmZGZhN2YyL3RhYmxlcmFuZ2U6NTJlYjg0OTFmNmQ4NGZmZmI1OTdjNTcyZmZkZmE3ZjJfMTktNC0xLTEtMA_6652d68d-6c4d-4797-9368-a6a53e4dd5b1"
      unitRef="usd">33161000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <lgnd:ScheduleOfShortTermInvestmentsTableTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1NDg_32fe1028-378a-4723-b612-3036d2d22f41">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our short-term investments consist of the following at March&#160;31, 2021 and December 31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.722%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Mutual fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Treasury bill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;262,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;324,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;324,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Viking warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;307,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;363,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</lgnd:ScheduleOfShortTermInvestmentsTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i47e88f0429c44134b883d6f3aa820b25_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNC0xLTEtMS0w_ff64a326-af8e-497d-a406-8ee61209e12f"
      unitRef="usd">51232000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i47e88f0429c44134b883d6f3aa820b25_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNC0zLTEtMS0w_32bb501d-d48e-4a31-b141-230ac2fb88b3"
      unitRef="usd">25000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i47e88f0429c44134b883d6f3aa820b25_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNC01LTEtMS0w_6fb96dd5-2269-47fa-8765-30566f1e41c5"
      unitRef="usd">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i47e88f0429c44134b883d6f3aa820b25_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNC03LTEtMS0w_911ddca6-dc30-4478-b16f-5652c11166f5"
      unitRef="usd">51253000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i9a07ebdd562e411fae6b15bb21f8c1aa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNC05LTEtMS0w_9aff40fb-b6aa-4d93-9518-34a5a0c92744"
      unitRef="usd">84120000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9a07ebdd562e411fae6b15bb21f8c1aa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNC0xMS0xLTEtMA_68fe819d-879d-48e7-9877-c933d7f4a7c6"
      unitRef="usd">35000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9a07ebdd562e411fae6b15bb21f8c1aa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNC0xMy0xLTEtMA_ee7b48e3-0c43-41cd-821f-c24abef3b59e"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9a07ebdd562e411fae6b15bb21f8c1aa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNC0xNS0xLTEtMA_880f9818-972e-49b1-a45c-c5a2b1e10b17"
      unitRef="usd">84154000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i24b1ae2706284cdca4eb23d9915a4450_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNS0xLTEtMS0w_0a3f54f5-13c0-409b-ba55-a1ba411e6d64"
      unitRef="usd">25853000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i24b1ae2706284cdca4eb23d9915a4450_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNS0zLTEtMS0w_3e707ca2-2480-41df-9537-cf4df2315ac9"
      unitRef="usd">72000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i24b1ae2706284cdca4eb23d9915a4450_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNS01LTEtMS0w_049977b4-1b0a-45ce-bd53-71fcd16c8ed8"
      unitRef="usd">8000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i24b1ae2706284cdca4eb23d9915a4450_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNS03LTEtMS0w_9b9014ed-b33f-4c27-a4b2-7ab343af75ec"
      unitRef="usd">25917000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6c916d897e674db5919221cdca2f97bb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNS05LTEtMS0w_3bd3b1f3-6056-458b-a37f-5a7717222ba8"
      unitRef="usd">30512000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6c916d897e674db5919221cdca2f97bb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNS0xMS0xLTEtMA_501a4698-eab2-437c-af12-56e5b536e133"
      unitRef="usd">99000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6c916d897e674db5919221cdca2f97bb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNS0xMy0xLTEtMA_ee923c5f-8cb8-4d9b-974d-85d6b3a65152"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6c916d897e674db5919221cdca2f97bb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNS0xNS0xLTEtMA_5b2cb5db-413a-4600-b9bb-a5fd6ee7b275"
      unitRef="usd">30610000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id7ca3f45fb8d4984b3709f858a5d4195_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi0xLTEtMS05MDE_dfb4e702-05a7-4883-b4d4-93f40a44f3b7"
      unitRef="usd">4501000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id7ca3f45fb8d4984b3709f858a5d4195_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi0zLTEtMS05MDE_ddebdedf-7885-4651-99b3-035c157b9dad"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id7ca3f45fb8d4984b3709f858a5d4195_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi01LTEtMS05MDE_624b0541-046c-4e86-a124-ce215acd1add"
      unitRef="usd">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id7ca3f45fb8d4984b3709f858a5d4195_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi03LTEtMS05MDE_20d49f35-6eac-429c-ae5d-1c06b278bdfb"
      unitRef="usd">4497000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if9eb656aa6e5479a85a382cc47a8eca1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi05LTEtMS0yNzg_773af0fc-d45a-46e9-9110-824962dd453e"
      unitRef="usd">4499000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if9eb656aa6e5479a85a382cc47a8eca1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi0xMS0xLTEtMjg5_b2e26bf1-384c-4e0f-8e30-5d81adcd01a6"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if9eb656aa6e5479a85a382cc47a8eca1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi0xMy0xLTEtMjk0_98e0f1ea-8bde-44c4-9154-39557cebc0d4"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if9eb656aa6e5479a85a382cc47a8eca1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi0xNS0xLTEtOTAx_d899b523-1465-4877-8fa0-9532166cd847"
      unitRef="usd">4501000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i4a8c5e7437834c46ae9735a7aaa4148c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi0xLTEtMS0w_2c4fecf9-5ccd-4638-b2fb-776e879768ee"
      unitRef="usd">19815000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4a8c5e7437834c46ae9735a7aaa4148c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi0zLTEtMS0w_cbfc9475-2958-43a1-858d-e311053cb73b"
      unitRef="usd">9000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4a8c5e7437834c46ae9735a7aaa4148c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi01LTEtMS0w_db7296de-b9da-4864-81b1-4d28257ec153"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4a8c5e7437834c46ae9735a7aaa4148c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi03LTEtMS0w_134d969b-4ecc-414f-921f-456eb56cfb64"
      unitRef="usd">19824000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i9cd22ab765384cccacfc57e8e1996cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi05LTEtMS0w_8cf310ec-670f-4452-8915-efef0310aa0e"
      unitRef="usd">45459000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9cd22ab765384cccacfc57e8e1996cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi0xMS0xLTEtMA_c54f1728-8e55-4917-a2a7-24fac80a5141"
      unitRef="usd">27000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9cd22ab765384cccacfc57e8e1996cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi0xMy0xLTEtMA_de5ca339-99fe-4820-8b46-87a6841b95db"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9cd22ab765384cccacfc57e8e1996cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNi0xNS0xLTEtMA_0a36f8a4-cf08-49ed-b4b5-2b3cc6af61bd"
      unitRef="usd">45485000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i27ccac3b42614165a6aa9e91ee7ff005_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNy0xLTEtMS0w_880c8388-a1f4-409c-93ab-bbee257cf64e"
      unitRef="usd">4456000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i27ccac3b42614165a6aa9e91ee7ff005_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNy0zLTEtMS0w_31ac4cb6-2d6d-4976-b1f7-db28514f90aa"
      unitRef="usd">3736000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i27ccac3b42614165a6aa9e91ee7ff005_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNy01LTEtMS0w_40bebbee-fe66-4835-afa9-5a9df335fa30"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i27ccac3b42614165a6aa9e91ee7ff005_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNy03LTEtMS0w_c6b01b53-099f-41fa-a135-a7c980b10053"
      unitRef="usd">8192000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if16401e5b6d848aea59ba13c03311074_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNy05LTEtMS0w_4608332a-888b-4d78-8031-0c5cc46a482d"
      unitRef="usd">4466000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if16401e5b6d848aea59ba13c03311074_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNy0xMS0xLTEtMA_339eaa94-86c9-4b55-9e91-5cd473325741"
      unitRef="usd">360000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if16401e5b6d848aea59ba13c03311074_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNy0xMy0xLTEtMA_2bb7444c-6b4a-4712-ba48-435ca6a7b9f4"
      unitRef="usd">1388000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if16401e5b6d848aea59ba13c03311074_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfNy0xNS0xLTEtMA_54350007-e59a-4b95-b6bd-f11747ccfd75"
      unitRef="usd">3438000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i87abf73938904ca5aa12b57c61dab1a0_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOC0xLTEtMS0w_93d7c807-c4d8-471c-a13e-90e0e59e198f"
      unitRef="usd">151830000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i87abf73938904ca5aa12b57c61dab1a0_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOC0zLTEtMS0w_e71ca65e-9872-4c91-9871-d3e61b09a063"
      unitRef="usd">53000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i87abf73938904ca5aa12b57c61dab1a0_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOC01LTEtMS0w_a0cb7c68-9151-4510-a2e3-c1d3c5e91f15"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i87abf73938904ca5aa12b57c61dab1a0_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOC03LTEtMS0w_9c89d6cc-c551-442d-b17b-91918b757158"
      unitRef="usd">151883000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i5bf3ec58e21145b6b4ceb58e80ec79b8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOC05LTEtMS0w_bea27d50-ed93-4989-8aa6-8a3cfa8195b5"
      unitRef="usd">151512000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5bf3ec58e21145b6b4ceb58e80ec79b8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOC0xMS0xLTEtMA_2d1d5e33-4604-4042-b796-80771c26c4ec"
      unitRef="usd">386000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5bf3ec58e21145b6b4ceb58e80ec79b8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOC0xMy0xLTEtMA_479260bd-4967-46bd-9214-0a3f6f520932"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5bf3ec58e21145b6b4ceb58e80ec79b8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOC0xNS0xLTEtMA_825c66f2-6a1f-4328-bc68-ea0a158a4055"
      unitRef="usd">151898000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1d3c8187465b443d8f77beeb3adb7d56_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtMS0xLTEtOTAz_f9258625-7406-4918-84b1-d7651c8c8f6d"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1d3c8187465b443d8f77beeb3adb7d56_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtMy0xLTEtOTAz_58c28287-111a-4679-a6b9-214b9674d3f7"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1d3c8187465b443d8f77beeb3adb7d56_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtNS0xLTEtOTAz_8d78a58e-c241-4ff2-93a4-d4c7594a982d"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1d3c8187465b443d8f77beeb3adb7d56_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtNy0xLTEtOTAz_5150b9f0-fabf-42f7-9d48-09d31ce83e5a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i680ece1eaa8f4e9e96ce0f42882bf0ce_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtOS0xLTEtMjgy_e88ed081-a125-4ae4-be2f-c835cd0eff33"
      unitRef="usd">3999000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i680ece1eaa8f4e9e96ce0f42882bf0ce_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtMTEtMS0xLTI5OA_2f70ac18-cd1a-4864-a00a-2379948b4ba3"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i680ece1eaa8f4e9e96ce0f42882bf0ce_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtMTMtMS0xLTI5OA_bdbfb54e-af03-462f-a965-729d750493f2"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i680ece1eaa8f4e9e96ce0f42882bf0ce_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtMTUtMS0xLTkwMw_dca188f0-080d-4e6a-be0e-a3d3ad65ace8"
      unitRef="usd">3999000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib28fef4680854a929dbf60cedeb06434_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOS0xLTEtMS0w_1fffb920-da1b-4e47-b10e-25e5352ef42d"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib28fef4680854a929dbf60cedeb06434_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOS0zLTEtMS0w_898443ff-e6d3-4132-8c7d-6bf1b8b18621"
      unitRef="usd">1422000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib28fef4680854a929dbf60cedeb06434_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOS01LTEtMS0w_de0d8985-12fd-462b-a9f5-f3824e82296d"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib28fef4680854a929dbf60cedeb06434_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOS03LTEtMS0w_e5f1d30c-7f29-4066-be80-1de1c8776e91"
      unitRef="usd">1422000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i18f2c42543b54aeaab387d94848006f1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOS05LTEtMS0w_d8b91fb4-8769-4cf4-9884-14552358b9f4"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i18f2c42543b54aeaab387d94848006f1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOS0xMS0xLTEtMA_7b4e1a10-354a-4fb9-804a-41533343a720"
      unitRef="usd">393000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i18f2c42543b54aeaab387d94848006f1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOS0xMy0xLTEtMA_d6a7f834-50de-41cc-a980-f01c4208dbbc"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i18f2c42543b54aeaab387d94848006f1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfOS0xNS0xLTEtMA_51856142-840a-4057-8a1f-04b66dbbfa37"
      unitRef="usd">393000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtMS0xLTEtMA_ef0952b2-2ed1-4381-99c1-331a5423b184"
      unitRef="usd">257687000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtMy0xLTEtMA_3e74c023-22bc-4ca4-9b01-e09773918e85"
      unitRef="usd">5317000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtNS0xLTEtMA_fb7a42e2-4cf5-4704-80e0-40dfaacf8be3"
      unitRef="usd">16000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtNy0xLTEtMA_87e7787e-8a7a-4364-aeec-b6456d37e5ad"
      unitRef="usd">262988000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtOS0xLTEtMA_60d01704-0b37-4f10-b1f1-4d56c3659413"
      unitRef="usd">324567000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtMTEtMS0xLTA_e86ca717-3ca0-429a-a6c7-6a41217af141"
      unitRef="usd">1302000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtMTMtMS0xLTA_39ae02f1-a206-40ad-8c59-1482f8762e33"
      unitRef="usd">1391000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTAtMTUtMS0xLTA_ed6e2f55-0891-49fd-8b02-e958c3f70a87"
      unitRef="usd">324478000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ie9b9c500f9c64c18aa188576147e659c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTItNy0xLTEtNDAwMw_1efd3764-093f-4fe1-82a6-fb340297d0ab"
      unitRef="usd">44366000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ic0c8207a04074c06b323ed60e1b6a82d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTItMTUtMS0xLTQwMTM_4315d57c-88ee-45d8-89d8-bed2734a5d06"
      unitRef="usd">32763000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ib28fef4680854a929dbf60cedeb06434_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTMtNy0xLTEtNDAwMw_b7a9ba94-4b85-461b-a752-4aa874c7d182"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i18f2c42543b54aeaab387d94848006f1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTMtMTUtMS0xLTQwMTM_cd504654-1c95-4087-aad8-6eaaf2cdffa1"
      unitRef="usd">6326000</us-gaap:EquitySecuritiesFvNi>
    <lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTQtNy0xLTEtNDEwMA_ac88e89d-6809-4db2-9435-b3cc8120363c"
      unitRef="usd">307354000</lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI>
    <lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmQ4NzU1MWI4MmFlMjRiMWM5YTUzMjk2OGUxN2RhNTViL3RhYmxlcmFuZ2U6ZDg3NTUxYjgyYWUyNGIxYzlhNTMyOTY4ZTE3ZGE1NWJfMTQtMTUtMS0xLTQxMDM_ccfa7eb9-3604-4f25-bb89-66899559e9a2"
      unitRef="usd">363567000</lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI>
    <lgnd:EquityMethodInvestmentSharesSold
      contextRef="i992a781875754f6cafea588cdb51c0ca_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjE5OTAyMzMwNTI1Mw_33a10d62-b7ae-4875-b262-e98fca99ef1d"
      unitRef="shares">300000</lgnd:EquityMethodInvestmentSharesSold>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i992a781875754f6cafea588cdb51c0ca_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjE5OTAyMzMwNTIzOQ_9c34fa85-d0ba-49bd-a03e-1c127964b346"
      unitRef="usd">2200000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i24b65a2994c74dc1966ff120cfabeae7_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMTgzMjc_4f2bffca-ed1d-4875-848c-4f3d26856c2d"
      unitRef="shares">1500000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i0997448e200d4b4ca09ddc4917d0b9fb_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMTgzODY_e7f508d6-665f-4327-b71a-1cbc6a036412"
      unitRef="usdPerShare">1.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjE5OTAyMzMwMzk1OQ_9b56b4f3-f4c8-4988-a2c1-fe6166a1a073"
      unitRef="shares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1Nzk_1216198d-40b7-4ff5-816a-44154941c7b8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;After one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmJjYzNiNjVkZmQ5ODQ3OTU4ZjRlNWQyMjRmYmViYjQ0L3RhYmxlcmFuZ2U6YmNjM2I2NWRmZDk4NDc5NThmNGU1ZDIyNGZiZWJiNDRfMi0xLTEtMS0w_7dbeec47-9c7c-4492-9ce8-f2a1a215195b"
      unitRef="usd">77913000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmJjYzNiNjVkZmQ5ODQ3OTU4ZjRlNWQyMjRmYmViYjQ0L3RhYmxlcmFuZ2U6YmNjM2I2NWRmZDk4NDc5NThmNGU1ZDIyNGZiZWJiNDRfMi0zLTEtMS0w_e857dbc8-37fc-427a-8b02-e0f73dbf850a"
      unitRef="usd">77981000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmJjYzNiNjVkZmQ5ODQ3OTU4ZjRlNWQyMjRmYmViYjQ0L3RhYmxlcmFuZ2U6YmNjM2I2NWRmZDk4NDc5NThmNGU1ZDIyNGZiZWJiNDRfMy0xLTEtMS0w_36591736-37e5-4a1b-a303-e3e69828d00b"
      unitRef="usd">23488000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmJjYzNiNjVkZmQ5ODQ3OTU4ZjRlNWQyMjRmYmViYjQ0L3RhYmxlcmFuZ2U6YmNjM2I2NWRmZDk4NDc5NThmNGU1ZDIyNGZiZWJiNDRfMy0zLTEtMS0w_3159167e-f567-4aaf-a518-01d73c2eabca"
      unitRef="usd">23509000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmJjYzNiNjVkZmQ5ODQ3OTU4ZjRlNWQyMjRmYmViYjQ0L3RhYmxlcmFuZ2U6YmNjM2I2NWRmZDk4NDc5NThmNGU1ZDIyNGZiZWJiNDRfNS0xLTEtMS0w_d7a609d5-028a-4579-ac0d-00b51ecf7b6e"
      unitRef="usd">101401000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmJjYzNiNjVkZmQ5ODQ3OTU4ZjRlNWQyMjRmYmViYjQ0L3RhYmxlcmFuZ2U6YmNjM2I2NWRmZDk4NDc5NThmNGU1ZDIyNGZiZWJiNDRfNS0zLTEtMS0w_3be77b85-1c24-4413-b5d3-424ef3201240"
      unitRef="usd">101490000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMTk3MjM_ca64cce5-04d5-4e1f-a399-1c41f2e15140"
      unitRef="position">11</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjAzMjY_5246d1a5-4ef7-4f39-90c9-ccacf799c126"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMTA0NDUzNjA1MTM3OTk_39e3452f-b0d8-4ef9-95ae-9a58cd3056ac"
      unitRef="usd">20000.00</lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1ODk_58415d71-1465-49e7-b682-e0f172fecac2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and other identifiable intangible assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;190,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Definite lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Complete technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;277,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;277,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(67,441)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(63,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Contractual relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total goodwill and other identifiable intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;774,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;784,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:Goodwill
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfMi0xLTEtMS0w_bbcca37f-0626-4934-960b-e2cec7c9f962"
      unitRef="usd">190515000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfMi0zLTEtMS0w_68ef91db-4286-4cec-8358-e6017c7c1870"
      unitRef="usd">189662000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7852648236234a7383fffb89802800ca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfNC0xLTEtMS0w_9f4dc064-1d23-4e43-96c3-88d7a2308d16"
      unitRef="usd">277980000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4ead48471b4147b89d513734d4b371ce_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfNC0zLTEtMS0w_ba108f5e-adf1-4701-83ab-4f1bdee196c0"
      unitRef="usd">277740000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7852648236234a7383fffb89802800ca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfNS0xLTEtMS0w_2a537586-6ad0-42b7-9eeb-86e0f1f62188"
      unitRef="usd">67441000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4ead48471b4147b89d513734d4b371ce_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfNS0zLTEtMS0w_534a184c-39cb-4cfa-aaa9-49fcf8d9b3bb"
      unitRef="usd">63600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7203c2e57ce64b9499cf15be8da138c9_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfNi0xLTEtMS0w_5174cf93-94ea-4739-97da-78901deb7e01"
      unitRef="usd">2642000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie5b27dc5beda4d28a2d31e5f523528e7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfNi0zLTEtMS0w_4bf4092d-1ee1-4b1a-915a-ac320c1cc4ec"
      unitRef="usd">2642000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7203c2e57ce64b9499cf15be8da138c9_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfNy0xLTEtMS0w_42a75402-aaa1-4692-8d0f-4bdaca282595"
      unitRef="usd">1345000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie5b27dc5beda4d28a2d31e5f523528e7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfNy0zLTEtMS0w_6b993f50-e645-4a43-b29a-563d1eb5a718"
      unitRef="usd">1312000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="idd0a1696112f4034b165e99d7e54c9c0_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfOC0xLTEtMS0w_fd63b254-3aaf-4f09-b742-23cbac3acc4f"
      unitRef="usd">40700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9c9320f5f705481e843a64fa98520fce_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfOC0zLTEtMS0w_c25929c6-ec62-4ba3-b978-57977fec324d"
      unitRef="usd">40700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="idd0a1696112f4034b165e99d7e54c9c0_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfOS0xLTEtMS0w_2aabfadc-968e-4052-aeac-f3c94d088095"
      unitRef="usd">16264000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9c9320f5f705481e843a64fa98520fce_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfOS0zLTEtMS0w_8769e6a5-3361-4b40-b4af-28c928d82826"
      unitRef="usd">15597000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3be05d22f1714924ba3f177f26a1f2ad_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfMTEtMS0xLTEtMzkw_81207791-a371-41df-a762-b5ddd6f33aea"
      unitRef="usd">362000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie6708118507a499aba0e32aaf3cbf208_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfMTEtMy0xLTEtMzgy_22532c77-89f5-48f3-b3f2-ccdd6b055d8d"
      unitRef="usd">362000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3be05d22f1714924ba3f177f26a1f2ad_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfMTItMS0xLTEtMzkw_09244dff-174d-45d9-a2a6-6a98a00e31b0"
      unitRef="usd">14487000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie6708118507a499aba0e32aaf3cbf208_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfMTItMy0xLTEtMzgy_b8e4f13f-964b-409c-8ead-7d46b033f30d"
      unitRef="usd">7243000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfMTAtMS0xLTEtMA_fa57e20c-a5d8-4e79-bca5-49d110825399"
      unitRef="usd">774300000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjg4YTdjN2NkZGExZDRlYjJiZTg3Y2Y3N2RmZjc2ZmM1L3RhYmxlcmFuZ2U6ODhhN2M3Y2RkYTFkNGViMmJlODdjZjc3ZGZmNzZmYzVfMTAtMy0xLTEtMA_ea1c3677-783c-4f6e-891d-c3c09c0b15a3"
      unitRef="usd">784992000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1ODU_175d0ff6-0a73-4728-95d1-3c86f22fd147">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial license and other economic rights consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aziyo and CorMatrix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,166&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,588)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Selexis and Dianomi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,285&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,871&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17,847)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10,451&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10,979&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Amounts represent accumulated amortization to principal of $11.9 million and credit loss adjustments of $6.0 million as of March&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(2) Amounts represent accumulated amortization to principal of $11.3 million and credit loss adjustments of $6.0 million as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if5726bdc386542a4a8883e9ff2d6dbac_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfMi0yLTEtMS0w_17e4e8c0-9a8b-4cce-96da-c96619c8dcdb"
      unitRef="usd">17696000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="if5726bdc386542a4a8883e9ff2d6dbac_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfMi00LTEtMS0w_d329d3ae-0c57-4a08-a79f-8d811ebc9154"
      unitRef="usd">9530000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if5726bdc386542a4a8883e9ff2d6dbac_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfMi02LTEtMS0w_1b3ff950-d114-436e-9bad-26ba240df0d0"
      unitRef="usd">8166000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if7981ffd8dd3442db85faa0971ba2b0f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfMi04LTEtMS0w_7671e83d-0c6c-4291-a0f8-71d77e9c047e"
      unitRef="usd">17696000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="if7981ffd8dd3442db85faa0971ba2b0f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfMi0xMC0xLTEtMA_82951c34-f962-4fbb-8ba8-aac7960ac4f0"
      unitRef="usd">9588000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if7981ffd8dd3442db85faa0971ba2b0f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfMi0xMi0xLTEtMA_933e30fb-f1b9-4580-bdfe-746f60c61071"
      unitRef="usd">8108000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i990fc430839b439297429383d8dc1565_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfNC0yLTEtMS0w_e6c42cab-f2f3-42f0-a902-41de800a8f76"
      unitRef="usd">10602000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i990fc430839b439297429383d8dc1565_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfNC00LTEtMS0w_c598a3cf-292d-4b4a-8593-f44688e556a3"
      unitRef="usd">8317000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i990fc430839b439297429383d8dc1565_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfNC02LTEtMS0w_c711d8a3-12ca-4a3c-b7d7-7a65e5ad7501"
      unitRef="usd">2285000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ibd41f0958aea453c93d67393583f4114_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfNC04LTEtMS0w_00516d8c-1b1c-466f-a391-a333237533bf"
      unitRef="usd">10602000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="ibd41f0958aea453c93d67393583f4114_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfNC0xMC0xLTEtMA_2d008aa9-d904-4751-9aa5-88174b6af5f5"
      unitRef="usd">7731000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ibd41f0958aea453c93d67393583f4114_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfNC0xMi0xLTEtMA_d8a61ae9-0146-40d8-91b8-c25ac57cd29b"
      unitRef="usd">2871000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib164760a00e846d5b34f96b078179fad_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfNS0yLTEtMS0w_30ba5e26-e918-4296-bbe1-0d3ece82f58d"
      unitRef="usd">28298000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="ib164760a00e846d5b34f96b078179fad_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfNS00LTEtMS0w_68bd4c6d-e64a-4162-9f88-18baf55f208f"
      unitRef="usd">17847000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib164760a00e846d5b34f96b078179fad_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfNS02LTEtMS0w_9c1d27e4-f60e-4465-abeb-f23c4a61ee4d"
      unitRef="usd">10451000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if664c4e0370e4eecb98b57e6559c8596_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfNS04LTEtMS0w_01eaaace-f7a8-4e76-bcc9-92f63204ec0c"
      unitRef="usd">28298000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="if664c4e0370e4eecb98b57e6559c8596_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfNS0xMC0xLTEtMA_ad412614-f21f-4f9b-8078-337f0b37f2d5"
      unitRef="usd">17319000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if664c4e0370e4eecb98b57e6559c8596_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjExNjAxYjU1YmFiZjRmMDViM2RiZDdmMjIzODQxNjljL3RhYmxlcmFuZ2U6MTE2MDFiNTViYWJmNGYwNWIzZGJkN2YyMjM4NDE2OWNfNS0xMi0xLTEtMA_1b37194c-1fb0-4301-92f7-cd8bea9e3538"
      unitRef="usd">10979000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib164760a00e846d5b34f96b078179fad_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjIwNDc_8be5615f-9540-4591-a3b9-56e5fc9bab41"
      unitRef="usd">11900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments
      contextRef="ib164760a00e846d5b34f96b078179fad_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjIwODQ_a64575c8-f946-47e1-85cb-fb22cb18f0a9"
      unitRef="usd">6000000.0</lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if664c4e0370e4eecb98b57e6559c8596_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMTA5OTUxMTY3MjIyMg_9f614490-44bf-4c9d-8dba-1242cc4e45db"
      unitRef="usd">11300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments
      contextRef="if664c4e0370e4eecb98b57e6559c8596_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMTA5OTUxMTY3MjI3Ng_1118d834-1af1-4f1b-8678-2f9cfd6c12ee"
      unitRef="usd">6000000.0</lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments>
    <lgnd:ForecastedCashFlowsEffectiveInterestRatePercent
      contextRef="i286a8bb93953439fafa3f00769457019_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjMyNDE_716cd584-f78b-45c0-ae5b-e43fc0269cd9"
      unitRef="number">0.23</lgnd:ForecastedCashFlowsEffectiveInterestRatePercent>
    <lgnd:ForecastedCashFlowsEffectiveInterestRatePercent
      contextRef="i0d642c075bb94ad9924379a085bcce17_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjE5OTAyMzMwMzk2OQ_7e25eebf-6595-4908-9374-4dbb4cc062a4"
      unitRef="number">0.21</lgnd:ForecastedCashFlowsEffectiveInterestRatePercent>
    <lgnd:CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss
      contextRef="i09abab2b25044ad981b26743b386f8ed_I20200101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjQ4Njk_216c8112-52d8-47d5-9882-9347d97e2773"
      unitRef="usd">5500000</lgnd:CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1Njg_769fb355-5573-40f7-a382-be2778d78b7d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties owed to third parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Return reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subcontractor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Supplier&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfMi0yLTEtMS0w_487baeb9-4c82-4379-bb22-43828a435022"
      unitRef="usd">3347000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfMi00LTEtMS0w_1ef1ae80-8a04-4114-a1eb-96fe796af37b"
      unitRef="usd">8810000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfMy0yLTEtMS0w_e72decbb-7f64-4717-8aef-3381c1ab160a"
      unitRef="usd">958000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfMy00LTEtMS0w_7347ca5d-e556-4c0b-b8e6-8b67a4926740"
      unitRef="usd">977000</us-gaap:AccruedProfessionalFeesCurrent>
    <lgnd:LicenseeAccrualCurrent
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfNC0yLTEtMS0w_fa1f68e3-d522-4257-8987-20154bc1b0ff"
      unitRef="usd">468000</lgnd:LicenseeAccrualCurrent>
    <lgnd:LicenseeAccrualCurrent
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfNC00LTEtMS0w_22dd51f7-20cf-44a0-be8c-35c836e15df0"
      unitRef="usd">421000</lgnd:LicenseeAccrualCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfNS0yLTEtMS0w_5a0eb9d7-729b-4f9e-859f-40635a58666d"
      unitRef="usd">102000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfNS00LTEtMS0w_b78679c7-3ad7-41b5-bad1-cbc9f5d8bc48"
      unitRef="usd">693000</us-gaap:AccruedRoyaltiesCurrent>
    <lgnd:ReturnsAccrual
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfNi0yLTEtMS0w_ccbccd53-1d90-40f0-a9bd-654fc6ee51cb"
      unitRef="usd">682000</lgnd:ReturnsAccrual>
    <lgnd:ReturnsAccrual
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfNi00LTEtMS0w_45e9ec3a-0b4b-448c-9b1c-b22de13c0af7"
      unitRef="usd">687000</lgnd:ReturnsAccrual>
    <lgnd:AccruedAssetAcquisitionsCurrent
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfNy0yLTEtMS05MTk_80cc359e-3068-4853-84d5-dba32a780f1b"
      unitRef="usd">1500000</lgnd:AccruedAssetAcquisitionsCurrent>
    <lgnd:AccruedAssetAcquisitionsCurrent
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfNy00LTEtMS00MjI_e2df8efb-2b05-4136-92a7-b4e4330cf4ee"
      unitRef="usd">1500000</lgnd:AccruedAssetAcquisitionsCurrent>
    <lgnd:AccruedSubcontractorExpensesCurrent
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfOS0yLTEtMS05MjI_c9857c18-a592-4608-8626-a26aedfa1e78"
      unitRef="usd">1034000</lgnd:AccruedSubcontractorExpensesCurrent>
    <lgnd:AccruedSubcontractorExpensesCurrent
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfOS00LTEtMS00MzA_a85a691a-d232-4bbb-9fdc-4a94af0dc985"
      unitRef="usd">733000</lgnd:AccruedSubcontractorExpensesCurrent>
    <lgnd:AccruedSupplierExpensesCurrent
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfMTAtMi0xLTEtOTIy_8c87f15d-c0b6-40c2-9026-41a8a18cde76"
      unitRef="usd">788000</lgnd:AccruedSupplierExpensesCurrent>
    <lgnd:AccruedSupplierExpensesCurrent
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfMTAtNC0xLTEtNDMw_43ad3487-d502-4fb6-bca8-c60902f348c9"
      unitRef="usd">604000</lgnd:AccruedSupplierExpensesCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfOC0yLTEtMS0w_08584a4e-e400-46f8-bfcf-2efe66572be6"
      unitRef="usd">1086000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfOC00LTEtMS0w_d1c8e048-eaad-4821-bf2f-aa17ac366d53"
      unitRef="usd">464000</us-gaap:InterestPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfOS0yLTEtMS0w_b194bd0b-2c9a-4a6d-84a9-5e7157ca1049"
      unitRef="usd">2145000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfOS00LTEtMS0w_7dcbaabe-272e-4a2b-b016-48198c432749"
      unitRef="usd">3641000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfMTAtMi0xLTEtMA_2ccd2956-bd47-4948-bc0d-90fa56dabc4d"
      unitRef="usd">12110000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i495e15f4221043e8829bac34d84a0a92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjYwYjVhOTk1YWZmNTQ2YThhN2YyMzU4MWFiMjk5MDI0L3RhYmxlcmFuZ2U6NjBiNWE5OTVhZmY1NDZhOGE3ZjIzNTgxYWIyOTkwMjRfMTAtNC0xLTEtMA_95ad2195-6e02-4552-8c9a-4e7525c26e19"
      unitRef="usd">18530000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1OTU_2ab47c3c-c182-40ed-ba2a-3f0874c55f64">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period until the last tranche vests. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three-year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <lgnd:ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1OTA_3f9ec636-b1c5-4cb7-b7ed-9d2824b35be4">The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</lgnd:ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ieb80e938ceac4acba68f8190bbb48240_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmZlYjYxMTg1ODVhYzRmMDZhOTI2ZDRlNGE0NzJkYWNmL3RhYmxlcmFuZ2U6ZmViNjExODU4NWFjNGYwNmE5MjZkNGU0YTQ3MmRhY2ZfMy0xLTEtMS0w_da4f74ed-c8fe-4ce8-98fe-b498630b99fe"
      unitRef="usd">3939000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i20687aac1929409b8e8ba72ed696b358_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmZlYjYxMTg1ODVhYzRmMDZhOTI2ZDRlNGE0NzJkYWNmL3RhYmxlcmFuZ2U6ZmViNjExODU4NWFjNGYwNmE5MjZkNGU0YTQ3MmRhY2ZfMy0zLTEtMS0w_c3d98aac-2425-48ac-be3b-b7c4e8f9b494"
      unitRef="usd">2397000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i7dbd1ffbbe68420b892aebb33efbf91e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmZlYjYxMTg1ODVhYzRmMDZhOTI2ZDRlNGE0NzJkYWNmL3RhYmxlcmFuZ2U6ZmViNjExODU4NWFjNGYwNmE5MjZkNGU0YTQ3MmRhY2ZfNC0xLTEtMS0w_6d3c6e88-53c4-433e-88b7-ae0771643f97"
      unitRef="usd">4466000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i01775962d3284134ba883acf9233e929_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmZlYjYxMTg1ODVhYzRmMDZhOTI2ZDRlNGE0NzJkYWNmL3RhYmxlcmFuZ2U6ZmViNjExODU4NWFjNGYwNmE5MjZkNGU0YTQ3MmRhY2ZfNC0zLTEtMS0w_3d5dfccc-3c27-45e4-9c53-852259b961f2"
      unitRef="usd">3256000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmZlYjYxMTg1ODVhYzRmMDZhOTI2ZDRlNGE0NzJkYWNmL3RhYmxlcmFuZ2U6ZmViNjExODU4NWFjNGYwNmE5MjZkNGU0YTQ3MmRhY2ZfNS0xLTEtMS0w_11b6f08d-4b79-4d58-a44a-01de1829faeb"
      unitRef="usd">8405000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOmZlYjYxMTg1ODVhYzRmMDZhOTI2ZDRlNGE0NzJkYWNmL3RhYmxlcmFuZ2U6ZmViNjExODU4NWFjNGYwNmE5MjZkNGU0YTQ3MmRhY2ZfNS0zLTEtMS0w_74eca78e-573c-42f2-9725-b8131091ade7"
      unitRef="usd">5653000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1OTE_48824c79-b911-46ee-b47d-368dab1695c4">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjI3OWEwN2YwNDQ5MDQxZGRiMmI2M2I1YzMyNmRkNWI2L3RhYmxlcmFuZ2U6Mjc5YTA3ZjA0NDkwNDFkZGIyYjYzYjVjMzI2ZGQ1YjZfMy0xLTEtMS0w_a2f0aae2-b2e7-48f4-bccd-02054e994d2f"
      unitRef="number">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjI3OWEwN2YwNDQ5MDQxZGRiMmI2M2I1YzMyNmRkNWI2L3RhYmxlcmFuZ2U6Mjc5YTA3ZjA0NDkwNDFkZGIyYjYzYjVjMzI2ZGQ1YjZfMy0zLTEtMS0w_c3de20db-7325-411b-9444-64ff45565018"
      unitRef="number">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjI3OWEwN2YwNDQ5MDQxZGRiMmI2M2I1YzMyNmRkNWI2L3RhYmxlcmFuZ2U6Mjc5YTA3ZjA0NDkwNDFkZGIyYjYzYjVjMzI2ZGQ1YjZfNC0xLTEtMS0w_c7781c8f-54f8-4ab8-a81e-46bca929c62a"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjI3OWEwN2YwNDQ5MDQxZGRiMmI2M2I1YzMyNmRkNWI2L3RhYmxlcmFuZ2U6Mjc5YTA3ZjA0NDkwNDFkZGIyYjYzYjVjMzI2ZGQ1YjZfNC0zLTEtMS0w_bb3d5a75-ed72-4886-8a83-711c240d4f14"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjI3OWEwN2YwNDQ5MDQxZGRiMmI2M2I1YzMyNmRkNWI2L3RhYmxlcmFuZ2U6Mjc5YTA3ZjA0NDkwNDFkZGIyYjYzYjVjMzI2ZGQ1YjZfNS0xLTEtMS0w_c0fda8ac-a975-4c96-8078-98861224b0b3"
      unitRef="number">0.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjI3OWEwN2YwNDQ5MDQxZGRiMmI2M2I1YzMyNmRkNWI2L3RhYmxlcmFuZ2U6Mjc5YTA3ZjA0NDkwNDFkZGIyYjYzYjVjMzI2ZGQ1YjZfNS0zLTEtMS0w_491fbf57-d352-494c-9256-d4d7cee6a4b7"
      unitRef="number">0.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjI3OWEwN2YwNDQ5MDQxZGRiMmI2M2I1YzMyNmRkNWI2L3RhYmxlcmFuZ2U6Mjc5YTA3ZjA0NDkwNDFkZGIyYjYzYjVjMzI2ZGQ1YjZfNi0xLTEtMS0w_78759ee2-0956-4657-8281-b776e11edc63">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjI3OWEwN2YwNDQ5MDQxZGRiMmI2M2I1YzMyNmRkNWI2L3RhYmxlcmFuZ2U6Mjc5YTA3ZjA0NDkwNDFkZGIyYjYzYjVjMzI2ZGQ1YjZfNi0zLTEtMS0w_30df53c4-a73b-4c38-b8da-95c20d14bf92">P4Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="if96bbf53f57741718a23af11bbf99850_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjE5OTAyMzMwMzk5OA_307284e0-73ce-4b91-8b04-89b809ab1754">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent
      contextRef="i72938e42d49d4e7eb47d38ac3ea3ef3c_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjE5OTAyMzMwMzk3NA_872a7852-c871-4767-b2d3-1f1d301bf8b0"
      unitRef="number">0</lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent>
    <lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent
      contextRef="i70472c97b924411e836f34d9300a0722_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjE5OTAyMzMwMzk3OQ_e1be2c3f-1795-414b-bf3a-707b591dbc1c"
      unitRef="number">2</lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1Njk_0557d067-5c3b-42b3-988a-ac22985188fa">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Income (Loss) Per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the applicable conversion price of the respective notes. It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 4, Convertible Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 6, Stockholders&#x2019; Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1NTU_77c86535-bc2a-44a8-b4d5-a41b96dce142">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.832%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.984%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive potential common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares used to compute diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Potentially dilutive shares excluded from calculation due to anti-dilutive effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RleHRyZWdpb246ZDRiNGQwZDlmMGNlNDhmYWE3MDVhMTlkYzE1ZDU5NmJfMjg1NTY_7db17bca-27a9-4807-89c1-20ca4ca4fbe9">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.832%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.984%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive potential common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares used to compute diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Potentially dilutive shares excluded from calculation due to anti-dilutive effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjY5YjIyN2RjMWVjMzRjMGQ5ODgzZWZhNzkzZmM1ZjMxL3RhYmxlcmFuZ2U6NjliMjI3ZGMxZWMzNGMwZDk4ODNlZmE3OTNmYzVmMzFfMy0xLTEtMS0w_70bb3aa8-b0fb-428e-98b3-24a8826c6180"
      unitRef="shares">16435000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjY5YjIyN2RjMWVjMzRjMGQ5ODgzZWZhNzkzZmM1ZjMxL3RhYmxlcmFuZ2U6NjliMjI3ZGMxZWMzNGMwZDk4ODNlZmE3OTNmYzVmMzFfMy0zLTEtMS0w_a491cb6d-84f3-4d4c-8c7a-eadf7bb32690"
      unitRef="shares">16529000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjY5YjIyN2RjMWVjMzRjMGQ5ODgzZWZhNzkzZmM1ZjMxL3RhYmxlcmFuZ2U6NjliMjI3ZGMxZWMzNGMwZDk4ODNlZmE3OTNmYzVmMzFfNS0xLTEtMS0w_c1d9b01f-3bc5-4c7c-b391-41e73f20b6ad"
      unitRef="shares">112000</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjY5YjIyN2RjMWVjMzRjMGQ5ODgzZWZhNzkzZmM1ZjMxL3RhYmxlcmFuZ2U6NjliMjI3ZGMxZWMzNGMwZDk4ODNlZmE3OTNmYzVmMzFfNS0zLTEtMS0w_8c068dab-69f0-4bb4-bfa2-18f13c9156be"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjY5YjIyN2RjMWVjMzRjMGQ5ODgzZWZhNzkzZmM1ZjMxL3RhYmxlcmFuZ2U6NjliMjI3ZGMxZWMzNGMwZDk4ODNlZmE3OTNmYzVmMzFfNi0xLTEtMS0w_27306ef3-4690-4d5d-b352-9461cd9a9974"
      unitRef="shares">701000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjY5YjIyN2RjMWVjMzRjMGQ5ODgzZWZhNzkzZmM1ZjMxL3RhYmxlcmFuZ2U6NjliMjI3ZGMxZWMzNGMwZDk4ODNlZmE3OTNmYzVmMzFfNi0zLTEtMS0w_ead1feab-c72b-4638-b0f1-5d7706c4a442"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjY5YjIyN2RjMWVjMzRjMGQ5ODgzZWZhNzkzZmM1ZjMxL3RhYmxlcmFuZ2U6NjliMjI3ZGMxZWMzNGMwZDk4ODNlZmE3OTNmYzVmMzFfNy0xLTEtMS0w_da8b2824-12e8-42dc-8d58-08cbfd2222eb"
      unitRef="shares">17248000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjY5YjIyN2RjMWVjMzRjMGQ5ODgzZWZhNzkzZmM1ZjMxL3RhYmxlcmFuZ2U6NjliMjI3ZGMxZWMzNGMwZDk4ODNlZmE3OTNmYzVmMzFfNy0zLTEtMS0w_20f2fc68-4bfc-4d63-a704-f379dbd0ab46"
      unitRef="shares">16529000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjY5YjIyN2RjMWVjMzRjMGQ5ODgzZWZhNzkzZmM1ZjMxL3RhYmxlcmFuZ2U6NjliMjI3ZGMxZWMzNGMwZDk4ODNlZmE3OTNmYzVmMzFfOC0xLTEtMS0w_7406d575-535c-45d6-8d7e-71744ebb4bef"
      unitRef="shares">4277000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNC9mcmFnOmQ0YjRkMGQ5ZjBjZTQ4ZmFhNzA1YTE5ZGMxNWQ1OTZiL3RhYmxlOjY5YjIyN2RjMWVjMzRjMGQ5ODgzZWZhNzkzZmM1ZjMxL3RhYmxlcmFuZ2U6NjliMjI3ZGMxZWMzNGMwZDk4ODNlZmE3OTNmYzVmMzFfOC0zLTEtMS0w_81c16c3c-0eb3-4a72-aca1-fb3c66c45583"
      unitRef="shares">10144000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RleHRyZWdpb246Zjc0ZDNjMmEyNzk0NDNkNmFiNGFiNGRiNDcxZmU1MzZfNTI2OA_b64bab1c-af21-4021-b423-732c22c9a289">Fair Value Measurements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term investments, excluding Viking&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;253,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;262,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;320,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;324,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment in Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment in Viking warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;253,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;307,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;320,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;363,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Crystal contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CyDex contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Metabasis contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Icagen contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pfenex contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;xCella contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;46,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.&#160;Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;Investment in Viking warrants, which we received as a result of Viking&#x2019;s partial repayment of the Viking note receivable and our purchase of Viking common stock and warrants in April 2016, are classified as level 1 as the fair value is determined using quoted market prices in active markets for the same securities. The change of the fair value is recorded in "Gain (loss) from short-term investments" in our condensed consolidated statement of operations. During the three months ended March&#160;31, 2021, we exercised all of the outstanding Viking warrants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Crystal contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on development or regulatory milestones as defined in the merger agreement with Crystal. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#x2019;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#x3b2; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;5.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#x2019;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;6.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Pfenex contingent liabilities was determined using a probability-adjusted income approach. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;7.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. Management concluded that no earnout liability would be recognized at the acquisition date in September 2020.  In the three months ended March&#160;31, 2021, management recorded an earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the level 3 financial instruments as of March&#160;31, 2021 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value adjustments to contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Contingent liabilities from xCella asset acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;240&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;46,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets Measured on a Non-Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets and long-lived assets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.&lt;/span&gt;&lt;/div&gt;There were no triggering events identified and no indication of impairment of our goodwill, indefinite-lived intangible assets, or long-lived assets during the three months ended March&#160;31, 2021.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RleHRyZWdpb246Zjc0ZDNjMmEyNzk0NDNkNmFiNGFiNGRiNDcxZmU1MzZfNTI3Mg_dfc3c939-657b-433a-bab6-a4903e7056a3">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term investments, excluding Viking&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;253,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;262,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;320,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;324,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment in Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment in Viking warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;253,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;307,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;320,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;363,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Crystal contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CyDex contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Metabasis contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Icagen contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pfenex contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;xCella contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;46,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.&#160;Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;Investment in Viking warrants, which we received as a result of Viking&#x2019;s partial repayment of the Viking note receivable and our purchase of Viking common stock and warrants in April 2016, are classified as level 1 as the fair value is determined using quoted market prices in active markets for the same securities. The change of the fair value is recorded in "Gain (loss) from short-term investments" in our condensed consolidated statement of operations. During the three months ended March&#160;31, 2021, we exercised all of the outstanding Viking warrants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Crystal contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on development or regulatory milestones as defined in the merger agreement with Crystal. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#x2019;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#x3b2; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;5.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#x2019;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;6.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Pfenex contingent liabilities was determined using a probability-adjusted income approach. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of the Company.&lt;/span&gt;&lt;/div&gt;7.The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. Management concluded that no earnout liability would be recognized at the acquisition date in September 2020.  In the three months ended March&#160;31, 2021, management recorded an earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement.</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i01ac0fd2b84c4fc5b18e59e48f25cc79_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMy0yLTEtMS0w_4edd886a-1d82-43a4-b112-ed1504767d96"
      unitRef="usd">8193000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i4dc6712b5fe940d29478311fd3e7cffd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMy00LTEtMS0w_ab3b49f3-f830-46a1-bcff-0c1a20f9f30c"
      unitRef="usd">253373000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iadf9c6df9fa44ab3b0c1c35c985251b4_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMy02LTEtMS0w_0dd2544c-ba14-44fb-a20d-0f2fff14a437"
      unitRef="usd">1422000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i21a101cfd24747168bf94b313b3708e4_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMy04LTEtMS0w_54b4e5a6-4959-4ba2-8669-71a7edd09638"
      unitRef="usd">262988000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic7f4f7589d8c492484b84f28687479b4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMy0xMC0xLTEtMA_62e79d7f-eb80-4663-94f6-87faf0bc2167"
      unitRef="usd">3438000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i676b57f3d66941bbb97cc26113e1e806_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMy0xMi0xLTEtMA_1636e155-3287-4920-a87d-51d1853197b6"
      unitRef="usd">320647000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i860855786f834ea394e0c7e66f585b07_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMy0xNC0xLTEtMA_612b3902-0c12-4cf3-9a4a-bd6a83c1e6f7"
      unitRef="usd">393000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9054c6008288417ea8d10ca0540acb93_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMy0xNi0xLTEtMA_d7e2dc9c-f951-4a34-b7bb-cf620eb535bd"
      unitRef="usd">324478000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6e0fd90b4eb14c3eb7f87756026effcf_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNC0yLTEtMS0w_c5bef006-7a55-40e9-83ec-164d66cff929"
      unitRef="usd">44366000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i94a7f3facc544380b14212b1d50f599d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNC00LTEtMS0w_5dc21d19-e5f4-4afd-9c35-020d45ddca66"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ifc3c971711634a419850f39be2cfa217_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNC02LTEtMS0w_7a73b89a-2668-46d8-a84b-9bc83605324b"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib5f5f82fc4c44419894bfd3fe856e02b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNC04LTEtMS0w_d3ec8e6e-b55a-4262-b3da-b8e29e9dc21a"
      unitRef="usd">44366000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i14699c2d32754f1197a391489d15ff48_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNC0xMC0xLTEtMA_87fdd99b-d9cd-4a8c-97f5-3b24181b6678"
      unitRef="usd">32763000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8e8d1f401b4d4013ac32b2787dcfde55_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNC0xMi0xLTEtMA_c5904ab7-22b4-4358-b04f-0d039a54ab07"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib0daa67408a4451890054460225dfe05_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNC0xNC0xLTEtMA_808d9d17-3d46-45ad-b421-9f307a53d659"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i53101502568a44758ee1969b8fdf9b5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNC0xNi0xLTEtMA_febc46ab-081d-48f9-b352-3d21b648f30e"
      unitRef="usd">32763000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if91f9465b6884e95a7b42fca92d3ff5d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNS0yLTEtMS0w_9262dfe7-df65-4bef-b928-eda65f220da3"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6913dd8993464fe78ba52964658dba31_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNS00LTEtMS0w_f29b7976-4bfe-4b7e-8b88-9f5c955abf47"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8f881c4d7c174319a38f46630210dcbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNS02LTEtMS0w_0d35ac37-cccc-4dc6-b623-a59d57a906ad"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6087cecae97d4d2abd6e060d610ce948_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNS04LTEtMS0w_c03fe2e9-38a4-4521-a924-d15215be513f"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i77031116cff2427bb586198ff9e95cb4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNS0xMC0xLTEtMA_de224c6f-f615-4799-87a0-70d173a8baed"
      unitRef="usd">6326000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2f9b50f07b984d18a9dbe45a0861f8a5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNS0xMi0xLTEtMA_1f41fb16-1a33-4bbe-9cad-e913f8f97047"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7364700da439492b9c9c4b04d2cd984f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNS0xNC0xLTEtMA_d32848fa-6e1c-4eba-876f-f601c8f810ce"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="idee4babfe9e4448e9679afd11c8e1932_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNS0xNi0xLTEtMA_5ee5d5f7-7508-4821-a579-d1cce9a28332"
      unitRef="usd">6326000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i06d16d86c2ee446498927c381c54d77a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNi0yLTEtMS0w_ea5830b4-473c-4fb2-a33d-7603feeac765"
      unitRef="usd">52559000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i19ca28155cef4fd5b5524f954cccaab7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNi00LTEtMS0w_9bf61aeb-b9ab-43d0-b7c2-d073a1a45b25"
      unitRef="usd">253373000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i40b8100a5b2440b48556561a4ba1e0d1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNi02LTEtMS0w_31864b55-d473-48b3-bc4e-e38f75a16034"
      unitRef="usd">1422000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i109de96646db44268497efcc2f95bdc9_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNi04LTEtMS0w_66254efe-ba1a-4619-bb4b-a5dd163cead6"
      unitRef="usd">307354000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i13a03a90dd824a3e802cc74fbc6ef67a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNi0xMC0xLTEtMA_3dc5ef7b-d614-442b-8431-f22d1b6d7d51"
      unitRef="usd">42527000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ifc817baab77c490b9eb5d576b2ff57d9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNi0xMi0xLTEtMA_b2e25218-9d94-446a-857f-b27ac94ec7f9"
      unitRef="usd">320647000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if692e5a3f16a4775a9bf2a0e13049d43_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNi0xNC0xLTEtMA_3e194307-c25b-431e-b2ed-4e296d7992a3"
      unitRef="usd">393000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9c91fdccad734cd3acfb28a7aaee6b08_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfNi0xNi0xLTEtMA_49d3b275-c1ee-427d-af5f-de259c29c93e"
      unitRef="usd">363567000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i39cdc2145c9b43dbb9e35f9deff11202_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOC0yLTEtMS0w_14270bb8-7916-462e-bff4-67aaeeab3b13"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5621884f55514f528b5732d922eb7ddd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOC00LTEtMS0w_bc78889f-1198-4a05-a52a-44dea0c29a37"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i14f70b29c1fe4ff7aba75d3e69a1823a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOC02LTEtMS0w_aff9532a-be0f-4220-bfa9-4c95369afa7e"
      unitRef="usd">800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i6b9807f967ff4cf582d5e8a8fece80fb_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOC04LTEtMS0w_3acb23b9-d0d2-4181-87a1-066fd1f24316"
      unitRef="usd">800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i79f0b8beb45a4a4bbba8ce8211ecd94e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOC0xMC0xLTEtMA_f526a7c7-d58e-4d78-83ee-0bfe70567e76"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ie0a9f236332f4dba8a23b8e155f3a30f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOC0xMi0xLTEtMA_5a72a302-a548-4685-8402-d334ffb6239c"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i71d6fc626ce745feb5e33003ac131708_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOC0xNC0xLTEtMA_f05602ad-e7f4-4b90-957e-f4dfec242903"
      unitRef="usd">800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic1d6ac0f98304bd8a2522d46969847b6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOC0xNi0xLTEtMA_1c4a66c4-c367-480d-b3f5-d0b9da156285"
      unitRef="usd">800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i833b7fb3b5b14e4e8b4ebb0909d05a2c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOS0yLTEtMS0w_11fe13f4-37bb-440a-a306-0cbc6dbcff73"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i4fddbe170634491dbd21d99d8b590f70_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOS00LTEtMS0w_fd56316c-4c98-4fa2-814d-f2fbca91ba07"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id4160bae3ab043dbb32c58acc74cd048_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOS02LTEtMS0w_ebe85218-ce47-40ad-8c3c-0b13d5e4cf17"
      unitRef="usd">496000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i6079969ef2d54e55ad4b585ec4ec53b9_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOS04LTEtMS0w_f86585a4-9b1a-4a98-b95d-62a7db24ce88"
      unitRef="usd">496000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i1f6a3b9c3c7b42919ab58c0e2df5585a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOS0xMC0xLTEtMA_b6178cd8-a0bf-4eba-9556-4b74513f4b5c"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id388d63d20d04cfabec6273b9266aa22_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOS0xMi0xLTEtMA_cb03cd50-42ce-46d6-b44b-63442cae1a95"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id897ba84812c48c2a65b9776129298aa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOS0xNC0xLTEtMA_c140a329-72e8-40bb-b439-024a45db02fe"
      unitRef="usd">508000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i357b9497652046d0aba3cbdc8518d7b4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfOS0xNi0xLTEtMA_6f55fa4c-2493-4e30-9af3-d1430216370d"
      unitRef="usd">508000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ife81c045c5a444e09b2d8bc249fece59_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTAtMi0xLTEtMA_0df33768-93d4-459f-aa8d-335d170dfcf7"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i931f4e016c724c36974f1c1989897bd3_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTAtNC0xLTEtMA_11756169-b0d9-4564-b387-3eef879e13b2"
      unitRef="usd">4182000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2a4a9dc8a3eb408d89b937d07499587e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTAtNi0xLTEtMA_452f630a-f120-4e70-9d32-cff254dad5e9"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2078f46e4a554de986254804e81be7c6_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTAtOC0xLTEtMA_80714dd5-2d35-4ae1-b487-e6dcedb7deb3"
      unitRef="usd">4182000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if8ff9c1d2a4e40b3a67f944c849a2bd2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTAtMTAtMS0xLTA_086d42fb-288b-41ac-b2ea-65e5c3b34912"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ie33ba4dc377840ee882fdaddd0d69bb0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTAtMTItMS0xLTA_6efc5efb-8780-4115-89c1-9374e8dd5930"
      unitRef="usd">3821000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia63b7b49beba4f378566a8be00c1898d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTAtMTQtMS0xLTA_8dcde095-9f75-464d-96e7-34f3d1c1d7f4"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ib65896a541534edc814e839cea969d72_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTAtMTYtMS0xLTA_8b0a7c2e-feee-4dfb-aa8d-7d38e54c4339"
      unitRef="usd">3821000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i820ccc6258144fb897101140c8a14d81_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTEtMi0xLTEtMA_6f883b06-e9f5-42ed-8afa-e286d8a2b13b"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0c972363fdac4ab6a767c041ae940266_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTEtNC0xLTEtMA_2c67b17f-a274-4218-8622-616514d1443d"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ie3c2d8108f0346fea380bd0c9a9a1e5a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTEtNi0xLTEtMA_570a0cc1-e7ce-4de9-84f1-3a664099b115"
      unitRef="usd">7439000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i261414f831ba4e1aac8a6551f971d92e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTEtOC0xLTEtMA_b3f20e77-2be7-4207-a8c8-f3a43f7ccf77"
      unitRef="usd">7439000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i43ca9b3cd64f442287f5c9dbd74d520d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTEtMTAtMS0xLTA_faf98fab-42e6-4bd6-ad46-4f2e56d0b810"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9bc8c1e565e1493fa5a29d2c0d691486_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTEtMTItMS0xLTA_ba45309f-191c-4d2c-b0bd-dbf557ac5490"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0660fc90350f4c508461c189c1838ea0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTEtMTQtMS0xLTA_1b5ae8e3-e081-455b-ae37-00b7515ff0f1"
      unitRef="usd">6404000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id89615ba04ac4f9f94097b92892cdf6f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTEtMTYtMS0xLTA_3045f398-4aa4-4139-809d-db8bf1f87185"
      unitRef="usd">6404000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia210fcf0a4934eb995df10b0db2c9c88_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItMi0xLTEtOTMw_99de4ab6-bd06-4535-a534-e9059231cb94"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8f9eb705d8b94a9283d4c25e1ece7d11_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItNC0xLTEtOTMw_9164c120-3fe9-4b03-8b5a-978e7e6b52e8"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if977d0d8bf974b6fa76de0a2e644188d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItNi0xLTEtOTMw_1bd45190-6a3b-4d58-be27-e72a85a335fa"
      unitRef="usd">37900000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if5b8469bd6b24519a53e1cba447d8c57_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItOC0xLTEtOTMw_b0eab3f7-1daf-400a-a2c6-8d5dc5f70766"
      unitRef="usd">37900000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="icf6b5d5d9635440999d3e164431442cc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItMTAtMS0xLTUxMQ_f2391ddd-3a35-4a48-8014-827acb25a100"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ief120523936f41ed9556d9c5fbe600ad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItMTItMS0xLTUxMQ_366a0875-51f8-4196-b3e2-4d69d8c51061"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id6205bd153ad465cbe32e8557a90f2df_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItMTQtMS0xLTUxMQ_c3a31fdf-bd26-4b2c-b88b-dde7a4131193"
      unitRef="usd">37600000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9214e2b7471f4a8588e5b99aada1a660_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItMTYtMS0xLTkzMA_9652b152-8c06-4a67-b8a5-2979ae5f1238"
      unitRef="usd">37600000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9ba8a0cf524d4e13b76c6e92d9cf97bf_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtMi0xLTEtMjM1Nw_b88f11a8-6eaa-4663-9269-87033f91a745"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i4294ac1f67eb491c96a6a8cce49fcabe_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtNC0xLTEtMjM1Nw_9c5dea85-9558-49d4-95ef-862cc5afa66a"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i92495438f1b146f898c4e64490283810_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtNi0xLTEtMjM1Nw_ac84c6d0-8467-4bf4-a9cf-c39591c7d8c8"
      unitRef="usd">240000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8eb4e94ac6604758b1ea1704401c3d58_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtOC0xLTEtMjY5OQ_11e93a02-392b-409b-a6c1-c8bcb5838ca3"
      unitRef="usd">240000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="icbad4460fcf648928ffdb191dbdb6530_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtMTAtMS0xLTIzOTg_8a59670a-ffc1-4069-8fed-b58446125317"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i03dd9ae0aed74d5a904172437cf8186f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtMTItMS0xLTIzOTg_74184841-c1e4-445f-be82-942f24bf08d2"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i58a521fe18574d6e968798b4c1586455_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtMTQtMS0xLTIzOTg_660bf2b3-f0c7-4060-a9be-936ec1844437"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i7ab71e0fd4724a4db71bf93a6413a975_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtMTYtMS0xLTI2OTk_88a9e49c-7c21-4496-9455-20033bfbc686"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="iee481251a6b54158be7b4a7effbb8c67_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItMi0xLTEtMA_1faa6d84-bd74-448c-9c89-9670c0d2165e"
      unitRef="usd">73000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic79acce6117446459676d52e173a1126_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItNC0xLTEtMA_2a4fc1b4-2707-4908-9d79-70fcf2bb47f8"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i943f22467f954f6993644f529795f102_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItNi0xLTEtMA_93d570a0-baa5-4bda-89dd-83ecf1568b23"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if3b0aff995404ab8acd400501adf43bd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItOC0xLTEtMA_ffcee557-6d51-487d-8cb4-1c67551d1f4c"
      unitRef="usd">73000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2a5a184f056f42c4b443fbae9b3fba2b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItMTAtMS0xLTA_b93d4d9b-8e10-41a2-adfb-f539f9a03371"
      unitRef="usd">60000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia5cd59ec89e943c8bddbe705cb6e15f6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItMTItMS0xLTA_c3e4b648-bba0-4a7a-bdc8-f37ebb1db40a"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i657fb3d5faae4a9990079266a0c01a60_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItMTQtMS0xLTA_32fbf6a2-fa38-4166-91a8-914f89668885"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i62031fdd8c3645a7b3c2189805b7a8cb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTItMTYtMS0xLTA_b299cb2a-5a29-4bdc-884d-01f4202dc551"
      unitRef="usd">60000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i06d16d86c2ee446498927c381c54d77a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtMi0xLTEtMA_58ce260b-c6fb-43f6-a6a1-a7211727671e"
      unitRef="usd">73000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i19ca28155cef4fd5b5524f954cccaab7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtNC0xLTEtMA_9b148b4f-b087-4d4d-9b84-0cea63d363f6"
      unitRef="usd">4182000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i40b8100a5b2440b48556561a4ba1e0d1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtNi0xLTEtMA_fdabf6ef-adef-4176-a469-db866d7cbec2"
      unitRef="usd">46875000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i109de96646db44268497efcc2f95bdc9_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtOC0xLTEtMA_4feb15a3-3c50-442b-9bd8-b6ce75482d72"
      unitRef="usd">51130000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i13a03a90dd824a3e802cc74fbc6ef67a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtMTAtMS0xLTA_df346cde-45d1-48b5-94fb-f23dc72781a4"
      unitRef="usd">60000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ifc817baab77c490b9eb5d576b2ff57d9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtMTItMS0xLTA_ebe2f9ad-963d-4032-995f-ecddfd31f9a6"
      unitRef="usd">3821000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if692e5a3f16a4775a9bf2a0e13049d43_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtMTQtMS0xLTA_116c21a4-e075-4e35-8a95-c9b1294017c0"
      unitRef="usd">45312000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9c91fdccad734cd3acfb28a7aaee6b08_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOjk5YzljMTUzOWZmMTQ1ZGRiYzZiODZkNjZjMzNiYWUxL3RhYmxlcmFuZ2U6OTljOWMxNTM5ZmYxNDVkZGJjNmI4NmQ2NmMzM2JhZTFfMTMtMTYtMS0xLTA_85e3b35b-4e8f-44c3-9296-f8a9ded202ea"
      unitRef="usd">49193000</us-gaap:LiabilitiesFairValueDisclosure>
    <lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare
      contextRef="i972be18486384106a14259204b8f719b_D20100101-20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RleHRyZWdpb246Zjc0ZDNjMmEyNzk0NDNkNmFiNGFiNGRiNDcxZmU1MzZfMjU0Ng_3ddd3085-0e08-4441-930b-ea87868d1503"
      unitRef="contingent_value_right">4</lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare>
    <lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries
      contextRef="i972be18486384106a14259204b8f719b_D20100101-20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RleHRyZWdpb246Zjc0ZDNjMmEyNzk0NDNkNmFiNGFiNGRiNDcxZmU1MzZfMjU2NA_bd4d205e-e1de-4fb2-afe4-7f6d2e5b7871"
      unitRef="contingent_value_right">1</lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries>
    <lgnd:NumberOfContingentValueRightsSeries
      contextRef="idce9b211fa9d42818fdc3f8ff61affb4_D20100101-20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RleHRyZWdpb246Zjc0ZDNjMmEyNzk0NDNkNmFiNGFiNGRiNDcxZmU1MzZfMjU4NA_ef1fd8d6-9d4c-4583-995c-4d2e04ea0df8"
      unitRef="contingent_value_right_series">4</lgnd:NumberOfContingentValueRightsSeries>
    <lgnd:BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders
      contextRef="i972be18486384106a14259204b8f719b_D20100101-20100131"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RleHRyZWdpb246Zjc0ZDNjMmEyNzk0NDNkNmFiNGFiNGRiNDcxZmU1MzZfMjcxOQ_68845909-5dcb-4d89-b110-1963e097632e">P6M</lgnd:BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders>
    <us-gaap:Investments
      contextRef="ic427fd87f48e4f049d21351088ee3bc2_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RleHRyZWdpb246Zjc0ZDNjMmEyNzk0NDNkNmFiNGFiNGRiNDcxZmU1MzZfMzUyMQ_39bac294-696f-4c16-8b7e-a85d41e8d557"
      unitRef="usd">375000000</us-gaap:Investments>
    <us-gaap:ContractWithCustomerAssetGross
      contextRef="i372f6d3fb38e43cd82744ef34999bd0a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RleHRyZWdpb246Zjc0ZDNjMmEyNzk0NDNkNmFiNGFiNGRiNDcxZmU1MzZfMzYzNg_8db042f6-1f14-482b-8be1-d788af461842"
      unitRef="usd">10000000</us-gaap:ContractWithCustomerAssetGross>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RleHRyZWdpb246Zjc0ZDNjMmEyNzk0NDNkNmFiNGFiNGRiNDcxZmU1MzZfMjE5OTAyMzI2NDM1NQ_d68cec29-eaa3-4109-8310-8a02de3b490d">A reconciliation of the level 3 financial instruments as of March&#160;31, 2021 is as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value adjustments to contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Contingent liabilities from xCella asset acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;240&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;46,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="id28435ac625f4e8f8e07977537c41fef_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOmJlMTEzMjI2MjE2YTQxOGY5MGEyNTM2ZjQ3ZWM2OWI3L3RhYmxlcmFuZ2U6YmUxMTMyMjYyMTZhNDE4ZjkwYTI1MzZmNDdlYzY5YjdfMS0xLTEtMS0yNDE5_6a3f5810-f213-4a0c-945e-005613abd0b9"
      unitRef="usd">45312000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i3739dfe7d8c541718c9f50a133133136_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOmJlMTEzMjI2MjE2YTQxOGY5MGEyNTM2ZjQ3ZWM2OWI3L3RhYmxlcmFuZ2U6YmUxMTMyMjYyMTZhNDE4ZjkwYTI1MzZmNDdlYzY5YjdfMS0xLTEtMS0yNDQ0_5379f076-a589-46dd-9e04-9fbc7afbb3db"
      unitRef="usd">1323000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition
      contextRef="i3739dfe7d8c541718c9f50a133133136_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOmJlMTEzMjI2MjE2YTQxOGY5MGEyNTM2ZjQ3ZWM2OWI3L3RhYmxlcmFuZ2U6YmUxMTMyMjYyMTZhNDE4ZjkwYTI1MzZmNDdlYzY5YjdfMi0xLTEtMS0zMzg0_4d7f2f3a-a1b9-43aa-99ba-6727a36a3c9f"
      unitRef="usd">240000</lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ife201f82dfa94172abde90879f18f167_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF8zNy9mcmFnOmY3NGQzYzJhMjc5NDQzZDZhYjRhYjRkYjQ3MWZlNTM2L3RhYmxlOmJlMTEzMjI2MjE2YTQxOGY5MGEyNTM2ZjQ3ZWM2OWI3L3RhYmxlcmFuZ2U6YmUxMTMyMjYyMTZhNDE4ZjkwYTI1MzZmNDdlYzY5YjdfMi0xLTEtMS0yNzA2_08158137-5928-4fe2-8327-a3d2fa46c32f"
      unitRef="usd">46875000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfODE1Mw_d62087b2-1f00-463a-ab65-cd7bffb1a8db">Acquisitions&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Pfenex Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On October 1, 2020, we acquired Pfenex, which develops next-generation and novel protein therapeutics to improve existing therapies and create new therapies for biological targets linked to critical, unmet diseases using a protein expression technology platform.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The preliminary purchase price of $465.1&#160;million included $429.6&#160;million cash consideration paid upon acquisition, and a contingent CVR payment of up to $77.8&#160;million in cash based on a certain specified milestone with an estimated initial fair value of $37.0&#160;million. The CVR will only be paid in full if the milestone is achieved by December&#160;31, 2021. The amount of the CVR included in the purchase price was reduced by $1.5&#160;million that was determined to be post-combination expense. The fair value of the CVR liability was determined using a probability-adjusted income approach. These cash flows were then discounted to present value using a discount rate based on market participants' cost of debt reflective of the Company, which was 7.1%. The liability is periodically assessed based on events and circumstances related to the underlying milestone, and any change in fair value is recorded in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In connection with the acquisition, a portion of Pfenex's equity awards that were outstanding and unvested prior to the acquisition became fully vested per the terms of the merger agreement. The acceleration of vesting required us to allocate the fair value of the equity attributable to pre-combination service to the purchase price and the remaining amount was considered our post-combination expense. We paid $17.3&#160;million in cash for equity compensation, which is attributable to pre-combination services and is reflected as a component of the total purchase price paid of $429.6&#160;million. In addition, the fair value of equity compensation attributable to the post-combination service period was $8.7&#160;million. These amounts were associated with the accelerated vesting of stock options previously granted to Pfenex employees and were fully paid in cash, which was recognized as general and administrative expenses during the fourth quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table sets forth an allocation of the preliminary purchase price to the identifiable tangible and intangible assets acquired and liabilities assumed, with the excess recorded to goodwill (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts and unbilled receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Intangibles acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;385,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;91,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,814)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,455)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(53,296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;465,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Goodwill represents the excess of the purchase price over the preliminary fair value of the underlying assets acquired and liabilities assumed. Goodwill is attributable to the assembled workforce of experienced personnel at Pfenex and expected synergies. None of the goodwill is expected to be deductible for tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Acquired intangibles include $362&#160;million of contractual relationships and $23&#160;million of core technology. The fair values of the contractual relationships were based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, collaboration and product revenue streams derived from the licensing of the related technologies over the estimated contractual relationship period. The fair value of the contractual relationships is being amortized on a straight-line basis over the weighted average estimated useful life of 12.9 years. The fair values of the acquired technologies were based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, collaboration and product revenue streams derived from the licensing of the related technologies over the estimated useful lives. These projected cash flows were discounted to present value using discount rate, which varies from 12% to 15%. The total acquired intangibles are being amortized on a straight-line basis over the weighted average estimated useful life of 13.0 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The estimated fair values of assets acquired and liabilities assumed, including deferred tax assets and liabilities, and purchased intangibles are provisional. The accounting for these amounts falls within the measurement period and therefore we may adjust these provisional amounts to reflect new information obtained about facts and circumstances that existed as of the acquisition date.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following summary presents our unaudited pro forma consolidated results of operations for the quarter ended March 31, 2020 as if the Pfenex acquisition had occurred on January 1, 2020, which gives effect to certain transaction accounting adjustments, including amortization of acquired intangibles and share based compensation expense for retained Pfenex employees. The pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as of the date indicated, nor is it necessarily indicative of future operating results (in thousands, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(37,939)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net loss per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Taurus Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On September 9, 2020, we acquired Taurus, which discovers and develops novel antibodies from immunized cows and cow-derived libraries. The purchase price of $5.1 million included $4.6 million in cash, and a $0.5 million holdback to satisfy indemnification obligations which will be settled by September 2021.  We also issued nontransferable CVRs for up to $4.5 million tied to partnered and internal research and development and for up to $25.0 million as a 25% share of post-clinical Taurus product revenues (including milestone payments) received by us. We evaluated this acquisition in accordance with ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, to discern whether the assets and operations of Taurus met the definition of a business. We concluded that substantially all of the fair value of the gross assets acquired is concentrated in the acquired core technology. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accordingly, we accounted for this transaction as an asset acquisition. Of the $5.1 million consideration transferred, we recognized (1) $0.05 million of tangible assets acquired, and (2) $5.0 million of core completed technology intangibles acquired. The core technology is being amortized on a straight-line basis over the estimated useful life of 10 years. We account for the CVRs in accordance with ASC 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, when the contingency is resolved and the liability becomes payable. None of the CVRs are recognized as of March&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;xCella Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On September 8, 2020, we acquired xCella, an antibody discovery company. We paid $7.1 million in cash (including a $0.5 million holdback to satisfy indemnification obligations which will be settled by September 2021), and issued earnout rights for up to $5.0 million tied to our use of the xCella technology for partnered research and development and for up to $25.75 million as a 25% share of any future milestone payments we received under a certain existing xCella partner arrangement. We evaluated this acquisition in accordance with ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, to discern whether the assets and operations of xCella met the definition of a business. We concluded that substantially all of the fair value of the gross assets acquired is concentrated in the acquired core technology. Accordingly, we accounted for this transaction as an asset acquisition. Of the $7.1 million consideration transferred, we recognized (1) $0.2 million of tangible assets acquired, (2) $(0.1) million of liabilities assumed, (3) $7.8 million of core completed technology acquired, and (4) $(0.8) million of deferred tax liability. The core technology is being amortized on a straight-line basis over the estimated useful life of 15 years. We account for the earnout rights in accordance with ASC 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, when the contingency is resolved and the liability becomes payable. None of the earnout rights are recognized as of the acquisition date. During the three months ended March&#160;31, 2021, we recognized $0.2 million in earnout rights when certain contingencies were resolved during the period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Icagen Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On April 1, 2020, we acquired the core assets, including its partnered programs and ion channel technology, from Icagen and certain of its affiliates. The acquisition was accounted for as a business combination and we applied the acquisition method of accounting. Accordingly, we recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the applicable date of acquisition. We did not incur any material acquisition-related costs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The purchase price of $19.9 million included $15.1 million cash consideration paid upon acquisition, and a contingent earn-out payment of up to $25.0&#160;million of cash payments based on certain revenue milestones with an estimated fair value of $4.8 million. The fair value of the earn-out liability was determined using a probability weighted income approach incorporating the estimated future cash flows from expected future milestones. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of Icagen. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 2, Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, for further discussion. The liability will be periodically assessed based on events and circumstances related to the underlying milestones, and any change in fair value will be recorded in our consolidated statements of operations. The carrying amount of the liability may fluctuate significantly and actual amount paid may be materially different than the carrying amount of the liability. There was no change in the fair value of the contingent liabilities during the second quarter of 2020. As the acquisition is not considered significant, pro forma information has not been provided. The results of Icagen have been included in our results of operations since the date of acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The allocation of the purchase price consisted of (1) $1.8 million of fair value of tangible assets acquired, (2) $(0.8) million of liabilities assumed, (3) $12.8 million of acquired intangibles, (4) $(3.7) million of deferred revenue in connection with assumed performance obligations under a collaboration agreement, (5) $0.8 million of deferred tax asset associated with the deferred revenue, and (6) $9.0 million of goodwill, the majority of which is deductible for tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Acquired intangibles include $11.1 million of customer relationships and $1.7 million of core technology. The fair values of the customer relationships were based on a discounted cash flow analysis incorporating the estimated future cash flows from these relationships during the contractual term. These cash flows were then discounted to present value using a discount rate of 17%. The fair value of the customer relationships is being amortized on a straight-line basis over the weighted average estimated useful life of 9.6 years. The fair value of the core technology was based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, and collaboration revenue streams derived from the licensing of the related technologies. These projected cash flows were discounted to present value using a discount rate of 17%. The fair value of the core technology is being amortized on a straight-line basis over the estimated useful life of 10 years. The total acquired intangibles are being amortized on a straight-line basis over the estimated useful life of 9.7 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i4464b8371b004313b6607d086dec25b2_D20201001-20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDM5ODA0NjUzMDk5MA_1f6b417c-a32d-45ec-aa9b-ed54e4089e56"
      unitRef="usd">465100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i4464b8371b004313b6607d086dec25b2_D20201001-20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDM5ODA0NjUzMTAxMg_c5773dd4-7a88-4d11-9a3f-e65d5e2f74db"
      unitRef="usd">429600000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDM5ODA0NjUzMTAzMg_b8dc8fc7-8639-4e53-bf65-d13ffb9f6a69"
      unitRef="usd">77800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDM5ODA0NjUzMTA1NA_dfda6592-cc20-4058-860f-02e6abb59e55"
      unitRef="usd">37000000.0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDM5ODA0NjUzMTA4MQ_ebb726b5-351a-446e-96b4-4ca3a6ad96af"
      unitRef="usd">1500000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i4243023110cb4a6ca65bf4c4c5d8878f_I20201001"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDM5ODA0NjUzMTEwNw_12cc0fd9-ad4f-44a2-9ea1-1b8866a1d696"
      unitRef="pure">0.071</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <lgnd:PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions
      contextRef="i4464b8371b004313b6607d086dec25b2_D20201001-20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDM5ODA0NjUzMTEyMw_b9333a41-ba24-44e0-9252-8f1bbd9dcba5"
      unitRef="usd">17300000</lgnd:PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i4464b8371b004313b6607d086dec25b2_D20201001-20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDM5ODA0NjUzMTE0NA_c5773dd4-7a88-4d11-9a3f-e65d5e2f74db"
      unitRef="usd">429600000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards
      contextRef="idc64562484fc4d23b336ec8ed3fd3947_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDM5ODA0NjUzMTE2MA_a02bcc00-adae-4026-ae26-0396c65ec4c6"
      unitRef="usd">8700000</us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjE5OTAyMzI4MzI5Mw_f8c6449e-7058-49bb-ac0f-8acd5d3834b1">The following table sets forth an allocation of the preliminary purchase price to the identifiable tangible and intangible assets acquired and liabilities assumed, with the excess recorded to goodwill (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts and unbilled receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Intangibles acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;385,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;91,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,814)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,455)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(53,296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;465,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;(1) Goodwill represents the excess of the purchase price over the preliminary fair value of the underlying assets acquired and liabilities assumed. Goodwill is attributable to the assembled workforce of experienced personnel at Pfenex and expected synergies. None of the goodwill is expected to be deductible for tax purposes.</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfMC0xLTEtMS0yNDc4_9f4158e5-a980-4673-843b-ff55bd3edc7f"
      unitRef="usd">51407000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash
      contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfMS0xLTEtMS0yNDc4_9e0f0e7b-054d-45e8-9c07-bc5fba3b2dbb"
      unitRef="usd">200000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfMi0xLTEtMS0yNDc4_6189e688-2289-408f-bf0e-5edbfb495a13"
      unitRef="usd">1359000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfMy0xLTEtMS0yNDc4_63e8748a-163b-4709-a8c3-22c0515a38cb"
      unitRef="usd">7823000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets
      contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfNC0xLTEtMS0yNDc4_98583c21-5bfe-4bf0-9930-01346a608f64"
      unitRef="usd">3070000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfNS0xLTEtMS0yNDc4_9ef499e2-50ec-457a-8c6c-b045c7cd4536"
      unitRef="usd">1338000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
      contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfNi0xLTEtMS0yNDc4_95abe231-a4b5-4779-a2c0-a85ec44e7541"
      unitRef="usd">385000000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets>
    <us-gaap:Goodwill
      contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfNy0xLTEtMS0yNDc4_ee075a3e-5812-40f1-8128-8d6f0eec1aef"
      unitRef="usd">91837000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfOC0xLTEtMS0yNDc4_87e4da09-75e2-4e15-b8d3-8b7b2528f67e"
      unitRef="usd">6814000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent
      contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfOS0xLTEtMS0yNDc4_a71e5875-721f-480e-9400-711f3f0d965c"
      unitRef="usd">8455000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfMTAtMS0xLTEtMjQ3OA_ae3aba59-d2cd-4bad-98e5-1c662001f99a"
      unitRef="usd">3908000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities
      contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfMTEtMS0xLTEtMjQ3OA_860c5915-31eb-45f6-b4e7-5767ede81961"
      unitRef="usd">3070000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfMTItMS0xLTEtMjQ3OA_e44c1f6b-12cf-4d99-8ef1-7ebcc4acbd3c"
      unitRef="usd">1382000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfMTMtMS0xLTEtMjQ3OA_5ba7016d-bc6f-4b6f-a4c9-475bfa4a5513"
      unitRef="usd">53296000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjBiOTkwMDU3NjFjODRjMTA5ZDE3NGE3YzMyMDRmNWFlL3RhYmxlcmFuZ2U6MGI5OTAwNTc2MWM4NGMxMDlkMTc0YTdjMzIwNGY1YWVfMTQtMS0xLTEtMjcxNw_95fb068f-5e4e-4de7-9db5-070857c34b45"
      unitRef="usd">465109000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="ia37942031dbb40cf81304422e5ff426c_I20201001"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjE5OTAyMzI4Nzc1Mg_ef2e8f51-bc8b-4d64-ba50-f33788b1a752"
      unitRef="usd">0</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i7cc2592d38964cbb996dc31f81ff2c9a_I20201001"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjE5OTAyMzI4MjA1Mg_e025ca0c-95f0-4faa-9dc7-540785ccf45f"
      unitRef="usd">362000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i1708e500e932475f92536d18e3d099b5_I20201001"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjE5OTAyMzI4MjA2Ng_78afb461-cdd3-438b-a9fd-d15587014e02"
      unitRef="usd">23000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i6037a4915521428790837dff8096a89d_D20201001-20201001"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMzg0ODI5MDcyOTMxNQ_6f4fa363-d7cc-4e0c-a58f-9dd1e0a12704">P12Y10M24D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate
      contextRef="i3ca2eca402bd48499cd198b19a231468_D20201001-20201001"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjE5OTAyMzI4MjA5MA_d1046dab-38ee-4fba-9e74-4121dfcf8418"
      unitRef="number">0.12</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate
      contextRef="ie98b3c08f75e4b61b0c8b64a85133b0c_D20201001-20201001"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjE5OTAyMzI4MjA5NQ_205ee95d-207c-4e8f-a81b-844e4b32edc2"
      unitRef="number">0.15</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i4464b8371b004313b6607d086dec25b2_D20201001-20201001"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMzg0ODI5MDcyOTE2Ng_18b279ef-3cfb-40fc-a9d7-e1901525dbe7">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjE5OTAyMzI4Nzc2MQ_f847d344-827e-4a04-bba6-ec12d6933df2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following summary presents our unaudited pro forma consolidated results of operations for the quarter ended March 31, 2020 as if the Pfenex acquisition had occurred on January 1, 2020, which gives effect to certain transaction accounting adjustments, including amortization of acquired intangibles and share based compensation expense for retained Pfenex employees. The pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as of the date indicated, nor is it necessarily indicative of future operating results (in thousands, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(37,939)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net loss per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="icbe299c7430a4957bb40d8a3d730a73e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjNlZGVhZThlMjUwMzRmYjJhMjAwMDY1MTU3Zjg4ZDljL3RhYmxlcmFuZ2U6M2VkZWFlOGUyNTAzNGZiMmEyMDAwNjUxNTdmODhkOWNfMS0xLTEtMS0yNzcx_d4678245-1d68-4d8a-b0d0-d5f8ed949ff5"
      unitRef="usd">33843000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="icbe299c7430a4957bb40d8a3d730a73e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjNlZGVhZThlMjUwMzRmYjJhMjAwMDY1MTU3Zjg4ZDljL3RhYmxlcmFuZ2U6M2VkZWFlOGUyNTAzNGZiMmEyMDAwNjUxNTdmODhkOWNfMi0xLTEtMS0yNzcx_11ff1c51-1edb-443c-ad04-a49edc7b33c4"
      unitRef="usd">-37939000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="icbe299c7430a4957bb40d8a3d730a73e_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjNlZGVhZThlMjUwMzRmYjJhMjAwMDY1MTU3Zjg4ZDljL3RhYmxlcmFuZ2U6M2VkZWFlOGUyNTAzNGZiMmEyMDAwNjUxNTdmODhkOWNfNC0xLTEtMS0yNzc4_94af7278-b863-485f-8d06-ff05cc286d0e"
      unitRef="usdPerShare">-2.30</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="icbe299c7430a4957bb40d8a3d730a73e_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RhYmxlOjNlZGVhZThlMjUwMzRmYjJhMjAwMDY1MTU3Zjg4ZDljL3RhYmxlcmFuZ2U6M2VkZWFlOGUyNTAzNGZiMmEyMDAwNjUxNTdmODhkOWNfNC0xLTEtMS0yNzc4_9a44cdf5-47d5-4a15-b6bc-f5ea94f816d2"
      unitRef="usdPerShare">-2.30</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i07f491d71a074d669d852a83c5014e96_D20200909-20200909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjAw_a1da8ff8-f62a-4ff2-98e0-ccbccefba574"
      unitRef="usd">5100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i07f491d71a074d669d852a83c5014e96_D20200909-20200909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjEy_359795ed-3a72-4395-a42e-125df18524ca"
      unitRef="usd">4600000</us-gaap:PaymentsToAcquireBusinessesGross>
    <lgnd:BusinessCombinationConsiderationTransferredHoldback
      contextRef="i07f491d71a074d669d852a83c5014e96_D20200909-20200909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjMw_2c537eb4-4c29-4575-bff6-92afea56b613"
      unitRef="usd">500000</lgnd:BusinessCombinationConsiderationTransferredHoldback>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i5ec4f52c7742457e9f9a93bcedf7c43a_I20200909"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMzY5_47507541-9ed5-441f-bb26-250df2aadb11"
      unitRef="usd">4500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i4a4df23c7dc04ee1b5aa7abe12902388_I20200909"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDQy_55995eaa-d584-4c95-b92b-3dfd30713385"
      unitRef="usd">25000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues
      contextRef="ieb5b853ff6c948499b25bc488e171d3a_D20200909-20200909"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDUw_34313018-c9d5-491b-9c8e-abb625eba2dd"
      unitRef="number">0.25</lgnd:BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i07f491d71a074d669d852a83c5014e96_D20200909-20200909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfOTI4_e60e4605-0a90-46df-9fa9-a81e8253fee5"
      unitRef="usd">5100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets
      contextRef="ie01bfe015cdf4254866d1eb4e646cb8b_I20200909"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfOTc2_48169b91-2709-4f68-9d20-cde7eac55a2c"
      unitRef="usd">50000.00</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i2f8e586c985a4f67aa1ae11d2c8cc48d_I20200909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMTAxNg_6f34704e-c603-4ae7-a996-289fef154433"
      unitRef="usd">5000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="if95207dfe47f4c9e9c0f43e8b93447ea_D20200909-20200909"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMTE2OA_373f86fc-75cb-4854-a789-725d337fc24f">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ie01bfe015cdf4254866d1eb4e646cb8b_I20200909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMTMwNw_24e4e9e7-1eab-430d-ae99-170267049ddc"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ib1211f6f3075428083696490bd9e932a_D20200908-20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMTQ2OQ_456ef140-b518-435d-8ea4-536b81b6aecd"
      unitRef="usd">7100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <lgnd:BusinessCombinationConsiderationTransferredHoldback
      contextRef="ib1211f6f3075428083696490bd9e932a_D20200908-20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMTQ5Mw_d9efc198-5144-41c4-a5a6-893a3d1b93b7"
      unitRef="usd">500000</lgnd:BusinessCombinationConsiderationTransferredHoldback>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iddbb15ce39fa4680a70e166c8f3a4d15_I20200908"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMTYyMg_36dd3c66-9d6e-40b0-8d61-d73da8407b2a"
      unitRef="usd">5000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia183c7bcb9ba4693bb9d0a6d905ad0d1_I20200908"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMTcxOQ_ca9e5c9d-7146-4adb-8d0d-24e852e610cd"
      unitRef="usd">25750000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues
      contextRef="i8d532605276c48f3a3a254c0df053fa9_D20200908-20200908"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMTcyNw_17447634-f045-4ad1-ab88-fcda6a6b8c73"
      unitRef="number">0.25</lgnd:BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ib1211f6f3075428083696490bd9e932a_D20200908-20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjIxNQ_bed4f4ad-7a09-4932-8e5e-bd1d668681d8"
      unitRef="usd">7100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets
      contextRef="ia8d7bcd2b95d4fdda48d8864d7b7c451_I20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjI2Mw_c1246843-7d2b-4063-a815-4c2bded96fb7"
      unitRef="usd">200000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="ia8d7bcd2b95d4fdda48d8864d7b7c451_I20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjI5OQ_81e3d0c6-08de-419f-af18-156fb6ab6694"
      unitRef="usd">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ib568c9bfd11849cba166b146a4953fc6_I20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjMzMA_72a0ff5e-2089-4965-bbb1-0afa11347035"
      unitRef="usd">7800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="ia8d7bcd2b95d4fdda48d8864d7b7c451_I20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjM4MA_39a1198a-eafe-4b62-8c4c-1825a995bce5"
      unitRef="usd">800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ia4acaa60d54747379cca9601b1b5b67e_D20200908-20200908"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjUwOA_3d0a2ae4-8907-4606-87f5-b5e1fe5495bd">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia8d7bcd2b95d4fdda48d8864d7b7c451_I20200908"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMjY1Nw_4ccdf85d-5c1e-47a7-ae86-40144c51bd5c"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency
      contextRef="i2e4887e0977c47cd936f0690fcc58a01_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMTA0NDUzNjA0OTY1NDQ_58f11d52-4735-4113-8b23-63357d282b1e"
      unitRef="usd">200000</lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="icabfd60e6d5c4e879961167fb0781d8a_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMzE4Mw_48ab111b-b8e8-443f-9a65-3a8d92ceb997"
      unitRef="usd">0</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="icabfd60e6d5c4e879961167fb0781d8a_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMzI1Ng_649101eb-8e76-485c-9376-833cf3a863d3"
      unitRef="usd">19900000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="icabfd60e6d5c4e879961167fb0781d8a_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMzI2OA_d4102397-df06-4b14-9c81-bf48c5fad2f1"
      unitRef="usd">15100000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic1c6304e54ea4ff6822ec9ee1766e372_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMzM1Ng_ba25c87b-44c6-47da-a5c1-38143cba3dd8"
      unitRef="usd">25000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="ic1c6304e54ea4ff6822ec9ee1766e372_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfMzQ0NA_92a9d68b-8ec4-4a79-8e47-c9bd52dd4a79"
      unitRef="usd">4800000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets
      contextRef="ic1c6304e54ea4ff6822ec9ee1766e372_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDU3Mg_0d41d869-483f-4f84-a889-8ee26db272fa"
      unitRef="usd">1800000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="ic1c6304e54ea4ff6822ec9ee1766e372_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDYyMg_931110bf-b010-4621-9d56-1e0323c90b20"
      unitRef="usd">800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ic1c6304e54ea4ff6822ec9ee1766e372_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDY1Mw_24429f3a-1c02-42f8-8227-e4cd3e56bae5"
      unitRef="usd">12800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="ic1c6304e54ea4ff6822ec9ee1766e372_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDY4NQ_a7868e3c-705a-4f6e-b6c2-25db8a880c8f"
      unitRef="usd">3700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="ic1c6304e54ea4ff6822ec9ee1766e372_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDc5Ng_d3599fb1-17ed-4699-b006-8bbdc6ef6e52"
      unitRef="usd">800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="icabfd60e6d5c4e879961167fb0781d8a_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDg2Nw_df380749-d9b2-4a9c-9eb3-20f63ba35cce"
      unitRef="usd">9000000.0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i1de02aee229949b29da1adff62f79608_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNDk2OA_a0b9d2c6-8511-4cc0-b5d2-a350861f4758"
      unitRef="usd">11100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="iafdcef1bca214ba4be93eb50ada39288_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNTAwMQ_ef579f5d-abec-46d9-bc73-3efb491c35b4"
      unitRef="usd">1700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate
      contextRef="i61296742d97b4da79a28c03d8f00b06c_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNTI5Ng_b3945656-d2cd-4568-bb4e-c3bc89fe7a7a"
      unitRef="number">0.17</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i61296742d97b4da79a28c03d8f00b06c_D20200401-20200401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNTQ0MA_bd39e3ed-1558-4248-bb5b-df6da5b34fad">P9Y7M6D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate
      contextRef="i9bd0a96ccb9e42b08636c5d927887d6f_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNTc4MA_a870888c-b7d7-479c-a802-e8e6650ac436"
      unitRef="number">0.17</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i9bd0a96ccb9e42b08636c5d927887d6f_D20200401-20200401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNTkwMA_857f4161-da16-4ac0-b4b5-aba313050e38">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="icabfd60e6d5c4e879961167fb0781d8a_D20200401-20200401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80MC9mcmFnOmFmYmE5ZmQ0YWQ5MjRmOGViNjMyN2MwZmVjMGUzOWExL3RleHRyZWdpb246YWZiYTlmZDRhZDkyNGY4ZWI2MzI3YzBmZWMwZTM5YTFfNjAyMA_bcc76dd3-fee9-4442-a857-8fbeb59b07b2">P9Y8M12D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfNTk3Mg_59754d95-6b06-4c9f-97e8-17e107dda6f3">Convertible Senior Notes&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;0.75%&#160;Convertible&#160;Senior&#160;Notes&#160;due 2023&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2018, we issued&#160;$750.0&#160;million&#160;aggregate principal amount of&#160;0.75%&#160;convertible&#160;senior&#160;notes. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $733.1 million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our election, based on an initial conversion rate, subject to adjustment, of&#160;4.0244&#160;shares per $1,000 principal amount of the 2023 Notes which represents an initial conversion price of approximately&#160;$248.48 per share.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the 2023 Notes may convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least 20 trading days (whether or not consecutive) during the 30 consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day is greater than 130% of the conversion price on such trading day; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) during the five business day period immediately following any 10 consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than 98% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the conversion price of $248.48. As of March&#160;31, 2021, the &#x201c;if-converted value&#x201d; did not exceed the principal amount of the 2023 Notes. In connection with the issuance of the 2023 Notes, we incurred $16.9 million of issuance costs, which primarily consisted of underwriting, legal and other professional fees. The portion of these costs allocated to the liability component totaling $13.7 million is amortized to interest expense using the effective interest method over the five year expected life of the 2023 Notes. It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2021, we repurchased $104.5&#160;million in principal of the 2023 Notes for $109.1&#160;million in cash, including accrued interest of $0.2&#160;million. We accounted for the repurchase as a debt extinguishment, which resulted in (1) a loss of $4.8&#160;million reflected in other income (expense), net, in our condensed consolidated statement of operations for the three months ended March&#160;31, 2021; (2) a $9.6 million reduction in debt discount, and (3) a $9.1&#160;million reduction to additional paid in capital, net of tax, related to the reacquisition of the equity component in our condensed consolidated balance sheet as of March&#160;31, 2021. After the repurchases, approximately $390.8&#160;million in principal amount of the 2023 Notes remain outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Convertible Bond Hedge and Warrant Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering 3,018,327 shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $248.48 per share and are exercisable when and if the 2023 Notes are converted. We paid $140.3 million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering approximately 3,018,327 shares of common stock with an exercise price of approximately $315.38 per share, subject to certain adjustments. We received $90.0 million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp;amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2021, in connection with the repurchases of $104.5&#160;million in principal of the 2023 Notes for $109.1&#160;million in cash, including accrued interest of $0.2&#160;million, during the quarter ended March 31, 2021, we entered into Warrant Early Unwind Agreements and Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp;amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We paid $16.5&#160;million as part of the Warrant Early Unwind Agreements reducing the number of shares covered by the warrants from 3,018,327 to 2,597,750. We received $16.9&#160;million as part of the Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to 645,500. These unwind transactions resulted in a $0.4&#160;million net increase in additional paid-in-capital in our condensed consolidated balance sheet as of March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about the 2023 Notes (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.099%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.646%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Principal amount of the 2023 Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;390,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;495,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unamortized discount (including unamortized debt issuance cost)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38,467)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(52,987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total long-term portion of notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;352,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;442,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Carrying value of equity component of the 2023 Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value of the 2023 Notes outstanding (Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;404,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;466,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5fa2bce4be0846e99213fe7062260432_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfOTk_04197e56-382a-43a3-983a-4ed2bf68a483"
      unitRef="usd">750000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5fa2bce4be0846e99213fe7062260432_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMTMy_c2edd0d7-792e-4675-9080-d5bd676081c9"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i73bb70b7323d4144a6e75d3e406c405c_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMjg4_a423d2d2-3366-4ff3-8cf4-c031164e5c24"
      unitRef="usd">733100000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i5fa2bce4be0846e99213fe7062260432_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfNjA5_20f0a442-20cd-49ff-b430-80e0c9ed3652"
      unitRef="usdPerShare">248.48</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i48864de303954560905e76c4450e4c12_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfOTQy_90645d61-6e59-4a81-ac00-b7a024de9a5b"
      unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i48864de303954560905e76c4450e4c12_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfOTk4_05d9410a-dbd3-4830-927d-364d9f739a32"
      unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i48864de303954560905e76c4450e4c12_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMTE5Mw_a50f4ffb-54ea-4fb1-80b2-6648de42341d"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i6f9fc4db17d04bf89dd453f8e14127a3_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMTI1OA_01c39852-2623-491e-b7f9-60a96dbb35fc"
      unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i6f9fc4db17d04bf89dd453f8e14127a3_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMTMwNw_54787fb8-c07c-46c9-8583-a1625a426cb6"
      unitRef="d">10</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger
      contextRef="i6f9fc4db17d04bf89dd453f8e14127a3_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMTQxNg_2ca3bfad-f0f5-4208-a22f-077d6be67897"
      unitRef="number">0.98</lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i5fa2bce4be0846e99213fe7062260432_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMTg0MA_4e474865-7212-4d03-bcea-c63322b3974b"
      unitRef="usdPerShare">248.48</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i9fce823aabcc4d3d949530fe19c30792_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMTk5Nw_fb5b2e84-23d2-4c7e-a8ff-489d2960d433"
      unitRef="usd">16900000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i9fce823aabcc4d3d949530fe19c30792_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMjE3MA_d28624a7-185d-4625-be87-2eb49975f993"
      unitRef="usd">13700000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i9fce823aabcc4d3d949530fe19c30792_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMjU4Nw_346fc57a-0623-4f11-a600-da2a50b784f0"
      unitRef="usd">104500000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i3951fe225b2c46a7b3923a0684c74ce9_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMjYyNQ_73f56650-dd05-4d83-a0c2-dd101702dd86"
      unitRef="usd">109100000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="i3951fe225b2c46a7b3923a0684c74ce9_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMjY2Nw_7de4cdec-2903-4f5c-8aac-34dd73536bb1"
      unitRef="usd">200000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i3951fe225b2c46a7b3923a0684c74ce9_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMjc1OA_6d2ba0c1-3bb3-4eb3-bc32-7a43b48143c1"
      unitRef="usd">-4800000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <lgnd:IncreaseDecreaseInDebtDiscount
      contextRef="i3951fe225b2c46a7b3923a0684c74ce9_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMjg3OA_602cc7a2-5115-4371-a74f-167196245249"
      unitRef="usd">-9600000</lgnd:IncreaseDecreaseInDebtDiscount>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i3951fe225b2c46a7b3923a0684c74ce9_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMjkxOQ_ff05da67-da3d-4041-9ed4-2e24c87424ff"
      unitRef="usd">-9100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:LongTermDebt
      contextRef="i9fce823aabcc4d3d949530fe19c30792_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMzExOQ_bfbca9fe-d316-4378-a84f-cac2e69e6d45"
      unitRef="usd">390800000</us-gaap:LongTermDebt>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i5fa2bce4be0846e99213fe7062260432_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMzM0Nw_1ccadb76-e933-40dc-ad51-1739884c0617"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i5fa2bce4be0846e99213fe7062260432_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMzYyMQ_ab453394-63b0-4da1-8fc3-e7e49f53fd22"
      unitRef="usdPerShare">248.48</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <lgnd:PaymentsForConvertibleBondHedges
      contextRef="i73bb70b7323d4144a6e75d3e406c405c_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMzcwNA_9f0ac84c-4b1e-4080-9fd8-e09a3d999872"
      unitRef="usd">140300000</lgnd:PaymentsForConvertibleBondHedges>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i5fa2bce4be0846e99213fe7062260432_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfNDYwNA_c8eb0d6a-640a-4641-afc1-7365400f17ea"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i5fa2bce4be0846e99213fe7062260432_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfNDY3MA_ec288234-875b-4bf4-a3ea-4819e1569c2e"
      unitRef="usdPerShare">315.38</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="i73bb70b7323d4144a6e75d3e406c405c_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfNDcyOA_61c1b6b5-009f-4462-b01f-1c5830c8c363"
      unitRef="usd">90000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i9fce823aabcc4d3d949530fe19c30792_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMzg0ODI5MDcwNjg3Mw_346fc57a-0623-4f11-a600-da2a50b784f0"
      unitRef="usd">104500000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i3951fe225b2c46a7b3923a0684c74ce9_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMzg0ODI5MDcwNjg5MA_73f56650-dd05-4d83-a0c2-dd101702dd86"
      unitRef="usd">109100000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="i3951fe225b2c46a7b3923a0684c74ce9_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMzg0ODI5MDcwNjkwNQ_7de4cdec-2903-4f5c-8aac-34dd73536bb1"
      unitRef="usd">200000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <lgnd:PaymentsToUnwindWarrants
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMzg0ODI5MDcxMTE2Mg_b89149ba-60c3-4792-8854-177c78050070"
      unitRef="usd">16500000</lgnd:PaymentsToUnwindWarrants>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i5fa2bce4be0846e99213fe7062260432_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMzg0ODI5MDcwNjU3OA_1ccadb76-e933-40dc-ad51-1739884c0617"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i9fce823aabcc4d3d949530fe19c30792_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMzg0ODI5MDcwNjcxMQ_2b50a698-256b-4ef7-8d4b-4d231bb3afaa"
      unitRef="shares">2597750</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <lgnd:ProceedsFromUnwindingConvertibleBondHedges
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMzg0ODI5MDcwNzAwNw_6f4dc338-8f9d-450a-aa4e-3504c3b05092"
      unitRef="usd">16900000</lgnd:ProceedsFromUnwindingConvertibleBondHedges>
    <lgnd:NumberOfOptionsUnderConvertibleBondHedges
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMjE5OTAyMzI3MDIxNA_92211a43-16ac-45d2-b6ca-df6176df5b6f"
      unitRef="option">645500</lgnd:NumberOfOptionsUnderConvertibleBondHedges>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfMjE5OTAyMzI2OTI1NQ_9cfa8b20-384d-4ffe-b5b2-17e5ecf0760b"
      unitRef="usd">400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RleHRyZWdpb246MzdkN2JhNGUxNDE0NDNlMWJhMGJhMDk3ODgyMWUwOGNfNTk3NA_d426a417-f40e-4f04-a98d-a4af38eacb08">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about the 2023 Notes (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.099%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.646%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Principal amount of the 2023 Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;390,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;495,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unamortized discount (including unamortized debt issuance cost)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38,467)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(52,987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total long-term portion of notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;352,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;442,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Carrying value of equity component of the 2023 Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value of the 2023 Notes outstanding (Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;404,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;466,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9fce823aabcc4d3d949530fe19c30792_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RhYmxlOjg1ZTdiNmE5OTUxMTQzN2NiZTI3Yzg5MGIxMDBkM2IwL3RhYmxlcmFuZ2U6ODVlN2I2YTk5NTExNDM3Y2JlMjdjODkwYjEwMGQzYjBfMS0xLTEtMS0w_1bcdff0b-2b43-4b95-a837-0e02258f99a4"
      unitRef="usd">390780000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i25e12db65ee14bebb0cc5ab9db2dea3a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RhYmxlOjg1ZTdiNmE5OTUxMTQzN2NiZTI3Yzg5MGIxMDBkM2IwL3RhYmxlcmFuZ2U6ODVlN2I2YTk5NTExNDM3Y2JlMjdjODkwYjEwMGQzYjBfMS0zLTEtMS0w_042f6e67-35ab-4507-bd09-1da8acb8b22e"
      unitRef="usd">495280000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i9fce823aabcc4d3d949530fe19c30792_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RhYmxlOjg1ZTdiNmE5OTUxMTQzN2NiZTI3Yzg5MGIxMDBkM2IwL3RhYmxlcmFuZ2U6ODVlN2I2YTk5NTExNDM3Y2JlMjdjODkwYjEwMGQzYjBfMi0xLTEtMS0w_25da41f8-d158-4146-85a4-acc7cf3c5101"
      unitRef="usd">38467000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i25e12db65ee14bebb0cc5ab9db2dea3a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RhYmxlOjg1ZTdiNmE5OTUxMTQzN2NiZTI3Yzg5MGIxMDBkM2IwL3RhYmxlcmFuZ2U6ODVlN2I2YTk5NTExNDM3Y2JlMjdjODkwYjEwMGQzYjBfMi0zLTEtMS0w_2028844d-0542-44e4-877c-4120f05dec8f"
      unitRef="usd">52987000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermNotesPayable
      contextRef="i9fce823aabcc4d3d949530fe19c30792_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RhYmxlOjg1ZTdiNmE5OTUxMTQzN2NiZTI3Yzg5MGIxMDBkM2IwL3RhYmxlcmFuZ2U6ODVlN2I2YTk5NTExNDM3Y2JlMjdjODkwYjEwMGQzYjBfMy0xLTEtMS0w_078b4f94-8675-4ab2-b425-93184a50e877"
      unitRef="usd">352313000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="i25e12db65ee14bebb0cc5ab9db2dea3a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RhYmxlOjg1ZTdiNmE5OTUxMTQzN2NiZTI3Yzg5MGIxMDBkM2IwL3RhYmxlcmFuZ2U6ODVlN2I2YTk5NTExNDM3Y2JlMjdjODkwYjEwMGQzYjBfMy0zLTEtMS0w_dce876fb-c02a-4598-99e2-583548dabe1d"
      unitRef="usd">442293000</us-gaap:LongTermNotesPayable>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="i9fce823aabcc4d3d949530fe19c30792_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RhYmxlOjg1ZTdiNmE5OTUxMTQzN2NiZTI3Yzg5MGIxMDBkM2IwL3RhYmxlcmFuZ2U6ODVlN2I2YTk5NTExNDM3Y2JlMjdjODkwYjEwMGQzYjBfNS0xLTEtMS0w_8037721b-34d7-4170-b118-b7b04b323d0d"
      unitRef="usd">35135000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="i25e12db65ee14bebb0cc5ab9db2dea3a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RhYmxlOjg1ZTdiNmE5OTUxMTQzN2NiZTI3Yzg5MGIxMDBkM2IwL3RhYmxlcmFuZ2U6ODVlN2I2YTk5NTExNDM3Y2JlMjdjODkwYjEwMGQzYjBfNS0zLTEtMS0w_09563713-e4ae-4429-9568-eb066e6513e2"
      unitRef="usd">48397000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i9fce823aabcc4d3d949530fe19c30792_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RhYmxlOjg1ZTdiNmE5OTUxMTQzN2NiZTI3Yzg5MGIxMDBkM2IwL3RhYmxlcmFuZ2U6ODVlN2I2YTk5NTExNDM3Y2JlMjdjODkwYjEwMGQzYjBfNi0xLTEtMS0w_ee7a4405-dc28-478b-805f-0f9cabfcaa33"
      unitRef="usd">404477000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i25e12db65ee14bebb0cc5ab9db2dea3a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80My9mcmFnOjM3ZDdiYTRlMTQxNDQzZTFiYTBiYTA5Nzg4MjFlMDhjL3RhYmxlOjg1ZTdiNmE5OTUxMTQzN2NiZTI3Yzg5MGIxMDBkM2IwL3RhYmxlcmFuZ2U6ODVlN2I2YTk5NTExNDM3Y2JlMjdjODkwYjEwMGQzYjBfNi0zLTEtMS0w_de73142b-adba-4c81-b214-a05c60e2d245"
      unitRef="usd">466053000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80OS9mcmFnOjI1NTEzMWQ3YWRlYzQyYWNhMWUyM2M2MDE4MWU2NjQxL3RleHRyZWdpb246MjU1MTMxZDdhZGVjNDJhY2ExZTIzYzYwMTgxZTY2NDFfMTAzOQ_e0c0a46b-b3a5-4620-8b31-da18362e071a">Income TaxOur effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in various state jurisdictions with different statutory rates, benefits related to tax credits, and the tax impact of non-deductible expenses, stock award activities and other permanent differences between income before income taxes and taxable income. The effective tax rate for the three months ended March&#160;31, 2021 and 2020 was (214.1)% and 20.7%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three months ended March&#160;31, 2021 was significantly impacted by discrete tax benefits related to net excess tax windfalls from share-based compensation resulting from increased stock option exercise activity, stock award vesting and appreciation of our stock price during the period.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80OS9mcmFnOjI1NTEzMWQ3YWRlYzQyYWNhMWUyM2M2MDE4MWU2NjQxL3RleHRyZWdpb246MjU1MTMxZDdhZGVjNDJhY2ExZTIzYzYwMTgxZTY2NDFfNDI5_ac781156-e365-4057-8345-69f0c5bbfee1"
      unitRef="number">-2.141</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i119a000c978f4b048a77543cbb616f54_D20200101-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF80OS9mcmFnOjI1NTEzMWQ3YWRlYzQyYWNhMWUyM2M2MDE4MWU2NjQxL3RleHRyZWdpb246MjU1MTMxZDdhZGVjNDJhY2ExZTIzYzYwMTgxZTY2NDFfNDM5ODA0NjUxMjE1NQ_a91109ba-b4a2-4ec3-a4e8-0184acca9177"
      unitRef="number">0.207</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RleHRyZWdpb246NDU1MzQzZDRhNTc0NGIxMzg0MDU1NzhmN2RmMzRjOGFfMTcxMw_4b8ac1d8-965e-41b9-a8ea-527ba14af223">Stockholders&#x2019; Equity&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We grant options and awards to employees and non-employee directors pursuant to a stockholder approved stock incentive plan, which is described in further detail in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 9, Stockholders&#x2019; Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, of the Notes to Consolidated Financial Statements in our 2020 Annual Report.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our stock option and restricted stock activity and related information:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,561,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;206,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;265,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;172.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;173.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Options exercised/RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(522,172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(88,959)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58,862)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,024)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,246,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;265,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021, outstanding options to purchase 1.2 million shares were exercisable with a weighted average exercise price per share of $89.20.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The price at which common stock is purchased under the Amended Employee Stock Purchase Plan, or ESPP, is equal to 85% of the fair market value of the common stock on the first or last day of the offering period, whichever is lower. As of March&#160;31, 2021, 52,808 shares were available for future purchases under the ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We did not have any share repurchases during the first quarter of 2021.&lt;/span&gt;&lt;/div&gt;On September 11, 2019, our Board of Directors approved a stock repurchase program authorizing, but not obligating, the repurchase of up to $500.0 million of our common stock from time to time over the next three years. We expect to acquire shares primarily through open-market transactions and may enter into Rule 10b5-1 trading plans, to facilitate open-market repurchases. The timing and amount of repurchase transactions will be determined by management based on our evaluation of market conditions, share price, legal requirements and other factors. Authorization to repurchase $248.8 million of our common stock remained available as of March&#160;31, 2021.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RleHRyZWdpb246NDU1MzQzZDRhNTc0NGIxMzg0MDU1NzhmN2RmMzRjOGFfMTcwOQ_ca9c6d16-242c-4774-9e13-a616020c5d1c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our stock option and restricted stock activity and related information:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,561,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;206,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;265,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;172.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;173.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Options exercised/RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(522,172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(88,959)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58,862)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,024)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,246,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;265,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RleHRyZWdpb246NDU1MzQzZDRhNTc0NGIxMzg0MDU1NzhmN2RmMzRjOGFfMTcxNA_429e3359-7257-4b14-ae18-b1d8182480f8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our stock option and restricted stock activity and related information:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,561,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;206,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;265,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;172.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;173.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Options exercised/RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(522,172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(88,959)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58,862)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,024)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,246,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;265,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="if492415c8fb84dc28c02e844ba8b7ba7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfMi0xLTEtMS0w_174aac1a-d5b9-4631-93a2-8c7cd68e11b5"
      unitRef="shares">2561822</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="if492415c8fb84dc28c02e844ba8b7ba7_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfMi0zLTEtMS0w_5eabd05e-9cf5-41aa-81a9-f2ac5bea7aba"
      unitRef="usdPerShare">85.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i05243f1221bc4fd7befab87ff60f8de9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfMi01LTEtMS0w_33509ba5-bbd4-41ff-b8f1-10e9f5c4c3c0"
      unitRef="shares">206202</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i05243f1221bc4fd7befab87ff60f8de9_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfMi03LTEtMS0w_7407a42d-aceb-4d60-904b-4cf0246cbb47"
      unitRef="usdPerShare">106.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i0057dd0957054317972b57951cde9e14_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfMy0xLTEtMS0w_20ebcb38-4bf2-46a1-98b2-29ccc45449a8"
      unitRef="shares">265529</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i0057dd0957054317972b57951cde9e14_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfMy0zLTEtMS0w_7266d2b0-b42e-4431-8fdb-37307f237ead"
      unitRef="usdPerShare">172.39</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="if96bbf53f57741718a23af11bbf99850_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfMy01LTEtMS0w_6b33cfce-85d0-46e4-b704-e23196b29e77"
      unitRef="shares">153166</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="if96bbf53f57741718a23af11bbf99850_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfMy03LTEtMS0w_300c1553-b1b0-4c01-8e27-3e2275744898"
      unitRef="usdPerShare">173.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i0057dd0957054317972b57951cde9e14_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfNC0xLTEtMS0w_9260689e-962b-4e17-8ece-fddad8d1c26c"
      unitRef="shares">522172</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i0057dd0957054317972b57951cde9e14_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfNC0zLTEtMS0w_4f168751-ac0f-4452-8ed3-c0501e544463"
      unitRef="usdPerShare">51.98</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="if96bbf53f57741718a23af11bbf99850_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfNC01LTEtMS0w_9e88842b-484e-44be-a2c5-7b7df6c8e57b"
      unitRef="shares">88959</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="if96bbf53f57741718a23af11bbf99850_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfNC03LTEtMS0w_05c1b016-72ac-4680-9bc5-928dfec56fd1"
      unitRef="usdPerShare">127.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i0057dd0957054317972b57951cde9e14_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfNS0xLTEtMS0w_a0be69a4-2df9-49d8-98bd-8f001a4d1b61"
      unitRef="shares">58862</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i0057dd0957054317972b57951cde9e14_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfNS0zLTEtMS0w_66b11e95-f359-42a3-96fb-a803ebaffee1"
      unitRef="usdPerShare">101.77</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="if96bbf53f57741718a23af11bbf99850_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfNS01LTEtMS0w_ce2c5607-f27a-455e-be5e-45e625b3804a"
      unitRef="shares">5024</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="if96bbf53f57741718a23af11bbf99850_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfNS03LTEtMS0w_b525383c-ad89-4918-a240-2ee5d88d1ba4"
      unitRef="usdPerShare">110.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i877eaef323064694bf3b6b4356d4f3fd_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfNi0xLTEtMS0w_5089f16f-0046-4e32-a725-ff4e2c6e757f"
      unitRef="shares">2246317</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i877eaef323064694bf3b6b4356d4f3fd_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfNi0zLTEtMS0w_e896c49d-876d-423e-b36d-2c097c6b998c"
      unitRef="usdPerShare">103.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="idaf759347d8c465a8cb4d42f49d35918_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfNi01LTEtMS0w_4259bffe-1454-4c5a-a5cb-3664756d48e5"
      unitRef="shares">265385</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="idaf759347d8c465a8cb4d42f49d35918_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RhYmxlOmQxZjdkNjVlYmUyNzRhOTU5YjQxMTExOGQ3Y2FkYzZkL3RhYmxlcmFuZ2U6ZDFmN2Q2NWViZTI3NGE5NTliNDExMTE4ZDdjYWRjNmRfNi03LTEtMS0w_28bdaf5f-4266-4e86-b5ef-a54e5682c76b"
      unitRef="usdPerShare">138.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RleHRyZWdpb246NDU1MzQzZDRhNTc0NGIxMzg0MDU1NzhmN2RmMzRjOGFfNDQ3_81164564-f986-40dd-ab45-2442147a03ff"
      unitRef="shares">1200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RleHRyZWdpb246NDU1MzQzZDRhNTc0NGIxMzg0MDU1NzhmN2RmMzRjOGFfNTI2_4867978b-4f57-4b0e-b3e3-070d944dfdb5"
      unitRef="usdPerShare">89.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
      contextRef="i4e9d28d4cd3a4c1682fedb85842a9f81_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RleHRyZWdpb246NDU1MzQzZDRhNTc0NGIxMzg0MDU1NzhmN2RmMzRjOGFfNjc1_68652898-8374-4e1e-be6e-5ccde9208986"
      unitRef="number">0.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate>
    <us-gaap:EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod
      contextRef="i4e9d28d4cd3a4c1682fedb85842a9f81_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RleHRyZWdpb246NDU1MzQzZDRhNTc0NGIxMzg0MDU1NzhmN2RmMzRjOGFfODAy_bf625f62-af38-4720-ac77-f5b8a9d4536f"
      unitRef="shares">52808</us-gaap:EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RleHRyZWdpb246NDU1MzQzZDRhNTc0NGIxMzg0MDU1NzhmN2RmMzRjOGFfMTAxOQ_08da452d-f33b-4227-b7fe-11fc2b2277c7"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="iae8337fd239a4e7e99cf32e1f3b34254_I20190911"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RleHRyZWdpb246NDU1MzQzZDRhNTc0NGIxMzg0MDU1NzhmN2RmMzRjOGFfMTIzNQ_3273d5f7-62b7-475b-9671-916d14d6c764"
      unitRef="usd">500000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramPeriodInForce1
      contextRef="ic0da24b8c33848ccb099afc62ba164b1_D20190911-20190911"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RleHRyZWdpb246NDU1MzQzZDRhNTc0NGIxMzg0MDU1NzhmN2RmMzRjOGFfMTI5MA_92c7b6dd-828b-46b5-ada8-92c0bc793b99">P3Y</us-gaap:StockRepurchaseProgramPeriodInForce1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i20dcdca84df1452281e6d47bd0f24185_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81Mi9mcmFnOjQ1NTM0M2Q0YTU3NDRiMTM4NDA1NTc4ZjdkZjM0YzhhL3RleHRyZWdpb246NDU1MzQzZDRhNTc0NGIxMzg0MDU1NzhmN2RmMzRjOGFfMTY1Nw_fe7ddb60-d35b-4f69-96d5-ef028733cddd"
      unitRef="usd">248800000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81NS9mcmFnOmQ0MDU4NDhhOTg2OTQzYTFiNWJkYTM2MjQyODdmMmNiL3RleHRyZWdpb246ZDQwNTg0OGE5ODY5NDNhMWI1YmRhMzYyNDI4N2YyY2JfMzY5OA_54de1286-612a-4f1a-ad32-8628ed1c494d">Commitment and Contingencies: Legal Proceedings&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC 450,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Contingencies&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. As additional information becomes available, we assess the potential liability related to our pending litigation and revises our estimates. Revisions in our estimates of potential liability could materially impact our results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 9, 2019, CyDex, our wholly-owned subsidiary, received a Paragraph IV certification Notice Letter from Alembic Global Holdings SA (&#x201c;Alembic&#x201d;) stating that Alembic had submitted an ANDA to the FDA, seeking approval to manufacture, offer to sell, and sell a generic version of EVOMELA&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; prior to the expiration of any of the &#x2019;077 patent; the &#x2019;088 patent, the &#x2019;582 patent, or U.S. Patent No. 10,040,872 (&#x201c;the &#x2019;872 patent&#x201d;), and alleging that these patents, each of which relates to Captisol&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, are invalid, unenforceable, and/or would not be infringed by Alembic&#x2019;s ANDA product. On May 23, 2019, CyDex filed a complaint against Alembic, Alembic Pharmaceuticals, Ltd., and Alembic Pharmaceuticals, Inc. in the U.S. District Court for the District of Delaware, asserting that the filing of Alembic&#x2019;s ANDA constitutes infringement of each of the &#x2019;088 patent and the &#x2019;582 patent. On July 29, 2019, Alembic filed an answer and counterclaims seeking declarations of non-infringement and invalidity as to each of the asserted patents and, on August 19, 2019, CyDex filed an answer to Alembic&#x2019;s counterclaims. On April 7, 2020, the Court ordered that the Scheduling Order be amended such that, inter alia, the fact discovery cut off occurred on November 2, 2020, the close of expert discovery was set for March 22, 2021, and that May 17, 2021 would remain the first day of a five-to-six-day bench trial.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 2, 2020, the District Court issued an order construing the disputed issues of claim construction, adopting the claim construction positions urged by CyDex. On January 13, 2021, the District Court entered an order noting that the parties were engaged in ongoing settlement efforts, and ordering that (i) all deadlines in the litigation be stayed, and (ii) the parties submit a joint status report within 30 days. In early February, and again in early March, the parties submitted status reports stating that they have made substantial progress toward finalizing an agreement. All deadlines are presently stayed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 16, 2019, CyDex received a Paragraph IV certification Notice Letter from Lupin Ltd. (&#x201c;Lupin&#x201d;) stating that Lupin had submitted an ANDA to the FDA, seeking approval to manufacture, offer to sell, and sell a generic version of EVOMELA&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; prior to the expiration of any of the &#x2019;077 patent; the &#x2019;088 patent, the &#x2019;582 patent, or the &#x2019;872 patent, and alleging that these patents, each of which relates to Captisol&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, are invalid, unenforceable, and/or would not be infringed by Lupin&#x2019;s ANDA product. CyDex filed a complaint on October 29, 2019, alleging patent infringement against Lupin. Lupin filed an answer on December 11, 2019 and counterclaimed for declaratory judgments of invalidity and non-infringement as to all four patents and CyDex filed its answer to Lupin&#x2019;s counterclaims on January 2, 2020. The parties entered into a settlement agreement on April 26, 2021 and the lawsuit has been dismissed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 31, 2019, we received three civil complaints filed in the US District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation (&#x201c;JPML&#x201d;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#x201c;MDL&#x201d;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;defendants other than the company and no individualized factual allegations have been advanced against us in any of the three complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May and August of 2019, Pfenex Inc., which was acquired by us in October 2020, filed three petitions (IPR2019- 01027, IPR2019-01028 and IPR2019-01478) for inter partes review of U.S. Patent No. 9,422,345 (&#x201c;the &#x2018;345 patent,&#x201d; entitled &#x201c;Expression System&#x201d;), which is owned by GlaxoSmithKline Biologicals S.A. (&#x201c;GSK&#x201d;) , with the Patent Trial and Appeal Board (&#x201c;PTAB&#x201d;) of the U.S. Patent and Trademark Office. In November 2019 and February 2020, the Board instituted trial on invalidity grounds in IPR2019-01028, but exercised its discretion not to institute trial on IPR2019-01027 or IPR2019-01478. In May 2020, GSK filed two petitions (IPR2020-00890 and IPR2020-00962) for inter partes review of U.S. Patent No. 8,530,171 (&#x201c;the &#x2018;171 patent,&#x201d; entitled &#x201c;High Level Expression of Recombinant Toxin Proteins&#x201d;), which is owned by Pfenex, with the PTAB of the U.S. Patent and Trademark Office. On June 29, 2020, GSK filed a motion to withdraw IPR2020-00890, which was granted on August 28, 2020. In October 2020, Pfenex and GSK executed a confidential settlement agreement agreeing to terminate the proceedings before the PTAB resolving these issues. Pfenex and GSK filed a joint motion to terminate IPR2019-01028 and IPR2020-00962 on October 30, 2020, and an amended joint motion to terminate on November 4, 2020. A decision granting the parties&#x2019; joint motion to terminate in IPR2019-01028 was issued on November 12, 2020. The PTAB subsequently granted the parties&#x2019; joint motion to terminate in IPR2020-00962 on December 30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 12, 2021, Abvivo submitted a JAMS arbitration demand naming the Company as respondent. Abvivo claims that the Company is in violation of the assignment provision of that certain Commercial Platform License and Services Agreement (&#x201c;CPLSA&#x201d;), dated October 9, 2019, by and among OMT and Crystal, on the one hand, and Abvivo, on the other hand because the Company allegedly withheld its consent to a proposed assignment required for Abvivo to negotiate a discovery and development alliance with certain third parties. On January 26, 2021, we submitted a response to the demand, denying all claims and alleging counterclaims against Abvivo and Brian Lundstrom, a Company employee and the sole owner of Abvivo. We allege that Mr. Lundstrom breached his fiduciary duty of loyalty to the Company and that Abvivo and Mr. Lundstrom fraudulently induced the Company, OMT and Crystal into certain business transactions and contracts. Abvivo and Mr. Lundstrom&#x2019;s response to these counterclaims was due on February 9, 2021, but they did not submit a response. Under JAMS rules, the counterclaims are deemed denied. On February 22, 2021, Abvivo submitted documents to JAMS which indicated that it seeks to dismiss its claim without prejudice, which we oppose. On February 25, 2021, we submitted additional counterclaims against Abvivo and Mr. Lundstrom.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These counterclaims allege that Abvivo and Mr. Lundstrom made false promises regarding the CPLSA, Abvivo&#x2019;s breach of and failure to perform under the CPLSA, and Abvivo&#x2019;s infringement of certain Ligand trademarks.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 11, 2021, Abvivo and Mr. Lundstrom submitted an answer to our amended counterclaims denying all of the claims and asserting various affirmative defenses.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The arbitration will be conducted by a three arbitrator panel, the members of which were appointed on March 30, 2021. We intend to vigorously defend ourselves against this action.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:GainContingencyPatentsAllegedlyInfringedUponNumber
      contextRef="i4829221eea044e2c99470e6c93d2698c_D20191029-20191029"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81NS9mcmFnOmQ0MDU4NDhhOTg2OTQzYTFiNWJkYTM2MjQyODdmMmNiL3RleHRyZWdpb246ZDQwNTg0OGE5ODY5NDNhMWI1YmRhMzYyNDI4N2YyY2JfMjE5OTAyMzI3NDMyMQ_b2ff389c-3b2d-4818-8013-4230dd09d89d"
      unitRef="patent">4</us-gaap:GainContingencyPatentsAllegedlyInfringedUponNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="i9d01e2b13cbc4db1979d2caa61ff4664_D20191031-20191031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81NS9mcmFnOmQ0MDU4NDhhOTg2OTQzYTFiNWJkYTM2MjQyODdmMmNiL3RleHRyZWdpb246ZDQwNTg0OGE5ODY5NDNhMWI1YmRhMzYyNDI4N2YyY2JfMjE5OTAyMzI3NDMwMw_f625c23e-2279-42ba-b726-d97a633091d3"
      unitRef="civil_complaint">3</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="i9d01e2b13cbc4db1979d2caa61ff4664_D20191031-20191031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81NS9mcmFnOmQ0MDU4NDhhOTg2OTQzYTFiNWJkYTM2MjQyODdmMmNiL3RleHRyZWdpb246ZDQwNTg0OGE5ODY5NDNhMWI1YmRhMzYyNDI4N2YyY2JfMjE5OTAyMzI3NDMwOQ_495af632-8b78-492c-b3d1-0c2ac4ea886c"
      unitRef="civil_complaint">3</us-gaap:LossContingencyNewClaimsFiledNumber>
    <lgnd:NumberOfPetitionsFiled
      contextRef="ied61350f910e4604aaf85a72e7548d42_D20190501-20190831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81NS9mcmFnOmQ0MDU4NDhhOTg2OTQzYTFiNWJkYTM2MjQyODdmMmNiL3RleHRyZWdpb246ZDQwNTg0OGE5ODY5NDNhMWI1YmRhMzYyNDI4N2YyY2JfMjE5OTAyMzI3NDI4MA_402d3f3c-efcf-46d1-b108-da9618f45d54"
      unitRef="petition">3</lgnd:NumberOfPetitionsFiled>
    <lgnd:NumberOfPetitionsFiled
      contextRef="i903410136b034df7806df0765a803943_D20200501-20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4OTA1MTE2Yjc2MzQ2OTRiMjc5MTdlNmFjMmE5ZWY0L3NlYzozODkwNTExNmI3NjM0Njk0YjI3OTE3ZTZhYzJhOWVmNF81NS9mcmFnOmQ0MDU4NDhhOTg2OTQzYTFiNWJkYTM2MjQyODdmMmNiL3RleHRyZWdpb246ZDQwNTg0OGE5ODY5NDNhMWI1YmRhMzYyNDI4N2YyY2JfMjE5OTAyMzI3NDI5MA_1af9dbf7-56c7-4e8b-a2a3-b7bd837fe4d3"
      unitRef="petition">2</lgnd:NumberOfPetitionsFiled>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045581350744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>May 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIGAND PHARMACEUTICALS INCORPORATED<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0160744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3911 Sorrento Valley Boulevard,  Suite 110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">550-7500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LGND<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,652,080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000886163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045580682648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 31,853<span></span>
</td>
<td class="nump">$ 47,619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">307,354<span></span>
</td>
<td class="nump">363,567<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">54,436<span></span>
</td>
<td class="nump">56,847<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">36,932<span></span>
</td>
<td class="nump">26,487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="nump">1,145<span></span>
</td>
<td class="nump">2,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">5,708<span></span>
</td>
<td class="nump">3,822<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">437,428<span></span>
</td>
<td class="nump">500,559<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes, net</a></td>
<td class="nump">27,432<span></span>
</td>
<td class="nump">24,320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">583,785<span></span>
</td>
<td class="nump">595,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">190,515<span></span>
</td>
<td class="nump">189,662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseRights', window );">Commercial license and other economic rights, net</a></td>
<td class="nump">10,451<span></span>
</td>
<td class="nump">10,979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">16,896<span></span>
</td>
<td class="nump">14,434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">7,611<span></span>
</td>
<td class="nump">6,892<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Financing lease right-of-use assets</a></td>
<td class="nump">17,950<span></span>
</td>
<td class="nump">15,842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">3,053<span></span>
</td>
<td class="nump">4,267<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,295,121<span></span>
</td>
<td class="nump">1,362,285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">9,469<span></span>
</td>
<td class="nump">3,784<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">12,110<span></span>
</td>
<td class="nump">18,530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CurrentPortionOfLiabilityForContingentValueRights', window );">Current contingent liabilities</a></td>
<td class="nump">41,509<span></span>
</td>
<td class="nump">39,884<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">25,107<span></span>
</td>
<td class="nump">29,435<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">2,173<span></span>
</td>
<td class="nump">1,885<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current financing lease liabilities</a></td>
<td class="nump">5,437<span></span>
</td>
<td class="nump">6,593<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">95,805<span></span>
</td>
<td class="nump">100,111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">2023 convertible senior notes, net</a></td>
<td class="nump">352,313<span></span>
</td>
<td class="nump">442,293<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_LiabilityForContingentValueRights', window );">Long-term contingent liabilities</a></td>
<td class="nump">9,548<span></span>
</td>
<td class="nump">9,249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes, net</a></td>
<td class="nump">56,812<span></span>
</td>
<td class="nump">64,598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">6,081<span></span>
</td>
<td class="nump">5,643<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">28,722<span></span>
</td>
<td class="nump">30,866<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">549,281<span></span>
</td>
<td class="nump">652,760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at March&#160;31, 2021 and December&#160;31, 2020</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; 60,000 shares authorized; 16,652 and 16,080 shares issued and outstanding at March&#160;31, 2021 and December&#160;31, 2020, respectively</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">336,621<span></span>
</td>
<td class="nump">318,358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(856)<span></span>
</td>
<td class="num">(801)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">410,058<span></span>
</td>
<td class="nump">391,952<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">745,840<span></span>
</td>
<td class="nump">709,525<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 1,295,121<span></span>
</td>
<td class="nump">$ 1,362,285<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CurrentPortionOfLiabilityForContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CurrentPortionOfLiabilityForContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LiabilityForContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LiabilityForContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045582030472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock authorized (shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock issued (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock outstanding (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock authorized (shares)</a></td>
<td class="nump">60,000,000<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued (shares)</a></td>
<td class="nump">16,652,000<span></span>
</td>
<td class="nump">16,080,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (shares)</a></td>
<td class="nump">16,652,000<span></span>
</td>
<td class="nump">16,080,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045581254152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (Unaudited) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 55,150<span></span>
</td>
<td class="nump">$ 33,161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Operating costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostDirectMaterial', window );">Cost of Captisol</a></td>
<td class="nump">8,153<span></span>
</td>
<td class="nump">4,683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization of intangibles</a></td>
<td class="nump">11,786<span></span>
</td>
<td class="nump">3,535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">17,879<span></span>
</td>
<td class="nump">11,891<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">12,617<span></span>
</td>
<td class="nump">9,264<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Total operating costs and expenses</a></td>
<td class="nump">50,435<span></span>
</td>
<td class="nump">29,373<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">4,715<span></span>
</td>
<td class="nump">3,788<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Gain (loss) from short-term investments</a></td>
<td class="nump">13,061<span></span>
</td>
<td class="num">(30,741)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">296<span></span>
</td>
<td class="nump">4,730<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(5,831)<span></span>
</td>
<td class="num">(8,548)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">(6,477)<span></span>
</td>
<td class="nump">356<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (loss), net</a></td>
<td class="nump">1,049<span></span>
</td>
<td class="num">(34,203)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes</a></td>
<td class="nump">5,764<span></span>
</td>
<td class="num">(30,415)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="nump">12,342<span></span>
</td>
<td class="nump">6,284<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 18,106<span></span>
</td>
<td class="num">$ (24,131)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings Per Share, Basic and Diluted:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per share (USD per share)</a></td>
<td class="nump">$ 1.10<span></span>
</td>
<td class="num">$ (1.46)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in basic per share calculations (shares)</a></td>
<td class="nump">16,435<span></span>
</td>
<td class="nump">16,529<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per share (USD per share)</a></td>
<td class="nump">$ 1.05<span></span>
</td>
<td class="num">$ (1.46)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in diluted per share calculations (shares)</a></td>
<td class="nump">17,248<span></span>
</td>
<td class="nump">16,529<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 7,112<span></span>
</td>
<td class="nump">$ 6,565<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember', window );">Captisol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">31,272<span></span>
</td>
<td class="nump">21,109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember', window );">Contract revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 16,766<span></span>
</td>
<td class="nump">$ 5,487<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostDirectMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of material used for good produced and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostDirectMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045579201560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss):</a></td>
<td class="nump">$ 18,106<span></span>
</td>
<td class="num">$ (24,131)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized net loss on available-for-sale securities, net of tax</a></td>
<td class="num">(55)<span></span>
</td>
<td class="num">(2,772)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,879)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="nump">$ 18,051<span></span>
</td>
<td class="num">$ (28,782)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045581890968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Adjustment</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional paid in capital</div></th>
<th class="th"><div>Accumulated other comprehensive loss</div></th>
<th class="th"><div>Retained earnings (Accumulated deficit)</div></th>
<th class="th">
<div>Retained earnings (Accumulated deficit) </div>
<div>Adjustment</div>
</th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at beginning of period (shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,823,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2019</a></td>
<td class="nump">$ 767,232,000<span></span>
</td>
<td class="num">$ (5,167,000)<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">$ 367,326,000<span></span>
</td>
<td class="num">$ (216,000)<span></span>
</td>
<td class="nump">$ 400,105,000<span></span>
</td>
<td class="num">$ (5,167,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net</a></td>
<td class="num">(1,008,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,008,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">5,653,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,653,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(878,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(73,287,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,000)<span></span>
</td>
<td class="num">(73,286,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(2,772,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,772,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment', window );">Foreign currency translation adjustment</a></td>
<td class="num">(1,879,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,879,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Reacquisition of equity due to 2023 debt extinguishment, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,745,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Reacquisition of equity due to 2023 debt extinguishment, net of tax</a></td>
<td class="num">(2,745,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(24,131,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,131,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Mar. 31, 2020</a></td>
<td class="nump">661,896,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">295,940,000<span></span>
</td>
<td class="num">(4,867,000)<span></span>
</td>
<td class="nump">370,807,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at beginning of period (shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,080,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="nump">709,525,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">318,358,000<span></span>
</td>
<td class="num">(801,000)<span></span>
</td>
<td class="nump">391,952,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">572,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net</a></td>
<td class="nump">20,581,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">20,580,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">8,405,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,405,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(55,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Reacquisition of equity due to 2023 debt extinguishment, net of tax</a></td>
<td class="num">(9,086,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,086,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions', window );">Warrant and bond hedge unwind transactions</a></td>
<td class="nump">396,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">396,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions', window );">Tax effect for 2023 Notes transactions</a></td>
<td class="num">(2,032,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,032,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">18,106,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,106,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,652,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Mar. 31, 2021</a></td>
<td class="nump">$ 745,840,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">$ 336,621,000<span></span>
</td>
<td class="num">$ (856,000)<span></span>
</td>
<td class="nump">$ 410,058,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Foreign Currency Translation Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Tax Effect of Convertible Senior Notes Transactions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=51819886&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045580868552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 18,106<span></span>
</td>
<td class="num">$ (24,131)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights', window );">Change in estimated fair value of contingent liabilities</a></td>
<td class="nump">1,684<span></span>
</td>
<td class="num">(372)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization of intangible assets</a></td>
<td class="nump">12,565<span></span>
</td>
<td class="nump">3,422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of premium (discount) on investments, net</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance fees</a></td>
<td class="nump">4,916<span></span>
</td>
<td class="nump">7,203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AmortizationOfOtherEconomicRights', window );">Amortization of commercial license and other economic rights</a></td>
<td class="nump">528<span></span>
</td>
<td class="nump">2,958<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss (gain) on debt extinguishment</a></td>
<td class="nump">4,840<span></span>
</td>
<td class="num">(659)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">8,405<span></span>
</td>
<td class="nump">5,653<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred income taxes</a></td>
<td class="num">(12,408)<span></span>
</td>
<td class="num">(10,419)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_GainLossOnShortTermInvestments', window );">Loss (gain) from short-term investments</a></td>
<td class="num">(13,090)<span></span>
</td>
<td class="nump">25,456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="nump">238<span></span>
</td>
<td class="nump">5,668<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="nump">2,411<span></span>
</td>
<td class="num">(8,398)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(9,670)<span></span>
</td>
<td class="nump">1,251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">470<span></span>
</td>
<td class="nump">2,114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax receivable and payable</a></td>
<td class="nump">1,072<span></span>
</td>
<td class="nump">4,081<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(5,695)<span></span>
</td>
<td class="nump">2,215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other</a></td>
<td class="num">(3,768)<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">10,754<span></span>
</td>
<td class="nump">16,922<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchase of short-term investments</a></td>
<td class="num">(72,148)<span></span>
</td>
<td class="num">(167,374)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Proceeds from sale of short-term investments</a></td>
<td class="nump">109,407<span></span>
</td>
<td class="nump">179,431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments', window );">Proceeds from maturity of short-term investments</a></td>
<td class="nump">31,500<span></span>
</td>
<td class="nump">297,005<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="num">(3,644)<span></span>
</td>
<td class="num">(526)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">65,115<span></span>
</td>
<td class="nump">308,536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repurchase of 2023 Notes</a></td>
<td class="num">(108,822)<span></span>
</td>
<td class="num">(203,210)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Payments under financing lease obligations</a></td>
<td class="num">(3,801)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromHedgeFinancingActivities', window );">Proceeds from convertible bond hedge settlement</a></td>
<td class="nump">16,855<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForHedgeFinancingActivities', window );">Payments to convertible bond holders for warrant purchases</a></td>
<td class="num">(16,459)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Net proceeds from stock option exercises and ESPP</a></td>
<td class="nump">26,493<span></span>
</td>
<td class="nump">421<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="num">(5,901)<span></span>
</td>
<td class="num">(1,429)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Share repurchase</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(73,287)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity', window );">Payments to CVR Holders</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,800)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(91,635)<span></span>
</td>
<td class="num">(279,305)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(169)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="num">(15,766)<span></span>
</td>
<td class="nump">45,984<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">47,963<span></span>
</td>
<td class="nump">72,273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">32,197<span></span>
</td>
<td class="nump">118,257<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">241<span></span>
</td>
<td class="nump">597<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash in other current assets</a></td>
<td class="nump">344<span></span>
</td>
<td class="nump">730<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental schedule of non-cash activity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accrued fixed asset purchases</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AccruedInventoryPurchases', window );">Accrued inventory purchases</a></td>
<td class="nump">775<span></span>
</td>
<td class="nump">1,445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized loss on AFS investments</a></td>
<td class="num">$ (55)<span></span>
</td>
<td class="num">$ (3,541)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedInventoryPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Inventory Purchases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedInventoryPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AmortizationOfOtherEconomicRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization of Other Economic Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AmortizationOfOtherEconomicRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_GainLossOnShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Short-term Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_GainLossOnShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Contingent Value Right Holders, Financing Activity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToContingentValueRightHoldersFinancingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForHedgeFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3581-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForHedgeFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromHedgeFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3581-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromHedgeFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045577704104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text">Basis of Presentation and Summary of Significant Accounting Policies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2020 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, &#8220;contract revenue&#8221; and &#8220;service revenue&#8221; presented in the condensed consolidated statement of operations for the three months ended March 31, 2020 have been combined into &#8220;contract revenue&#8221; in the condensed consolidated statement of operations to conform with the current period presentation. &#160;In addition, &#8220;gain (loss) from Viking&#8221; and a portion of &#160;&#8220;other expense, net&#8221; that related to other short-term investments presented in the condensed consolidated statement of operations for the three months ended March 31, 2020 have been combined into &#8220;gain (loss) from short-term investments&#8221; in the condensed consolidated statement of operations to conform with the current period presentation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have described our significant accounting policies in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements in our 2020 Annual Report. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of COVID-19 Pandemic</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current COVID-19 worldwide pandemic has presented substantial public health and economic challenges and is affecting our employees and partners, patients, communities and business operations, as well as the U.S. and global economy and financial markets. International and U.S. governmental authorities in impacted regions have taken actions in an effort to slow the spread of COVID-19, including issuing varying forms of &#8220;stay-at-home&#8221; orders, and restricting business functions outside of one&#8217;s home. In response, we have restricted in-person access to our executive offices, our administrative employees are mostly working remotely, and we have limited the number of staff in our research and development laboratories and other facilities. The continued spread of the COVID-19 pandemic and the measures taken by the governments of countries have affected, and could continue to affect, our business and the business of our partners, including future disruptions to our supply chain and the manufacture or shipment of drug substance and finished drug product for Captisol, delays by us or our partners in the initiation or enrollment of patients in clinical trials, discontinuations by patients enrolled in clinical trials, difficulties launching or commercializing products and other related activities, which could delay ongoing clinical trials, increase development costs, reduce royalty revenues and have a material adverse effect on our business, financial condition and results of operations. Several of our partners have reported that their operations have been impacted including delays in research and development programs and deprioritizing clinical trials in favor of treating patients who have contracted the virus or to prevent the spread of the virus. This may lead to clinical trial protocol deviations or to discontinuation of treatment for patients who are currently enrolled in the clinical trials being conducted by us or our partners. In addition, certain of our partners have reported negative impacts on product sales which will impact our royalty revenues.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our partners are working to develop drugs to treat COVID-19. For example, we are supplying Captisol to partners, including Gilead for Veklury (remdesivir), the first FDA-approved treatment for COVID-19 for the treatment of patients with COVID-19 requiring hospitalization. In addition, certain of our OmniAb partners have initiated antibody discovery programs for the potential treatment of COVID-19.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The full extent to which the COVID-19 pandemic will directly or indirectly impact our business, the businesses of our partners, our results of operations and our financial condition will depend on future developments that are highly uncertain and cannot be accurately predicted, including new information that may emerge concerning COVID-19, the actions taken to contain it or treat its impact, including the timing and extent of governments reopening or further restricting activities, and the economic impact on local, regional, national and international markets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The new guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP. This standard removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. This standard is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020 and adoption must be as of the beginning of the Company&#8217;s annual fiscal year. We are currently evaluating the impact of this standard on our consolidated financial statements and related disclosures. We intend to adopt this standard on January 1, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on our condensed consolidated financial statements or disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Royalties </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we own. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a sales-based royalty to be recorded when the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues are adjusted for in the period in which they become known, typically the following quarter. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Contract Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contract revenue includes service revenue, license fees and future contingent milestone based payments. We recognize service revenue for contracted R&amp;D services performed for our customers over time. We measure our progress using an input method based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time we estimate it will take us to complete the activities, or costs we incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make estimates and use judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We include contingent milestone based payments in the estimated transaction price when there is a basis to reasonably estimate the amount of the payment.  These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the&#160;transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon or after the development milestone or regulatory approval.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Captisol Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue when control of Captisol material is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. We have elected to recognize the cost for freight and shipping when or after control over Captisol material has transferred to the customer as an expense in cost of Captisol. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. We use an observable price to determine the stand-alone selling price for separate performance obligations or a cost plus margin approach when one is not available. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry a contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue. During the three months ended March&#160;31, 2021, the amount recognized as revenue that was deferred at December 31, 2020 was $7.3 million. During the three months ended March&#160;31, 2020, the amount recognized as revenue that was deferred at December 31, 2019 was $1.0 million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation&#160;of&#160;Revenue </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:61.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,565&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service Revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,043&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Milestone</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,766&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,487&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,161&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Investments </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term investments consist of the following at March&#160;31, 2021 and December 31, 2020 (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.368%"><tr><td style="width:1.0%"/><td style="width:21.722%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.410%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.509%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.359%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.909%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.359%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.509%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.659%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,388)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Treasury bill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257,687&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,317&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">262,988&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">324,567&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,391)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">324,478&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307,354&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">363,567&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2021, we sold 0.3&#160;million shares of Viking and recognized a realized gain of $2.2&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2021, we exercised all outstanding Viking warrants to purchase 1.5 million shares of Viking's common stock at an exercise price of $1.50 per share. As of March&#160;31, 2021, we have zero Viking warrants outstanding.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (loss) from short-term investments in our condensed consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allowances are recorded for available-for-sale debt securities with unrealized losses. This limits of the amount of credit losses that can be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The provisions of the credit losses standard did not have a material impact on our available-for-sale debt securities during the three months ended March&#160;31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,913&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,401&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,490&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment policy is capital preservation and we only invested in U.S.-dollar denominated investments. We held a total of 11 positions which were in an unrealized loss position as of March&#160;31, 2021. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, no credit losses were recognized for the three months ended March&#160;31, 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Credit Losses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers. During the three months ended March&#160;31, 2021, we considered the current and expected future economic and market conditions including, but not limited to, the anticipated unfavorable impacts of the surrounding novel coronavirus (COVID-19) pandemic on our business and recorded an adjustment of $0.02&#160;million of allowance for credit losses as of March&#160;31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Other Identifiable Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other identifiable intangible assets consist of the following (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">190,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189,662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">277,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">277,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67,441)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(63,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,345)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,312)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,597)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contractual relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,487)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,243)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">774,300&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">784,992&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial License and Other Economic Rights</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license and other economic rights consist of the following (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,530)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,166</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,588)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,108</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,317)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,285</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,731)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,871</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17,847)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,451</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17,319)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,979</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $11.9 million and credit loss adjustments of $6.0 million as of March&#160;31, 2021.</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $11.3 million and credit loss adjustments of $6.0 million as of December&#160;31, 2020.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commercial license and other economics rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis in April 2013 and April 2015, CorMatrix in May 2016, and Dianomi in January 2019. Commercial license rights acquired are accounted for as financial assets and other economic rights are accounted for as funded research and developments as further discussed below and in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 1,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Notes to Consolidated Financial Statements in our 2020 Annual Report. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In May 2017, we entered into a Royalty Agreement with Aziyo pursuant to which we will receive royalties from certain marketed products that Aziyo acquired from CorMatrix. We account for the Aziyo commercial license right as a financial asset, and in accordance with ASC 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Receivables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, we amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the Royalty Agreement with Aziyo as of March&#160;31, 2021 is 23%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The payments received during the three months ended March&#160;31, 2021 were accordingly allocated between revenue and the amortization of the commercial license rights.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to 2020, we accounted for commercial license rights related to developmental pipeline products such as Selexis and Dianomi on a non-accrual basis. Starting in 2020, given the expected cash flow from the Selexis program, we started to account for the Selexis commercial license right as a financial asset in accordance with ASC 310, and amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the royalty agreement with Selexis as of March&#160;31, 2021 is 21%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. The payments received during the three months ended March&#160;31, 2021 were accordingly allocated between revenue and the amortization of the commercial license rights. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We recorded a $5.5 million pre-tax reserve for credit losses upon adoption of the credit losses standard (ASU 2016-13) on January 1, 2020. We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the three months ended March&#160;31, 2021, we further considered the current and expected future economic and market conditions surrounding novel coronavirus (COVID-19) pandemic and concluded no further adjustment was needed on the allowance for credit losses as of March 31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accrued Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,347&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties owed to third parties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Return reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subcontractor</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,110&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,530&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period until the last tranche vests. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,397&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,405&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,653&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three-year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the applicable conversion price of the respective notes. It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 4, Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 6, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"><tr><td style="width:1.0%"/><td style="width:72.133%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.832%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.984%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,435&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,248&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,277&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,144&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045577514824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured on a Recurring Basis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.830%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, excluding Viking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">253,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">262,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">320,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">324,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,559&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">253,373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,422&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">307,354&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,527&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">320,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">363,567&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pfenex contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">xCella contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensor</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,182&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46,875&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51,130&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,312&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49,193&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.&#160;Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Investment in Viking warrants, which we received as a result of Viking&#8217;s partial repayment of the Viking note receivable and our purchase of Viking common stock and warrants in April 2016, are classified as level 1 as the fair value is determined using quoted market prices in active markets for the same securities. The change of the fair value is recorded in "Gain (loss) from short-term investments" in our condensed consolidated statement of operations. During the three months ended March&#160;31, 2021, we exercised all of the outstanding Viking warrants. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Crystal contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on development or regulatory milestones as defined in the merger agreement with Crystal. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Pfenex contingent liabilities was determined using a probability-adjusted income approach. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of the Company.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. Management concluded that no earnout liability would be recognized at the acquisition date in September 2020.  In the three months ended March&#160;31, 2021, management recorded an earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the level 3 financial instruments as of March&#160;31, 2021 is as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent liabilities from xCella asset acquisition</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of March 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46,875&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Measured on a Non-Recurring Basis</span></div><div style="text-indent:22pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets and long-lived assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.</span></div>There were no triggering events identified and no indication of impairment of our goodwill, indefinite-lived intangible assets, or long-lived assets during the three months ended March&#160;31, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045579650152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions</a></td>
<td class="text">Acquisitions<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Pfenex Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On October 1, 2020, we acquired Pfenex, which develops next-generation and novel protein therapeutics to improve existing therapies and create new therapies for biological targets linked to critical, unmet diseases using a protein expression technology platform.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preliminary purchase price of $465.1&#160;million included $429.6&#160;million cash consideration paid upon acquisition, and a contingent CVR payment of up to $77.8&#160;million in cash based on a certain specified milestone with an estimated initial fair value of $37.0&#160;million. The CVR will only be paid in full if the milestone is achieved by December&#160;31, 2021. The amount of the CVR included in the purchase price was reduced by $1.5&#160;million that was determined to be post-combination expense. The fair value of the CVR liability was determined using a probability-adjusted income approach. These cash flows were then discounted to present value using a discount rate based on market participants' cost of debt reflective of the Company, which was 7.1%. The liability is periodically assessed based on events and circumstances related to the underlying milestone, and any change in fair value is recorded in our consolidated statements of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the acquisition, a portion of Pfenex's equity awards that were outstanding and unvested prior to the acquisition became fully vested per the terms of the merger agreement. The acceleration of vesting required us to allocate the fair value of the equity attributable to pre-combination service to the purchase price and the remaining amount was considered our post-combination expense. We paid $17.3&#160;million in cash for equity compensation, which is attributable to pre-combination services and is reflected as a component of the total purchase price paid of $429.6&#160;million. In addition, the fair value of equity compensation attributable to the post-combination service period was $8.7&#160;million. These amounts were associated with the accelerated vesting of stock options previously granted to Pfenex employees and were fully paid in cash, which was recognized as general and administrative expenses during the fourth quarter of 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table sets forth an allocation of the preliminary purchase price to the identifiable tangible and intangible assets acquired and liabilities assumed, with the excess recorded to goodwill (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts and unbilled receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Right-of-use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangibles acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">385,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91,837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,814)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,455)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,908)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,070)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,382)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(53,296)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">465,109&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Goodwill represents the excess of the purchase price over the preliminary fair value of the underlying assets acquired and liabilities assumed. Goodwill is attributable to the assembled workforce of experienced personnel at Pfenex and expected synergies. None of the goodwill is expected to be deductible for tax purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Acquired intangibles include $362&#160;million of contractual relationships and $23&#160;million of core technology. The fair values of the contractual relationships were based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, collaboration and product revenue streams derived from the licensing of the related technologies over the estimated contractual relationship period. The fair value of the contractual relationships is being amortized on a straight-line basis over the weighted average estimated useful life of 12.9 years. The fair values of the acquired technologies were based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, collaboration and product revenue streams derived from the licensing of the related technologies over the estimated useful lives. These projected cash flows were discounted to present value using discount rate, which varies from 12% to 15%. The total acquired intangibles are being amortized on a straight-line basis over the weighted average estimated useful life of 13.0 years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The estimated fair values of assets acquired and liabilities assumed, including deferred tax assets and liabilities, and purchased intangibles are provisional. The accounting for these amounts falls within the measurement period and therefore we may adjust these provisional amounts to reflect new information obtained about facts and circumstances that existed as of the acquisition date.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following summary presents our unaudited pro forma consolidated results of operations for the quarter ended March 31, 2020 as if the Pfenex acquisition had occurred on January 1, 2020, which gives effect to certain transaction accounting adjustments, including amortization of acquired intangibles and share based compensation expense for retained Pfenex employees. The pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as of the date indicated, nor is it necessarily indicative of future operating results (in thousands, except per share amounts):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37,939)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net loss per common share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic and diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Taurus Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 9, 2020, we acquired Taurus, which discovers and develops novel antibodies from immunized cows and cow-derived libraries. The purchase price of $5.1 million included $4.6 million in cash, and a $0.5 million holdback to satisfy indemnification obligations which will be settled by September 2021.  We also issued nontransferable CVRs for up to $4.5 million tied to partnered and internal research and development and for up to $25.0 million as a 25% share of post-clinical Taurus product revenues (including milestone payments) received by us. We evaluated this acquisition in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, to discern whether the assets and operations of Taurus met the definition of a business. We concluded that substantially all of the fair value of the gross assets acquired is concentrated in the acquired core technology. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accordingly, we accounted for this transaction as an asset acquisition. Of the $5.1 million consideration transferred, we recognized (1) $0.05 million of tangible assets acquired, and (2) $5.0 million of core completed technology intangibles acquired. The core technology is being amortized on a straight-line basis over the estimated useful life of 10 years. We account for the CVRs in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, when the contingency is resolved and the liability becomes payable. None of the CVRs are recognized as of March&#160;31, 2021.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">xCella Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 8, 2020, we acquired xCella, an antibody discovery company. We paid $7.1 million in cash (including a $0.5 million holdback to satisfy indemnification obligations which will be settled by September 2021), and issued earnout rights for up to $5.0 million tied to our use of the xCella technology for partnered research and development and for up to $25.75 million as a 25% share of any future milestone payments we received under a certain existing xCella partner arrangement. We evaluated this acquisition in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, to discern whether the assets and operations of xCella met the definition of a business. We concluded that substantially all of the fair value of the gross assets acquired is concentrated in the acquired core technology. Accordingly, we accounted for this transaction as an asset acquisition. Of the $7.1 million consideration transferred, we recognized (1) $0.2 million of tangible assets acquired, (2) $(0.1) million of liabilities assumed, (3) $7.8 million of core completed technology acquired, and (4) $(0.8) million of deferred tax liability. The core technology is being amortized on a straight-line basis over the estimated useful life of 15 years. We account for the earnout rights in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, when the contingency is resolved and the liability becomes payable. None of the earnout rights are recognized as of the acquisition date. During the three months ended March&#160;31, 2021, we recognized $0.2 million in earnout rights when certain contingencies were resolved during the period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Icagen Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 1, 2020, we acquired the core assets, including its partnered programs and ion channel technology, from Icagen and certain of its affiliates. The acquisition was accounted for as a business combination and we applied the acquisition method of accounting. Accordingly, we recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the applicable date of acquisition. We did not incur any material acquisition-related costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The purchase price of $19.9 million included $15.1 million cash consideration paid upon acquisition, and a contingent earn-out payment of up to $25.0&#160;million of cash payments based on certain revenue milestones with an estimated fair value of $4.8 million. The fair value of the earn-out liability was determined using a probability weighted income approach incorporating the estimated future cash flows from expected future milestones. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of Icagen. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 2, Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, for further discussion. The liability will be periodically assessed based on events and circumstances related to the underlying milestones, and any change in fair value will be recorded in our consolidated statements of operations. The carrying amount of the liability may fluctuate significantly and actual amount paid may be materially different than the carrying amount of the liability. There was no change in the fair value of the contingent liabilities during the second quarter of 2020. As the acquisition is not considered significant, pro forma information has not been provided. The results of Icagen have been included in our results of operations since the date of acquisition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The allocation of the purchase price consisted of (1) $1.8 million of fair value of tangible assets acquired, (2) $(0.8) million of liabilities assumed, (3) $12.8 million of acquired intangibles, (4) $(3.7) million of deferred revenue in connection with assumed performance obligations under a collaboration agreement, (5) $0.8 million of deferred tax asset associated with the deferred revenue, and (6) $9.0 million of goodwill, the majority of which is deductible for tax purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Acquired intangibles include $11.1 million of customer relationships and $1.7 million of core technology. The fair values of the customer relationships were based on a discounted cash flow analysis incorporating the estimated future cash flows from these relationships during the contractual term. These cash flows were then discounted to present value using a discount rate of 17%. The fair value of the customer relationships is being amortized on a straight-line basis over the weighted average estimated useful life of 9.6 years. The fair value of the core technology was based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, and collaboration revenue streams derived from the licensing of the related technologies. These projected cash flows were discounted to present value using a discount rate of 17%. The fair value of the core technology is being amortized on a straight-line basis over the estimated useful life of 10 years. The total acquired intangibles are being amortized on a straight-line basis over the estimated useful life of 9.7 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045577579432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Convertible Senior Notes</a></td>
<td class="text">Convertible Senior Notes<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">0.75%&#160;Convertible&#160;Senior&#160;Notes&#160;due 2023</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued&#160;$750.0&#160;million&#160;aggregate principal amount of&#160;0.75%&#160;convertible&#160;senior&#160;notes. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $733.1 million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our election, based on an initial conversion rate, subject to adjustment, of&#160;4.0244&#160;shares per $1,000 principal amount of the 2023 Notes which represents an initial conversion price of approximately&#160;$248.48 per share.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes may convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances: </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least 20 trading days (whether or not consecutive) during the 30 consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day is greater than 130% of the conversion price on such trading day; </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) during the five business day period immediately following any 10 consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than 98% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the conversion price of $248.48. As of March&#160;31, 2021, the &#8220;if-converted value&#8221; did not exceed the principal amount of the 2023 Notes. In connection with the issuance of the 2023 Notes, we incurred $16.9 million of issuance costs, which primarily consisted of underwriting, legal and other professional fees. The portion of these costs allocated to the liability component totaling $13.7 million is amortized to interest expense using the effective interest method over the five year expected life of the 2023 Notes. It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, we repurchased $104.5&#160;million in principal of the 2023 Notes for $109.1&#160;million in cash, including accrued interest of $0.2&#160;million. We accounted for the repurchase as a debt extinguishment, which resulted in (1) a loss of $4.8&#160;million reflected in other income (expense), net, in our condensed consolidated statement of operations for the three months ended March&#160;31, 2021; (2) a $9.6 million reduction in debt discount, and (3) a $9.1&#160;million reduction to additional paid in capital, net of tax, related to the reacquisition of the equity component in our condensed consolidated balance sheet as of March&#160;31, 2021. After the repurchases, approximately $390.8&#160;million in principal amount of the 2023 Notes remain outstanding. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Bond Hedge and Warrant Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering 3,018,327 shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $248.48 per share and are exercisable when and if the 2023 Notes are converted. We paid $140.3 million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering approximately 3,018,327 shares of common stock with an exercise price of approximately $315.38 per share, subject to certain adjustments. We received $90.0 million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, in connection with the repurchases of $104.5&#160;million in principal of the 2023 Notes for $109.1&#160;million in cash, including accrued interest of $0.2&#160;million, during the quarter ended March 31, 2021, we entered into Warrant Early Unwind Agreements and Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We paid $16.5&#160;million as part of the Warrant Early Unwind Agreements reducing the number of shares covered by the warrants from 3,018,327 to 2,597,750. We received $16.9&#160;million as part of the Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to 645,500. These unwind transactions resulted in a $0.4&#160;million net increase in additional paid-in-capital in our condensed consolidated balance sheet as of March 31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the 2023 Notes (in thousands): </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.099%"><tr><td style="width:1.0%"/><td style="width:68.646%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.655%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Principal amount of the 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">390,780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38,467)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52,987)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total long-term portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">352,313&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">442,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying value of equity component of the 2023 Notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of the 2023 Notes outstanding (Level 2)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">404,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">466,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045579578776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax</a></td>
<td class="text">Income TaxOur effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in various state jurisdictions with different statutory rates, benefits related to tax credits, and the tax impact of non-deductible expenses, stock award activities and other permanent differences between income before income taxes and taxable income. The effective tax rate for the three months ended March&#160;31, 2021 and 2020 was (214.1)% and 20.7%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three months ended March&#160;31, 2021 was significantly impacted by discrete tax benefits related to net excess tax windfalls from share-based compensation resulting from increased stock option exercise activity, stock award vesting and appreciation of our stock price during the period.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045577506152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders&#8217; Equity<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grant options and awards to employees and non-employee directors pursuant to a stockholder approved stock incentive plan, which is described in further detail in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of the Notes to Consolidated Financial Statements in our 2020 Annual Report.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,561,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">265,529&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,166&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">173.32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(522,172)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(88,959)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58,862)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,024)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.91&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,246,317&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">265,385&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, outstanding options to purchase 1.2 million shares were exercisable with a weighted average exercise price per share of $89.20.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price at which common stock is purchased under the Amended Employee Stock Purchase Plan, or ESPP, is equal to 85% of the fair market value of the common stock on the first or last day of the offering period, whichever is lower. As of March&#160;31, 2021, 52,808 shares were available for future purchases under the ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not have any share repurchases during the first quarter of 2021.</span></div>On September 11, 2019, our Board of Directors approved a stock repurchase program authorizing, but not obligating, the repurchase of up to $500.0 million of our common stock from time to time over the next three years. We expect to acquire shares primarily through open-market transactions and may enter into Rule 10b5-1 trading plans, to facilitate open-market repurchases. The timing and amount of repurchase transactions will be determined by management based on our evaluation of market conditions, share price, legal requirements and other factors. Authorization to repurchase $248.8 million of our common stock remained available as of March&#160;31, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045579039800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies: Legal Proceedings<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitment and Contingencies: Legal Proceedings</a></td>
<td class="text">Commitment and Contingencies: Legal Proceedings<div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 450,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Contingencies</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As additional information becomes available, we assess the potential liability related to our pending litigation and revises our estimates. Revisions in our estimates of potential liability could materially impact our results of operations.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 9, 2019, CyDex, our wholly-owned subsidiary, received a Paragraph IV certification Notice Letter from Alembic Global Holdings SA (&#8220;Alembic&#8221;) stating that Alembic had submitted an ANDA to the FDA, seeking approval to manufacture, offer to sell, and sell a generic version of EVOMELA</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> prior to the expiration of any of the &#8217;077 patent; the &#8217;088 patent, the &#8217;582 patent, or U.S. Patent No. 10,040,872 (&#8220;the &#8217;872 patent&#8221;), and alleging that these patents, each of which relates to Captisol</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, are invalid, unenforceable, and/or would not be infringed by Alembic&#8217;s ANDA product. On May 23, 2019, CyDex filed a complaint against Alembic, Alembic Pharmaceuticals, Ltd., and Alembic Pharmaceuticals, Inc. in the U.S. District Court for the District of Delaware, asserting that the filing of Alembic&#8217;s ANDA constitutes infringement of each of the &#8217;088 patent and the &#8217;582 patent. On July 29, 2019, Alembic filed an answer and counterclaims seeking declarations of non-infringement and invalidity as to each of the asserted patents and, on August 19, 2019, CyDex filed an answer to Alembic&#8217;s counterclaims. On April 7, 2020, the Court ordered that the Scheduling Order be amended such that, inter alia, the fact discovery cut off occurred on November 2, 2020, the close of expert discovery was set for March 22, 2021, and that May 17, 2021 would remain the first day of a five-to-six-day bench trial.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 2, 2020, the District Court issued an order construing the disputed issues of claim construction, adopting the claim construction positions urged by CyDex. On January 13, 2021, the District Court entered an order noting that the parties were engaged in ongoing settlement efforts, and ordering that (i) all deadlines in the litigation be stayed, and (ii) the parties submit a joint status report within 30 days. In early February, and again in early March, the parties submitted status reports stating that they have made substantial progress toward finalizing an agreement. All deadlines are presently stayed.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 16, 2019, CyDex received a Paragraph IV certification Notice Letter from Lupin Ltd. (&#8220;Lupin&#8221;) stating that Lupin had submitted an ANDA to the FDA, seeking approval to manufacture, offer to sell, and sell a generic version of EVOMELA</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> prior to the expiration of any of the &#8217;077 patent; the &#8217;088 patent, the &#8217;582 patent, or the &#8217;872 patent, and alleging that these patents, each of which relates to Captisol</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, are invalid, unenforceable, and/or would not be infringed by Lupin&#8217;s ANDA product. CyDex filed a complaint on October 29, 2019, alleging patent infringement against Lupin. Lupin filed an answer on December 11, 2019 and counterclaimed for declaratory judgments of invalidity and non-infringement as to all four patents and CyDex filed its answer to Lupin&#8217;s counterclaims on January 2, 2020. The parties entered into a settlement agreement on April 26, 2021 and the lawsuit has been dismissed.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2019, we received three civil complaints filed in the US District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation (&#8220;JPML&#8221;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#8220;MDL&#8221;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of </span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">defendants other than the company and no individualized factual allegations have been advanced against us in any of the three complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May and August of 2019, Pfenex Inc., which was acquired by us in October 2020, filed three petitions (IPR2019- 01027, IPR2019-01028 and IPR2019-01478) for inter partes review of U.S. Patent No. 9,422,345 (&#8220;the &#8216;345 patent,&#8221; entitled &#8220;Expression System&#8221;), which is owned by GlaxoSmithKline Biologicals S.A. (&#8220;GSK&#8221;) , with the Patent Trial and Appeal Board (&#8220;PTAB&#8221;) of the U.S. Patent and Trademark Office. In November 2019 and February 2020, the Board instituted trial on invalidity grounds in IPR2019-01028, but exercised its discretion not to institute trial on IPR2019-01027 or IPR2019-01478. In May 2020, GSK filed two petitions (IPR2020-00890 and IPR2020-00962) for inter partes review of U.S. Patent No. 8,530,171 (&#8220;the &#8216;171 patent,&#8221; entitled &#8220;High Level Expression of Recombinant Toxin Proteins&#8221;), which is owned by Pfenex, with the PTAB of the U.S. Patent and Trademark Office. On June 29, 2020, GSK filed a motion to withdraw IPR2020-00890, which was granted on August 28, 2020. In October 2020, Pfenex and GSK executed a confidential settlement agreement agreeing to terminate the proceedings before the PTAB resolving these issues. Pfenex and GSK filed a joint motion to terminate IPR2019-01028 and IPR2020-00962 on October 30, 2020, and an amended joint motion to terminate on November 4, 2020. A decision granting the parties&#8217; joint motion to terminate in IPR2019-01028 was issued on November 12, 2020. The PTAB subsequently granted the parties&#8217; joint motion to terminate in IPR2020-00962 on December 30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 12, 2021, Abvivo submitted a JAMS arbitration demand naming the Company as respondent. Abvivo claims that the Company is in violation of the assignment provision of that certain Commercial Platform License and Services Agreement (&#8220;CPLSA&#8221;), dated October 9, 2019, by and among OMT and Crystal, on the one hand, and Abvivo, on the other hand because the Company allegedly withheld its consent to a proposed assignment required for Abvivo to negotiate a discovery and development alliance with certain third parties. On January 26, 2021, we submitted a response to the demand, denying all claims and alleging counterclaims against Abvivo and Brian Lundstrom, a Company employee and the sole owner of Abvivo. We allege that Mr. Lundstrom breached his fiduciary duty of loyalty to the Company and that Abvivo and Mr. Lundstrom fraudulently induced the Company, OMT and Crystal into certain business transactions and contracts. Abvivo and Mr. Lundstrom&#8217;s response to these counterclaims was due on February 9, 2021, but they did not submit a response. Under JAMS rules, the counterclaims are deemed denied. On February 22, 2021, Abvivo submitted documents to JAMS which indicated that it seeks to dismiss its claim without prejudice, which we oppose. On February 25, 2021, we submitted additional counterclaims against Abvivo and Mr. Lundstrom.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These counterclaims allege that Abvivo and Mr. Lundstrom made false promises regarding the CPLSA, Abvivo&#8217;s breach of and failure to perform under the CPLSA, and Abvivo&#8217;s infringement of certain Ligand trademarks.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11, 2021, Abvivo and Mr. Lundstrom submitted an answer to our amended counterclaims denying all of the claims and asserting various affirmative defenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The arbitration will be conducted by a three arbitrator panel, the members of which were appointed on March 30, 2021. We intend to vigorously defend ourselves against this action.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045582310168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of PresentationOur condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2020 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, &#8220;contract revenue&#8221; and &#8220;service revenue&#8221; presented in the condensed consolidated statement of operations for the three months ended March 31, 2020 have been combined into &#8220;contract revenue&#8221; in the condensed consolidated statement of operations to conform with the current period presentation. &#160;In addition, &#8220;gain (loss) from Viking&#8221; and a portion of &#160;&#8220;other expense, net&#8221; that related to other short-term investments presented in the condensed consolidated statement of operations for the three months ended March 31, 2020 have been combined into &#8220;gain (loss) from short-term investments&#8221; in the condensed consolidated statement of operations to conform with the current period presentation.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Accounting Standards Recently Adopted and Accounting Standards Not Yet Adopted</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The new guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP. This standard removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. This standard is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020 and adoption must be as of the beginning of the Company&#8217;s annual fiscal year. We are currently evaluating the impact of this standard on our consolidated financial statements and related disclosures. We intend to adopt this standard on January 1, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on our condensed consolidated financial statements or disclosures.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Royalties </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we own. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a sales-based royalty to be recorded when the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues are adjusted for in the period in which they become known, typically the following quarter. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Contract Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contract revenue includes service revenue, license fees and future contingent milestone based payments. We recognize service revenue for contracted R&amp;D services performed for our customers over time. We measure our progress using an input method based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time we estimate it will take us to complete the activities, or costs we incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make estimates and use judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We include contingent milestone based payments in the estimated transaction price when there is a basis to reasonably estimate the amount of the payment.  These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the&#160;transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon or after the development milestone or regulatory approval.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Captisol Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue when control of Captisol material is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. We have elected to recognize the cost for freight and shipping when or after control over Captisol material has transferred to the customer as an expense in cost of Captisol. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. We use an observable price to determine the stand-alone selling price for separate performance obligations or a cost plus margin approach when one is not available. </span></div>The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry a contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue. During the three months ended March&#160;31, 2021, the amount recognized as revenue that was deferred at December 31, 2020 was $7.3 million. During the three months ended March&#160;31, 2020, the amount recognized as revenue that was deferred at December 31, 2019 was $1.0 million.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period until the last tranche vests. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,397&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,405&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,653&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three-year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income (loss) Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the applicable conversion price of the respective notes. It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 4, Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 6, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045579221416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Revenue by Source</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:61.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,565&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service Revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,043&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Milestone</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,766&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,487&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,161&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock', window );">Schedule of Short-Term Investments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term investments consist of the following at March&#160;31, 2021 and December 31, 2020 (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.368%"><tr><td style="width:1.0%"/><td style="width:21.722%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.410%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.509%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.359%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.909%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.359%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.509%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.659%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,388)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Treasury bill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257,687&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,317&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">262,988&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">324,567&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,391)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">324,478&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307,354&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">363,567&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Available-for-Sale Debt Securities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,913&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,401&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,490&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Goodwill and Other Identifiable Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other identifiable intangible assets consist of the following (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">190,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189,662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">277,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">277,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67,441)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(63,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,345)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,312)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,597)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contractual relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,487)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,243)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">774,300&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">784,992&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock', window );">Schedule of Commercial License and Other Economic Rights</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license and other economic rights consist of the following (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,530)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,166</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,588)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,108</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,317)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,285</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,731)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,871</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17,847)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,451</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17,319)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,979</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $11.9 million and credit loss adjustments of $6.0 million as of March&#160;31, 2021.</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $11.3 million and credit loss adjustments of $6.0 million as of December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,347&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties owed to third parties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Return reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subcontractor</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,110&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,530&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock', window );">Schedule of Accounting for Share-Based Compensation</a></td>
<td class="text">The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,397&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,405&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,653&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule of Fair-Value Options Awarded to Employees and Directors</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Earnings per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"><tr><td style="width:1.0%"/><td style="width:72.133%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.832%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.984%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,435&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,248&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,277&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,144&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Commercial License Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Short-Term investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleOfShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045594219368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Assets and Liabilities Measured at Fair Value</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.830%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, excluding Viking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">253,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">262,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">320,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">324,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,559&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">253,373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,422&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">307,354&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,527&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">320,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">363,567&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pfenex contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">xCella contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensor</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,182&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46,875&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51,130&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,312&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49,193&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.&#160;Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Investment in Viking warrants, which we received as a result of Viking&#8217;s partial repayment of the Viking note receivable and our purchase of Viking common stock and warrants in April 2016, are classified as level 1 as the fair value is determined using quoted market prices in active markets for the same securities. The change of the fair value is recorded in "Gain (loss) from short-term investments" in our condensed consolidated statement of operations. During the three months ended March&#160;31, 2021, we exercised all of the outstanding Viking warrants. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Crystal contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on development or regulatory milestones as defined in the merger agreement with Crystal. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Pfenex contingent liabilities was determined using a probability-adjusted income approach. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of the Company.</span></div>7.The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. Management concluded that no earnout liability would be recognized at the acquisition date in September 2020.  In the three months ended March&#160;31, 2021, management recorded an earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Reconciliation of Level 3 Financial Instruments</a></td>
<td class="text">A reconciliation of the level 3 financial instruments as of March&#160;31, 2021 is as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent liabilities from xCella asset acquisition</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of March 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46,875&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2C<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=SL7498348-110258<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045579614808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text">The following table sets forth an allocation of the preliminary purchase price to the identifiable tangible and intangible assets acquired and liabilities assumed, with the excess recorded to goodwill (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts and unbilled receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Right-of-use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangibles acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">385,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91,837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,814)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,455)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,908)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,070)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,382)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(53,296)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">465,109&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>(1) Goodwill represents the excess of the purchase price over the preliminary fair value of the underlying assets acquired and liabilities assumed. Goodwill is attributable to the assembled workforce of experienced personnel at Pfenex and expected synergies. None of the goodwill is expected to be deductible for tax purposes.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Schedule of Pro Forma Information</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following summary presents our unaudited pro forma consolidated results of operations for the quarter ended March 31, 2020 as if the Pfenex acquisition had occurred on January 1, 2020, which gives effect to certain transaction accounting adjustments, including amortization of acquired intangibles and share based compensation expense for retained Pfenex employees. The pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as of the date indicated, nor is it necessarily indicative of future operating results (in thousands, except per share amounts):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37,939)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net loss per common share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic and diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045577540264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Carrying Values and Coupon Rates on Financing Arrangements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the 2023 Notes (in thousands): </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.099%"><tr><td style="width:1.0%"/><td style="width:68.646%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.655%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Principal amount of the 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">390,780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38,467)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52,987)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total long-term portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">352,313&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">442,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying value of equity component of the 2023 Notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of the 2023 Notes outstanding (Level 2)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">404,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">466,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045577591704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Plan Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,561,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">265,529&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,166&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">173.32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(522,172)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(88,959)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58,862)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,024)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.91&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,246,317&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">265,385&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,561,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">265,529&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,166&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">173.32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(522,172)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(88,959)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58,862)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,024)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.91&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,246,317&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">265,385&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045588881416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>position </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized from milestone method revenue</a></td>
<td class="nump">$ 7,300,000<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of positions in an unrealized loss position | position</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Credit losses related to available-for-sale debt securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease', window );">Additional allowance for credit losses recorded related to COVID-19</a></td>
<td class="nump">$ 20,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss', window );">Allowance for credit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (shares) | shares</a></td>
<td class="nump">4,277,000<span></span>
</td>
<td class="nump">10,144,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Performance period for awards</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Fair value of equity securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,326,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Fair value of equity securities</a></td>
<td class="nump">$ 44,366,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,763,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember', window );">Viking Therapeutics, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (USD per share) | $ / shares</a></td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember', window );">Viking Therapeutics, Inc. | Common Stock | Short-term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_EquityMethodInvestmentSharesSold', window );">Stock sold in equity method investment (shares) | shares</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Realized gain on sale of stock in equity method investment</a></td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_RoyaltyAgreementsMember', window );">Royalty Agreements | Aziyo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent', window );">Effective interest rate for forecasted cash flows (as a percent)</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_RoyaltyAgreementsMember', window );">Royalty Agreements | Selexis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent', window );">Effective interest rate for forecasted cash flows (as a percent)</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent', window );">Payout range (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent', window );">Payout range (as a percent)</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Viking Therapeutics, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Outstanding warrants to purchase shares of Viking's common stock (shares) | shares</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commercial License and Other Economic Rights, Allowance for Credit Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_EquityMethodInvestmentSharesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Shares Sold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_EquityMethodInvestmentSharesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Forecasted Cash Flows, Effective Interest Rate, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ForecastedCashFlowsEffectiveInterestRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922900-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922900-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_RoyaltyAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_RoyaltyAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_AziyoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_AziyoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_SelexisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_SelexisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045581641624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 55,150<span></span>
</td>
<td class="nump">$ 33,161<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">7,112<span></span>
</td>
<td class="nump">6,565<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_KyprolisMember', window );">Kyprolis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">4,287<span></span>
</td>
<td class="nump">4,405<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_EvomelaMember', window );">Evomela</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">2,333<span></span>
</td>
<td class="nump">1,576<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">492<span></span>
</td>
<td class="nump">584<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember', window );">Captisol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">31,272<span></span>
</td>
<td class="nump">21,109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember', window );">Contract revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">16,766<span></span>
</td>
<td class="nump">5,487<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueServiceMember', window );">Service Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">5,462<span></span>
</td>
<td class="nump">3,357<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMember', window );">License Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,043<span></span>
</td>
<td class="nump">975<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MilestoneMember', window );">Milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">8,417<span></span>
</td>
<td class="nump">334<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 1,844<span></span>
</td>
<td class="nump">$ 821<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_KyprolisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_KyprolisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_EvomelaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_EvomelaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_LicenseFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045581861240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">$ 257,687<span></span>
</td>
<td class="nump">$ 324,567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">5,317<span></span>
</td>
<td class="nump">1,302<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(1,391)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">262,988<span></span>
</td>
<td class="nump">324,478<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI', window );">Estimated fair value</a></td>
<td class="nump">307,354<span></span>
</td>
<td class="nump">363,567<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember', window );">Bank deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">51,232<span></span>
</td>
<td class="nump">84,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">51,253<span></span>
</td>
<td class="nump">84,154<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">25,853<span></span>
</td>
<td class="nump">30,512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">25,917<span></span>
</td>
<td class="nump">30,610<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AgencySecuritiesMember', window );">Agency bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">4,501<span></span>
</td>
<td class="nump">4,499<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">4,497<span></span>
</td>
<td class="nump">4,501<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">19,815<span></span>
</td>
<td class="nump">45,459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">19,824<span></span>
</td>
<td class="nump">45,485<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Corporate equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">4,456<span></span>
</td>
<td class="nump">4,466<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">3,736<span></span>
</td>
<td class="nump">360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,388)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">8,192<span></span>
</td>
<td class="nump">3,438<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember', window );">Mutual fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">151,830<span></span>
</td>
<td class="nump">151,512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">386<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">151,883<span></span>
</td>
<td class="nump">151,898<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">Treasury bill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,999<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Estimated fair value</a></td>
<td class="nump">44,366<span></span>
</td>
<td class="nump">32,763<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">1,422<span></span>
</td>
<td class="nump">393<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">1,422<span></span>
</td>
<td class="nump">393<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Estimated fair value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 6,326<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available for Sale and Equity Securities, FV-NI</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AgencySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AgencySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045577623992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis', window );">Within one year</a></td>
<td class="nump">$ 77,913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis', window );">After one year through five years</a></td>
<td class="nump">23,488<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis', window );">Total</a></td>
<td class="nump">101,401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue', window );">Within one year</a></td>
<td class="nump">77,981<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue', window );">After one year through five years</a></td>
<td class="nump">23,509<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate', window );">Total</a></td>
<td class="nump">$ 101,490<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=d3e62586-112803<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045581801416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 190,515<span></span>
</td>
<td class="nump">$ 189,662<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Total goodwill and other identifiable intangible assets, net</a></td>
<td class="nump">774,300<span></span>
</td>
<td class="nump">784,992<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember', window );">Complete technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">277,980<span></span>
</td>
<td class="nump">277,740<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(67,441)<span></span>
</td>
<td class="num">(63,600)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">2,642<span></span>
</td>
<td class="nump">2,642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(1,345)<span></span>
</td>
<td class="num">(1,312)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">40,700<span></span>
</td>
<td class="nump">40,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(16,264)<span></span>
</td>
<td class="num">(15,597)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember', window );">Contractual relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">362,000<span></span>
</td>
<td class="nump">362,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(14,487)<span></span>
</td>
<td class="num">(7,243)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Commercial license rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">28,298<span></span>
</td>
<td class="nump">28,298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(11,900)<span></span>
</td>
<td class="num">(11,300)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Commercial license rights | Selexis and Dianomi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">10,602<span></span>
</td>
<td class="nump">10,602<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Commercial license rights | Aziyo and CorMatrix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">$ 17,696<span></span>
</td>
<td class="nump">$ 17,696<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_SelexisAndDianomiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_SelexisAndDianomiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_AziyoAndCorMatrixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_AziyoAndCorMatrixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045579903048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Commercial License and Other Economic Rights (Details) - Commercial license rights - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract', window );"><strong>Commercial License and Other Economic Rights</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">$ 28,298<span></span>
</td>
<td class="nump">$ 28,298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(17,847)<span></span>
</td>
<td class="num">(17,319)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">10,451<span></span>
</td>
<td class="nump">10,979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization on finite-lived intangible assets</a></td>
<td class="num">(11,900)<span></span>
</td>
<td class="num">(11,300)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments', window );">Credit loss adjustments of finite-lived intangible assets</a></td>
<td class="num">(6,000)<span></span>
</td>
<td class="num">(6,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Aziyo and CorMatrix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract', window );"><strong>Commercial License and Other Economic Rights</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">17,696<span></span>
</td>
<td class="nump">17,696<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(9,530)<span></span>
</td>
<td class="num">(9,588)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">8,166<span></span>
</td>
<td class="nump">8,108<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Selexis and Dianomi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract', window );"><strong>Commercial License and Other Economic Rights</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">10,602<span></span>
</td>
<td class="nump">10,602<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(8,317)<span></span>
</td>
<td class="num">(7,731)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 2,285<span></span>
</td>
<td class="nump">$ 2,871<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commercial License and Other Economic Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseAndOtherEconomicRightsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-lived Intangible Assets, Credit Loss Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_AziyoAndCorMatrixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_AziyoAndCorMatrixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_SelexisAndDianomiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_SelexisAndDianomiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045588880408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Compensation</a></td>
<td class="nump">$ 3,347<span></span>
</td>
<td class="nump">$ 8,810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional fees</a></td>
<td class="nump">958<span></span>
</td>
<td class="nump">977<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_LicenseeAccrualCurrent', window );">Amounts owed to former licensees</a></td>
<td class="nump">468<span></span>
</td>
<td class="nump">421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Royalties owed to third parties</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">693<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ReturnsAccrual', window );">Return reserve</a></td>
<td class="nump">682<span></span>
</td>
<td class="nump">687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AccruedAssetAcquisitionsCurrent', window );">Acquisition related liabilities</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AccruedSubcontractorExpensesCurrent', window );">Subcontractor</a></td>
<td class="nump">1,034<span></span>
</td>
<td class="nump">733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AccruedSupplierExpensesCurrent', window );">Supplier</a></td>
<td class="nump">788<span></span>
</td>
<td class="nump">604<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">1,086<span></span>
</td>
<td class="nump">464<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">2,145<span></span>
</td>
<td class="nump">3,641<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued liabilities</a></td>
<td class="nump">$ 12,110<span></span>
</td>
<td class="nump">$ 18,530<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedAssetAcquisitionsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Asset Acquisitions, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedAssetAcquisitionsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedSubcontractorExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Subcontractor Expenses, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedSubcontractorExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedSupplierExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Supplier Expenses, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedSupplierExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LicenseeAccrualCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensee Accrual, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LicenseeAccrualCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ReturnsAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Returns Accrual</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ReturnsAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045581446024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">$ 8,405<span></span>
</td>
<td class="nump">$ 5,653<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">SBC - Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">3,939<span></span>
</td>
<td class="nump">2,397<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">SBC - General and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">$ 4,466<span></span>
</td>
<td class="nump">$ 3,256<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BasisOfPresentationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basis of presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BasisOfPresentationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045579191784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate (as a percent)</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility (as a percent)</a></td>
<td class="nump">63.00%<span></span>
</td>
<td class="nump">47.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045579975592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Summary of computation of basic and diluted net income (loss) per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average shares outstanding (shares)</a></td>
<td class="nump">16,435<span></span>
</td>
<td class="nump">16,529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Dilutive potential common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock', window );">Restricted stock (in shares)</a></td>
<td class="nump">112<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock options (in shares)</a></td>
<td class="nump">701<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used to compute diluted income per share (shares)</a></td>
<td class="nump">17,248<span></span>
</td>
<td class="nump">16,529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (shares)</a></td>
<td class="nump">4,277<span></span>
</td>
<td class="nump">10,144<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045503822008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2010 </div>
<div>contingent_value_right_series </div>
<div>contingent_value_right</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_NumberOfContingentValueRightsSeries', window );">Number of CVR Series | contingent_value_right_series</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisMember', window );">Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare', window );">Number of CVRs issued per acquiree share | contingent_value_right</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries', window );">Number of CVRs issued from each CVR series | contingent_value_right</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders', window );">Frequency of cash payments to CVR holders</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 307,354,000<span></span>
</td>
<td class="nump">$ 363,567,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,130,000<span></span>
</td>
<td class="nump">49,193,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - Crystal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">496,000<span></span>
</td>
<td class="nump">508,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,182,000<span></span>
</td>
<td class="nump">3,821,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,439,000<span></span>
</td>
<td class="nump">6,404,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,900,000<span></span>
</td>
<td class="nump">37,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Liability for restricted investments owed to former licensees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,000<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">262,988,000<span></span>
</td>
<td class="nump">324,478,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,366,000<span></span>
</td>
<td class="nump">32,763,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Investment in warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,326,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,559,000<span></span>
</td>
<td class="nump">42,527,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,000<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Contingent liabilities - Crystal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Contingent liabilities - CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Contingent liabilities - Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Contingent liabilities - Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Contingent liabilities - xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Liability for restricted investments owed to former licensees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,000<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,193,000<span></span>
</td>
<td class="nump">3,438,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,366,000<span></span>
</td>
<td class="nump">32,763,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Investment in warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,326,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">253,373,000<span></span>
</td>
<td class="nump">320,647,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,182,000<span></span>
</td>
<td class="nump">3,821,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Other Observable Inputs (Level 2) | Contingent liabilities - Crystal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Other Observable Inputs (Level 2) | Contingent liabilities - CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Other Observable Inputs (Level 2) | Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,182,000<span></span>
</td>
<td class="nump">3,821,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Other Observable Inputs (Level 2) | Contingent liabilities - Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Other Observable Inputs (Level 2) | Contingent liabilities - Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Other Observable Inputs (Level 2) | Contingent liabilities - xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Other Observable Inputs (Level 2) | Liability for restricted investments owed to former licensees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Other Observable Inputs (Level 2) | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">253,373,000<span></span>
</td>
<td class="nump">320,647,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Other Observable Inputs (Level 2) | Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Other Observable Inputs (Level 2) | Investment in warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,422,000<span></span>
</td>
<td class="nump">393,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,875,000<span></span>
</td>
<td class="nump">45,312,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Unobservable Inputs (Level 3) | Contingent liabilities - Crystal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Unobservable Inputs (Level 3) | Contingent liabilities - CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">496,000<span></span>
</td>
<td class="nump">508,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Unobservable Inputs (Level 3) | Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Unobservable Inputs (Level 3) | Contingent liabilities - Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,439,000<span></span>
</td>
<td class="nump">6,404,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Unobservable Inputs (Level 3) | Contingent liabilities - Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,900,000<span></span>
</td>
<td class="nump">37,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Unobservable Inputs (Level 3) | Contingent liabilities - xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Unobservable Inputs (Level 3) | Liability for restricted investments owed to former licensees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Unobservable Inputs (Level 3) | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,422,000<span></span>
</td>
<td class="nump">393,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Unobservable Inputs (Level 3) | Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Significant Unobservable Inputs (Level 3) | Investment in warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember', window );">Transferred over Time | Phase 3 Clinical Trial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGross', window );">Gross contract asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Transferred over Time | Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 375,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Number of Contingent Value Rights Issued per Acquiree Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NumberOfContingentValueRightsSeries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Contingent Value Rights Series</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NumberOfContingentValueRightsSeries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyCrystalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyCrystalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyCydexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyCydexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyIcagenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyIcagenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyPfenexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyPfenexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyXCellaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyXCellaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_Phase3ClinicalTrialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_Phase3ClinicalTrialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045582686632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details) - Level 3<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Financial and Nonfinancial Liabilities, Fair Value Disclosure [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value of level 3 financial instruments as of December 31, 2020</a></td>
<td class="nump">$ 45,312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Fair value adjustments to contingent liabilities</a></td>
<td class="nump">1,323<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition', window );">Contingent liabilities from xCella asset acquisition</a></td>
<td class="nump">240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value of level 3 financial instruments as of March 31, 2021</a></td>
<td class="nump">$ 46,875<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045581115464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 09, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 08, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred in acquisition</a></td>
<td class="nump">$ 465,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payments for acquisition</a></td>
<td class="nump">429,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="nump">77,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Fair value of contingent earn-out payment</a></td>
<td class="nump">37,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Post-combination expense</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions', window );">Gross payments to acquire business attributable to vested portion of stock options</a></td>
<td class="nump">$ 17,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards', window );">Cash to settle unvested stock options recognized as share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability acquired in connection with the acquired intangibles</a></td>
<td class="num">$ (53,296,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue acquired</a></td>
<td class="num">$ (3,908,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex | Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability, measurement input (as a percent)</a></td>
<td class="nump">0.071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex | Contractual Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="nump">$ 362,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">12 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex | Core Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="nump">$ 23,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex | Core Technology | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate', window );">Discount rate used to value intangible assets acquired (as a percent)</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex | Core Technology | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate', window );">Discount rate used to value intangible assets acquired (as a percent)</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_TaurusBiosciencesLLCMember', window );">Taurus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payments for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationConsiderationTransferredHoldback', window );">Holdback from acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets', window );">Tangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_TaurusBiosciencesLLCMember', window );">Taurus | Contingent Value Right for Internal Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_TaurusBiosciencesLLCMember', window );">Taurus | Contingent Value Right on Product Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues', window );">Proportion of milestone payments (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_TaurusBiosciencesLLCMember', window );">Taurus | Core Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember', window );">xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationConsiderationTransferredHoldback', window );">Holdback from acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets', window );">Tangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability acquired in connection with the acquired intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember', window );">xCella | Earnout Rights for Partner Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency', window );">Earnout rights recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember', window );">xCella | Milestone Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues', window );">Proportion of milestone payments (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember', window );">xCella | Core Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_IcagenMember', window );">Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payments for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Fair value of contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets', window );">Tangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred tax assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_IcagenMember', window );">Icagen | Core Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate', window );">Discount rate used to value intangible assets acquired (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_IcagenMember', window );">Icagen | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate', window );">Discount rate used to value intangible assets acquired (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationConsiderationTransferredHoldback">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Holdback</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationConsiderationTransferredHoldback</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Percentage of Acquiree Revenues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Discount Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Acquire Businesses, Gross, Attributable to Vested Portion of Stock Options</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash paid by the entity during the period to settle equity instruments granted under equity-based payment arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_TaurusBiosciencesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_TaurusBiosciencesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=lgnd_ContingentValueRightOnProductRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=lgnd_ContingentValueRightOnProductRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=lgnd_MilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=lgnd_MilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_IcagenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_IcagenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045581629976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions - Assets Acquired and Liabilities Assumed (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Oct. 01, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 190,515,000<span></span>
</td>
<td class="nump">$ 189,662,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,407,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts and unbilled receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,359,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,823,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets', window );">Right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,070,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,338,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets', window );">Intangibles acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">385,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,837,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,814,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,455,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,908,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,070,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,382,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability acquired in connection with the acquired intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53,296,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">465,109,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill acquired that is expected to be deductible for tax purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045582356200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Pro Forma Financial Information (Details) - Pfenex<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue | $</a></td>
<td class="nump">$ 33,843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net loss | $</a></td>
<td class="num">$ (37,939)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareProFormaAbstract', window );"><strong>Net loss per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic', window );">Basic (USD per share) | $ / shares</a></td>
<td class="num">$ (2.30)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted', window );">Diluted (USD per share) | $ / shares</a></td>
<td class="num">$ (2.30)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareProFormaAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareProFormaAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045588801000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 31, 2018 </div>
<div>USD ($) </div>
<div>d </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>option </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,840,000<span></span>
</td>
<td class="num">$ (659,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Adjustments to additional paid in capital, equity component of convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,086,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Adjustments to additional paid-in-capital from warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_PaymentsToUnwindWarrants', window );">Payments to unwind warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ProceedsFromUnwindingConvertibleBondHedges', window );">Proceeds from unwinding convertible bond hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_NumberOfOptionsUnderConvertibleBondHedges', window );">Number of options under convertible bond hedges | option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">645,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Adjustments to additional paid in capital, equity component of convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,086,000<span></span>
</td>
<td class="nump">$ 2,745,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount outstanding</a></td>
<td class="nump">$ 750,000,000.0<span></span>
</td>
<td class="nump">390,780,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 495,280,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from debt, net of issuance costs</a></td>
<td class="nump">$ 733,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Initial conversion rate (shares per $1,000)</a></td>
<td class="nump">0.0040244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price (USD per share) | $ / shares</a></td>
<td class="nump">$ 248.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Repurchased amount of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments of notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Accrued Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_IncreaseDecreaseInDebtDiscount', window );">Increase (decrease) in debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Adjustments to additional paid in capital, equity component of convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 390,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued in public offering (shares) | shares</a></td>
<td class="nump">3,018,327<span></span>
</td>
<td class="nump">2,597,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_PaymentsForConvertibleBondHedges', window );">Payments for convertible bond hedges</a></td>
<td class="nump">$ 140,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (USD per share) | $ / shares</a></td>
<td class="nump">$ 315.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Adjustments to additional paid-in-capital from warrants</a></td>
<td class="nump">$ 90,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes | Debt Instrument, Redemption, Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | d</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days | d</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Stock price trigger to classify convertible debt as current (as a percent)</a></td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes | Debt Instrument, Redemption, Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | d</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days | d</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger', window );">Maximum threshold of debt trading price trigger (as a percent)</a></td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_IncreaseDecreaseInDebtDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Debt Discount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_IncreaseDecreaseInDebtDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NumberOfOptionsUnderConvertibleBondHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Options under Convertible Bond Hedges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NumberOfOptionsUnderConvertibleBondHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsForConvertibleBondHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Convertible Bond Hedges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsForConvertibleBondHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToUnwindWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Unwind Warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToUnwindWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ProceedsFromUnwindingConvertibleBondHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Unwinding Convertible Bond Hedges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ProceedsFromUnwindingConvertibleBondHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=51819886&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109126253&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase for accrued, but unpaid interest on the debt instrument for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value amount of debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045582878312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible Senior Notes - Notes Payable (Details) - Convertible Notes - 2023 Convertible Senior Notes - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>May 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract', window );"><strong>Notes Payable, Current and Noncurrent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount of the 2023 Notes outstanding</a></td>
<td class="nump">$ 390,780,000<span></span>
</td>
<td class="nump">$ 495,280,000<span></span>
</td>
<td class="nump">$ 750,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount (including unamortized debt issuance cost)</a></td>
<td class="num">(38,467,000)<span></span>
</td>
<td class="num">(52,987,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Total long-term portion of notes payable</a></td>
<td class="nump">352,313,000<span></span>
</td>
<td class="nump">442,293,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Carrying value of equity component of the 2023 Notes</a></td>
<td class="nump">35,135,000<span></span>
</td>
<td class="nump">48,397,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair value of the 2023 Notes outstanding (Level 2)</a></td>
<td class="nump">$ 404,477,000<span></span>
</td>
<td class="nump">$ 466,053,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045579184584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate (as a percent)</a></td>
<td class="num">(214.10%)<span></span>
</td>
<td class="nump">20.70%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045581326920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at beginning of period (shares) | shares</a></td>
<td class="nump">2,561,822<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (shares) | shares</a></td>
<td class="nump">265,529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (shares) | shares</a></td>
<td class="num">(522,172)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (shares) | shares</a></td>
<td class="num">(58,862)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at end of period (shares) | shares</a></td>
<td class="nump">2,246,317<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at beginning of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 85.59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (USD per share) | $ / shares</a></td>
<td class="nump">172.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised (USD per share) | $ / shares</a></td>
<td class="nump">51.98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (USD per share) | $ / shares</a></td>
<td class="nump">101.77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at end of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 103.24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Restricted Stock Awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (shares) | shares</a></td>
<td class="nump">206,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (shares) | shares</a></td>
<td class="nump">153,166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">RSUs vested (shares) | shares</a></td>
<td class="num">(88,959)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (shares) | shares</a></td>
<td class="num">(5,024)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (shares) | shares</a></td>
<td class="nump">265,385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 106.88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (USD per share) | $ / shares</a></td>
<td class="nump">173.32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">RSUs vested (USD per share) | $ / shares</a></td>
<td class="nump">127.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (USD per share) | $ / shares</a></td>
<td class="nump">110.91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 138.85<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045581701496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 11, 2019</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Outstanding options that are exercisable (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Outstanding options that are exercisable, weighted average exercise price (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 89.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_EmployeeStockPurchasePlanAbstract', window );"><strong>Employee Stock Purchase Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock repurchased during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 73,287,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Authorized stock repurchase amount</a></td>
<td class="nump">$ 500,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramPeriodInForce1', window );">Period in force of stock repurchase program</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized stock repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 248,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lgnd_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_EmployeeStockPurchasePlanAbstract', window );"><strong>Employee Stock Purchase Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate', window );">Share purchase price as percent of market price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod', window );">Shares available for future purchases (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_EmployeeStockPurchasePlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plan [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_EmployeeStockPurchasePlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares to be repurchased in accordance with a policy to use treasury stock to satisfy share-award conversions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount rate from fair value on purchase date that participants pay for shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramPeriodInForce1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramPeriodInForce1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lgnd_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lgnd_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045582767736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies: Legal Proceedings - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 31, 2019 </div>
<div>civil_complaint</div>
</th>
<th class="th">
<div>Oct. 29, 2019 </div>
<div>patent</div>
</th>
<th class="th">
<div>May 31, 2020 </div>
<div>petition</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>petition</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=lgnd_LupinPatentInfringementMember', window );">Lupin Patent Infringement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingenciesLineItems', window );"><strong>Gain Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber', window );">Number of patents allegedly infringed upon | patent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember', window );">US District Court for the Northern District of Ohio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingenciesLineItems', window );"><strong>Gain Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Number of civil complaints filed against entity | civil_complaint</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=lgnd_InterPartesReviewOfPatentMember', window );">Inter Partes Review of Patent | Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingenciesLineItems', window );"><strong>Gain Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_NumberOfPetitionsFiled', window );">Number of petitions filed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=lgnd_InterPartesReviewOfPatentMember', window );">Inter Partes Review of Patent | GSK</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingenciesLineItems', window );"><strong>Gain Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_NumberOfPetitionsFiled', window );">Number of petitions filed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NumberOfPetitionsFiled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Petitions Filed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NumberOfPetitionsFiled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of entity's patents that another entity has allegedly infringed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=lgnd_LupinPatentInfringementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=lgnd_LupinPatentInfringementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=lgnd_InterPartesReviewOfPatentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=lgnd_InterPartesReviewOfPatentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=lgnd_PfenexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=lgnd_PfenexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=lgnd_GlaxoSmithKlineBiologicalsSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=lgnd_GlaxoSmithKlineBiologicalsSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140045578995160">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
<td class="text">us-gaap:AccountingStandardsUpdate201613Member<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 24: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>54
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MF0?@_E)*?3HQ+RBV7T?_ 5!+ P04    " #H@*923IJS"!X'  "-'@  &
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MGDH\5B0-K5,Z$87&B?*B^6&6I4]I]NUWF!-H#U%$Q@*:)Z+0.%&.:^)32EU
M9"+%\R+)8T8P)@>0/!8[@83&04(Q9?TJVT*5,92<K6I*;5"C;:1"IAZ\",J(
M,RL\@.&4!F,\(8;&$?.;;AYW._1OR! N33+!YUL0GQ7E@4*.3L"A\8W2M^U
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ME0V ZQLIS>O$GL'U.]?\+U!+ P04    " #H@*92TN_#6HP%  !D%@  &
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M'0^_;7@2L;SX%2V^E[%X0F=W&2VC&*S/T1#=W<[1V2_GDY$ 4#+T**P!S/8
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M*RCT6:*[;\CD3 U:_/R>W$Z([0 R09/%9;VMM%8[-@<:S8$"90Y<+=I\$"
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M;$U02DUJ2?WP9:TT(O&X<-D1R4LS^=()&[5,@]VXOO ZTCKHA'-@,H$H .Y
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MTQDP]'P\<W,MHB&(#SP!!AW/@".&T7@!FQM'D_%"_=208[YN@'N&@+'%>*
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M*2,W<]G;Z,[[A>[0"F=?_"5H .^)DA'Z6B0Y[4E&+Q%7YN(5:W_0L?MX 8I
M93W'(R*3\11_3$=+5J]T.,M=7-GBT.?H)[9Y$0^^6,_DMD7/>7#VX+:# %;3
M;M,GJGR(]>:%!>NLZ,ANVB= 0T)(TQ_VJ/3<*+F5=Q*-(-(;#B 8FJAS?R7G
M6?"GC>BF2?P#3JBL@27YKQRY;Y7]&U'7_*>1_.O\!Z9^HM.$1N5Z#4,'_?GT
M">>Q[(>ZW-,?2EJ5=5WNZ->MCH$3\05XOBYA__(!%W!_.>O[_P-02P,$%
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M[:NDU]?C$%W0+2?&DR U?U^T^X%%9(5?\2L+^Y'/+*((7_BM!6=+T+9M\F%
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MU<\E4M 4=72Z-:#EVY6$VR78//,14&!RSW"T1]T[R.*/6&?0!()"S%<N(74
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M_N+*-?]./B^=*W/^N%(224,+\'Y1XD#A"REH_G#B]7\!4$L#!!0    ( .B
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ML-X:2[ET%3%V"]4957]9T\R&-&8T/9O&%80)R=BCQI$UWS1(@]?65$O[(4G
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M4-%Z3P_6%BQGMIBII9&5I?&@6IO"A$"A@Z2IM)IHZ]5BPTL<]-SI"P^11:"
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MFF(HP?Z)Q<A@I# DK0;TH.IK#5^&RCK5,HT!.\TF3.8XCM@>KU3X45,(FE@
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M7VC_+@0:34T+,#]3.'__0@S&#Y)G_P502P,$%     @ Z("F4K-IA4M8"@
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MOI7^AM>.M=Q*IVY,^:<N_.KEX&(@"K603>D_F,VO*JZ'#<Q-Z?B_V(2QL]%
MY(WSIHJ384&EZW"5]Q&'WH2+8Q/2."%ENX,BMO*U]/+JA34;86DTI-$-+Y5G
MPSA=DU,^>HNO&O/\U1NIK?@LRT:)=TJZQBH@[IUX^DG>ELH]>W'NH87&GN=1
MXJL@,3TB,1/O3.U73OQ2%ZIX./\<UG4FIJV)K]*3 M]).Q39.!'I*!V?D)=U
M2\Y87O;M);_6+B\-K=J)?UW?.F\1)?\^H6/2Z9BPCLD1'1^1/$53*F$6XMHY
M!41E78C?M+S5I?8:^B+<A9!>[$PZA/=I59]62BQ,B>S2]5)X<IM ?CIVH\?'
ME596VGRUQ3 K3&.%W%E4]BRJ>A8MR*([!NFIKB''- [CW;/GXAT)ZQPB7JM<
M5;?*MF]&XC=UITHQCM<T7C/QR7A9?N-K .NY^+@RUI]Y92NAZSOE/(=E(M1]
M7C8%K?2S_D*7I^-GXHFX2,:7&:[I-$NR.=V-DTF:TIM9FEQ>7. N2R897]-1
M,IO,Z8[G9.DDF<POQ-M.#U2VXG-352 /Y&'^14PF23:;B1]_N$C'Z<_=-;[.
MTF0^R_:^QM<'I6^DM9+3+7VV-_'Q=99DZ;[R\#: %_WZ1$S39#J]/(A'-IHG
MV72"NPD&I?-#@,RR9#J;]Z/UN;BQ6T<Z<B0W3*=U]&/G:49N:(WJWUV,1MW_
MT]]OMJ_5_3$%>Z!?SOCO\?OIZ(+_WBFD@G3:';5XLH-\DHPOTB-/68+KHZ>W
M.0I6?53R=-^9<P3?9?R_[\+):!+_OU^H^C@(3V?[DK-Y<@GPXN7 UUGX2I=[
M*G_RJ/3YOO1T,N*_;P7G=64:"F2S 7]X0U13@1-*G:. @W;F^XF!5[-]P7@5
M@KEOV1/!,1P<@^LLN9A/*<['R3BC\)F-.,')-_@\3;(QC[MD6A@/Q2\=;1#_
MZ0.YF/ 7=Y!V:!1:EB\JL&NA;CV3I_K::+\53N6-#89*JT1>(@_U0A.1XLV=
MU"5-.P,D9TYB?F\\-12%,"2^1DB1MI](G<<-FI; T204E%Q&PD1)(5KO,73'
M\ EIQ$>G^FM\9!_/*:+J9@WE7QOC<;^V\);C*J$+,B"'&_#@=(4E$&PHD,TC
M1$@?C"/!M?&QRTK8[LH4JCP+>DBIY#[,JWQ5ZZ]-U+19:5036990LZP!6PY"
M)"9KJG6$ *+-K5/VCM'G:J2B]N&10L'V-;[! A8-RE9_X; 6 @!>K7R@S+;0
M_7[]^1DY@^3#B5X4<MO"O596FV(H_@3<\NZ!EWNAT8-ZH_T*Z.FEKF$%^L?V
M P0NT3_#9(*NAD(EMDI263X6?SU?<?WFQ-@RR"%6*.4:>%W6X2WAR88;IX[8
MAQD.'G&+;5@O7*(+DEHK5;"5I K#+<G'+L"R_]P0I4S( D/QE(A-Q.-A3G6%
M#8T(^F-*O(4UE?BHL UP CV+E6O5(,0<Q.5#M+;H-CU!L9;;*O8N\-1&6;+:
M^U+16@&0I&:MP"JHVZ$\T!:>^MI(2XC"['0TOMS/F^QTWG2)^*J4J/3HWPP,
MBN-@F88#*6FVO4S]5JBDP]-5/XG!#P@MFBCD36","!J)"S.8&^<_.V!CO48T
M6151:E5&R<C 5A:[FU @+ZX;K!(KW(E\V-C0N,YE,/0:5% 2D+/D *65L8,+
M7-,'%-6V4!2]Z%$1KXX417()0=ARC&[W8QV+$!>0-">K?I@.*58$C$>Y.N!!
M31&6&UN$Z!C\#=M0\10AYIZ%@#N<4 ,:S.%ML$FIR?6X<Z;4!;L9G8Y7+;[]
MT'^]BSN_L@KFA[V.HKW.H\Z8<T/=*YMK4M"E)-;1>&BH^VULBSYV.F')O45B
MUC>ZKXT\ +P$V.:VY8H-[T\9)K@>H;'&5YFOAMBNN2Z.>O*[/*0 Z-*C(-^;
M=<#& OQE4TIO[':7P4ZP-0LVI65K99?(3@GB"[@R.\95[2T87G7-[7]4B!!F
M.0A=+/ BY&"(!PXC7:\;SVQ&>G9EAHL/+3;6_5W:=MG4IC7%T%+:HO,LZAWA
M5Q</$ 1$P$L#@#8R<F4]!5P/%.K",>\@+D-QL[,[5.F="94D:H$+D=_E-J[V
M4;@/Q839%UZJXZE&J#)4$W+PMV-2)M-V[2]T_5W6H,<M)?2(HU*CO%*\=H.8
M!D!YA;*4BI"'K7#!''+S^0.8BI@9=R&I%' @)3P09+6.GD*-C@4.0Q-.:1[:
MTT/T'?Q-<@5U&:#V8Y; J[ETJUXLPCJ+M@L/!!($W"DLS.G[-A/QCJ<$9@BD
MBHAI7# =#LVYOO%3(!S:IEOFUEIQ>I.GZX[.=[85MED^R !(6UI9 1\)]9B(
M\02=7BZ#)(SEI/[$%;:-I);K&((3G-DCRY8_N2ABRJ[7ZJ2ASU&VW-)\"([$
M"5KA-Y+[\W9).U,H[!9EDZ-50NGHM6" =[]#?$CB7&-S;K)D;/_74A?!$-;3
MY7N([UO5#_%"(\:YN> VR'^'N6CWR.&R_ N^">W)K5+$^#YL2,(>I6W\=R3Q
M^1_IQ>AR&*_,.D":JET\1X2D3Q_.?OSA<C+[&:LSM7:1R]:&>W99AM83/<^:
MF]4":'+QZ.M9;5%30HL!.'"IM$Q$L76E7J/UYJ??KS_^&OKH?YY=__9Z*/[H
M8*5H<2T$CSBU7=1&M9#''.,E-VOZ_R3#[@F\5$:RZ,&6]*F+E%.?0"6,>M@>
MP^,+*@\=%EFSE65H;.L>"@MTWS9DE^NM7(HGXU&GN^UB.,9T#?:2+8%)\9X[
ME@S-![[05L13X S%]%"!/+TC_]_5Q[8D6,I\F':R*H;-1]></?)D6-+_B^-W
M%\?9H< X?:#R[< XD\5_&G<P,#ZQE5QM%J79N+!9@558M'8Y,5C(NG@<&XUJ
ME;1CA"7J[2)HM[D-[7ZNU]08_H0EA#CDXP>K%BTAQ="\,14&;H<G3J^GW>GU
M]+M/KS^@O:YS0-%E9GM@^P8;VYJ)X>WN8.#0^?5)9?2KTW.WEKEZ.6"<[)T:
M7%US6_]0+U>"J'O1Z>X?2D@FQ4?GTSIT#7Q"[O8.L]\\");O$;]_WMV=./6$
MA:B)&UES+/S&299F\-S!C]RAQ!.[P!3]'H\.Y?ZZ\8^PZ8[2#@7->>]7)>[?
MR10Z3D7,AA^8NK?=SW/7X5>IW?#PVQ[4+F$,3%Q@ZF@X1TC8\'M9>/!FS;]1
MW1KO3<6W*R51[V@ OB\,"DM\( 7=CY97_P502P,$%     @ Z("F4H]?^JS7
M!   > H  !D   !X;"]W;W)K<VAE971S+W-H965T,3@N>&ULC59;;]LV%/XK
M!T8?8D"-9<N.[2 QD*2[=&BWH,VVAV$/M'1D<:5(EZ3BI+]^'RE9L8?&V(LM
MDN?RG>]<R*N=L5]<Q>SIJ5;:70\J[[>7HY'+*ZZ%.S=;UC@IC:V%Q])N1FYK
M6111J5:C29I>C&HA]6!U%??N[>K*-%Y)S?>67%/7PC[?LC*[Z\%XL-_X)#>5
M#QNCU=56;/@S^]^W]Q:K46^ED#5K)XTFR^7UX&9\>3L+\E'@#\D[=_!-(9*U
M,5_"XGUQ/4@#(%:<^V!!X.^1[UBI8 @POG8V![W+H'CXO;?^8XP=L:R%XSNC
M_I2%KZX'BP$57(I&^4]F]S-W\42 N5$N_M*NE9U/!Y0WSINZ4P:"6NKV7SQU
M/!PH+-)7%":=PB3B;AU%E.^$%ZLK:W9D@S2LA8\8:M0&.*E#4CY[BU,)/;^Z
MR;\VTLG D*.S![%6[(97(P_306"4=V9N6S.35\QD]-%H7SGZ01=<'.N/ *G'
M-=GCNIV<-/A1V'/*Q@E-TLGXA+VLCS.+]K)7[-TV#CO.T9VIUU*+-N"_;M;.
M6U3&WR=<3'L7T^AB^HJ+SVB8HE%,IJ1/G)N-EM^XH/<%:R]+B<\;Y]@[BIQ;
MK(4NZ(,4:ZF0 ';AO*G_2U_+UDG7H7,OW5;D?#U :SJVCSQ8/51,I5%H.ZDW
MY$-J*?I'*_L*SDG@,(]4!,P>\M!6$F6&_J1M8_,*!8]-F3-Y$R5D%TXTYX7>
MR/ 1(I'Z9=D&*@X#50>!BC;0!,4.),$L/^4A.Q:\6510\+8QIMA)I>A,:LB8
MQL&,&U[2G7 5O:'9.)FF<U"-%,K<0RD/!QA'8#@WC0X(X+C1\*MP#.,L'V.)
MTSC)9DNZMYANUC]'.0;8+>:-3TAC&LZ3Q22C.*7>FO)MX[JP*$O2>4J_ ;7=
M!PIKV8+>]P0<A)XM9DD*2#_UT8R'M!PGBVS^ G,KGB.?9Q?)8CP=A@/;\#%G
M9XMD.IL-Z1V7;&T,YY%U Z4L6::+(7W@D*PCE0AUV&$].@'BQ>3 F!=/AP(M
M!6>S+)DL+X8@>WHQ2\;IDD[TR:SOD]G_[A,D@.)T!7GM#8-B_%[]GS9Y7.K=
M!4.Q%0*]IK&H M$4,E3)%CZC+\HQ XR2A?"13H=)[@*J4!3=A(!@K,^OC; >
M)'*8;X3IE%?[\92B"DBV_7-?LN:G-OOM5*5*%&3RO(DT8_V+T$U URFC!RH)
M8QM<3HZX+'%=A>K/49<B%+X5VHG]%1;K)<0HBG]P.81J1:ZDSA6""]LU>EM^
MZWNZ+T-Y6)LH=E<)R_$^0]N8&G>\:Y7X*7QS#-QR@ ")+BRNM\H\,[MS>HC#
M8D]DB8FA<RD4_/1I).E(&X]*"JTMK%3/."YDF#B/O)\X'=? OD^ KX3'7=ZH
M MP%P3UY@<F@<LCNFEG'/(:<AS0*M[<<TKIW&&:-1D2 )$\A*AO?V.^!.II!
M21Q76T\0ZY@$\:&3,9T>*LM\=!UB1+6=^H:R+%E,,_H5S:4,YMT;].@\66;+
MX<M>,(J4U(@NVKZD6^%D'M-62-6$**$W.<_2X??:<73P&JC9;N*;QU$LG?9A
MT._VSZJ;]C7Q(MZ^R5#G&XDN4%Q"-3V?HPUM^\YI%]YLX]MB;3Q>*O&SPM.0
M;1# >6F,WR^"@_ZQN?H74$L#!!0    ( .B IE)SMYF#& ,  &@&   9
M>&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;'U5WV_:,!#^5T[1'EHI:T(2"E2
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M%,>_BH7ZT$J=$M]"4C%(<]E+I:TT*NWV8;4/GF"8:)*8VF:FW4^_3J 8XLN
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M6K+3.-G;1RO1@*D6Q6-D1U/+87JV1@6U8*5QL!Z:9^IK1.#4^2+(#<-HE.)
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M@=%-S^K553>M)J0VOH,M%=E^Z(>Y_0&A=@?L?J84?4Y<4ZQ_:>,/4$L#!!0
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M@)K/PCQ205H#,YX+H5\;]AG4/WNW_P%02P,$%     @ Z("F4DH(DUK? @
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M4H7PS175<-1N <UG2ME]QVU0_Q6,_P)02P,$%     @ Z("F4DS!6%9$ P
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MA@'S6#]\*M 3.-!;P7<]YP48/8D*UB1T$CX5W@E\GWX(?-V;;QK&)NXS6@8
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MMJR6T76IIP0 J%G/OL\99S^6K+O&.76P\T !H#S 4?YL0C4@)^IP;2E8CP0
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MKHF<RB71)(FEV(&TV0;-+IQ55VW$46X/Y5%+\Y2:.IU<IZ\55=1V2,$%K*0
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MH<W$<LO<_")0V@3S?"V$/FPL0?O327X#4$L#!!0    ( .B IE*8N6*ID@8
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M%A!M*9\%\610^:15/OD!Y8>L.&R4@X7@.5@;)NBV?0HG'85V!@8$3EN!4Z_
M&_+8JJN*-2M2KXAI1P2<1!X9<2LC]LL0/*$TE748:B$Z-Y],W9QK<2N:+OL)
M$G=R#TYF'FFS5MK,*^U3E<^I,'G4$$?+2_6- 6G@>].N3^.L$[Y)&$5#"F'@
M=IE@1YH-K0@/+N#6)@;?@D<0N0[0_[W &P43SPJO&=;3$$W#:#"/H*,ZQ-Y1
M;A<#=17PW6P<& Q5";[8.MC#\$TFS\$9[J#S<BGHDB@*2L&*A)5ZVDC.*S,W
ME9**V*7<6]M$G5!/:YH\GY4+V 4TG@73N-OT0X_7<!:A>!@%T.$<^GE^52BJ
MZPT%A!GO'I& @)**1 >VOWKSNPN.IM%/ODEP&(<[./X$H&81'(""VM7!I*Q(
MD5"]3&0OU<\;WT_F 6/H@2=T8(=^LE\5>BGKC*C7:'T LK&K*S<3/? .'NB>
M^@-8>S?\:[4%1T$0!B@,![0YLD,_VGNTZ136D=HSM9Q19D7NZW7J:MA>E74_
M\38SPO@HC/L5(@=VY >[7;P[)_"B\1*]>/-#COT([E:@#\DYJ_+>KF&W:SSU
M=>UV!>3?%6YI68EDI<^I:0N4ND;5.\*&9[V:4%=3$/KJ%.0@COP0UZ(V)9,6
M4W0QW4C /1)FOB6%'-&1OWX_2Q)1Z9AL8-3;?]CI'_DZ=[1'?MJ__O" NN@.
M8Y\61V.TB\:)H#H]P%Y*ZZM]4RO8#$F93$S*]"KJUM*SB4^1PS#R8_@_*&10
MMP;WYY5#-?*C^B,OEH<ZI?+AOKM%MMZ%O9/I8(S\,/[:'#LL[JB-55G-,Y;H
MP"RH,*>!9L\P/!YF,>H6V3B ,4;39R5%3T,4S::Z ND?"G;4QGYJMX>J!1\\
M)_1);]P^.<.$ ?:$%SN.8S_'F_#J=:O+%2;I/]SIFEZV=SH,HR,\L--A!WO\
M(T> UYR4SW%?J1_XHKCU8.9?+N'U[\\*\ -P2U.:VS/B ;C1F<U3\&M!?<^-
MW-: WZ38QP[_V(__SRN=&"N>I4 )8H_H*7DTH^Q[^'B.N^A'0W/@J(_]U->A
MEC2I[*/3%XGHTAX/B7"@QW[0WRF>?&O6D!)LN=1+2*=MDA$IV>*Q0W*@CPI)
M)829E-W'AAV=0VQ*8-_! 3OH8S_TWRJC/Z^Y3Y_;%O#L39Z%.EB'?EB_+J/#
M;J4=]>=2Z- <^M'\VH0.>TKN@80.'7]#/W^OR0/+JQRH-AR;6GLCZ6FR[T[B
M'1W.XJ$<'F^];\FI6-H777KYF'*N?A/1WFU?IIW95TC/[E_ ]Y?U*S'GIGY#
M=TW$4I\A0$87VJ4YAH^ J%]ZU5\4+^U;G3E7BN?V<D5)2H5IH']?<+T6FB^F
M@_;5X^G?4$L#!!0    ( .B IE)AN[FY$@,  )4(   9    >&PO=V]R:W-H
M965T<R]S:&5E=#,W+GAM;(U676_:,!3]*U:TAU9JFY!/J "I!56;M$VHK-O#
MM <3+F#5L3/;@;)?O^LDS>B2L/% [/B<>\^YUXDS/DCUK'< AKQD7.B)LS,F
MOW5=G>X@H_I&YB!P92-51@U.U=;5N0*Z+DD9=WW/B]V,,N%,Q^6]A9J.96$X
M$[!01!=91M7Q'K@\3)R!\WKCD6UWQMYPI^.<;F$)YBE?*)RY390URT!H)@51
ML)DX=X/;>6+Q)> K@X,^&1/K9"7ELYU\6$\<SPH"#JFQ$2A>]C #SFT@E/&S
MCNDT*2WQ=/P:_:'TCEY65,-,\F]L;7839^B0-6QHP<VC/+R'VD]DXZ62Z_*?
M'&JLYY"TT$9F-1D59$Q45_I2U^&$, A["'Y-\/^7$-2$X&]"W$,(:T)85J:R
M4M9A3@V=CI4\$&71&,T.RF*6;+3/A&W[TBA<9<@STYD4>U"&K3B0)0@F%?DL
M#6AR75\7]$CMXL4<#&5<7^+**>D5[7M^0,Y$>UK.R<6[R[%K4+7-[::UPOM*
MH=^C\!-5-R087-D,@P[Z[#Q]#FE#]SKH\W]E/];LP? MV\5*-^7VFW+[9;B@
M)]R;FEZ16:$4"$.H6&.A1%I/O]^MM%'X2/PXDS)H4@9ERK GY4(QD;*<<D(S
M66!TN2%F!U7#*CWX.M &-3"Q[>I/%3\NX]O7R'X:C+QDZ.%O[.Y/6]%&AJ/(
M[T#.V\@D\JI?@WQC-VSLAF?M/@FTB5OP%ZS)FNFTM'R!)>"%]4>*TW58&<*T
M+JA(@:12F\[]626,3K1>!\,P3MK^.Y"1/QHFO:ZBQE5TUM47:;"!7(KMM0&5
MD=Q:P-<F]E*4+<RK+=4E/VJ)"B(_& 1M^6UD&/K^*.B5'S?RX[/R9U2IHZW^
MGO("K&KX63!SQ)IGN130M2N[K,0=5@9!U';2!H;#8-3?AZ0QDIPU\D"9^F.B
M_S$B%Q]A#YSXG1LJ:3\F7A@F'1NJ QG'7M31$??D#+ '-KXVMTQHPF&#7.\F
MP6*HZA"L)D;FY;&PD@8/F7*XP^\&4!: ZQN)INJ)/6F:+Y'I;U!+ P04
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MX/8L>#7::<7SNZ*=&$$E=D$]B9HW%+T:_L7+21"''<2,KI*@7]$K PBIEWI
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MXP5N):@JSYD\O\=,G):.[UP&[ODAU6; 72U*=L 'U)_+K:2>VUI)>(Z%XJ(
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MJ\?"H+,PZ/7^NLKOT(#.H,F.!:$4KC!5#R#;8%*H2JX<W^%H N>-D6%MQ%7
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M&)-'EZ =E"R<.:-D&3A*=BJ4T 4P!,D)2-XBY!U'D!D!F;4".:YQPD\19$Y
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M'6_7^N?M[\O'9N^YW'%V\)=E]0M02P,$%     @ Z("F4B/5;@VH 0  N!D
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M_Q%/CD'ZZO-1.^V,LE]ZA^O]T';5S<.Q;KG^CK_.^*1_80X!DD."Y$A <MR
MY)B Y+@%R7$'DN,>) <?HP1!(2I'02I'82I'@2I'H2I'P2I'X2I' 2M'(:M
M(:M (:M (:M (:M (:M (:M (:M (:M (:M (:M$(:M$(:M$(:M$(:M$(:M$
M(:M$(:M$(:M$(:M$(6N"0M8$A:S)?Y+U7>O57_]+:->X5F5S]&?=#YOY)U!+
M 0(4 Q0    ( .B IE('04UB@0   +$    0              "  0    !D
M;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ Z("F4J/"L+_N    *P(  !$
M             ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @
MZ("F4IE<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H
M96UE,2YX;6Q02P$"% ,4    " #H@*921 >$+%8%  "*%0  &
M    @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
MZ("F4DZ:LP@>!P  C1X  !@              ("!F0T  'AL+W=O<FMS:&5E
M=',O<VAE970R+GAM;%!+ 0(4 Q0    ( .B IE+F[ZN3U0(  '\)   8
M          " @>T4  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4
M    " #H@*92TN_#6HP%  !D%@  &               @('X%P  >&PO=V]R
M:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ Z("F4BA0+_7> @  9@<
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M965T.2YX;6Q02P$"% ,4    " #H@*92='G$=2\/  "&,@  &0
M    @(%T7P  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    (
M .B IE(JB1,UE0L  $0A   9              " @=IN  !X;"]W;W)K<VAE
M971S+W-H965T,3$N>&UL4$L! A0#%     @ Z("F4BPQ*;-C P  B <  !D
M             ("!IGH  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"
M% ,4    " #H@*92";%< (8$  "V"0  &0              @(% ?@  >&PO
M=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( .B IE+@FNB@A T
M .TC   9              " @?V"  !X;"]W;W)K<VAE971S+W-H965T,30N
M>&UL4$L! A0#%     @ Z("F4CI<)O;T$0  8C0  !D              ("!
MN)   'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " #H@*92
M541#H7P*  "<'   &0              @('CH@  >&PO=V]R:W-H965T<R]S
M:&5E=#$V+GAM;%!+ 0(4 Q0    ( .B IE*S:85+6 H  , <   9
M      " @9:M  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%
M  @ Z("F4H]?^JS7!   > H  !D              ("!);@  'AL+W=O<FMS
M:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    " #H@*92<[>9@Q@#  !H!@
M&0              @($SO0  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+
M 0(4 Q0    ( .B IE(J%'A>-0,  !4)   9              " @8+   !X
M;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ Z("F4I4.<D(K
M!@  \QD  !D              ("![L,  'AL+W=O<FMS:&5E=',O<VAE970R
M,2YX;6Q02P$"% ,4    " #H@*924F]_)B$$  "N$@  &0
M@(%0R@  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( .B
MIE*'R!"/3P8  /DC   9              " @:C.  !X;"]W;W)K<VAE971S
M+W-H965T,C,N>&UL4$L! A0#%     @ Z("F4IW1(BB> @  W@8  !D
M         ("!+M4  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4
M    " #H@*927_X,IFL$   P%   &0              @($#V   >&PO=V]R
M:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( .B IE+?V/^ICP,  ,8,
M   9              " @:7<  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL
M4$L! A0#%     @ Z("F4E3,1I!R P   @L  !D              ("!:^
M 'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " #H@*922@B3
M6M\"  !S"   &0              @($4Y   >&PO=V]R:W-H965T<R]S:&5E
M=#(X+GAM;%!+ 0(4 Q0    ( .B IE*WJIU,V@(  "$(   9
M  " @2KG  !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @
MZ("F4DS!6%9$ P  ]P@  !D              ("!.^H  'AL+W=O<FMS:&5E
M=',O<VAE970S,"YX;6Q02P$"% ,4    " #H@*92K%H)*%D+  "A80  &0
M            @(&V[0  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4
M Q0    ( .B IE)JNWM P@(  -,&   9              " @4;Y  !X;"]W
M;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ Z("F4O*4_^:L"
MM30  !D              ("!/_P  'AL+W=O<FMS:&5E=',O<VAE970S,RYX
M;6Q02P$"% ,4    " #H@*921O8S @$$  #R#0  &0              @($B
M!0$ >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( .B IE+Y
M*"RCF (  ( &   9              " @5H) 0!X;"]W;W)K<VAE971S+W-H
M965T,S4N>&UL4$L! A0#%     @ Z("F4IBY8JF2!@  AAP  !D
M     ("!*0P! 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .B IE+M"9Y#'@,  .0)   9              "
M@:P@ 0!X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ Z("F
M4MI<^+WA 0  5 0  !D              ("! 20! 'AL+W=O<FMS:&5E=',O
M<VAE970T,BYX;6Q02P$"% ,4    " #H@*92A 1P@"D#  #\$@  #0
M        @ $9)@$ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( .B IE*7BKL<
MP    !,"   +              "  6TI 0!?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( .B IE)\Y5H6K0,  (@<   /              "  58J 0!X;"]W;W)K
M8F]O:RYX;6Q02P$"% ,4    " #H@*92OLLS09D!  !U&0  &@
M    @ $P+@$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M" #H@*92(]5N#:@!  "X&0  $P              @ $!, $ 6T-O;G1E;G1?
@5'EP97-=+GAM;%!+!08     ,@ R )4-  #:,0$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>244</ContextCount>
  <ElementCount>397</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>80</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>13</UnitCount>
  <MyReports>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2114102 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2118103 - Disclosure - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/Acquisitions</Role>
      <ShortName>Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2123104 - Disclosure - Convertible Senior Notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotes</Role>
      <ShortName>Convertible Senior Notes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2127105 - Disclosure - Income Tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/IncomeTax</Role>
      <ShortName>Income Tax</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2129106 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2133107 - Disclosure - Commitment and Contingencies: Legal Proceedings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings</Role>
      <ShortName>Commitment and Contingencies: Legal Proceedings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>15</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2315302 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/FairValueMeasurements</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2319303 - Disclosure - Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/AcquisitionsTables</Role>
      <ShortName>Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/Acquisitions</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2324304 - Disclosure - Convertible Senior Notes (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesTables</Role>
      <ShortName>Convertible Senior Notes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/ConvertibleSeniorNotes</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2330305 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/StockholdersEquity</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2406403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2407404 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2408405 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2409406 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License and Other Economic Rights (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Commercial License and Other Economic Rights (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2410407 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2411408 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2412409 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2413410 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2416411 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2417412 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails</Role>
      <ShortName>Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2420413 - Disclosure - Acquisitions - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/AcquisitionsNarrativeDetails</Role>
      <ShortName>Acquisitions - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2421414 - Disclosure - Acquisitions - Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails</Role>
      <ShortName>Acquisitions - Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2422415 - Disclosure - Acquisitions - Pro Forma Financial Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails</Role>
      <ShortName>Acquisitions - Pro Forma Financial Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2425416 - Disclosure - Convertible Senior Notes - Narrative (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails</Role>
      <ShortName>Convertible Senior Notes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2426417 - Disclosure - Convertible Senior Notes - Notes Payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails</Role>
      <ShortName>Convertible Senior Notes - Notes Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2428418 - Disclosure - Income Tax - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/IncomeTaxNarrativeDetails</Role>
      <ShortName>Income Tax - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2431419 - Disclosure - Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails</Role>
      <ShortName>Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2432420 - Disclosure - Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2434421 - Disclosure - Commitment and Contingencies: Legal Proceedings - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails</Role>
      <ShortName>Commitment and Contingencies: Legal Proceedings - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="lgnd-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - lgnd-20210331.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - lgnd-20210331.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="lgnd-20210331.htm">lgnd-20210331.htm</File>
    <File>lgnd-20210331.xsd</File>
    <File>lgnd-20210331_cal.xml</File>
    <File>lgnd-20210331_def.xml</File>
    <File>lgnd-20210331_lab.xml</File>
    <File>lgnd-20210331_pre.xml</File>
    <File>lgnd_33121exhibit311.htm</File>
    <File>lgnd_33121exhibit312.htm</File>
    <File>lgnd_33121exhibit321.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>lgnd-20210331_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>60
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "lgnd-20210331.htm": {
   "axisCustom": 0,
   "axisStandard": 25,
   "contextCount": 244,
   "dts": {
    "calculationLink": {
     "local": [
      "lgnd-20210331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "lgnd-20210331_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "lgnd-20210331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lgnd-20210331_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lgnd-20210331_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "lgnd-20210331.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 523,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 2,
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 7
   },
   "keyCustom": 51,
   "keyStandard": 346,
   "memberCustom": 37,
   "memberStandard": 38,
   "nsprefix": "lgnd",
   "nsuri": "http://www.ligand.com/20210331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.ligand.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118103 - Disclosure - Acquisitions",
     "role": "http://www.ligand.com/role/Acquisitions",
     "shortName": "Acquisitions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123104 - Disclosure - Convertible Senior Notes",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotes",
     "shortName": "Convertible Senior Notes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127105 - Disclosure - Income Tax",
     "role": "http://www.ligand.com/role/IncomeTax",
     "shortName": "Income Tax",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129106 - Disclosure - Stockholders' Equity",
     "role": "http://www.ligand.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133107 - Disclosure - Commitment and Contingencies: Legal Proceedings",
     "role": "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings",
     "shortName": "Commitment and Contingencies: Legal Proceedings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315302 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.ligand.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319303 - Disclosure - Acquisitions (Tables)",
     "role": "http://www.ligand.com/role/AcquisitionsTables",
     "shortName": "Acquisitions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324304 - Disclosure - Convertible Senior Notes (Tables)",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesTables",
     "shortName": "Convertible Senior Notes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "i20dcdca84df1452281e6d47bd0f24185_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)",
     "role": "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "i20dcdca84df1452281e6d47bd0f24185_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2330305 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://www.ligand.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "i70e6045ea57e4960b5e7b991ff6afe59_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:ScheduleOfShortTermInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "i20dcdca84df1452281e6d47bd0f24185_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:ScheduleOfShortTermInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "i20dcdca84df1452281e6d47bd0f24185_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "i20dcdca84df1452281e6d47bd0f24185_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407404 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "i20dcdca84df1452281e6d47bd0f24185_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "i20dcdca84df1452281e6d47bd0f24185_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408405 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "i20dcdca84df1452281e6d47bd0f24185_I20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsNetIncludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ib164760a00e846d5b34f96b078179fad_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409406 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License and Other Economic Rights (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Commercial License and Other Economic Rights (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ib164760a00e846d5b34f96b078179fad_I20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "i20dcdca84df1452281e6d47bd0f24185_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410407 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "i20dcdca84df1452281e6d47bd0f24185_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411408 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412409 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "i20dcdca84df1452281e6d47bd0f24185_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "role": "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "i20dcdca84df1452281e6d47bd0f24185_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413410 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "idce9b211fa9d42818fdc3f8ff61affb4_D20100101-20100131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:NumberOfContingentValueRightsSeries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contingent_value_right_series",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416411 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "role": "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
     "shortName": "Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "idce9b211fa9d42818fdc3f8ff61affb4_D20100101-20100131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:NumberOfContingentValueRightsSeries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contingent_value_right_series",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "id28435ac625f4e8f8e07977537c41fef_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417412 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)",
     "role": "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails",
     "shortName": "Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "id28435ac625f4e8f8e07977537c41fef_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "i4464b8371b004313b6607d086dec25b2_D20201001-20201001",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420413 - Disclosure - Acquisitions - Narrative (Details)",
     "role": "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
     "shortName": "Acquisitions - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "i4464b8371b004313b6607d086dec25b2_D20201001-20201001",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "i20dcdca84df1452281e6d47bd0f24185_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421414 - Disclosure - Acquisitions - Assets Acquired and Liabilities Assumed (Details)",
     "role": "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
     "shortName": "Acquisitions - Assets Acquired and Liabilities Assumed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia37942031dbb40cf81304422e5ff426c_I20201001",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "icbe299c7430a4957bb40d8a3d730a73e_D20200101-20200331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422415 - Disclosure - Acquisitions - Pro Forma Financial Information (Details)",
     "role": "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails",
     "shortName": "Acquisitions - Pro Forma Financial Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "icbe299c7430a4957bb40d8a3d730a73e_D20200101-20200331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425416 - Disclosure - Convertible Senior Notes - Narrative (Details)",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
     "shortName": "Convertible Senior Notes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "i9fce823aabcc4d3d949530fe19c30792_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426417 - Disclosure - Convertible Senior Notes - Notes Payable (Details)",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails",
     "shortName": "Convertible Senior Notes - Notes Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "i9fce823aabcc4d3d949530fe19c30792_I20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428418 - Disclosure - Income Tax - Narrative (Details)",
     "role": "http://www.ligand.com/role/IncomeTaxNarrativeDetails",
     "shortName": "Income Tax - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "if492415c8fb84dc28c02e844ba8b7ba7_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431419 - Disclosure - Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)",
     "role": "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails",
     "shortName": "Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "if492415c8fb84dc28c02e844ba8b7ba7_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)",
     "role": "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
     "shortName": "Condensed Consolidated Statements of Operations (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostDirectMaterial",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "i20dcdca84df1452281e6d47bd0f24185_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432420 - Disclosure - Stockholders' Equity - Narrative (Details)",
     "role": "http://www.ligand.com/role/StockholdersEquityNarrativeDetails",
     "shortName": "Stockholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "i20dcdca84df1452281e6d47bd0f24185_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "i4829221eea044e2c99470e6c93d2698c_D20191029-20191029",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainContingencyPatentsAllegedlyInfringedUponNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "patent",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434421 - Disclosure - Commitment and Contingencies: Legal Proceedings - Narrative (Details)",
     "role": "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails",
     "shortName": "Commitment and Contingencies: Legal Proceedings - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "i4829221eea044e2c99470e6c93d2698c_D20191029-20191029",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainContingencyPatentsAllegedlyInfringedUponNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "patent",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)",
     "role": "http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ie09c209670384c35b1d40e0d01cdef82_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited)",
     "role": "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ie09c209670384c35b1d40e0d01cdef82_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "role": "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114102 - Disclosure - Fair Value Measurements",
     "role": "http://www.ligand.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210331.htm",
      "contextRef": "ia81a7d59e89040b19580de880bef9bdc_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": null,
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - lgnd-20210331.htm",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - lgnd-20210331.htm",
     "subGroupType": "",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 80,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "lgnd_AccruedAssetAcquisitionsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Asset Acquisitions, Current",
        "label": "Accrued Asset Acquisitions, Current",
        "terseLabel": "Acquisition related liabilities"
       }
      }
     },
     "localname": "AccruedAssetAcquisitionsCurrent",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AccruedInventoryPurchases": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Inventory Purchases",
        "label": "Accrued Inventory Purchases",
        "terseLabel": "Accrued inventory purchases"
       }
      }
     },
     "localname": "AccruedInventoryPurchases",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AccruedSubcontractorExpensesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Subcontractor Expenses, Current",
        "label": "Accrued Subcontractor Expenses, Current",
        "terseLabel": "Subcontractor"
       }
      }
     },
     "localname": "AccruedSubcontractorExpensesCurrent",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AccruedSupplierExpensesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Supplier Expenses, Current",
        "label": "Accrued Supplier Expenses, Current",
        "terseLabel": "Supplier"
       }
      }
     },
     "localname": "AccruedSupplierExpensesCurrent",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Foreign Currency Translation Adjustment",
        "label": "Adjustments to Additional Paid in Capital, Foreign Currency Translation Adjustment",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Tax Effect of Convertible Senior Notes Transactions",
        "label": "Adjustments to Additional Paid in Capital, Tax Effect of Convertible Senior Notes Transactions",
        "negatedTerseLabel": "Tax effect for 2023 Notes transactions"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions",
        "label": "Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions",
        "terseLabel": "Warrant and bond hedge unwind transactions"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AmortizationOfOtherEconomicRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of Other Economic Rights",
        "label": "Amortization of Other Economic Rights",
        "verboseLabel": "Amortization of commercial license and other economic rights"
       }
      }
     },
     "localname": "AmortizationOfOtherEconomicRights",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AziyoAndCorMatrixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aziyo and CorMatrix",
        "label": "Aziyo and CorMatrix [Member]",
        "terseLabel": "Aziyo and CorMatrix"
       }
      }
     },
     "localname": "AziyoAndCorMatrixMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_AziyoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "AziyoMember",
        "terseLabel": "Aziyo"
       }
      }
     },
     "localname": "AziyoMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_BasisOfPresentationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of presentation.",
        "label": "Basis of Presentation [Line Items]",
        "terseLabel": "Basis of Presentation [Line Items]"
       }
      }
     },
     "localname": "BasisOfPresentationLineItems",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_BasisOfPresentationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of Presentation.",
        "label": "Basis of Presentation [Table]",
        "terseLabel": "Basis of Presentation [Table]"
       }
      }
     },
     "localname": "BasisOfPresentationTable",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_BusinessCombinationConsiderationTransferredHoldback": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Holdback",
        "label": "Business Combination, Consideration Transferred, Holdback",
        "terseLabel": "Holdback from acquisition"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredHoldback",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency",
        "label": "Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency",
        "terseLabel": "Earnout rights recognized"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Fair Value Disclosure",
        "label": "Business Combination, Contingent Consideration, Liability, Fair Value Disclosure",
        "terseLabel": "Fair value of contingent earn-out payment"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Percentage of Acquiree Revenues",
        "label": "Business Combination, Contingent Consideration, Liability, Percentage of Acquiree Revenues",
        "terseLabel": "Proportion of milestone payments (as a percent)"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders",
        "label": "Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders",
        "terseLabel": "Frequency of cash payments to CVR holders"
       }
      }
     },
     "localname": "BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series",
        "label": "Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series",
        "terseLabel": "Number of CVRs issued from each CVR series"
       }
      }
     },
     "localname": "BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Number of Contingent Value Rights Issued per Acquiree Share",
        "label": "Business Combination, Number of Contingent Value Rights Issued per Acquiree Share",
        "terseLabel": "Number of CVRs issued per acquiree share"
       }
      }
     },
     "localname": "BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities, Current",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities, Current",
        "negatedTerseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets",
        "terseLabel": "Intangibles acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Discount Rate",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Discount Rate",
        "terseLabel": "Discount rate used to value intangible assets acquired (as a percent)"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Lease Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Lease Liabilities",
        "negatedTerseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets",
        "terseLabel": "Right-of-use asset"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets",
        "terseLabel": "Tangible assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)",
        "label": "COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)",
        "terseLabel": "Additional allowance for credit losses recorded related to COVID-19"
       }
      }
     },
     "localname": "COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_CommercialLicenseAndOtherEconomicRightsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial License and Other Economic Rights",
        "label": "Commercial License and Other Economic Rights [Abstract]",
        "verboseLabel": "Commercial License and Other Economic Rights"
       }
      }
     },
     "localname": "CommercialLicenseAndOtherEconomicRightsAbstract",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial License and Other Economic Rights, Allowance for Credit Loss",
        "label": "Commercial License and Other Economic Rights, Allowance for Credit Loss",
        "terseLabel": "Allowance for credit loss"
       }
      }
     },
     "localname": "CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_CommercialLicenseRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "CommercialLicenseRights",
        "terseLabel": "Commercial license and other economic rights, net"
       }
      }
     },
     "localname": "CommercialLicenseRights",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Value Right for Internal Research and Development",
        "label": "Contingent Value Right for Internal Research and Development [Member]",
        "terseLabel": "Contingent Value Right for Internal Research and Development"
       }
      }
     },
     "localname": "ContingentValueRightForInternalResearchAndDevelopmentMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ContingentValueRightOnProductRevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Value Right on Product Revenues",
        "label": "Contingent Value Right on Product Revenues [Member]",
        "terseLabel": "Contingent Value Right on Product Revenues"
       }
      }
     },
     "localname": "ContingentValueRightOnProductRevenuesMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ContractRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Revenue",
        "label": "Contract Revenue [Member]",
        "terseLabel": "Contract revenue"
       }
      }
     },
     "localname": "ContractRevenueMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ContractRevenueServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Revenue, Service",
        "label": "Contract Revenue, Service [Member]",
        "terseLabel": "Service Revenue"
       }
      }
     },
     "localname": "ContractRevenueServiceMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ConvertibleSeniorNotesDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes due 2023",
        "label": "Convertible Senior Notes due 2023 [Member]",
        "terseLabel": "2023 Convertible Senior Notes"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2023Member",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_CurrentPortionOfLiabilityForContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "CurrentPortionOfLiabilityForContingentValueRights",
        "verboseLabel": "Current contingent liabilities"
       }
      }
     },
     "localname": "CurrentPortionOfLiabilityForContingentValueRights",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger",
        "terseLabel": "Maximum threshold of debt trading price trigger (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available for Sale and Equity Securities, FV-NI",
        "label": "Debt Securities, Available for Sale and Equity Securities, FV-NI",
        "totalLabel": "Estimated fair value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "",
        "label": "Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties [Member]",
        "terseLabel": "Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties"
       }
      }
     },
     "localname": "DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnout Rights for Partner Research and Development",
        "label": "Earnout Rights for Partner Research and Development [Member]",
        "terseLabel": "Earnout Rights for Partner Research and Development"
       }
      }
     },
     "localname": "EarnoutRightsForPartnerResearchAndDevelopmentMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_EmployeeStockPurchasePlanAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan [Abstract]",
        "label": "Employee Stock Purchase Plan [Abstract]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanAbstract",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "EmployeeStockPurchasePlanMember",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_EquityMethodInvestmentSharesSold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Shares Sold",
        "label": "Equity Method Investment, Shares Sold",
        "terseLabel": "Stock sold in equity method investment (shares)"
       }
      }
     },
     "localname": "EquityMethodInvestmentSharesSold",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "lgnd_EvomelaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Evomela",
        "label": "Evomela [Member]",
        "terseLabel": "Evomela"
       }
      }
     },
     "localname": "EvomelaMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition",
        "terseLabel": "Contingent liabilities from xCella asset acquisition"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments",
        "negatedTerseLabel": "Adjustments"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-lived Intangible Assets, Credit Loss Adjustments",
        "label": "Finite-lived Intangible Assets, Credit Loss Adjustments",
        "negatedLabel": "Credit loss adjustments of finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsCreditLossAdjustments",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_ForecastedCashFlowsEffectiveInterestRatePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forecasted Cash Flows, Effective Interest Rate, Percent",
        "label": "Forecasted Cash Flows, Effective Interest Rate, Percent",
        "terseLabel": "Effective interest rate for forecasted cash flows (as a percent)"
       }
      }
     },
     "localname": "ForecastedCashFlowsEffectiveInterestRatePercent",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_GainLossOnShortTermInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) on Short-term Investments",
        "label": "Gain (Loss) on Short-term Investments",
        "negatedLabel": "Loss (gain) from short-term investments"
       }
      }
     },
     "localname": "GainLossOnShortTermInvestments",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_GlaxoSmithKlineBiologicalsSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "GlaxoSmithKline Biologicals S.A.",
        "label": "GlaxoSmithKline Biologicals S.A. [Member]",
        "terseLabel": "GSK"
       }
      }
     },
     "localname": "GlaxoSmithKlineBiologicalsSAMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_IcagenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Icagen",
        "label": "Icagen [Member]",
        "terseLabel": "Icagen"
       }
      }
     },
     "localname": "IcagenMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_IncreaseDecreaseInDebtDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Debt Discount",
        "label": "Increase (Decrease) in Debt Discount",
        "negatedLabel": "Increase (decrease) in debt discount"
       }
      }
     },
     "localname": "IncreaseDecreaseInDebtDiscount",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_InterPartesReviewOfPatentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inter Partes Review of Patent",
        "label": "Inter Partes Review of Patent [Member]",
        "terseLabel": "Inter Partes Review of Patent"
       }
      }
     },
     "localname": "InterPartesReviewOfPatentMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_KyprolisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kyprolis",
        "label": "Kyprolis [Member]",
        "terseLabel": "Kyprolis"
       }
      }
     },
     "localname": "KyprolisMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "LiabilityForContingentValueRights",
        "verboseLabel": "Long-term contingent liabilities"
       }
      }
     },
     "localname": "LiabilityForContingentValueRights",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyCrystalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, Crystal [Member]",
        "label": "Liability For Contingent Value Rights Company, Crystal [Member]",
        "terseLabel": "Contingent liabilities - Crystal"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyCrystalMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyCydexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, Cydex",
        "label": "Liability For Contingent Value Rights Company, Cydex [Member]",
        "verboseLabel": "Contingent liabilities - CyDex"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyCydexMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyIcagenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, Icagen",
        "label": "Liability For Contingent Value Rights Company, Icagen [Member]",
        "terseLabel": "Contingent liabilities - Icagen"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyIcagenMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, Metabasis",
        "label": "Liability For Contingent Value Rights Company, Metabasis [Member]",
        "terseLabel": "Contingent liabilities - Metabasis"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyMetabasisMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyPfenexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, Pfenex",
        "label": "Liability For Contingent Value Rights Company, Pfenex [Member]",
        "terseLabel": "Contingent liabilities - Pfenex"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyPfenexMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyXCellaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, xCella",
        "label": "Liability For Contingent Value Rights Company, xCella [Member]",
        "terseLabel": "Contingent liabilities - xCella"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyXCellaMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability for Restricted Investments Owed to Former Licensees [Member]",
        "label": "Liability for Restricted Investments Owed to Former Licensees [Member]",
        "terseLabel": "Liability for restricted investments owed to former licensees"
       }
      }
     },
     "localname": "LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LicenseFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License Fees",
        "label": "License Fees [Member]",
        "terseLabel": "License Fees"
       }
      }
     },
     "localname": "LicenseFeesMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License Fees, Milestones, and Product, Other, Product, Other",
        "label": "License Fees, Milestones, and Product, Other, Product, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "LicenseFeesMilestonesAndProductOtherProductOtherMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LicenseeAccrualCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensee Accrual, Current",
        "label": "Licensee Accrual, Current",
        "terseLabel": "Amounts owed to former licensees"
       }
      }
     },
     "localname": "LicenseeAccrualCurrent",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LupinPatentInfringementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lupin Patent Infringement",
        "label": "Lupin Patent Infringement [Member]",
        "terseLabel": "Lupin Patent Infringement"
       }
      }
     },
     "localname": "LupinPatentInfringementMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MaterialSalesCaptisolMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material Sales, Captisol",
        "label": "Material Sales, Captisol [Member]",
        "verboseLabel": "Captisol"
       }
      }
     },
     "localname": "MaterialSalesCaptisolMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MetabasisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Metabasis",
        "label": "Metabasis [Member]",
        "terseLabel": "Metabasis"
       }
      }
     },
     "localname": "MetabasisMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone",
        "label": "Milestone [Member]",
        "terseLabel": "Milestone"
       }
      }
     },
     "localname": "MilestoneMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MilestonePaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone Payments",
        "label": "Milestone Payments [Member]",
        "terseLabel": "Milestone Payments"
       }
      }
     },
     "localname": "MilestonePaymentsMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "NonCashChangeInEstimatedFairValueOfContingentValueRights",
        "negatedLabel": "Change in estimated fair value of contingent liabilities"
       }
      }
     },
     "localname": "NonCashChangeInEstimatedFairValueOfContingentValueRights",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_NumberOfContingentValueRightsSeries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Contingent Value Rights Series",
        "label": "Number of Contingent Value Rights Series",
        "terseLabel": "Number of CVR Series"
       }
      }
     },
     "localname": "NumberOfContingentValueRightsSeries",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_NumberOfOptionsUnderConvertibleBondHedges": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Options under Convertible Bond Hedges",
        "label": "Number of Options under Convertible Bond Hedges",
        "terseLabel": "Number of options under convertible bond hedges"
       }
      }
     },
     "localname": "NumberOfOptionsUnderConvertibleBondHedges",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_NumberOfPetitionsFiled": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Petitions Filed",
        "label": "Number of Petitions Filed",
        "terseLabel": "Number of petitions filed"
       }
      }
     },
     "localname": "NumberOfPetitionsFiled",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_PaymentsForConvertibleBondHedges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Convertible Bond Hedges",
        "label": "Payments for Convertible Bond Hedges",
        "terseLabel": "Payments for convertible bond hedges"
       }
      }
     },
     "localname": "PaymentsForConvertibleBondHedges",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Acquire Businesses, Gross, Attributable to Vested Portion of Stock Options",
        "label": "Payments to Acquire Businesses, Gross, Attributable to Vested Portion of Stock Options",
        "terseLabel": "Gross payments to acquire business attributable to vested portion of stock options"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToContingentValueRightHoldersFinancingActivity": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Contingent Value Right Holders, Financing Activity",
        "label": "Payments to Contingent Value Right Holders, Financing Activity",
        "negatedLabel": "Payments to CVR Holders"
       }
      }
     },
     "localname": "PaymentsToContingentValueRightHoldersFinancingActivity",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToUnwindWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Unwind Warrants",
        "label": "Payments to Unwind Warrants",
        "terseLabel": "Payments to unwind warrants"
       }
      }
     },
     "localname": "PaymentsToUnwindWarrants",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PfenexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pfenex",
        "label": "Pfenex [Member]",
        "terseLabel": "Pfenex"
       }
      }
     },
     "localname": "PfenexMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails",
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_Phase3ClinicalTrialMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Phase 3 Clinical Trial",
        "label": "Phase 3 Clinical Trial [Member]",
        "terseLabel": "Phase 3 Clinical Trial"
       }
      }
     },
     "localname": "Phase3ClinicalTrialMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ProceedsFromUnwindingConvertibleBondHedges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Unwinding Convertible Bond Hedges",
        "label": "Proceeds from Unwinding Convertible Bond Hedges",
        "terseLabel": "Proceeds from unwinding convertible bond hedges"
       }
      }
     },
     "localname": "ProceedsFromUnwindingConvertibleBondHedges",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_ReturnsAccrual": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Returns Accrual",
        "label": "Returns Accrual",
        "terseLabel": "Return reserve"
       }
      }
     },
     "localname": "ReturnsAccrual",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_RoyaltyOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty, Other",
        "label": "Royalty, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "RoyaltyOtherMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlock [Table Text Block]",
        "verboseLabel": "Schedule of Accounting for Share-Based Compensation"
       }
      }
     },
     "localname": "ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Commercial License Rights",
        "label": "Schedule of Commercial License Rights [Table Text Block]",
        "terseLabel": "Schedule of Commercial License and Other Economic Rights"
       }
      }
     },
     "localname": "ScheduleOfCommercialLicenseRightsTableTextBlock",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_ScheduleOfShortTermInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Short-Term investments",
        "label": "Schedule of Short-Term investments [Table Text Block]",
        "terseLabel": "Schedule of Short-Term Investments"
       }
      }
     },
     "localname": "ScheduleOfShortTermInvestmentsTableTextBlock",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_SelexisAndDianomiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Selexis and Dianomi",
        "label": "Selexis and Dianomi [Member]",
        "terseLabel": "Selexis and Dianomi"
       }
      }
     },
     "localname": "SelexisAndDianomiMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_SelexisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Selexis",
        "label": "Selexis [Member]",
        "terseLabel": "Selexis"
       }
      }
     },
     "localname": "SelexisMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent",
        "label": "Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent",
        "terseLabel": "Payout range (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_TaurusBiosciencesLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Taurus Biosciences, LLC",
        "label": "Taurus Biosciences, LLC [Member]",
        "terseLabel": "Taurus"
       }
      }
     },
     "localname": "TaurusBiosciencesLLCMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US District Court for the Northern District of Ohio",
        "label": "US District Court for the Northern District of Ohio [Member]",
        "terseLabel": "US District Court for the Northern District of Ohio"
       }
      }
     },
     "localname": "USDistrictCourtForTheNorthernDistrictOfOhioMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_XCellaBiosciencesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "xCella Biosciences, Inc.",
        "label": "xCella Biosciences, Inc. [Member]",
        "terseLabel": "xCella"
       }
      }
     },
     "localname": "XCellaBiosciencesIncMember",
     "nsuri": "http://www.ligand.com/20210331",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r46",
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r112",
      "r119",
      "r193",
      "r326",
      "r327",
      "r328",
      "r341",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r112",
      "r119",
      "r193",
      "r326",
      "r327",
      "r328",
      "r341",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r112",
      "r119",
      "r193",
      "r326",
      "r327",
      "r328",
      "r341",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r287",
      "r289",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r449",
      "r502",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r287",
      "r289",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r449",
      "r502",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r168",
      "r265",
      "r268",
      "r450",
      "r501",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r168",
      "r265",
      "r268",
      "r450",
      "r501",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r276",
      "r287",
      "r289",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r449",
      "r502",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r276",
      "r287",
      "r289",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r449",
      "r502",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r113",
      "r114",
      "r115",
      "r116",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r341",
      "r342",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible List]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r5",
      "r21",
      "r171",
      "r172"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Amortization of premium (discount) on investments, net"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Total accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails",
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities [Abstract]",
        "verboseLabel": "Accrued Liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r33"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "verboseLabel": "Professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r33"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Royalties, Current",
        "terseLabel": "Royalties owed to third parties"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r24",
      "r51",
      "r52",
      "r53",
      "r490",
      "r512",
      "r516"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r50",
      "r53",
      "r54",
      "r109",
      "r110",
      "r111",
      "r378",
      "r507",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted-average estimated useful life of finite-lived intangible assets acquired"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r22",
      "r329"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r109",
      "r110",
      "r111",
      "r326",
      "r327",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": {
     "auth_ref": [
      "r233"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.",
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt",
        "negatedLabel": "Adjustments to additional paid in capital, equity component of convertible debt",
        "verboseLabel": "Reacquisition of equity due to 2023 debt extinguishment, net of tax"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).",
        "label": "Adjustments to Additional Paid in Capital, Other",
        "terseLabel": "Reacquisition of equity due to 2023 debt extinguishment, net of tax"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r290",
      "r292",
      "r331",
      "r332"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r232",
      "r243",
      "r251"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "verboseLabel": "Adjustments to additional paid-in-capital from warrants"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net income (loss) to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AgencySecuritiesMember": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities issued by government sponsored entities.",
        "label": "Agency Securities [Member]",
        "terseLabel": "Agency bonds"
       }
      }
     },
     "localname": "AgencySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, after Tax",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r89",
      "r410"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt discount and issuance fees"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potentially dilutive shares excluded from calculation due to anti-dilutive effect (shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r101",
      "r157",
      "r160",
      "r166",
      "r189",
      "r374",
      "r379",
      "r399",
      "r466",
      "r488"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r45",
      "r101",
      "r189",
      "r374",
      "r379",
      "r399"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "verboseLabel": "Assets, fair value"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r179"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross unrealized gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r180"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross unrealized losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r176",
      "r201"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Amortized cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost",
        "terseLabel": "Within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value",
        "terseLabel": "Within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost",
        "terseLabel": "After one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value",
        "terseLabel": "After one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate": {
     "auth_ref": [
      "r181",
      "r182",
      "r482"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r174",
      "r177",
      "r201",
      "r472"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Estimated fair value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r294",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r384",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "verboseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r286",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r286",
      "r288",
      "r353",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.",
        "label": "Business Acquisition, Transaction Costs",
        "terseLabel": "Post-combination expense"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": {
     "auth_ref": [
      "r351",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Basic",
        "terseLabel": "Basic (USD per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": {
     "auth_ref": [
      "r351",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Diluted",
        "terseLabel": "Diluted (USD per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r351",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Schedule of Pro Forma Information"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r371"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill acquired that is expected to be deductible for tax purposes"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r351",
      "r352"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r351",
      "r352"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r350"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Acquisition related costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r365",
      "r366",
      "r368"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Consideration transferred in acquisition"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r364",
      "r367",
      "r370"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent earn-out payment"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Contingent consideration liability, measurement input (as a percent)"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/Acquisitions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r356"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "verboseLabel": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r356"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts and unbilled receivables"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r356"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "negatedTerseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "auth_ref": [
      "r356"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "negatedLabel": "Deferred revenue",
        "negatedTerseLabel": "Deferred revenue acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r356"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "terseLabel": "Deferred tax assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r356"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedLabel": "Deferred tax liability acquired in connection with the acquired intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r355",
      "r356"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Finite-lived intangible assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r356"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "negatedLabel": "Liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r355",
      "r356"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "totalLabel": "Total consideration"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r356"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "negatedLabel": "Other liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r356"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 14.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r355",
      "r356"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r93",
      "r94",
      "r95"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Accrued fixed asset purchases"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r28",
      "r91"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r84",
      "r91",
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r84",
      "r400"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "verboseLabel": "Warrant exercise price (USD per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "netLabel": "Outstanding warrants to purchase shares of Viking's common stock (shares)",
        "verboseLabel": "Warrants issued in public offering (shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Warrants outstanding (shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r39",
      "r226",
      "r474",
      "r494"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r223",
      "r224",
      "r225",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitment and Contingencies: Legal Proceedings"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r109",
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Common stock, par value (USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Common stock authorized (shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "verboseLabel": "Common stock issued (shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r20",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock outstanding (shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, $0.001 par value; 60,000 shares authorized; 16,652 and 16,080 shares issued and outstanding at March\u00a031, 2021 and December\u00a031, 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r56",
      "r58",
      "r59",
      "r62",
      "r476",
      "r498"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetGross": {
     "auth_ref": [
      "r253",
      "r255"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, before Allowance for Credit Loss",
        "terseLabel": "Gross contract asset"
       }
      }
     },
     "localname": "ContractWithCustomerAssetGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r253",
      "r254",
      "r266"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized from milestone method revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualRightsMember": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights that arise from a contractual arrangement with a third party (not including franchise rights and license agreements).",
        "label": "Contractual Rights [Member]",
        "terseLabel": "Contractual relationships",
        "verboseLabel": "Contractual Relationships"
       }
      }
     },
     "localname": "ContractualRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt, Fair Value Disclosures",
        "verboseLabel": "Fair value of the 2023 Notes outstanding (Level 2)"
       }
      }
     },
     "localname": "ConvertibleDebtFairValueDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Convertible Debt, Noncurrent",
        "terseLabel": "2023 convertible senior notes, net"
       }
      }
     },
     "localname": "ConvertibleDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleNotesPayableMember": {
     "auth_ref": [
      "r15",
      "r467",
      "r485",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Convertible Notes Payable [Member]",
        "terseLabel": "Convertible Notes"
       }
      }
     },
     "localname": "ConvertibleNotesPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r277",
      "r285",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostDirectMaterial": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of material used for good produced and service rendered.",
        "label": "Cost, Direct Material",
        "terseLabel": "Cost of Captisol"
       }
      }
     },
     "localname": "CostDirectMaterial",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldAmortization": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.",
        "label": "Cost, Amortization",
        "terseLabel": "Amortization of intangibles"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships",
        "verboseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Convertible Senior Notes"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r15",
      "r17",
      "r18",
      "r467",
      "r468",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": {
     "auth_ref": [
      "r234"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.",
        "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component",
        "terseLabel": "Carrying value of equity component of the 2023 Notes"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Initial conversion price (USD per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r36",
      "r244",
      "r247",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Initial conversion rate (shares per $1,000)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Stock price trigger to classify convertible debt as current (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Threshold trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r409",
      "r411"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermNotesPayable",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Principal amount of the 2023 Notes outstanding",
        "verboseLabel": "Aggregate principal amount outstanding"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentIncreaseAccruedInterest": {
     "auth_ref": [
      "r105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.",
        "label": "Debt Instrument, Increase, Accrued Interest",
        "terseLabel": "Accrued Interest"
       }
      }
     },
     "localname": "DebtInstrumentIncreaseAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period One"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Two"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRepurchaseAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value amount of debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchase Amount",
        "terseLabel": "Repurchased amount of debt instrument"
       }
      }
     },
     "localname": "DebtInstrumentRepurchaseAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r37",
      "r104",
      "r244",
      "r248",
      "r249",
      "r250",
      "r408",
      "r409",
      "r411",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r408",
      "r411"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermNotesPayable",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedTerseLabel": "Unamortized discount (including unamortized debt issuance cost)"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r408",
      "r411"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Debt Instrument, Unamortized Premium",
        "terseLabel": "Debt premium"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "auth_ref": [
      "r178",
      "r201",
      "r205",
      "r206"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Allowance for Credit Loss",
        "terseLabel": "Credit losses related to available-for-sale debt securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Schedule of Available-for-Sale Debt Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Unrealized Gain (Loss)",
        "terseLabel": "Unrealized net gain (loss) on available-for-sale securities, net of deferred tax"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r186",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions",
        "terseLabel": "Number of positions in an unrealized loss position"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Amortized Cost [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableforsaleAmortizedCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r410"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r334",
      "r335"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r334",
      "r335"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DemandDepositsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts that may or may not bear interest and that depositor is entitled to withdraw at anytime without prior notice. Checking and negotiable order of withdrawal (NOW) accounts are the most common forms of demand deposits.",
        "label": "Demand Deposits [Member]",
        "terseLabel": "Bank deposits"
       }
      }
     },
     "localname": "DemandDepositsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r89",
      "r155"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "verboseLabel": "Depreciation and amortization of intangible assets"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DilutiveSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]",
        "terseLabel": "Dilutive potential common shares:"
       }
      }
     },
     "localname": "DilutiveSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r265",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Revenue by Source"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r63",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r125",
      "r128",
      "r133",
      "r134",
      "r135",
      "r138",
      "r139",
      "r477",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Basic net income (loss) per share (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Summary of computation of basic and diluted net income (loss) per share",
        "verboseLabel": "Earnings Per Share, Basic and Diluted:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r63",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r128",
      "r133",
      "r134",
      "r135",
      "r138",
      "r139",
      "r477",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net income (loss) per share (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r97",
      "r136",
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "verboseLabel": "Net Income (loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareProFormaAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Pro Forma [Abstract]",
        "terseLabel": "Net loss per common share:"
       }
      }
     },
     "localname": "EarningsPerShareProFormaAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r400"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate (as a percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "verboseLabel": "Compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards": {
     "auth_ref": [
      "r318"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cash paid by the entity during the period to settle equity instruments granted under equity-based payment arrangements.",
        "label": "Share-based Payment Arrangement, Cash Used to Settle Award",
        "terseLabel": "Cash to settle unvested stock options recognized as share-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares to be repurchased in accordance with a policy to use treasury stock to satisfy share-award conversions.",
        "label": "Share-based Payment Arrangement, Shares Expected to be Repurchased, Next Fiscal Period",
        "verboseLabel": "Shares available for future purchases (shares)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r109",
      "r110",
      "r111",
      "r114",
      "r122",
      "r124",
      "r140",
      "r193",
      "r243",
      "r251",
      "r326",
      "r327",
      "r328",
      "r341",
      "r342",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r507",
      "r508",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvesteeMember": {
     "auth_ref": [
      "r188",
      "r454",
      "r456",
      "r458",
      "r460",
      "r462",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity that issued voting stock held by an investor and that is accounted for under the equity method of accounting by the investor.",
        "label": "Equity Method Investee [Member]",
        "terseLabel": "Viking Therapeutics, Inc."
       }
      }
     },
     "localname": "EquityMethodInvesteeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "auth_ref": [
      "r66",
      "r67",
      "r89"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.",
        "label": "Equity Method Investment, Realized Gain (Loss) on Disposal",
        "terseLabel": "Realized gain on sale of stock in equity method investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r398"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 1.0,
       "parentTag": "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "netLabel": "Fair value of equity securities",
        "terseLabel": "Estimated fair value"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r12",
      "r16",
      "r187",
      "r486",
      "r520",
      "r521",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Corporate equity securities",
        "verboseLabel": "Investment in Viking common stock"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r386",
      "r387",
      "r388",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r386",
      "r387",
      "r388",
      "r395",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "verboseLabel": "Schedule of Assets and Liabilities Measured at Fair Value"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Fair Value by Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r386",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r285",
      "r387",
      "r422",
      "r423",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r394",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r386",
      "r387",
      "r390",
      "r391",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "verboseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r277",
      "r278",
      "r283",
      "r285",
      "r387",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "verboseLabel": "Quoted Prices in Active Markets for Identical Assets (Level 1)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r277",
      "r278",
      "r283",
      "r285",
      "r387",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "verboseLabel": "Significant Other Observable Inputs (Level 2)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r285",
      "r387",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3",
        "verboseLabel": "Significant Unobservable Inputs (Level 3)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Financial and Nonfinancial Liabilities, Fair Value Disclosure [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r392",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Level 3 Financial Instruments"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r393"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Fair value adjustments to contingent liabilities"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Fair value of level 3 financial instruments as of March 31, 2021",
        "periodStartLabel": "Fair value of level 3 financial instruments as of December 31, 2020"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r285",
      "r422",
      "r423",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r394",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "verboseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r413"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Current financing lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r414",
      "r415"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedTerseLabel": "Payments under financing lease obligations"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r412"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Financing lease right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r184",
      "r185",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r203",
      "r204",
      "r207",
      "r208",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r219"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Less: accumulated amortization",
        "negatedTerseLabel": "Accumulated amortization on finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r214",
      "r216",
      "r219",
      "r220",
      "r451",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r219",
      "r452"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      },
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "netLabel": "Gross",
        "verboseLabel": "Definite lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r214",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r219",
      "r451"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Gain Contingencies [Line Items]",
        "terseLabel": "Gain Contingencies [Line Items]"
       }
      }
     },
     "localname": "GainContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainContingenciesTable": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sets forth the existing conditions, situations, or sets of circumstances involving uncertainties as of the balance sheet date (or before issuance of the financial statements) that might result in a gain, typically reflecting care to avoid misleading implications as to the likelihood of realization, and previously disclosed contingent gains that were recognized as income in the period.",
        "label": "Gain Contingencies [Table]",
        "terseLabel": "Gain Contingencies [Table]"
       }
      }
     },
     "localname": "GainContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of entity's patents that another entity has allegedly infringed.",
        "label": "Gain Contingency, Patents Allegedly Infringed upon, Number",
        "terseLabel": "Number of patents allegedly infringed upon"
       }
      }
     },
     "localname": "GainContingencyPatentsAllegedlyInfringedUponNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r70",
      "r89",
      "r175"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "verboseLabel": "Gain (loss) from short-term investments"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r89",
      "r237",
      "r238"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Loss (gain) on debt extinguishment",
        "negatedTerseLabel": "Loss on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "verboseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "verboseLabel": "SBC - General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r209",
      "r210",
      "r465"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": 1.0
      },
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r211"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis": {
     "auth_ref": [
      "r183",
      "r481"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date.",
        "label": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Amortized Cost",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r106",
      "r157",
      "r159",
      "r162",
      "r165",
      "r167"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r338",
      "r339",
      "r340",
      "r343",
      "r345",
      "r347",
      "r348",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Tax"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/IncomeTax"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r102",
      "r123",
      "r124",
      "r156",
      "r336",
      "r344",
      "r346",
      "r500"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r42",
      "r473",
      "r496"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income taxes receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income tax receivable and payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current liabilities classified as other.",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r135"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Stock options (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r213",
      "r217"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "verboseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.",
        "label": "Intangible Assets, Net (Including Goodwill)",
        "totalLabel": "Total goodwill and other identifiable intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net (Including Goodwill) [Abstract]",
        "verboseLabel": "Summary of Goodwill and Other Identifiable Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r60",
      "r154",
      "r407",
      "r410",
      "r478"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r82",
      "r85",
      "r92"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r9",
      "r10",
      "r33"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r4",
      "r43"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "verboseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r69",
      "r153"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r495"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r32",
      "r101",
      "r161",
      "r189",
      "r375",
      "r379",
      "r380",
      "r399"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r27",
      "r101",
      "r189",
      "r399",
      "r469",
      "r492"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r34",
      "r101",
      "r189",
      "r375",
      "r379",
      "r380",
      "r399"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r386"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "verboseLabel": "Liabilities, fair value"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Commercial license rights"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r18",
      "r235",
      "r468",
      "r489"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "totalLabel": "Total long-term portion of notes payable"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r37",
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Payable, Current and Noncurrent [Abstract]",
        "terseLabel": "Notes Payable, Current and Noncurrent [Abstract]"
       }
      }
     },
     "localname": "LongtermNotesPayableCurrentAndNoncurrentTotalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "Number of civil complaints filed against entity"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Discount Rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MutualFundMember": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulated investment instrument that pools funds from multiple investors to invest principally in a portfolio of securities and money market instruments to match the investment objective.",
        "label": "Mutual Fund [Member]",
        "terseLabel": "Mutual fund"
       }
      }
     },
     "localname": "MutualFundMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r84",
      "r86",
      "r90"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r55",
      "r57",
      "r61",
      "r90",
      "r101",
      "r113",
      "r117",
      "r118",
      "r119",
      "r120",
      "r123",
      "r124",
      "r132",
      "r157",
      "r159",
      "r162",
      "r165",
      "r167",
      "r189",
      "r399",
      "r475",
      "r497"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss):"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Accounting Standards Recently Adopted and Accounting Standards Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental schedule of non-cash activity:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (loss), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Operating Costs and Expenses",
        "totalLabel": "Total operating costs and expenses"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingCostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Costs and Expenses [Abstract]",
        "verboseLabel": "Operating costs and expenses:"
       }
      }
     },
     "localname": "OperatingCostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r157",
      "r159",
      "r162",
      "r165",
      "r167"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r413"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r413"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r412"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "netLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r2",
      "r108",
      "r150",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r33"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r48",
      "r49",
      "r51"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "verboseLabel": "Unrealized net loss on available-for-sale securities, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "verboseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "verboseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentedTechnologyMember": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patented technology to exploit the technology for a period of time specified by law.",
        "label": "Patented Technology [Member]",
        "verboseLabel": "Complete technology"
       }
      }
     },
     "localname": "PatentedTechnologyMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForHedgeFinancingActivities": {
     "auth_ref": [
      "r81",
      "r87"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.",
        "label": "Payments for Hedge, Financing Activities",
        "negatedTerseLabel": "Payments to convertible bond holders for warrant purchases"
       }
      }
     },
     "localname": "PaymentsForHedgeFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r73",
      "r75",
      "r107"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Share repurchase"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedLabel": "Taxes paid related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r74",
      "r369"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash payments for acquisition"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Payments to Acquire Short-term Investments",
        "negatedTerseLabel": "Purchase of short-term investments"
       }
      }
     },
     "localname": "PaymentsToAcquireShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r294",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock authorized (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock issued (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock outstanding (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at March\u00a031, 2021 and December\u00a031, 2020"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r77"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from debt, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromHedgeFinancingActivities": {
     "auth_ref": [
      "r78",
      "r87"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.",
        "label": "Proceeds from Hedge, Financing Activities",
        "terseLabel": "Proceeds from convertible bond hedge settlement"
       }
      }
     },
     "localname": "ProceedsFromHedgeFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments": {
     "auth_ref": [
      "r73",
      "r75"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Maturities, Prepayments and Calls of Short-term Investments",
        "terseLabel": "Proceeds from maturity of short-term investments"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfShortTermInvestments": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Sale of Short-term Investments",
        "verboseLabel": "Proceeds from sale of short-term investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r76",
      "r321"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Net proceeds from stock option exercises and ESPP"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r1",
      "r55",
      "r57",
      "r83",
      "r101",
      "r113",
      "r123",
      "r124",
      "r157",
      "r159",
      "r162",
      "r165",
      "r167",
      "r189",
      "r373",
      "r376",
      "r377",
      "r381",
      "r382",
      "r399",
      "r479"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r13",
      "r14",
      "r221",
      "r493"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "verboseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r284",
      "r416",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r284",
      "r416",
      "r418",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Repurchase of 2023 Notes"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r80"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "terseLabel": "Repayments of notes"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r333",
      "r523"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "verboseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "verboseLabel": "SBC - Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r3",
      "r11",
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted cash in other current assets"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock Awards"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r23",
      "r251",
      "r329",
      "r491",
      "r511",
      "r516"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r109",
      "r110",
      "r111",
      "r114",
      "r122",
      "r124",
      "r193",
      "r326",
      "r327",
      "r328",
      "r341",
      "r342",
      "r507",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained earnings (Accumulated deficit)"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r151",
      "r152",
      "r158",
      "r163",
      "r164",
      "r168",
      "r169",
      "r170",
      "r264",
      "r265",
      "r450"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Total revenue",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r98",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "verboseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RoyaltyAgreementsMember": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement, generally for a defined period of time, entitling the entity to use the rights and property of another party. Examples include, but not limited to, licensing the use of copyrighted materials and leasing the extraction of natural resources.",
        "label": "Royalty Agreements [Member]",
        "terseLabel": "Royalty Agreements"
       }
      }
     },
     "localname": "RoyaltyAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RoyaltyMember": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money for usage-based right to asset.",
        "label": "Royalty [Member]",
        "terseLabel": "Royalties",
        "verboseLabel": "Royalties"
       }
      }
     },
     "localname": "RoyaltyMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "verboseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r353",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "verboseLabel": "Schedule of Carrying Values and Coupon Rates on Financing Arrangements"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Schedule of Computation of Basic and Diluted Earnings per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r214",
      "r218",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "verboseLabel": "Schedule of Goodwill and Other Identifiable Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "verboseLabel": "Schedule of Restricted Stock Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r29",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r294",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r298",
      "r309",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "verboseLabel": "Schedule of Stock Option Plan Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "verboseLabel": "Schedule of Fair-Value Options Awarded to Employees and Directors"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r40",
      "r99",
      "r141",
      "r142",
      "r240",
      "r241",
      "r242",
      "r244",
      "r245",
      "r246",
      "r248",
      "r249",
      "r250",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period",
        "terseLabel": "Performance period for awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate from fair value on purchase date that participants pay for shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date",
        "terseLabel": "Share purchase price as percent of market price (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Nonvested at end of period (shares)",
        "periodStartLabel": "Nonvested at beginning of period (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "verboseLabel": "Restricted Stock Awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Nonvested at end of period (USD per share)",
        "periodStartLabel": "Nonvested at beginning of period (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "RSUs vested (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "RSUs vested (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Outstanding options that are exercisable (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Outstanding options that are exercisable, weighted average exercise price (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r300",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Balance at end of period (shares)",
        "periodStartLabel": "Balance at beginning of period (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "verboseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Balance at end of period (USD per share)",
        "periodStartLabel": "Balance at beginning of period (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r291",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Options exercised (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r97",
      "r294",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "verboseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r313",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance at end of period (shares)",
        "periodStartLabel": "Balance at beginning of period (shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r16",
      "r470",
      "r471",
      "r487"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r519",
      "r520",
      "r521",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-term Investments [Member]",
        "terseLabel": "Short-term Investments",
        "verboseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r41",
      "r109",
      "r110",
      "r111",
      "r114",
      "r122",
      "r124",
      "r140",
      "r193",
      "r243",
      "r251",
      "r326",
      "r327",
      "r328",
      "r341",
      "r342",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r507",
      "r508",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r109",
      "r110",
      "r111",
      "r140",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r19",
      "r20",
      "r243",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under employee stock compensation plans, net (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r19",
      "r20",
      "r243",
      "r251",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Options exercised (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r19",
      "r20",
      "r251",
      "r293",
      "r310"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under employee stock compensation plans, net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Authorized stock repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramPeriodInForce1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Stock Repurchase Program, Period in Force",
        "terseLabel": "Period in force of stock repurchase program"
       }
      }
     },
     "localname": "StockRepurchaseProgramPeriodInForce1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining authorized stock repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r19",
      "r20",
      "r243",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedTerseLabel": "Repurchase of common stock (shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r19",
      "r20",
      "r243",
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedLabel": "Repurchase of common stock",
        "terseLabel": "Stock repurchased during period"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r20",
      "r25",
      "r26",
      "r101",
      "r173",
      "r189",
      "r399"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r100",
      "r251",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "verboseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Core Technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r265",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]",
        "terseLabel": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r265",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
        "label": "Timing of Transfer of Good or Service [Domain]",
        "terseLabel": "Timing of Transfer of Good or Service [Domain]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "verboseLabel": "Trade name"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredOverTimeMember": {
     "auth_ref": [
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred over time.",
        "label": "Transferred over Time [Member]",
        "terseLabel": "Transferred over Time"
       }
      }
     },
     "localname": "TransferredOverTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r184",
      "r185",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r277",
      "r285",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "Treasury bill"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r89"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "verboseLabel": "Unrealized loss on AFS investments"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Investment in warrants",
        "verboseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r127",
      "r135"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Shares used in diluted per share calculations (shares)",
        "totalLabel": "Shares used to compute diluted income per share (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "terseLabel": "Weighted average shares outstanding (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r125",
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Shares used in basic per share calculations (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesRestrictedStock": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.",
        "label": "Weighted Average Number of Shares, Restricted Stock",
        "verboseLabel": "Restricted stock (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesRestrictedStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 13
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2646-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27405-111563"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=117311354&loc=d3e32014-111567"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4724-112606"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=51819886&loc=SL6014347-161799"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031898-161870"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130533-203044"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(k)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e1043-128460"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5227-128473"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5419-128473"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5419-128473"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL7498348-110258"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62586-112803"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121641442&loc=d3e19393-158473"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r524": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r525": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r526": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r527": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r528": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r529": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3581-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>61
<FILENAME>0000886163-21-000069-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000886163-21-000069-xbrl.zip
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M@%AY:RBN(#NC].[E]6=6(*NB4M@Q+QV6C&)MJ(I,")IPZIVMK.RLLKK%A:Q
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MA0',..I2%1B-M0$L.12(CQQ 5>5%E@%,<T1M)[@=C2KE!?4$@;MWT=C@!)&
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MD^F'$-09$IQAB%@/Y$)KY[%6%FL#_),)50%J5DS03]MVWW((-//GRR&E!&X
ME%*'5)0\,"NP14Y9D8J684KAEPJX+[165BZO/'W@.AL(F%D)(3YX<B[3U(U7
MAGH)?Y TC(![&<FA*I+[B0@?',FAB45R2$;@8%YB@](><J&]XL0HZCC"+&@Q
M%J%&NG[YH9PB;)EA/NR_RWI]EX6N"_VMK=7G%ZB&_SU0H#=O_06!\N#2IB@G
M)2.,RZ"C-II:%WR4CM%Q:#[+<KS>=@R?^O#$W"19OCN_G@TK)'K?]N2-7@Z&
M-^1=(+JA'])BQPJ,Y762PZ1<Q"R [598=@L_O[*68IB/A#KI'6(A8,N-D<8&
M3#0B='Q.T=SB9[L[3G38 <ATAY-+<IE;O 3+K>(T1N%T$759PJUC2@4LL0=[
M4QX'4@%G9KU:0-A&^,&=CXQPIH3P.)7 $TPXJ^SL6Z59D..S&  25> *M%]Q
MPZ*0QF 3,/;$*0=VP,^^:&9Q!F3N81,U)TCZ&!A$($X'[5!D-"BK*6,RE,EO
M5/B9=?=A<<JF%Y$BR1E12%&A!=/(>IW6J:[!IB[!IF85;/\LT%%9IAL"W>RZ
M%Q&H>KA U00$ZKVU0 8"U=$PH9"1*& AG(H4XA?,KYS.S,KQH61SW>3=WG P
M6K:!\/8##&\WY-.,;E\&9-]Y'34!KV.P@M#6.JLMX$93:[5'1GB-N/'(X]G'
MS<1%,W'$7NT9^6#.BPV#)<&&\IP2@3B1 G@K&!)J(-)PR$<$\:W1B^PDR@B2
MZ7LIHSS8&D^LYIY%[PV$0R!L!G^5CO%%M#:SHNR6"^6TC1YCQ;2S!MA#.B0B
MK6/1Z,0"BF:6XYU9@8UAQADCD.=,,DFE=LYH@;#%EELA0^4CY@8_TW<?)#"E
M9$!:@K>0SJ<#2)'0*#K'E4&X1(G25;3S&+1-):?;&?"& @7AN6-!2:T%QD)&
MBZ3"7EW.D;#+9 Y6UBRD36< B,]O,-C#DSG8A/)QL!,4L<!9,"Q&H0@)3H>
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M\?(/YMS Y^?T9UC5$9_0T4[46HFLI(1ZAADS(DCN:6#@RQCBA3]+V!@5MZM
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M:MK#4/O/Y QQVMM6ZQ_^4\[)C[7\20B_;\WV"M\SE8KRW/ ?F]7=PJI6V'\
M]J^GMIP,$G-$ZER  C D=5U+P>J6<V<M)\:;N/1VZWWS)_FK%;J?-\DP>=/O
M\PLO#?_E3IS2YFB_M )L7BD ,49S&6)=(R_JS&,%H;[R=4(,Z(43#$0'S U"
MK*;I>_/OVOMVSYIVK6'RXS!X:"+6 V?^_JD2ST1RH!>R^,BD^ZT?U._-KD_9
M/*%FSVON,+CC&C3L&*AP*-+24M!^(X'^-_Q[[=#T:S%K0[AOVFVXF+;EI5F
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MO#-1R:4?-'(I;3XM##HFMDXN"?%-%@S]^&VU&/1>-_QX<^JEP&A1P_>D-ZH
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M<;%[<?X5NN@M>.O:.&7QO_NUF/6A6;5_#TT^")>[.QLF=X>URUV="Z3V-^"
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M4=0(%$8X:8M<SMJD?<7RC4TNF@K7J>%0<4XLC9HH('XF$(]GN6(3G)& F/+
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M]>Q!/2KQA:V6UHD(EB,%C"L-6N$(#F&"-1*24KFQ29N<EIC^M?;CO O]4-5
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MC' 9X3+"\\X=<4%[$@U346+&6%24(*^8=E09SJ5^>K/&G6 '8^W8?FC4-MH
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M&\ @],[&TTO6RW=1-\E1'=!F+VJ>K</.49ZBXS1#)0;]J<3T?EQH!&HY"LH
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M6/H,>G0XS ^X\.ZJ.:EX22P]R/TXIPC RT"YAF> FF=M(*-^>2TQO6PD\Y-
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MEQ=(ER** -2C29-*VD;>&@&KCV9MW<6%U=3%^.BXQ##SBGD>];+58I/FT)B
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M2W+K[. 5.L)U[1>H=P[CP)_=8G7ZNNE!ZXQ107G+$A?)Z<"-YHXI;)(6VHK
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MLE/(Q.B0ECD-(TE*M-[8EFJ3\XL%5+_>M#ARA2K'.XU>#7;2:?2=:/2<KPB
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M[6O_0]1JA(7$2,(V_O0WZWVUL1J,  $U,8T%>I=:\GDRLRHK$Z@-Q"07B8Z
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M5,R".#@Z!8A3EZ!.[T<WC)V_;;[[LUF^)DS\O9@3TU7KZ09#60!"@*,<-#;
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M*S1-]](W-$"[HT9$SG=UL1/SQ8?C_D+)KDM+A,TL*Q2S=RG-^.&^-=?%3%"
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M7Q+\I]&XV11>GX33EAV@O[J?\9\[R04N-_@U&GE!.$N92,(W2A?/#J@;I?*
MM1=_8W\_$UEQ$\$Y,YUGA>\F8G!AR."JV0K_=>VP]8MZ^$#!D-?KVJ7!D,>C
M>"82DC)7ZJ-S;R! #M(SDZ1-8#*7(6B[MW7[*.?&*+L@!F9U@AI_;E=]$M3X
M67[XWCO8WOWS^^OW'P^W=]^P4B_TP_>/W=>O/G[>.?AXL/U]I_OA_9_G@AI?
M[_8.7K_?_H;/DQ\//WS;>?77YX^__^L VPP[AV_XSN'V]VW^K_V/NTVVLI-Y
M2>T4HS'*$18-)R <$,\8)RDR24OIN6C5V@NSSNSYJO8W/+-Q,<O?Z7FMRD3/
MD8D@!J49]S(G"S1R"]H(QG(428><8V6BU6$B.L^;Z(4'FP7)1E "RC'B<;8(
M#<QQFO$;6LH<2K$N=.6BRD6/@XM<S#8H_)$=0!%Q%.<@9+!&<LD\5"Y:'2[B
M,RZB,7()$(AW# A ]@0Y*))RPC5G!@Y*\#M;!W[KI'R5B2H3W0L3<>8890$]
M--"@F3(^6_"""2\T-:DRT0HQ$<R82(*'))TB8*4EX!TG1BE+-',:73=JE3!H
M%2F^;LVMTVU4+JI<="]<%'2&K*6QT02P' QX YD;99":[,0JHHQ7+GIX+OJV
M/3WIOKFG>-(VZDR2-\5'4X)8R(H8G5VF/G"FT"X2ZR J%U4N>AQ<I+3R4F<1
M4:T"\]Y;'0)7C(G$DJ&J<M$J<5%WQD5,"968E$1PH]$\XI0XHR.1+#(C!;/:
M*^0B3M<5W#3K1F6CRD8/PT9&42.E-BH; <D)"XD&G93*TDA/]>5L5"GG;BAG
M9\'\8=P+2WE9D^8$0D;SQX$C/BIG1&!)Y6+^U*VR2C>/A&XLE1 4I88; TPG
M9R*CP>%?J0O>BFK\K!(3S8V?J!./P0:2K60$G #BM?<D9,5I\E)('XOQ ^N@
M5\D5>P:1PUNS4+!.MS^) )O5&+NRA-4S+*2S?&\NT1PM]9 \@R"2U]EH+17E
M"OL><EWE7A%"0[-J'H44I$^94D6T0X<.:++$B!0(4X!N><C9<KOV F!=*+5"
MU7(J>)=LC8#36607@@00AB*$.9K<+$J:I;77#-RYK.9%Q>V2<#N/V9$Q<!:9
M)4EF0#,D1V*#D 1MQ@@RQN"46L4R5Q6XRP5ND]1),\V8$N" 68.(%=8G'K+C
M3%?@K@1PYP$NVFGAC76$JY*P745#G %/K ]&*"K1<_ 5N$\?N%YFF0W/ 0)
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MY*'L[3,P5V2MK0!^  #/]_719)*"EL*-E@4TH7D@'AT@$GV64KL@P58 /P,
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M &#"V!DQJ.Y.]=N-KOX&#ZJJY,*/S]6&3>_5[(4M*<Y:+;?\_>HT%E.5UV=
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M:0L/8..2]-*KH'6IT_*UM$KN]19[0BM+F[.RDV5%^*->5\_/=\\/&/>>IF#
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MFQGZJ%%XJ3?T9BP 'A6@<\JDQP.45YE;#]F,'W"D<QW&NIF-4G#P[BR,-3<
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M[(E5X$F:$%BDEO&2RB=/&=\T\^+6'7P8HTO7\,25F+'S1[1^)\OCGSAJ!A/
MMQY'/W.M]3VY?J;;S$2W9K+ /W:8YW?CV5ZZ,<,&ZC#?-K,DA;<\>BLI=T%J
M:8P/S #1-I8+)@M]S;26[#?=4\_D=GWE;^#"'^^@MKF=&>=6!T9E$:PC0L<(
MI,\!Z8NE)))Q%A*XP))I7+R+<]K0R%:SEPC&(3S5J511NH(Y"HY:(:U63 CX
M96TO#]Q> .PY53$:%> )E0CV@/-6,T>TE/!,!8_! Y-CBP7(]5R_:E247>9Y
M6L3U[\0N;C5X:LTNOBV[>(ZN ]..ER8F(GQRV(H([,*$DD1F*%-<!1=+,#@Q
MG2T\QRY^A$C,_LRV/T>%;CQOI K=Y(V^7430?'[V8]7@RR;JN[@2@6?\TQW!
MRK6]R:A%1$0\? Z S8Q)2K;7&^6!)_4@Y9/I=-1F)%<]('$8$_IPY_ >>]&I
MIM?61VM]Y^3(L,O4X^<Z?;C9W7ZUZK([Z' N.=X1-S@;PSGXI5- *PKXN3NJ
M!]BUV64]A1*'>6YV5@G:?=N11,MBQ,/!"[SR5],;L!XYE&._?.?U ?"4,@@I
MB>8ET!A+)7'.%B1ZQD-AA B)SX\0^K[+?3J\"%;O21Y)U"1G<$+H6=_"4JY&
MIPZJG69V\BR\^:PW/W:V69F3,5^QC_.&=BRL\DX]"YWB&JBGJ#>ID]92.+*P
MZ_I<<)>WW__8_AF>7?WAQFLX1)^D$_-P.ERC/@YQ,7;&TV'C;<2HEGF>M]C&
MJ7JCGTQI6LX+8$6/CNS$ZYN9#5B/.LL7/HPU'LP/6*L ;'HC$]#%OD=GKPTG
MP"KZ T093(N!4]2[@)=QZG![DG5]K_.(V>H!5--O!V>] /<.W]C</+R3B^-N
M8QZZFY_Y+![A8VV^$-&\#U<$I]2]ZHS2V?ALN.RD9J9*;>14WVD&XOI.UNB*
M\Z9N,S!JV9"@!S:\IS2;4JF[']ZC-X6\V6&OJ>VYK(3GBK<NJ;NIQFC=3YF)
MF0.W<FF9R?[1,,;.#KSO:-1YGO$G&],L",W4"OS0Y>GS=^6R$1M5D.B6-1(/
MNR3K9K?@MB59#[3HZF87O4*JR[O(C?&E%-1*HTJL00C:BE#"'TH1*Q^TX8UT
M803M;:JO6@1SU##,GZN_<;?W\>7?1Q_WCWH[Q^_.=[Z\.?EP_)^CG>.M\YWM
M#W#.[\3'XT/Y<;MWO%!1Q?_^]/']B][>RW<7N_M;7W9??NS"=5SL;&^=[QZ_
M^[R['T[VMH\^[;W?G9TF\L5_/@BR*#67BK!0X,1D;8FC@9*@DH[!2).2>O)4
MB TMOUJE>J7E\BA+[V^V5G?CN-,;C!8ZA[ZZLOZA7>C-D7C9%3YHO%VE9^ .
M '<$UPL_W1'R@@&^ZH-[$_]LSY]?X^\-\+<[A[^,I<2\8H3%X(B4PA,;J"3P
MH''0G!/"H\QVN6'$8CGK#]D*\*!P9[EKT !L=D3!SD]@?69_]+=+&YMNVPMQ
M1]M5A>;BH=S6Y9CWAQUU?0Z3A"Z.7UZ0_5UO8#_)!O97'+[%]7*W&QEO[6,W
MCD,_M\,^W-%1<TK9"'_T<N1[W;-F1D-\06EB:5/)2TV<+@216B6B RU(2E1Y
MSW41:+S:HWS ]K%=0=/:0K[*0JR4/B34K0[PCT45P\)YDE2T1B;-BH!UE)MB
M47?B 9&<2=M-I9(\F[7]?AG:2UMR%LA,E<2Q9\.S4:=E^C]"IGFOWWD;3\<1
MRW,Z9I+3:17;5=?5Y'ERR1@\TBH-$^(_L3<XQ43)/]A\TQ]WW2!,RL>Z)R=G
MN?H&X.>\3L4.SDE3$-?KNF$N-JOS,7,=1VFEPG!:)FE8*)FEI0Q%88)6W&KA
M%983FZ+&-$,-:7Z8<=[4UU6(/P.WK1OJO-L^)KVJC#M[Q&7?6^<'E@6K4](D
M%=P2F1)'42]*O'? UI.SJ@2W2VVRQ1:<ILB[;D!9K4W@/JWA+WN1$YG[@[JR
MIS&/.'HY;#ONC\\"GE\<"&5*HV(@PI:<2&$4^-P\$L952 R>BO3VR5.YN=B
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MQEUFA2]MMX_B=5-RLS=]JW_,28\MNKO][LON\1;=VP<[W7Y]H'1B+"@.-BK
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M2M-6/3ZWZU.ZE6VN^Y3NWN)>TYVM Q>$B0(\+::4)I)+M#CE2$A%L,H)F6Q
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M6EE)K/>E3\(K1AFP-+TAB\4<]\*J6!$OOBD+F_O*2X,+CWX!WXZ$K!?P]US
M4S("ST9K*0.A2G(B9<0>2!PKQ7#*L8('HM.3IXIO&/U %O C"'WMX\"#3F_0
M/R38@M0NCZR&W9Q65=GKH-?:-?Q^M*H1&ES:)[ &XAL \46+2=%2.YD,P&]1
M*B*MX\1)KH@13$NK: 18!B8%2"S8HA#.0_0*U_&N-:@]A'C7&M3N&=2F[#+
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M4T^MQ+>@UE"RO5XMKI@E\HBSE1K,"6)YM>M5"D2361F-PDRH8;Y2J9KJ]M>
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M=/D@X^?-[-5J6M-?S5[]5\_V5YO>_/T& U;8;\?U\%<_.#G!K:2:#SN:\(\
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M9S6[0)>=VW>W]AR2QE(97.6 'MU^Q9%PS3NP#_RJR8:;K<:.@'^.LBF<#L8
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M-$"!C^_F+XF%[ 5OP:.IO""K&K[PQ)3O?L=>(,@8SSWV7>AVDCRH!!.\@,'
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M5]H\F0'R 163%6,8^YPLD5.8Z2V:3\/P%CNEBA2O0- %+(<&FF\Z]=?2UPW
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M'G%TF;R2&2.;TCLTAPA_%,.ZKG07$P/PEM&_"<I:0M_J])U*.)63OMF7J0R
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M';-:$!#=396H(UHLJ,<)UW]65%E2Y.KBQ#8\=PKU)%-P)T.1&;VMM"G'89H
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MW6XG:HN8F $WXYXBW%[@YOXTN[6CY+&:S^@QM*"2V0L P4O "-Y:@<-&CEK
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ME/MT.'\4OK1WISLY=,T:=-K3P<1M:%#(CS6<6P%'!TVJ*-$;_DP]A;Y_'_8
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M)2>GA"T!#8BBW%J;-FRJTNAK-TPY"2WE;V^_/9*PU=VDKN6!QT 4=C//C+Z
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M;90_KO5PTUB?/:CLD:@^ -ZX>?*9('8W_W2I<\^>T"GY],/_ %!+ P04
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M%DVO_&D59MSJ=K>W$:IN RP +,2[\-V#Y/#5=F!)<G9>ULY(B#21Q+3%@,N
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MSL)<(JPD$E')"^J$RP&:K'[?BVP;!IF?;!*K:ZZ*5]'X#G[W\X+&TW*4:Q'
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M9JRTO3KE\G!E?+P\E?@^OYV,3\JZT'P_ J16GEM&DBT=W:P-Q$O&B-:4I:1
M!-YD^V@3H,=P1'Y?"MUNT%C!.-7>FX5T\+:\TA^Z(0KZU8\N#AL.:)3)*"B7
M!)6FWSAID& 5$&6UX>"#T;9)%>R=J!Y#!6!MTM0S4Y.S[_^ = +K9(9H)&*S
MA LTM&0>D24?R]%\E3'8""$U<3C;@'L$E7ZU:53=9BV.JF\$9JDUI1B'4#!
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MLU#"0>*$EI(.68*VD+DBR4;IA(LQMNFRU$"6/@7MCXSXK1AS<.K?UN@@!ZU
M9T&T1"5*83GFT$H28R E;K(S["#+3=M#/O+D>-FH>9"CR3:P0'*VAD@%&&<#
MDX1#0$<77=:LR7&:6@+T:2H\$(,K3WV[<:$_,]X5_E!N_L:,B$"I?Y4<-6D9
M#41FFZ05,5O=Y,AW/1'Z-+_UG,V5^=#3-82_3R;I^W TPE]8W*N8\!'X[:*@
M-_BP\<FP-/^83F%VK/J$72 >=]5@;Z566BZX.=8[F%W>EW.!<9"4"\9:36B,
MM!R0+[N*((DSSF@?C)%MG-HVX/9N+GPAI F@M52>!.?*3<E!$1]"(DI$"$J!
M8*%)BK)>D.-&$=59<:M'\"Y:KWFZ&^5_BXXZW91TON$P\(HFH-R3#*43B(5R
MDQ[/1#&!_IHQ[5T3PM\'K$]S<W..5+72(;BSLF]U[8X0C&FC8<D0G/%MJ9<(
MQ(LDB%>!:D4-Y:95NX '0GW@GE#;C?1C$JR&*7L:SI7C5N4(J1^]'4883^$B
M!+G>ZO](D=P#T1TWB-M'E97BMSLXC._+P$2>$V 6%&4HY^DPL?;.!Z0OE4F"
M#"8UZ1EU-ZR]#NP]_*U]T4%:7"GW//W7V447:!VBBC%:$EUICBD<)39G=!_9
M4$\%!B%9;E666PE0KXJ8*M+JVC&^8QCO<&&CD,HI\(Q C.5VE)2)!7PYP$EO
MF9:QT34DCREL;,"L)O;IZ>Q]N\'JQ9QST31KY4?'*N78!>.1BSCV5FNE^?PV
MD&4KP0& 3%XF2WR6!B-=+C#(Q4B7&XJ&\T%3UF9E>1.BO4^6( \GYP#+;A-K
M1*9<Y) PH\N>E0(_C+:#->5*Y!S1(;AR&5638R;W(>O36DT=QMPZ6E+5.%5O
MOD1ARR7!,)V6-WST&JXP,4L32%F:>**7EU0H8A6F9S2[%()D2N@FYY+NAM6G
MZ;<-6RJ:I4Y7CV4^!G-@?G0!1 E&J3*>>%NN .*)$J^=(RIZI4%H)F&[KAWK
MG]^KDMJJAJZEU-J.X./DW(]6A<L8^BO&#7&L[!][EHD75**LVFKJM.6F2<*[
M <\#&^ ](D;4-$2==_XCS,ZZ\73)SD%F3EIO.4DJE>Z?((AG*A$IC46GD[.0
M;JMW_?IS^]2*KL$[OH<2*]W_NI!IGK8]C_]]-IP.YWWO+B3S6LF<J"(>*")R
MG!,K4O$V 06,"2>6[4Y3WS-0G^Y^;6#GFFJN:OA/9R$N*^8GW:L?I<?<BE-A
M,4>J,A'>!B*#CB30((A(U+N4 EHX/,3X=PWVP YMCY0 U=1=F01?OXZ&< M0
MLN"5<(:4XF<B-;?$93 D:YU]I)Y9SQYF_[7C].D6UI:FWU_)%:_!F$$'T]GR
M1I=+&4TV.,DX8BF4QI(I$Q? 8L[I4/IDN(8F6Z?KX3SP;M5'Q(N*9JA[8^9F
M,17P:)GT&(L(G*$LNBE7^@EB4IDYYUG1-M2X&]9#+UM]A!RI:)?^+K(O/\F;
M6MX>;VE]6V1'7U#?287';+AU6;5;_EB\M%-\U19]MX]D\*TP'=?4#U?;,8W\
MRG=C_.>T["A_@ 4UCV3;NZ <UZ1;*ZG2KM<_Y[,AIJ/?H/,G\.[L-$#W/K\<
MCL[PT_GPT_=GL^D,)4!< VLI1J&EWL]B3BH5E Y$$$B6$%ETSJ4VJWP/Q+EO
M!+1AN/DX*\,42\?GX[2$,<@F&"8U:B=0C6D;9R2D%(G0&8*SBG+3Y!J'W>#V
M:2^M)0]OAE$',&ZU4/PNK-./F"]TPU@4-._A;DRB+D9/(&F)L65IFY$AD\2"
M=C9P&VB3QB</ =FG+;F^D&XO0]:]#[,4>?G1\F* .;;G,X06SF8E*_T\N0HH
MEWWAGW>='Y_ HCA,T!BC=)$P&A616D;BP5'BDF=HH 16\S:+!OM"[],&XB%I
M>6"C-TP[+X/A/\!/S[JE67<(+-<_:/^P< N ^X;G:X?8O7G[78]KI(\6[=;7
M#K2H3L3OK2RD+'^>_.SR5R;CC^4(:K>,!_9)1EO :&2%FLII8CT<=S*.B&PN
M[R2_A6\P$LM;2/SHS1CGT[/Y-VL;[.$C-[+1GBK8URRK6Y>[*/?:[^^OHLUP
M:@JZNRM=\Y2Z0K=PG*O/KW'OQ)W/JZN.MO="K(YT<88"/RG>\9K/G"_'0:JD
ML@>,5%>9NXI8:8WJ][/I< S3<N@KH'LKD(KS.QF7OD6KQ_>OXWR^#F<YZ9#+
M3HO3F$X9#T1:"L1JB*4';["<B:1LDU6:RG+LM=U?$\O\K-W[_.=T^>5!:0.K
M R1BE&6HX(#)@,J&F)@,=Y)K9L1]Q&^.LD^K7\=D^+4"A=[0HDY12U5Q+M=H
MRI5[ Q=\!!<E83)$(CWWQ.D4B<TLR])A)MOM#C&VP]BGI;:?D^&[4Z+:JEU-
M>3YTDZ_0S<X_C,K>U.*BBZ\EA1CH&&V*6A'J96FF5$Y]4F&)CQ(2 Y& -MGV
M.8AT?5K[Z\-[TE]J]6]6>(L9.:Q\/) F"%1P(%25*UI"X,336"X!\MY9R8)S
M].#SPDV4#SP<T?;$>Q\HWR]>](_F-T]U#T Q;:)DQ&?TVC(%1ZS@@OC@9&))
MRBCLP6E^$V6?3HS\E"S?BQ:]#(%*(+><GK[YT7Q_R\1 :?*E^M:I<G.V(RXH
M35AFRDKMTJULMG^QSVVQ^G3*I@_O1@_)U,\79%%LO/J#11';=%FY/DC!ZAPT
M^@ &GDAM4?N.)0)&"F&CA<2;% $<5,H'GE'Z^2.H_G/MD;Q.+R$#?I:6ER0/
M'+=:*)6($2D2&2,G#E@H25+*3 II>.]3[WNE?."YK_]YG8[/M5Z^3A<"??8_
M5I,O&X6V46JB1;G2@BE)7/8<TS :=(0<,^M]"+=>M <>C/N?%^=(K.KEV[)T
M"(MOXE, P]1213 PU-#(!)!DM28R9TN"%II06B[DTU0SVZ2;SR&$Z]4YP9_U
MC:G"K%Z^,^\FXWAK'IT?S$3E:Y3,!:(5.,SM4"P?$YK!:$&M<\!S_^L*-HJW
MU7MSL#:I/^N+4XE>U5Z=RW;?-H9HE(A$4:6(=%03FRTC+I6N8L8[=W7U_-$N
M:?C_:3=[+POU;X=A\['V'!EH,)0(7UH@6&M*#SM; JZHG-#1W[S.^0!;#?NU
M(3A8)_\^$+6G5.EE=#'W]%=SP')7Q5$C;*2J-((I-T2B^[?*H*ODR2GGC'3)
M]3VP6"O95B_+H;KT]>%=Z2>G&I[:6BTS_M!-7D^Z4[]RAB&7?Y<?5BJAWF:(
MNK73#Q9JW]KT%Y/Q-^AF95/V$XR'$S3];+<S"QN>M+]^MH'81@V['^"X\WFM
M5-+B4,?ZD6H<[]CRR:V4U?;(QX8QRQ_+S:CZFEOS\&;*NT^02F<Y+IKZKXXW
MT)P9I8TE-$>.^2RHTNX,"(]&1 LQ)&];Q#?KP.P;#99[2J_.WKWVL5RQ?8:Q
MJ95,2*XCL2&66TBE(R& )RY*Y7.4T;:Y:WD3H#Z=?]B;%3?CIRI6J)8A7$?S
MY]A?7+K^<CB=[V</M/'9!I&(\\J5.^ IL=(K$J.@(7&>N(#VY%B#[(%G"-IF
MLXUILJ]A&H;);\;X5_CL?^PRNUS]\OZSQP8@^\ZNEX^M$8=L?EA%^=M&&_,V
M,%\F(WR_IJ5\;':^BR+6/&5_#=P'K;[HNP?M&Y_50@TM@O7;H\P_>3]O\5?.
M4N"W;S0/>AZ1E>4N]MU?H JCME#P?J+7-T4-7[7%4UNHLG6N='HZG-\7B!]C
MOE$:',*XM#=\"R=^]*&;1(#2NFC'9&GKI]?(EG83Y7 JK).Y[SS:(56\/6N7
ML5?Y(_@I_.TO_P]02P,$%     @ Z8"F4G^L;8%K8P  WET$ !4   !L9VYD
M+3(P,C$P,S,Q7V1E9BYX;6SLO5MS6SF2+?P^OZ).S>M!%^Z7CNDYX?*EQO&Y
M;(?MFIXW!BX)B]T4Z2$IE]6__DM0I"X4*6V2 $G1GNAQ29;,O9!K;2 32&3^
MQ__[=C[XZ2N,)_W1\&\_L[_0GW^"81RE_O#SWW[^X],K8G_^?__Y;__V'_^'
MD/_Y]<.;GUZ,XL4Y#*<_/1^#GT+ZZ<_^].RGOR>8_/.G/!Z=__3WT?B?_:^>
MD/^<_:/GHR^7X_[GL^E/G'*V_-/Q7[/DH,$[(ITJ?TA&K%22J,P@JA"UR?[_
M?OYKE-I1;SG)H"V123H29'0D:DJU$XQ38+,/'?2'__QK^2/X"?R$@QM.9M_^
M[>>SZ?3+7W_YY<\___S+MS >_&4T_OP+IU3\LOCMG^>__NW>[_\I9K_-G'._
MS'YZ_:N3_JI?Q(]EO_S/[V\^QC,X]Z0_G$S],-X\ !^?IM?_\#8:]<O5#_%7
M)_V_3F;__LTH^NF,GD>'\-/:WRC?D<6OD?)7A'$BV%^^3=+/__EO/_UT93D_
MCN/1 #Y _FG^Y1\?7M]'VA].?TG]\U_FO_.+'PP0\>P3II=?X&\_3_KG7P:P
M^+NS,>2UZ!=#+J!4@?/OY=-^V1G3&0(9QXL !/\6AD7@%3&N^O3=,5]_%DF0
M_<5@6A'Q_<^NBG=T[OLU#7SOHRN@G7T0.8?S ..:4.]\[BV<"Y#+",M'#OJ?
M_3#])8[.?YF!>S["6?B]_PR/ QM\'B92IE,JKE[@?[_YQ[>>CC3WA_TR<[S!
M;^>?4)ZU#0[X-H5A@O3S3_WTMY_[R6D1O $&H&72.O#$M?22.>I$%**W$M%F
M]L#'#2>0\(O):-!/9;7YU0_*1/KQ#& Z^6/H+U)_6C!M8['N'U_!IEN.9<GJ
M(5D&U(J T[?,.7D6A4DJ:@Y&)VI[6XZJ$2_O_1@]A3.8]J/OL#[L1-+=9^V3
ML0=&N42?YLE'SS/ST4@ML@^0=/;,"BFHXFX3^M:.=V<N/T[QS^+B34;Y'2YR
M,]^CP<OVV'/:<+C1Z);X$Y C<RD[DZ-4-%A)'1? DA(J>NI7\_?8$\LP%P,=
MC.(= (/B^HVNUZH!*F8P^]O>Q81\]OY+[_K3T3+P&K^<]$ E&H*)Q'N7B-0<
MO]+<D<2C5CEF(PQ?N=+-5KGL)V&VU,V?@$L>I[_ 8#I9_$WAEA+*YM[COZ^'
M<L7A]H/[ %]A> &39V$R'?LX[5F%:X[CF5"D@L@</ G">F) "6E!.0FFQ="6
M@=P=V(T\GXT70YS['%LZ)262JLKS=%31LE?TX0!^_FDT3C#^V\^T$M.O<-SX
M[LP@_1T#R^<7D^GH',:OAW%P46+29Y,)X/_2)_^M%Y0$G#8I,5Q3(D.*Q*8@
M24X636 @!JT:BF$3K/O7RVX$KU9+,W;N"XKM*JCY3#O\_'PTF4Z>#=/+;U_*
MU'QC$)#9>PJ2I,@4 LR4V,PHB<DK02/$#*Z%?!Y%]N0GE[JV;R".@NM%?PQQ
M^CL.?-SW@UZB"80SG@AJ$1&(3$+0 =\67-Q%"H$YVT(-]Z'LG_[*?(VJ&KL1
M_>_R;Z-1*H/]"..O_0B3CZ-!>G8^&D_[_YJY:#U>]DD,CM=2AS-FHCAC:L6)
MP.$:);G$3VXEB<?AG:),*I-R7SI\=S]E OB!9PCQ!2Z*@]&7,FW.#='C3AGF
M,I! LR.2,TM<IA(M83EW&K*SNHU'\@"J4Q-*/0KNZT/LJH_?8(AC'R"V9^D<
M#5W&.^U_A04\:IEU-C D$?^0FCEB@TDD"N6RBY(FGULHY!%<IZ:1FC3<5XEL
MYISV/./&>&Y(4K@H2I,5"0"<) O:V+)CQ)JX(6L1G9HRZIC^OB94-4U@-(5!
MU9O19-)S3&7#E2+.4(RA=!EH6?:" 0,V!]"!-57##9;3"4JVM&\#9^+=] S&
M;T?#T5UH<T5>RUTK([+')2TYAPN90\I"#$!D3"D6S:-%FJB@$[RG+XSZ++1P
M+- R1;/OAJ^'7V$RG6TH]S(/PIK@" 2*XP:(!%<O3WQ.&C1((;5OXDZL0G.
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MF+L9S/UOT%;6T/TSOV8L-3@0O-JMOKDE]^KKVWY/9DV+2X]AGRA)B#9A<,8
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MR)30AB?M<?*+,+N$03P );AX^9R82!::M'78ER8>V7X^G"0V,7RS'E"WRXK
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M,/I19*<AD[H$U"PB-@NS%KI] 5?_?3TLF%[T)[-*[SV0(27K@&BK17&7,W$
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MON=S?3[7];ZN]W5];K0A&A[@/F]H8@@P,#  U^E? &T2N&H0['X+ ,S,@&,
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M>O14ZO/:Q W93.E4'#WGE2<EJ4E:TS'.1 V[Y.XP3OJ $O"6?#UAA TQ.:;
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MR ITE,DCWP&O$@N"V\.1W=HC2W>*"&E+\DC2^D.;+GX+R()//0Q4$GN>;WH
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M6S2 RNXP[3_I,U3@H'75M;&Z/S-:<9DWWW'F19!P!;S39H;YRJ^>S,M?P]%
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M8.3NC=KD=T/_V3K: 70<%1C0DP,'S0BKD4YZ>>\\-A+"[-QB;0UA+X&;J<$
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MC@)^1@3U%9BVODD9,=^4];=L;R',\N">=AL'+.:--<J):&RJ(K""FQW "D"
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MM+BL52N=N[]TKG!E,IK)FU6+TS#G:I1:W64P,/U]KW)O0:!$!](^A !1.Q8
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M"$N2&5FCI[0]QZV4-,9JK4O?)%6E\/C#@+U*_;)O?U*7AME_C,6?&XM<V\:
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MM0Y@I="X8"%E' X8QZKR,$_83$B:PY%2]%:[OU- _!]-4^MA$@0YS+\+6G;
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MG)6I%%@3]9%]K%5XIH[JDX/Y@AXZ364P=D!N\8<V[(+8GO,HN+]R^:6-Y_7
M*B>WX0#89*D]G(B>@B^;X[4(B#@3O%:01X32L;!/9#:_O/<!G=M=J^HI;V]
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M_NB'/ZRQW3_]%!F]US]>[@O'A.>S L_X7"OMM^/H#>,+.]@Y^ OCWR]FASH
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MH8>MSQ4-HW^@DI$XFY.^L+_>F&0G'IF.U<KHD$GK<#_"@P@8/X#BZK[#Y?[
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M4$8X\(J6@(*'1AQ+$[C7-%GHOP')'UA%KI$# QW4V+5YN9J.#CXP^"] *\&
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MZ!OU*;[38]XL==V@LS%&4$4)&O@778/LO2$4Z]/A"T"5?DI,2+F2>?6X]!D
MT9M-[RTGW5",WX*R%TM[6U+VNY-[X<!WB\KTFQ!"/W.EZ3DDKY=:67_+M= S
M$@6Q5,:^RP2"2!(&F<H2&#.2!J;D0AH)VP*"QP::FBYLL((6K'[Y#%Q-*>@
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M<J"5A>R[H58V%_53'Y]E1?.%%%V1!ZVC'N\?YV;;]U:JG.?5+(@SE9H4F##
M!"*6,4A-/5/.)$\4QBPC@5L<Q.E!IQ<;T6$&L@7MIDPL>+;3*'ZY&UBMK$A;
MU8QYM8$7M( ]5JBS9\>G@K$8=50M8\_"<U7C<.6992P_2+UIJNLY7ZNO9=,8
M8);0($Y(2K5]PDU<9R0@36,"><PPY9E,0DQG"VE9:.'H6&Y^L*$K'ZQ+-\X-
M5K T8&&AX&/9-0OI6>-R+\]VJN9\_L:N>UD#O6C*N!OV--BF6<@ -3"/D3)(
M-<R] [Y,7<QCLA^LD'GTHK[]A5FU]K)\U0])H>VDO\M5/=X921A6@@F8A3*
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M>M<69P@I3C =K5ZKOQD>OOCJQOP^*[TZD9FU6Y1?=*X&7JD]!&VNPC(WY+P
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M)>_+&18\EIDVF(+4A&WC!$&**-,_J2PB:<QQF+GLNPX/-;5]5UT-?@LJ^,V
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M6S3%D3[H-^]ZL=GJ&'$BZUS)IF,;%Q32#&'("45Q%F,2I:';BG)BQ.FM)&O
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M&@=6<;T8[)]:<9J301(EC@S[,FD/IWDXF,1@<6D/Z^;R[_E3T:Y6B :2)*&
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MB5/LM/GT@FIJ:KO&"AY78,&M1NOH+O,S75X,4O^3, DK=2T6:"9L+1@PDET
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M#E$86>VM[(:;F@;IRLTT#7=JS!=-'=,2;,!VKLMSC/'CNL0_CP.KDW,I[%/
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MAH$I/B NGL$)/BAC>1HG]L XNC)'GKCCKM&QP(SH:AV9WVW7[=B#]W,-F63
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M2G!&81R@&"+C:L0909 '$H4X"Y"(B$N@U,:]IQ85U:3".\<0[&/-SLSJR<7
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M7\"FYA]9+\^.M;Y]392=XGH)^@?6<77WDK4<%V E(]1V)BRI:6+2X=]TDE^
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M@D6&56'\0_K;RR.]P.NM$E0RCXL\B2@F5E7#+XXPM8]P*V3;RDX;HP*\ZSL
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M:ALM0UD:48$20?@-L68#P1Z3H(]"RP00M<BF+J"6V3?>EI3M$\70['T45B9
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M##XU%NE60SJLRFQD!T>5FWT6Q!Y6)2D0U('IQZ( =MBR20-@&Z_@]:L641J
MC%N!:R\EE>K-V/FSXCO^HY0_:T8U^[2U,D<\6O>W6AQM>-&O]&7UO/EFP@OT
M7[F^;!YE/(URP:'@"89(,@$Q+QBD68J)E%&>":M6REZEFAHS-A*".BX#O*$5
MH.:TV$AJ6:_6[YQ9^+!>8R8"$V<3*U/K!+I*F8W?3JW&R[-3#&PUFX%V#FOE
M9J!5[S5FS\'%]AJS.))3;M39=//G^4:]UP/H;;#Q?(:^\3GP,GI_N+?VB-\D
M7STL3;WW[I%\<\"X=7+<+<6V(9E9_JM*?TKB[?-ZK6_H_H%S4S&^TF+7M8@*
MR1,4Q3E4A!&(4KW^,A''D.;ZXQ&"8*IW(6W8Z/U-_17#*6'%,8<1L/<C+-U;
M*4U71B/FS5T9 [X&=ON>Z<WJ:W:"W*M^&"G3*+_W"9N FHZ:H 5@!EH(NG\T
M:U#[UGR]\M;X:"89?O8"MZ$,J,!K-[ ,/S<6K2]'$.*6Q/-N>40IVZRC)(\R
M6J@4)G58,4(IQ$6602J(*'"&,J$&)$N?&VIJF\5_E/]A3I_N?\@U?9+/FY(W
M95+_94C>]%EL[=8)/X@%)O5SE66E#)#8=1T-_PG59T=[A;3J/JW/)U?WWC&\
M7.%]6_5L'A&B)%<(XDQ0S0Y$$T.B_R>3199F1<9):N5U.O?PJ?'!ON*>:2GI
M7HMP!YK=9S\4BL ?^F'=0;^%!H_5]5U></?\T8L*'FMVKI3@R37#OD]3/Z4N
M1O.NK/AB94[FJEULJRPXR7B>0Y;(#*(XR2#),J4_6BHYIXE2;@6K^@:;VO=;
M%Y:IA04=:6W"9=UQMOO$?:$7^),?#IPS"]@@XI,5>L<;E25L-#]F#:M[AB8"
M=?IP,*(8,@=*&!<0<?T3B7@*$<U%)/*$Q(E3)?.A?3)&X(B.:*X9.>X=*Z;9
M4>(Z  .29 (W8WBU9@D6S0Q\-1O0.\^UI)5\)YO_?ER^DTJNUU*TM<CG7/!$
MRB2'*3%EPW&10,)S 8L\BEBA\CC"3L;XU1&G]O5NQ0/K1C[GIC97 +;]L#W"
M%OQS;V0$;[;2_@+*)=@!^>T*D$/ZOMB!X[E;RY5!Q^ZQ8H?!F<XHEC<.HY@[
MKI];'],]FF:U_]7V.C#61>ULO%N*KVOY6#X_5MWUCN2J$"A5$$NSJ6 H,[7)
M4XAC)#+%"JZ2PJUZRS!!!IQ<A3ZTZHA?9T$U0H,WHM7D%Z#_4';[,"VEHVMA
MX*39<5G B1B'X'8*@#==%7XQL['3HCY4VNHQ T%LH-N0],F& R49E2)O0^N8
M-V]\VC R??M<;5:/<EW7B3%I5C_*IVTI-T)QBBC)8"(1ADBDYCPE8=I<2VD1
MXT@E*G*KG- SFLO7.$ZAA*VP34&KK;1NM-<'+TH)YJ9&<F%:<R-NJN"31.]?
MDX(2KK'-,N)B"'L"=PP3> ?MMS#0VBT;G@ +O#:<QRK F94%'#X)OF^X45G<
M0N]CJK:Y9:!Q>Q3#O8_N/HSUUN0LBRS"$<2%4IH]HAR2F#$8Y9PRRO-84B<?
MN>W 4Z.2VTN&6T-N:8P& #(PQ5@DB7@T,1WQ\6I4VHX]KAGIB,B)X>AZ_]"^
M/OHS,S9G<VAO F972V."U@F;3/(XQBG5)J));2MHJG]B%!;:>%2,9"KE3A$X
MO:--CH2:N)*]D(.28?L!MF,?;[ %IAQGQ ;TD+% PF__F+X!1^X=8Z'[:=\8
MFYL&%E_7V]5UR?4R77>G:<WT2"I>*,)AFL3F*"!&)ATVAHS*",N8XCAWXHRS
MHTR-*_9"@J:MTMV *LCG\;2CB)M1"DP-)P %J+O>!X'7JNMG!QJWYGJ?KB<5
MUWLOGDQR2W.E?HHL?YH[JWF6H"P5J9X EF@JH9EFD8ARJ!(E&$DBPMU.%<<0
M>FK,M$M#,([FYZ768E&?4NX$?O5LEM-YMZ.\J<UF8 8-G+NR+6'ZS>+-F$+&
MRL6IFGBBRJG<_]WS4R[.Q AI*9?''E[XY>-2+Y=U_O)G_3FV;:KR3"59%&50
M8B[U3EC_#XT+"2.94QX5/(MSIZ7HTD!36SYJ+])>T!DPHCKV_+H*KAW?^X!L
M#)^;.UJ#"K#T0>&[V,K9L48OK-*G\;DB*KW7A_#D_T8W[;^^K1;Z*0__6]+U
M_9^K^Q_KU?/#CP_E3]D> YO4]&KS*ZW*:EXPR@A#$DK3Q!EIJQ:27*90<"Y8
ME'+$E5.)R@ R3HV5[M3&5&-=2O"BI0>;1G:@M/#U;QR-VA"SZN-<(?A<O?X1
MQ RT2K[HORYJYFNMU>]:7VW(;O\,WNF_:/.T 0+0^@WXHM^ %@Q@T  &(#/.
M%A5@8!GKF..FZ1KO1&28F!,Z/+D)9[=SEMN&<EMCJO5F_ENY+!^?'UO7GY0J
M8SC*(5**ZO])8\CR*(&Y2O,\P33/8F&S,IP\>6I\W@IGQ]JG./5S[4W:!V;(
M5BZ/WM"+VO80C+ZG0R[Z7\?$<OK04>C@HB[;C_CR!0/JX6TWF2^:"=ZN]&9T
M^:!-QSK)Z5OY\&-C]JU/=/GR_[R5BP7=-IJ-1"%EDD)99R%'M("8:^P8S:F@
MB'$D[6O?#9%@:I_R7FZPZ/B;(/BK%MJA6MJ@^>BG@E%0#DP9._%-DS30@;M)
MDVQ4 *T.LQ;VZP3C"7^'RG2AYV&D*G2#YL-3F;E;(.PM*3?HP>.5C[M%[X-2
M<3<]:.#)&5V8LG/??TBY^62F5[^=K1],Q(Q)I T\RAM/@()4" PY35"A(HQ1
MX>0)N#S4U%:-5E)0BPJVL@[T,_8@;'FRY 6WT.=! R%S/[RYBH;7(Y?+HXU[
M4')5ZY/CC>MW#(VS>6H;_WY1GU<;N2OVE[%8) 5C$$<FZS:)!:1I1"&E::%X
M'I$TIFZA-N<'FAI;[.4TN51+(ZEKI,T%1.WXP0=.@=GA$*):2/^%"*_AX#?H
MYL)8(\?=]&M\&GISY?IAC/#E2:ZI,58^F5S<G1'3'HK.:1+)A%$,"U$H;4=(
M!0E-)>29D+*@>FOJ%C?3/]S4V&$;T;#:2@T6=9YY9SOJQA97T+;C#'\8!F:.
MG:"@EG2V"QMYV06+^&,0.U1\\LB5$4=E$SOMCSG%\JXA'2':[BW&%7ZVAO;[
MO\R/YN]-?.O]ZOWCTV+U(J5)9'U7KB77\UT=]J@XZLR"J!(TPPQ29:IZI@F"
ME/ "8D;RF*99A++<+@%U-)E=OLZ1^GUW^^PT$7[FBU6K-;A4%=^E3\$8[X&%
MIVYJ<QN8><.H&Z03T.C3T]\ 80Q!1FR.,"*NAXT3QAQXP/JD17F4:U[2Q:>2
M&T$:']T<10G"6)D.;$Q"Q"DW6V ,N63:%&94+S*1]2',A4$F9^7NQ-2&;2UG
M'36QVOR0:R#U:[9Z+#E8U[([E';IQ=F"LCV@%YAE+TCHB1.OZ-]+8Y?N'8]Y
MKDA_0!;7KAWP?3=>]E_+5<5+J:6M/B[YMFR)$$0@P6%">*RWM$D**396(XYR
MEJ=)FB7VYZR7QYG:5^Y\:-H#H<77ZP>8P!]P>Z+9D;*IC3_DC+,'+H>33#^P
MC71>>0D^3P1X'8M>#NRY?3P:O*[# 1-:7#Z #-__7#W*W;DZ82+.4!'#-!61
MWC5G"N*\T%MGI@2).,Y1;%49Y/314Z.\5CB'C_@0*0N:&ZQ_8&9KY1I"9(<8
M.'#78"Q&HJMKKX,;.YW5MI>0#N\8CX/.2GI .^>O&%@Q;K6L2W<_TT5CQK4O
M4I8RS#$6IE0_TF97D4&<JES3CN8<O>6*<VD5@7IEG*EQ4$?,FPK%74 UEJ9W
MD39F)3=EGHB,("81@4DFLUB#BI"P=(%ZQ'6D^GL=9&^I$W<!6;NS& ]H!=^D
M=F!J(L@"U(;KA\%K7;@+0XU;$ZY?WY-Z<%<N'UAPZ7QSTG7=&-JLI[^^["_Y
MVAP>U\ZVIH#+/J>M^F)</?<_Z/++4_T5?5BME2PWIA/#/Z416(H[_5'3!_DW
M_?"-R9_9=6V8(Y;*/"52<TXF(9*40RPC"4F.,HQYGI$\=:KL- FUIK:.M+)+
M =[\_OV=:?@-*H."9<OO:8%K6ZQJ$L).B,N; SEV<B '.I@ ]@*ZU[6X-&6$
M9J MK-7!!M3@@(U&![3PS$ 'H!G80@1:C$ -4IU&!_9M=3R6YIK4O'NM 38-
MS<8M-C8-G2\LS1.3SLT2$+*<OU]N:CGT(J0MC/*GU ^FVX"B#*N"1GD!,QSK
MM9D8-T_*,JAX+E!.&<H*J[7YVD!36RT;64%'6,-6]&K4D1NZ_:N83\Q">XL&
MPF7-[+98[+FVVI)M)?F_/*Q^_D_]B(9G]0_']'KU\:,0GJV26PJROC[0]J"Z
M1&TM@;W_RQS*5<8)_56NRY4XHK'MW[^N2R[G253$+$D+R(E),\9) FF>YE!E
MA$N>Q5$JA)LG8EP%IN?@:+4 LA4SM.GO]WWP9.*_VAQ/P)2OKMCR.VM]!X)I
M>]7 <,9JWUX%:BQ&-->#S.&H9KE?#:9E?@>9'6<S.XP40[.DZCYD^T:X29SC
M1 H$"3:]P=*<0<+,FU2HHB!I1/)4NJUMQT-,;_792OBOKOE01]C9K0.WX!&8
MJ;>B!6D5?$EOO_E.1V.,G.=T7L/3_*8+U_EK(+Z/&,\0Q0P5">3:+H6(D@A2
M@A7,428S03A.L6/KJM[QIO=U=[IA_R:ID79 N^!^C.T^?&^X!6:!2^W#O<;"
M.X$2NH/XR/'J3KK;]!"_-4Y\^^S/<O.65C^^KE<_2R'%KR^_:POEXW*7.W5G
M]NU-0=GMFB>Q8(P7$60RUWOA(DX@D075YD/$&<621EGA1B_N0DR/<XP"0"U6
M?U; 3'LGJY+NI'>T-@;,C1TMA<4[,%=IX4$-]E9\LX]\8S30^\-?P#XM<Z]%
M$.-F.(@^N6V %*,2WG"4CEGPAB<-;?FDZ?7':J'OJ)KS$).9ON?@O3' (J*?
M@*6VL)AF1(%S2"4F4.:*QG$44_UK1^^@[=C3(\*NZ/^C/9%U;05E"[RE&RX$
MF*$]:&=0K,M3= RT0/:9,UQ^^TC9#CYR3RE'3$[[2[D^8"!IM:F)7]1YIU0M
M1^MU:AGSY2CA.*%)4;"<04Y0 A$3"60(Z<G"*2](CEF,'?U!MPLU09KK9)8W
MG9H:!<!7?=G6]G EOMLGSY(11YV0$0\;=F<(>]_K]B1AMIN4()G>_J'U2JNW
M2S4NWWI#\82(_3UY2.W<YZ=R^95N]'OY<:G69?N.ME'92:2-R"(A$"-<0)2E
M&.(X8K"0D:!%G&.49/9%<ON&FEI(2RTL:*0%77%=ZK#V8MM/C'X1"TQX%\$:
M5+VV%S67,K6^T!NK'JWS*^=8<]8&C_[BLKU/&+&*K(TFA^5BK>[P&?G3,/;=
M4GS4^BQ-K)&QPZJOJT7)7^81BB22C,$\(=JDE2B'6%*]01<(*<&)RHGK!MU=
MB@G:L#>50+IE0BS-U+ @OZY="OYH) YDA@Z'+GSL2;\8$P@@L<+)+@K$[E$#
M3$F?70+WG6^-BW6N$!)Z[T]AGA,3$<(HI$@QJ+DRQQ2)%%%D;8>&DW-J1FRG
M=S/7XCD880'GTL+NG<8,!6;C0&UA.W/^=C)S[F"U3V/N1S+Y7_D=<-L_A)^9
MWLU'P.''V[F$Q_!@VS/"<.ZMTMX^/SZ;^@$_Y7NE)-\T :9?U)U8-::)^/?G
M:M/9\W,<D2P6Y@S3=%.C>N''2B*8B#S)<482A:V[J;D./K4E?2^??<\U9\#[
ME^C0, 9>=_>B@T;V61O#7Y?D;>6?@;T&GGN\#87NUC9PSN..UBEN*"+=9G*#
MGS%@H[-_5G6_NA.B- /0Q5=:ZCW56_I4;NCBPVHMRX=EDUO&7^[U+KMJBJ;L
M[YYG*<),H1CFJ:FHS1)33#O*8)0RQA632*56^:)>I9H:X[4R ]X*#39[J0%U
MI$._\V>QE7F-60E,H!V5P&8%]DH!HY7)B6KUJNL:U'.W50UT= .N2YG?N7/8
MDKS&'(ZT 1EQ+MTV&[XQ[]U:>!MLO(V$;WP.M@W>'SYDD>5\_6SB*7_J!ZW6
M+U_U*_^#5K*:"ZPRC@B%,F<I1!DAD$6)@&D:L2+!DC*A[%?-2\-,;1EL!=6?
M9"LI>-J*ZD*?%U&U6<M\8!5Z<6IAV@D)OGJ%R679\ '76.O  -@<"?T:&OT,
M??'N$2GWF@:'''KUZJ'%9[[)A]+$DR\WG_6,SC7;%5$A*8RSV-!AD4 B9 &E
M0JE0:4Q0;A6C<VF J1%A(R/8"PF,E*XU9HY [&<_'] $YCU'5 :4DCFO^LTE
M9(X>.W+IF/-*G9:,N7#=P$;"K5>V=K=6M7'U2?_BXT8^5O.<FBI2108IQQ(B
MC BD&4^AC% J:6[J]EI9-S:#3>W3WAV'=(0%?QAQ02VO:SOA/ISM CY\H3?6
M6:(S<.Y-A2T0\=I6N&^\<1L+6VA^TEK8YAX_L18?UO(_G\U6[(NJT]+:]J7W
MJ[/MT?_>9'[,<ZQQSZ,,I@E&$"6<05ID,4PX$05#4:P$OB6R8I!44^.EG1+F
MB,!$4H!=C][-"KS]QS?0)M+<=MH^; :'Q5,$GY=7B9XXF*@F)[<[43O5VM("
M;8'NO[_>Y-T6&!%\$E\U#"+,9-X<\W 3Z*X1#L,&>]5XAIOPN1:]<-O#AZ9=
MTTT=(/M%G29-.A8ZL'K6A&AV)^\NJ_ X!3A$)0,GE/PF^]H,/'*BKP,6ITF^
M+C>/W!>AS6G[\KRI-G0I]-?;5V3NVVJQ4*NUN7%.$J)$@A/(9($AHA)!4NA_
M%I&01!*B<N6T1QY?A:E9N%NQH6/URJF\$9;L.^EY#DWEMW<SV%5 [0!QM?)I
MF!7BU69R$OT)AFLQ@5R6,6;)6]^!VR49MJK6[0T^KY:[JET?EWSU*-L^WCNK
M$^4DRW.50,05AR@A!-(DES!.:)%D(DDX3=WR".T&=N&UD<IWUVU5REI8\$8V
MXO[B6.#,$G6[U<8_DH%7B ;"KL3@8XMG*_0O0<C<#2B?!&PY\JBDZ8;&,=$Y
MWCVT8G,E]4T_[I;BG?PI%ZLGPY?M&&T,N<HR(12-88&D9B9$<HA5$<$\X<96
MCZ22V+6(\]51IT=+WW]]"R#8BEZG[(B]\*#E*<=*L#;XVW&49TP#$]0!C!UY
M02MP@%:+#@#Y+2)]?=B1ZTI;XW!::MK^UF%\U/@SODO^O*XSEMI/(-5ZYDAH
MXBFPIJ!89I"F:0QYEA(2YS31+.3B)C@_S-2V\F]7ZZ?5VC2+DXV'KMH)[,8R
M%U EF6 HSC!,1&).#$4!J20%E%@F1!&98]?:DK?C.@Z7FUBN-B6H7()_E/]A
M+"2]NC[J371EW&M>\+4C[MLQ"\S5K7MX+V$ <NX'P2<?7QAI5 KNU_:8=:]<
M/;SS'6_YI2Y-IFGF[>IYN5F_O%T).8\SEO%<13"E$D.4%P+BC">09:Q(8APG
MIJR-8P.\GO&F1KWOMXW=.C+/0"VUAAFTD@,CNGM/O#[<^SDC )JAR<,#D(.Z
MY5G XZ%I7M\HH_?.LU#Y7 L]F]N&67-WG)MG5=\DE^5/DYUN*FVW32"9$#FC
MA8(9,PXO%2%(,[VMS(I"2DP*FG"K7'";P:9&+UM9P7HG[ PLI67ZG!6\=L:'
M+] "L\@.KV\=O*C24P7N%HO5GU1_(T 9/EE+46[ IU55S?QUX71!RZ>MTCO>
MJ!:+C>;'=HO5/<.(Y9UDFWT'X;<K;<ZO-Z6II*KAK\S9^/V:&A?_._I2S25/
M,48*PT)FJ:DZ'>G=(\YAK$Q>=E;0O+"J.35H]*E1STY&DWUMA 1"2^E&/&[P
MVS%1,% #4Y.1N],5?@8ZHL_ 'NU6>O"N#VUG1AJ$FD^*<A-@5,X:A,TQB0U[
MR$!SR2)9MSX5F*<R201C FKNBC2C80$I3QA$>F\69P5)$EPXV4ZV(T^-S;Y)
MVLF36*FMITP\2Q-:JE_:% CSA<J_S!&*OO)'\Y5J8\M<OJ%_.=I<UG-D:8"%
M0#ZT-69?:J 6W:,!YHJ65VO,>O!Q33-73$[L-.<'#$AS^4UO+-<E77RG"UGI
MAV[*:K78UJ97*"DDH1!K6H.(* I9GJ10B*+@4M((I\C.#WUMJ.EYHK?R.:0L
M]$'93SH^X0G,,5LI02WF#&P%'5*'O@\PA[0-3\"-E(EQ"4!/Z1068/1F2/3=
M/U[2@X46!WD,-M?[V-%^DT(^UO%J3?6S=ZM'6B[G"!&A(I% G&"]D4U1"G&6
M%##.4"Q)C"41=/A&]OR@4[/X3O9;>[%WY?_^:$1W3#*VFH(AF]G;@1U[#SL$
MTQOWKOT@A=NR7ACW%7>J_4CT;U"OW#O </NXU%_U5[K>R.J;_%G*/[^HIOM&
MNX#*O. BRE+(N$ 098H;,X[7P6()XRK&(K%..[XRV-2XJ!87-/*"1F"SJ6Q$
M=C!0KF%L8=5Y1"XPV?2"-L2\NX:>@XGG$<61S+QAKZ";K6>)2J^]=^T9X]E\
MEMH<V'VV]PST^_VDY<*<CWQ8K8UE:2A]'^YQQWE3$5>*OZU75?7[<BWIPI3]
M-J=<OTJU6LM[^M<\2F4:4\GTWMET"I:(09+&$2QXSJCB&<Z4F"_E@WF0I5?0
MAUQ6WPQIOIFN=.$^F5I:\+P3%RSTOUU#ZOS,F:6/<+1Y&-'<W"LP SL%H186
M5M2<G'34 LV,[15KSW=9K1NX[_'ANGL8?6+MU?OH1;!Q/9,^L3SQ6GI]^ ##
M^/.SH?XOZFR]@N_:^I;5G*0,T31.(56:F)&(.&2%2&&2BCC#&$E!8VOCV&+
MJ1G(C<AUU8]_? .-C Z6G0W$%K:Q9^ "LV,'LPN%48+@Z& E>\9S)$OY9ES=
MC&8'D'H-9YOGC&<\.VAU8$"[W#<TH/E."/V^5%]7U88N_M_RJ8ZG94H5A*<8
M%A'-(,()ACB2!8PHDG%.4LR556.&_F&FQKMMU&TKZ@PTP@(M[:"0Y;/(]A.O
M/[P"T^U0J 8$)?<A<7,L\MF'CQR"W*?@:>1Q[]7#=M)'&?U;UJD+ G02_W^E
M5<E-$ENY>-97SQ.DS3.<"9B1(C/)#@H2Q!@4:2%S3C GW"E <)@84R.17340
MVE8#J8S\%5CM-0!OFM_]XK9Y'CA-=KOE\. '9J23*BQ[R^5[,P,'15MJ19H\
MVD85?YOAVZ#TN?L=*,FHV]W;T#K>W][XM!"GT/=_KK8E 9#(<)0BF&CJU%95
MAB$Q2;F1C%DFTT((8655.8X[-8:T.3?5POL\AM[/@8^3Z$'(3N P6LL=( G5
M$:OQSJ3W0T_H6/H$#[>3Z=/;!_C@FM38W^3FQTKL<[J;5?+[:B'FFHLT,44)
MC"DRAR)Q#ADN)%09IX(8ZXXQ:P?<M=&F1D]UH4A0F>R#<KF-C'ZLQ:^;#[49
M\&XVG!WN%EXYGVB&WB,VT#6R@KVPLZU!9N3U"9^#,\XGC"-YXFZ#T\T-9PM/
MKP_NZD/&<\#9ZG/@?;.^:0 %O_WRCX_O8G*:[+=+S/RP6C=IF>;HI2'_CTN^
MEK22[V3SWWDN,$D%2R&EN=Z!%[R ).<8*E[0E,292I%]\P(O(DV-S#M9%O0@
MY94W*:_-(;9)*#93)_0/S=FI*;!N\( Q<6 H/[-JL0J,/E>!EXHMUO4!]FG.
M<D^V<FO:;G4#;[;:N2S,?N;-8?D9??Y&6J-&G4>W)<TKY+WKGI^1QEL<O2)S
ML(+Z?;*W9F-?URL][B-]3]?+<OE@QMT6ORWYG,<2YSS)81&E B)2Q! +'D.:
M*11G1'":.WEI7 68VA+:>$K?_/[]'7B2Z\:=[>BY=IX#.R]-2&0#+WCG&I9I
M$ERO0"T^V,IO>+&Q[UN7==!&9E;H!6YNUB_#:S<\LT+(H@F:W7.&,=[?5BOQ
M9[E8S$F1%BA+*!0QP:8$;0I9CA+(J<"%($QDA7*K5+A]M,N7-$Y&Z%8R-V+:
M0<4I%S(3,91$*(@R2: F_@SRE"<X(2IAQ.DL<PA08Y#YC3#9\?(0Y0/S[56]
MG>GS6$F?M+A[]JAT=ZS1,8V=_'U@OQS^0XKGA?RBCH-1]X&HGW9M2B.4%XE(
M%,19E$"DK2^($U5 (3"+5:1(4EC%@@X:?6I?KT4(^ WM8MTFQHX*@L$]QG&:
M#Z3=.[L,0<QK4Q8G <;MIS($FY-6*(,>XAY>^:YUN=ROZ;(Q^K[)I]5Z,Z>:
MT_)4:N!)HLTRSJ6FM$S 5!99+"(L16J5C]XWR.28JY43[ 4%C:3V4947 >VG
M(E\PA68<=X2<@BFO07!#*.7%1X\62'E-N6X8Y=5K0P0!W?U55G.:HCCC2'_S
M)#*>);TI8W&L8$%Q)#(N8I1%_N)_S)"3HP&;D@E&<*]%*&KP[>P5OY".8:3<
MAJ;G:)\N0.,%^M2C3BC&IXN"6WC/P9VW;J_.-W1[__BT6+U(68>Y?-6OX@]]
MQ5?]7IG4DJ8K7%4]-T)5]\8ZNI=_;7[5VO_'G O&*4HYE&F<:<LE4Y#)B$!9
M*)7E<2(CVY)C(T@[/1_55ED3D_R!EFO8Y%&U+?::)I/-V?-6[:J-4%Y+KC]+
MQV3KD&^"Z^[O56<W, UWI[6G>>A6V::---BJ"XR^,[#3&'14!G_42@.C-:C5
M#K+1##8Y8;:E_L5]I4UL,-PO;WG##7G;Z6RGQ?TWR5</2Y-T_E%H 4M5UB?&
M524WS0G*6HJ[I?BD?UTNFK1U(YP4GS7^39WTSM^:JK*9WG$G@F<PRRB!*)7$
M>!$I3'-2Q"IC41HAMRH?XPANQ7*CE@%I>F0N]G(..PD./-]NY\<3F,.13YT[
M&IM=PU9GT%4:-%J#K=JU*=)1#K2:S\!>]^[?O9<Q'G>Z0AQS!Y;\50['QYF-
M2T?J(XWN+?3H[:K:?%%;<9J,WMH11?GVS]4\3U/*"$L@0C&%*",19$6:P#1E
MTH3VDIA:=1&[48ZI.8],RC/D^PG?-H^].1;):E+<EI2 4(^U1AQ$)G4$!K7$
M0>.07" +'(YD)<IK1R6YX&41G.3TN&'4^'9!J^J+^B==Z^=NOJSKDB:=!-TY
MHFFD*5#"B"4I1#DJ(,V+#":: DFD4B12IW/_:P-.C>Q:07W4#;B*M1VU^40P
M,(?5HAIW3"NLZ9E8BSOK%@'P1V&VT/CDJJMCCDI*M@@<LX_U?0,KFS3/;7._
M.>5$,)Q#R3("41SGD#)>0!45$9)IE$KNV+GYX/G3<SAO2<2QSL@!:(7@,F+:
M^HPHY=HB1<RTNXYA+%.9QZ*(1)XY57D9"MDXI:F[':[_] "?';<.!B4PD6[Y
MTW_5@+,:>ZU]<C# N"5-SNEV4JGD[$7#:.Z^?-1<^4751IHR!4],K.:7]7>Y
M_EER69]_*\42FJ4,1E$L(1*%J3@O$IAPQF@:9XJZ56NR&'-J7W<CLK$+MD*;
MGXW8QD!H!1\4?V S 79,X!G6P/S@!5%G[G# R">CV P[*L\XX'#,/BZW#N.D
MXS2^C\L[SM?/TN3WK1Y-&6%9?:4OQD<W3Q-$XH(F,(N$,<S2#.)4%K# .,H8
M4I@*[L)-#F-/C:,:"4V'Q4Z7Z]KU_M0([$9,+K-@1U"!L U,5&?RBHV%UZ)=
M"PV^7@'8F:<&0.63KUR&'Y6W!N!RS%]#'C&D4M*E@_$[5FW6E&_F>1RK7.0"
MLHAHLZHP71@Y9Y D&5>(I"F1TKY4TK7AIL96?3$M+I5]KL+<STW^P0M,1WVX
M:7.I%=BEG<]U"%VJ(_F$<JSR2#="ZE@@R1:A_@I)5Y\R8HDD6XT.:R19WS7,
MBFRCE*H/J_7?I7B0'\HE77)MNM[Q3?FS/JF=$VI,1!7!/,,Q1#+/-1FG,2S2
M7#$EXAQQL@WNN;<W(BV&'A"><S_&06DKN8DDY?O>ZX"MM!EIFJ]K&>H*+*V#
M"SRU$^?HZ;*9'#NCTA?6X[#W#E^#82WO#.PD!GN1_5F2#OCXM"!MAAW5<G3
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MJGJS6%75+UV/U2U16^?1MN/=FQ$,3)U;^4Q<:.-VFH%:1H^%R/H@\%J/[.Q
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M+Q?EUF7::;&U]8R^_(V6RT^KJFHBC,WA_+;5SIQ(33.9S"!&<:Z-",4@CK"
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MYD+.F?[V46SE\.\98VK??",F:.6< 2.IQA$865V[3Y\"VD\ GF *_/4/0FA
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MR+BQM,=L?!,=>_3"P3OWSV*U?KU;Z'1K2ZY/K3SK1<=G-?A_6HNG<A8CGJ-
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MO4)#_*_]5#CVMQYI;&S_:K_-!_RI)VX8'"5/%.+/>F)4U9F]E=_+.I!SAJ-
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M@DS G.<(JK\0R:,TH9%58-SA9J8V?=$HP0Y,\*,":IDC^ BI9F)S/E6>Q64
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M#3$+K [>&[0Y-:FI4>F5$)O_G"^J+$D*LY[12XT:D ?UKW(-1)7'UTYU3/K
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M[3__I?V)^D,G7_K/?_E?4$L#!!0    ( .F IE)9[A5^PHP  %%R!@ 5
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M\.C=T-!\I/)P<3:!AE<7,#O'0_ OL^Z/Q9>S[N+23Z]'1D;-J F$<L6)9+:
MFI>;FRQ= D^Y-;VA8BL)NZ&C^1#E\>)M B6?OL!D<D-]"; R'BE).N/Y1[-
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M>,Y2%>?B)*G5#^EJQJ&KMSWUJ9D&[*4G_(E[NZZ 9#(SF3 GEEF>@J K 02
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MQQ990T496E(Z%HIR<Q'1_14)?^19:".$455"$0_)&#:$VH?F']]('BSF 1W
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M$D,1N5*W8='  5!!):H]K=-D]8!F;C_%/=?ATF\ .@\2952T;IDCD]'W*Z-
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MK/XN'3!"1&^1<"@&C;)XY 0 8EW,&;RPL-D1\HF 42_D[!;7IC\8) =2U]
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MI[D&8/CB'*;Q^A$7I9Y2))Y(YHHC%]*28+S#9>6I]4H"=;P&_K:3,VS233/
MZT%7#2#NKN+]@[^\O0OP(G,7;";:E-%.LEPW*0@EQY"&Y+1QM@K@ME(S;,O4
M9O!VO*8:@-MF*^L;:R%+IAP-!);3IXWTQ(L4B-(F>^N]974:4&TG9]A^I\T
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M9:4-Y&1,E023&P*&15$])7<]R+N!7>N99;;L-37RC ?0UJ(4G"+2!DJL0B-
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MF4@L,9K3?_O,J+T4?U!FU#Y::#4!QMG@DX=(D!&ZCK%F"43BMR:')'$E5D^
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M@+!,::+B_U_>FRVY>23I@O?S+CXG]N5FS$B*5-,.2^205-7<P6+Q('&4!-@
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MXPRG_-W)X+1#)5C0^SK6O2CJY.JR.T?:7KT=G K<N,R:R,@QQ! @,UN+RE3
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MN6X;H)^64\+;ILU@_NW&"YZ)5%8CLP&8IC)5,:I: Q>A#NA-&(LP5MQY;?)
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MX_)@Y76 S<MY(^?A[&*,TN6\\91<TBH"Q8DZ14D4B$5'*-);YC/C2C091?0
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MH0[J]J=^)M&]I+_^8R*##CH["RQ%#BI1ENF=5R!$8)$9BV1/[;F\HF?<$#@
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MDC7-^1I W)A:D[/M3J_?_=1MM_K=ZRMR_8G<]+I7[>Y-ZY)T?NNTO_2[_^W
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MTF*?9)EN*K^*.(JBJ]L&6R(:: @=-7O0#$M(IJC,@#'P!8"WY%(E#7F2SA,
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MN2=E",;"/258L!P<F7QSK"W=+#;TY8?;(%OQ:RWF+6Y_NZ(N">F8$<7&G$U
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MGI;]MH9W?*;!"T"@U?;/TT,.TPZ/IGKS+JC_AXP\S.0R"IDJ& "TP)AKJS#
MBL5V'*RQS;7)HKY13%#+'5E*,<=_+M,^V,A!IX O6@KNV^T0G0XU]SE5'!?
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M+3(P,C$P,S,Q+FAT;5!+ 0(4 Q0    ( .F IE+UD4,$BA$  %NX   1
M          "  4O1 0!L9VYD+3(P,C$P,S,Q+GAS9%!+ 0(4 Q0    ( .F
MIE*>+ADQG20  &"" 0 5              "  03C 0!L9VYD+3(P,C$P,S,Q
M7V-A;"YX;6Q02P$"% ,4    " #I@*92?ZQM@6MC  #>700 %0
M    @ '4!P( ;&=N9"TR,#(Q,#,S,5]D968N>&UL4$L! A0#%     @ Z8"F
M4C^.W(.#D@  *LH  !0              ( !<FL" &QG;F0M,C R,3 S,S%?
M9S$N:G!G4$L! A0#%     @ Z8"F4M[ :\WW]P  D%X* !4
M ( !)_X" &QG;F0M,C R,3 S,S%?;&%B+GAM;%!+ 0(4 Q0    ( .F IE)9
M[A5^PHP  %%R!@ 5              "  5'V P!L9VYD+3(P,C$P,S,Q7W!R
M92YX;6Q02P$"% ,4    " #I@*92PB%8B+<(  #".@  &
M@ %&@P0 ;&=N9%\S,S$R,65X:&EB:70S,3$N:'1M4$L! A0#%     @ Z8"F
M4E%V@;^M"   JSL  !@              ( !,XP$ &QG;F1?,S,Q,C%E>&AI
M8FET,S$R+FAT;5!+ 0(4 Q0    ( .F IE*5]4"5M 8  -0K   8
M      "  1:5! !L9VYD7S,S,3(Q97AH:6)I=#,R,2YH=&U02P4&      H
,"@"> @   )P$

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
